Citrus Sinensis ID: 048160
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 344 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LSV3 | 433 | Putative wall-associated | no | no | 0.918 | 0.729 | 0.355 | 1e-52 | |
| Q7X8C5 | 748 | Wall-associated receptor | no | no | 0.918 | 0.422 | 0.375 | 1e-51 | |
| Q9SA25 | 720 | Wall-associated receptor | no | no | 0.947 | 0.452 | 0.356 | 5e-50 | |
| Q9LMN6 | 738 | Wall-associated receptor | no | no | 0.901 | 0.420 | 0.351 | 7e-50 | |
| Q9S9M2 | 761 | Wall-associated receptor | no | no | 0.927 | 0.419 | 0.352 | 2e-49 | |
| Q9LMN8 | 741 | Wall-associated receptor | no | no | 0.944 | 0.438 | 0.353 | 4e-49 | |
| Q9LMN7 | 733 | Wall-associated receptor | no | no | 0.901 | 0.422 | 0.342 | 2e-48 | |
| Q9S9M3 | 730 | Wall-associated receptor | no | no | 0.895 | 0.421 | 0.349 | 6e-48 | |
| Q9LMP1 | 732 | Wall-associated receptor | no | no | 0.895 | 0.420 | 0.352 | 1e-47 | |
| Q9LMT9 | 764 | Putative wall-associated | no | no | 0.901 | 0.405 | 0.351 | 3e-47 |
| >sp|Q9LSV3|WAKLS_ARATH Putative wall-associated receptor kinase-like 16 OS=Arabidopsis thaliana GN=WAKL16 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 207 bits (526), Expect = 1e-52, Method: Compositional matrix adjust.
Identities = 120/338 (35%), Positives = 192/338 (56%), Gaps = 22/338 (6%)
Query: 9 ESSKKAEKRKFMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPEKVITKDLL 68
+ K +++ F KNG +L + ++ + FT +++K ATN YD +++ +
Sbjct: 60 QKDTKIQRQLFFEKNGGGMLIERLSGAGSSNIDFKIFTEEDMKEATNGYDVSRILGQGGQ 119
Query: 69 YKLYKGFLQDRPISVMK---FGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELP 125
+ +YKG L D I +K G N E++ N + SQ++H+N++K +GCCLETE+P
Sbjct: 120 WTVYKGILPDNSIVAIKKTRLGDNNQVEQF--INEVLVLSQINHRNVVKLLGCCLETEVP 177
Query: 126 ILVFEFVACGTLADRIHDPNGSQ-LEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDI 184
+LV+EF+ G+L D +H GS + +HRL++A+E+A A+AYLH G S PI+ RDI
Sbjct: 178 LLVYEFITGGSLFDHLH---GSMFVSSLTWEHRLEIAIEVAGAIAYLHSGASIPIIHRDI 234
Query: 185 KPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDV 244
K IL E AK DF S P K + V GT G++ PEY +T NEKSDV
Sbjct: 235 KTENILLDENLTAKVADFGASKLKPMDKEQL--TTMVQGTLGYLDPEYYTTWLLNEKSDV 292
Query: 245 YSFGALLLELLTGKRISYSSCFENGE--EYFLQELVRKSIESNSFKEIVDPIIVGEEGLW 302
YSFG +L+EL++G++ + CFE E ++ + V + E N EI+D ++ E
Sbjct: 293 YSFGVVLMELISGQK---ALCFERPETSKHLVSYFVLATKE-NRLHEIIDDQVLNE---- 344
Query: 303 PEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340
E ++++ +A++C ++RP M++VA +L L
Sbjct: 345 -ENQREIHEAARVAVECTRLKGEERPRMIEVAAELETL 381
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 204 bits (518), Expect = 1e-51, Method: Compositional matrix adjust.
Identities = 123/328 (37%), Positives = 190/328 (57%), Gaps = 12/328 (3%)
Query: 17 RKFMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPEKVITKDLLYKLYKGFL 76
RKF +NG LL++ +A G+ + F++ EL+ AT+N++ +V+ + +YKG L
Sbjct: 376 RKFFRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRVLGQGGQGTVYKGML 435
Query: 77 QDRPISVMKFGGNLNSEEYCCF-NCIAFASQMSHKNILKFVGCCLETELPILVFEFVACG 135
D I +K ++ + F N + +Q++H+NI+K +GCCLETE+P+LV+EFV G
Sbjct: 436 VDGRIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNG 495
Query: 136 TLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN 195
L R+HD S + RL +A+EIA A++YLH S PI RDIK + IL E+N
Sbjct: 496 DLCKRLHDE--SDDYTMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERN 553
Query: 196 VAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELL 255
AK DF S S+ +TH+ +V GTFG++ PEY ++ EKSDVYSFG +L+ELL
Sbjct: 554 RAKVSDFGTSRSVTIDQTHL--TTQVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELL 611
Query: 256 TGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTEL 315
TG++ SS + E L ++++ N +IVD I E + Q++S L
Sbjct: 612 TGEKP--SSRVRSEENRGLAAHFVEAVKENRVLDIVDDRIKDECNM-----DQVMSVANL 664
Query: 316 AIKCLSKSEQDRPTMVQVAKQLRQLHKS 343
A +CL++ + RP M +V+ +L + S
Sbjct: 665 ARRCLNRKGKKRPNMREVSIELEMIRSS 692
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 198 bits (504), Expect = 5e-50, Method: Compositional matrix adjust.
Identities = 122/342 (35%), Positives = 194/342 (56%), Gaps = 16/342 (4%)
Query: 3 LCLGTSESSKKAEKRKFMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPEKV 62
LC + +KRKF +NG LLQ+ + +G N + F++ +L+ AT+ ++ ++
Sbjct: 336 LCKANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDRFNASRI 395
Query: 63 ITKDLLYKLYKGFLQDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCC 119
+ + +YKG L+D I +K L N EE+ N I SQ++H+N++K +GCC
Sbjct: 396 LGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEF--INEIILLSQINHRNVVKILGCC 453
Query: 120 LETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPI 179
LETE+PILV+EF+ L D +H+P S+ P + RL +A E+A+A++YLH S PI
Sbjct: 454 LETEVPILVYEFIPNRNLFDHLHNP--SEDFPMSWEVRLCIACEVADALSYLHSAVSIPI 511
Query: 180 VFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCN 239
RD+K + IL E++ AK DF +S S+ TH+ V GT G++ PEY+ + +
Sbjct: 512 YHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHL--TTIVQGTIGYVDPEYLQSNHFT 569
Query: 240 EKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEE 299
KSDVYSFG LL+ELLTG++ S E L +++ ++ EI+D I E
Sbjct: 570 GKSDVYSFGVLLIELLTGEKP--VSLLRRQEVRMLGAYFLEAMRNDRLHEILDARIKEE- 626
Query: 300 GLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLH 341
+++L+ +LA +CLS + + RPTM V +L ++
Sbjct: 627 ----CDREEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRMQ 664
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN6|WAK4_ARATH Wall-associated receptor kinase 4 OS=Arabidopsis thaliana GN=WAK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (502), Expect = 7e-50, Method: Compositional matrix adjust.
Identities = 116/330 (35%), Positives = 187/330 (56%), Gaps = 20/330 (6%)
Query: 16 KRKFMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPEKVITKDLLYKLYKGF 75
+++F +NG +L + ++ ++ FT + +K AT+ YD +++ + +YKG
Sbjct: 369 RQQFFEQNGGGMLMQRLSGAGPSNVDVKIFTEEGMKEATDGYDENRILGQGGQGTVYKGI 428
Query: 76 LQDRPISVMK---FGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132
L D I +K G N E++ N + SQ++H+N++K +GCCLETE+P+LV+EF+
Sbjct: 429 LPDNSIVAIKKARLGDNSQVEQF--INEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFI 486
Query: 133 ACGTLADRIHDPNGSQLEPFL-MKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF 191
+ GTL D +H GS + L +HRL++A+EIA +AYLH S PI+ RDIK + IL
Sbjct: 487 SSGTLFDHLH---GSMFDSSLTWEHRLRMAVEIAGTLAYLHSSASIPIIHRDIKTANILL 543
Query: 192 QEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALL 251
E AK DF S IP K + V GT G++ PEY +T NEKSDVYSFG +L
Sbjct: 544 DENLTAKVADFGASRLIPMDKEDL--ATMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVL 601
Query: 252 LELLTGKRISYSSCFENGE-EYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLL 310
+ELL+G++ + CFE + + + + N EI+D ++ E ++++
Sbjct: 602 MELLSGQK---ALCFERPQTSKHIVSYFASATKENRLHEIIDGQVMNE-----NNQREIQ 653
Query: 311 SYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340
+A++C + ++RP M +VA +L L
Sbjct: 654 KAARIAVECTRLTGEERPGMKEVAAELEAL 683
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 196 bits (497), Expect = 2e-49, Method: Compositional matrix adjust.
Identities = 118/335 (35%), Positives = 194/335 (57%), Gaps = 16/335 (4%)
Query: 12 KKAEKRKFMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPEKVITKDLLYKL 71
+ + R F +NG LL++ +A G+ + F++ EL+ AT+N++ +V+ + +
Sbjct: 379 RSSRMRVFFRRNGGMLLKQQLARKEGNVEMSKIFSSNELEKATDNFNTNRVLGQGGQGTV 438
Query: 72 YKGFLQDRPISVMKFGGNLNSEEYCCF-NCIAFASQMSHKNILKFVGCCLETELPILVFE 130
YKG L D I +K ++ ++ F N + +Q++H+NI+K +GCCLETE+P+LV+E
Sbjct: 439 YKGMLVDGRIVAVKRSKAMDEDKVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYE 498
Query: 131 FVACGTLADRIHDPNGSQLEPFLMKH--RLKVAMEIANAVAYLHVGFSRPIVFRDIKPST 188
FV G L R+ D + + ++M RL +A+EIA A++YLH S PI RDIK +
Sbjct: 499 FVPNGDLCKRLRD----ECDDYIMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTN 554
Query: 189 ILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFG 248
IL E+ K DF S S+ +TH+ +V GTFG++ PEY ++ +KSDVYSFG
Sbjct: 555 ILLDEKYQVKVSDFGTSRSVTIDQTHL--TTQVAGTFGYVDPEYFQSSKFTDKSDVYSFG 612
Query: 249 ALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQ 308
+L+EL+TGK + SS ++ E +++ N F +IVD I E L Q
Sbjct: 613 VVLVELITGK--NPSSRVQSEENRGFAAHFVAAVKENRFLDIVDERIKDECNL-----DQ 665
Query: 309 LLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343
+++ +LA +CL++ + RP M +V+ +L ++ S
Sbjct: 666 VMAVAKLAKRCLNRKGKKRPNMREVSVELERIRSS 700
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN8|WAK3_ARATH Wall-associated receptor kinase 3 OS=Arabidopsis thaliana GN=WAK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 195 bits (495), Expect = 4e-49, Method: Compositional matrix adjust.
Identities = 122/345 (35%), Positives = 192/345 (55%), Gaps = 20/345 (5%)
Query: 2 SLCLGTSESSKKAEK--RKFMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDP 59
++C+ + +K K R+F +NG +L + ++ + FT + +K ATN YD
Sbjct: 358 AICIQHATKQRKYTKLRRQFFEQNGGGMLIQRLSGAGLSNIDFKIFTEEGMKEATNGYDE 417
Query: 60 EKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCF-NCIAFASQMSHKNILKFVGC 118
+++ + +YKG L D I +K +S + F + + SQ++H+N++K +GC
Sbjct: 418 SRILGQGGQGTVYKGILPDNTIVAIKKARLADSRQVDQFIHEVLVLSQINHRNVVKILGC 477
Query: 119 CLETELPILVFEFVACGTLADRIHDPNGSQLEPFL-MKHRLKVAMEIANAVAYLHVGFSR 177
CLETE+P+LV+EF+ GTL D +H GS + L +HRL++A+E+A +AYLH S
Sbjct: 478 CLETEVPLLVYEFITNGTLFDHLH---GSIFDSSLTWEHRLRIAIEVAGTLAYLHSSASI 534
Query: 178 PIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTAN 237
PI+ RDIK + IL E AK DF S IP K + V GT G++ PEY +T
Sbjct: 535 PIIHRDIKTANILLDENLTAKVADFGASKLIPMDKEQL--TTMVQGTLGYLDPEYYTTGL 592
Query: 238 CNEKSDVYSFGALLLELLTGKRISYSSCFE--NGEEYFLQELVRKSIESNSFKEIVDPII 295
NEKSDVYSFG +L+ELL+G++ + CFE ++ + V + E N EI+D +
Sbjct: 593 LNEKSDVYSFGVVLMELLSGQK---ALCFERPQASKHLVSYFV-SATEENRLHEIIDDQV 648
Query: 296 VGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340
+ E+ L K++ +A +C ++RP M +VA +L L
Sbjct: 649 LNEDNL-----KEIQEAARIAAECTRLMGEERPRMKEVAAKLEAL 688
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN7|WAK5_ARATH Wall-associated receptor kinase 5 OS=Arabidopsis thaliana GN=WAK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 193 bits (490), Expect = 2e-48, Method: Compositional matrix adjust.
Identities = 113/330 (34%), Positives = 188/330 (56%), Gaps = 20/330 (6%)
Query: 16 KRKFMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPEKVITKDLLYKLYKGF 75
+++F +NG +L + ++ ++ FT + +K AT+ Y+ +++ + +YKG
Sbjct: 367 RQQFFEQNGGGMLIQRLSGAGPSNVDVKIFTEEGMKEATDGYNESRILGQGGQGTVYKGI 426
Query: 76 LQDRPISVMK---FGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132
LQD I +K G E++ N + SQ++H+N++K +GCCLETE+P+LV+EF+
Sbjct: 427 LQDNSIVAIKKARLGDRSQVEQF--INEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFI 484
Query: 133 ACGTLADRIHDPNGSQLEPFL-MKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF 191
+ GTL D +H GS + L +HRL++A+E+A +AYLH S PI+ RD+K + IL
Sbjct: 485 SSGTLFDHLH---GSMFDSSLTWEHRLRIAIEVAGTLAYLHSYASIPIIHRDVKTANILL 541
Query: 192 QEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALL 251
E AK DF S IP + + V GT G++ PEY +T NEKSDVYSFG +L
Sbjct: 542 DENLTAKVADFGASRLIPMDQEQL--TTMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVL 599
Query: 252 LELLTGKRISYSSCFENGEEY-FLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLL 310
+ELL+G++ + CFE + L +++ N EI+D ++ E ++++
Sbjct: 600 MELLSGEK---ALCFERPQSSKHLVSYFVSAMKENRLHEIIDGQVMNE-----YNQREIQ 651
Query: 311 SYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340
+A++C ++RP+M +VA +L L
Sbjct: 652 ESARIAVECTRIMGEERPSMKEVAAELEAL 681
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 191 bits (485), Expect = 6e-48, Method: Compositional matrix adjust.
Identities = 116/332 (34%), Positives = 193/332 (58%), Gaps = 24/332 (7%)
Query: 18 KFMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPEKVITKDLLYKLYKGFLQ 77
KF +NG LL++ + + +G + F+++EL+ AT+N+ ++V+ + +YK L
Sbjct: 389 KFFKRNGGLLLKQQLTTKDGSVEMSKIFSSRELEKATDNFSIDRVLGQGGQGTVYKRMLV 448
Query: 78 DRPISVMKFGGNLNSEEYCCF-NCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGT 136
D I +K ++ ++ F N I SQ++H+NI+K +GCCLETE+PILV+E++ G
Sbjct: 449 DGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGD 508
Query: 137 LADRIHDPNGSQLEPFLMKH--RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ 194
L R+HD + + ++M RL++A+EIA A++Y+H S PI RDIK + IL E+
Sbjct: 509 LFKRLHD----EYDDYMMTWEVRLRIAVEIAGALSYMHSAASFPIFHRDIKTTNILLDEK 564
Query: 195 NVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLEL 254
AK DF S S+ +TH+ V GTFG++ PEY ++ KSDVYSFG +L+EL
Sbjct: 565 YRAKISDFGTSRSVATDQTHL--TTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVEL 622
Query: 255 LTGKRISYSSCFENG---EEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLS 311
+TG++ E G YFL+ +++ N +I+D I ++ KQ+++
Sbjct: 623 ITGEKPMSRVRSEEGIGLATYFLE-----AMKENRAVDIIDIRI-------KDESKQVMA 670
Query: 312 YTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343
+LA +CL++ RP M +V+ +L ++ S
Sbjct: 671 VAKLARRCLNRKGNKRPNMREVSIKLERIRSS 702
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMP1|WAK2_ARATH Wall-associated receptor kinase 2 OS=Arabidopsis thaliana GN=WAK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 190 bits (483), Expect = 1e-47, Method: Compositional matrix adjust.
Identities = 117/332 (35%), Positives = 187/332 (56%), Gaps = 24/332 (7%)
Query: 16 KRKFMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPEKVITKDLLYKLYKGF 75
++KF +NG +L + ++ ++ FT + +K ATN Y +++ + +YKG
Sbjct: 363 RQKFFEQNGGGMLIQRVSGAGPSNVDVKIFTEKGMKEATNGYHESRILGQGGQGTVYKGI 422
Query: 76 LQDRPISVMK---FGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132
L D I +K G E++ N + SQ++H+N++K +GCCLETE+P+LV+EF+
Sbjct: 423 LPDNSIVAIKKARLGNRSQVEQF--INEVLVLSQINHRNVVKVLGCCLETEVPLLVYEFI 480
Query: 133 ACGTLADRIHDPNGSQLEPFL-MKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF 191
GTL D +H GS + L +HRL++A E+A ++AYLH S PI+ RDIK + IL
Sbjct: 481 NSGTLFDHLH---GSLYDSSLTWEHRLRIATEVAGSLAYLHSSASIPIIHRDIKTANILL 537
Query: 192 QEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALL 251
+ AK DF S IP K + V GT G++ PEY +T NEKSDVYSFG +L
Sbjct: 538 DKNLTAKVADFGASRLIPMDKEQL--TTIVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVL 595
Query: 252 LELLTGKRISYSSCFENGEEYFLQELVR---KSIESNSFKEIVDPIIVGEEGLWPEKEKQ 308
+ELL+G++ + CFE + + LV + ++N F EI+D ++ E + +++
Sbjct: 596 MELLSGQK---ALCFE--RPHCPKNLVSCFASATKNNRFHEIIDGQVMNE-----DNQRE 645
Query: 309 LLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340
+ +A +C ++RP M +VA +L L
Sbjct: 646 IQEAARIAAECTRLMGEERPRMKEVAAELEAL 677
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 189 bits (479), Expect = 3e-47, Method: Compositional matrix adjust.
Identities = 117/333 (35%), Positives = 191/333 (57%), Gaps = 23/333 (6%)
Query: 15 EKRKFMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPEKVITKDLLYKLYKG 74
KRKF +NG LLQ+ + + G + F+++EL+ AT+N++ +VI + +YKG
Sbjct: 412 RKRKFFKRNGGLLLQQQLNTTQGRVEKTKLFSSRELEKATDNFNDNRVIGQGGQGTVYKG 471
Query: 75 FLQD-RPISVMKFGGNLNSEEYC--CFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131
L D R ++V K N+ E+ N + SQ++H++++K +GCCLETE+PILV+EF
Sbjct: 472 MLVDGRSVAVKK--SNVVDEDKLQEFINEVIILSQINHRHVVKLLGCCLETEVPILVYEF 529
Query: 132 VACGTLADRIHDPNGSQLEPF--LMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTI 189
+ G L +H+ + + + L R+++A++I+ A +YLH PI RDIK + I
Sbjct: 530 IPNGNLFQHLHE----EFDDYTALWGVRMRIAVDISGAFSYLHTAACSPIYHRDIKSTNI 585
Query: 190 LFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGA 249
L E+ AK DF S S+ TH + GT G++ PEY +++ EKSDVYSFG
Sbjct: 586 LLDEKYRAKVSDFGTSRSVSIDHTHW--TTVISGTVGYVDPEYYGSSHFTEKSDVYSFGV 643
Query: 250 LLLELLTGKR--ISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEK 307
+L+EL+TG++ I+ S E E L + R ++ N EI+D I + L +
Sbjct: 644 VLVELITGEKPVITLS---ETQEITGLADYFRLAMRENRLFEIIDARIRNDCKL-----E 695
Query: 308 QLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340
Q+++ LA++CL K+ + RP M +V+ L ++
Sbjct: 696 QVIAVANLALRCLKKTGKTRPDMREVSTALERI 728
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 344 | ||||||
| 255582635 | 331 | receptor protein kinase, putative [Ricin | 0.941 | 0.978 | 0.531 | 3e-92 | |
| 224123144 | 344 | predicted protein [Populus trichocarpa] | 0.976 | 0.976 | 0.497 | 2e-88 | |
| 255542662 | 330 | serine-threonine protein kinase, plant-t | 0.941 | 0.981 | 0.496 | 4e-78 | |
| 255542656 | 331 | serine-threonine protein kinase, plant-t | 0.947 | 0.984 | 0.452 | 1e-71 | |
| 255542658 | 356 | serine-threonine protein kinase, plant-t | 0.941 | 0.910 | 0.441 | 4e-71 | |
| 359493231 | 497 | PREDICTED: inactive serine/threonine-pro | 0.953 | 0.659 | 0.412 | 4e-61 | |
| 296081092 | 1111 | unnamed protein product [Vitis vinifera] | 0.970 | 0.300 | 0.408 | 8e-61 | |
| 225460075 | 380 | PREDICTED: wall-associated receptor kina | 0.889 | 0.805 | 0.425 | 3e-60 | |
| 297740944 | 375 | unnamed protein product [Vitis vinifera] | 0.895 | 0.821 | 0.422 | 4e-60 | |
| 297740943 | 321 | unnamed protein product [Vitis vinifera] | 0.909 | 0.975 | 0.425 | 2e-56 |
| >gi|255582635|ref|XP_002532098.1| receptor protein kinase, putative [Ricinus communis] gi|223528232|gb|EEF30288.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 344 bits (883), Expect = 3e-92, Method: Compositional matrix adjust.
Identities = 176/331 (53%), Positives = 237/331 (71%), Gaps = 7/331 (2%)
Query: 12 KKAEKRKFMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPEKVITKDLLYKL 71
KKAE + L NG+ LL+KLIASC+G NPI+ F+A EL AT++YDP K+IT+D YKL
Sbjct: 4 KKAESERISLMNGRMLLEKLIASCDGRCNPIRIFSADELSRATDDYDPRKIITQDSGYKL 63
Query: 72 YKGFLQDRPISVMKFGGNLNSEEY-CCFNCIAFASQMS-HKNILKFVGCCLETELPILVF 129
Y G L +R ISV KF SE+Y C+N I FA+QMS HKN LK +GCCLET++P+LVF
Sbjct: 64 YNGLLHERTISVKKFKDK--SEQYKYCYNDIMFATQMSKHKNFLKLLGCCLETQIPVLVF 121
Query: 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTI 189
E + GTLA R++ PN + +P L +HRLK+A+EIANAV+YLH FSRPIVFR+IKP I
Sbjct: 122 EPIEYGTLAGRLYGPNKTLYQPLLWRHRLKIAVEIANAVSYLHTAFSRPIVFRNIKPLNI 181
Query: 190 LFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGA 249
E +VAK DF +++SIPEG++HV D + G +G IAPEY T+ NE DVY+FG
Sbjct: 182 FLDECHVAKLSDFSLAVSIPEGESHVKD--MLAGAWGLIAPEYAKTSCFNESQDVYNFGV 239
Query: 250 LLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQL 309
LL LLTG+++ S + GEE L + V+K I + F E VD II+G EG PEK++QL
Sbjct: 240 FLLMLLTGQKVVDSYRPQAGEELGLVDHVKKFIADDRFYETVDSIILG-EGSLPEKDQQL 298
Query: 310 LSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340
++T L+ +C+S++++DRP M+ VAK+LR++
Sbjct: 299 QAFTLLSFRCISEADEDRPMMIDVAKELRKI 329
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123144|ref|XP_002319005.1| predicted protein [Populus trichocarpa] gi|222857381|gb|EEE94928.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 332 bits (851), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 171/344 (49%), Positives = 238/344 (69%), Gaps = 8/344 (2%)
Query: 1 MSLCLGTSESSKKAEKRKFMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPE 60
MS C T + KK K +KNG LL+KL+ C+G N I++F+A ELK ATNNYDP+
Sbjct: 1 MSTCWETKKD-KKVNKETAFIKNGSKLLEKLVDICDGKCNSIRSFSATELKKATNNYDPQ 59
Query: 61 KVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCC 119
K++T D YKLYKGFLQ RP+SV KF + EY CFN I +AS+MS HK+ +K +GCC
Sbjct: 60 KILTGDSGYKLYKGFLQGRPVSVKKFKDDDEQYEY-CFNDIVYASKMSVHKSFMKLLGCC 118
Query: 120 LETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPI 179
LE +PILVFE+V TL+D + ++ +P L R K+AM++ANAVA+LH FS+PI
Sbjct: 119 LEARIPILVFEYVGDWTLSDFLWGSEEARCQPLLWIPRSKIAMDMANAVAFLHAAFSKPI 178
Query: 180 VFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCN 239
VFR+IKP IL + + AK DF +SISIP+G++HV D+ V G G IAPEY++T N N
Sbjct: 179 VFRNIKPLNILLDDNHEAKLSDFSISISIPKGESHVRDS--VAGATGLIAPEYLTTGNFN 236
Query: 240 EKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEE 299
EK DV++FG LL LL+G+ + S E +E LQ+ V+K IE + F +++D I+ E
Sbjct: 237 EKQDVFNFGVFLLVLLSGQMVVDFSRPE--KEILLQDHVKKCIEDDRFNKVIDSTIIA-E 293
Query: 300 GLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343
G WP KE+QL +YT L+++C+S+ +DRPTM+ V+K+LR+++ S
Sbjct: 294 GTWPGKEQQLQAYTALSLRCISELAEDRPTMIDVSKELRKIYWS 337
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542662|ref|XP_002512394.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548355|gb|EEF49846.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 297 bits (761), Expect = 4e-78, Method: Compositional matrix adjust.
Identities = 164/330 (49%), Positives = 214/330 (64%), Gaps = 6/330 (1%)
Query: 15 EKRKFMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPEKVITKDLLYKLYKG 74
E ++ L NG LL+K +A CNG NPI+NF+++EL+ AT NY+ ++V+ D ++LYKG
Sbjct: 2 EVKEAFLINGSKLLEKSVAFCNGRCNPIRNFSSEELEKATRNYNEKQVLKLDGYFELYKG 61
Query: 75 FLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCCLETELPILVFEFVA 133
FLQDRP+ V KF E N I +AS MS H N +K +GCCLET PILVFE
Sbjct: 62 FLQDRPVIVKKFLEV--GVEQLAINEIVYASAMSVHINSIKLLGCCLETPSPILVFESAK 119
Query: 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE 193
TLADRI D N EP K RLK+ +IAN V Y+H F RPIV R+IK S IL E
Sbjct: 120 EKTLADRIIDRNDDHFEPVKWKLRLKIVADIANVVVYIHTAFPRPIVHRNIKASNILLDE 179
Query: 194 QNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLE 253
VAK DF + +SIPEGK+ V D + GT G IA E ++T NEKSDVYSFG +LL
Sbjct: 180 DYVAKLSDFSLCVSIPEGKSRVRD--IMAGTMGLIASESLATGYFNEKSDVYSFGVVLLV 237
Query: 254 LLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYT 313
+LTG+R S E GE++ L V+K IE+ FKE+VDPIIV EE K ++L +
Sbjct: 238 VLTGQRSFDFSRTETGEQFLLVNHVKKHIETGGFKEMVDPIIVAEEA-GNRKGQELEDFR 296
Query: 314 ELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343
+LA++C+ S ++RPTM++VAKQLR ++ S
Sbjct: 297 DLALRCIHDSAEERPTMIEVAKQLRHIYLS 326
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542656|ref|XP_002512391.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548352|gb|EEF49843.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 276 bits (706), Expect = 1e-71, Method: Compositional matrix adjust.
Identities = 156/345 (45%), Positives = 213/345 (61%), Gaps = 19/345 (5%)
Query: 1 MSLCLGTSESSKKAEKRKFMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPE 60
M C G S+ K +++NG+ LL+K +A NG NP++ F+ +EL+ ATN+Y
Sbjct: 1 MFSCFGDSKYEKA------LMRNGRSLLEKSVALNNGRGNPVRCFSVKELQNATNSYSQH 54
Query: 61 KVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCC 119
V D +LYKG ++DRP+ V K+ SE+ + I AS+MS H+N+LK +GCC
Sbjct: 55 NVFYIDGTCRLYKGLIRDRPVIVKKYDYKHPSED--PVSDIVIASEMSVHRNVLKLLGCC 112
Query: 120 LETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPI 179
LE+E+PI VFE+ GTL D + Q L K RLK+A+++A+ +AYLH F RPI
Sbjct: 113 LESEIPIPVFEYAEKGTLEDYV------QKTALLWKDRLKIAVDVASVIAYLHTAFPRPI 166
Query: 180 VFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCN 239
V RDI ++IL E AK F +SISIPEG+TH+ D +V GT G++APEY N
Sbjct: 167 VHRDISLASILLDEDCAAKVTGFSLSISIPEGETHIED--EVAGTIGYVAPEYFMKRMFN 224
Query: 240 EKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEE 299
EK DVYSFG +LL LLTG S N E + L V I++ F EI+DP I+ EE
Sbjct: 225 EKIDVYSFGVVLLVLLTGHGPILRSPTTN-ESHALVVFVEAKIKNERFNEIIDPAIL-EE 282
Query: 300 GLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKSI 344
G WPEKE+QL S+ LA++C K E+DRP + VAKQLR ++ S+
Sbjct: 283 GPWPEKEQQLKSFLTLAMQCTRKDEEDRPEITDVAKQLRHIYHSL 327
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542658|ref|XP_002512392.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548353|gb|EEF49844.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 274 bits (701), Expect = 4e-71, Method: Compositional matrix adjust.
Identities = 154/349 (44%), Positives = 210/349 (60%), Gaps = 25/349 (7%)
Query: 15 EKRKFMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPEKVITKDLLYKLYKG 74
E +++NG LL+K IA NG NPI+ F+ EL+ ATN+Y VI + + LYKG
Sbjct: 11 ENETALMRNGGILLEKSIAFNNGRGNPIRWFSVDELQTATNSYSQNNVIYEGGWHTLYKG 70
Query: 75 FLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCCLETELPILVFEFVA 133
FL+DRP+ V ++ N++ E C N I FAS+MS HKN+LK +GCCLE+E+PILVFE+
Sbjct: 71 FLRDRPVIVKRYRNNIH-ERVCPINDIVFASEMSRHKNVLKLLGCCLESEIPILVFEYAE 129
Query: 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE 193
G L D I+ + + P L K RLK+A++ AN +AYLH RP+V RDI S I E
Sbjct: 130 KGKLQDYIYKTDSASFRPLLWKSRLKIAVDAANVIAYLHTACPRPVVHRDITLSNIWLDE 189
Query: 194 QNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLE 253
VAK DF VS+SI EG+TH+ D V+GT G+ APEY+ + NEK DV+SFG LLL
Sbjct: 190 DYVAKVTDFTVSMSILEGETHIED--FVLGTCGYAAPEYVRSGIFNEKIDVFSFGVLLLV 247
Query: 254 LLTGKRISYSSCFEN------GEEYFLQELVRKSIES-------------NSFKEIVDPI 294
LLT ++ + +EN +E +V K + S +DPI
Sbjct: 248 LLTDQK-PFQGNWENILKDARFDEIIGSLIVEKGLWSEKEQLETFLTRTRQKLDLTIDPI 306
Query: 295 IVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343
IV EEG WPEKE+QL ++ L ++C+ E++RP + VAKQLR + S
Sbjct: 307 IV-EEGPWPEKEQQLKAFLMLGVQCIDPDEENRPEITDVAKQLRHFYLS 354
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493231|ref|XP_002265528.2| PREDICTED: inactive serine/threonine-protein kinase At1g67470-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 241 bits (615), Expect = 4e-61, Method: Compositional matrix adjust.
Identities = 139/337 (41%), Positives = 202/337 (59%), Gaps = 9/337 (2%)
Query: 14 AEKRK-FMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPEKVITKDLLYKLY 72
A+KR+ F LKNG LL+KL++S NG NPI+NF+ +EL+ ATN Y+ + + + Y
Sbjct: 2 AKKREEFFLKNGSLLLEKLVSSLNGRSNPIRNFSIKELEQATNKYNSSLIFDRWTYSEWY 61
Query: 73 KGFLQDRPISVMKFGGNLNSEEY-CCFNCIAFASQMS-HKNILKFVGCCLETELPILVFE 130
KG L+ R +SV KF ++ I FA+Q+S HKN+LK GCCLET+ P+LV+E
Sbjct: 62 KGSLEGRFVSVRKFHPVIDDAFLERVIKEITFATQLSAHKNVLKLFGCCLETQTPVLVYE 121
Query: 131 FVACGT--LADRIH-DPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPS 187
+ G L D IH +G + K RL+++ +IA+ +AYLH F R I+ R++ S
Sbjct: 122 YPVNGVVPLYDVIHPSTDGKSRQRLPWKSRLRISGDIAHVIAYLHTAFPRAIIHREVTLS 181
Query: 188 TILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSF 247
E V K +F +I++PEG+ +V D V+G GFIAPEY T EK DV+SF
Sbjct: 182 FFFLDEDCVPKLSNFFFAIALPEGRKYVVDG--VMGIEGFIAPEYEMTGMVTEKVDVFSF 239
Query: 248 GALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEK 307
G LLLELLTG+R N E LQ+ ++ +E + VD I+ G E E
Sbjct: 240 GKLLLELLTGRRTIDFGPLGNDGELLLQDCIKTYVEDHELDGFVDASILPRGGEIHE-EL 298
Query: 308 QLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKSI 344
QLL+ T+LA++C+ + + RPTMV++AK+LR++ + I
Sbjct: 299 QLLAVTKLALRCIMTAAEQRPTMVEIAKELRRIQRGI 335
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296081092|emb|CBI18286.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 240 bits (612), Expect = 8e-61, Method: Compositional matrix adjust.
Identities = 141/345 (40%), Positives = 207/345 (60%), Gaps = 11/345 (3%)
Query: 8 SESSKK--AEKRK-FMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPEKVIT 64
++ +KK A+KR+ F LKNG LL+KL++S NG NPI+NF+ +EL+ ATN Y+ +
Sbjct: 608 AQQTKKLMAKKREEFFLKNGSLLLEKLVSSLNGRSNPIRNFSIKELEQATNKYNSSLIFD 667
Query: 65 KDLLYKLYKGFLQDRPISVMKFGGNLNSEEY-CCFNCIAFASQMS-HKNILKFVGCCLET 122
+ + YKG L+ R +SV KF ++ I FA+Q+S HKN+LK GCCLET
Sbjct: 668 RWTYSEWYKGSLEGRFVSVRKFHPVIDDAFLERVIKEITFATQLSAHKNVLKLFGCCLET 727
Query: 123 ELPILVFEFVACGT--LADRIH-DPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPI 179
+ P+LV+E+ G L D IH +G + K RL+++ +IA+ +AYLH F R I
Sbjct: 728 QTPVLVYEYPVNGVVPLYDVIHPSTDGKSRQRLPWKSRLRISGDIAHVIAYLHTAFPRAI 787
Query: 180 VFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCN 239
+ R++ S E V K +F +I++PEG+ +V D V+G GFIAPEY T
Sbjct: 788 IHREVTLSFFFLDEDCVPKLSNFFFAIALPEGRKYVVDG--VMGIEGFIAPEYEMTGMVT 845
Query: 240 EKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEE 299
EK DV+SFG LLLELLTG+R N E LQ+ ++ +E + VD I+
Sbjct: 846 EKVDVFSFGKLLLELLTGRRTIDFGPLGNDGELLLQDCIKTYVEDHELDGFVDASILPRG 905
Query: 300 GLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKSI 344
G E E QLL+ T+LA++C+ + + RPTMV++AK+LR++ + I
Sbjct: 906 GEIHE-ELQLLAVTKLALRCIMTAAEQRPTMVEIAKELRRIQRGI 949
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225460075|ref|XP_002271888.1| PREDICTED: wall-associated receptor kinase-like 8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 238 bits (607), Expect = 3e-60, Method: Compositional matrix adjust.
Identities = 142/334 (42%), Positives = 202/334 (60%), Gaps = 28/334 (8%)
Query: 20 MLKNGKFLLQKLIASCNGDY-NPIQNFTAQELKAATNNYDPEKVITKDL--LYKLYKGFL 76
MLKNG LL+K I+ G Y NPI NF+ QE++ AT+N++ + D+ YK YKG L
Sbjct: 16 MLKNGSLLLEKRISYFGGRYSNPIHNFSIQEIQRATDNFNGNLIFNDDVSSFYKWYKGSL 75
Query: 77 QDRPISVMK-FGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCCLETELPILVFEFVAC 134
+ R I + K F + N IA A+QMS HKN LK +GCCLET +PILV+EF +C
Sbjct: 76 EGRVICIRKIFRSSFAENPQIVTNEIAVATQMSSHKNALKLLGCCLETRVPILVYEFSSC 135
Query: 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ 194
LA++I D N EPF +K RLK+A EIA+ +AYLH F RPI+ RDIKP
Sbjct: 136 EPLAEKIFDCN----EPFPLKGRLKIAYEIASVIAYLHTAFPRPIIHRDIKPHHFFLDNG 191
Query: 195 NVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLEL 254
+ K +F +SI++PEG+T V D + GT G++APE S EK+DV+SFG L+LEL
Sbjct: 192 STPKLSNFELSIALPEGETRVKDVPR--GTLGYLAPELFSW-EYTEKTDVFSFGTLILEL 248
Query: 255 LTGKRISY------SSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQ 308
LT +R S+ S ++GE++ IE+ +I+DP + E G E ++Q
Sbjct: 249 LTRRRASFLAKRKGVSMRKHGEDH---------IETYGIHDILDPSSLVEGGGVLE-QQQ 298
Query: 309 LLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342
+ +LA+KC + +DRPT+V AK++R++ +
Sbjct: 299 FEAVCQLALKCTEEFAEDRPTIVDAAKEIRRIQR 332
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297740944|emb|CBI31256.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 238 bits (606), Expect = 4e-60, Method: Compositional matrix adjust.
Identities = 142/336 (42%), Positives = 203/336 (60%), Gaps = 28/336 (8%)
Query: 20 MLKNGKFLLQKLIASCNGDY-NPIQNFTAQELKAATNNYDPEKVITKDL--LYKLYKGFL 76
MLKNG LL+K I+ G Y NPI NF+ QE++ AT+N++ + D+ YK YKG L
Sbjct: 16 MLKNGSLLLEKRISYFGGRYSNPIHNFSIQEIQRATDNFNGNLIFNDDVSSFYKWYKGSL 75
Query: 77 QDRPISVMK-FGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCCLETELPILVFEFVAC 134
+ R I + K F + N IA A+QMS HKN LK +GCCLET +PILV+EF +C
Sbjct: 76 EGRVICIRKIFRSSFAENPQIVTNEIAVATQMSSHKNALKLLGCCLETRVPILVYEFSSC 135
Query: 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ 194
LA++I D N EPF +K RLK+A EIA+ +AYLH F RPI+ RDIKP
Sbjct: 136 EPLAEKIFDCN----EPFPLKGRLKIAYEIASVIAYLHTAFPRPIIHRDIKPHHFFLDNG 191
Query: 195 NVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLEL 254
+ K +F +SI++PEG+T V D + GT G++APE S EK+DV+SFG L+LEL
Sbjct: 192 STPKLSNFELSIALPEGETRVKDVPR--GTLGYLAPELFS-WEYTEKTDVFSFGTLILEL 248
Query: 255 LTGKRISY------SSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQ 308
LT +R S+ S ++GE++ IE+ +I+DP + E G E ++Q
Sbjct: 249 LTRRRASFLAKRKGVSMRKHGEDH---------IETYGIHDILDPSSLVEGGGVLE-QQQ 298
Query: 309 LLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKSI 344
+ +LA+KC + +DRPT+V AK++R++ + +
Sbjct: 299 FEAVCQLALKCTEEFAEDRPTIVDAAKEIRRIQRFV 334
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297740943|emb|CBI31255.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 225 bits (574), Expect = 2e-56, Method: Compositional matrix adjust.
Identities = 141/331 (42%), Positives = 203/331 (61%), Gaps = 18/331 (5%)
Query: 16 KRKFMLKNGKFLLQKLIASCNGDY-NPIQNFTAQELKAATNNYDPEKVITKDLLYKL-YK 73
K++ MLKNG LL++ I+ NG Y NPI++F +EL+ AT++Y+ + D+ + YK
Sbjct: 2 KKESMLKNGSLLLKERISYFNGKYFNPIRSFCMKELQNATDDYNTGLIFDHDVGNCIWYK 61
Query: 74 GFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCCLETELPILVFEFV 132
G L+ R ISV N N I ASQMS HKN LK +GCCLET +PILV+EF
Sbjct: 62 GSLEGRTISVRT---NFYEGVEMAINEIVIASQMSAHKNALKLLGCCLETRIPILVYEFP 118
Query: 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ 192
+ G+L DRI P P K RL++A +IAN +AYLH+ F R I+ DIKPS+
Sbjct: 119 SGGSLIDRIFSPPN----PLSWKSRLRIAYDIANVIAYLHIAFPRSIIHTDIKPSSFFLD 174
Query: 193 EQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLL 252
+ AK DF +SI++PEG+ HV D ++ GTFG++APE + + EK+DV+SFG LLL
Sbjct: 175 QDCAAKLSDFSLSITLPEGEMHVED--EIRGTFGYLAPETLISGVYTEKNDVFSFGILLL 232
Query: 253 ELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGE-EGLWPEKEKQLLS 311
ELL GKR ++S E E +Q+ + + + IVDPII+ + G+ +E Q +
Sbjct: 233 ELLIGKR-AHSIMHE--ERASIQDYAQSFVNTYDINGIVDPIILAQPRGI--HEELQFQA 287
Query: 312 YTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342
+LA++C K +RPT+V AK++R++ K
Sbjct: 288 IFDLAMRCSMKDMDERPTIVNAAKEVRRIQK 318
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 344 | ||||||
| TAIR|locus:2076586 | 351 | AT3G57710 [Arabidopsis thalian | 0.959 | 0.940 | 0.369 | 7.8e-55 | |
| TAIR|locus:2094468 | 433 | AT3G25490 [Arabidopsis thalian | 0.918 | 0.729 | 0.357 | 1.7e-50 | |
| TAIR|locus:2076681 | 359 | AT3G57720 [Arabidopsis thalian | 0.965 | 0.924 | 0.349 | 2.8e-50 | |
| TAIR|locus:2076671 | 355 | AT3G57730 [Arabidopsis thalian | 0.953 | 0.923 | 0.342 | 4.6e-50 | |
| TAIR|locus:2076646 | 334 | AT3G57750 [Arabidopsis thalian | 0.944 | 0.973 | 0.372 | 5.8e-50 | |
| TAIR|locus:2200562 | 748 | WAKL2 "wall associated kinase- | 0.933 | 0.429 | 0.369 | 8.6e-49 | |
| TAIR|locus:2014952 | 738 | WAK4 "wall associated kinase 4 | 0.921 | 0.429 | 0.352 | 1.2e-48 | |
| TAIR|locus:2014897 | 741 | WAK3 "wall associated kinase 3 | 0.941 | 0.437 | 0.358 | 1.3e-48 | |
| TAIR|locus:2076596 | 340 | AT3G57700 [Arabidopsis thalian | 0.968 | 0.979 | 0.364 | 6e-48 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.950 | 0.454 | 0.359 | 9.6e-48 |
| TAIR|locus:2076586 AT3G57710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 566 (204.3 bits), Expect = 7.8e-55, P = 7.8e-55
Identities = 128/346 (36%), Positives = 203/346 (58%)
Query: 6 GTSESSKKAEKRKFMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPEKVITK 65
GT + KA KR F L NG L++L+A CNG PI++F+ +++ ATNN+D +++
Sbjct: 11 GTRKEKDKA-KRWF-LDNGSIFLRELVADCNGKSIPIRSFSPEQILKATNNFDSSCFVSQ 68
Query: 66 DLLYKLYKGFLQDRPISVMKFGGN-LNSEEYCC---FNCIAFASQMS-HKNILKFVGCCL 120
D+ YK Y+G ++DR + +F + + + + +N I +++MS H N L+ +GCCL
Sbjct: 69 DVYYKWYRGEIEDRSYMIKRFSEDEITGKRHRVKEVYNDIVLSARMSNHSNFLQLLGCCL 128
Query: 121 ETELPILVFEFVACGTLADRIHD-PNGSQ-LEPFLMKHRLKVAMEIANAVAYLHVGFSRP 178
E P+LVFEF G + R NG + L P+ + RLK+ EIANAV YLH F +
Sbjct: 129 EFPFPVLVFEFAEHGAMNQRGGVIVNGEESLLPWSV--RLKIGKEIANAVTYLHTAFPKI 186
Query: 179 IVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANC 238
I+ RD+KP + + AK D SIS+PEGK+ + + V+GTFG+I P Y T
Sbjct: 187 IIHRDVKPMHVFLDKNWTAKLSDLSFSISLPEGKSRI-EAEWVLGTFGYIDPLYHKTCFV 245
Query: 239 NEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGE 298
E +DVYSFG LL ++TGK + +G+ + LVR+ E+ E++DP ++ +
Sbjct: 246 TEYTDVYSFGICLLVIITGKPAIMT--ISDGDLQGILSLVRELCENGKLDEVIDPRLMKD 303
Query: 299 EGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKSI 344
+ + Q+ + LA++C + ++DRP M+QVAK+L+Q+ S+
Sbjct: 304 --ITSGQRLQVEACVVLALRCCKERDEDRPKMIQVAKELKQIEASL 347
|
|
| TAIR|locus:2094468 AT3G25490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 525 (189.9 bits), Expect = 1.7e-50, P = 1.7e-50
Identities = 121/338 (35%), Positives = 192/338 (56%)
Query: 9 ESSKKAEKRKFMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPEKVITKDLL 68
+ K +++ F KNG +L + ++ + FT +++K ATN YD +++ +
Sbjct: 60 QKDTKIQRQLFFEKNGGGMLIERLSGAGSSNIDFKIFTEEDMKEATNGYDVSRILGQGGQ 119
Query: 69 YKLYKGFLQDRPISVMK---FGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELP 125
+ +YKG L D I +K G N E++ N + SQ++H+N++K +GCCLETE+P
Sbjct: 120 WTVYKGILPDNSIVAIKKTRLGDNNQVEQF--INEVLVLSQINHRNVVKLLGCCLETEVP 177
Query: 126 ILVFEFVACGTLADRIHDPNGSQLEPFLM-KHRLKVAMEIANAVAYLHVGFSRPIVFRDI 184
+LV+EF+ G+L D +H GS L +HRL++A+E+A A+AYLH G S PI+ RDI
Sbjct: 178 LLVYEFITGGSLFDHLH---GSMFVSSLTWEHRLEIAIEVAGAIAYLHSGASIPIIHRDI 234
Query: 185 KPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDV 244
K IL E AK DF S P K + V GT G++ PEY +T NEKSDV
Sbjct: 235 KTENILLDENLTAKVADFGASKLKPMDKEQLT--TMVQGTLGYLDPEYYTTWLLNEKSDV 292
Query: 245 YSFGALLLELLTGKRISYSSCFENGE--EYFLQELVRKSIESNSFKEIVDPIIVGEEGLW 302
YSFG +L+EL++G++ + CFE E ++ + V + E N EI+D ++ EE
Sbjct: 293 YSFGVVLMELISGQK---ALCFERPETSKHLVSYFVLATKE-NRLHEIIDDQVLNEEN-- 346
Query: 303 PEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340
++++ +A++C ++RP M++VA +L L
Sbjct: 347 ---QREIHEAARVAVECTRLKGEERPRMIEVAAELETL 381
|
|
| TAIR|locus:2076681 AT3G57720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 523 (189.2 bits), Expect = 2.8e-50, P = 2.8e-50
Identities = 122/349 (34%), Positives = 195/349 (55%)
Query: 2 SLCLGTSESSKKAEK----RKFMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNY 57
SL G+ E K+ EK K+ L NG L++LIA CNG PI+NF++ ++ AT+N+
Sbjct: 11 SLRSGSLEKRKEKEKDIQEEKWFLDNGSIFLKELIADCNGKSIPIRNFSSDQILKATSNF 70
Query: 58 DPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCC---FNCIAFASQMS-HKNIL 113
+T + Y YKG ++DR + +F +Y +N I +++MS H N L
Sbjct: 71 GSSCFVTAEGFYVWYKGIIEDRSYMIKRFS-EYKVTQYRVAEVYNEIVLSARMSNHNNFL 129
Query: 114 KFVGCCLETELPILVFEFVACGTLADRIHD-PNGSQ-LEPFLMKHRLKVAMEIANAVAYL 171
K +G CLE LP+LVFE+ G L R NG + + P + RLK+ EIANAV YL
Sbjct: 130 KLIGFCLEFSLPVLVFEYAEHGVLNHRGGVIVNGEEVILPLSL--RLKIGKEIANAVTYL 187
Query: 172 HVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPE 231
H+ F + ++ R IKP + E K DF +SI++PEGK+ + + V GT G++ P
Sbjct: 188 HMAFPKILIHRHIKPRNVFLDENWTPKLSDFSISINLPEGKSRI-EVECVQGTIGYLDPV 246
Query: 232 YMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291
Y +T E +DVYSFG L+ +LTGK + +S +G+ + V+ E+ ++
Sbjct: 247 YYTTKMVTEYTDVYSFGVFLMVILTGKP-ALASTSSDGDYKHIASYVKGFHENGQLDGVI 305
Query: 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340
DP ++ E + ++ + + LA++C +++RP M+Q+AK+L+Q+
Sbjct: 306 DPKVM--EDITSAQKVHVEACVVLALRCCELRDENRPKMIQIAKELKQI 352
|
|
| TAIR|locus:2076671 AT3G57730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 521 (188.5 bits), Expect = 4.6e-50, P = 4.6e-50
Identities = 117/342 (34%), Positives = 192/342 (56%)
Query: 9 ESSKKAEKRKFMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPEKVITKDLL 68
+ K +K ++ L+NG L++LI CNG PI++FT+ +++ AT N+D + ++
Sbjct: 19 KKEKSMKKERWFLENGSIFLKELIVDCNGKSIPIRSFTSSQIRKATKNFDLSCFVAEEGF 78
Query: 69 YKLYKGFLQDRPISVMKFGGNLNSEEYCC---FNCIAFASQMS-HKNILKFVGCCLETEL 124
Y YKG ++DR + +F +Y + I +++MS H N LK +GCCLE
Sbjct: 79 YIWYKGVIEDRSYMIKRFS-EYKVTDYRVSEVYKDIVLSARMSNHNNFLKLLGCCLEFPF 137
Query: 125 PILVFEFVACGTLADRIH-DPNGSQ-LEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFR 182
P+LVFEF G L R NG + L P + RLK+ EIANA+AYLH+ F + I++R
Sbjct: 138 PVLVFEFAEHGVLNYRGGITVNGEESLLPLSL--RLKIGKEIANALAYLHMAFPKIIIYR 195
Query: 183 DIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKS 242
D+KP + AK D SIS+ EGK+ + + V+GT+G++ P Y +T E +
Sbjct: 196 DVKPLHVFLDNNWTAKLSDLSFSISLEEGKSQIEAED-VLGTYGYLDPLYFATRIVTEYT 254
Query: 243 DVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLW 302
DVYSFG L+ ++TG + ++ +G + ++ E+ EIV P+I+ E +
Sbjct: 255 DVYSFGVFLMVVITGISVYFTG--SDGYPVGILGYMKGLAENGKLNEIVYPMIMKE--MT 310
Query: 303 PEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKSI 344
+ Q+ + LA++C + +DRP M+QVAK+L+++ +
Sbjct: 311 SAQRLQVEACVLLALRCCEERVEDRPKMIQVAKELKRIEHHV 352
|
|
| TAIR|locus:2076646 AT3G57750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 520 (188.1 bits), Expect = 5.8e-50, P = 5.8e-50
Identities = 127/341 (37%), Positives = 202/341 (59%)
Query: 8 SESSKKAEKRKFMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPEKVITKDL 67
S+++KK KR++ LKNG LL++LIAS +G NPI+ F++ ++ AT+N+ ++I+
Sbjct: 2 SKNNKK--KRRWDLKNGGILLEELIASFDGKTNPIRCFSSDQILKATDNFSESRIISSWG 59
Query: 68 LYKLYKGFLQDRPISVMKFGG-NLNSEEYCCFNCIAFASQMS-HKNILKFVGCCLETELP 125
+ YKG +++R +S+ K+ NL+S + I+ +SQMS HKN LK +GCCLE +LP
Sbjct: 60 YFIWYKGVIEERQVSIKKWSSQNLSSFTEA-YRDISVSSQMSGHKNALKLIGCCLEFDLP 118
Query: 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIK 185
LV E+ G L +R + + P+ K RLK+A EIA++V YLH F IV R+I
Sbjct: 119 ALVCEYTEHGPL-NRDGGLSSGVVLPW--KVRLKIAKEIASSVTYLHTAFPETIVHRNIN 175
Query: 186 PSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVY 245
P+ I E AK DF ++IPEG+ +V D+ K G GF+ P+Y T EK D+Y
Sbjct: 176 PTNIFIDENWTAKLSDFWFCVAIPEGELYVEDDVK--GVIGFVDPDYYWTMKVTEKVDIY 233
Query: 246 SFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPE- 304
SFG ++L LL+G+ ++ E L + V + +E F EIVD I + G +
Sbjct: 234 SFGVVMLVLLSGRAAVFNGPDE--APMSLNDHVSEVMEKGEFDEIVDKEIWNDLGGDDDL 291
Query: 305 --KEKQLLSYTELAIKCLSKSEQDRPT-MVQVAKQLRQLHK 342
+ Q+ ++ LA++C+ ++D + M++VAK+L+ + K
Sbjct: 292 VLRRSQVKAFLRLALRCVRYKKEDPVSGMLEVAKELKLIEK 332
|
|
| TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 511 (184.9 bits), Expect = 8.6e-49, P = 8.6e-49
Identities = 123/333 (36%), Positives = 192/333 (57%)
Query: 12 KKAEKRKFMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPEKVITKDLLYKL 71
K RKF +NG LL++ +A G+ + F++ EL+ AT+N++ +V+ + +
Sbjct: 371 KLIRMRKFFRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRVLGQGGQGTV 430
Query: 72 YKGFLQDRPISVMKFGGNLNSEEYCCF-NCIAFASQMSHKNILKFVGCCLETELPILVFE 130
YKG L D I +K ++ + F N + +Q++H+NI+K +GCCLETE+P+LV+E
Sbjct: 431 YKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYE 490
Query: 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTIL 190
FV G L R+HD + + + RL +A+EIA A++YLH S PI RDIK + IL
Sbjct: 491 FVPNGDLCKRLHDESDDYTMTWEV--RLHIAIEIAGALSYLHSAASFPIYHRDIKTTNIL 548
Query: 191 FQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGAL 250
E+N AK DF S S+ +TH+ +V GTFG++ PEY ++ EKSDVYSFG +
Sbjct: 549 LDERNRAKVSDFGTSRSVTIDQTHLT--TQVAGTFGYVDPEYFQSSKFTEKSDVYSFGVV 606
Query: 251 LLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLL 310
L+ELLTG++ S S + E L ++++ N +IVD I E + Q++
Sbjct: 607 LVELLTGEKPS--SRVRSEENRGLAAHFVEAVKENRVLDIVDDRIKDECNM-----DQVM 659
Query: 311 SYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343
S LA +CL++ + RP M +V+ +L + S
Sbjct: 660 SVANLARRCLNRKGKKRPNMREVSIELEMIRSS 692
|
|
| TAIR|locus:2014952 WAK4 "wall associated kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 509 (184.2 bits), Expect = 1.2e-48, P = 1.2e-48
Identities = 119/338 (35%), Positives = 191/338 (56%)
Query: 9 ESSKKAEKRK-FMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPEKVITKDL 67
+++K E R+ F +NG +L + ++ ++ FT + +K AT+ YD +++ +
Sbjct: 361 KNTKDTELRQQFFEQNGGGMLMQRLSGAGPSNVDVKIFTEEGMKEATDGYDENRILGQGG 420
Query: 68 LYKLYKGFLQDRPISVMK---FGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETEL 124
+YKG L D I +K G N E++ N + SQ++H+N++K +GCCLETE+
Sbjct: 421 QGTVYKGILPDNSIVAIKKARLGDNSQVEQF--INEVLVLSQINHRNVVKLLGCCLETEV 478
Query: 125 PILVFEFVACGTLADRIHDPNGSQLEPFLM-KHRLKVAMEIANAVAYLHVGFSRPIVFRD 183
P+LV+EF++ GTL D +H GS + L +HRL++A+EIA +AYLH S PI+ RD
Sbjct: 479 PLLVYEFISSGTLFDHLH---GSMFDSSLTWEHRLRMAVEIAGTLAYLHSSASIPIIHRD 535
Query: 184 IKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSD 243
IK + IL E AK DF S IP K + V GT G++ PEY +T NEKSD
Sbjct: 536 IKTANILLDENLTAKVADFGASRLIPMDKEDLA--TMVQGTLGYLDPEYYNTGLLNEKSD 593
Query: 244 VYSFGALLLELLTGKRISYSSCFENGE-EYFLQELVRKSIESNSFKEIVDPIIVGEEGLW 302
VYSFG +L+ELL+G++ + CFE + + + + N EI+D ++ E
Sbjct: 594 VYSFGVVLMELLSGQK---ALCFERPQTSKHIVSYFASATKENRLHEIIDGQVMNENN-- 648
Query: 303 PEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340
++++ +A++C + ++RP M +VA +L L
Sbjct: 649 ---QREIQKAARIAVECTRLTGEERPGMKEVAAELEAL 683
|
|
| TAIR|locus:2014897 WAK3 "wall associated kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 509 (184.2 bits), Expect = 1.3e-48, P = 1.3e-48
Identities = 124/346 (35%), Positives = 196/346 (56%)
Query: 2 SLCLGTSESSKKAEK--RKFMLKNGK-FLLQKLIASCNGDYNPIQNFTAQELKAATNNYD 58
++C+ + +K K R+F +NG L+Q+L + + + + FT + +K ATN YD
Sbjct: 358 AICIQHATKQRKYTKLRRQFFEQNGGGMLIQRLSGAGLSNID-FKIFTEEGMKEATNGYD 416
Query: 59 PEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCF-NCIAFASQMSHKNILKFVG 117
+++ + +YKG L D I +K +S + F + + SQ++H+N++K +G
Sbjct: 417 ESRILGQGGQGTVYKGILPDNTIVAIKKARLADSRQVDQFIHEVLVLSQINHRNVVKILG 476
Query: 118 CCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLM-KHRLKVAMEIANAVAYLHVGFS 176
CCLETE+P+LV+EF+ GTL D +H GS + L +HRL++A+E+A +AYLH S
Sbjct: 477 CCLETEVPLLVYEFITNGTLFDHLH---GSIFDSSLTWEHRLRIAIEVAGTLAYLHSSAS 533
Query: 177 RPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA 236
PI+ RDIK + IL E AK DF S IP K + V GT G++ PEY +T
Sbjct: 534 IPIIHRDIKTANILLDENLTAKVADFGASKLIPMDKEQLT--TMVQGTLGYLDPEYYTTG 591
Query: 237 NCNEKSDVYSFGALLLELLTGKRISYSSCFENGE--EYFLQELVRKSIESNSFKEIVDPI 294
NEKSDVYSFG +L+ELL+G++ + CFE + ++ + V + E N EI+D
Sbjct: 592 LLNEKSDVYSFGVVLMELLSGQK---ALCFERPQASKHLVSYFV-SATEENRLHEIIDDQ 647
Query: 295 IVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340
++ E+ L K++ +A +C ++RP M +VA +L L
Sbjct: 648 VLNEDNL-----KEIQEAARIAAECTRLMGEERPRMKEVAAKLEAL 688
|
|
| TAIR|locus:2076596 AT3G57700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 501 (181.4 bits), Expect = 6.0e-48, P = 6.0e-48
Identities = 127/348 (36%), Positives = 195/348 (56%)
Query: 3 LCLGTSESSKKAEKRKFMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPEKV 62
L L + +K E+ + KNG LL++LIA+ G YNPI+ F++ ++ ATN++D V
Sbjct: 2 LRLFRKKKKQKKEEEINLQKNGSLLLEELIATSGGIYNPIRTFSSDQILQATNHFDWNYV 61
Query: 63 ITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCCLE 121
I++D + YKG +++RP+ + KF + + IA +S MS HKN+LK +GCCLE
Sbjct: 62 ISEDR-FVWYKGMIENRPVLIKKFQDCSVFDADNFYRDIAVSSLMSSHKNVLKLLGCCLE 120
Query: 122 TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVF 181
P+LV E+ G L G + P+ + RL++A EIA+AVAYLH F R I+
Sbjct: 121 FPRPVLVCEYPEHGALNCIRCGKEGVRSFPWNV--RLRIAKEIADAVAYLHTEFPRTIIH 178
Query: 182 RDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEK 241
RD+K + I E AK F +SI +PEG+T VND V T +I P+Y +T E
Sbjct: 179 RDLKLANIFLDENWSAKLSSFSLSIVLPEGETGVND--MVCRTSSYIEPDYFNTGLVTEN 236
Query: 242 SDVYSFGALLLELLTGKRISYSSCFENGEEYF--LQELVRKSIESNSFKEIVDPIIVGE- 298
D+YS G ++L +LTGK Y+S Y L V K +E E++DP I+
Sbjct: 237 VDIYSLGIIMLIILTGKS-EYNS---EVAVYLPVLPVYVGKFLERGLLTELIDPSILDST 292
Query: 299 -EGLWPEKEKQLLSYTELAIKCLS-KSEQDRPTMVQVAKQLRQLHKSI 344
+ + Q+ ++ ELA +C+ + ++ P M+ VAK+L+++ K I
Sbjct: 293 SDDIPKHSRLQMEAFIELAFRCVRFRPGENVPRMIDVAKELKKIEKHI 340
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 500 (181.1 bits), Expect = 9.6e-48, P = 9.6e-48
Identities = 122/339 (35%), Positives = 194/339 (57%)
Query: 3 LCLGTSESSKKAEKRKFMLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPEKV 62
LC + +KRKF +NG LLQ+ + +G N + F++ +L+ AT+ ++ ++
Sbjct: 336 LCKANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDRFNASRI 395
Query: 63 ITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCF-NCIAFASQMSHKNILKFVGCCLE 121
+ + +YKG L+D I +K L E F N I SQ++H+N++K +GCCLE
Sbjct: 396 LGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILLSQINHRNVVKILGCCLE 455
Query: 122 TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVF 181
TE+PILV+EF+ L D +H+P S+ P + RL +A E+A+A++YLH S PI
Sbjct: 456 TEVPILVYEFIPNRNLFDHLHNP--SEDFPMSWEVRLCIACEVADALSYLHSAVSIPIYH 513
Query: 182 RDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEK 241
RD+K + IL E++ AK DF +S S+ TH+ V GT G++ PEY+ + + K
Sbjct: 514 RDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLT--TIVQGTIGYVDPEYLQSNHFTGK 571
Query: 242 SDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGL 301
SDVYSFG LL+ELLTG++ S E L +++ ++ EI+D I E
Sbjct: 572 SDVYSFGVLLIELLTGEKPV--SLLRRQEVRMLGAYFLEAMRNDRLHEILDARIKEE--- 626
Query: 302 WPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340
++E ++L+ +LA +CLS + + RPTM V +L ++
Sbjct: 627 -CDRE-EVLAVAKLARRCLSLNSEHRPTMRDVFIELDRM 663
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pm.C_LG_XIII000087 | hypothetical protein (344 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 344 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-28 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-26 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-25 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-25 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-25 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-24 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-23 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-23 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-21 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-16 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-15 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-15 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-14 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-13 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-12 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-11 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-10 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-10 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-10 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-10 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-10 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-09 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-09 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-09 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-09 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-08 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-08 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-07 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-07 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-07 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-07 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-07 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-06 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-06 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-06 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-05 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-05 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-05 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-04 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-04 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-04 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-04 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-04 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-04 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 0.001 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.001 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 0.001 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 0.001 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 0.001 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 0.002 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.002 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.002 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 0.002 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 0.002 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 0.002 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.002 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 0.002 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 0.002 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 0.003 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 0.003 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 0.003 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 0.003 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 0.003 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 0.004 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.004 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 0.004 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-28
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 34/203 (16%)
Query: 97 CFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKH 156
I +++H NI+K G + LV E+ G+L D + + G E ++
Sbjct: 38 LLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEIL-- 95
Query: 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN-VAKFFDFCVSISIPEGKTHV 215
++ ++I + YLH S I+ RD+KP IL N K DF +S + K
Sbjct: 96 --RILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK--- 147
Query: 216 NDNNKVIGTFGFIAPE-YMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFL 274
+ ++GT ++APE + +EKSD++S G +L EL L
Sbjct: 148 SLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------PEL 190
Query: 275 QELVRKSIESN-----SFKEIVD 292
++L+RK ++ + S KEI++
Sbjct: 191 KDLIRKMLQKDPEKRPSAKEILE 213
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 2e-26
Identities = 57/235 (24%), Positives = 89/235 (37%), Gaps = 36/235 (15%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
I ++ H NI++ + + LV E+ G L D +
Sbjct: 48 IKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-----RLSEDEARFY 102
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
+I +A+ YLH S+ IV RD+KP IL E K DF ++ + G+
Sbjct: 103 LRQILSALEYLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL----TT 155
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280
+GT ++APE + + D++S G +L ELLTGK F ++
Sbjct: 156 FVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP-----FPGDDQLLEL----- 205
Query: 281 SIESNSFKEIVDPIIV--GEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQV 333
FK+I P E + K L+ K L K + R T +
Sbjct: 206 ------FKKIGKPKPPFPPPEWDISPEAKDLIR------KLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 3e-25
Identities = 61/238 (25%), Positives = 96/238 (40%), Gaps = 30/238 (12%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDPNGSQLEP--FLMKHRLKV 160
++ H N+++ +G C E E LV E++ G L D R P E +K L
Sbjct: 51 KKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF 110
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
A++IA + YL S+ V RD+ L E V K DF +S + + +
Sbjct: 111 AIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGG 167
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280
+ ++APE + KSDV+SFG LL E+ T Y + EE V +
Sbjct: 168 KLPIR-WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL--SNEE------VLE 218
Query: 281 SIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338
+ + P +E EL + C +DRPT ++ ++L
Sbjct: 219 YLRKGYR--LPKPEYCPDE------------LYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-25
Identities = 48/159 (30%), Positives = 74/159 (46%), Gaps = 8/159 (5%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
++SH NI++ +G C + E +V E++ G L D + E +K L++A++I
Sbjct: 56 KKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG----EKLTLKDLLQMALQI 111
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
A + YL S+ V RD+ L E V K DF +S I E + +
Sbjct: 112 AKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPI 168
Query: 225 FGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYS 263
++APE + KSDV+SFG LL E+ T Y
Sbjct: 169 K-WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYP 206
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 9e-25
Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 29/228 (12%)
Query: 107 MSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIAN 166
+SH NI++ + + + LV E+ G L D + S+ P K+A++I
Sbjct: 55 LSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYL-----SRGGPLSEDEAKKIALQILR 109
Query: 167 AVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFG 226
+ YLH S I+ RD+KP IL E V K DF ++ + + + + +GT
Sbjct: 110 GLEYLH---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT---FVGTPW 163
Query: 227 FIAPEYMSTAN-CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285
++APE + N K DV+S G +L ELLTG + +S + ++ ++ +E +
Sbjct: 164 YMAPEVLLGGNGYGPKVDVWSLGVILYELLTG-KPPFSGENILDQLQLIRRILGPPLEFD 222
Query: 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQV 333
K EE K L+ KCL+K RPT ++
Sbjct: 223 EPK----WSSGSEEA------KDLIK------KCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 3e-24
Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 11/161 (6%)
Query: 101 IAFASQMSHKNILKFVGCCLETELP-ILVF-EFVACGTLADRIHDPNGSQLEPFLMKHRL 158
I S + H NI+++ G + E + +F E+V+ G+L+ + +L +++
Sbjct: 50 IRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK--KFGKLPEPVIRKYT 107
Query: 159 KVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDN 218
+ +I +AYLH S IV RDIK + IL V K DF + +
Sbjct: 108 R---QILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRL-GDIETGEGT 160
Query: 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKR 259
V GT ++APE + +D++S G ++E+ TGK
Sbjct: 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 5e-23
Identities = 56/236 (23%), Positives = 93/236 (39%), Gaps = 37/236 (15%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
++ H N++K +G C E E +V E++ G L + + L A++I
Sbjct: 56 RKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNR----PKLSLSDLLSFALQI 111
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
A + YL S+ + RD+ L E V K DF +S + + + K+
Sbjct: 112 ARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLP-- 166
Query: 225 FGFI---APEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS 281
I APE + KSDV+SFG LL E+ T Y
Sbjct: 167 ---IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM---------------- 207
Query: 282 IESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337
S +E+++ + G L Y L ++C ++ +DRPT ++ + L
Sbjct: 208 ----SNEEVLEYLKNGYR-LPQPPNCPPELYD-LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 8e-23
Identities = 61/236 (25%), Positives = 100/236 (42%), Gaps = 36/236 (15%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
++ H NI+K +G C E E ++V E++ G L D + +L + L A++I
Sbjct: 56 RKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELS---LSDLLSFALQI 112
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
A + YL S+ + RD+ L E V K DF +S + + + K+
Sbjct: 113 ARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLP-- 167
Query: 225 FGFI---APEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS 281
I APE + KSDV+SFG LL E+ T GEE +
Sbjct: 168 ---IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT-----------LGEEPY-------- 205
Query: 282 IESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337
S E+++ + G L Y +L ++C ++ +DRPT ++ + L
Sbjct: 206 -PGMSNAEVLEYLKKGYR-LPKPPNCPPELY-KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 3e-22
Identities = 65/237 (27%), Positives = 99/237 (41%), Gaps = 36/237 (15%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
I + H NI+K+ G L+ + +V EF + G+L D + S + V
Sbjct: 48 IQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLK----STNQTLTESQIAYV 103
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
E+ + YLH S I+ RDIK + IL K DF +S + + K N
Sbjct: 104 CKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK----ARNT 156
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280
++GT ++APE ++ + K+D++S G +EL GK YS
Sbjct: 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK-PPYS----------------- 198
Query: 281 SIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337
E K + G GL EK + + KCL K+ + RPT A+QL
Sbjct: 199 --ELPPMKALFKIATNGPPGL-RNPEKWSDEFKDFLKKCLQKNPEKRPT----AEQL 248
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 93.3 bits (230), Expect = 3e-21
Identities = 60/244 (24%), Positives = 95/244 (38%), Gaps = 23/244 (9%)
Query: 108 SHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANA 167
NI+K + LV E+V G+L D + + P L + +I +A
Sbjct: 56 HPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK--KIGRKGPLSESEALFILAQILSA 113
Query: 168 VAYLHVGFSRPIVFRDIKPSTILFQEQ-NVAKFFDFCVSISIPEGKTHVNDN---NKVIG 223
+ YLH S+ I+ RDIKP IL V K DF ++ +P+ + + + +G
Sbjct: 114 LEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170
Query: 224 TFGFIAPEYMSTANCNE---KSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280
T G++APE + + SD++S G L ELLTG FE + K
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP-----FEGEKNSSATSQTLK 225
Query: 281 SIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340
I + P+ L + LL K L+K ++R +
Sbjct: 226 IILELPTPSLASPLSPSNPELISKAASDLLK------KLLAKDPKNRLSSSSDLSHDLLA 279
Query: 341 HKSI 344
H +
Sbjct: 280 HLKL 283
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 6e-18
Identities = 64/235 (27%), Positives = 99/235 (42%), Gaps = 36/235 (15%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
+++H NI+K+ E +V E+ G L+ +I +PF + L +++
Sbjct: 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEG-KPFPEEQILDWFVQL 112
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT---HVNDNNKV 221
A+ YLH SR I+ RDIKP I + K DF +S K V+ V
Sbjct: 113 CLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGIS------KVLSSTVDLAKTV 163
Query: 222 IGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS 281
+GT +++PE N KSD++S G +L EL T K L EL K
Sbjct: 164 VGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--------LLELALK- 214
Query: 282 IESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336
I + I P E L + L+S L K ++RP++ Q+ +
Sbjct: 215 ILKGQYPPI--PSQYSSE-L-----RNLVS------SLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-17
Identities = 59/233 (25%), Positives = 102/233 (43%), Gaps = 32/233 (13%)
Query: 107 MSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIAN 166
+ H+N+++ G L L ++V E G+L DR+ L FL+ A++IAN
Sbjct: 53 LDHENLIRLYGVVLTHPL-MMVTELAPLGSLLDRLRKD---ALGHFLISTLCDYAVQIAN 108
Query: 167 AVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH--VNDNNKVIGT 224
+ YL S+ + RD+ IL + K DF + ++P+ + H + ++ KV
Sbjct: 109 GMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--P 163
Query: 225 FGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES 284
F + APE + T + SDV+ FG L E+ T ++ +G + + K I+
Sbjct: 164 FAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL--SGSQ------ILKKIDK 215
Query: 285 NSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337
GE PE Q + ++C + + DRPT + + L
Sbjct: 216 E-----------GERLERPEACPQ--DIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 7e-16
Identities = 64/249 (25%), Positives = 106/249 (42%), Gaps = 30/249 (12%)
Query: 99 NCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLM---- 154
+ IA ++ H NI+K +G C + L+ E++ G L L
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI------------EGKNLSEVLRNLSW 779
Query: 155 KHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214
+ R K+A+ IA A+ +LH S +V ++ P I+ ++ + +S+P
Sbjct: 780 ERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH-----LRLSLPG--LL 832
Query: 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFL 274
D I + ++APE T + EKSD+Y FG +L+ELLTGK + E G +
Sbjct: 833 CTDTKCFISS-AYVAPETRETKDITEKSDIYGFGLILIELLTGKS---PADAEFGVHGSI 888
Query: 275 QELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVA 334
E R +DP I G+ + + +++ LA+ C + RP V
Sbjct: 889 VEWARYCYSDCHLDMWIDPSIRGDVSV---NQNEIVEVMNLALHCTATDPTARPCANDVL 945
Query: 335 KQLRQLHKS 343
K L +S
Sbjct: 946 KTLESASRS 954
|
Length = 968 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 49/163 (30%), Positives = 79/163 (48%), Gaps = 21/163 (12%)
Query: 101 IAFASQMSHKNILKFVGCCL-ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLK 159
I + H NI+K++G L I + E+ G+L I G E + +
Sbjct: 50 IDLLKNLKHPNIVKYIGSIETSDSLYI-ILEYAENGSLRQIIK-KFGPFPESLVAVY--- 104
Query: 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNN 219
V ++ +AYLH + ++ RDIK + IL + V K DF V+ T +ND +
Sbjct: 105 VY-QVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVA-------TKLNDVS 153
Query: 220 K----VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
K V+GT ++APE + + + SD++S G ++ELLTG
Sbjct: 154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 57/238 (23%), Positives = 96/238 (40%), Gaps = 38/238 (15%)
Query: 102 AFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVA 161
+ + + H N+++ +G L+ +V E++A G+L D + + + + +L A
Sbjct: 52 SVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVIT---LAQQLGFA 108
Query: 162 MEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKV 221
+++ + YL + V RD+ +L E VAK DF G +
Sbjct: 109 LDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDF--------GLAKEASQGQD 157
Query: 222 IGTF--GFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR 279
G + APE + + KSDV+SFG LL E+ + R+ Y L+++V
Sbjct: 158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP-------RIPLKDVVP 210
Query: 280 KSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337
+E E EG PE K + C RPT Q+ +QL
Sbjct: 211 H-VEKGYRME-------APEGCPPEVYKVMK-------DCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 55/249 (22%), Positives = 99/249 (39%), Gaps = 36/249 (14%)
Query: 92 SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEP 151
E N I S + H NI+ + ++ ++ E+ GTL D+I + +
Sbjct: 41 KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI-----VRQKG 95
Query: 152 FLMKHRLKVAM--EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209
L + + + +I +AV+Y+H I+ RDIK I + + K DF +S +
Sbjct: 96 QLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG 152
Query: 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENG 269
+ V+GT +++PE N KSD+++ G +L ELLT
Sbjct: 153 SEYSMAE---TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT------------- 196
Query: 270 EEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT 329
++++ ++ + +V I+ G P L L + + RPT
Sbjct: 197 --------LKRTFDATNPLNLVVKIVQGNYT--PVVSVYSSELISLVHSLLQQDPEKRPT 246
Query: 330 MVQVAKQLR 338
+V Q
Sbjct: 247 ADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 4e-15
Identities = 37/114 (32%), Positives = 52/114 (45%), Gaps = 9/114 (7%)
Query: 147 SQLEPFLMKHRLKVAM-EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205
SQ F + ++K + EI A+ YLH S+ I+ RDIKP IL EQ DF ++
Sbjct: 92 SQKVKF-SEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIA 147
Query: 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKR 259
+ GT G++APE + + D +S G E L GKR
Sbjct: 148 TKVTPDTL----TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 4e-15
Identities = 42/159 (26%), Positives = 72/159 (45%), Gaps = 12/159 (7%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
+ H N++K+ G + E + E+ + GTL + + ++ + +++
Sbjct: 54 ELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLE---HGRILDEHVIRVY--TLQL 108
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF-CVSISIPEGKTHVNDNNKVIG 223
+AYLH S IV RDIKP+ I V K DF C T + + G
Sbjct: 109 LEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAG 165
Query: 224 TFGFIAPEYMSTANCNEK---SDVYSFGALLLELLTGKR 259
T ++APE ++ +D++S G ++LE+ TGKR
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 4e-15
Identities = 49/162 (30%), Positives = 76/162 (46%), Gaps = 11/162 (6%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHD--PNGSQLEPFLMKHRL 158
+ SQ +H N++K+ + + LV +++ G+L D + P G E +
Sbjct: 50 VQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA---- 105
Query: 159 KVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDN 218
V E+ + YLH S + RDIK IL E K DF VS S+ +G
Sbjct: 106 TVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV 162
Query: 219 NK-VIGTFGFIAPEYMSTAN-CNEKSDVYSFGALLLELLTGK 258
K +GT ++APE M + + K+D++SFG +EL TG
Sbjct: 163 RKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 25/167 (14%)
Query: 107 MSHKNILKFVGCCLETELPI--LVFEFVACGTLADRIHDPNGSQLEPFLMKHR------- 157
+ H+NI+K+ G C + L+ E++ G+L D +L +HR
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRD------------YLQRHRDQINLKR 110
Query: 158 -LKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN 216
L + +I + YL S+ + RD+ IL + +++ K DF ++ +PE K +
Sbjct: 111 LLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYY 167
Query: 217 DNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYS 263
+ APE + T+ + SDV+SFG L EL T S S
Sbjct: 168 VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 59/223 (26%), Positives = 91/223 (40%), Gaps = 44/223 (19%)
Query: 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKP 186
+V E++ G+LAD + G EP L +A +I + YLH R I+ RDIKP
Sbjct: 76 IVLEYMDGGSLAD-LLKKVGKIPEPVLAY----IARQILKGLDYLHT--KRHIIHRDIKP 128
Query: 187 STILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYS 246
S +L + K DF +S + N +GT +++PE + + + +D++S
Sbjct: 129 SNLLINSKGEVKIADFGISKVLENTLD---QCNTFVGTVTYMSPERIQGESYSYAADIWS 185
Query: 247 FGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKE 306
G LLE GK + SF E++ I G P +E
Sbjct: 186 LGLTLLECALGK-------------FPFL-----PPGQPSFFELMQAICDGPPPSLPAEE 227
Query: 307 -----KQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKSI 344
+ +S CL K + RP+ A +L Q H I
Sbjct: 228 FSPEFRDFIS------ACLQKDPKKRPS----AAELLQ-HPFI 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 5e-14
Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 11/155 (7%)
Query: 107 MSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIAN 166
+ H NI++++G CL+ + EFV G+++ I + G EP K+ +I +
Sbjct: 59 LKHVNIVQYLGTCLDDNTISIFMEFVPGGSIS-SILNRFGPLPEPVFCKY----TKQILD 113
Query: 167 AVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNN---KVIG 223
VAYLH + +V RDIK + ++ + K DF + + H +N + G
Sbjct: 114 GVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 224 TFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
T ++APE ++ + KSD++S G + E+ TGK
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 51/169 (30%), Positives = 80/169 (47%), Gaps = 22/169 (13%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDP-------NGSQLEPFLMK 155
+ H+NI+KF G C E + PI+VFE++ G L R H P S + +
Sbjct: 63 TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122
Query: 156 HRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHV 215
L++A++IA+ + YL S+ V RD+ L V K DF +S + +
Sbjct: 123 QLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV-----YT 174
Query: 216 NDNNKVIGT----FGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKR 259
D +V G ++ PE + +SDV+SFG +L E+ T GK+
Sbjct: 175 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 23/158 (14%)
Query: 107 MSHKNILKFVGCCLET--ELPILVFEFVACGTLADRI--HDPNGSQLEPFLMKHRLKVAM 162
+ H+NI+K+ GCC E + L+ E+V G+L D + H N +QL F A
Sbjct: 63 LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLF--------AQ 114
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHV----NDN 218
+I +AYLH S+ + RD+ +L + K DF ++ ++PEG + + +
Sbjct: 115 QICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
+ V + A E + + SDV+SFG L ELLT
Sbjct: 172 SPVF----WYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 64/235 (27%), Positives = 94/235 (40%), Gaps = 31/235 (13%)
Query: 101 IAFASQMSHKNILKFVGCCL---ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHR 157
+ I+K+ G L + + I + E+ G+L D I+ + K
Sbjct: 50 LEINKSCKSPYIVKYYGAFLDESSSSIGIAM-EYCEGGSL-DSIYKKVKKRGGRIGEKVL 107
Query: 158 LKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217
K+A + ++YLH SR I+ RDIKPS IL + K DF VS G+ +
Sbjct: 108 GKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSL 159
Query: 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL 277
GT ++APE + + SDV+S G LLE+ R + E EL
Sbjct: 160 AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQN-RFPFPP--EGEPPLGPIEL 216
Query: 278 VRKSIESNSFKEIVDPIIVGEEGL---WPEKEKQLLSYTELAIKCLSKSEQDRPT 329
+ S N +P + E G W E+ K + CL K RPT
Sbjct: 217 L--SYIVNMP----NPELKDEPGNGIKWSEEFKDFIKQ------CLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 31/232 (13%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIA 165
++SH +++ G C E LVFEF+ G L+D + G F + L + +++
Sbjct: 55 KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK----FSQETLLGMCLDVC 110
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTF 225
+AYL S ++ RD+ L E V K DF ++ + + + + K
Sbjct: 111 EGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF--PV 165
Query: 226 GFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285
+ +PE S + + KSDV+SFG L+ E+ + + Y E+
Sbjct: 166 KWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPY--------------------ENR 205
Query: 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337
S E+V+ I G P Q S EL C + +DRP+ + QL
Sbjct: 206 SNSEVVETINAGFRLYKPRLASQ--SVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 6e-13
Identities = 39/154 (25%), Positives = 70/154 (45%), Gaps = 9/154 (5%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
+++ I+++ L+ +V E+ G L + G L + + ++I
Sbjct: 54 AKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV---WRFFIQI 110
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
+A+LH S+ I+ RDIK + + K D V+ + + N N ++GT
Sbjct: 111 LLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL---SDNTNFANTIVGT 164
Query: 225 FGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
+++PE NEKSDV++ G +L E TGK
Sbjct: 165 PYYLSPELCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 9e-13
Identities = 52/195 (26%), Positives = 97/195 (49%), Gaps = 12/195 (6%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
IA ++ H+NI++++G L+ + + E+V G++A ++ N E L+++ ++
Sbjct: 57 IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN--NYGAFEETLVRNFVR- 113
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
+I + YLH +R I+ RDIK + IL + K DF +S + N
Sbjct: 114 --QILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA 168
Query: 221 ---VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL 277
+ G+ ++APE + + K+D++S G L++E+LTGK + C + + + E
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKH-PFPDCTQLQAIFKIGEN 227
Query: 278 VRKSIESNSFKEIVD 292
I SN E +D
Sbjct: 228 ASPEIPSNISSEAID 242
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 42/157 (26%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 107 MSHKNILKFVGCCLETELPILVF-EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIA 165
+ H NI++++G TE + +F E+V G++ + + E L++ ++
Sbjct: 65 LDHLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRF---FTEQVL 118
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND-NNKVIGT 224
+AYLH S+ I+ RD+K +L + K DF IS + ND N + G+
Sbjct: 119 EGLAYLH---SKGILHRDLKADNLLVDADGICKISDF--GISKKSDDIYDNDQNMSMQGS 173
Query: 225 FGFIAPEYMSTANC--NEKSDVYSFGALLLELLTGKR 259
++APE + + + + K D++S G ++LE+ G+R
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 28/169 (16%)
Query: 106 QMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
++ H +++ C E E PI +V E+++ G+L D + G +L + + +A +I
Sbjct: 57 KLRHDKLVQLYAVCSEEE-PIYIVTEYMSKGSLLDFLKSGEGKKL---RLPQLVDMAAQI 112
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
A +AYL SR + RD+ IL E V K DF G + ++++
Sbjct: 113 AEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADF--------GLARLIEDDEYTAR 161
Query: 225 FG------FIAPEYMSTANCNE---KSDVYSFGALLLELLTGKRISYSS 264
G + APE AN KSDV+SFG LL E++T R+ Y
Sbjct: 162 EGAKFPIKWTAPE---AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-12
Identities = 48/157 (30%), Positives = 81/157 (51%), Gaps = 13/157 (8%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
+SH NI+++ LE + ++V E+ GTLA+ I S L+ L ++I
Sbjct: 54 KLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDE---DTILHFFVQI 110
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILF-QEQNVAKFFDFCVS-ISIPEGKTHVNDNNKVI 222
A+ ++H ++ I+ RD+K IL + + V K DF +S I + K + V+
Sbjct: 111 LLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-----VV 162
Query: 223 GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKR 259
GT +I+PE N+KSD+++ G +L EL + KR
Sbjct: 163 GTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-12
Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 8/158 (5%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIA 165
Q H NI+K +G C++ + +V E V G+L + ++L +K L+++++ A
Sbjct: 48 QYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKK-KNRLT---VKKLLQMSLDAA 103
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTF 225
+ YL S+ + RD+ L E NV K DF +S G V+D K I
Sbjct: 104 AGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI-PI 159
Query: 226 GFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYS 263
+ APE ++ +SDV+S+G LL E + Y
Sbjct: 160 KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYP 197
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-12
Identities = 46/159 (28%), Positives = 80/159 (50%), Gaps = 13/159 (8%)
Query: 105 SQMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAME 163
+Q+ H N+++ +G +E + + +V E++A G+L D + S L + LK +++
Sbjct: 54 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL---LKFSLD 110
Query: 164 IANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIG 223
+ A+ YL + V RD+ +L E NVAK DF + + + D K+
Sbjct: 111 VCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDF----GLTKEASSTQDTGKL-- 161
Query: 224 TFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISY 262
+ APE + + KSDV+SFG LL E+ + R+ Y
Sbjct: 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 45/169 (26%), Positives = 77/169 (45%), Gaps = 18/169 (10%)
Query: 101 IAFASQMSHKNILKFV--GCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRL 158
A +++ H NI+ + G L VFE+V TL + + L
Sbjct: 29 TALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVLA--ADGALPAGETGR-- 83
Query: 159 KVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNV---AKFFDFCVSISIP----EG 211
+ +++ +A+A H ++ IV RD+KP I+ + V AK DF + +P
Sbjct: 84 -LMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDAD 139
Query: 212 KTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRI 260
+ +V+GT + APE + SD+Y++G + LE LTG+R+
Sbjct: 140 VATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRV 188
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 8e-12
Identities = 51/187 (27%), Positives = 80/187 (42%), Gaps = 30/187 (16%)
Query: 107 MSHKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDPNGSQLE--------PFLMKH 156
+ H++I++F G C E ++VFE++ G L R H P+ L +
Sbjct: 64 LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQ 123
Query: 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN 216
L +A +IA+ + YL S V RD+ L + V K DF +S I +
Sbjct: 124 MLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-----YST 175
Query: 217 DNNKVIG----TFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYS-------S 264
D +V G ++ PE + +SD++SFG +L E+ T GK+ Y
Sbjct: 176 DYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235
Query: 265 CFENGEE 271
C G E
Sbjct: 236 CITQGRE 242
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 9e-12
Identities = 47/147 (31%), Positives = 72/147 (48%), Gaps = 12/147 (8%)
Query: 112 ILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYL 171
I+ F G L + EF+ CG+L DRI+ G P ++ K+A+ + + YL
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGG----PIPVEILGKIAVAVVEGLTYL 119
Query: 172 HVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPE 231
+ I+ RDIKPS IL + K DF VS G+ + + +GT +++PE
Sbjct: 120 Y--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFVGTSTYMSPE 172
Query: 232 YMSTANCNEKSDVYSFGALLLELLTGK 258
+ KSDV+S G ++EL GK
Sbjct: 173 RIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 51/176 (28%), Positives = 83/176 (47%), Gaps = 21/176 (11%)
Query: 102 AFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVA 161
A +++ HKN+++ +G L L I V E ++ G L + + G L + L+ +
Sbjct: 51 AVMTKLHHKNLVRLLGVILHNGLYI-VMELMSKGNLVNFLRT-RGRALVS--VIQLLQFS 106
Query: 162 MEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKV 221
+++A + YL S+ +V RD+ IL E VAK DF ++ G DN+K+
Sbjct: 107 LDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----DNSKL 159
Query: 222 IGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISY--------SSCFENG 269
+ APE + + KSDV+S+G LL E+ + R Y C E G
Sbjct: 160 --PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG 213
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 42/163 (25%), Positives = 73/163 (44%), Gaps = 16/163 (9%)
Query: 98 FNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHR 157
N I H NI+ + L + +V E++ G+L D I +Q + + +
Sbjct: 63 INEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII-----TQNFVRMNEPQ 117
Query: 158 LK-VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKF--FDFCVSISIPEGKTH 214
+ V E+ + YLH S+ ++ RDIK IL + K F F ++ + K
Sbjct: 118 IAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK-- 172
Query: 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
N V+GT ++APE + + K D++S G + +E+ G
Sbjct: 173 ---RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-11
Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVF-EFVACGTLADRIHDPNGSQLEPFLMKHRLK 159
I + H+ I+++ GC L + + +F E++ G++ D++ G+ E K+
Sbjct: 55 IQLLKNLQHERIVQYYGC-LRDDETLSIFMEYMPGGSVKDQLK-AYGALTETVTRKY--- 109
Query: 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNN 219
+I V YLH S IV RDIK + IL K DF S + +
Sbjct: 110 -TRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMK 165
Query: 220 KVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
V GT +++PE +S K+DV+S G ++E+LT K
Sbjct: 166 SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 7e-11
Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 9/154 (5%)
Query: 109 HKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAV 168
HK+++ C E ++ E + G+L + P G L + + +A ++A +
Sbjct: 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLP---VASLIDMACQVAEGM 117
Query: 169 AYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFI 228
AYL + + RD+ IL E V K DF ++ I E +++ + K+ + +
Sbjct: 118 AYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKI--PYKWT 171
Query: 229 APEYMSTANCNEKSDVYSFGALLLELLTGKRISY 262
APE S + KSDV+SFG LL E+ T ++ Y
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFTYGQVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 9e-11
Identities = 47/173 (27%), Positives = 70/173 (40%), Gaps = 40/173 (23%)
Query: 108 SHKNILKFVGCCLETELPI------LVFEFVACGT---LADRIHDPNGSQLEP---FLMK 155
+H NI F G ++ P LV E G+ L + E ++++
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 156 HRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS--ISIPEGKT 213
E +AYLH ++ RDIK IL + K DF VS + G+
Sbjct: 121 -------ETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR 170
Query: 214 HVNDNNKVIGTFGFIAPEYMSTANCNE--------KSDVYSFGALLLELLTGK 258
N IGT ++APE ++ C+E +SDV+S G +EL GK
Sbjct: 171 -----NTFIGTPYWMAPEVIA---CDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 43/170 (25%), Positives = 79/170 (46%), Gaps = 30/170 (17%)
Query: 98 FNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLAD-----RIHDPNGSQLEPF 152
FN + H NI++ L + +V EF+ G L D R+++ Q+
Sbjct: 64 FNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE---QIA-- 118
Query: 153 LMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKF--FDFC--VSISI 208
V + + A+++LH ++ ++ RDIK +IL K F FC VS +
Sbjct: 119 ------TVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169
Query: 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
P K+ ++GT ++APE +S + D++S G +++E++ G+
Sbjct: 170 PRRKS-------LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 1e-10
Identities = 42/133 (31%), Positives = 60/133 (45%), Gaps = 13/133 (9%)
Query: 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKH-RLKVAMEIANAVAYLHVGFSRPIVFRDIK 185
LV E+ G L + S+ F + R A EI A+ YLH S I++RD+K
Sbjct: 70 LVLEYAPGGELFSHL-----SKEGRFSEERARFYAA-EIVLALEYLH---SLGIIYRDLK 120
Query: 186 PSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVY 245
P IL K DF ++ + + N GT ++APE + + D +
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNT---FCGTPEYLAPEVLLGKGYGKAVDWW 177
Query: 246 SFGALLLELLTGK 258
S G LL E+LTGK
Sbjct: 178 SLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 45/174 (25%), Positives = 75/174 (43%), Gaps = 30/174 (17%)
Query: 159 KVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDN 218
K+ + I A+ YL ++ RD+KPS IL K DF +S + + K
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---- 171
Query: 219 NKVIGTFGFIAPEYMSTANCNEK----SDVYSFGALLLELLTGKRISYSSCFENGEEYFL 274
+ G ++APE + + N K +DV+S G L+EL TG+ ++N + F
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ-----FPYKNCKTEF- 225
Query: 275 QELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP 328
E++ K ++ P + EG P+ + CL+K + RP
Sbjct: 226 -EVLTKILQEEP------PSLPPNEGFSPD-------FCSFVDLCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 43/161 (26%), Positives = 73/161 (45%), Gaps = 20/161 (12%)
Query: 109 HKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAV 168
H +++ C E +V E + G+L + + G L+ + + +A ++A+ +
Sbjct: 60 HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALK---LPQLIDMAAQVASGM 116
Query: 169 AYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT---F 225
AYL ++ + RD+ +L E N+ K DF ++ I E + G
Sbjct: 117 AYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKE-----DIYEAREGAKFPI 168
Query: 226 GFIAPEYMSTANCNE---KSDVYSFGALLLELLTGKRISYS 263
+ APE A N KSDV+SFG LL E++T R+ Y
Sbjct: 169 KWTAPE---AALYNRFSIKSDVWSFGILLTEIVTYGRMPYP 206
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 56/234 (23%), Positives = 84/234 (35%), Gaps = 52/234 (22%)
Query: 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKP 186
V E+ G L I GS E R A EI A+ YLH S+ I+ RD+KP
Sbjct: 79 FVLEYAPNGELLQYIR-KYGSLDEKCT---RFYAA-EILLALEYLH---SKGIIHRDLKP 130
Query: 187 STILFQEQNVAKFFDF------------------CVSISIPEGKTHVNDNNKVIGTFGFI 228
IL + K DF +I K + V GT ++
Sbjct: 131 ENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFV-GTAEYV 189
Query: 229 APEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288
+PE ++ + SD+++ G ++ ++LTGK F EY + + K SF
Sbjct: 190 SPELLNEKPAGKSSDLWALGCIIYQMLTGK-----PPFRGSNEYLTFQKILK--LEYSFP 242
Query: 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342
P +L K L QDR + + +L+ H
Sbjct: 243 PNFPPDAK-----------------DLIEKLLVLDPQDRLGVNEGYDELKA-HP 278
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 46/143 (32%), Positives = 70/143 (48%), Gaps = 25/143 (17%)
Query: 123 ELPILVFEFVACGTL-ADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVF 181
E+ +L+ EF+ G+L I D E FL VA +I + +AYLH R IV
Sbjct: 146 EIQVLL-EFMDGGSLEGTHIAD------EQFLAD----VARQILSGIAYLH---RRHIVH 191
Query: 182 RDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNE- 240
RDIKPS +L K DF VS + + ++ N +GT +++PE ++T + N
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRILAQT---MDPCNSSVGTIAYMSPERINT-DLNHG 247
Query: 241 -----KSDVYSFGALLLELLTGK 258
D++S G +LE G+
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 48/160 (30%), Positives = 74/160 (46%), Gaps = 16/160 (10%)
Query: 108 SHKNILKFVGCCL-ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIAN 166
+ I+ F G ++ I + E++ G+L + + G E L K +A+ +
Sbjct: 57 NSPYIVGFYGAFYNNGDISICM-EYMDGGSLDKILKEVQGRIPERILGK----IAVAVLK 111
Query: 167 AVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKV-IGTF 225
+ YLH I+ RD+KPS IL + K DF VS VN K +GT
Sbjct: 112 GLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVS------GQLVNSLAKTFVGTS 163
Query: 226 GFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSC 265
++APE + + + KSD++S G L+EL TG R Y
Sbjct: 164 SYMAPERIQGNDYSVKSDIWSLGLSLIELATG-RFPYPPE 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 45/154 (29%), Positives = 67/154 (43%), Gaps = 13/154 (8%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIA 165
Q+ H+NI+ LVFE+V L P G L P ++ ++
Sbjct: 56 QLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGG--LPPDAVR---SYIWQLL 110
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT-HVNDNNKVIGT 224
A+AY H S I+ RDIKP IL E V K DF + ++ + D + T
Sbjct: 111 QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD---YVAT 164
Query: 225 FGFIAPEYM-STANCNEKSDVYSFGALLLELLTG 257
+ APE + N + DV++ G ++ ELL G
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 41/170 (24%), Positives = 72/170 (42%), Gaps = 23/170 (13%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIH--------------DPNGSQL-- 149
Q++H +++K G C + +L+ E+ G+L + + N S L
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 150 ---EPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206
M + A +I+ + YL +V RD+ +L E K DF +S
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
+ E ++V + I ++A E + +SDV+SFG LL E++T
Sbjct: 176 DVYEEDSYVKRSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 52/169 (30%), Positives = 73/169 (43%), Gaps = 32/169 (18%)
Query: 101 IAFASQMSHKNILKFVGCCL-ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLK 159
I+ Q I+K+ G T+L I V E+ G+++D +MK K
Sbjct: 49 ISILKQCDSPYIVKYYGSYFKNTDLWI-VMEYCGAGSVSD-------------IMKITNK 94
Query: 160 VAME--IA-------NAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210
E IA + YLH S + RDIK IL E+ AK DF VS +
Sbjct: 95 TLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL-- 149
Query: 211 GKTHVN-DNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
T N VIGT ++APE + N K+D++S G +E+ GK
Sbjct: 150 --TDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-10
Identities = 39/155 (25%), Positives = 74/155 (47%), Gaps = 8/155 (5%)
Query: 102 AFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVA 161
A ++ H N+++ +G C ++ EF+ G L D + + N ++ ++ L +A
Sbjct: 54 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL---LYMA 110
Query: 162 MEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKV 221
+I++A+ YL + + RD+ L E ++ K DF +S + + K
Sbjct: 111 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 167
Query: 222 IGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
+ APE ++ + KSDV++FG LL E+ T
Sbjct: 168 --PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-10
Identities = 34/160 (21%), Positives = 71/160 (44%), Gaps = 10/160 (6%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
I ++++H +I++ +G E L E++A G+++ + F +
Sbjct: 54 IRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK-----YGAFKEAVIINY 108
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ-NVAKFFDFCVSISIPEGKTHVND-N 218
++ ++YLH I+ RD+K + +L + DF + + T +
Sbjct: 109 TEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQ 165
Query: 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
+++GT F+APE + DV+S G +++E+ T K
Sbjct: 166 GQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 5e-10
Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 12/206 (5%)
Query: 54 TNNYDPEKVITKDLLYKLYKG--FLQDRPISVMK---FGGNLNSEEYCCFNCIAFASQMS 108
N+ EK I K +YK L R +++ K F C I Q+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 109 HKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAV 168
H N++K++ +E +V E G L+ I Q + K +++ +A+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSAL 119
Query: 169 AYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFI 228
++H S+ I+ RDIKP+ + V K D + T + ++GT ++
Sbjct: 120 EHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH---SLVGTPYYM 173
Query: 229 APEYMSTANCNEKSDVYSFGALLLEL 254
+PE + N KSD++S G LL E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 6e-10
Identities = 41/166 (24%), Positives = 68/166 (40%), Gaps = 9/166 (5%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDPNGSQLEPFLMKHRLKVAM 162
S+ +H+NI++ +G E ++ E +A G L R + P + MK L A
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQ---EQNVAKFFDFCVSISIPEGKTHVNDNN 219
++A YL + RDI L VAK DF ++ I ++
Sbjct: 124 DVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI-YRASYYRKGG 179
Query: 220 KVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSC 265
+ + ++ PE K+DV+SFG LL E+ + + Y
Sbjct: 180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-10
Identities = 53/189 (28%), Positives = 88/189 (46%), Gaps = 11/189 (5%)
Query: 70 KLYKGFLQDR-PISVMKFGGNLNSEEYCCFNCIA-FASQMSHKNILKFVGCCLETELPIL 127
+++KG L+D+ P++V +L E F A Q H NI+K +G C + + +
Sbjct: 10 EVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYI 69
Query: 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPS 187
V E V G + + + K +K A++ A +AYL S+ + RD+
Sbjct: 70 VMELVPGGDFLSFLR----KKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAAR 122
Query: 188 TILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSF 247
L E NV K DF +S +G + + K I + APE ++ + +SDV+S+
Sbjct: 123 NCLVGENNVLKISDFGMSRQEDDG-IYSSSGLKQI-PIKWTAPEALNYGRYSSESDVWSY 180
Query: 248 GALLLELLT 256
G LL E +
Sbjct: 181 GILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 7e-10
Identities = 52/229 (22%), Positives = 104/229 (45%), Gaps = 29/229 (12%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIA 165
Q+ H NI+++ LE + +V + + L + + + + F + + +++
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLK-EKKQRFTEERIWNIFVQMV 123
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTF 225
A+ YLH + IV RD+ P+ I+ E + DF + + K + V+GT
Sbjct: 124 LALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF----GLAKQKQPESKLTSVVGTI 177
Query: 226 GFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285
+ PE + EK+DV++FG +L ++ T + YS+ + L K +E+
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN--------MLSLATKIVEA- 228
Query: 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVA 334
+ +P+ EG++ E T++ CL+ + RP ++QV+
Sbjct: 229 ----VYEPL---PEGMYSED------VTDVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 52/242 (21%), Positives = 93/242 (38%), Gaps = 40/242 (16%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDP--NGSQLEPFLMKHRLKV 160
++SHKN+++ +G C E E ++ E+ G L R + P K ++ +
Sbjct: 63 RKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE-GKTHVNDN- 218
+IA + +L +R V RD+ L Q K +S+ K N
Sbjct: 123 CTQIALGMDHLSN--AR-FVHRDLAARNCLVSSQREVK-------VSLLSLSKDVYNSEY 172
Query: 219 ---NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQ 275
+ ++APE + + + KSDV+SFG L+ E+ T + + +E L
Sbjct: 173 YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL---SDEEVLN 229
Query: 276 ELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335
L +E P E +L +C + + +DRP+ ++
Sbjct: 230 RLQAGKLE------------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271
Query: 336 QL 337
L
Sbjct: 272 AL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 1e-09
Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 26/163 (15%)
Query: 109 HKNILKFVGCCLETELP------ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAM 162
H+NI + G ++ P LV EF G++ D I + G+ L+ + + +
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY---ICR 118
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVI 222
EI +++LH ++ RDIK +L E K DF VS + V N I
Sbjct: 119 EILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT---VGRRNTFI 172
Query: 223 GTFGFIAPEYMSTANCNE--------KSDVYSFGALLLELLTG 257
GT ++APE ++ C+E KSD++S G +E+ G
Sbjct: 173 GTPYWMAPEVIA---CDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 46/174 (26%), Positives = 79/174 (45%), Gaps = 8/174 (4%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIA 165
Q SH NI++ +G C + + +V E V G + G +L+ +K +++ A
Sbjct: 49 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT-EGPRLK---VKELIQMVENAA 104
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTF 225
+ YL S+ + RD+ L E+NV K DF +S +G K I
Sbjct: 105 AGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI-PV 160
Query: 226 GFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR 279
+ APE ++ + +SDV+SFG LL E + + Y++ +++ VR
Sbjct: 161 KWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR 214
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 43/158 (27%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 106 QMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
Q+ H +++ T+ PI ++ E++ G+L D + P G +L + + +A +I
Sbjct: 57 QLQHPRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPEGIKLT---INKLIDMAAQI 111
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
A +A++ + + RD++ + IL E K DF ++ I + + + K
Sbjct: 112 AEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF--P 166
Query: 225 FGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISY 262
+ APE ++ KSDV+SFG LL E++T RI Y
Sbjct: 167 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 45/163 (27%), Positives = 69/163 (42%), Gaps = 23/163 (14%)
Query: 109 HKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDPNGSQL---------EPFLMKHR 157
HKNI+ +G C + +V E+ A G L D R P G E K
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 158 LKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217
+ A ++A + +L S+ + RD+ +L E +V K DF ++ I H D
Sbjct: 135 VSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDI-----HHID 186
Query: 218 NNKVIGT----FGFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
+ ++APE + +SDV+SFG LL E+ T
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 41/171 (23%), Positives = 73/171 (42%), Gaps = 22/171 (12%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIA 165
++SH N+++ G C + +V E++A G L + + + + L + ++
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLR----ERKGKLGTEWLLDMCSDVC 110
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTF 225
A+ YL S + RD+ L E NV K DF G +++ +
Sbjct: 111 EAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDF--------GLARYVLDDQYTSSQ 159
Query: 226 G------FIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGE 270
G + PE + + KSDV+SFG L+ E+ + ++ Y F N E
Sbjct: 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER-FSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 32/101 (31%), Positives = 46/101 (45%), Gaps = 10/101 (9%)
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF------CVSISIPEGKTHVN 216
EI A+ YLH S I+ RD+KP IL K DF V I
Sbjct: 101 EIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK- 156
Query: 217 DNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
++ +++GT +IAPE + ++ D +S G +L E L G
Sbjct: 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 71/292 (24%), Positives = 127/292 (43%), Gaps = 37/292 (12%)
Query: 56 NYDPEKVITKDLLYKLYKG--FLQDRPISVMK---FGGNLNSEEYCCFNCIAFASQMSHK 110
N+ EK I + ++Y+ L +P+++ K F C I Q++H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 111 NILKFVGCCLETELPILVFEFVACGTLADRI-HDPNGSQLEPFLMKHRLKVAMEIANAVA 169
N++K++ +E +V E G L+ I + +L P + K +++ +AV
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIP--ERTVWKYFVQLCSAVE 120
Query: 170 YLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIA 229
++H SR ++ RDIKP+ + V K D + T + ++GT +++
Sbjct: 121 HMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH---SLVGTPYYMS 174
Query: 230 PEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289
PE + N KSD++S G LL E+ + Y G++ L L +K IE +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFY------GDKMNLFSLCQK-IEQCDY-- 225
Query: 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM---VQVAKQLR 338
P + E + EK ++L+S C+ RP + Q+AKQ+
Sbjct: 226 ---PPLPTEH--YSEKLRELVSM------CIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 59/246 (23%), Positives = 109/246 (44%), Gaps = 29/246 (11%)
Query: 97 CFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRI-HDPNGSQLEPFLMK 155
C I Q++H N++K+ +E +V E G L+ I H +L P K
Sbjct: 49 CIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP--EK 106
Query: 156 HRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHV 215
K +++ +A+ ++H SR ++ RDIKP+ + V K D + T
Sbjct: 107 TVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163
Query: 216 NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQ 275
+ ++GT +++PE + N KSD++S G LL E+ + Y G++ L
Sbjct: 164 H---SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY------GDKMNLY 214
Query: 276 ELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335
L +K IE + P + + + E+ +QL++ C++ + RP + V
Sbjct: 215 SLCKK-IEQCDY-----PPLPSDH--YSEELRQLVNM------CINPDPEKRPDITYVYD 260
Query: 336 QLRQLH 341
+++H
Sbjct: 261 VAKRMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 48/187 (25%), Positives = 75/187 (40%), Gaps = 27/187 (14%)
Query: 107 MSHKNILKFVG---------CCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKH 156
M+ K +L G C +T+ + V E+V G L I + F
Sbjct: 43 MTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ-----RSGRFDEPR 97
Query: 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN 216
A EI + +LH R I++RD+K +L + K DF + EG
Sbjct: 98 ARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMC---KEGILGGV 151
Query: 217 DNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFE-NGEEYFLQ 275
+ GT +IAPE +S D ++ G LL E+L G+ S FE + E+ Q
Sbjct: 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ-----SPFEGDDEDELFQ 206
Query: 276 ELVRKSI 282
++ +
Sbjct: 207 SILEDEV 213
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 49/171 (28%), Positives = 80/171 (46%), Gaps = 21/171 (12%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDPN------GSQLEPFLMKH 156
+ + H++I+KF G C+E + I+VFE++ G L R H P+ G++
Sbjct: 62 TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121
Query: 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN 216
L +A +IA + YL S+ V RD+ L E + K DF +S + +
Sbjct: 122 MLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV-----YST 173
Query: 217 DNNKVIG----TFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISY 262
D +V G ++ PE + +SDV+S G +L E+ T GK+ Y
Sbjct: 174 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 37/153 (24%), Positives = 60/153 (39%), Gaps = 32/153 (20%)
Query: 159 KVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDN 218
+ E+ V LH R I+ RDIKP +L + K DF +S + +N
Sbjct: 101 QYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLS-------RNGLEN 150
Query: 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELV 278
K +GT ++APE + ++ SD +S G ++ E L G
Sbjct: 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYP------------------- 191
Query: 279 RKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLS 311
+ + + D I+ WPE+ K+ S
Sbjct: 192 --PFHAETPDAVFDNILSRRIN-WPEEVKEFCS 221
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 34/155 (21%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 107 MSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIAN 166
+ H ++++ +G CL + L+ + + G L D + + + + L ++IA
Sbjct: 66 VDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKD-NIGSQYL---LNWCVQIAK 120
Query: 167 AVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN-DNNKVIGTF 225
++YL + +V RD+ +L + K DF ++ + + + + KV
Sbjct: 121 GMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV--PI 175
Query: 226 GFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKR 259
++A E + KSDV+S+G + EL+T G +
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 38/156 (24%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 107 MSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIAN 166
+ H +++ + E ++ E++A G+L D + G ++ L+ + + +IA
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKV---LLPKLIDFSAQIAE 114
Query: 167 AVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFG 226
+AY+ + + RD++ + +L E + K DF ++ I + + + K
Sbjct: 115 GMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF--PIK 169
Query: 227 FIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISY 262
+ APE ++ + KSDV+SFG LL E++T +I Y
Sbjct: 170 WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 45/163 (27%), Positives = 74/163 (45%), Gaps = 26/163 (15%)
Query: 109 HKNILKFVGCCLETELP------ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAM 162
H+NI + G ++ P LV EF G++ D + + G+ L+ + + +
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY---ICR 128
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVI 222
EI +A+LH ++ RDIK +L E K DF VS + V N I
Sbjct: 129 EILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT---VGRRNTFI 182
Query: 223 GTFGFIAPEYMSTANCNE--------KSDVYSFGALLLELLTG 257
GT ++APE ++ C+E +SD++S G +E+ G
Sbjct: 183 GTPYWMAPEVIA---CDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 5e-09
Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 18/170 (10%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVF-EFVACGTLADRIHDPNGSQLEPFLMKHRLK 159
IA S++ H NI++++G E + + +F E V G+LA ++ GS EP + +
Sbjct: 53 IALLSKLQHPNIVQYLGTEREED-NLYIFLELVPGGSLA-KLLKKYGSFPEPVIRLY--- 107
Query: 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNN 219
+I + YLH R V RDIK + IL V K DF ++ + E
Sbjct: 108 -TRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE-----FSFA 158
Query: 220 K-VIGTFGFIAPEY-MSTANCNEKSDVYSFGALLLELLTGKRISYSSCFE 267
K G+ ++APE +D++S G +LE+ TGK +S
Sbjct: 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK-PPWSQLEG 207
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 43/142 (30%), Positives = 71/142 (50%), Gaps = 9/142 (6%)
Query: 122 TELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIV 180
+E PI +V EF+ G+L D + + +G L+ + + +A +IA+ +AY+ +
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDGKYLK---LPQLVDMAAQIADGMAYIE---RMNYI 124
Query: 181 FRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNE 240
RD++ + IL + V K DF ++ I + + K + APE
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTI 182
Query: 241 KSDVYSFGALLLELLTGKRISY 262
KSDV+SFG LL EL+T R+ Y
Sbjct: 183 KSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 6e-09
Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 9/158 (5%)
Query: 101 IAFASQMSHKNILKFVGCCLET--ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRL 158
I + H+NI+K+ G C E L+ EF+ G+L + + N +++ +K +L
Sbjct: 57 IEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKIN---LKQQL 112
Query: 159 KVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDN 218
K A++I + YL SR V RD+ +L + ++ K DF ++ +I K +
Sbjct: 113 KYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 169
Query: 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
+ + + APE + + SDV+SFG L ELLT
Sbjct: 170 DDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 7e-09
Identities = 42/166 (25%), Positives = 65/166 (39%), Gaps = 29/166 (17%)
Query: 106 QMSHKNILKFVGCCLETELP--ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAM- 162
++ H NI++ +VFE++ HD G L +K
Sbjct: 54 KLRHPNIVRLKEIVTSKGKGSIYMVFEYMD--------HDLTG-----LLDSPEVKFTES 100
Query: 163 -------EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHV 215
++ + YLH S I+ RDIK S IL V K DF ++ +
Sbjct: 101 QIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPY-TKRNSA 156
Query: 216 NDNNKVIGTFGFIAPE-YMSTANCNEKSDVYSFGALLLELLTGKRI 260
+ N+VI T + PE + + D++S G +L EL GK I
Sbjct: 157 DYTNRVI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 8e-09
Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 15/159 (9%)
Query: 109 HKNILKFVGCCLETELPILVFEFVACGTLADRI-----------HDPNGSQLEPFLMKHR 157
HKNI+ +G C + ++ E+ + G L + + ++P E K
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 158 LKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217
+ A ++A + YL S+ + RD+ +L E NV K DF ++ I +
Sbjct: 143 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
N + ++APE + +SDV+SFG LL E+ T
Sbjct: 200 TNGRL-PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 48/170 (28%), Positives = 79/170 (46%), Gaps = 11/170 (6%)
Query: 92 SEEYCCFNC-IAFASQMSHKNILKFVGCCLE-TELPILVF-EFVACGTLADRIHDPNGSQ 148
S+E C I + H+ I+++ GC + E + +F E++ G++ D++ G+
Sbjct: 45 SKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGAL 103
Query: 149 LEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208
E K+ +I ++YLH S IV RDIK + IL K DF S +
Sbjct: 104 TESVTRKY----TRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156
Query: 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
V GT +++PE +S K+DV+S G ++E+LT K
Sbjct: 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 43/159 (27%), Positives = 71/159 (44%), Gaps = 15/159 (9%)
Query: 109 HKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDPNGSQL---------EPFLMKHR 157
HKNI+ +G C + ++ E+ A G L + R P G E K
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 158 LKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217
+ A ++A + YL SR + RD+ +L E NV K DF ++ + + +
Sbjct: 137 VSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
+N + ++APE + +SDV+SFG L+ E+ T
Sbjct: 194 SNGRL-PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 41/145 (28%), Positives = 65/145 (44%), Gaps = 28/145 (19%)
Query: 131 FVACGTLADRIHDP----------NGSQLEPFLMKHRLK-------VAMEIANAVAYLHV 173
F+ C T A H P NG L L +H + A EI + ++H
Sbjct: 58 FIVCMTYA--FHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH- 114
Query: 174 GFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYM 233
+R +V+RD+KP+ IL E + D ++ + K H + +GT G++APE +
Sbjct: 115 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVL 167
Query: 234 STANCNEKS-DVYSFGALLLELLTG 257
+ S D +S G +L +LL G
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 46/153 (30%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 108 SHKNILKFVGCCLETE-LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVA--MEI 164
SH N+L +G CL +E P++V ++ G L + I + L+ L+VA ME
Sbjct: 54 SHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGME- 112
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH-VNDNNKVIG 223
YL S+ V RD+ + E K DF ++ I + + + V+++
Sbjct: 113 -----YLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL 164
Query: 224 TFGFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
++A E + T KSDV+SFG LL EL+T
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 49/171 (28%), Positives = 80/171 (46%), Gaps = 24/171 (14%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDPNGSQL---EPFLMK---- 155
+ + H++I+KF G C + + I+VFE++ G L R H P+ L +P K
Sbjct: 62 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121
Query: 156 --HRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213
L +A +IA+ + YL S+ V RD+ L + K DF +S +
Sbjct: 122 LSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV----- 173
Query: 214 HVNDNNKVIG----TFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKR 259
+ D +V G ++ PE + +SDV+SFG +L E+ T GK+
Sbjct: 174 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVI 222
E+A A+ +LH S I++RD+KP IL E+ K DF +S E H
Sbjct: 106 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLS---KESIDHEKKAYSFC 159
Query: 223 GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
GT ++APE ++ + +D +SFG L+ E+LTG
Sbjct: 160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 59/242 (24%), Positives = 96/242 (39%), Gaps = 46/242 (19%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDPNGSQLEPFLMKHRL 158
+ F Q+ H N +++ GC L+ LV E+ G+ +D +H ++E + H
Sbjct: 72 VKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAITH-- 128
Query: 159 KVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF-CVSISIPEGKTHVND 217
+AYLH S ++ RDIK IL E K DF S S P
Sbjct: 129 ----GALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA------- 174
Query: 218 NNKVIGTFGFIAPEY---MSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFL 274
N +GT ++APE M + K DV+S G +EL K ++ + Y +
Sbjct: 175 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHI 232
Query: 275 QELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVA 334
+ +++SN W + + + Y CL K Q+RP ++
Sbjct: 233 AQNDSPTLQSNE---------------WTDSFRGFVDY------CLQKIPQERPASAELL 271
Query: 335 KQ 336
+
Sbjct: 272 RH 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 31/209 (14%)
Query: 122 TELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIV 180
+E PI +V E+++ G+L D + D G L+ + + + +A ++A +AY+ +
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKDGEGRALK---LPNLVDMAAQVAAGMAYIE---RMNYI 124
Query: 181 FRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNE 240
RD++ + IL + V K DF ++ I + + K + APE
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTI 182
Query: 241 KSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEG 300
KSDV+SFG LL EL+T R+ Y + +E+++ + G
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGM--------------------NNREVLEQVERGYRM 222
Query: 301 LWPEKEKQLLSYTELAIKCLSKSEQDRPT 329
P+ +S EL ++C K ++RPT
Sbjct: 223 PCPQDCP--ISLHELMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 31/209 (14%)
Query: 122 TELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIV 180
+E PI +V E+++ G+L D + G L + + +A +IA+ +AY+ V
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLR---LPQLVDMAAQIASGMAYVE---RMNYV 124
Query: 181 FRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNE 240
RD++ + IL E V K DF ++ I + + K + APE
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTI 182
Query: 241 KSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEG 300
KSDV+SFG LL EL T R+ Y +E++D + G
Sbjct: 183 KSDVWSFGILLTELTTKGRVPYPGMVN--------------------REVLDQVERGYRM 222
Query: 301 LWPEKEKQLLSYTELAIKCLSKSEQDRPT 329
P + + S +L +C K ++RPT
Sbjct: 223 PCPPECPE--SLHDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 40/159 (25%), Positives = 69/159 (43%), Gaps = 15/159 (9%)
Query: 109 HKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDPNGSQL---------EPFLMKHR 157
HKNI+ +G C + ++ E+ + G L + R P G + E K
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 158 LKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217
+ ++A + YL S+ + RD+ +L E NV K DF ++ + +
Sbjct: 140 VSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
N + ++APE + +SDV+SFG L+ E+ T
Sbjct: 197 TNGRL-PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 50/171 (29%), Positives = 77/171 (45%), Gaps = 13/171 (7%)
Query: 92 SEEYCCFNC-IAFASQMSHKNILKFVGCCLETE---LPILVFEFVACGTLADRIHDPNGS 147
S+E C I + H I+++ GC + E L I V E++ G++ D++ G+
Sbjct: 45 SKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFV-EYMPGGSIKDQL-KAYGA 102
Query: 148 QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207
E ++ +I V+YLH S IV RDIK + IL K DF S
Sbjct: 103 LTENVTRRY----TRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155
Query: 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
I V GT +++PE +S K+DV+S ++E+LT K
Sbjct: 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 12/98 (12%)
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF--CVSISIPEG-KTHVNDNN 219
EI+ A+ +LH + I++RD+KP IL Q K DF C SI EG TH
Sbjct: 108 EISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKE-SIHEGTVTHT---- 159
Query: 220 KVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
GT ++APE + + + D +S GAL+ ++LTG
Sbjct: 160 -FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 42/172 (24%), Positives = 72/172 (41%), Gaps = 21/172 (12%)
Query: 102 AFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLE----------- 150
A ++ H NI+K +G C + L+FE++A G L + + +
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119
Query: 151 ------PFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV 204
P +L +A ++A +AYL R V RD+ L E V K DF +
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGL 176
Query: 205 SISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
S +I + N I ++ PE + +SDV+++G +L E+ +
Sbjct: 177 SRNIYSADYYKASENDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 99 NCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRL 158
N I + H NI+ ++ L + +V E++A G+L D + + + ++ +
Sbjct: 65 NEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIA--- 118
Query: 159 KVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKF--FDFCVSISIPEGKTHVN 216
V E A+ +LH S ++ RDIK IL K F FC I+ PE +
Sbjct: 119 AVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQ----S 170
Query: 217 DNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
+ ++GT ++APE ++ K D++S G + +E++ G+
Sbjct: 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 40/165 (24%), Positives = 78/165 (47%), Gaps = 20/165 (12%)
Query: 98 FNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHR 157
FN + H+N++ L + +V EF+ G L D + ++ +
Sbjct: 67 FNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------EQI 120
Query: 158 LKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKF--FDFCVSIS--IPEGKT 213
V + + A++YLH ++ ++ RDIK +IL K F FC +S +P+ K+
Sbjct: 121 ATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS 177
Query: 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
++GT ++APE +S + D++S G +++E++ G+
Sbjct: 178 -------LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 46/171 (26%), Positives = 82/171 (47%), Gaps = 22/171 (12%)
Query: 98 FNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHR 157
FN + H+N+++ L E ++ EF+ G L D + SQ L + +
Sbjct: 66 FNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV-----SQTR--LNEEQ 118
Query: 158 LKVAME-IANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKF--FDFCVSIS--IPEGK 212
+ E + A+ YLH S+ ++ RDIK +IL K F FC IS +P+ K
Sbjct: 119 IATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175
Query: 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYS 263
+ ++GT ++APE +S + D++S G +++E++ G+ +S
Sbjct: 176 S-------LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 38/125 (30%), Positives = 61/125 (48%), Gaps = 18/125 (14%)
Query: 140 RIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKF 199
+++D + E L K +A+ I A+ YLH S ++ RD+KPS +L K
Sbjct: 92 KVYDKGLTIPEDILGK----IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKL 145
Query: 200 FDFCVSISIPEGKTHVNDNNKVI--GTFGFIAPEY----MSTANCNEKSDVYSFGALLLE 253
DF +S + V+ K I G ++APE ++ + KSDV+S G ++E
Sbjct: 146 CDFGISGYL------VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE 199
Query: 254 LLTGK 258
L TG+
Sbjct: 200 LATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 42/142 (29%), Positives = 73/142 (51%), Gaps = 9/142 (6%)
Query: 122 TELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIV 180
T+ PI ++ EF+A G+L D + GS+ + + + +IA +A++ R +
Sbjct: 71 TKEPIYIITEFMAKGSLLDFLKSDEGSKQP---LPKLIDFSAQIAEGMAFIE---QRNYI 124
Query: 181 FRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNE 240
RD++ + IL V K DF ++ I + + + K + APE ++ +
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGSFTI 182
Query: 241 KSDVYSFGALLLELLTGKRISY 262
KSDV+SFG LL+E++T RI Y
Sbjct: 183 KSDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 46/160 (28%), Positives = 72/160 (45%), Gaps = 25/160 (15%)
Query: 105 SQMSHKNILKFVGCCL-ETELPILVFEFVACGTLADRIHDPNGSQL-EP---FLMKHRLK 159
S+ H NI+ E +L IL+ EF G L D I L EP ++ + L+
Sbjct: 57 SECKHPNIVGLYEAYFYENKLWILI-EFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLE 114
Query: 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNN 219
A+ +LH S ++ RD+K IL K DF VS + K+ + +
Sbjct: 115 -------ALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVS---AKNKSTLQKRD 161
Query: 220 KVIGTFGFIAPEYMSTANC-----NEKSDVYSFGALLLEL 254
IGT ++APE ++ + K+D++S G L+EL
Sbjct: 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 6e-08
Identities = 44/158 (27%), Positives = 69/158 (43%), Gaps = 12/158 (7%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
I Q+ H+N++ + + LVFEFV L D PNG L+ ++ K
Sbjct: 51 IRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVR---KY 105
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
+I + + H S I+ RDIKP IL + V K DF + ++ D
Sbjct: 106 LFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD--- 159
Query: 221 VIGTFGFIAPEYM-STANCNEKSDVYSFGALLLELLTG 257
+ T + APE + D+++ G L+ E+LTG
Sbjct: 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 7e-08
Identities = 49/182 (26%), Positives = 79/182 (43%), Gaps = 17/182 (9%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
+A S M H NI+++ E +V ++ G L +I+ G F L
Sbjct: 50 VAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGV---LFPEDQILDW 106
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
++I A+ ++H R I+ RDIK I + K DF ++ + + V
Sbjct: 107 FVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL---NSTVELART 160
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280
IGT +++PE N KSD+++ G +L E+ T K FE G ++ LV K
Sbjct: 161 CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKH-----AFEAGN---MKNLVLK 212
Query: 281 SI 282
I
Sbjct: 213 II 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-08
Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 12/158 (7%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
I SQ + K+ G L+ ++ E++ G+ D + + F + LK
Sbjct: 53 ITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR---AGPFDEFQIATMLK- 108
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
EI + YLH S + RDIK + +L EQ K DF V+ + + + N
Sbjct: 109 --EILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---KRNT 160
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
+GT ++APE + + + K+D++S G +EL G+
Sbjct: 161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 7e-08
Identities = 44/166 (26%), Positives = 72/166 (43%), Gaps = 19/166 (11%)
Query: 102 AFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLM--KHRLK 159
S +H NI+K +G CL E ++ E + G L + D + P L+ K L
Sbjct: 51 HLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLD 110
Query: 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN-----VAKFFDFCVSISIPEGKTH 214
+ +++A YL + RD+ L E+ V K DF ++ I +
Sbjct: 111 ICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI-----Y 162
Query: 215 VNDNNKVIG----TFGFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
+D + G ++APE + +SDV+SFG L+ E+LT
Sbjct: 163 KSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 7/100 (7%)
Query: 159 KVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDN 218
KV++ + +AYL I+ RD+KPS IL + K DF VS G+ +
Sbjct: 107 KVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMA 159
Query: 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
N +GT +++PE + + + +SD++S G L+EL G+
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 8e-08
Identities = 43/163 (26%), Positives = 71/163 (43%), Gaps = 22/163 (13%)
Query: 101 IAFASQMSHKNILKFVGCCLE-TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLK 159
I F SQ I K+ G L+ ++L I + E+ G+ D + + +
Sbjct: 50 IQFLSQCRSPYITKYYGSFLKGSKLWI-IMEYCGGGSCLDLL------KPGKLDETYIAF 102
Query: 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDN- 218
+ E+ + YLH + RDIK + IL E+ K DF VS +
Sbjct: 103 ILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVS-------GQLTSTM 152
Query: 219 ---NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
N +GT ++APE + + +EK+D++S G +EL G+
Sbjct: 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 8e-08
Identities = 40/165 (24%), Positives = 74/165 (44%), Gaps = 20/165 (12%)
Query: 98 FNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDP--NGSQLEPFLMK 155
FN + H+N+++ L + +V EF+ G L D + N Q+
Sbjct: 65 FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----- 119
Query: 156 HRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKF--FDFCVSISIPEGKT 213
V + + A++ LH ++ ++ RDIK +IL K F FC +S
Sbjct: 120 ---AVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-----K 168
Query: 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
V ++GT ++APE +S + D++S G +++E++ G+
Sbjct: 169 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 8e-08
Identities = 45/172 (26%), Positives = 77/172 (44%), Gaps = 25/172 (14%)
Query: 159 KVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDN 218
++A+ + + YL +S I+ RD+KPS +L + K DF VS + VN
Sbjct: 99 RIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL------VNSI 149
Query: 219 NKV-IGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL 277
K +GT ++APE +S SDV+S G +EL G R Y +N +L
Sbjct: 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALG-RFPYPQIQKNQGSLMPLQL 208
Query: 278 VRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT 329
++ ++ + P++ G + EK + +C+ K ++RP
Sbjct: 209 LQCIVDEDP------PVL--PVGQFSEK------FVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-08
Identities = 55/234 (23%), Positives = 100/234 (42%), Gaps = 35/234 (14%)
Query: 105 SQMSHKNILKFVGCCL-ETELPILVFEFVACGTLADRIHDPNGSQL-EPFLMKHRLKVAM 162
SQ+ H NI+ + E L +V F G L ++ + G L E +++ +++AM
Sbjct: 54 SQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAM 113
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVI 222
A+ YLH + I+ RD+K + N+ K D ++ + + + + +I
Sbjct: 114 ----ALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL---ENQCDMASTLI 163
Query: 223 GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282
GT +++PE S N KSDV++ G + E+ T ++ +
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT---------------------LKHAF 202
Query: 283 ESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336
+ +V II G+ P+ L EL LSK + RP++ + +Q
Sbjct: 203 NAKDMNSLVYRIIEGKLPPMPKDYSPELG--ELIATMLSKRPEKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 9e-08
Identities = 43/159 (27%), Positives = 69/159 (43%), Gaps = 23/159 (14%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHR------L 158
+Q+ H I++ +G C L +LV E G L +L K R L
Sbjct: 51 AQLDHPCIVRLIGVCKGEPL-MLVMELAPLGPLLK------------YLKKRREIPVSDL 97
Query: 159 KV-AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217
K A ++A +AYL S+ V RD+ +L ++ AK DF +S ++ G +
Sbjct: 98 KELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154
Query: 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
+ APE ++ + KSDV+S+G L E +
Sbjct: 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 32/96 (33%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 164 IANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG-KTHVNDNNKVI 222
+ A YLH +R I++RD+KP +L K DF + + G KT
Sbjct: 102 VVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-----FC 153
Query: 223 GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
GT ++APE + + D +S G LL ELLTG+
Sbjct: 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 44/167 (26%), Positives = 71/167 (42%), Gaps = 23/167 (13%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
IA S + H+NI++++G E + E V G+L+ + S+ P + +
Sbjct: 56 IALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLR----SKWGPLKDNEQTII 111
Query: 161 --AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE-QNVAKFFDFCVSISI----PEGKT 213
+I + YLH IV RDIK +L V K DF S + P +T
Sbjct: 112 FYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET 168
Query: 214 HVNDNNKVIGTFGFIAPEYMSTA--NCNEKSDVYSFGALLLELLTGK 258
GT ++APE + +D++S G ++E+ TGK
Sbjct: 169 FT-------GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 9/98 (9%)
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
A EI + ++H F +V+RD+KP+ IL E + D ++ + K H +
Sbjct: 103 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 155
Query: 221 VIGTFGFIAPEYMSTANCNEKS-DVYSFGALLLELLTG 257
+GT G++APE + + S D +S G +L +LL G
Sbjct: 156 -VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 42/159 (26%), Positives = 69/159 (43%), Gaps = 15/159 (9%)
Query: 109 HKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDPNGSQL---------EPFLMKHR 157
HKNI+ +G C + ++ E+ + G L + R P G E K
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 158 LKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217
+ A ++A + YL S+ + RD+ +L E NV K DF ++ + +
Sbjct: 137 VSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
N + ++APE + +SDV+SFG LL E+ T
Sbjct: 194 TNGRL-PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 66/267 (24%), Positives = 108/267 (40%), Gaps = 53/267 (19%)
Query: 81 ISVMKFGGNLNSEEYC-CFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLAD 139
I M + G ++E++ + F ++ H N +++ GC L LV E+ G+ +D
Sbjct: 55 IKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY-CLGSASD 113
Query: 140 --RIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA 197
+H ++E + H A++ +AYLH S ++ RDIK IL E
Sbjct: 114 LLEVHKKPLQEVEIAAITHG---ALQ---GLAYLH---SHNMIHRDIKAGNILLTEPGQV 164
Query: 198 KFFDF-CVSISIPEGKTHVNDNNKVIGTFGFIAPEY---MSTANCNEKSDVYSFGALLLE 253
K DF SI+ P N +GT ++APE M + K DV+S G +E
Sbjct: 165 KLADFGSASIASPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 216
Query: 254 LLTGKRISYSSCFENGEEYFLQE---LVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLL 310
L K ++ + + Q ++ + S+ F+ VD
Sbjct: 217 LAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD------------------ 258
Query: 311 SYTELAIKCLSKSEQDRPTMVQVAKQL 337
CL K QDRPT ++ K +
Sbjct: 259 -------SCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 64/259 (24%), Positives = 102/259 (39%), Gaps = 53/259 (20%)
Query: 81 ISVMKFGGNLNSEEYC-CFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLAD 139
I M + G ++E++ + F ++ H N +++ GC L LV E+ G+ +D
Sbjct: 45 IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-CLGSASD 103
Query: 140 --RIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA 197
+H ++E + H A++ +AYLH S ++ RD+K IL E +
Sbjct: 104 LLEVHKKPLQEVEIAAVTHG---ALQ---GLAYLH---SHNMIHRDVKAGNILLSEPGLV 154
Query: 198 KFFDF-CVSISIPEGKTHVNDNNKVIGTFGFIAPEY---MSTANCNEKSDVYSFGALLLE 253
K DF SI P N +GT ++APE M + K DV+S G +E
Sbjct: 155 KLGDFGSASIMAPA--------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 206
Query: 254 LLTGKRISYSSCFENGEEYFLQE---LVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLL 310
L K ++ + + Q ++ S F+ VD
Sbjct: 207 LAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD------------------ 248
Query: 311 SYTELAIKCLSKSEQDRPT 329
CL K QDRPT
Sbjct: 249 -------SCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 27/107 (25%), Positives = 50/107 (46%), Gaps = 13/107 (12%)
Query: 158 LKVAMEIANAVAYLHVGF--SRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG---- 211
++ ++ A+ H ++ RD+KP+ I N K DF ++ +
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167
Query: 212 KTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
KT+V GT +++PE ++ + +EKSD++S G L+ EL
Sbjct: 168 KTYV-------GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 48/170 (28%), Positives = 78/170 (45%), Gaps = 11/170 (6%)
Query: 92 SEEYCCFNC-IAFASQMSHKNILKFVGCCLET-ELPILVF-EFVACGTLADRIHDPNGSQ 148
S+E C I + H+ I+++ GC + E + +F E + G++ D++ G+
Sbjct: 45 SKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKS-YGAL 103
Query: 149 LEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208
E K+ +I V+YLH S IV RDIK + IL K DF S +
Sbjct: 104 TENVTRKY----TRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156
Query: 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
V GT +++PE +S K+D++S G ++E+LT K
Sbjct: 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (125), Expect = 2e-07
Identities = 48/167 (28%), Positives = 73/167 (43%), Gaps = 28/167 (16%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
I+ ++ H NI+K + LVFE+ L + L P L+K +
Sbjct: 49 ISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDK-RPGPLSPNLIKSIMY- 105
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS--ISIPEGK-THVND 217
++ +AY H S I+ RD+KP IL V K DF ++ IP TH
Sbjct: 106 --QLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH--- 157
Query: 218 NNKVIGTFGFIAPE------YMSTANCNEKSDVYSFGALLLELLTGK 258
+V+ T + APE + STA D++S G + E++TGK
Sbjct: 158 --EVV-TLWYRAPEILLGSKHYSTA-----VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 40/162 (24%), Positives = 71/162 (43%), Gaps = 18/162 (11%)
Query: 101 IAFASQMSH---KNILKFVGCCLE-TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKH 156
+A SQ+ NI K+ G L+ L I + E+ G++ + P K+
Sbjct: 50 VALLSQLRQSQPPNITKYYGSYLKGPRLWI-IMEYAEGGSVRTL------MKAGPIAEKY 102
Query: 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN 216
+ E+ A+ Y+H ++ RDIK + IL K DF V+ + + +
Sbjct: 103 ISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK-- 157
Query: 217 DNNKVIGTFGFIAPEY-MSTANCNEKSDVYSFGALLLELLTG 257
+ +GT ++APE + K+D++S G + E+ TG
Sbjct: 158 -RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 7/98 (7%)
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
A EI + LH IV+RD+KP IL + + D +++ +PEG+T
Sbjct: 108 AAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT----IKG 160
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
+GT G++APE + D ++ G LL E++ G+
Sbjct: 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 36/105 (34%), Positives = 50/105 (47%), Gaps = 10/105 (9%)
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF--CVSISIPEGKTHVNDN 218
A E+A+A+ YLH S I++RD+KP IL Q DF C PE T
Sbjct: 102 AAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT----- 153
Query: 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYS 263
+ GT ++APE + + D + GA+L E+L G YS
Sbjct: 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 50/165 (30%), Positives = 72/165 (43%), Gaps = 34/165 (20%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVAC-GTLADRIHDPNGSQLEPFLMKHRLK 159
+ F Q+ H N +++ GC L LV E+ C G+ +D + + K L+
Sbjct: 66 VRFLQQLRHPNTIEYKGCYLREHTAWLVMEY--CLGSASDILE----------VHKKPLQ 113
Query: 160 VAMEIA-------NAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212
+EIA +AYLH S + RDIK IL E K DF S S+
Sbjct: 114 -EVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFG-SASL---- 164
Query: 213 THVNDNNKVIGTFGFIAPEY---MSTANCNEKSDVYSFGALLLEL 254
V+ N +GT ++APE M + K DV+S G +EL
Sbjct: 165 --VSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 29/100 (29%), Positives = 51/100 (51%), Gaps = 7/100 (7%)
Query: 159 KVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDN 218
K+++ + + YL I+ RD+KPS IL + K DF VS G+ +
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMA 155
Query: 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
N +GT +++PE + + +SD++S G L+E+ G+
Sbjct: 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-07
Identities = 57/238 (23%), Positives = 98/238 (41%), Gaps = 43/238 (18%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
++M H NI+ F E +V E+ G L RI+ G L ++I
Sbjct: 54 AKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSE---DQILSWFVQI 110
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQN-VAKFFDFCVSISIPEGKTHVNDNNKV-- 221
+ + ++H R I+ RDIK I + VAK DF ++ + ND+ ++
Sbjct: 111 SLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-------NDSMELAY 160
Query: 222 --IGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR 279
+GT +++PE N K+D++S G +L EL T ++
Sbjct: 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT---------------------LK 199
Query: 280 KSIESNSFKEIVDPIIVGE-EGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336
E N+ ++V I G + P + L S L + S +DRP++ + K+
Sbjct: 200 HPFEGNNLHQLVLKICQGYFAPISPNFSRDLRS---LISQLFKVSPRDRPSITSILKR 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 47/184 (25%), Positives = 71/184 (38%), Gaps = 37/184 (20%)
Query: 82 SVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLAD-- 139
SVMK FNC ++++ +G + ++V E +A G L
Sbjct: 61 SVMK-----------EFNC---------HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL 100
Query: 140 RIHDPNGSQLEPFLMKHRLKV---AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNV 196
R P K A EIA+ +AYL ++ V RD+ + E
Sbjct: 101 RSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLT 157
Query: 197 AKFFDFCVSISIPEGKTHVNDNNKVIGT----FGFIAPEYMSTANCNEKSDVYSFGALLL 252
K DF ++ I E D + G ++APE + KSDV+SFG +L
Sbjct: 158 VKIGDFGMTRDIYE-----TDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLW 212
Query: 253 ELLT 256
E+ T
Sbjct: 213 EMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 40/158 (25%), Positives = 71/158 (44%), Gaps = 12/158 (7%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
I SQ I ++ G L+ ++ E++ G+ D + + P + +
Sbjct: 53 ITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL------KPGPLEETYIATI 106
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
EI + YLH S + RDIK + +L EQ K DF V+ + + + N
Sbjct: 107 LREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---KRNT 160
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
+GT ++APE + + + K+D++S G +EL G+
Sbjct: 161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 16/144 (11%)
Query: 118 CCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFS 176
C +T + V E+V G L I Q+ F H + A EIA + +LH S
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHIQ-----QVGKFKEPHAVFYAAEIAIGLFFLH---S 119
Query: 177 RPIVFRDIKPSTILFQEQNVAKFFDF--CVSISIPEGKTHVNDNNKVIGTFGFIAPEYMS 234
+ I++RD+K ++ + K DF C +I GKT GT +IAPE ++
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADFGMCKE-NIFGGKT----TRTFCGTPDYIAPEIIA 174
Query: 235 TANCNEKSDVYSFGALLLELLTGK 258
+ D ++FG LL E+L G+
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 37/160 (23%), Positives = 70/160 (43%), Gaps = 35/160 (21%)
Query: 158 LKVAMEIANAVAYLHVGFSRPIVFRDIKPSTIL---FQEQ-----NVAKFF----DFCVS 205
L + +I + Y+H S+ ++ RD+KP IL F E A F + +
Sbjct: 116 LSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 206 ISIP-EGKTHVNDN--NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT------ 256
I + + + K++GT ++APE + +E +D+Y+ G +L ++LT
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232
Query: 257 ---GKRISYSSCFENGEEY--------FLQELVRKSIESN 285
G++ISY + E FL ++ K++ +
Sbjct: 233 RKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVD 272
|
Length = 932 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 48/183 (26%), Positives = 81/183 (44%), Gaps = 17/183 (9%)
Query: 106 QMSHKNILKFVGCCLETELPIL-VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
Q S+ L + C +TE + V E+V G L H +L +H + EI
Sbjct: 51 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLM--FHMQRQRKLPE---EHARFYSAEI 105
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
+ A+ YLH R I++RD+K +L + K D+ + EG + + GT
Sbjct: 106 SLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSTFCGT 159
Query: 225 FGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRI-----SYSSCFENGEEYFLQELVR 279
+IAPE + + D ++ G L+ E++ G+ S + +N E+Y Q ++
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 219
Query: 280 KSI 282
K I
Sbjct: 220 KQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 5e-07
Identities = 39/162 (24%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 99 NCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRL 158
N I ++ + NI+ F+ L + +V E++A G+L D + + + +
Sbjct: 65 NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQI------A 118
Query: 159 KVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKF--FDFCVSISIPEGKTHVN 216
V E A+ +LH + ++ RDIK +L K F FC I+ + K
Sbjct: 119 AVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---- 171
Query: 217 DNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
+ ++GT ++APE ++ K D++S G + +E++ G+
Sbjct: 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 39/155 (25%), Positives = 75/155 (48%), Gaps = 19/155 (12%)
Query: 108 SHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFL-MKHRLKVAMEIAN 166
+H+NI+ +G C +++ E+ G L + + + E FL ++ L + ++A
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR----RKRESFLTLEDLLSFSYQVAK 152
Query: 167 AVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFG 226
+A+L S+ + RD+ +L + K DF ++ I +ND+N V+
Sbjct: 153 GMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDI------MNDSNYVVKGNA 203
Query: 227 FIAPEYM---STANC--NEKSDVYSFGALLLELLT 256
+ ++M S NC +SDV+S+G LL E+ +
Sbjct: 204 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 5e-07
Identities = 40/158 (25%), Positives = 70/158 (44%), Gaps = 12/158 (7%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
I SQ + K+ G L+ ++ E++ G+ D + +P P +
Sbjct: 53 ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPG-----PLDETQIATI 106
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
EI + YLH S + RDIK + +L E K DF V+ + + + N
Sbjct: 107 LREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI---KRNT 160
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
+GT ++APE + + + K+D++S G +EL G+
Sbjct: 161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 52/169 (30%), Positives = 71/169 (42%), Gaps = 25/169 (14%)
Query: 107 MSHKNILKFVGCCLETELPILV---FEFVACGTLADRIHDPNGSQLEPFLMKHRLKV--- 160
MS +N+L + P LV F F L + NG +L L + R +
Sbjct: 43 MSERNVL-----LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR 97
Query: 161 ----AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF--CVSISIPEGKTH 214
A EIA+A+ YLH S IV+RD+KP IL Q DF C G T
Sbjct: 98 ARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT- 153
Query: 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYS 263
+ GT ++APE + + D + GA+L E+L G YS
Sbjct: 154 ----STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 6e-07
Identities = 44/158 (27%), Positives = 66/158 (41%), Gaps = 15/158 (9%)
Query: 101 IAFASQMSHKNILKFVGCCL-ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLK 159
I+ + H NI+ + G L +L I V E+ G+L D G L + +
Sbjct: 51 ISMLKECRHPNIVAYFGSYLRRDKLWI-VMEYCGGGSLQDIYQVTRGP-LSELQIAY--- 105
Query: 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNN 219
V E +AYLH + RDIK + IL E K DF VS + +
Sbjct: 106 VCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL---TATIAKRK 159
Query: 220 KVIGTFGFIAPEYMSTANC---NEKSDVYSFGALLLEL 254
IGT ++APE + + K D+++ G +EL
Sbjct: 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 35/100 (35%), Positives = 47/100 (47%), Gaps = 10/100 (10%)
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF--CVSISIPEGKTHVNDN 218
A EI + +LH S+ IV+RD+K IL K DF C + + KT
Sbjct: 102 AAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT----- 153
Query: 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
GT +IAPE + N D +SFG LL E+L G+
Sbjct: 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-07
Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 21/164 (12%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLADRI--HDPN------------GSQLE 150
S + H NI+ +G C + + ++FE++A G L + + + P+ S L+
Sbjct: 63 SDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLD 122
Query: 151 PFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210
H +A++IA + YL S V RD+ L E K DF +S I
Sbjct: 123 CSDFLH---IAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYS 176
Query: 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLEL 254
+ + ++ ++ PE + +SD++SFG +L E+
Sbjct: 177 ADYYRVQSKSLL-PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 6e-07
Identities = 41/171 (23%), Positives = 80/171 (46%), Gaps = 22/171 (12%)
Query: 106 QMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
++SH+ +++ G C + PI +V E+++ G L + + + F L++ ++
Sbjct: 55 KLSHEKLVQLYGVC-TKQRPIYIVTEYMSNGCLLNYLR----EHGKRFQPSQLLEMCKDV 109
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKV--I 222
+AYL S+ + RD+ L +Q K DF +S +V D+ +
Sbjct: 110 CEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLS-------RYVLDDEYTSSV 159
Query: 223 GT---FGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGE 270
G+ + PE + + + KSDV++FG L+ E+ + ++ Y F N E
Sbjct: 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER-FNNSE 209
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 33/125 (26%), Positives = 57/125 (45%), Gaps = 12/125 (9%)
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
A EI + LH V+RD+KP IL + + D +++ IPEG++
Sbjct: 108 AAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES----IRG 160
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280
+GT G++APE ++ D + G L+ E++ G+ S F +E +E V +
Sbjct: 161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ-----SPFRGRKEKVKREEVDR 215
Query: 281 SIESN 285
+
Sbjct: 216 RVLET 220
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 7e-07
Identities = 36/103 (34%), Positives = 50/103 (48%), Gaps = 6/103 (5%)
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
A EIA+A+ YLH S I++RD+KP IL Q DF + EG H +
Sbjct: 102 AAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLC---KEGIEHSKTTST 155
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYS 263
GT ++APE + + D + GA+L E+L G YS
Sbjct: 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 8e-07
Identities = 48/173 (27%), Positives = 75/173 (43%), Gaps = 25/173 (14%)
Query: 101 IAFASQMSHKNILKFVGCCLETELP--ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRL 158
I + H NI+K+ G C LV E++ G+L D +L KHR
Sbjct: 56 IEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRD------------YLQKHRE 103
Query: 159 KV--------AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210
++ A +I + YL S+ V RD+ IL + +N K DF ++ +P+
Sbjct: 104 RLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160
Query: 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYS 263
K + + APE ++ + + SDV+SFG +L EL T S S
Sbjct: 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 34/97 (35%), Positives = 47/97 (48%), Gaps = 6/97 (6%)
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
A EIA+A+ YLH S IV+RD+KP IL Q DF + EG +
Sbjct: 102 AAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLC---KEGIAQSDTTTT 155
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
GT ++APE + + D + GA+L E+L G
Sbjct: 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 8e-07
Identities = 43/167 (25%), Positives = 64/167 (38%), Gaps = 28/167 (16%)
Query: 105 SQMSHKNILKFVG-----------CCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPF 152
S M K I + C +TE + V E+ A G L IH + F
Sbjct: 45 SLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT------DVF 98
Query: 153 LMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF--CVSISIPE 210
+ A + + YLH IV+RD+K +L + K DF C E
Sbjct: 99 SEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLC-----KE 150
Query: 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
G + + GT F+APE ++ + D + G L+ E+L G
Sbjct: 151 GMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 9e-07
Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 9/98 (9%)
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
A EI A+ YLH S+ IV+RD+KP IL ++ K DF + K +
Sbjct: 107 ASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFA------KKLRDRTWT 157
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
+ GT ++APE + + N+ D ++ G L+ E+L G
Sbjct: 158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 9e-07
Identities = 25/80 (31%), Positives = 44/80 (55%), Gaps = 4/80 (5%)
Query: 179 IVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANC 238
IV+RD+KP IL ++ + D +++ IPEG+T +GT G++APE ++
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET----VRGRVGTVGYMAPEVINNEKY 178
Query: 239 NEKSDVYSFGALLLELLTGK 258
D + G L+ E++ G+
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 41/160 (25%), Positives = 73/160 (45%), Gaps = 18/160 (11%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNG--SQLEPFLMKHRLKVAME 163
Q SH NI++ G + + +++ E++ G L + D +G S + M + M+
Sbjct: 62 QFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMK 121
Query: 164 IANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI---PEGKTHVNDNNK 220
+ + Y+H RD+ IL K DF +S + PEG T+ K
Sbjct: 122 YLSDMNYVH---------RDLAARNILVNSNLECKVSDFGLSRVLEDDPEG-TYTTSGGK 171
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKR 259
+ + APE ++ SDV+SFG ++ E+++ G+R
Sbjct: 172 I--PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 19/179 (10%)
Query: 89 NLNSEEYCCF-NCIAFASQMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNG 146
N E CC NC F+ H++ K E L I LV ++ G L I
Sbjct: 76 NRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAK 135
Query: 147 SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS- 205
+ F + +++ AV ++H S+ ++ RDIK + IL + K DF S
Sbjct: 136 TN-RTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSK 191
Query: 206 -----ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKR 259
+S G+T GT ++APE ++K+D++S G LL ELLT KR
Sbjct: 192 MYAATVSDDVGRTFC-------GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 39/172 (22%), Positives = 75/172 (43%), Gaps = 10/172 (5%)
Query: 88 GNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNG 146
G+++ E N I + ++H NI+ + L+ +V E+ G L+ I
Sbjct: 36 GSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISK-RK 94
Query: 147 SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206
+ + + ++ +++ + LH + I+ RD+K + IL ++ K D +S
Sbjct: 95 KKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISK 151
Query: 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
+ + IGT ++APE + KSD++S G LL E+ T
Sbjct: 152 VLKKNMA-----KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 26/98 (26%), Positives = 47/98 (47%), Gaps = 7/98 (7%)
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
A +I + +LH R IV+RD+KP +L + + D +++ + GK
Sbjct: 101 AAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK----IKG 153
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
GT G++APE + + D ++ G L E++ G+
Sbjct: 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 30/100 (30%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 159 KVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDN 218
KV++ + + YL I+ RD+KPS IL + K DF VS G+ +
Sbjct: 107 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMA 159
Query: 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
N +GT +++PE + + + +SD++S G L+E+ G+
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 27/175 (15%)
Query: 101 IAFASQMSHKNILKFVGCCLE-TELPI-LVFEFVACGTLADRIHD---PNGSQLEPFLMK 155
IA ++ H+N++ V LE + + L+F++ A L I + P ++K
Sbjct: 53 IALLRELKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVK 111
Query: 156 HRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTIL----FQEQNVAKFFDF-----CVSI 206
L +I N V YLH S ++ RD+KP+ IL E+ V K D +
Sbjct: 112 SLLW---QILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
Query: 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKS-DVYSFGALLLELLTGKRI 260
P + D + V+ T + APE + A K+ D+++ G + ELLT + I
Sbjct: 166 LKP-----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 29/99 (29%), Positives = 49/99 (49%), Gaps = 13/99 (13%)
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKF--FDFCVSISIPEGKTHVNDN 218
A ++ A+ YLH S IV+RD+KP +L K F F + +G+T+
Sbjct: 107 AAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV---KGRTYT--- 157
Query: 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
+ GT ++APE + + + D ++ G L+ E+L G
Sbjct: 158 --LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 33/101 (32%), Positives = 49/101 (48%), Gaps = 12/101 (11%)
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
A EI + +LH + I++RD+K +L + K DF + K ++N K
Sbjct: 102 AAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMC------KENMNGEGK 152
Query: 221 V---IGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
GT +IAPE + NE D +SFG LL E+L G+
Sbjct: 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 7/98 (7%)
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
A EI + LH IV+RD+KP IL + + D +++ IPEG+T
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET----IRG 160
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
+GT G++APE + D + G L+ E++ GK
Sbjct: 161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 19/157 (12%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIH---DPNGSQLEPFLMKHRLKVA 161
+ M H ++++ +G CL + LV + + G L D +H D GSQL L
Sbjct: 64 ASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQL-------LLNWC 115
Query: 162 MEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG--KTHVNDNN 219
++IA + YL R +V RD+ +L + N K DF ++ + EG K + D
Sbjct: 116 VQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLA-RLLEGDEKEYNADGG 171
Query: 220 KVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
K+ ++A E + +SDV+S+G + EL+T
Sbjct: 172 KM--PIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 57/241 (23%), Positives = 96/241 (39%), Gaps = 37/241 (15%)
Query: 109 HKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEP-FLMKHR---------- 157
H NI+ +G C L E+ G L D + + +P F + +
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 158 LKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217
L A ++A + YL + + RD+ IL E VAK DF +S
Sbjct: 127 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLS---------RGQ 174
Query: 218 NNKVIGTFGFIAPEYMSTANCN-----EKSDVYSFGALLLELLTGKRISYS--SCFENGE 270
V T G + +M+ + N SDV+S+G LL E+++ Y +C E E
Sbjct: 175 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 234
Query: 271 EYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM 330
+ + K + N E+ D + W EK + S+ ++ + L++ ++R T
Sbjct: 235 KLPQGYRLEKPL--NCDDEVYDLM----RQCWREKPYERPSFAQILVS-LNRMLEERKTY 287
Query: 331 V 331
V
Sbjct: 288 V 288
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 48/181 (26%), Positives = 76/181 (41%), Gaps = 15/181 (8%)
Query: 106 QMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
Q S L + C +T + LV E+V G L H +L +H A EI
Sbjct: 51 QASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLM--FHMQRQRKLPE---EHARFYAAEI 105
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
A+ +LH R I++RD+K +L K D+ + EG + + GT
Sbjct: 106 CIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMC---KEGLGPGDTTSTFCGT 159
Query: 225 FGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKR---ISYSSCFENGEEYFLQELVRKS 281
+IAPE + D ++ G L+ E++ G+ I + N E+Y Q ++ K
Sbjct: 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP 219
Query: 282 I 282
I
Sbjct: 220 I 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 40/158 (25%), Positives = 78/158 (49%), Gaps = 16/158 (10%)
Query: 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKP 186
LV + G L I++ LE M+ + + +I + +LH S IV+RD+KP
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERGLE---MERVIHYSAQITCGILHLH---SMDIVYRDMKP 123
Query: 187 STILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYS 246
+L +Q + D +++ + +GKT + GT G++APE + + D ++
Sbjct: 124 ENVLLDDQGNCRLSDLGLAVELKDGKT----ITQRAGTNGYMAPEILKEEPYSYPVDWFA 179
Query: 247 FGALLLELLTGKRISYSSCFENGEEYFL-QELVRKSIE 283
G + E++ G+ + F++ +E +EL R+++E
Sbjct: 180 MGCSIYEMVAGR-----TPFKDHKEKVAKEELKRRTLE 212
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 3e-06
Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 20/164 (12%)
Query: 99 NCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDP--NGSQLEPFLMKH 156
N I + + NI+ ++ L + +V E++A G+L D + + + Q+
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA------ 119
Query: 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKF--FDFCVSISIPEGKTH 214
V E A+ +LH S ++ RDIK IL K F FC I+ + K
Sbjct: 120 --AVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172
Query: 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
+ ++GT ++APE ++ K D++S G + +E++ G+
Sbjct: 173 ---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVI 222
E+ A YLH S+ I++RD+KP +L + K DF + +P+ +T +
Sbjct: 126 ELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-RTFT-----LC 176
Query: 223 GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
GT ++APE + + + D ++ G LL E + G
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 30/107 (28%), Positives = 53/107 (49%), Gaps = 4/107 (3%)
Query: 150 EPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209
EP ++ + + ++A + +L SR + RD+ IL E NV K DF ++ I
Sbjct: 168 EPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
+ +V + + ++APE + +SDV+SFG LL E+ +
Sbjct: 225 KDPDYVRKGDARL-PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 20/164 (12%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACG--TLADRIHDPNGSQLEPFLMKHRL 158
I+ ++ H NI+ ++ L+FEF++ D + P G ++ L+K L
Sbjct: 50 ISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSL--PKGQYMDAELVKSYL 107
Query: 159 KVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV--SISIP-EGKTHV 215
+I + + H SR ++ RD+KP +L + V K DF + + IP TH
Sbjct: 108 Y---QILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH- 160
Query: 216 NDNNKVIGTFGFIAPE-YMSTANCNEKSDVYSFGALLLELLTGK 258
+V+ T + APE + + + D++S G + E+ T K
Sbjct: 161 ----EVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 60/253 (23%), Positives = 104/253 (41%), Gaps = 40/253 (15%)
Query: 88 GNLNSEEYCCFNCIA-FASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHD--P 144
G LN E N A S++ H I+KF LE + ++ E+ L ++ +
Sbjct: 39 GELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKH 98
Query: 145 NGSQL-EPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFC 203
G L E + + +++ + V Y+H R I+ RD+K I F + N+ K DF
Sbjct: 99 TGKTLSENQVCEWFIQLLL----GVHYMHQ---RRILHRDLKAKNI-FLKNNLLKIGDFG 150
Query: 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYS 263
VS + + GT +++PE + + KSD++S G +L E+
Sbjct: 151 VSRLL---MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM--------- 198
Query: 264 SCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEK-EKQLLSYTELAIKCLSK 322
C + + E +F +V I+ G PE +QL S + L+K
Sbjct: 199 CCLAH------------AFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ---SMLNK 243
Query: 323 SEQDRPTMVQVAK 335
RP+ ++ +
Sbjct: 244 DPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 40/158 (25%), Positives = 72/158 (45%), Gaps = 8/158 (5%)
Query: 98 FNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHR 157
F + Q+SHK+I+ G C+ I+V EFV G L +H + + +
Sbjct: 52 FETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH----RKSDVLTTPWK 107
Query: 158 LKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217
KVA ++A+A++YL + +V ++ IL + + + +S P V
Sbjct: 108 FKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS 164
Query: 218 NNKVIGTFGFIAPEYMS-TANCNEKSDVYSFGALLLEL 254
+ + +IAPE + + N + +D +SFG L E+
Sbjct: 165 RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 6e-06
Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 20/164 (12%)
Query: 99 NCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDP--NGSQLEPFLMKH 156
N I + + NI+ ++ L + +V E++A G+L D + + + Q+
Sbjct: 65 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA------ 118
Query: 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKF--FDFCVSISIPEGKTH 214
V E A+ +LH S ++ RDIK IL K F FC I+ + K
Sbjct: 119 --AVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 171
Query: 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
+ ++GT ++APE ++ K D++S G + +E++ G+
Sbjct: 172 ---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 7e-06
Identities = 54/242 (22%), Positives = 99/242 (40%), Gaps = 35/242 (14%)
Query: 106 QMSHKNILKFVGCCLETE------LPILVFEFVACGTLAD-RIHDPNGSQLEPFLMKHRL 158
+ H N+++ +G CL+T P+++ F+ G L ++ G + + +
Sbjct: 56 EFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLV 115
Query: 159 KVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDN 218
K +IA+ + YL S+ + RD+ + E DF +S I G +
Sbjct: 116 KFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGR 172
Query: 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEY-FLQEL 277
+ +IA E ++ KSDV+SFG + E+ T + Y EN E Y +L+
Sbjct: 173 IAKM-PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV-ENSEIYDYLR-- 228
Query: 278 VRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337
+ N K+ D + +GL+ L C + +DRP+ + +L
Sbjct: 229 -----QGNRLKQPPDCL----DGLY-----------SLMSSCWLLNPKDRPSFETLRCEL 268
Query: 338 RQ 339
+
Sbjct: 269 EK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 8e-06
Identities = 55/253 (21%), Positives = 93/253 (36%), Gaps = 54/253 (21%)
Query: 109 HKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHR----------- 157
H NI+ +G C + E+ G L D + + +P K
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 158 LKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217
L+ A ++A + YL + + RD+ +L E +K DF +S +
Sbjct: 122 LQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLS---------RGE 169
Query: 218 NNKVIGTFGFIAPEYMSTANCN-----EKSDVYSFGALLLELLTGKRISYS--SCFENGE 270
V T G + +M+ + N KSDV+SFG LL E+++ Y +C E E
Sbjct: 170 EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229
Query: 271 EYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM 330
+ L + R N E+ EL +C +RP
Sbjct: 230 K--LPQGYRMEKPRNCDDEVY----------------------ELMRQCWRDRPYERPPF 265
Query: 331 VQVAKQLRQLHKS 343
Q++ QL ++ ++
Sbjct: 266 AQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 8e-06
Identities = 33/117 (28%), Positives = 54/117 (46%), Gaps = 6/117 (5%)
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVI 222
EI +A+ YLH SR +V+RDIK ++ + K DF + EG +
Sbjct: 103 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC---KEGISDGATMKTFC 156
Query: 223 GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR 279
GT ++APE + + D + G ++ E++ G+ Y+ E E L E +R
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 8e-06
Identities = 46/160 (28%), Positives = 77/160 (48%), Gaps = 20/160 (12%)
Query: 107 MSHKNILKFVGCCLE-TELPILVFEFVACGTLAD-----RIHDPNGSQLEPFLMKHRL-K 159
+SH+NIL + C+E E P +++ ++ G L R+ + N Q L +L
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQA---LSTQQLVH 121
Query: 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHV---N 216
+A++IA ++YLH R ++ +DI + E+ K D +S + H N
Sbjct: 122 MAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDN 178
Query: 217 DNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
+N V ++A E + + SDV+SFG LL EL+T
Sbjct: 179 ENRPV----KWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 8e-06
Identities = 34/152 (22%), Positives = 66/152 (43%), Gaps = 10/152 (6%)
Query: 109 HKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHR-LKVAMEIAN 166
H + + +T+ + LV + G L R H N + P + R +I +
Sbjct: 51 HSRFIVSLAYAFQTKTDLCLVMTIMNGGDL--RYHIYNVDEENPGFPEPRACFYTAQIIS 108
Query: 167 AVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFG 226
+ +LH R I++RD+KP +L + D +++ + +G+ + GT G
Sbjct: 109 GLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ---SKTKGYAGTPG 162
Query: 227 FIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
F+APE + + D ++ G L E++ +
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 8e-06
Identities = 39/133 (29%), Positives = 64/133 (48%), Gaps = 13/133 (9%)
Query: 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKP 186
V E+V G L +I Q+ F H + A EIA + +LH S+ I++RD+K
Sbjct: 78 FVMEYVNGGDLMYQIQ-----QVGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKL 129
Query: 187 STILFQEQNVAKFFDFCV-SISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVY 245
++ + K DF + ++ +G T GT +IAPE ++ + D +
Sbjct: 130 DNVMLDSEGHIKIADFGMCKENMWDGVT----TKTFCGTPDYIAPEIIAYQPYGKSVDWW 185
Query: 246 SFGALLLELLTGK 258
+FG LL E+L G+
Sbjct: 186 AFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 30/108 (27%), Positives = 52/108 (48%), Gaps = 4/108 (3%)
Query: 149 LEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208
P M+ + + ++A + +L SR + RD+ IL E NV K DF ++ I
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDI 224
Query: 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
+ +V + + ++APE + +SDV+SFG LL E+ +
Sbjct: 225 YKDPDYVRKGSARL-PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 40/134 (29%), Positives = 60/134 (44%), Gaps = 14/134 (10%)
Query: 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKP 186
LVFE+V L PNG E KV I + +H IV RDIKP
Sbjct: 77 LVFEYVEKNMLELLEEMPNGVPPE--------KVRSYIYQLIKAIHWCHKNDIVHRDIKP 128
Query: 187 STILFQEQNVAKFFDFCVSISIPEGKTHVNDNN--KVIGTFGFIAPEYMSTANCNEKSDV 244
+L +V K DF + ++ EG ++ N + + T + +PE + A + D+
Sbjct: 129 ENLLISHNDVLKLCDFGFARNLSEG----SNANYTEYVATRWYRSPELLLGAPYGKAVDM 184
Query: 245 YSFGALLLELLTGK 258
+S G +L EL G+
Sbjct: 185 WSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 36/157 (22%), Positives = 75/157 (47%), Gaps = 13/157 (8%)
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVI 222
EI +A+ YLH G IV+RD+K ++ + K DF + EG T
Sbjct: 103 EIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLC---KEGITDAATMKTFC 156
Query: 223 GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR--K 280
GT ++APE + + D + G ++ E++ G+ Y+ E E L E ++ +
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR 216
Query: 281 SIESNSFKEIVDPIIVGEE----GLWPEKEKQLLSYT 313
++ +++ K ++ +++ + G P+ K+++ ++
Sbjct: 217 TLSADA-KSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 36/162 (22%), Positives = 64/162 (39%), Gaps = 19/162 (11%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
I H ++K + +LV E++ L++ + D P
Sbjct: 50 IKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEE----RPLPEAQVKSY 104
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK----THVN 216
+ VAY+H + I+ RD+KP+ +L V K DF ++ E + +H
Sbjct: 105 MRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH-- 159
Query: 217 DNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTG 257
+ T + APE + A + D+++ G + ELL G
Sbjct: 160 ----QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 55/222 (24%), Positives = 82/222 (36%), Gaps = 56/222 (25%)
Query: 101 IAFASQM---SHKNILK----FVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPF 152
IA Q+ H NI++ G + EL + LVFE V LA + L P
Sbjct: 49 IALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPE 107
Query: 153 LMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212
+K ++ ++ V +LH S IV RD+KP IL K DF G
Sbjct: 108 TIKDLMR---QLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADF--------GL 153
Query: 213 THVNDNN----KVIGTFGFIAPE------YMSTANCNEKSDVYSFGALLLELLTGKRISY 262
+ V+ T + APE Y + D++S G + EL
Sbjct: 154 ARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPV------DMWSVGCIFAEL-------- 199
Query: 263 SSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPE 304
+ + L R + E++ +I D I + E WP
Sbjct: 200 ---------FRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 32/103 (31%), Positives = 48/103 (46%), Gaps = 9/103 (8%)
Query: 159 KVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDN 218
K+A+ A+ YL I+ RD+KPS IL K DF +S + + D
Sbjct: 111 KIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD- 167
Query: 219 NKVIGTFGFIAPEYMSTANCNE---KSDVYSFGALLLELLTGK 258
G ++APE + + + +SDV+S G L E+ TGK
Sbjct: 168 ---AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 43/143 (30%), Positives = 61/143 (42%), Gaps = 16/143 (11%)
Query: 118 CCLET-ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFS 176
CC +T + V EFV G L I + F A EI +A+ +LH
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQ-----KSRRFDEARARFYAAEITSALMFLH---D 114
Query: 177 RPIVFRDIKPSTILFQEQNVAKFFDF--CVSISIPEGKTHVNDNNKVIGTFGFIAPEYMS 234
+ I++RD+K +L + K DF C I GKT + GT +IAPE +
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GIFNGKT----TSTFCGTPDYIAPEILQ 169
Query: 235 TANCNEKSDVYSFGALLLELLTG 257
D ++ G LL E+L G
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 39/164 (23%), Positives = 71/164 (43%), Gaps = 18/164 (10%)
Query: 98 FNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLAD-----RIHDPNGSQLEPF 152
FNC ++++ +G + + +++ E + G L R N P
Sbjct: 66 FNC---------HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116
Query: 153 LMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212
+K +++A EIA+ +AYL+ + V RD+ + E K DF ++ I E
Sbjct: 117 SLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-T 172
Query: 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
+ K + +++PE + SDV+SFG +L E+ T
Sbjct: 173 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 41/149 (27%), Positives = 61/149 (40%), Gaps = 14/149 (9%)
Query: 109 HKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAV 168
H NI+ + G L + + EF G+L D H P V+ E +
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-----PLSESQIAYVSRETLQGL 119
Query: 169 AYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFI 228
YLH S+ + RDIK + IL + K DF VS I + IGT ++
Sbjct: 120 YYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQI---TATIAKRKSFIGTPYWM 173
Query: 229 APEYMST---ANCNEKSDVYSFGALLLEL 254
APE + N+ D+++ G +EL
Sbjct: 174 APEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 60/252 (23%), Positives = 102/252 (40%), Gaps = 64/252 (25%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLK------ 159
Q H NI++ G ++ +++ E++ NGS L+ FL ++ K
Sbjct: 61 QFDHPNIIRLEGVVTKSRPVMIITEYME-----------NGS-LDKFLRENDGKFTVGQL 108
Query: 160 VAM--EIANAVAYL-HVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN 216
V M IA+ + YL + + V RD+ IL V K DF +S +
Sbjct: 109 VGMLRGIASGMKYLSEMNY----VHRDLAARNILVNSNLVCKVSDFGLS-------RRLE 157
Query: 217 DNNKVIGTFG------FIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGE 270
D+ T G + APE ++ SDV+SFG ++ E++ SY GE
Sbjct: 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM-----SY------GE 206
Query: 271 EYFLQELVRKSIESNSFKEIVDPIIVGEEG--LWPEKEKQLLSYTELAIKCLSKSEQDRP 328
+ S ++++ + E+G L P + Y +L + C K +RP
Sbjct: 207 ---------RPYWDMSNQDVIKAV---EDGYRLPPPMDCPSALY-QLMLDCWQKDRNERP 253
Query: 329 TMVQVAKQLRQL 340
T Q+ L ++
Sbjct: 254 TFSQIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 28/107 (26%), Positives = 52/107 (48%), Gaps = 4/107 (3%)
Query: 150 EPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209
+ ++ + + ++A + +L SR + RD+ IL E NV K DF ++ I
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIY 230
Query: 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
+ +V + + ++APE + +SDV+SFG LL E+ +
Sbjct: 231 KDPDYVRKGDARL-PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 42/157 (26%), Positives = 63/157 (40%), Gaps = 14/157 (8%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
I + H NI+ + G L E + E+ G+L D H P V
Sbjct: 57 IFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG-----PLSELQIAYV 111
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
E +AYLH S+ + RDIK + IL + K DF V+ I +
Sbjct: 112 CRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKI---TATIAKRKS 165
Query: 221 VIGTFGFIAPEYMS---TANCNEKSDVYSFGALLLEL 254
IGT ++APE + N+ D+++ G +EL
Sbjct: 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 3e-05
Identities = 55/250 (22%), Positives = 91/250 (36%), Gaps = 54/250 (21%)
Query: 109 HKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEP-FLMKH----------R 157
H NI+ +G C L E+ G L D + + +P F + +
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 158 LKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217
L A ++A + YL + + RD+ IL E VAK DF +S
Sbjct: 115 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLS---------RGQ 162
Query: 218 NNKVIGTFGFIAPEYMSTANCN-----EKSDVYSFGALLLELLTGKRISYS--SCFENGE 270
V T G + +M+ + N SDV+S+G LL E+++ Y +C E E
Sbjct: 163 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 222
Query: 271 EYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM 330
+ L + R N E+ +L +C + +RP+
Sbjct: 223 K--LPQGYRLEKPLNCDDEVY----------------------DLMRQCWREKPYERPSF 258
Query: 331 VQVAKQLRQL 340
Q+ L ++
Sbjct: 259 AQILVSLNRM 268
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 45/189 (23%), Positives = 82/189 (43%), Gaps = 22/189 (11%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLADRI------------HDPNGSQLEPF 152
+++ H NI+ +G + + ++FE++ G L + + D +G+
Sbjct: 62 AELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSL 121
Query: 153 LMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212
L +A++IA + YL F V +D+ IL EQ K D +S I
Sbjct: 122 DHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178
Query: 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEE 271
+ ++ ++ PE + + SD++SFG +L E+ + G + Y F N E
Sbjct: 179 YYRVQPKSLL-PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG--FSNQE- 234
Query: 272 YFLQELVRK 280
+ E+VRK
Sbjct: 235 --VIEMVRK 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 5e-05
Identities = 46/175 (26%), Positives = 77/175 (44%), Gaps = 27/175 (15%)
Query: 119 CLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSR 177
C +TE + V EFV+ G L H +L +H + EI+ A+ +LH R
Sbjct: 64 CFQTESRLFFVIEFVSGGDLM--FHMQRQRKLPE---EHARFYSAEISLALNFLH---ER 115
Query: 178 PIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTAN 237
I++RD+K +L + K D+ + EG + + GT +IAPE + +
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGMC---KEGIRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 238 CNEKSDVYSFGALLLELLTGKRISYSSCF----------ENGEEYFLQELVRKSI 282
D ++ G L+ E++ G+ S F +N E+Y Q ++ K I
Sbjct: 173 YGFSVDWWALGVLMFEMMAGR-----SPFDIVGMSDNPDQNTEDYLFQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 35/151 (23%), Positives = 69/151 (45%), Gaps = 9/151 (5%)
Query: 111 NILKFVGCCLETELPILVFEFVACGTLAD-----RIHDPNGSQLEPFLMKHRLKVAMEIA 165
++++ +G + + ++V E +A G L R N P ++ +++A EIA
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTF 225
+ +AYL+ ++ V RD+ + K DF ++ I E + K +
Sbjct: 130 DGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPV 185
Query: 226 GFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
++APE + SD++SFG +L E+ +
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 6e-05
Identities = 46/153 (30%), Positives = 70/153 (45%), Gaps = 19/153 (12%)
Query: 109 HKNILKFVGCCL-ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVA-MEIAN 166
H NI+K + E L IL+ EF A G + D +LE L + +++V +
Sbjct: 61 HPNIVKLLDAFYYENNLWILI-EFCAGGAV-----DAVMLELERPLTEPQIRVVCKQTLE 114
Query: 167 AVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFG 226
A+ YLH I+ RD+K ILF K DF VS + + + IGT
Sbjct: 115 ALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVS---AKNTRTIQRRDSFIGTPY 168
Query: 227 FIAPEYMSTANCNE-----KSDVYSFGALLLEL 254
++APE + + K+DV+S G L+E+
Sbjct: 169 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 6e-05
Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 12/166 (7%)
Query: 91 NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLE 150
+S + F + SQ+SHK+++K G C+ E I+V E+V G L +H +
Sbjct: 44 DSLAF--FETASLMSQLSHKHLVKLYGVCVRDE-NIMVEEYVKFGPLDVFLH----REKN 96
Query: 151 PFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210
+ +L VA ++A+A+ YL + +V ++ IL + + + + +S P
Sbjct: 97 NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153
Query: 211 GKTHVNDNNKVIGTFGFIAPEYM--STANCNEKSDVYSFGALLLEL 254
V + + +IAPE + A+ +D +SFG LLE+
Sbjct: 154 IPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 17/152 (11%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIA 165
Q+ + I++ +G C E E +LV E G L FL K++ I
Sbjct: 52 QLDNPYIVRMIGIC-EAESWMLVMELAELGPL------------NKFLQKNKHVTEKNIT 98
Query: 166 NAVAYLHVGF----SRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKV 221
V + +G V RD+ +L Q+ AK DF +S ++ + +
Sbjct: 99 ELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158
Query: 222 IGTFGFIAPEYMSTANCNEKSDVYSFGALLLE 253
+ APE M+ + KSDV+SFG L+ E
Sbjct: 159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 6e-05
Identities = 33/169 (19%), Positives = 71/169 (42%), Gaps = 21/169 (12%)
Query: 107 MSHKNILKFVGCCLETELPILVFEFVACGTL-----ADRIHDPNGSQLEPFLMKHRLKVA 161
++H N+L+ +G C+E+ +LV EF G L ++R +Q ++ ++A
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQ--KDVL---QRMA 106
Query: 162 MEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKV 221
E+A+ + +LH + D+ K D+ +++ ++ +
Sbjct: 107 CEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHA 163
Query: 222 IGTFGFIAPEYMS-------TANCNEKSDVYSFGALLLELLTGKRISYS 263
+ ++APE + + +KS+++S G + EL T Y
Sbjct: 164 V-PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP 211
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 7e-05
Identities = 49/171 (28%), Positives = 72/171 (42%), Gaps = 23/171 (13%)
Query: 113 LKFVGCCLET-ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYL 171
L + C +T E V EF+ G L I D F + A EI + +L
Sbjct: 58 LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFL 112
Query: 172 HVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKV---IGTFGFI 228
H S+ I++RD+K ++ K DF + K +V +N+ GT +I
Sbjct: 113 H---SKGIIYRDLKLDNVMLDRDGHIKIADFGMC------KENVFGDNRASTFCGTPDYI 163
Query: 229 APEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR 279
APE + D +SFG LL E+L G+ S F +E L E +R
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQ-----SPFHGDDEDELFESIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 47/174 (27%), Positives = 72/174 (41%), Gaps = 28/174 (16%)
Query: 98 FNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRI--HDPNGSQLEPFLMK 155
I + Q+ H NIL +V + +V +A G+ D + H P G L +
Sbjct: 47 QQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG--LPELAIA 104
Query: 156 HRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKF--FDFCVSISIPEGKT 213
LK ++ NA+ Y+H S+ + R +K S IL + VS+ I GK
Sbjct: 105 FILK---DVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSM-IKHGKR 157
Query: 214 HVNDNNKVIGTFG--------FIAPE--YMSTANCNEKSDVYSFGALLLELLTG 257
+V+ F +++PE + NEKSD+YS G EL G
Sbjct: 158 Q-----RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 30/100 (30%), Positives = 50/100 (50%), Gaps = 12/100 (12%)
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDN-NKV 221
+I + Y+H S I+ RD+KPS + E K DF ++ H +D
Sbjct: 128 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMTGY 177
Query: 222 IGTFGFIAPEYM-STANCNEKSDVYSFGALLLELLTGKRI 260
+ T + APE M + + N+ D++S G ++ ELLTG+ +
Sbjct: 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 217
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 26/86 (30%), Positives = 42/86 (48%), Gaps = 11/86 (12%)
Query: 179 IVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANC 238
I+ RD+KP+ +L K DF VS ++ N IG ++APE + +
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-----IGCQSYMAPERIKSGGP 178
Query: 239 NE------KSDVYSFGALLLELLTGK 258
N+ +SDV+S G +LE+ G+
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 39/135 (28%), Positives = 61/135 (45%), Gaps = 16/135 (11%)
Query: 127 LVFEFVACGTLADRIHDPNGSQLEPF-LMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIK 185
L+ ++V G L + Q E F + R+ +A EI A+ +LH I++RDIK
Sbjct: 82 LILDYVNGGELFTHL-----YQREHFTESEVRVYIA-EIVLALDHLH---QLGIIYRDIK 132
Query: 186 PSTILFQEQNVAKFFDFCVS-ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANC--NEKS 242
IL + DF +S + E + GT ++APE + + ++
Sbjct: 133 LENILLDSEGHVVLTDFGLSKEFLAEEEERAYS---FCGTIEYMAPEVIRGGSGGHDKAV 189
Query: 243 DVYSFGALLLELLTG 257
D +S G L ELLTG
Sbjct: 190 DWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 12/98 (12%)
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS-ISIPEGKTHVNDNNKV 221
+I + Y+H S +V RD+KPS IL E K DF ++ I P+ +V+
Sbjct: 116 QILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS----- 167
Query: 222 IGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGK 258
T + APE M T + + D++S G + E+L GK
Sbjct: 168 --TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 47/221 (21%), Positives = 91/221 (41%), Gaps = 24/221 (10%)
Query: 65 KDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETE- 123
++ K G Q + ++K +S+ A + H N++K +G L +
Sbjct: 16 REAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRA 75
Query: 124 -----LPILVFEFVACGTL-----ADRIHDPNGSQLEPFLMKHR--LKVAMEIANAVAYL 171
+P+++ F+ G L RI + EPF + + ++ ++IA+ + YL
Sbjct: 76 KGRLPIPMVILPFMKHGDLHTFLLMSRIGE------EPFTLPLQTLVRFMIDIASGMEYL 129
Query: 172 HVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPE 231
S+ + RD+ + E DF +S I G + + ++A E
Sbjct: 130 S---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL-PVKWLALE 185
Query: 232 YMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEY 272
++ SDV++FG + E++T + Y+ EN E Y
Sbjct: 186 SLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG-VENSEIY 225
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 25/178 (14%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDPN-GSQLEPFLMKHRLKVA 161
+ + + ++ + +G CL + + L+ + + G L D R H N GSQ + L
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ-------YLLNWC 115
Query: 162 MEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS-ISIPEGKTHVNDNNK 220
++IA + YL R +V RD+ +L + K DF ++ + + K + + K
Sbjct: 116 VQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGK 172
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISY--------SSCFENGE 270
V ++A E + +SDV+S+G + EL+T Y SS E GE
Sbjct: 173 V--PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 228
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 1e-04
Identities = 54/250 (21%), Positives = 95/250 (38%), Gaps = 49/250 (19%)
Query: 106 QMSHKNILKFVGCCLETE------LPILVFEFVACGTL-----ADRIHDPNGSQLEPFLM 154
H N++K +G C E P+++ F+ G L R+ G E +
Sbjct: 57 DFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRL----GGLPEKLPL 112
Query: 155 KHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG--- 211
+ LK ++IA + YL +R + RD+ + +E DF +S I G
Sbjct: 113 QTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYY 169
Query: 212 -KTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGE 270
+ + +IA E ++ KSDV++FG + E+ T + Y EN E
Sbjct: 170 RQGRIAKM-----PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG-VENHE 223
Query: 271 EYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM 330
Y + +R ++ +D L+ +L C +DRPT
Sbjct: 224 IY---DYLRHGNRLKQPEDCLD-------ELY-----------DLMYSCWRADPKDRPTF 262
Query: 331 VQVAKQLRQL 340
++ + L +
Sbjct: 263 TKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 41/157 (26%), Positives = 66/157 (42%), Gaps = 18/157 (11%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIA 165
+++H NI+K + LVFEF T ++ L L+K L ++
Sbjct: 54 ELNHPNIIKLLDVFRHKGDLYLVFEF--MDTDLYKLIKDRQRGLPESLIKSYL---YQLL 108
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF--CVSISIPEGK-THVNDNNKVI 222
+A+ H S I+ RD+KP +L + V K DF S P TH +
Sbjct: 109 QGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH------YV 159
Query: 223 GTFGFIAPEYMSTANC-NEKSDVYSFGALLLELLTGK 258
T + APE + + D++S G + ELL+ +
Sbjct: 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 19/161 (11%)
Query: 101 IAFASQMSHKNILKFVGCCL-ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLK 159
I + +H I+K +G + +L I++ EF G + D +L+ L + +++
Sbjct: 60 IEILATCNHPYIVKLLGAFYWDGKLWIMI-EFCPGGAV-----DAIMLELDRGLTEPQIQ 113
Query: 160 V-AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDN 218
V ++ A+ YLH S I+ RD+K +L K DF VS KT +
Sbjct: 114 VICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK--NVKT-LQRR 167
Query: 219 NKVIGTFGFIAPEY-----MSTANCNEKSDVYSFGALLLEL 254
+ IGT ++APE M + K+D++S G L+E+
Sbjct: 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 31/118 (26%), Positives = 54/118 (45%), Gaps = 7/118 (5%)
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV-SISIPEGKTHVNDNNKV 221
EI +A+ YLH + +V+RD+K ++ + K DF + I +G T
Sbjct: 103 EIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM----KTF 156
Query: 222 IGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR 279
GT ++APE + + D + G ++ E++ G+ Y+ E E L E +R
Sbjct: 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 214
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 36/133 (27%), Positives = 60/133 (45%), Gaps = 13/133 (9%)
Query: 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKP 186
V E+V G L I Q+ F + A EI+ + +LH R I++RD+K
Sbjct: 78 FVMEYVNGGDLMYHIQ-----QVGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKL 129
Query: 187 STILFQEQNVAKFFDFCV-SISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVY 245
++ + K DF + + +G T GT +IAPE ++ + D +
Sbjct: 130 DNVMLDSEGHIKIADFGMCKEHMVDGVT----TRTFCGTPDYIAPEIIAYQPYGKSVDWW 185
Query: 246 SFGALLLELLTGK 258
++G LL E+L G+
Sbjct: 186 AYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 35/142 (24%), Positives = 65/142 (45%), Gaps = 18/142 (12%)
Query: 138 ADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA 197
+D + + P + L+ + ++A + +L S+ + RD+ +L + VA
Sbjct: 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVA 251
Query: 198 KFFDFCVSISIPEGKTHVNDNNKVIG-----TFGFIAPEYMSTANC--NEKSDVYSFGAL 250
K DF ++ I +ND+N V+ ++APE S +C +SDV+S+G L
Sbjct: 252 KICDFGLARDI------MNDSNYVVKGNARLPVKWMAPE--SIFDCVYTVQSDVWSYGIL 303
Query: 251 LLELLTGKRISYSSCFENGEEY 272
L E+ + + Y N + Y
Sbjct: 304 LWEIFSLGKSPYPGILVNSKFY 325
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 36/151 (23%), Positives = 70/151 (46%), Gaps = 11/151 (7%)
Query: 107 MSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIAN 166
+ H I++ +G C L LV + G+L D + S L+P + L ++IA
Sbjct: 66 LDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDS-LDPQRL---LNWCVQIAK 120
Query: 167 AVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS-ISIPEGKTHVNDNNKVIGTF 225
+ YL +V R++ IL + ++ + DF V+ + P+ K + +K
Sbjct: 121 GMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT--PI 175
Query: 226 GFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
++A E + +SDV+S+G + E+++
Sbjct: 176 KWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 31/117 (26%), Positives = 53/117 (45%), Gaps = 6/117 (5%)
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVI 222
EI +A+ YLH S +V+RD+K ++ + K DF + EG +
Sbjct: 103 EIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLC---KEGISDGATMKTFC 156
Query: 223 GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR 279
GT ++APE + + D + G ++ E++ G+ Y+ E E L E +R
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 46/156 (29%), Positives = 69/156 (44%), Gaps = 27/156 (17%)
Query: 118 CCLETELPI-LVFEFVA---CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHV 173
C ET+ + +V E+V C TL I G+ P M R+ A E A+ YLH
Sbjct: 68 CSFETKRHLCMVMEYVEGGDCATLLKNI----GAL--PVDMA-RMYFA-ETVLALEYLH- 118
Query: 174 GFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS-ISIPEGKTHVNDNN-----------KV 221
+ IV RD+KP +L K DF +S I + T++ + + +V
Sbjct: 119 --NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176
Query: 222 IGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
GT +IAPE + + D ++ G +L E L G
Sbjct: 177 CGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 43/189 (22%), Positives = 76/189 (40%), Gaps = 24/189 (12%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIH--------------DPNGSQLE 150
S++ NI++ +G C++ + ++ E++ G L + P L
Sbjct: 74 SRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLP 133
Query: 151 PFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210
L VA++IA+ + YL S V RD+ L E K DF +S ++
Sbjct: 134 AISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190
Query: 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKR------ISYSS 264
G + V+ ++A E + SDV++FG L E+L + ++
Sbjct: 191 GDYYRIQGRAVL-PIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ 249
Query: 265 CFENGEEYF 273
EN E+F
Sbjct: 250 VIENAGEFF 258
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 60/256 (23%), Positives = 114/256 (44%), Gaps = 61/256 (23%)
Query: 106 QMSHKNILKFVGCCLET---ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRL-KVA 161
++ HKNI++++ L +L IL+ EF G L+ I ++ + +H + +
Sbjct: 68 ELKHKNIVRYIDRFLNKANQKLYILM-EFCDAGDLSRNIQ--KCYKMFGKIEEHAIVDIT 124
Query: 162 MEIANAVAYLHVGFSRP----IVFRDIKPSTILF------------QEQN-----VAKFF 200
++ +A+AY H P ++ RD+KP I Q N +AK
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184
Query: 201 DFCVSISIP-EGKTHVNDNNKVIGTFGFIAPEYM--STANCNEKSDVYSFGALLLELLTG 257
DF +S +I E H +GT + +PE + T + ++KSD+++ G ++ EL +G
Sbjct: 185 DFGLSKNIGIESMAH-----SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
Query: 258 KRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAI 317
K + ++N+F +++ + G + K K+L + I
Sbjct: 240 KTPFH--------------------KANNFSQLISELKRGPDLPIKGKSKEL----NILI 275
Query: 318 K-CLSKSEQDRPTMVQ 332
K L+ S ++RP+ +Q
Sbjct: 276 KNLLNLSAKERPSALQ 291
|
Length = 1021 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 5e-04
Identities = 60/247 (24%), Positives = 102/247 (41%), Gaps = 44/247 (17%)
Query: 98 FNCIAFASQMSHKNILKFV-GCCLETELPILVFEFVACGTL-----ADRIHDPNGSQLEP 151
F + SQ+SH + L FV G C+ I+V EFV G L ++ P
Sbjct: 64 FETASLMSQVSHIH-LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVP------- 115
Query: 152 FLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211
+ ++ VA ++A+A++YL + +V ++ IL +A+ + +S P
Sbjct: 116 --VAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV 170
Query: 212 KTHVNDNNKVIGTFGFIAPEYM-STANCNEKSDVYSFGALLLELLTGKRISYSSCFENGE 270
+ + +IAPE + + + +D +SFG LLE+ CF+
Sbjct: 171 SFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI----------CFDG-- 218
Query: 271 EYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM 330
E L+E R E F E + L PE + L+ L +CL+ RP+
Sbjct: 219 EVPLKE--RTPSEKERFYE-------KKHRL-PEPSCKELA--TLISQCLTYEPTQRPSF 266
Query: 331 VQVAKQL 337
+ + L
Sbjct: 267 RTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 40/167 (23%), Positives = 68/167 (40%), Gaps = 25/167 (14%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAM-EI 164
++ H+NI+ V +E + LV + +A L + + L + ++K + +I
Sbjct: 76 EIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR------KIRLTESQVKCILLQI 128
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF-------CVSISIPEGKTHVND 217
N + LH + RD+ P+ I + + K DF S K
Sbjct: 129 LNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 218 NN-----KVIGTFGFIAPEYMSTANC-NEKSDVYSFGALLLELLTGK 258
KV+ T + APE + A + D++S G + ELLTGK
Sbjct: 186 RREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 6e-04
Identities = 40/181 (22%), Positives = 77/181 (42%), Gaps = 25/181 (13%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIA 165
++SH +++ G C + + +V EF+ G L + + G +L ++ L + ++
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG-KLSKDML---LSMCQDVC 110
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTF 225
+ YL + RD+ L V K DF G T +++ +
Sbjct: 111 EGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDF--------GMTRYVLDDEYTSSS 159
Query: 226 G------FIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR 279
G + PE + + + KSDV+SFG L+ E+ T ++ FE Y + E++
Sbjct: 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP----FEKKSNYEVVEMIS 215
Query: 280 K 280
+
Sbjct: 216 R 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 6e-04
Identities = 34/159 (21%), Positives = 72/159 (45%), Gaps = 18/159 (11%)
Query: 103 FASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAM 162
Q+ + I++ +G C E E +LV E + G L + + + + + +++
Sbjct: 48 IMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPL----NKFLSGKKDEITVSNVVELMH 102
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVI 222
+++ + YL + V RD+ +L Q+ AK DF +S ++ +D+
Sbjct: 103 QVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALG-----ADDSYYKA 154
Query: 223 GTFG-----FIAPEYMSTANCNEKSDVYSFGALLLELLT 256
+ G + APE ++ + +SDV+S+G + E +
Sbjct: 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 6e-04
Identities = 30/101 (29%), Positives = 44/101 (43%), Gaps = 9/101 (8%)
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
A E+ A+ LH IV RD+ P+ IL ++ + F + + D
Sbjct: 91 AAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEA 143
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRIS 261
V + APE + E D +S GA+L ELLTGK +
Sbjct: 144 VENMY--CAPEVGGISEETEACDWWSLGAILFELLTGKTLV 182
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 41/169 (24%), Positives = 71/169 (42%), Gaps = 31/169 (18%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACG--TLADRIHDPNGSQLEPFLMKHRL 158
I+ +++H NI++ + LVFEF+ D P L+P L+K
Sbjct: 49 ISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSS--PLTG-LDPPLIK--- 102
Query: 159 KVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV--SISIP-EGKTHV 215
++ +AY H S ++ RD+KP +L + K DF + + +P TH
Sbjct: 103 SYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH- 158
Query: 216 NDNNKVIGTFGFIAPE------YMSTANCNEKSDVYSFGALLLELLTGK 258
+V+ T + APE ST D++S G + E++ +
Sbjct: 159 ----EVV-TLWYRAPEILLGSRQYSTP-----VDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 9e-04
Identities = 43/167 (25%), Positives = 74/167 (44%), Gaps = 27/167 (16%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
I+ +++H NI+K + LVFEF+ L + S + L+K L
Sbjct: 50 ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYL-- 106
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV--SISIP-EGKTHVND 217
++ +A+ H S ++ RD+KP +L + K DF + + +P TH
Sbjct: 107 -FQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--- 159
Query: 218 NNKVIGTFGFIAPE------YMSTANCNEKSDVYSFGALLLELLTGK 258
+V+ T + APE Y STA D++S G + E++T +
Sbjct: 160 --EVV-TLWYRAPEILLGCKYYSTA-----VDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 40/161 (24%), Positives = 73/161 (45%), Gaps = 21/161 (13%)
Query: 109 HKNILKFVGCCLETELPI-----LVFEFVACGTLADRIHD--PNGSQLEPFLMKHRLKVA 161
H N++KF G + ++ LV E G++ D + G ++E ++ + L A
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 162 MEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKV 221
+ + +LHV + + RD+K + IL + K DF VS + + N
Sbjct: 134 LM---GLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR---RNTS 184
Query: 222 IGTFGFIAPEYMST-----ANCNEKSDVYSFGALLLELLTG 257
+GT ++APE ++ + + + DV+S G +EL G
Sbjct: 185 VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 52/247 (21%), Positives = 104/247 (42%), Gaps = 28/247 (11%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRI--HDPNGSQLE---PFLMK 155
I S++ NI++ + C+ ++ ++ E++ G L + H+P + + +
Sbjct: 70 IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129
Query: 156 HRLK-VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214
L +A +IA+ + YL S V RD+ L + K DF +S ++ G +
Sbjct: 130 STLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186
Query: 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFL 274
V+ +++ E + SDV++FG L E+LT C E
Sbjct: 187 RIQGRAVL-PIRWMSWESILLGKFTTASDVWAFGVTLWEILT-------LCKEQPYSQLS 238
Query: 275 QELVRKSIESNS--FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQ 332
E V IE+ F++ + + + L P+ S +L + C ++ ++RP+ +
Sbjct: 239 DEQV---IENTGEFFRDQGRQVYLPKPALCPD------SLYKLMLSCWRRNAKERPSFQE 289
Query: 333 VAKQLRQ 339
+ L +
Sbjct: 290 IHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.001
Identities = 46/163 (28%), Positives = 65/163 (39%), Gaps = 20/163 (12%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
I ++ H NI+ + LVFEF+ L I D + L +K
Sbjct: 53 IKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKS-----IVLTPADIKS 106
Query: 161 AM-EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF--CVSISIPEGK-THVN 216
M + YLH S I+ RD+KP+ +L V K DF S P K TH
Sbjct: 107 YMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH-- 161
Query: 217 DNNKVIGTFGFIAPEYMSTANC-NEKSDVYSFGALLLELLTGK 258
+V+ T + APE + A D++S G + ELL
Sbjct: 162 ---QVV-TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 40/158 (25%), Positives = 65/158 (41%), Gaps = 17/158 (10%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
++M H NI+ F +V E+ G L +I G + F L+ +++
Sbjct: 53 AKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRG---KLFPEDTILQWFVQM 109
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF----CVSISIPEGKTHVNDNNK 220
V ++H + ++ RDIK I + K DF ++ T+V
Sbjct: 110 CLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV----- 161
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
GT ++ PE N KSD++S G +L EL T K
Sbjct: 162 --GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.001
Identities = 30/99 (30%), Positives = 45/99 (45%), Gaps = 13/99 (13%)
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDN---N 219
E+ A+ +LH IV+RD+KP IL DF +S K ++ DN N
Sbjct: 104 ELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLS------KANLTDNKTTN 154
Query: 220 KVIGTFGFIAPE-YMSTANCNEKSDVYSFGALLLELLTG 257
GT ++APE + + D +S G L+ E+ G
Sbjct: 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 40/142 (28%), Positives = 62/142 (43%), Gaps = 23/142 (16%)
Query: 127 LVFEFVACG---TLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLH-VGFSRPIVFR 182
LV E+ G +L +R D + F + E+ A+ +H +G+ V R
Sbjct: 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA-------ELVLAIHSVHQMGY----VHR 126
Query: 183 DIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKS 242
DIKP +L K DF + + K VN V GT +IAPE ++T N + K
Sbjct: 127 DIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPV-GTPDYIAPEVLTTMNGDGKG 184
Query: 243 ------DVYSFGALLLELLTGK 258
D +S G + E++ G+
Sbjct: 185 TYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 49/197 (24%), Positives = 89/197 (45%), Gaps = 19/197 (9%)
Query: 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIK 185
+L+ E+ + G L +I L PF + +I A+ +H SR ++ RD+K
Sbjct: 141 LLIMEYGSGGDLNKQIKQRLKEHL-PFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLK 196
Query: 186 PSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVY 245
+ I + K DF S + ++ + GT ++APE ++K+D++
Sbjct: 197 SANIFLMPTGIIKLGDFGFSKQYSD-SVSLDVASSFCGTPYYLAPELWERKRYSKKADMW 255
Query: 246 SFGALLLELLTGKRISYSSCFEN-GEEYFLQELVRKSIE------SNSFKEIVDPIIVGE 298
S G +L ELLT R F+ + +Q+++ + S+ K ++DP++
Sbjct: 256 SLGVILYELLTLHRP-----FKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKN 310
Query: 299 EGLWPEKEKQLLSYTEL 315
L P + QLL +TE
Sbjct: 311 PALRPTTQ-QLL-HTEF 325
|
Length = 478 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 29/124 (23%), Positives = 50/124 (40%), Gaps = 11/124 (8%)
Query: 151 PFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210
P + L + +I + YLH ++ I+ RD+K I + + D +
Sbjct: 153 PLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAA----- 204
Query: 211 GKTHVNDNN--KVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFEN 268
+ V + GT APE ++ N K+D++S G +L E+L +
Sbjct: 205 -QFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPST 263
Query: 269 GEEY 272
EEY
Sbjct: 264 PEEY 267
|
Length = 357 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 38/159 (23%), Positives = 68/159 (42%), Gaps = 28/159 (17%)
Query: 106 QMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHR------- 157
Q H +I+K +G TE P+ +V E G +L +L ++
Sbjct: 63 QFDHPHIVKLIGVI--TENPVWIVMELAPLG------------ELRSYLQVNKYSLDLAS 108
Query: 158 -LKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN 216
+ + +++ A+AYL S+ V RDI +L + K DF +S + + +
Sbjct: 109 LILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKA 165
Query: 217 DNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELL 255
K+ ++APE ++ SDV+ FG + E+L
Sbjct: 166 SKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.002
Identities = 30/110 (27%), Positives = 54/110 (49%), Gaps = 14/110 (12%)
Query: 156 HRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHV 215
H+ + ++ A+ Y+H S ++ RD+KPS IL K DF ++ S+ + +
Sbjct: 108 HKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSL----SEL 160
Query: 216 NDNNKV------IGTFGFIAPEYMSTANCNEKS-DVYSFGALLLELLTGK 258
+N + + T + APE + + K D++S G +L E+L GK
Sbjct: 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.002
Identities = 31/122 (25%), Positives = 46/122 (37%), Gaps = 31/122 (25%)
Query: 163 EIANAVAYLH-VGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT-------- 213
E+ A+ +H +GF + RDIKP IL K DF + + + K
Sbjct: 109 ELVLALDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS 164
Query: 214 ---------------HVNDN---NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELL 255
H N +GT +IAPE + + D +S G +L E+L
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
Query: 256 TG 257
G
Sbjct: 225 YG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 28/98 (28%), Positives = 44/98 (44%), Gaps = 5/98 (5%)
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDN-NKV 221
+I + Y+H S ++ RD+KP +L K DF ++ E +
Sbjct: 113 QILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY 169
Query: 222 IGTFGFIAPEYM-STANCNEKSDVYSFGALLLELLTGK 258
+ T + APE M S + + DV+S G +L ELL K
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 26/166 (15%)
Query: 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKP 186
L+ +++ G L + SQ E F + + EI A+ +LH I++RDIK
Sbjct: 82 LILDYINGGELFTHL-----SQRERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKL 133
Query: 187 STILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK----VIGTFGFIAPEYMSTANC--NE 240
IL DF +S K D + GT ++AP+ + + ++
Sbjct: 134 ENILLDSNGHVVLTDFGLS------KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDK 187
Query: 241 KSDVYSFGALLLELLTGKRISYSSCFE-NGEEYFLQELVRKSIESN 285
D +S G L+ ELLTG +S F +GE+ E+ R+ ++S
Sbjct: 188 AVDWWSMGVLMYELLTG-----ASPFTVDGEKNSQAEISRRILKSE 228
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.002
Identities = 57/241 (23%), Positives = 96/241 (39%), Gaps = 41/241 (17%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDPNGSQLEPFLMKHRLKVAME 163
Q H NI+ G +++ ++V E++ G+L R HD + ++ M + M+
Sbjct: 61 QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMK 120
Query: 164 IANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI---PEGKTHVNDNNK 220
+ + Y+H RD+ IL V K DF +S + PE + K
Sbjct: 121 YLSDMGYVH---------RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA-AYTTRGGK 170
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280
+ + APE ++ SDV+S+G ++ E+ +SY GE + +
Sbjct: 171 I--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEV-----MSY------GERPYWE----- 212
Query: 281 SIESNSFKEIVDPIIVGEEGL-WPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQ 339
SN D I EEG P + +L + C K +RP Q+ L +
Sbjct: 213 --MSNQ-----DVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265
Query: 340 L 340
L
Sbjct: 266 L 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 52/237 (21%), Positives = 101/237 (42%), Gaps = 32/237 (13%)
Query: 39 YNPIQNFTAQELKAATNNYDPEKVITKDLLYKLYK------GFLQDRPISVMKFGGNLNS 92
YN + L T+ ++ + I K K+YK G L + ++ +++
Sbjct: 7 YNSSM-LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLA--AVKILDPISDVDE 63
Query: 93 EEYCCFNCIAFASQMSHKNILKFVGCCLETELPI-----LVFEFVACGTLADRIHD--PN 145
E +N + +H N++KF G + + + LV E G++ + +
Sbjct: 64 EIEAEYNILQSLP--NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC 121
Query: 146 GSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205
G +L+ ++ + L A+ + +LH + I+ RD+K + IL + K DF VS
Sbjct: 122 GQRLDEAMISYILYGALL---GLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175
Query: 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMST-----ANCNEKSDVYSFGALLLELLTG 257
+ + N +GT ++APE ++ + + + DV+S G +EL G
Sbjct: 176 AQLTSTRLR---RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 13/147 (8%)
Query: 112 ILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYL 171
+ + +G CL + + LV + + G L D + + L L ++IA ++YL
Sbjct: 71 VCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDL----LNWCVQIAKGMSYL 125
Query: 172 HVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS--ISIPEGKTHVNDNNKVIGTFGFIA 229
+V RD+ +L + N K DF ++ + I E + H D KV ++A
Sbjct: 126 E---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA-DGGKV--PIKWMA 179
Query: 230 PEYMSTANCNEKSDVYSFGALLLELLT 256
E + +SDV+S+G + EL+T
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 22/79 (27%), Positives = 40/79 (50%), Gaps = 6/79 (7%)
Query: 179 IVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANC 238
IV+RD+KP +L + K DF + + + +T+ + GT +IAPE +
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFA-KVVDTRTYT-----LCGTPEYIAPEILLNVGH 205
Query: 239 NEKSDVYSFGALLLELLTG 257
+ +D ++ G + E+L G
Sbjct: 206 GKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.003
Identities = 54/248 (21%), Positives = 103/248 (41%), Gaps = 29/248 (11%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHD-------PNGSQLEPFL 153
I S++ + NI++ +G C+ + ++ E++ G L + + + +
Sbjct: 68 IKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 154 MKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213
+ + L +A++IA+ + YL S V RD+ L K DF +S ++ G
Sbjct: 128 IANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184
Query: 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYF 273
+ V+ ++A E + SDV++FG L E+ ++ C E
Sbjct: 185 YRIQGRAVL-PIRWMAWESILLGKFTTASDVWAFGVTLWEM-------FTLCKEQPYSLL 236
Query: 274 LQELVRKSIESNS--FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMV 331
E V IE+ F+ I + + L P +L ++C S+ +DRPT
Sbjct: 237 SDEQV---IENTGEFFRNQGRQIYLSQTPLCPS------PVFKLMMRCWSRDIKDRPTFN 287
Query: 332 QVAKQLRQ 339
++ LR+
Sbjct: 288 KIHHFLRE 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.003
Identities = 24/93 (25%), Positives = 41/93 (44%), Gaps = 7/93 (7%)
Query: 167 AVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFG 226
+ YLH F I+ RD+K S +L ++ K DF ++ + + T
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY---GLPAKPMTPKVVTLW 173
Query: 227 FIAPEYMSTANCNEKS-DVYSFGALLLELLTGK 258
+ APE + + D+++ G +L ELL K
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 33/99 (33%), Positives = 49/99 (49%), Gaps = 12/99 (12%)
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS---ISIPEGKTHVNDNN 219
EI A+ +LH IV+RDIK IL + DF +S +S + +T+
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY----- 164
Query: 220 KVIGTFGFIAPEYMSTANCNEKS-DVYSFGALLLELLTG 257
GT ++APE + + K+ D +S G L+ ELLTG
Sbjct: 165 SFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 29/98 (29%), Positives = 47/98 (47%), Gaps = 12/98 (12%)
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKV- 221
E+ A+ LH +++RD+KP IL Q DF + K ++ D++K
Sbjct: 101 ELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLC------KLNMKDDDKTN 151
Query: 222 --IGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
GT ++APE + + D ++ G LL E+LTG
Sbjct: 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.004
Identities = 41/177 (23%), Positives = 78/177 (44%), Gaps = 21/177 (11%)
Query: 89 NLNSEEYCCFNCIAFAS---QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPN 145
++ +EE F I AS + H NI+ E VFE++ I P
Sbjct: 39 SMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPG 98
Query: 146 GSQLEPFLMKHRLKVAM-EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV 204
G L + +++ M ++ +AY+H + I+ RD+KP +L K DF +
Sbjct: 99 G------LHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGL 149
Query: 205 --SISIPEGKTHVNDNNKVIGTFGFIAPE-YMSTANCNEKSDVYSFGALLLELLTGK 258
+ SIP +T+ ++ + T + P+ + + + D++ G + +E+L G+
Sbjct: 150 ARAKSIP-SQTYSSE----VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 10/97 (10%)
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVI 222
++ + Y+H S I+ RD+KPS + E + DF ++ + T +
Sbjct: 126 QLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT------GYV 176
Query: 223 GTFGFIAPEYM-STANCNEKSDVYSFGALLLELLTGK 258
T + APE M + + N+ D++S G ++ ELL GK
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 344 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.98 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.68 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.65 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.42 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.42 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.41 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.37 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.34 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.26 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.24 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.23 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.22 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.11 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.04 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.04 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.89 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.79 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.75 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.73 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.71 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.54 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.48 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.48 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.46 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.43 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.42 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.41 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.38 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.32 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.2 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.14 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.12 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.04 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.99 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.92 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.91 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.85 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.82 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.6 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.58 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.54 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.43 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.22 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.06 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.98 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.84 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.84 | |
| PLN02236 | 344 | choline kinase | 96.79 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.79 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.68 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.59 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.54 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.49 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.44 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.29 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.14 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.12 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.95 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.79 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.99 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 93.98 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.63 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.44 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.94 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 92.32 | |
| PTZ00296 | 442 | choline kinase; Provisional | 91.87 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-56 Score=407.10 Aligned_cols=289 Identities=38% Similarity=0.643 Sum_probs=247.2
Q ss_pred ccccccHHHHHHHhcCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEE
Q 048160 41 PIQNFTAQELKAATNNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCC 119 (344)
Q Consensus 41 ~~~~~~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~ 119 (344)
+.+.|+++|+..+|++|+..+.||+|+||.||+|.. ++..||||++.........+|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 788999999999999999999999999999999999 4489999988776543145599999999999999999999999
Q ss_pred eeCC-ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcce
Q 048160 120 LETE-LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAK 198 (344)
Q Consensus 120 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 198 (344)
.+++ ..+||+|||++|||.++|....+. +++|.+|+.|+.++|.||.|||+....+|+||||||.|||+|.++.+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9998 599999999999999999876532 789999999999999999999976666899999999999999999999
Q ss_pred EeeeecccccCC-CCcccccCCcc-ccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHH
Q 048160 199 FFDFCVSISIPE-GKTHVNDNNKV-IGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQE 276 (344)
Q Consensus 199 l~dfg~a~~~~~-~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 276 (344)
|+|||+|+..+. ..... .. .||.+|+|||++..+..+.|+||||||+++.|++||+.+...... .....+.+
T Consensus 218 lsDFGLa~~~~~~~~~~~----~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~--~~~~~l~~ 291 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVS----TTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP--RGELSLVE 291 (361)
T ss_pred ccCccCcccCCcccccee----eecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC--cccccHHH
Confidence 999999976654 22111 12 789999999999999999999999999999999999987765431 22333788
Q ss_pred HHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 048160 277 LVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLH 341 (344)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~ 341 (344)
|.++.+....+.+++|+.+.+. .++.. .....+..+...|++.+|.+||+|.+|++.|+.+.
T Consensus 292 w~~~~~~~~~~~eiiD~~l~~~--~~~~~-~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 292 WAKPLLEEGKLREIVDPRLKEG--EYPDE-KEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHHHHCcchhheeCCCccCC--CCChH-HHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 8888888889999999987631 11111 45566899999999999999999999999997654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-53 Score=383.92 Aligned_cols=255 Identities=26% Similarity=0.401 Sum_probs=210.6
Q ss_pred CCCCCccccCCCceEEEEEECCcc-EEEEEecCCCCch--hhhHhhHHHHHhcCCCCceeeeeeEEeeCC-ccEEEEeec
Q 048160 57 YDPEKVITKDLLYKLYKGFLQDRP-ISVMKFGGNLNSE--EYCCFNCIAFASQMSHKNILKFVGCCLETE-LPILVFEFV 132 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~~~~~-vavk~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-~~~lv~e~~ 132 (344)
+...+.||+|+||+||+|.|.|.. ||||++....... .+.|.+|+.+|.+++|||||+++|+|.+.. .+++||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 344566999999999999998888 9999998764433 358999999999999999999999999887 799999999
Q ss_pred CCCCccccccCC-CCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCC-eeeecccccceEeecCC-cceEeeeecccccC
Q 048160 133 ACGTLADRIHDP-NGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRP-IVFRDIKPSTILFQEQN-VAKFFDFCVSISIP 209 (344)
Q Consensus 133 ~~gsL~~~l~~~-~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~dlk~~Nill~~~~-~~kl~dfg~a~~~~ 209 (344)
++|+|..++... . ..+++..++.++.|||.|+.||| +.+ ||||||||+|||++.++ ++||+|||+++...
T Consensus 123 ~~GsL~~~l~~~~~----~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRK----RKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred CCCcHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 999999999773 2 47999999999999999999999 888 99999999999999997 99999999998765
Q ss_pred CCCcccccCCccccccccccccccC--cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMS--TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
..... .....||..|||||++. ...|+.|+||||||+++|||+||+.||..... . .........+
T Consensus 196 ~~~~~---~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----~----~~~~~v~~~~-- 262 (362)
T KOG0192|consen 196 ISKTS---MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP----V----QVASAVVVGG-- 262 (362)
T ss_pred ccccc---ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----H----HHHHHHHhcC--
Confidence 43211 11357899999999999 56899999999999999999999999975421 1 1111111111
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
..+..|. .+++.+..|+..||+.||..||++.+|+..|+.+...
T Consensus 263 ----------~Rp~~p~--~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 263 ----------LRPPIPK--ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred ----------CCCCCCc--cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 1111122 3677899999999999999999999999999988653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=365.28 Aligned_cols=251 Identities=22% Similarity=0.283 Sum_probs=215.0
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch-hhhHhhHHHHHhcCCCCceeeeeeEEeeCC-ccEEEEee
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE-EYCCFNCIAFASQMSHKNILKFVGCCLETE-LPILVFEF 131 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-~~~lv~e~ 131 (344)
+++..+.||+|..|+||++.+ +++.+|+|.+....+.. .+++.+|+++++..+||+||.+||+|.... ...|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 345568899999999999999 68899999996554433 467889999999999999999999999988 49999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
|++|||++++...+ .+++...-.++.++++||.|||+ ..+||||||||+|||+++.|.+||||||.+..+...
T Consensus 160 MDgGSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred cCCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 99999999998654 58999999999999999999993 399999999999999999999999999999887554
Q ss_pred CcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
..++++||..|||||.+.+..|+.++||||||+.++|+++|+.|+.+... ....+-+++
T Consensus 233 -----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~----------------~~~~~~~Ll 291 (364)
T KOG0581|consen 233 -----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP----------------PYLDIFELL 291 (364)
T ss_pred -----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC----------------CCCCHHHHH
Confidence 23378999999999999999999999999999999999999999876411 112334445
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+.++.+..+..|.. .+++++.+|+..||++||.+|||+.++++
T Consensus 292 ~~Iv~~ppP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 292 CAIVDEPPPRLPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHHhcCCCCCCCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 55555566666653 58889999999999999999999999875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-51 Score=371.21 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=209.8
Q ss_pred CCCccccCCCceEEEEEECCc-cEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCCc
Q 048160 59 PEKVITKDLLYKLYKGFLQDR-PISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTL 137 (344)
Q Consensus 59 ~~~~ig~G~~g~V~~~~~~~~-~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL 137 (344)
..+.||+|-||+||.|.|++. .||+|.++.... ..+.|.+|+++|++|+|+|||+++|+|..+...|||||||+.|+|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 357799999999999999776 999999987633 346788999999999999999999999998899999999999999
Q ss_pred cccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCccccc
Q 048160 138 ADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217 (344)
Q Consensus 138 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~ 217 (344)
.++|+...+ ..+...+.+.++.|||.|++||. ++++|||||.++|||++++..+||+|||+|+....+......
T Consensus 289 l~yLr~~~~---~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 289 LDYLRTREG---GLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred HHHhhhcCC---CccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 999987444 36788899999999999999999 999999999999999999999999999999955444332222
Q ss_pred CCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccccccc
Q 048160 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVG 297 (344)
Q Consensus 218 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (344)
...-+..|.|||.+..+.++.||||||||++|||++|-...+++... . .+++..+-.|
T Consensus 363 --~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-------n-------------~ev~~~le~G 420 (468)
T KOG0197|consen 363 --GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-------N-------------EEVLELLERG 420 (468)
T ss_pred --CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-------H-------------HHHHHHHhcc
Confidence 22336789999999999999999999999999999985554443221 1 1222222222
Q ss_pred CCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 298 EEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 298 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.+.|.+..|+..+.+||..||..+|++|||++.+...|+.+..
T Consensus 421 --yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 421 --YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred --CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 3344444899999999999999999999999999999888764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=350.94 Aligned_cols=258 Identities=22% Similarity=0.345 Sum_probs=208.6
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeee-EEeeCCc-cEEEE
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVG-CCLETEL-PILVF 129 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~-~~~~~~~-~~lv~ 129 (344)
+|.+.+.||.|.||+||++.. +|..||.|.+.-+.- ...+....|+.+|++|+|||||++++ .+..+.. ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 477789999999999999998 899999999875532 33456789999999999999999999 4444444 89999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCC-CCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGF-SRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||.+|+|...++....+. .-+++.+++.++.|++.||.++|+.. ...|+||||||.||+++.+|.+||+|||+++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qk-r~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQK-RLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhcc-ccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999886543222 46899999999999999999999311 134999999999999999999999999999988
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
....... ...+||+.||+||.+...+|+.|+||||+||++|||+.-.+||+.. ++.
T Consensus 179 ~s~~tfA---~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---------------------n~~ 234 (375)
T KOG0591|consen 179 SSKTTFA---HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---------------------NLL 234 (375)
T ss_pred cchhHHH---HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---------------------cHH
Confidence 6544332 2679999999999999999999999999999999999999999863 112
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQ 339 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~ 339 (344)
++..++..+..++.|.. -.+.++.+|+..|+..||+.||+...+++.+.+
T Consensus 235 ~L~~KI~qgd~~~~p~~-~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 235 SLCKKIEQGDYPPLPDE-HYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHHHHHcCCCCCCcHH-HhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 22223333444444432 567789999999999999999996666555544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=355.50 Aligned_cols=198 Identities=23% Similarity=0.392 Sum_probs=179.9
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCC--CCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGN--LNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
.++|...+.||+|+||+||+|++ ++..||||.+... .....+.+..|+.+|+.++|||||.+++++..++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 46788888999999999999999 6788999998776 4444566789999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC------CcceEeeee
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ------NVAKFFDFC 203 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~------~~~kl~dfg 203 (344)
|||.||+|.++++.++ .+++.++..++.|+|.||++|| +++||||||||+|||++.. -.+||+|||
T Consensus 89 EyC~gGDLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG-----RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 9999999999999875 5999999999999999999999 9999999999999999765 468999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCC
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYS 263 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 263 (344)
+|+.+....... +..|++.|||||++..+.|+.|+|+||+|+++|++++|+.||..
T Consensus 161 fAR~L~~~~~a~----tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 161 FARFLQPGSMAE----TLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhhhCCchhHHH----HhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 999987544322 67899999999999999999999999999999999999999974
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-50 Score=366.88 Aligned_cols=246 Identities=20% Similarity=0.301 Sum_probs=208.9
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCC---CCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGN---LNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
..|...+.||+|||+.+|.++. .|..||+|.+.+. .....+.+.+|+++.++|+|||||+++++|++.+..|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 3488999999999999999999 7889999998663 2234466789999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
|+|++++|..+++.+. ++++.+++.++.||+.||.||| +.+|+|||||..|++++++.++||+|||+|..+.
T Consensus 98 ELC~~~sL~el~Krrk-----~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK-----PLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EecCCccHHHHHHhcC-----CCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeec
Confidence 9999999999998654 7999999999999999999999 9999999999999999999999999999999887
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
..... ..+..||+.|.|||++.....+..+||||+||+||-|+.|++||..... ...+..+.
T Consensus 170 ~~~Er---k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v----kety~~Ik----------- 231 (592)
T KOG0575|consen 170 YDGER---KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV----KETYNKIK----------- 231 (592)
T ss_pred Ccccc---cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH----HHHHHHHH-----------
Confidence 55332 2367999999999999988999999999999999999999999965311 11111111
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. .....|. ..+.+..+||.++|++||.+|||+++|+.
T Consensus 232 ------~-~~Y~~P~--~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 232 ------L-NEYSMPS--HLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ------h-cCccccc--ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 1122222 44556789999999999999999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-50 Score=350.87 Aligned_cols=251 Identities=21% Similarity=0.290 Sum_probs=205.7
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch-------hhhHhhHHHHHhcCCCCceeeeeeEEeeCC
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE-------EYCCFNCIAFASQMSHKNILKFVGCCLETE 123 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~~~~~~~~~~ 123 (344)
..+.|...+.||+|+||.|-+|.. +++.||||++++..... ...+.+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 445677889999999999999988 88999999997663322 223469999999999999999999999999
Q ss_pred ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC---CcceEe
Q 048160 124 LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ---NVAKFF 200 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~ 200 (344)
..|+||||+.||+|.+++-.++ .+.+..-..++.|++.|+.||| +.||+||||||+|||+..+ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEec
Confidence 9999999999999999987765 4677777889999999999999 9999999999999999766 789999
Q ss_pred eeecccccCCCCcccccCCccccccccccccccCcCCC---CcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHH
Q 048160 201 DFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANC---NEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL 277 (344)
Q Consensus 201 dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 277 (344)
|||+|+.......- .+++||+.|.|||++.+..+ ..++|+||+||++|-+++|.+||......
T Consensus 322 DFGlAK~~g~~sfm----~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~---------- 387 (475)
T KOG0615|consen 322 DFGLAKVSGEGSFM----KTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD---------- 387 (475)
T ss_pred ccchhhccccceeh----hhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC----------
Confidence 99999987643322 26899999999999987653 34789999999999999999999754321
Q ss_pred HHHHhccCCcccccccccccCCCCChh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 278 VRKSIESNSFKEIVDPIIVGEEGLWPE-KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+.+++..|.....|. ....+.+..+|+..||..||+.|||++|+++
T Consensus 388 ----------~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 388 ----------PSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ----------ccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 11223333444444432 2345677899999999999999999999875
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=378.37 Aligned_cols=260 Identities=22% Similarity=0.352 Sum_probs=217.5
Q ss_pred CCCCCCccccCCCceEEEEEEC-------CccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 56 NYDPEKVITKDLLYKLYKGFLQ-------DRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~~-------~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
+....+.||+|.||+||+|+.. ...||||.++..... ...+|+||++++..++|||||+++|+|..++++++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 4455688999999999999983 256999999888666 56889999999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCC---------CccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcce
Q 048160 128 VFEFVACGTLADRIHDPNGSQ---------LEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAK 198 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 198 (344)
|+|||..|+|.+||.....+. ..+|+..+.+.|+.|||.|+.||- +..+|||||.++|+|++++..+|
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEE
Confidence 999999999999997644311 235889999999999999999999 99999999999999999999999
Q ss_pred EeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHH
Q 048160 199 FFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQEL 277 (344)
Q Consensus 199 l~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~ 277 (344)
|+|||+++.+...+......+ -.-+++|||||.+..++|+++||||||||+|||+++ |+.|++...+
T Consensus 644 IsDfGLsRdiYssDYYk~~~~-t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn----------- 711 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGN-TLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN----------- 711 (774)
T ss_pred ecccccchhhhhhhhhcccCC-ceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-----------
Confidence 999999998776554432211 234789999999999999999999999999999996 8888876532
Q ss_pred HHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 278 VRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.++++.+..|. .++.++.|+..+.+||..||+.+|++||+++||-..|++...
T Consensus 712 ----------~EVIe~i~~g~--lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 712 ----------QEVIECIRAGQ--LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred ----------HHHHHHHHcCC--cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 11122122222 244455889999999999999999999999999999998654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-49 Score=332.84 Aligned_cols=268 Identities=19% Similarity=0.267 Sum_probs=204.8
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch--hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE--EYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
.|+...++|+|+||+||+++. .|+.||||+|....+.. .+..+||+++|++++|+|+|.++.+|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 477788999999999999999 78899999997654422 35578999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
|+. ++.+-|.... .-++...+..++.|++.|+.|+| +++++||||||+|||+..++.+||||||.|+.+...
T Consensus 83 ~dh-TvL~eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 83 CDH-TVLHELERYP----NGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred cch-HHHHHHHhcc----CCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 985 4555554433 23788889999999999999999 999999999999999999999999999999998754
Q ss_pred CcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc----CC
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES----NS 286 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~ 286 (344)
+.... ..+.|.+|.|||.+.+ .+|..++||||+||++.||++|.+.|.+..+-+ .-+.+...+...... ..
T Consensus 155 gd~YT---DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD-QLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 155 GDNYT---DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID-QLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred cchhh---hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHH-HHHHHHHHHcccCHHHHHHhc
Confidence 33222 4688999999999988 579999999999999999999998876654322 222222222222111 01
Q ss_pred cccccccccccC----CCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 287 FKEIVDPIIVGE----EGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 287 ~~~~~~~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
-...+.-+...+ .+.....+..+..+.+|+..||+.||++|++.++++.
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111111111111 1111112344557899999999999999999998764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=337.28 Aligned_cols=241 Identities=25% Similarity=0.312 Sum_probs=201.3
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
.++|+..+.||+|+||.||.++. .++.+|+|.+++..- .+.+..+.|..+|.+++||.||+++-.|.+...+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 45699999999999999999999 678899999876522 2345567999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
+||+.||.|..+|++.+ .|++..+..++.+|+.||.||| +.+||||||||+|||+|.+|.++|+|||+++..
T Consensus 104 ld~~~GGeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG-----RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EeccCCccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 99999999999998765 6999999999999999999999 999999999999999999999999999999866
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
-..+.. ..+++||+.|||||++...+|+..+|.||+|+++|||++|.+||+.... .++...
T Consensus 176 ~~~~~~---t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~--------~~~~~~-------- 236 (357)
T KOG0598|consen 176 LKDGDA---TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV--------KKMYDK-------- 236 (357)
T ss_pred ccCCCc---cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH--------HHHHHH--------
Confidence 544332 2258999999999999999999999999999999999999999975421 111111
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCC
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP 328 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 328 (344)
+..+.....|. ..+.+.++++...|+.||++|.
T Consensus 237 -----I~~~k~~~~p~--~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 237 -----ILKGKLPLPPG--YLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -----HhcCcCCCCCc--cCCHHHHHHHHHHhccCHHHhc
Confidence 11111111111 2345678999999999999995
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-49 Score=350.58 Aligned_cols=269 Identities=18% Similarity=0.231 Sum_probs=210.1
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhh-HhhHHHHHhcCC-CCceeeeeeEEeeCC-ccEEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYC-CFNCIAFASQMS-HKNILKFVGCCLETE-LPILV 128 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~-~~~E~~~l~~l~-H~niv~~~~~~~~~~-~~~lv 128 (344)
-++|...+.||.|+||.||+|+. .+..||||++++....-.+. -+||+..|++++ |||||++..++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 35577789999999999999998 78889999999887654444 359999999999 999999999998887 99999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
||||+ .+|+++++.++ .+|++..+..|+.||+.||+|+| .+|+.|||+||+|||+..+..+||+|||+|+.+
T Consensus 89 fE~Md-~NLYqLmK~R~----r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred HHhhh-hhHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccc
Confidence 99997 79999999885 58999999999999999999999 999999999999999998999999999999988
Q ss_pred CCCCcccccCCccccccccccccccC-cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMS-TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
....-.. ..+.|.+|+|||++. ..-|+.+.||||+|||++|+++-++.|.+..+ -+.-+.+.+.+.........
T Consensus 161 ~SkpPYT----eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE-~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 161 RSKPPYT----EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE-IDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred ccCCCcc----hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH-HHHHHHHHHHhCCCccccch
Confidence 6543222 467899999999865 56799999999999999999999988765433 22233333333221111100
Q ss_pred c-cccccccccCCC---CChh---hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 288 K-EIVDPIIVGEEG---LWPE---KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 288 ~-~~~~~~~~~~~~---~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. ..+...+.-..+ ..+. .+.++.+..+++.+|+.|||++||||.+.++
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 0 000011100100 0000 1246678999999999999999999999876
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=351.67 Aligned_cols=265 Identities=23% Similarity=0.330 Sum_probs=213.9
Q ss_pred HHHHHHhcCCCCCCccccCCCceEEEEEECCccEEEEEecCC--CCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCcc
Q 048160 48 QELKAATNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGN--LNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELP 125 (344)
Q Consensus 48 ~~i~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~ 125 (344)
+++....+.+.....||+|.||+||+|+|.|. ||||+++-+ .....+.|..|+.++++-+|.||+-+.|+|.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd-VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD-VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccc-eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 44444555566778999999999999999876 999998755 33456889999999999999999999999998877
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
.||+.+|+|.+|+.+++... ..|.+.+.+.|+.|++.|+.||| .++|||||||..||++.+++++||+|||++
T Consensus 463 AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccce
Confidence 89999999999999998776 57999999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCcccccCCccccccccccccccCc---CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMST---ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
..-... ..........|...|||||++.- .+|+..+||||||+++|||++|..||. ...
T Consensus 536 tvk~~w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~---------------- 597 (678)
T KOG0193|consen 536 TVKTRW-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQN---------------- 597 (678)
T ss_pred eeeeee-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCC----------------
Confidence 765432 11222234567889999999864 579999999999999999999999986 211
Q ss_pred ccCCccccccccccc--CCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 283 ESNSFKEIVDPIIVG--EEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 283 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
...++=.+-.| .........++++++.+|+..||..++++||++.+|+..|+.+..+
T Consensus 598 ----~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 598 ----RDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ----hhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 01111111111 0011112236788999999999999999999999999998887764
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=341.86 Aligned_cols=267 Identities=20% Similarity=0.250 Sum_probs=205.9
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch-h-hhHhhHHHHHhcCCCCceeeeeeEEeeC--CccEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE-E-YCCFNCIAFASQMSHKNILKFVGCCLET--ELPILV 128 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~-~-~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv 128 (344)
+.|+..++||+|+||.||+|+. +|+.||+|++.-+.... . ....||+.+|++|.||||+++.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 4577889999999999999999 78899999998765322 2 3345999999999999999999998876 689999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
+|||++ +|..++...+ ..|++.++.-++.|++.||+||| +++|+|||||..|||||++|.+||+|||+|+++
T Consensus 197 FeYMdh-DL~GLl~~p~----vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG----VKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred Eecccc-hhhhhhcCCC----cccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 999984 8999888765 47999999999999999999999 999999999999999999999999999999988
Q ss_pred CCCCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc--C
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES--N 285 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~ 285 (344)
........ +..+-|.+|.|||++.+. .|++.+|+||.||||.||++|+++|....+... +..++...-.+ .
T Consensus 269 ~~~~~~~~--T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ----l~kIfklcGSP~e~ 342 (560)
T KOG0600|consen 269 TPSGSAPY--TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ----LHKIFKLCGSPTED 342 (560)
T ss_pred cCCCCccc--ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH----HHHHHHHhCCCChh
Confidence 76543322 245779999999999875 699999999999999999999998876543222 22222211100 0
Q ss_pred Ccc--cccccccccCCCCChh-----hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 SFK--EIVDPIIVGEEGLWPE-----KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ~~~--~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+. .+.....-.....++. ....+...++|+..+|..||.+|.||.++++
T Consensus 343 ~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 343 YWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 011 1110000001111110 1123456899999999999999999998875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=345.32 Aligned_cols=247 Identities=21% Similarity=0.334 Sum_probs=211.5
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
.|....+||+|..|.||.+.. .+..||||++........+-++.|+.+|+..+|+|||.++..+.-++.+|+|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 466678999999999999998 778899999988877777778899999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
||+|.+.+... .+++.++..|..+++.||+||| ..+|+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 354 ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 354 GGSLTDVVTKT------RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred CCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999999875 4899999999999999999999 99999999999999999999999999999888765443
Q ss_pred ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDP 293 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (344)
...+.+||+.|||||++....|++|+||||||++++||+.|.+||+... ... .++ . +..+
T Consensus 425 ---KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~---Plr-Aly-L----Ia~n-------- 484 (550)
T KOG0578|consen 425 ---KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN---PLR-ALY-L----IATN-------- 484 (550)
T ss_pred ---ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC---hHH-HHH-H----Hhhc--------
Confidence 3336799999999999999999999999999999999999999997521 100 000 0 0111
Q ss_pred ccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 294 IIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+........++.+.+|+.+||+.||++||++.|+|+
T Consensus 485 ----g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 485 ----GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred ----CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 12222333467788999999999999999999999986
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=331.88 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=202.7
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCC--ccEEEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETE--LPILVF 129 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~--~~~lv~ 129 (344)
..++...+.||+|+||+||++.. +|...|||.+........+.+.+|+.+|++++|||||+++|...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 34577789999999999999999 46899999987664434667889999999999999999999754443 689999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec-CCcceEeeeeccccc
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE-QNVAKFFDFCVSISI 208 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~dfg~a~~~ 208 (344)
||+++|||.+++.+.++ .+++..+..+..|++.||.||| +++|+||||||+|||++. ++.+||+|||++...
T Consensus 96 Ey~~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 99999999999988764 5899999999999999999999 999999999999999999 799999999999877
Q ss_pred CCCCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
..............||+.|||||++..+ .....+|||||||++.||+||+.||..... ....+-......
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~-------~~~~~~~ig~~~-- 239 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE-------EAEALLLIGRED-- 239 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc-------hHHHHHHHhccC--
Confidence 6422222233357899999999999863 334599999999999999999998864200 001111111111
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
..+.+|. ..+.+..+++.+|+..||++||||.++++.
T Consensus 240 ----------~~P~ip~--~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 240 ----------SLPEIPD--SLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred ----------CCCCCCc--ccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 1112222 455678999999999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=332.38 Aligned_cols=264 Identities=23% Similarity=0.279 Sum_probs=210.7
Q ss_pred HHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCC-CCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 52 AATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGN-LNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 52 ~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
...+.|.....||.|..++||+|+. .+..||||++.-+ .+.+.+.+.+|+..|+.++||||++++..|..+..+|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 3446788999999999999999999 7789999998755 334468899999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|.||.+||+.++++..-. .-+.+..+..|+.++++||.||| .+|.||||||+.||||+.+|.+||+|||.+..+
T Consensus 103 mpfMa~GS~ldIik~~~~---~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYP---DGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ehhhcCCcHHHHHHHHcc---ccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 999999999999876433 23788889999999999999999 999999999999999999999999999987776
Q ss_pred CCCCcccccC-CccccccccccccccCc--CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 209 PEGKTHVNDN-NKVIGTFGFIAPEYMST--ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 209 ~~~~~~~~~~-~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
...+...... +++.||+.|||||++.. ..|+.|+||||||++..||++|..||.... .....+..+ . +
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p---PmkvLl~tL-----q-n 247 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP---PMKVLLLTL-----Q-N 247 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC---hHHHHHHHh-----c-C
Confidence 6554333322 57799999999999654 469999999999999999999999986421 111111111 1 1
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
...... . ..............+.+++..||+.||.+|||++++++
T Consensus 248 ~pp~~~-t----~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 248 DPPTLL-T----SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCCCcc-c----ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111000 0 01111222345668999999999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=339.15 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=210.2
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCc
Q 048160 51 KAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQM-SHKNILKFVGCCLETEL 124 (344)
Q Consensus 51 ~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~ 124 (344)
....++|...+.||.|+|++|++|+. .++.+|||++.+..- ...+.+.+|-.+|.+| .||.|++|+-.|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 34456799999999999999999999 788999999765521 2235566888899999 79999999999999999
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeec
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV 204 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~ 204 (344)
+|+|+||+++|+|.+++++.+ .|++..+..++.+|+.||+||| ++|||||||||+|||+|.+|+++|.|||.
T Consensus 149 LYFvLe~A~nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGs 220 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGS 220 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccc
Confidence 999999999999999999875 6999999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCcc----------cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHH
Q 048160 205 SISIPEGKTH----------VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFL 274 (344)
Q Consensus 205 a~~~~~~~~~----------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 274 (344)
|+.++..... ......++||..|.+||++.....++.+|||+|||++|+|+.|.+||... +....+
T Consensus 221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~----NeyliF 296 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA----NEYLIF 296 (604)
T ss_pred cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc----cHHHHH
Confidence 9988643222 11124589999999999999999999999999999999999999999754 222223
Q ss_pred HHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 275 QELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+++..-+ .+|. ..++.+.+|+.+.|..||.+|+|+++|.+
T Consensus 297 qkI~~l~y------------------~fp~--~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 297 QKIQALDY------------------EFPE--GFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHHHhcc------------------cCCC--CCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 33332111 1111 34456899999999999999999988764
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=330.30 Aligned_cols=263 Identities=17% Similarity=0.252 Sum_probs=209.0
Q ss_pred CCccccccHHHHHHHhcCCCCCCccccCCCceEEEEEECCccEEEEEecCCCCch---hhhHhhHHHHHhcCCCCceeee
Q 048160 39 YNPIQNFTAQELKAATNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSE---EYCCFNCIAFASQMSHKNILKF 115 (344)
Q Consensus 39 ~~~~~~~~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~~ 115 (344)
...++.++.+++. ......||+|++|.||+|.++++.||||++....... .+.+.+|+.+|++++||||+++
T Consensus 9 ~~~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~ 83 (283)
T PHA02988 9 INDIKCIESDDID-----KYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKI 83 (283)
T ss_pred cCcceecCHHHcC-----CCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEE
Confidence 3456666777762 3334679999999999999999999999987654333 3567799999999999999999
Q ss_pred eeEEee----CCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCC-CCeeeecccccceE
Q 048160 116 VGCCLE----TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFS-RPIVFRDIKPSTIL 190 (344)
Q Consensus 116 ~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlk~~Nil 190 (344)
+|++.+ ....++||||+++|+|.+++.... .+++.+...++.+++.||.||| . .+++||||||+||+
T Consensus 84 ~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nil 155 (283)
T PHA02988 84 YGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFL 155 (283)
T ss_pred eeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEE
Confidence 999877 346789999999999999997643 5788899999999999999999 6 48899999999999
Q ss_pred eecCCcceEeeeecccccCCCCcccccCCccccccccccccccCc--CCCCcccchHHHHHHHHHHHcCCCCCCCCCccC
Q 048160 191 FQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST--ANCNEKSDVYSFGALLLELLTGKRISYSSCFEN 268 (344)
Q Consensus 191 l~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 268 (344)
++.++.+|++|||+++....... ...++..|+|||++.+ ..++.++||||||+++|||++|..||.....
T Consensus 156 l~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-- 227 (283)
T PHA02988 156 VTENYKLKIICHGLEKILSSPPF------KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-- 227 (283)
T ss_pred ECCCCcEEEcccchHhhhccccc------cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--
Confidence 99999999999999876543221 3467889999999876 6789999999999999999999999864311
Q ss_pred cchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 269 GEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
..+... ...... ....| ..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 228 ---~~~~~~---i~~~~~------------~~~~~--~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 228 ---KEIYDL---IINKNN------------SLKLP--LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ---HHHHHH---HHhcCC------------CCCCC--CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 111111 111000 00111 1345578999999999999999999999999998754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=308.47 Aligned_cols=266 Identities=19% Similarity=0.203 Sum_probs=208.0
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch--hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE--EYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
+.|...++||+|.||.||+|+. .|+.||||+++.....+ .....||+++|+.++|+||+.+++++...+.+-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3577789999999999999999 78999999998764332 3557899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
||+ .+|...+++.. ..++..++..++.++++||.||| .+.|+||||||.|+|++.+|.+|++|||+|+.+..
T Consensus 82 fm~-tdLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred ecc-ccHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 997 69999998776 57999999999999999999999 99999999999999999999999999999998865
Q ss_pred CCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc--CCc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES--NSF 287 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 287 (344)
...... ..+-|.+|.|||.+-+. .|+..+||||.||++.||+.|.+.|.+..+ -..+...+.....+ ..+
T Consensus 154 p~~~~~---~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD----idQL~~If~~LGTP~~~~W 226 (318)
T KOG0659|consen 154 PNRIQT---HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD----IDQLSKIFRALGTPTPDQW 226 (318)
T ss_pred CCcccc---cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch----HHHHHHHHHHcCCCCcccC
Confidence 543322 23679999999988764 599999999999999999988865554322 22233333322211 111
Q ss_pred c---cccccccccCCCCCh---hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 288 K---EIVDPIIVGEEGLWP---EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 288 ~---~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. .+-|-......+..+ -.+.++.+..+|+..+|..||.+|+|++++++
T Consensus 227 P~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 227 PEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred ccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 1 111111111111111 11245567899999999999999999999876
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=346.32 Aligned_cols=269 Identities=23% Similarity=0.342 Sum_probs=214.8
Q ss_pred cccccHHHHHHHhcCCCCCCccccCCCceEEEEEE--C-C--cc-EEEEEecCC---CCchhhhHhhHHHHHhcCCCCce
Q 048160 42 IQNFTAQELKAATNNYDPEKVITKDLLYKLYKGFL--Q-D--RP-ISVMKFGGN---LNSEEYCCFNCIAFASQMSHKNI 112 (344)
Q Consensus 42 ~~~~~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~--~-~--~~-vavk~~~~~---~~~~~~~~~~E~~~l~~l~H~ni 112 (344)
.+.+.-+.+....++....++||+|.||.||+|++ . + .. ||||..+.. ......++++|+++|++++||||
T Consensus 144 ~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NV 223 (474)
T KOG0194|consen 144 KRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNV 223 (474)
T ss_pred cccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCE
Confidence 34445555666666777779999999999999999 2 2 23 899998853 23456778999999999999999
Q ss_pred eeeeeEEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEee
Q 048160 113 LKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ 192 (344)
Q Consensus 113 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 192 (344)
|++||++....++++|||+|.||+|.++|+...+ .++..+++.++.+.|.||+||| +++++||||-++|+|+.
T Consensus 224 Vr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~ 296 (474)
T KOG0194|consen 224 VRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYS 296 (474)
T ss_pred EEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheec
Confidence 9999999999999999999999999999998763 5899999999999999999999 99999999999999999
Q ss_pred cCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcch
Q 048160 193 EQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEE 271 (344)
Q Consensus 193 ~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~ 271 (344)
.++.+||+|||+++.......... .-.-+..|+|||.+....|+.++|||||||++||+++ |..|+.+...
T Consensus 297 ~~~~vKISDFGLs~~~~~~~~~~~---~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~----- 368 (474)
T KOG0194|consen 297 KKGVVKISDFGLSRAGSQYVMKKF---LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN----- 368 (474)
T ss_pred CCCeEEeCccccccCCcceeeccc---cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH-----
Confidence 999999999999877642111110 1134789999999999999999999999999999998 6666654311
Q ss_pred hHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 272 YFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
......+ .. ...+.+.+...+..+..++.+||..||++||||.+|.+.|+.+..
T Consensus 369 ~~v~~kI---~~--------------~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 369 YEVKAKI---VK--------------NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred HHHHHHH---Hh--------------cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence 1111111 01 111112222556678899999999999999999999999998865
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=340.22 Aligned_cols=242 Identities=24% Similarity=0.376 Sum_probs=204.6
Q ss_pred CCCCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCCc
Q 048160 58 DPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTL 137 (344)
Q Consensus 58 ~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL 137 (344)
...+-||.|+.|.||+|++.+..||||+++.- ...+++.|++|+||||+.|.|+|.+..-+|||||||..|.|
T Consensus 127 sELeWlGSGaQGAVF~Grl~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLHNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhhccCcccceeeeeccCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 34577999999999999999999999997433 23568999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCccccc
Q 048160 138 ADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217 (344)
Q Consensus 138 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~ 217 (344)
...|+... +++....+.+..+||.|+.||| ...|||||||.-||||..+..+||+|||.++......+..
T Consensus 200 ~~VLka~~-----~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkM-- 269 (904)
T KOG4721|consen 200 YEVLKAGR-----PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKM-- 269 (904)
T ss_pred HHHHhccC-----ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhh--
Confidence 99998764 6888999999999999999999 9999999999999999999999999999998776543222
Q ss_pred CCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccccccc
Q 048160 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVG 297 (344)
Q Consensus 218 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (344)
.+.||..|||||++...+.+.|+|||||||+||||+||..|+....... ++|. +-.
T Consensus 270 --SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA--------IIwG--------------VGs 325 (904)
T KOG4721|consen 270 --SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA--------IIWG--------------VGS 325 (904)
T ss_pred --hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe--------eEEe--------------ccC
Confidence 5789999999999999999999999999999999999999986532100 0000 000
Q ss_pred CCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 298 EEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 298 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
.....|.+..|+..+.-|+++||+..|..||++.+|+.-|.-.
T Consensus 326 NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 326 NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 1112333447888999999999999999999999999887643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=336.12 Aligned_cols=264 Identities=20% Similarity=0.323 Sum_probs=203.9
Q ss_pred hcCCCCCCccccCCCceEEEEEE-------CCccEEEEEecCCCC-chhhhHhhHHHHHhcC-CCCceeeeeeEEeeC-C
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL-------QDRPISVMKFGGNLN-SEEYCCFNCIAFASQM-SHKNILKFVGCCLET-E 123 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~-------~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~-~ 123 (344)
.++|...+.||+|+||.||+|.+ .++.||+|++..... .....+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46788999999999999999975 235799999875433 2345688999999999 899999999988764 4
Q ss_pred ccEEEEeecCCCCccccccCCCCC--------------------------------------------------------
Q 048160 124 LPILVFEFVACGTLADRIHDPNGS-------------------------------------------------------- 147 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 147 (344)
..++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 678999999999999988643210
Q ss_pred -CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcccccCCccccccc
Q 048160 148 -QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFG 226 (344)
Q Consensus 148 -~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~ 226 (344)
...++++.++..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+++......... ......++..
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~~~~~ 241 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-RKGSARLPLK 241 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchh-cccCCCCCcc
Confidence 0134778889999999999999999 9999999999999999999999999999998654322211 1123345678
Q ss_pred cccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhh
Q 048160 227 FIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEK 305 (344)
Q Consensus 227 y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (344)
|+|||++.+..++.++||||||+++|||++ |..||..... ...+...+ ..+. ....|
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~----~~~~~~~~----~~~~------------~~~~~-- 299 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI----NEEFCQRL----KDGT------------RMRAP-- 299 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc----cHHHHHHH----hcCC------------CCCCC--
Confidence 999999988899999999999999999997 8888754321 01111111 1110 00001
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 306 EKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 306 ~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
...+..+.+|+.+||+.||++|||+.+|++.|+++...
T Consensus 300 ~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 300 ENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 13345689999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=364.40 Aligned_cols=262 Identities=22% Similarity=0.368 Sum_probs=211.5
Q ss_pred CCCCCCccccCCCceEEEEEE---CCc----cEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 56 NYDPEKVITKDLLYKLYKGFL---QDR----PISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~---~~~----~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
+......||+|.||.||.|.. ++. .||+|.+..... .....|.+|..+|++++|||||+++|+|.+....+|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 344567899999999999999 333 389999877644 345679999999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCCC--CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 128 VFEFVACGTLADRIHDPNGS--QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
++|||++|+|..+|++.... ....+.....+.++.|||+|++||+ ++++|||||.++|+|++....+||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999876321 1246889999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
+-+.......... ...-+..|||||.+..+.|+.|+|||||||++||++|...++|+... ....+
T Consensus 850 rDiy~~~yyr~~~-~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~---n~~v~----------- 914 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHG-EAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS---NFEVL----------- 914 (1025)
T ss_pred HhhhhchheeccC-ccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc---hHHHH-----------
Confidence 9544333222211 22446799999999999999999999999999999997776665432 11111
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
.....+. +.+.+..|+..+.++|.+||+.+|++||++..|++++..+.+.
T Consensus 915 ------~~~~~gg--RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 915 ------LDVLEGG--RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred ------HHHHhCC--ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 1111111 2333347788899999999999999999999999999988754
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=340.49 Aligned_cols=244 Identities=21% Similarity=0.320 Sum_probs=206.9
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
++|...+.||+|+||+||+|+. +.+.||+|.+.+... .+.+.+.+|+++++.++|||||.++++++...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4577788999999999999999 567899998865533 345668899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
||.| +|..++...+ .++++.+..++.+++.||.||| +++|+|||+||+|||++..+.+|+||||+|+....
T Consensus 82 ~a~g-~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred hhhh-hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 9975 9999998765 6999999999999999999999 99999999999999999999999999999998765
Q ss_pred CCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEI 290 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (344)
+..-. ....||+.|||||++.+++|+..+|+||+||++||+++|++||+.... ...+.
T Consensus 153 ~t~vl---tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si--------~~Lv~----------- 210 (808)
T KOG0597|consen 153 NTSVL---TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI--------TQLVK----------- 210 (808)
T ss_pred Cceee---eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH--------HHHHH-----------
Confidence 43221 256799999999999999999999999999999999999999985321 11111
Q ss_pred cccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 048160 291 VDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVA 334 (344)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~ 334 (344)
.+. .+...||. +.+..+..+++..|..||.+|.|-.+++
T Consensus 211 --~I~-~d~v~~p~--~~S~~f~nfl~gLL~kdP~~RltW~~Ll 249 (808)
T KOG0597|consen 211 --SIL-KDPVKPPS--TASSSFVNFLQGLLIKDPAQRLTWTDLL 249 (808)
T ss_pred --HHh-cCCCCCcc--cccHHHHHHHHHHhhcChhhcccHHHHh
Confidence 111 13334444 6777899999999999999999987765
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-47 Score=355.29 Aligned_cols=270 Identities=20% Similarity=0.363 Sum_probs=223.1
Q ss_pred cccccHHHHHHHhcCC---------CCCCccccCCCceEEEEEE-----CCccEEEEEecCCCCc-hhhhHhhHHHHHhc
Q 048160 42 IQNFTAQELKAATNNY---------DPEKVITKDLLYKLYKGFL-----QDRPISVMKFGGNLNS-EEYCCFNCIAFASQ 106 (344)
Q Consensus 42 ~~~~~~~~i~~~~~~~---------~~~~~ig~G~~g~V~~~~~-----~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~ 106 (344)
+..+++++-..+..+| .+.++||.|.||+|++|++ ....||||.++..... ....|+.|+.+|.+
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ 686 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ 686 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence 3445666654444333 3578899999999999999 2357999999987543 45779999999999
Q ss_pred CCCCceeeeeeEEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccc
Q 048160 107 MSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKP 186 (344)
Q Consensus 107 l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~ 186 (344)
++||||++|.|+.....+.+||+|||++|+|+.||+.+.| .|++.+.+.++++|+.|++||. +.+.|||||.+
T Consensus 687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAA 759 (996)
T KOG0196|consen 687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAA 759 (996)
T ss_pred CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhh
Confidence 9999999999999999999999999999999999998886 4888999999999999999999 99999999999
Q ss_pred cceEeecCCcceEeeeecccccCCCCcccccCCcccc--ccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCC
Q 048160 187 STILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIG--TFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYS 263 (344)
Q Consensus 187 ~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g--~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~ 263 (344)
+|||++++-.||++|||+++.+.++..... .+..| +.+|.|||.+...+++..+||||||++|||.++ |..|+..
T Consensus 760 RNILVNsnLvCKVsDFGLSRvledd~~~~y--tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd 837 (996)
T KOG0196|consen 760 RNILVNSNLVCKVSDFGLSRVLEDDPEAAY--TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 837 (996)
T ss_pred hheeeccceEEEeccccceeecccCCCccc--cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc
Confidence 999999999999999999998865542111 12222 478999999999999999999999999999764 7788764
Q ss_pred CCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 264 SCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
..+ ++++..+- +..+.|.+.+|+..|.+||..||++|-++||.+.+|+..|.+++..
T Consensus 838 mSN---------------------QdVIkaIe--~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 838 MSN---------------------QDVIKAIE--QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred cch---------------------HHHHHHHH--hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 321 12222221 2344555569999999999999999999999999999999999753
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=334.69 Aligned_cols=248 Identities=22% Similarity=0.274 Sum_probs=203.9
Q ss_pred HHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCC----CC-chhhhHhhHHHHHhcCC-CCceeeeeeEEeeCC
Q 048160 52 AATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGN----LN-SEEYCCFNCIAFASQMS-HKNILKFVGCCLETE 123 (344)
Q Consensus 52 ~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~ 123 (344)
...++|...+.||+|+||.|+.|.. .+..||+|.+... .. ...+.+.+|+.+++.++ ||||++++.++...+
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456799999999999999999988 7899999976553 11 12344568999999999 999999999999999
Q ss_pred ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC-CcceEeee
Q 048160 124 LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ-NVAKFFDF 202 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~df 202 (344)
..++||||+.||+|.+++...+ .+.+..+..++.|+++|++||| +.+|+||||||+|||++.+ +++||+||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecc
Confidence 9999999999999999998843 6889999999999999999999 9999999999999999999 99999999
Q ss_pred ecccccCCCCcccccCCccccccccccccccCcCC-CC-cccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHH
Q 048160 203 CVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTAN-CN-EKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280 (344)
Q Consensus 203 g~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 280 (344)
|++...... .....+..||+.|+|||++.+.. |+ .++||||+|+++|.|++|..||... .....+..+
T Consensus 166 G~s~~~~~~---~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~----~~~~l~~ki--- 235 (370)
T KOG0583|consen 166 GLSAISPGE---DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS----NVPNLYRKI--- 235 (370)
T ss_pred ccccccCCC---CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc----cHHHHHHHH---
Confidence 999887411 12223678999999999999987 86 7899999999999999999999752 111111111
Q ss_pred HhccCCcccccccccccCCCCChhhHHH-HHHHHHHHHHccccCCCCCCCHHHHH
Q 048160 281 SIESNSFKEIVDPIIVGEEGLWPEKEKQ-LLSYTELAIKCLSKSEQDRPTMVQVA 334 (344)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPs~~ei~ 334 (344)
..+. ...|. .. +.++..|+.+||..||.+|+|+.+|+
T Consensus 236 --------------~~~~-~~~p~--~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 236 --------------RKGE-FKIPS--YLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred --------------hcCC-ccCCC--CcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1111 11111 22 56689999999999999999999998
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=327.09 Aligned_cols=247 Identities=21% Similarity=0.292 Sum_probs=206.4
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
..|+....||+|+||.||+|.. .++.||+|++.-+.. ...+.+.+|+.++.+++++||.++||.+..+..+|++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3477789999999999999999 678999999876643 3456788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
|.||++.+.++..+ .+.+....-++.+++.||.||| ..+.+|||||+.|||+..+|.+||+|||++.+.+..
T Consensus 93 ~~gGsv~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN-----ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred hcCcchhhhhccCC-----CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeech
Confidence 99999999998754 4577777889999999999999 999999999999999999999999999999887654
Q ss_pred CcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
.... .+++||+.|||||++.+..|+.|+||||||++.+||++|.+|+.... + ++.++
T Consensus 165 ~~rr---~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~h------------------P--mrvlf 221 (467)
T KOG0201|consen 165 VKRR---KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLH------------------P--MRVLF 221 (467)
T ss_pred hhcc---ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccC------------------c--ceEEE
Confidence 4332 47899999999999998899999999999999999999999975321 0 01110
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+....++.-+. .+++.+.+|+..||+.||+.||||.++++
T Consensus 222 --lIpk~~PP~L~~-~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 222 --LIPKSAPPRLDG-DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred --eccCCCCCcccc-ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 011111111111 56677999999999999999999999876
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=318.85 Aligned_cols=254 Identities=17% Similarity=0.272 Sum_probs=201.9
Q ss_pred cCCCCCCccccCCCceEEEEEE-----CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL-----QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
++|+..+.||+|+||.||+|.+ .+..||+|.+...... ....+.+|+..+++++||||++++|++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 4588889999999999999986 2457999998765432 335688999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||+++|+|.+++.... ..+++.+++.++.|++.||+||| +.+++||||||+||+++.++.++++|||.+...
T Consensus 85 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 85 TEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEeCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999987643 25889999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
...... ......++..|+|||++.+..++.++||||||+++||+++ |..||..... ....+.+ ....
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-----~~~~~~~----~~~~- 225 (266)
T cd05064 158 KSEAIY--TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-----QDVIKAV----EDGF- 225 (266)
T ss_pred cccchh--cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----HHHHHHH----HCCC-
Confidence 221111 1112234678999999988999999999999999999775 8888864321 1111111 1100
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
..+....++..+.+++.+||+.+|.+|||+.+|++.|.++
T Consensus 226 -------------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 -------------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0011114556789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=305.82 Aligned_cols=235 Identities=21% Similarity=0.279 Sum_probs=198.5
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchh---hhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEE---YCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~---~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|.....||.|+||+|..++. ++.-+|+|.+.++.--.. +-...|-.+|+.+.||.++++++.+.+.+.+|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 4588889999999999999999 778899999877643333 33458999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||.+||.|..++++.+ .|++..+..++.+|+.||+||| +++|++|||||+|||+|++|.+||.|||.|+.+.
T Consensus 124 eyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 9999999999998765 6999999999999999999999 9999999999999999999999999999999876
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
.... +.+||+.|+|||.+.+.+|+.++|.||||+++|||+.|.+||+.... -..+.++
T Consensus 196 ~rT~------TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----~~iY~KI------------ 253 (355)
T KOG0616|consen 196 GRTW------TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----IQIYEKI------------ 253 (355)
T ss_pred CcEE------EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHHH------------
Confidence 5422 57899999999999999999999999999999999999999986421 1111111
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCC
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDR 327 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 327 (344)
+.+. -..|. ....++.+|+...|+.|-.+|
T Consensus 254 -----~~~~-v~fP~--~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 254 -----LEGK-VKFPS--YFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -----HhCc-ccCCc--ccCHHHHHHHHHHHhhhhHhh
Confidence 1111 11111 344568899999999998888
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=320.18 Aligned_cols=250 Identities=19% Similarity=0.278 Sum_probs=198.1
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
+|+..+.||+|+||.||+|.. ++..||+|.+..... .....+.+|+.++++++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999998 688999998865421 223456789999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|+++|+|.+++..... ..+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNMGN---PGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 9999999887754322 25889999999999999999999 99999999999999999999999999999877543
Q ss_pred CCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEI 290 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (344)
.... ....|+..|+|||++.+..++.++|||||||++|+|++|+.||........ .+.+........
T Consensus 155 ~~~~----~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-----~~~~~~~~~~~~---- 221 (285)
T cd05631 155 GETV----RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-----REEVDRRVKEDQ---- 221 (285)
T ss_pred CCee----cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-----HHHHHHHhhccc----
Confidence 2211 134689999999999999999999999999999999999999975432111 011111110000
Q ss_pred cccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 048160 291 VDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT-----MVQVAK 335 (344)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ei~~ 335 (344)
...+ ...+..+.+|+.+||+.||++||+ ++++++
T Consensus 222 ---------~~~~--~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 ---------EEYS--EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ---------ccCC--ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0001 123456889999999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=329.35 Aligned_cols=250 Identities=24% Similarity=0.309 Sum_probs=211.1
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCC--CCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCc-cEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGN--LNSEEYCCFNCIAFASQMSHKNILKFVGCCLETEL-PILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~-~~lv~ 129 (344)
++|...+.||+|+||.++..++ +++.+++|++.-. .....+...+|+.++++++|||||.+.+.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5688889999999999998888 7788999997654 33344568899999999999999999999998887 99999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
+||+||+|.+.+....+ ..|+++.+..++.|++.|+.||| ++.|+|||||+.||++..++.++|+|||+|+...
T Consensus 84 ~Y~eGg~l~~~i~~~k~---~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKG---VLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eecCCCCHHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 99999999999977654 46899999999999999999999 9999999999999999999999999999999887
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
.... ...+.+||+.|++||.+.+.+|+.|+|||||||++|||++-+.+|.... +..
T Consensus 158 ~~~~---~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~---------------------m~~ 213 (426)
T KOG0589|consen 158 PEDS---LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN---------------------MSE 213 (426)
T ss_pred Cchh---hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc---------------------hHH
Confidence 6542 2236899999999999999999999999999999999999999986431 122
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
++.++..+...+ .....+.++..++..||+.+|..||++.+++..
T Consensus 214 Li~ki~~~~~~P--lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 214 LILKINRGLYSP--LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHHhhccCCC--CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 222222222122 222567789999999999999999999999876
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=331.54 Aligned_cols=245 Identities=22% Similarity=0.239 Sum_probs=208.0
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
+-|...+.||.|+.|.|-.|++ +|+.+|||.+.+... .....+.+|+.+|+-+.||||+++|++|.+...+|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4577889999999999999999 899999999876622 23355789999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++|.|.+++-..+ ++++.++..++.||+.|+.|+| ..+|+||||||+|+|+|..+++||+|||+|..-.
T Consensus 92 Eyv~gGELFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG-----PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EecCCchhHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 9999999999998776 6999999999999999999999 9999999999999999999999999999997655
Q ss_pred CCCcccccCCccccccccccccccCcCCCC-cccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCN-EKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
.+.... +.+|++.|+|||++.+.+|. .++||||.|||||.|+||+.||..+ +....+.+..
T Consensus 164 ~gklLe----TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd----Nir~LLlKV~---------- 225 (786)
T KOG0588|consen 164 PGKLLE----TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD----NIRVLLLKVQ---------- 225 (786)
T ss_pred CCcccc----ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc----cHHHHHHHHH----------
Confidence 444332 56899999999999999985 7899999999999999999999742 3333333322
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.|.. ..+...+.+..+|+.+|+..||.+|.|+.||++
T Consensus 226 -------~G~f---~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 226 -------RGVF---EMPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred -------cCcc---cCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 1111 111144566889999999999999999999986
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=318.72 Aligned_cols=264 Identities=18% Similarity=0.226 Sum_probs=199.2
Q ss_pred cCCCCCCccccCCCceEEEEEEC------------------CccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFLQ------------------DRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKF 115 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~~------------------~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~ 115 (344)
+.|...+.||+|+||.||+|.+. +..||+|.+...... ....+.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 46888899999999999999862 236999998765332 34568899999999999999999
Q ss_pred eeEEeeCCccEEEEeecCCCCccccccCCCC--------------CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeee
Q 048160 116 VGCCLETELPILVFEFVACGTLADRIHDPNG--------------SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVF 181 (344)
Q Consensus 116 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 181 (344)
++++.+.+..++||||+++|+|.+++..... .....+++.++..++.|++.||.||| +.+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 9999999999999999999999998854321 01124677889999999999999999 999999
Q ss_pred ecccccceEeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcC--CC
Q 048160 182 RDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG--KR 259 (344)
Q Consensus 182 ~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g--~~ 259 (344)
|||||+|||++.++.+||+|||+++......... ......++..|+|||++....++.++||||||+++|||+++ ..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR-IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeE-ecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999987654332211 11233457889999999888899999999999999999874 45
Q ss_pred CCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048160 260 ISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338 (344)
Q Consensus 260 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~ 338 (344)
||..... . ................... ... +.++..+.+|+.+||+.||++|||+.+|.+.|+
T Consensus 241 p~~~~~~----~-~~~~~~~~~~~~~~~~~~~-----~~~------~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTD----E-QVIENAGEFFRDQGRQVYL-----FRP------PPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCH----H-HHHHHHHHHhhhccccccc-----cCC------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 5543211 1 1111111111111000000 000 133456899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=330.14 Aligned_cols=261 Identities=19% Similarity=0.283 Sum_probs=201.6
Q ss_pred hcCCCCCCccccCCCceEEEEEE-------CCccEEEEEecCCCC-chhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL-------QDRPISVMKFGGNLN-SEEYCCFNCIAFASQM-SHKNILKFVGCCLETEL 124 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~-------~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~ 124 (344)
.++|+..+.||+|+||.||+|++ .+..||+|+++.... ...+.+.+|+.++..+ +||||+++++++..++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 44688899999999999999975 245799999875432 3345678999999999 89999999999999999
Q ss_pred cEEEEeecCCCCccccccCCCCCC--------------------------------------------------------
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQ-------------------------------------------------------- 148 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~-------------------------------------------------------- 148 (344)
.++|||||++|+|.+++.......
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999886432100
Q ss_pred --------------CccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 149 --------------LEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 149 --------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 014778889999999999999999 999999999999999999999999999999766433221
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDP 293 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (344)
. ......++..|+|||++.+..++.++||||||+++|||++ |..||..... .....+.+.. ...
T Consensus 271 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~----~~~~~~~~~~----~~~------ 335 (375)
T cd05104 271 V-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV----DSKFYKMIKE----GYR------ 335 (375)
T ss_pred c-ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc----hHHHHHHHHh----Ccc------
Confidence 1 1112334667999999999999999999999999999998 7777654321 1111111111 100
Q ss_pred ccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 294 IIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
...|. ..+.++.+|+..||+.||++|||+.+|++.|++.
T Consensus 336 ------~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 ------MLSPE--CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ------CCCCC--CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 00000 2234689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=309.80 Aligned_cols=265 Identities=18% Similarity=0.221 Sum_probs=202.4
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchh--hhHhhHHHHHhcCCCCceeeeeeEEeeC--CccEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEE--YCCFNCIAFASQMSHKNILKFVGCCLET--ELPILV 128 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~--~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv 128 (344)
++|...+.|++|+||.||+|+. ++..||+|+++-+....- -.-+||+.+|.+.+|||||.+-.+.... +..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4588889999999999999999 788999999876543221 2246999999999999999998887643 578999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
||||+ -+|..++.... .+|...++.-++.|+++|++||| .+.|+|||||++|+|+...|.+||+|||+|+.+
T Consensus 156 Me~~E-hDLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred HHHHH-hhHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhh
Confidence 99997 58999998765 47999999999999999999999 999999999999999999999999999999998
Q ss_pred CCCCcccccCCccccccccccccccCcCC-CCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC--
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTAN-CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN-- 285 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 285 (344)
....... ...+-|.+|.|||.+.+.. |++..|+||+|||+.|++++++.|.+..+-+. +..++...-.+.
T Consensus 228 gsp~k~~---T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ----l~~If~llGtPte~ 300 (419)
T KOG0663|consen 228 GSPLKPY---TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ----LDKIFKLLGTPSEA 300 (419)
T ss_pred cCCcccC---cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH----HHHHHHHhCCCccc
Confidence 7653322 2456799999999998864 99999999999999999999988876544222 222222211110
Q ss_pred Ccc-----cccccccccCCCCChhh----HH--HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 SFK-----EIVDPIIVGEEGLWPEK----EK--QLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ~~~-----~~~~~~~~~~~~~~~~~----~~--~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.++ ......- -...++... .. .+..-.+|+...|.+||.+|.||++.++
T Consensus 301 iwpg~~~lp~~k~~~-f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMT-FSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cCCCccccchhhccc-cCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 011 0110000 000000000 01 2245689999999999999999999774
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=318.37 Aligned_cols=248 Identities=30% Similarity=0.475 Sum_probs=191.3
Q ss_pred CCccccCCCceEEEEEEC------CccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 60 EKVITKDLLYKLYKGFLQ------DRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~~------~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
.+.||.|.||.||+|.+. +..|+||.++..... ..+.+.+|+..+++++||||++++|++...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999996 578999999765443 3577899999999999999999999999888899999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++|+|.+++..... ..+++.++..++.|++.||.||| +.+++|+||+++||+++.++.+||+|||++.......
T Consensus 84 ~~g~L~~~L~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 84 PGGSLDDYLKSKNK---EPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp TTEBHHHHHHHTCT---TTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc---ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 99999999987622 36899999999999999999999 8999999999999999999999999999998773322
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
.. ...........|+|||.+....++.++||||||+++||+++ |..|+... . ... ..... ......
T Consensus 158 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~----~-~~~---~~~~~-~~~~~~--- 224 (259)
T PF07714_consen 158 KY-KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY----D-NEE---IIEKL-KQGQRL--- 224 (259)
T ss_dssp SE-EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS----C-HHH---HHHHH-HTTEET---
T ss_pred cc-cccccccccccccccccccccccccccccccccccccccccccccccccc----c-ccc---ccccc-cccccc---
Confidence 22 11223456788999999988889999999999999999999 56665432 1 111 11111 111100
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L 337 (344)
+....++..+.+++.+||+.||++|||+.+|++.|
T Consensus 225 -----------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 -----------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -----------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -----------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 01113455688999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=314.72 Aligned_cols=317 Identities=19% Similarity=0.277 Sum_probs=235.5
Q ss_pred ccccccccccHHHHHH-----H-HHHHhchHHHHHHHHhhC--CCCCccccccHHHHHHHhcCCCCCCccccCCCceEEE
Q 048160 2 SLCLGTSESSKKAEKR-----K-FMLKNGKFLLQKLIASCN--GDYNPIQNFTAQELKAATNNYDPEKVITKDLLYKLYK 73 (344)
Q Consensus 2 ~~~~~~~~~~~~~~~~-----~-~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~~~~~~~~~~ig~G~~g~V~~ 73 (344)
..|+..++...+++.+ + ....+|+..+.+++.... +.-..+..+-...|. ......+.||+|.||+||+
T Consensus 153 ~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~stl~Dll~~~~tSGSGSGlplLVQRTia---rqI~L~e~IGkGRyGEVwr 229 (513)
T KOG2052|consen 153 LGCFYRKRRYHERQRPNREDPSTEATLAGDSTLKDLLDDLETSGSGSGLPLLVQRTIA---RQIVLQEIIGKGRFGEVWR 229 (513)
T ss_pred heeeeeeecchhhccccccCccccccccCCccHHHHHHhhccCCCCCCchhHhHHhhh---heeEEEEEecCccccceee
Confidence 3577776664433221 1 123667788888885432 222233333333332 3466778999999999999
Q ss_pred EEECCccEEEEEecCCCCchhhhHhhHHHHHhcC--CCCceeeeeeEEeeC----CccEEEEeecCCCCccccccCCCCC
Q 048160 74 GFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQM--SHKNILKFVGCCLET----ELPILVFEFVACGTLADRIHDPNGS 147 (344)
Q Consensus 74 ~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~ 147 (344)
|.|.|..||||+|... +.+.+++|.++++.+ +|+||..+++.-..+ .++|||++|.++|||.|+|...
T Consensus 230 G~wrGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~--- 303 (513)
T KOG2052|consen 230 GRWRGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN--- 303 (513)
T ss_pred ccccCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc---
Confidence 9999999999999766 567899999999886 899999999986654 3789999999999999999874
Q ss_pred CCccccHHHHHHHHHHHHHHHHHhh-----cCCCCCeeeecccccceEeecCCcceEeeeecccccCCC-CcccccCCcc
Q 048160 148 QLEPFLMKHRLKVAMEIANAVAYLH-----VGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG-KTHVNDNNKV 221 (344)
Q Consensus 148 ~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~-~~~~~~~~~~ 221 (344)
.++....+.++..+|.||.||| .+....|.|||||+.|||+.+++.+.|+|+|+|...... ...+...+..
T Consensus 304 ---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~r 380 (513)
T KOG2052|consen 304 ---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPR 380 (513)
T ss_pred ---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCc
Confidence 6999999999999999999999 244789999999999999999999999999999887655 3445566788
Q ss_pred ccccccccccccCcCC----C--CcccchHHHHHHHHHHHcCC----------CCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 222 IGTFGFIAPEYMSTAN----C--NEKSDVYSFGALLLELLTGK----------RISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 222 ~g~~~y~aPE~~~~~~----~--~~~~Di~slG~il~el~~g~----------~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
+||.+|||||++.... + -..+||||||+++||++.+. .||+.....+.......+.
T Consensus 381 VGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkV-------- 452 (513)
T KOG2052|consen 381 VGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKV-------- 452 (513)
T ss_pred cceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcc--------
Confidence 9999999999986521 2 25699999999999997543 3444332211111111100
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
-..++.....+.+|... .+...+.++|..||..+|..|-|+--|.+.|.++.+
T Consensus 453 ---VCv~~~RP~ipnrW~s~-~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 453 ---VCVQKLRPNIPNRWKSD-PALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ---eeecccCCCCCcccccC-HHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 01111112234445554 667789999999999999999999999999999874
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=322.52 Aligned_cols=264 Identities=19% Similarity=0.258 Sum_probs=203.4
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
.++|+..+.||+|+||.||+++. .+..||+|.+...... ....+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 36799999999999999999999 5778899988765332 23568899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCC-CeeeecccccceEeecCCcceEeeeecccccC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSR-PIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
|+++++|.+++.... .+++..+..++.|++.||.||| +. +|+||||||+||+++.++.++|+|||++....
T Consensus 84 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 84 HMDGGSLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred cCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 999999999997643 5788899999999999999999 65 69999999999999999999999999987654
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCC---
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNS--- 286 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 286 (344)
... .....|+..|+|||++.+..++.++|||||||++|||++|+.||..... ..+...+........
T Consensus 156 ~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~ 225 (331)
T cd06649 156 DSM-----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA-----KELEAIFGRPVVDGEEGE 225 (331)
T ss_pred ccc-----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHhcccccccccCC
Confidence 321 1234689999999999988899999999999999999999999864321 111111111000000
Q ss_pred ---------------------------cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 287 ---------------------------FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 287 ---------------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
....++.+.....+..+. ...+.++.+|+.+||+.||++|||+.+|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 226 PHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPN-GVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCC-ccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000011111111111 1345678999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=327.77 Aligned_cols=263 Identities=19% Similarity=0.321 Sum_probs=203.4
Q ss_pred HhcCCCCCCccccCCCceEEEEEE-------CCccEEEEEecCCCCc-hhhhHhhHHHHHhcC-CCCceeeeeeEEeeCC
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL-------QDRPISVMKFGGNLNS-EEYCCFNCIAFASQM-SHKNILKFVGCCLETE 123 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~-------~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~ 123 (344)
..++|...+.||+|+||.||+|.+ .+..||+|++...... ....+.+|+.+++.+ +|+|||++++++..+.
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 345688999999999999999986 1246999998765332 345678999999999 8999999999999999
Q ss_pred ccEEEEeecCCCCccccccCCCC---------------------------------------------------------
Q 048160 124 LPILVFEFVACGTLADRIHDPNG--------------------------------------------------------- 146 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 146 (344)
..++||||+++|+|.+++.....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999988753210
Q ss_pred --------CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcccccC
Q 048160 147 --------SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDN 218 (344)
Q Consensus 147 --------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~ 218 (344)
....++++.+++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++......... ..
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~-~~ 271 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV-VK 271 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee-ec
Confidence 00124788889999999999999999 9999999999999999999999999999987654332211 11
Q ss_pred CccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccccccccccc
Q 048160 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVG 297 (344)
Q Consensus 219 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (344)
....++..|+|||++.+..++.++||||||+++|+|++ |+.||..... .......... . ..
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~----~~~~~~~~~~----~-~~--------- 333 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV----NSKFYKMVKR----G-YQ--------- 333 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc----cHHHHHHHHc----c-cC---------
Confidence 12234567999999988889999999999999999997 9988865321 1111111110 0 00
Q ss_pred CCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 048160 298 EEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLH 341 (344)
Q Consensus 298 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~ 341 (344)
...+. ..+.++.+++.+||+.||++|||+.+|++.|+++.
T Consensus 334 --~~~~~--~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 334 --MSRPD--FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred --ccCCC--CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 00000 12356899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=314.86 Aligned_cols=259 Identities=22% Similarity=0.324 Sum_probs=204.0
Q ss_pred cCCCCCCccccCCCceEEEEEECC-------ccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFLQD-------RPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPI 126 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~~~-------~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~ 126 (344)
++|+..+.||+|+||.||+|...+ ..||+|.+...... ....+.+|+.++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357888999999999999999832 45899988654332 3456789999999999999999999999989999
Q ss_pred EEEeecCCCCccccccCCCCCC-----------CccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC
Q 048160 127 LVFEFVACGTLADRIHDPNGSQ-----------LEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN 195 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 195 (344)
++|||+++++|.+++....... ...+++.++..++.|++.||.||| +.+++|+||||+||+++.++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence 9999999999999886542111 135788889999999999999999 99999999999999999999
Q ss_pred cceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHH
Q 048160 196 VAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFL 274 (344)
Q Consensus 196 ~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~ 274 (344)
.++|+|||++.......... ......+++.|+|||++.+..++.++||||||+++|||++ |..||+.... ..+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-----~~~ 235 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYR-VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-----QEV 235 (283)
T ss_pred cEEECCCcceeecccccccc-ccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHH
Confidence 99999999987653322111 1113456788999999988889999999999999999998 8888865321 111
Q ss_pred HHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 275 QELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
...+ ..... . +....++..+.+|+.+||+.||++||++.+|++.|+++
T Consensus 236 ~~~i----~~~~~------------~--~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 236 IEMI----RSRQL------------L--PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHH----HcCCc------------C--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1111 11110 0 11124566799999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=319.31 Aligned_cols=243 Identities=21% Similarity=0.268 Sum_probs=198.1
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||.||+|.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4688899999999999999999 578899999864321 23355778999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 9999999999997653 5888999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
... ....|++.|+|||++.+..++.++|||||||++|+|++|..||..... ........ . ..
T Consensus 153 ~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~----~~~~~~i~----~-~~--- 214 (291)
T cd05612 153 DRT------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP----FGIYEKIL----A-GK--- 214 (291)
T ss_pred CCc------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH----h-CC---
Confidence 321 134689999999999988899999999999999999999999865321 11111111 0 00
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT-----MVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ei~~ 335 (344)
..+|. ..+..+.+|+.+||+.||.+||+ +.++++
T Consensus 215 ----------~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 215 ----------LEFPR--HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred ----------cCCCc--cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 00111 22445789999999999999995 777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=314.43 Aligned_cols=262 Identities=20% Similarity=0.298 Sum_probs=206.9
Q ss_pred hcCCCCCCccccCCCceEEEEEE-------CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL-------QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPI 126 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~-------~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~ 126 (344)
.++|...+.||+|+||.||++.. ++..+|+|.+..........+.+|+.++++++||||+++++++..++..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 35788899999999999999985 23458899887665555667889999999999999999999999999999
Q ss_pred EEEeecCCCCccccccCCCC--------CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcce
Q 048160 127 LVFEFVACGTLADRIHDPNG--------SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAK 198 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 198 (344)
+|+||+++++|.+++..... .....+++.++..++.|++.||.||| +.+++||||||+||+++.++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence 99999999999998864321 11235899999999999999999999 99999999999999999999999
Q ss_pred EeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHH
Q 048160 199 FFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQEL 277 (344)
Q Consensus 199 l~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~ 277 (344)
|+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++ |..||..... .. .
T Consensus 161 l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~----~~----~ 231 (288)
T cd05093 161 IGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN----NE----V 231 (288)
T ss_pred eccCCccccccCCcee-ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HH----H
Confidence 9999998765433211 11113345778999999988889999999999999999998 7887754321 11 1
Q ss_pred HHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 278 VRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
..... .... ...+ ...+..+.+|+.+||+.||.+|||+.+|.+.|+++..
T Consensus 232 ~~~i~-~~~~------------~~~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 232 IECIT-QGRV------------LQRP--RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHHHH-cCCc------------CCCC--CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 11111 1110 0001 1234568999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=313.97 Aligned_cols=270 Identities=19% Similarity=0.217 Sum_probs=199.1
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
++|...+.||+|+||.||+|+. ++..||+|++..... ...+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 3688889999999999999999 567899999875422 234567799999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|++++++..+.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 99987776554332 25888999999999999999999 99999999999999999999999999999987643
Q ss_pred CCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHH--------HHHHh
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL--------VRKSI 282 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~ 282 (344)
..... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||........ ....... .....
T Consensus 153 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 153 GSNAN--YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred ccccc--ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHHHHhhh
Confidence 32211 1235689999999999888899999999999999999999998865321110 0000000 00000
Q ss_pred ccCCcccccccccccCCCCCh-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ESNSFKEIVDPIIVGEEGLWP-EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..........+.......... .....+..+.+|+.+||+.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000000000000 00123567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=322.14 Aligned_cols=240 Identities=18% Similarity=0.210 Sum_probs=194.0
Q ss_pred CccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCC
Q 048160 61 KVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACG 135 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 135 (344)
+.||+|+||.||+++. +++.||+|++.... ......+.+|+.++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999998 67889999987542 122345678999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCccc
Q 048160 136 TLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHV 215 (344)
Q Consensus 136 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~ 215 (344)
+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~- 151 (323)
T cd05571 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT- 151 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc-
Confidence 9999887643 5889999999999999999999 999999999999999999999999999998754322211
Q ss_pred ccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccccc
Q 048160 216 NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPII 295 (344)
Q Consensus 216 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (344)
.....||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+. ...
T Consensus 152 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~~~~~----~~~--------- 211 (323)
T cd05571 152 --MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELIL----MEE--------- 211 (323)
T ss_pred --ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-----HHHHHHHH----cCC---------
Confidence 1245689999999999998999999999999999999999999975321 11111110 000
Q ss_pred ccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048160 296 VGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-----TMVQVAK 335 (344)
Q Consensus 296 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ei~~ 335 (344)
...|. ..+..+.+|+.+||+.||++|| ++.++++
T Consensus 212 ----~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 212 ----IRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred ----CCCCC--CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 00111 2345688999999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=308.69 Aligned_cols=250 Identities=18% Similarity=0.300 Sum_probs=198.1
Q ss_pred cCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
++|...+.||+|+||.||++.+ .+..+|+|.+.... .....+.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3477788999999999999999 55589999876443 234568889999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+|+|.+++....+ .+++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.++++|||.++.......
T Consensus 83 ~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 83 NGCLLNYLRQRQG----KLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCcHHHHHHhCcc----CCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 9999999875432 4788999999999999999999 99999999999999999999999999999876543222
Q ss_pred ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
... ....++..|+|||++.+..++.++||||||+++|++++ |+.||.... .......+. ....
T Consensus 156 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~-----~~~~~~~i~---~~~~------ 219 (256)
T cd05114 156 TSS--SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-----NYEVVEMIS---RGFR------ 219 (256)
T ss_pred ecc--CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHH---CCCC------
Confidence 111 12234568999999988889999999999999999999 788875431 111111111 1000
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L 337 (344)
...|. ..+..+.+++.+||+.+|++|||+.+|++.|
T Consensus 220 -------~~~~~--~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 220 -------LYRPK--LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -------CCCCC--CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 00011 2234689999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=324.41 Aligned_cols=264 Identities=16% Similarity=0.188 Sum_probs=199.9
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
..|...+.||+|+||.||++.. .++.||+|... ...+.+|+.++++++||||+++++++..+...++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 5699999999999999999998 67889999743 234678999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
. ++|..++.... .+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.......
T Consensus 166 ~-~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 166 K-TDLYCYLAAKR-----NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred C-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 5 78888886543 5788999999999999999999 9999999999999999999999999999986543221
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcc---hhHHHHHHHHHhccC----
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGE---EYFLQELVRKSIESN---- 285 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~---- 285 (344)
.. ......||+.|+|||++.+..++.++|||||||++|||++|..||+......+. ...+...+.......
T Consensus 237 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 237 AN--KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred cc--ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 11 111357899999999999889999999999999999999999988754321111 111111111110000
Q ss_pred -C----ccccc----c--cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 -S----FKEIV----D--PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 -~----~~~~~----~--~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. ..... . .......+.|......+.++.+|+.+||+.||++|||+.|+++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 00000 0 0000111222232345667999999999999999999999985
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=309.53 Aligned_cols=254 Identities=21% Similarity=0.298 Sum_probs=202.9
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
.+|...+.||+|+||.||+|.+ .+..||+|.+... ......+.+|+.++++++|+||+++++++..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 3477789999999999999998 5788999988654 234567889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++++|.+++..... ..+++..++.++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 85 TYGNLLDYLRECNR---QEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred CCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999865432 35788899999999999999999 9999999999999999999999999999987765432
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
.... ....++..|+|||.+.+..++.++||||||+++|||++ |..||.... .......+. ... .
T Consensus 159 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----~~~~~~~~~----~~~-~--- 223 (263)
T cd05052 159 YTAH--AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLE----KGY-R--- 223 (263)
T ss_pred eecc--CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHH----CCC-C---
Confidence 2111 12233567999999988899999999999999999998 777775321 111111111 000 0
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
...+ ...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 224 --------~~~~--~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 --------MERP--EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred --------CCCC--CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0001 13445689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=323.45 Aligned_cols=242 Identities=17% Similarity=0.278 Sum_probs=197.2
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||.||+|++ +++.||+|.+.... ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 5688889999999999999999 57889999986542 123456789999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 98 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred cCCCCChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 9999999999987653 5788889999999999999999 9999999999999999999999999999987654
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......+ . ....
T Consensus 170 ~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-----~~~~~~~i---~-~~~~-- 232 (329)
T PTZ00263 170 DRT------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT-----PFRIYEKI---L-AGRL-- 232 (329)
T ss_pred CCc------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC-----HHHHHHHH---h-cCCc--
Confidence 322 13468999999999999889999999999999999999999996432 11111111 1 0100
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT-----MVQVA 334 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ei~ 334 (344)
..|. ..+..+.+|+.+||+.||++||+ +.+++
T Consensus 233 -----------~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 233 -----------KFPN--WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred -----------CCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 0011 12345789999999999999997 56665
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=311.73 Aligned_cols=258 Identities=22% Similarity=0.340 Sum_probs=204.5
Q ss_pred cCCCCCCccccCCCceEEEEEEC-------CccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFLQ-------DRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPI 126 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~~-------~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~ 126 (344)
++|...+.||+|+||.||+|... +..||+|.+...... ..+.+.+|+.++++++|+||+++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45778899999999999999872 367999998766544 3467889999999999999999999999999999
Q ss_pred EEEeecCCCCccccccCCCC---------CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcc
Q 048160 127 LVFEFVACGTLADRIHDPNG---------SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA 197 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 197 (344)
+||||+++++|.+++...+. .....+++.++..++.|++.||.||| +.+++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence 99999999999999875432 11235788899999999999999999 9999999999999999999999
Q ss_pred eEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHH
Q 048160 198 KFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQE 276 (344)
Q Consensus 198 kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~ 276 (344)
+|+|||++.......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||..... . ....
T Consensus 162 kl~d~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~----~-~~~~ 235 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYR-VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN----E-EVIE 235 (280)
T ss_pred EECCcccceecccCccee-cCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH----H-HHHH
Confidence 999999987653322111 1113345778999999999999999999999999999998 9998864321 1 1111
Q ss_pred HHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048160 277 LVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQ 339 (344)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~ 339 (344)
.+. .+.. ...+ ...+..+.+++.+||+.||++||++.||++.|++
T Consensus 236 ~~~----~~~~------------~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 236 CIT----QGRL------------LQRP--RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHH----cCCc------------CCCC--CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111 1110 0001 1344568999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=313.65 Aligned_cols=265 Identities=16% Similarity=0.236 Sum_probs=197.8
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
++|...+.||+|+||.||+|+. ++..||+|++...... ....+.+|+.++++++||||+++++++..+...++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 4688899999999999999998 6788999998654322 234567999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
++ |+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 85 LD-SDLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CC-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 97 58998886544 25788899999999999999999 999999999999999999999999999998765432
Q ss_pred CcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc--C---
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES--N--- 285 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~--- 285 (344)
... .....+++.|+|||++.+ ..++.++||||+||++|+|++|..||..... ...+.........+ .
T Consensus 157 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07871 157 TKT---YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV----KEELHLIFRLLGTPTEETWP 229 (288)
T ss_pred Ccc---ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCChHHhh
Confidence 211 113467899999998865 5689999999999999999999999865321 11111111110000 0
Q ss_pred ------CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 ------SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+.....+..... +.....+....++.+|+..||++||.+|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 230 GITSNEEFRSYLFPQYRAQ-PLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccchhhhccccCccCCC-chHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000000 000000122356789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=319.14 Aligned_cols=198 Identities=18% Similarity=0.268 Sum_probs=172.3
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
.++|+..+.||+|+||.||++.+ .+..+|+|.+...... ....+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 46799999999999999999999 5677888887655332 23568899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCC-CeeeecccccceEeecCCcceEeeeecccccC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSR-PIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
|+++|+|.+++.... .+++..+..++.+++.||.||| +. +|+|+||||+||+++.++.++|+|||++....
T Consensus 84 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 84 HMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred cCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 999999999997643 5788888999999999999999 64 79999999999999999999999999987653
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCC
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSS 264 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 264 (344)
... .....|+..|+|||++.+..++.++|||||||++|++++|+.||...
T Consensus 156 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 156 DSM-----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hhc-----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 221 12346889999999998888999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=318.79 Aligned_cols=237 Identities=22% Similarity=0.264 Sum_probs=190.6
Q ss_pred cccCCCceEEEEEE--CCccEEEEEecCC---CCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCCc
Q 048160 63 ITKDLLYKLYKGFL--QDRPISVMKFGGN---LNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTL 137 (344)
Q Consensus 63 ig~G~~g~V~~~~~--~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL 137 (344)
||+|+||.||+|+. +++.||+|.+... .......+.+|+.++++++||||+++++++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999 5778999998643 222345577899999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCccccc
Q 048160 138 ADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217 (344)
Q Consensus 138 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~ 217 (344)
.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++....... .
T Consensus 81 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~ 149 (312)
T cd05585 81 FHHLQREG-----RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---K 149 (312)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC---c
Confidence 99987643 5889999999999999999999 99999999999999999999999999999875432221 1
Q ss_pred CCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccccccc
Q 048160 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVG 297 (344)
Q Consensus 218 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (344)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||..... . +........ .
T Consensus 150 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~----~----~~~~~~~~~-~----------- 209 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV----N----EMYRKILQE-P----------- 209 (312)
T ss_pred cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH----H----HHHHHHHcC-C-----------
Confidence 1245689999999999999999999999999999999999999964321 1 111111110 0
Q ss_pred CCCCChhhHHHHHHHHHHHHHccccCCCCCCC---HHHHH
Q 048160 298 EEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT---MVQVA 334 (344)
Q Consensus 298 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~ei~ 334 (344)
...|. ..+..+.+++.+||+.||++||+ +.+++
T Consensus 210 --~~~~~--~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 210 --LRFPD--GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred --CCCCC--cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 00111 33456889999999999999986 45554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=322.48 Aligned_cols=251 Identities=21% Similarity=0.347 Sum_probs=212.0
Q ss_pred CCCccccCCCceEEEEEECC------ccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 59 PEKVITKDLLYKLYKGFLQD------RPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 59 ~~~~ig~G~~g~V~~~~~~~------~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
...+||.|-||.||+|.+.+ -.||||..+.+.+. ..+.|+.|+.+|+++.|||||+++|+|.+ .+.|||||.
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL 471 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMEL 471 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEec
Confidence 46789999999999999932 35899998886443 45679999999999999999999999975 578999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
++-|.|..+|+.+. ..++..+...++.|++.||.||| +..+|||||..+|||+.+.-.+|++|||+++.+...
T Consensus 472 ~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 472 APLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred ccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 99999999998876 46888999999999999999999 999999999999999999999999999999988765
Q ss_pred CcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHH-cCCCCCCCCCccCcchhHHHHHHHHHhccCCcccc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELL-TGKRISYSSCFENGEEYFLQELVRKSIESNSFKEI 290 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (344)
...... ...-+..|||||.+....+++.+|||.||+.+||++ .|..||....+ .++
T Consensus 545 ~yYkaS--~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN---------------------sDV 601 (974)
T KOG4257|consen 545 AYYKAS--RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN---------------------SDV 601 (974)
T ss_pred chhhcc--ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc---------------------cce
Confidence 433222 233467899999999999999999999999999987 58899976432 233
Q ss_pred cccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 291 VDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
+-.+-+|+. .|.++.|++.+..|+.+||.++|.+||.+.+|...|..+..
T Consensus 602 I~~iEnGeR--lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 602 IGHIENGER--LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EEEecCCCC--CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 333334444 44444899999999999999999999999999999988764
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=320.76 Aligned_cols=251 Identities=16% Similarity=0.218 Sum_probs=201.1
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||.||+|+. .+..||+|++.... ......+.+|+.++..++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 3688889999999999999999 57899999987542 123455778999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 9999999999997543 5889999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
. ......||+.|+|||++.+..++.++|||||||++|||++|..||..... ...... +.. .. .
T Consensus 153 ~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~~~~~-i~~---~~---~ 215 (333)
T cd05600 153 T------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP----NETWEN-LKY---WK---E 215 (333)
T ss_pred c------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH----HHHHHH-HHh---cc---c
Confidence 3 11245789999999999988999999999999999999999999864321 111111 110 00 0
Q ss_pred ccccccccCCCCChh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 290 IVDPIIVGEEGLWPE-KEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
.+. .+.... ....+.++.+++.+||+.+|++||++.+|++.
T Consensus 216 ~~~------~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 216 TLQ------RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccc------CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000 000000 01334568899999999999999999999853
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=309.42 Aligned_cols=268 Identities=22% Similarity=0.314 Sum_probs=201.1
Q ss_pred CCCCCccccCCCceEEEEEE------CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeC--CccEE
Q 048160 57 YDPEKVITKDLLYKLYKGFL------QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLET--ELPIL 127 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~------~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~l 127 (344)
|...+.||+|+||+||.+.+ ++..||+|.+..... .....+.+|+.++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988764 456799999876533 2346678999999999999999999988653 45789
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
||||+++++|.+++... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++.
T Consensus 86 v~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccc
Confidence 99999999999998653 4889999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
...............++..|+|||.+.+..++.++||||||+++|+|++|..|+...... ..+...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~------~~~~~~~~~~~~~~ 230 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK------FEEMIGPKQGQMTV 230 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch------hhhhhcccccccch
Confidence 654322111111234566799999998888999999999999999999999987543210 00000000000000
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLH 341 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~ 341 (344)
..+.+....+. ..+.....+..+.+++.+||+.+|++|||+.+|++.|+.+.
T Consensus 231 ~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 231 VRLIELLERGM--RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhhcCC--CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00000000000 01111134567999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=325.57 Aligned_cols=243 Identities=20% Similarity=0.272 Sum_probs=207.1
Q ss_pred HHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCC---CCchhhhHhhHHHHHhcCC-CCceeeeeeEEeeCCcc
Q 048160 52 AATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGN---LNSEEYCCFNCIAFASQMS-HKNILKFVGCCLETELP 125 (344)
Q Consensus 52 ~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~ 125 (344)
...++|...++||+|.||.|+.+.. ++..+|||.++++ ...+.+..+.|.+++.... ||.+++++..|...+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 3456799999999999999999999 6778999999887 3344566778888888875 99999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
++||||+.||++..+.+.. .|++..+..++..++.||+||| .++||+||||.+|||+|.+|.+||+|||++
T Consensus 445 ~fvmey~~Ggdm~~~~~~~------~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHTD------VFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEecCCCcEEEEEecc------cccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccc
Confidence 9999999999976666543 5999999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
+..-..+. ..+++.||+.|+|||++.+..|+..+|.|||||+||||+.|..||....+
T Consensus 516 Ke~m~~g~---~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE------------------- 573 (694)
T KOG0694|consen 516 KEGMGQGD---RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE------------------- 573 (694)
T ss_pred cccCCCCC---ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-------------------
Confidence 87653332 23478999999999999999999999999999999999999999975432
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCH
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM 330 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 330 (344)
.+++|.++. ....+|. ..+.+..+|+.++|..+|++|.-+
T Consensus 574 --ee~FdsI~~-d~~~yP~--~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 574 --EEVFDSIVN-DEVRYPR--FLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --HHHHHHHhc-CCCCCCC--cccHHHHHHHHHHhccCcccccCC
Confidence 334444443 3344454 667788999999999999999765
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=308.19 Aligned_cols=254 Identities=19% Similarity=0.314 Sum_probs=202.5
Q ss_pred cCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
++|+..++||+|+||.||+|.. ++..||+|.+.... ...+.+.+|+.++++++|+||+++++++..++..++|+||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 5688899999999999999998 56779999876543 235678899999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+++|.+++....+ ..+++.++..++.|++.||.||| +.+++|+||||+||+++.++.++++|||++........
T Consensus 85 ~~~L~~~l~~~~~---~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 85 KGSLLDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999865432 35788889999999999999999 99999999999999999999999999999987654322
Q ss_pred ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
... ....++..|+|||++....++.++||||||+++|+|++ |..||..... . .....+....
T Consensus 159 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~----~-~~~~~~~~~~---------- 221 (261)
T cd05072 159 TAR--EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN----S-DVMSALQRGY---------- 221 (261)
T ss_pred ecc--CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH----H-HHHHHHHcCC----------
Confidence 111 12345678999999988889999999999999999998 8888753211 1 1111111000
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
..+.....+.++.+++.+||+.+|++|||+++|.+.|+++
T Consensus 222 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 222 --------RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred --------CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0011113345688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=323.77 Aligned_cols=266 Identities=17% Similarity=0.299 Sum_probs=205.5
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEEC-------CccEEEEEecCCCCc-hhhhHhhHHHHHhcCC-CCceeeeeeEEee
Q 048160 51 KAATNNYDPEKVITKDLLYKLYKGFLQ-------DRPISVMKFGGNLNS-EEYCCFNCIAFASQMS-HKNILKFVGCCLE 121 (344)
Q Consensus 51 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-------~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~-H~niv~~~~~~~~ 121 (344)
....+.|.+.+.||+|+||.||+|.+. +..||+|++...... ..+.+.+|+.+++++. ||||+++++++..
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 334567888999999999999999872 235999998755332 3456889999999996 9999999999999
Q ss_pred CCccEEEEeecCCCCccccccCCCCC------------------------------------------------------
Q 048160 122 TELPILVFEFVACGTLADRIHDPNGS------------------------------------------------------ 147 (344)
Q Consensus 122 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 147 (344)
....++|||||++|+|.+++......
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 99999999999999999887542110
Q ss_pred -------------------------------------CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceE
Q 048160 148 -------------------------------------QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTIL 190 (344)
Q Consensus 148 -------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil 190 (344)
....+++.++..++.|++.||.||| +.+|+||||||+||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEE
Confidence 0124778888999999999999999 999999999999999
Q ss_pred eecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCc
Q 048160 191 FQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENG 269 (344)
Q Consensus 191 l~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~ 269 (344)
++.++.++|+|||+++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~--- 345 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV--- 345 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch---
Confidence 999999999999998765432221 11123356778999999988889999999999999999997 8888754311
Q ss_pred chhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 270 EEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.......+ ... . ..+.....+..+.+++.+||+.||++|||+.+|.+.|.++.+
T Consensus 346 -~~~~~~~~----~~~------------~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 346 -DSTFYNKI----KSG------------Y--RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -hHHHHHHH----hcC------------C--CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 00011111 000 0 001111345678999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=312.62 Aligned_cols=255 Identities=23% Similarity=0.287 Sum_probs=199.9
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--------------chhhhHhhHHHHHhcCCCCceee
Q 048160 51 KAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--------------SEEYCCFNCIAFASQMSHKNILK 114 (344)
Q Consensus 51 ~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~ 114 (344)
.+..+.|.+.+.||+|.||.|-+|+. +++.||||++.+... ...+.+.+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 45567899999999999999999999 889999999854311 11246789999999999999999
Q ss_pred eeeEEeeC--CccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEee
Q 048160 115 FVGCCLET--ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ 192 (344)
Q Consensus 115 ~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 192 (344)
|+.+..+. +.+|||+|||..|.+...-... ..+.+.+++.++.+++.||+||| ..+|+||||||.|+|++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~-----~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK-----PELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLS 244 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCc-----ccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEc
Confidence 99998654 5889999999988886544322 13899999999999999999999 99999999999999999
Q ss_pred cCCcceEeeeecccccCCCCcc--cccCCccccccccccccccCcCC----CCcccchHHHHHHHHHHHcCCCCCCCCCc
Q 048160 193 EQNVAKFFDFCVSISIPEGKTH--VNDNNKVIGTFGFIAPEYMSTAN----CNEKSDVYSFGALLLELLTGKRISYSSCF 266 (344)
Q Consensus 193 ~~~~~kl~dfg~a~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Di~slG~il~el~~g~~p~~~~~~ 266 (344)
.+|.+||+|||.+.....+... ........||+.|+|||.+.++. .+.+.||||+||+||.|+.|+.||.....
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 9999999999999877433111 11112358999999999987732 25789999999999999999999986432
Q ss_pred cCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 267 ENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. +++++++. ..-..|..+.....+.+|+.++|.+||++|.+..+|..
T Consensus 325 ----~-----------------~l~~KIvn-~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 325 ----L-----------------ELFDKIVN-DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred ----H-----------------HHHHHHhc-CcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 1 12222221 11122333244556899999999999999999988864
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=325.97 Aligned_cols=264 Identities=21% Similarity=0.279 Sum_probs=215.8
Q ss_pred HHHHHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCc
Q 048160 47 AQELKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETEL 124 (344)
Q Consensus 47 ~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~ 124 (344)
++.++.-..+....++||-|-||.||.|.| ..-.||||.++.+.. ..++|+.|+.+|+.++|||+|+++|+|.....
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 356666666677789999999999999999 567899999887753 56889999999999999999999999999999
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeec
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV 204 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~ 204 (344)
+|||+|||..|+|.++|+..+.. -++.--.+.++.||.+|++||. .+++|||||.++|+|+..+..+|++|||+
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~---ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRS---EVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchh---hcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccch
Confidence 99999999999999999876642 3455556889999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhc
Q 048160 205 SISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIE 283 (344)
Q Consensus 205 a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (344)
++....+...... -..-++.|.|||.+..+.++.|+|||+||++|||+.| |..|+... + ....+.++.+-
T Consensus 412 sRlMtgDTYTAHA--GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-d----lSqVY~LLEkg-- 482 (1157)
T KOG4278|consen 412 SRLMTGDTYTAHA--GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-D----LSQVYGLLEKG-- 482 (1157)
T ss_pred hhhhcCCceeccc--CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-c----HHHHHHHHhcc--
Confidence 9998766543322 1223678999999999999999999999999999997 55555432 2 11111111111
Q ss_pred cCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 284 SNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.+...++.|++.+.+||..||++.|.+||++.||-+.++.+..
T Consensus 483 ----------------yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 483 ----------------YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred ----------------ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 1111222778889999999999999999999999999998864
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=308.78 Aligned_cols=255 Identities=20% Similarity=0.324 Sum_probs=206.4
Q ss_pred hcCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
..+|...+.||+|+||.||+|.+ .+..+++|.+..........+.+|+.+++.++|+||+++++++......++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45688889999999999999999 67889999987765545667889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++++|.+++....+ ..+++.++..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||.+.......
T Consensus 85 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 85 EKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ccCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999976443 35788999999999999999999 9999999999999999999999999999987764332
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
.... ...++..|+|||++....++.++||||||+++|+|++ |..||.... ....+. .+.. ..
T Consensus 159 ~~~~---~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~----~~~~~~-~~~~---~~------ 221 (261)
T cd05148 159 YLSS---DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN----NHEVYD-QITA---GY------ 221 (261)
T ss_pred cccc---CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC----HHHHHH-HHHh---CC------
Confidence 2111 2345678999999988889999999999999999998 777775421 111111 1110 00
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
..+....++..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 222 ---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 ---------RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ---------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0011113445688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=302.80 Aligned_cols=269 Identities=18% Similarity=0.237 Sum_probs=203.8
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCc-eeeeeeEEeeCC------c
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKN-ILKFVGCCLETE------L 124 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~~~~~~~~~~------~ 124 (344)
.|...++||+|+||+||+|+. +|+.||+|++.-.... ......+|+.+++.++|+| ||.+++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 355667899999999999999 7889999998876542 2345679999999999999 999999998877 8
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeec
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV 204 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~ 204 (344)
+++|+||++ -+|..++....... ..++...+..++.|++.||+||| +.+|+||||||+|||++++|.+||+|||+
T Consensus 92 l~lvfe~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 92 LYLVFEFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred EEEEEEeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence 899999996 69999987654211 13666889999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhc
Q 048160 205 SISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE 283 (344)
Q Consensus 205 a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (344)
|+...-.... ....++|.+|.|||++.+. .|++..||||+||++.||++++..|....+ ...+..++.....
T Consensus 167 Ara~~ip~~~---yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se----~~ql~~If~~lGt 239 (323)
T KOG0594|consen 167 ARAFSIPMRT---YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE----IDQLFRIFRLLGT 239 (323)
T ss_pred HHHhcCCccc---ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH----HHHHHHHHHHcCC
Confidence 9966533322 2245789999999998876 699999999999999999999988876543 2223333322222
Q ss_pred c--CCcccccc-cccccCCCCChhh-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 284 S--NSFKEIVD-PIIVGEEGLWPEK-------EKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 284 ~--~~~~~~~~-~~~~~~~~~~~~~-------~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
+ ..++.+.. +......+.|+.. +....+..+++.+||+++|.+|.|+..++..
T Consensus 240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1 11221110 0001012222211 1111368999999999999999999998764
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=317.19 Aligned_cols=255 Identities=16% Similarity=0.193 Sum_probs=203.5
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchh---hhHhhHHHHHhcCCCCceeeeeeEEeeCCcc
Q 048160 51 KAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEE---YCCFNCIAFASQMSHKNILKFVGCCLETELP 125 (344)
Q Consensus 51 ~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~---~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~ 125 (344)
....++|...+.||+|+||.||.|+- .|..+|+|++++..-... .-+..|=.+|....+|+||+++-.|.+...+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 34567899999999999999999998 788999999987643333 3355788889999999999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
||||||++||++..+|...+ .|++..+..++.+++.|++-|| ..|+|||||||+|+|||..|++||+|||++
T Consensus 217 YLiMEylPGGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLS 288 (550)
T ss_pred EEEEEecCCccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeecccccc
Confidence 99999999999999998775 7999999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCC---------------------cccc----c-------------------CCccccccccccccccCcCCCCcc
Q 048160 206 ISIPEGK---------------------THVN----D-------------------NNKVIGTFGFIAPEYMSTANCNEK 241 (344)
Q Consensus 206 ~~~~~~~---------------------~~~~----~-------------------~~~~~g~~~y~aPE~~~~~~~~~~ 241 (344)
..+.... .... . ....+|||-|+|||++.+..|+..
T Consensus 289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~ 368 (550)
T KOG0605|consen 289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE 368 (550)
T ss_pred chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence 6542200 0000 0 012579999999999999999999
Q ss_pred cchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccc
Q 048160 242 SDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLS 321 (344)
Q Consensus 242 ~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 321 (344)
+|+||||||+|||+.|-+||.+... ......+..|.... .+|.....+.+..+||.+|+.
T Consensus 369 cDwWSLG~ImyEmLvGyPPF~s~tp-~~T~rkI~nwr~~l-------------------~fP~~~~~s~eA~DLI~rll~ 428 (550)
T KOG0605|consen 369 CDWWSLGCIMYEMLVGYPPFCSETP-QETYRKIVNWRETL-------------------KFPEEVDLSDEAKDLITRLLC 428 (550)
T ss_pred ccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhhhc-------------------cCCCcCcccHHHHHHHHHHhc
Confidence 9999999999999999999986421 11111222222111 122222344678999999999
Q ss_pred cCCCCCCC---HHHHH
Q 048160 322 KSEQDRPT---MVQVA 334 (344)
Q Consensus 322 ~dP~~RPs---~~ei~ 334 (344)
||+.|.- +.||.
T Consensus 429 -d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 429 -DPENRLGSKGAEEIK 443 (550)
T ss_pred -CHHHhcCcccHHHHh
Confidence 9999964 55543
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=306.16 Aligned_cols=259 Identities=22% Similarity=0.349 Sum_probs=205.3
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||.||+|+. +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5788999999999999999998 77899999875422 122345778999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++++|.+++....... ..+++.++..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQK-RLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 9999999998875321111 25788899999999999999999 9999999999999999999999999999987765
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
...... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||+.... . ...+...+. ...
T Consensus 158 ~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~--~-~~~~~~~~~----~~~--- 224 (267)
T cd08228 158 SKTTAA---HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--N-LFSLCQKIE----QCD--- 224 (267)
T ss_pred chhHHH---hcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc--c-HHHHHHHHh----cCC---
Confidence 332211 134678899999999888899999999999999999999999865321 1 111111110 000
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
.+..+ ....+..+.+++.+||+.+|++|||+.+|++.|+++
T Consensus 225 ---------~~~~~-~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 ---------YPPLP-TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ---------CCCCC-hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 00001 113446689999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=313.51 Aligned_cols=256 Identities=16% Similarity=0.312 Sum_probs=201.5
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCc----cEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDR----PISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~----~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
.+|+..+.||+|+||.||+|.+ ++. .||+|.+..... ...+.+.+|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 4588999999999999999997 333 389999875432 3346688999999999999999999999765 5679
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
|+||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 86 v~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEcccccccc
Confidence 999999999999997654 35788889999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
.......... ....++..|+|||++.+..++.++||||||+++|||++ |..||.... ...+..... ...
T Consensus 159 ~~~~~~~~~~-~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~-----~~~~~~~~~----~~~ 228 (316)
T cd05108 159 LGADEKEYHA-EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILE----KGE 228 (316)
T ss_pred ccCCCcceec-cCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHh----CCC
Confidence 6543322111 12234678999999998899999999999999999998 888875321 111111111 100
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
..+....++.++.+++.+||+.+|++|||+.+|+..|..+..
T Consensus 229 --------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 229 --------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred --------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 011111334568899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=333.95 Aligned_cols=251 Identities=20% Similarity=0.232 Sum_probs=199.6
Q ss_pred CCCCCccccCCCceEEEEEE--C-CccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 57 YDPEKVITKDLLYKLYKGFL--Q-DRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~-~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
|...+.||+|+||.||+|.. + +..||+|.+..........+.+|+.+++.++|||||++++++..++..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 78889999999999999988 3 56788887655544444567789999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+|+|.+++...... ..++++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 149 gg~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 149 GGDLNKQIKQRLKE-HLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999877542111 135888999999999999999999 99999999999999999999999999999987643321
Q ss_pred ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDP 293 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (344)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... . ........
T Consensus 225 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~----~----~~~~~~~~---------- 285 (478)
T PTZ00267 225 L-DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ----R----EIMQQVLY---------- 285 (478)
T ss_pred c-ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH----H----HHHHHHHh----------
Confidence 1 112245689999999999998999999999999999999999999864311 1 11111111
Q ss_pred ccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 294 IIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+.....|. ..+..+.+|+..||+.||++||++.+++.
T Consensus 286 ---~~~~~~~~--~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 286 ---GKYDPFPC--PVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---CCCCCCCc--cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11111111 23456899999999999999999999864
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=321.09 Aligned_cols=266 Identities=18% Similarity=0.234 Sum_probs=194.9
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCC-----ccE
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETE-----LPI 126 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-----~~~ 126 (344)
.|...+.||+|+||.||+|.. ++..||+|++..... .....+.+|+.++++++||||+++++++...+ ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 367788999999999999998 678999999875322 23355789999999999999999999886432 479
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
+||||+. ++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 81 VVFELME-SDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEecCC-CCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 9999995 78998887543 5889999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCCCcccccCCccccccccccccccCc--CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh--
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMST--ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI-- 282 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 282 (344)
................|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...... ..+ ..+....
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~----~~~-~~~~~~~~~ 226 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV----HQL-DLITDLLGT 226 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH----HHH-HHHHHHhCC
Confidence 65332221111124578999999999865 57899999999999999999999998643210 000 0000000
Q ss_pred ---------ccCCcccccccccccCCCCC-hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ---------ESNSFKEIVDPIIVGEEGLW-PEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ---------~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
........+........... ...+..+..+.+++.+||+.||++|||+.++++
T Consensus 227 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred CCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000000000000000000 000123356789999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=317.57 Aligned_cols=240 Identities=18% Similarity=0.226 Sum_probs=192.8
Q ss_pred CccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCC
Q 048160 61 KVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACG 135 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 135 (344)
+.||+|+||.||+++. ++..||+|.+..... .....+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999998 678899999875421 23345668999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCccc
Q 048160 136 TLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHV 215 (344)
Q Consensus 136 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~ 215 (344)
+|..++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++.........
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~- 151 (323)
T cd05595 81 ELFFHLSRER-----VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT- 151 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc-
Confidence 9998886543 5889999999999999999999 999999999999999999999999999998754222111
Q ss_pred ccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccccc
Q 048160 216 NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPII 295 (344)
Q Consensus 216 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (344)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||..... ........ ...
T Consensus 152 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~----~~~~~~~~-----~~~--------- 211 (323)
T cd05595 152 --MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELIL-----MEE--------- 211 (323)
T ss_pred --cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHh-----cCC---------
Confidence 1235689999999999988999999999999999999999999865321 11111110 000
Q ss_pred ccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048160 296 VGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-----TMVQVAK 335 (344)
Q Consensus 296 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ei~~ 335 (344)
...|. ..+..+.+++.+||+.||++|| ++.++++
T Consensus 212 ----~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 212 ----IRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ----CCCCC--CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 00111 2345688999999999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=306.85 Aligned_cols=268 Identities=17% Similarity=0.195 Sum_probs=203.4
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEee-----CC
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLE-----TE 123 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-----~~ 123 (344)
....|...+.||+|+||.|.++.. ++..||+|++..... ...+...||+.+++.++|+||+.+.+++.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 344566678999999999999999 788999999985543 345667899999999999999999998875 34
Q ss_pred ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeee
Q 048160 124 LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFC 203 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg 203 (344)
..|+|+|+|+ .+|...++... .++...+..++.|++.||+|+| +.+|+||||||.|++++.+..+|++|||
T Consensus 100 DvYiV~elMe-tDL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEecccc
Confidence 6799999994 79999998753 5999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
+|+..... .....-+..+.|.+|.|||++.. ..|+...||||.|||+.||++|++.|.+.....+. ..+....
T Consensus 171 LAR~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql-----~lI~~~l 244 (359)
T KOG0660|consen 171 LARYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQL-----QLILELL 244 (359)
T ss_pred ceeecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHH-----HHHHHhc
Confidence 99988654 22222224678999999998754 67999999999999999999999988764321111 1111111
Q ss_pred ccC-----------CcccccccccccCCCCCh-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ESN-----------SFKEIVDPIIVGEEGLWP-EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ~~~-----------~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
... .....+..........+. ..+...+..++|+.+||..||.+|+|++|.++
T Consensus 245 GtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 245 GTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred CCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 111 011111111110111111 11234467899999999999999999999875
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=310.08 Aligned_cols=271 Identities=21% Similarity=0.297 Sum_probs=202.6
Q ss_pred cCCCCCCccccCCCceEEEEEE------CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEee--CCccE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL------QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLE--TELPI 126 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~------~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~ 126 (344)
+.|...+.||+|+||.||++.+ ++..||+|++........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678889999999999999985 467899999877665556778899999999999999999998754 34688
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
+|+||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.
T Consensus 84 lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccc
Confidence 9999999999999986543 25889999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhc-cC
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE-SN 285 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 285 (344)
................++..|+|||++.+..++.++||||||++++||++|..++...... .......... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~~~~~~~~ 230 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE------FMRMMGNDKQGQM 230 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh------hhhhccccccccc
Confidence 7654332111111223345699999998888999999999999999999988765432110 0000000000 00
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
......+ .+. .....+.....+..+.+|+.+||+.+|++|||+.+|++.|+++
T Consensus 231 ~~~~~~~-~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 231 IVYHLIE-LLK-NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred chHHHHH-HHh-cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000000 000 0011111123455789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=312.77 Aligned_cols=268 Identities=15% Similarity=0.204 Sum_probs=197.5
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
.++|...+.||+|+||.||+|+. +++.||+|++...... ....+.+|+.+++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 36799999999999999999999 6788999998754322 23456789999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|++ ++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 84 YVH-TDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred CCC-cCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 996 68888776543 25788899999999999999999 99999999999999999999999999999875432
Q ss_pred CCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc--CCc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES--NSF 287 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 287 (344)
.... .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||..... ....+.......... ..+
T Consensus 156 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~ 229 (303)
T cd07869 156 PSHT---YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD---IQDQLERIFLVLGTPNEDTW 229 (303)
T ss_pred CCcc---CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc---HHHHHHHHHHHhCCCChhhc
Confidence 2211 113467899999999865 4588999999999999999999999975422 111111111110000 000
Q ss_pred ccc-----ccc-ccc-cCCCCChhh---HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 288 KEI-----VDP-IIV-GEEGLWPEK---EKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 288 ~~~-----~~~-~~~-~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
... +.+ ... ......... ...+..+.+|+.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000 000 000 000000000 012245789999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=311.18 Aligned_cols=261 Identities=20% Similarity=0.290 Sum_probs=206.5
Q ss_pred CCCCCCccccCCCceEEEEEEC-------CccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 56 NYDPEKVITKDLLYKLYKGFLQ-------DRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~~-------~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
+|.....||+|+||.||+|.+. +..+++|.+........+.+.+|+.++++++|+||+++++++..+...++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 4777889999999999999862 345888988766555556788999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCC-----------CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcc
Q 048160 129 FEFVACGTLADRIHDPNGS-----------QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA 197 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 197 (344)
|||+++++|.+++...... ....+++.+++.++.|++.||.||| +++|+||||||+||+++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcE
Confidence 9999999999998653210 1124788999999999999999999 9999999999999999999999
Q ss_pred eEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHH
Q 048160 198 KFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQE 276 (344)
Q Consensus 198 kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~ 276 (344)
+|+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++ |..||..... . ...+
T Consensus 163 ~l~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----~-~~~~ 236 (291)
T cd05094 163 KIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN----T-EVIE 236 (291)
T ss_pred EECCCCcccccCCCcee-ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----H-HHHH
Confidence 99999998765433221 11123456788999999988889999999999999999998 8888764321 1 1111
Q ss_pred HHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 277 LVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
. ........ .+ ...+..+.+++.+||+.||++|||+.+|++.|.++.+.
T Consensus 237 ~----~~~~~~~~------------~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 237 C----ITQGRVLE------------RP--RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred H----HhCCCCCC------------CC--ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1 11111100 00 12345688999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=305.74 Aligned_cols=255 Identities=20% Similarity=0.336 Sum_probs=203.1
Q ss_pred cCCCCCCccccCCCceEEEEEEC-----CccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFLQ-----DRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~~-----~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
++|+..+.||+|+||.||+|.+. ...||+|.+...... ....+.+|+.++++++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 56888999999999999999982 246899988655332 345688999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||+++++|.+++....+ .+++.++..++.|++.||.||| +.+|+|+||||+||+++.++.++++|||++...
T Consensus 84 ~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 84 TEYMENGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEcCCCCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 999999999999876542 5889999999999999999999 999999999999999999999999999999877
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
......... ....++..|+|||.+.+..++.++||||||+++|++++ |..||..... ......+.. ...
T Consensus 157 ~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-----~~~~~~~~~----~~~ 226 (266)
T cd05033 157 EDSEATYTT-KGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-----QDVIKAVED----GYR 226 (266)
T ss_pred cccccceec-cCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHHc----CCC
Confidence 522211111 12234578999999988889999999999999999998 8888753211 111111110 000
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
.+....++..+.+++.+||+.+|++||++.+|++.|.++
T Consensus 227 --------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 --------------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000113345688999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=305.61 Aligned_cols=250 Identities=18% Similarity=0.253 Sum_probs=198.0
Q ss_pred CCCCCCccccCCCceEEEEEECC-ccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 56 NYDPEKVITKDLLYKLYKGFLQD-RPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~~~-~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
+|...+.||+|+||.||.|.+.+ ..+|+|.+..... ..+.+.+|+.++++++||||+++++++...+..++||||+.+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 47777899999999999999844 4699998875432 346688999999999999999999999998999999999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
|+|.+++.... ..+++.+++.++.|++.||.||| +.+++|+||||+||+++.++.++++|||.++........
T Consensus 84 ~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 84 GCLLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999987643 25889999999999999999999 999999999999999999999999999998765433221
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDP 293 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (344)
.. ....++..|+|||++.+..++.++||||||+++|+|++ |..||..... ......+ .. .
T Consensus 157 ~~--~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~~~~~~~---~~-~-------- 217 (256)
T cd05113 157 SS--VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-----SETVEKV---SQ-G-------- 217 (256)
T ss_pred ec--CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----HHHHHHH---hc-C--------
Confidence 11 11234678999999988889999999999999999998 8888753211 1111111 10 0
Q ss_pred ccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048160 294 IIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338 (344)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~ 338 (344)
.....+. ..+..+.+++.+||+.||.+|||+.+|++.|+
T Consensus 218 ----~~~~~~~--~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 218 ----LRLYRPH--LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ----CCCCCCC--CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0000011 23456899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=303.84 Aligned_cols=247 Identities=20% Similarity=0.301 Sum_probs=194.0
Q ss_pred ccccCCCceEEEEEE----CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCC
Q 048160 62 VITKDLLYKLYKGFL----QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACG 135 (344)
Q Consensus 62 ~ig~G~~g~V~~~~~----~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 135 (344)
.||+|+||.||+|.+ ++..+|+|++...... ..+.+.+|+.+++.+.||||+++++++. +...++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999976 4678999988655332 2456889999999999999999999885 45678999999999
Q ss_pred CccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCccc
Q 048160 136 TLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHV 215 (344)
Q Consensus 136 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~ 215 (344)
+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||.||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 81 PLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 9999986543 5889999999999999999999 9999999999999999999999999999987765433221
Q ss_pred ccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccc
Q 048160 216 NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPI 294 (344)
Q Consensus 216 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (344)
.......++..|+|||.+....++.++||||||+++|||++ |..||.... .......+. ...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~i~----~~~-------- 215 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK-----GNEVTQMIE----SGE-------- 215 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHH----CCC--------
Confidence 11112234578999999988889999999999999999998 888875421 111111111 111
Q ss_pred cccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 295 IVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 295 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
....|. ..+.++.+++.+||+.||++||++.+|.+.|++.
T Consensus 216 ----~~~~~~--~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 216 ----RMECPQ--RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred ----CCCCCC--CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 011111 3445689999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=320.49 Aligned_cols=243 Identities=19% Similarity=0.274 Sum_probs=196.9
Q ss_pred cCCCCCCccccCCCceEEEEEE--C-CccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--Q-DRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~-~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
++|...+.||+|+||.||+|.+ . +..||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 4588889999999999999987 2 2579999886431 22345677899999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++...
T Consensus 110 ~Ey~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 99999999999997653 5889999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
.... ....||+.|+|||++.+..++.++|||||||++|||++|..||..... ........ ...
T Consensus 182 ~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~~~~~~i~-----~~~-- 244 (340)
T PTZ00426 182 DTRT------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP----LLIYQKIL-----EGI-- 244 (340)
T ss_pred CCCc------ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH----HHHHHHHh-----cCC--
Confidence 4321 145789999999999888899999999999999999999999975321 11111111 000
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-----TMVQVAK 335 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ei~~ 335 (344)
...|. ..+..+.+++.+||+.||++|+ +++++++
T Consensus 245 -----------~~~p~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 245 -----------IYFPK--FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred -----------CCCCC--CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 00111 2234578999999999999995 7888765
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=303.08 Aligned_cols=248 Identities=18% Similarity=0.276 Sum_probs=193.2
Q ss_pred ccccCCCceEEEEEEC----CccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCC
Q 048160 62 VITKDLLYKLYKGFLQ----DRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGT 136 (344)
Q Consensus 62 ~ig~G~~g~V~~~~~~----~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gs 136 (344)
.||+|+||.||+|.+. +..||+|.+...... ..+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999872 345899988765432 2356889999999999999999999885 457799999999999
Q ss_pred ccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcccc
Q 048160 137 LADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN 216 (344)
Q Consensus 137 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~ 216 (344)
|.+++.... ..+++.++..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++...........
T Consensus 81 L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 81 LNKFLSGKK----DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 999987543 35889999999999999999999 99999999999999999999999999999876543322111
Q ss_pred cCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccccccccc
Q 048160 217 DNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPII 295 (344)
Q Consensus 217 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (344)
......++..|+|||.+....++.++||||||+++|++++ |..||..... ...... .....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~----~~~~~--------- 215 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-----PEVMSF----IEQGK--------- 215 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-----HHHHHH----HHCCC---------
Confidence 1111223568999999988889999999999999999996 8888754311 111111 11110
Q ss_pred ccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 296 VGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 296 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
....+ ..++.++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 216 ---~~~~~--~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 216 ---RLDCP--AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ---CCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 00111 13456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=318.73 Aligned_cols=246 Identities=22% Similarity=0.260 Sum_probs=190.9
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
++|...+.||+|+||.||+|++ +++.||+|.+...... ....+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 3466678899999999999998 6789999998655332 235678999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+++|+|.... ...+..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 154 ~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 154 MDGGSLEGTH---------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred CCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 9999986532 2456677889999999999999 999999999999999999999999999998766432
Q ss_pred CcccccCCccccccccccccccCc-----CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMST-----ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
.. ......||..|+|||++.. ...+.++|||||||++|||++|+.||..... ...... ...... .
T Consensus 222 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--~~~~~~---~~~~~~-~- 291 (353)
T PLN00034 222 MD---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--GDWASL---MCAICM-S- 291 (353)
T ss_pred cc---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccHHHH---HHHHhc-c-
Confidence 21 1124578999999998743 2245689999999999999999999863211 111111 100000 0
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... .....+.++.+|+.+||+.||++|||+.||++
T Consensus 292 -----------~~~~--~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 292 -----------QPPE--APATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred -----------CCCC--CCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00134456899999999999999999999986
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=317.53 Aligned_cols=240 Identities=18% Similarity=0.228 Sum_probs=193.6
Q ss_pred CccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCC
Q 048160 61 KVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACG 135 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 135 (344)
+.||+|+||.||+++. +++.||+|++.... ......+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4689999999999998 67899999987542 223456778999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCccc
Q 048160 136 TLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHV 215 (344)
Q Consensus 136 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~ 215 (344)
+|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 150 (328)
T cd05593 81 ELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-- 150 (328)
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--
Confidence 9998886543 5889999999999999999999 99999999999999999999999999999875432211
Q ss_pred ccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccccc
Q 048160 216 NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPII 295 (344)
Q Consensus 216 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (344)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+ . ..
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~~~~~~~---~-~~---------- 210 (328)
T cd05593 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELI---L-ME---------- 210 (328)
T ss_pred -ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----HHHHHHh---c-cC----------
Confidence 11235689999999999988999999999999999999999999964321 1111110 0 00
Q ss_pred ccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048160 296 VGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-----TMVQVAK 335 (344)
Q Consensus 296 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ei~~ 335 (344)
. ...|. ..+.++.+|+.+||+.||++|| ++.++++
T Consensus 211 --~-~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 211 --D-IKFPR--TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred --C-ccCCC--CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 0 00111 2345688999999999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=303.64 Aligned_cols=254 Identities=19% Similarity=0.314 Sum_probs=202.4
Q ss_pred hcCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
.++|+..+.||+|++|.||+|.+ .++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688889999999999999998 56789999986543 23466889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++++|.+++....+ ..+++.++..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 84 KYGSLLEYLQGGAG---RALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cCCcHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999876432 35889999999999999999999 9999999999999999999999999999998765322
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
.... .....+..|+|||++.+..++.++||||||+++|+|++ |..||.... ...+...+.. ...
T Consensus 158 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~~~~---~~~----- 222 (261)
T cd05068 158 YEAR--EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT-----NAEVLQQVDQ---GYR----- 222 (261)
T ss_pred cccc--CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHHc---CCC-----
Confidence 1111 01122457999999988889999999999999999999 887775421 1111111110 000
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQ 339 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~ 339 (344)
.+.....+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 223 ----------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 ----------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ----------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 00111334568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=304.69 Aligned_cols=256 Identities=20% Similarity=0.331 Sum_probs=202.1
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCc---cEEEEEecCCC-CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDR---PISVMKFGGNL-NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~---~vavk~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
++|+..+.||+|+||.||+|.. ++. .+++|.+.... ....+.+..|+.++++++|+||+++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 4688889999999999999998 233 58999886553 23345688999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||+++++|.+++.... ..+++.++..++.|++.||.||| +.+++|+||||+||+++.++.++++|||++...
T Consensus 85 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 85 TEYMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 99999999999987543 25888999999999999999999 999999999999999999999999999998766
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
...............+..|+|||++.+..++.++||||||+++||+++ |..||..... . .....+. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~----~-~~~~~i~---~~~-- 227 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN----H-EVMKAIN---DGF-- 227 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH----H-HHHHHHh---cCC--
Confidence 433221111111223457999999988889999999999999999997 8988854321 1 1111111 000
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
..|.....+..+.+++.+||+.+|++||++.+|++.|.++
T Consensus 228 -------------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 -------------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011113445689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=305.42 Aligned_cols=256 Identities=17% Similarity=0.277 Sum_probs=198.9
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCc----cEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDR----PISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~----~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
++|+..+.||+|+||+||+|.+ ++. .+++|.+..... .....+..|+..++++.||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 3577889999999999999998 444 477787754432 22355678888999999999999999876 445788
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
++||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||+++.
T Consensus 86 i~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 999999999999997644 25889999999999999999999 99999999999999999999999999999986
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
........ ......++..|+|||++.+..++.++||||||+++||+++ |..||.... .....+.+. .+.
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----~~~~~~~~~----~~~ 228 (279)
T cd05111 159 LYPDDKKY-FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR-----PHEVPDLLE----KGE 228 (279)
T ss_pred ccCCCccc-ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHH----CCC
Confidence 64332211 1113456778999999988889999999999999999998 888875431 111222211 111
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
. ...+. .++.++.+++.+||+.||++|||+.++++.|..+.+
T Consensus 229 ~------------~~~~~--~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 229 R------------LAQPQ--ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred c------------CCCCC--CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0 00011 233457889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=304.80 Aligned_cols=253 Identities=22% Similarity=0.274 Sum_probs=200.2
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
++|...+.||+|+||.||+|+. ++..||+|++..........+.+|+.++++++||||+++++++..+...++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688999999999999999998 67789999987655445566789999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++++|.+++.... ++++.++..++.|++.||.||| +.+|+||||+|+||+++.++.++++|||++.......
T Consensus 89 ~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 89 GGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 9999999886543 5889999999999999999999 9999999999999999999999999999987664322
Q ss_pred cccccCCccccccccccccccC---cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMS---TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
. ......++..|+|||.+. ...++.++|+||||+++|+|++|..||........ . ..
T Consensus 161 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~----~-------------~~ 220 (267)
T cd06646 161 A---KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA----L-------------FL 220 (267)
T ss_pred c---ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh----h-------------ee
Confidence 1 112346788999999874 34578899999999999999999999854311000 0 00
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L 337 (344)
...... ..+.++.....+..+.+++.+||+.+|++|||+++|++.|
T Consensus 221 ~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 221 MSKSNF--QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred eecCCC--CCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000000 0011111113345789999999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=306.82 Aligned_cols=258 Identities=21% Similarity=0.287 Sum_probs=200.5
Q ss_pred cCCCCCCccccCCCceEEEEEE------CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL------QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~------~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
++|+..+.||+|+||.||+|.+ .+..|++|.+...... ....+.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3477789999999999999985 3467999998754332 23567899999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCC------------CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC
Q 048160 128 VFEFVACGTLADRIHDPNG------------SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN 195 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 195 (344)
||||+++++|.+++..... .....+++.+++.++.|++.||.||| +.+++||||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence 9999999999998853211 00124788889999999999999999 99999999999999999999
Q ss_pred cceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHH
Q 048160 196 VAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFL 274 (344)
Q Consensus 196 ~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~ 274 (344)
.++++|||+++......... ......++..|+|||++.+..++.++||||||+++|||++ |..||.... ....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~-----~~~~ 235 (283)
T cd05090 162 HVKISDLGLSREIYSADYYR-VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-----NQEV 235 (283)
T ss_pred cEEeccccccccccCCccee-cccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-----HHHH
Confidence 99999999997664332111 1113345678999999988889999999999999999998 888876431 1111
Q ss_pred HHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048160 275 QELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQ 339 (344)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~ 339 (344)
.+.+. ..... ..+ ..++..+.+++.+||+.||++||++.+|++.|.+
T Consensus 236 ~~~~~----~~~~~------------~~~--~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 IEMVR----KRQLL------------PCS--EDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHH----cCCcC------------CCC--CCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111 11100 001 1334568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=301.19 Aligned_cols=260 Identities=23% Similarity=0.361 Sum_probs=206.9
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|+..+.||+|+||.||+|.. +++.||+|.++... ....+.+.+|+.++++++|+||+++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5788999999999999999999 68889999876422 122456889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++++|..++....... ..+++.++..++.+++.||.||| +.+++|+||+|+||+++.++.++++|||++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQK-RLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhcccC-CCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 9999999999885422111 35788999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
..... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... .......... .+
T Consensus 158 ~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~-~~---- 223 (267)
T cd08224 158 SKTTA---AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIE-KC---- 223 (267)
T ss_pred CCCcc---cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc------cHHHHHhhhh-cC----
Confidence 32211 1134578889999999888899999999999999999999999864321 1111111100 00
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLH 341 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~ 341 (344)
..+..|. ...+..+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus 224 --------~~~~~~~-~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 224 --------DYPPLPA-DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --------CCCCCCh-hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1111111 134556899999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=305.35 Aligned_cols=246 Identities=19% Similarity=0.262 Sum_probs=192.2
Q ss_pred cccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCCc
Q 048160 63 ITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTL 137 (344)
Q Consensus 63 ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL 137 (344)
||+|+||.||+++. .++.||+|.+..... .....+..|+.++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999998 688999999864321 1233456799999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCccccc
Q 048160 138 ADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217 (344)
Q Consensus 138 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~ 217 (344)
.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~--- 151 (277)
T cd05607 81 KYHIYNVGE---RGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI--- 151 (277)
T ss_pred HHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCcee---
Confidence 988754332 25788889999999999999999 999999999999999999999999999998766433221
Q ss_pred CCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccccccc
Q 048160 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVG 297 (344)
Q Consensus 218 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (344)
....|+..|+|||++.+..++.++|||||||++|+|++|..||........ ........... ...
T Consensus 152 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~----~~~~~~~~~~~-~~~--------- 216 (277)
T cd05607 152 -TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA----KEELKRRTLED-EVK--------- 216 (277)
T ss_pred -eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh----HHHHHHHhhcc-ccc---------
Confidence 134678999999999888899999999999999999999999864322111 11111111110 000
Q ss_pred CCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048160 298 EEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337 (344)
Q Consensus 298 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L 337 (344)
.+ ....+.++.+|+..||+.||++||++.|+++.+
T Consensus 217 ----~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 217 ----FE-HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ----cc-cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 00 012345689999999999999999997766544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=313.94 Aligned_cols=263 Identities=20% Similarity=0.331 Sum_probs=202.7
Q ss_pred hcCCCCCCccccCCCceEEEEEEC-------CccEEEEEecCCCC-chhhhHhhHHHHHhcC-CCCceeeeeeEEee-CC
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQ-------DRPISVMKFGGNLN-SEEYCCFNCIAFASQM-SHKNILKFVGCCLE-TE 123 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~-------~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~-~~ 123 (344)
.++|++.+.||+|+||.||+|... ++.||+|++..... ...+.+.+|+.++.++ +|+||+++++++.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 346888999999999999999752 36799999875432 2335677899999999 89999999998864 45
Q ss_pred ccEEEEeecCCCCccccccCCCCC--------------------------------------------------------
Q 048160 124 LPILVFEFVACGTLADRIHDPNGS-------------------------------------------------------- 147 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 147 (344)
..++++||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 788999999999999887542210
Q ss_pred CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcccccCCcccccccc
Q 048160 148 QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGF 227 (344)
Q Consensus 148 ~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y 227 (344)
....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++..+....... ......++..|
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~-~~~~~~~~~~y 241 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-RKGDARLPLKW 241 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh-hccCCCCCccc
Confidence 0125788999999999999999999 9999999999999999999999999999998764433221 11234556789
Q ss_pred ccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhH
Q 048160 228 IAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKE 306 (344)
Q Consensus 228 ~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (344)
+|||++.+..++.++|||||||++|||++ |..||..... ...+...+ ...... ..+ .
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~----~~~~~~~~----~~~~~~------------~~~--~ 299 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI----DEEFCRRL----KEGTRM------------RAP--E 299 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc----cHHHHHHH----hccCCC------------CCC--c
Confidence 99999999999999999999999999997 8888754211 00111111 111000 000 1
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 307 KQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 307 ~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
..+..+.+++.+||+.+|++||++.+|++.|.++.+
T Consensus 300 ~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 300 YATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 234568999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=307.78 Aligned_cols=266 Identities=17% Similarity=0.216 Sum_probs=194.6
Q ss_pred cCCCCCCccccCCCceEEEEEE---CCccEEEEEecCCCCc--hhhhHhhHHHHHhcC---CCCceeeeeeEEee-----
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL---QDRPISVMKFGGNLNS--EEYCCFNCIAFASQM---SHKNILKFVGCCLE----- 121 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~---~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l---~H~niv~~~~~~~~----- 121 (344)
++|...+.||+|+||.||+|+. .+..||+|++...... ....+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3588889999999999999987 3567999988654322 223456787777766 69999999999852
Q ss_pred CCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEee
Q 048160 122 TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFD 201 (344)
Q Consensus 122 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~d 201 (344)
....++||||+. ++|.+++..... ..+++.++..++.|++.||.||| +.+|+||||||+|||++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEcc
Confidence 356899999996 689988865432 24788999999999999999999 99999999999999999999999999
Q ss_pred eecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHH
Q 048160 202 FCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS 281 (344)
Q Consensus 202 fg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 281 (344)
||++....... ......|++.|+|||++.+..++.++|||||||++|||++|..||..... ...+...+...
T Consensus 154 fg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~----~~~~~~i~~~~ 225 (290)
T cd07862 154 FGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD----VDQLGKILDVI 225 (290)
T ss_pred ccceEeccCCc----ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH----HHHHHHHHHHh
Confidence 99997654321 11245689999999999888899999999999999999999999875422 12222222211
Q ss_pred hcc--CCccc---ccccccccCCC-CChh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 282 IES--NSFKE---IVDPIIVGEEG-LWPE-KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 282 ~~~--~~~~~---~~~~~~~~~~~-~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
... ..+.. ........... ..+. .+..+..+.+++.+||+.||++|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 226 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 100 00000 00000000000 0000 0123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=330.68 Aligned_cols=262 Identities=20% Similarity=0.248 Sum_probs=204.8
Q ss_pred HHHHHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeC
Q 048160 47 AQELKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLET 122 (344)
Q Consensus 47 ~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~ 122 (344)
..++....++|...+.||+|+||+||+|+. +++.||||.+..... .....+.+|+..+..++|+||++++..+...
T Consensus 24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 344556668899999999999999999988 788999999865432 2345577999999999999999998876543
Q ss_pred C--------ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC
Q 048160 123 E--------LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ 194 (344)
Q Consensus 123 ~--------~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 194 (344)
. ..++||||+++|+|.+++...... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.+
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~-~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~ 179 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSN 179 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCC
Confidence 2 367999999999999988653221 136889999999999999999999 9999999999999999999
Q ss_pred CcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHH
Q 048160 195 NVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFL 274 (344)
Q Consensus 195 ~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 274 (344)
+.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 180 ~~vkL~DFGls~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------- 250 (496)
T PTZ00283 180 GLVKLGDFGFSKMYAATVSD-DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-------- 250 (496)
T ss_pred CCEEEEecccCeeccccccc-cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--------
Confidence 99999999998765432211 112245789999999999998999999999999999999999999864311
Q ss_pred HHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 275 QELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
......... +.....| ...+..+.+++..||+.||.+||++.++++.
T Consensus 251 ~~~~~~~~~-------------~~~~~~~--~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 251 EEVMHKTLA-------------GRYDPLP--PSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHHhc-------------CCCCCCC--CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111111111 1111111 1344568999999999999999999998763
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=302.31 Aligned_cols=257 Identities=22% Similarity=0.333 Sum_probs=198.2
Q ss_pred CCCCCccccCCCceEEEEEEC--C---ccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCc-----
Q 048160 57 YDPEKVITKDLLYKLYKGFLQ--D---RPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETEL----- 124 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~~--~---~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~----- 124 (344)
|...+.||+|+||.||+|.+. + ..||+|+++.... .....+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456789999999999999982 2 5699999875532 234568899999999999999999999876554
Q ss_pred -cEEEEeecCCCCccccccCCCC-CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeee
Q 048160 125 -PILVFEFVACGTLADRIHDPNG-SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF 202 (344)
Q Consensus 125 -~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~df 202 (344)
.++|+||+++|+|..++..... .....+++..+..++.|++.||.||| +.+++||||||+||++++++.++|+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 7999999999999988744321 11236889999999999999999999 999999999999999999999999999
Q ss_pred ecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHH
Q 048160 203 CVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKS 281 (344)
Q Consensus 203 g~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 281 (344)
|+++.......... .....++..|+|||++.+..++.++||||||+++|||++ |..||.... .....+.+.
T Consensus 158 g~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~-----~~~~~~~~~-- 229 (273)
T cd05035 158 GLSKKIYSGDYYRQ-GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-----NHEIYDYLR-- 229 (273)
T ss_pred cceeeccccccccc-cccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHH--
Confidence 99987654322111 112234678999999988889999999999999999999 777764321 111111111
Q ss_pred hccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 282 IESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
. .. ....+ ..++..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 230 -~-~~------------~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 -H-GN------------RLKQP--EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -c-CC------------CCCCC--cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 00 00001 13445689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=313.73 Aligned_cols=244 Identities=18% Similarity=0.234 Sum_probs=190.4
Q ss_pred CccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 61 KVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
+.||+|+||.||+++. +++.||+|.++.... ...+.+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999998 678899999875422 2234577899999998 699999999999999999999999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
|+|.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++.......
T Consensus 81 g~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~- 151 (329)
T cd05588 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD- 151 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-
Confidence 99998886543 5899999999999999999999 99999999999999999999999999999865322111
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPI 294 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (344)
......||..|+|||++.+..++.++|||||||++|+|++|+.||..............+..........
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-------- 221 (329)
T cd05588 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-------- 221 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------
Confidence 1124578999999999999999999999999999999999999996432211111111111111111111
Q ss_pred cccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCH
Q 048160 295 IVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM 330 (344)
Q Consensus 295 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 330 (344)
...|. ..+..+.+++.+||+.||.+||++
T Consensus 222 -----~~~p~--~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 222 -----IRIPR--SLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred -----CCCCC--CCCHHHHHHHHHHhccCHHHcCCC
Confidence 00111 234457899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=304.30 Aligned_cols=259 Identities=20% Similarity=0.276 Sum_probs=195.7
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCC-----ccEEE
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETE-----LPILV 128 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-----~~~lv 128 (344)
.|...+++|+|+||.||.|.. .+..||||++..+. +...+|+.+|+.+.|||||++.-++.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 466789999999999999999 67899999986653 23458999999999999999988876432 34589
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC-CcceEeeeecccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ-NVAKFFDFCVSIS 207 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~dfg~a~~ 207 (344)
||||+ .+|.++++...... ..++.-.+..+.+||.+||.||| +.+|+||||||+|+|+|.+ |.+||||||.|+.
T Consensus 101 leymP-~tL~~~~r~~~~~~-~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRAN-QRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHhch-HHHHHHHHHHhhcC-CCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 99998 68998887421100 24677778889999999999999 9999999999999999976 9999999999998
Q ss_pred cCCCCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
+..+.... ....|..|+|||.+.+. .|+.+.||||.||++.||+-|++.|.+... ...+..++.-.. ..+
T Consensus 176 L~~~epni----SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~----~dQL~eIik~lG-~Pt 246 (364)
T KOG0658|consen 176 LVKGEPNI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS----VDQLVEIIKVLG-TPT 246 (364)
T ss_pred eccCCCce----eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH----HHHHHHHHHHhC-CCC
Confidence 87655443 45679999999998875 599999999999999999999988876422 222222222111 111
Q ss_pred cccc-----------cccccccCCCCCh--hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 287 FKEI-----------VDPIIVGEEGLWP--EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 287 ~~~~-----------~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+++ +.++. ...|. .....+++..+|+.++|+++|.+|.++.+++.
T Consensus 247 ~e~I~~mn~~y~~~~~p~ik---~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 247 REDIKSMNPNYTEFKFPQIK---AHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHHHhhcCcccccccCcccc---cccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1111 11111 11111 11245567899999999999999999998764
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=306.83 Aligned_cols=263 Identities=22% Similarity=0.276 Sum_probs=201.8
Q ss_pred CCCCCCccccCCCceEEEEEE------CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeC--CccE
Q 048160 56 NYDPEKVITKDLLYKLYKGFL------QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLET--ELPI 126 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~------~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~ 126 (344)
.|...+.||+|+||.||.+++ .+..||+|.+..... .....+.+|+.++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467889999999999999985 467799999875533 2335688999999999999999999998775 5688
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
+||||+++++|.+++.... ..+++.++..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.
T Consensus 85 lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccc
Confidence 9999999999999986543 25889999999999999999999 9999999999999999999999999999988
Q ss_pred ccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccC-------cchhHHHHHHH
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFEN-------GEEYFLQELVR 279 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~ 279 (344)
................++..|+|||++.+..++.++||||||+++|+|+++..|+....... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 76543322111123456778999999988889999999999999999999887654321100 00000000000
Q ss_pred HHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 280 KSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
..... . ..+.....+..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 238 -~~~~~------------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 -VLEEG------------K--RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -HHHcC------------c--cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000 0 0111113456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=307.38 Aligned_cols=250 Identities=20% Similarity=0.274 Sum_probs=197.7
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc---hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS---EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
+|+..+.||+|+||+||++.. +++.||+|++...... ....+.+|+.++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 477889999999999999998 6789999998654221 22346789999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|+++|+|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMGN---PGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 9999999988754322 35889999999999999999999 99999999999999999999999999999876543
Q ss_pred CCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEI 290 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (344)
.... ....|+..|+|||++.+..++.++||||||+++|++++|..||...... ...+.+........
T Consensus 155 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~---- 221 (285)
T cd05605 155 GETI----RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-----VKREEVERRVKEDQ---- 221 (285)
T ss_pred CCcc----ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-----hHHHHHHHHhhhcc----
Confidence 2211 1346889999999998888999999999999999999999998653211 11111111111000
Q ss_pred cccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048160 291 VDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-----TMVQVAK 335 (344)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ei~~ 335 (344)
...+ ...+..+.+|+.+||+.||++|| ++.++++
T Consensus 222 ---------~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 ---------EEYS--EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ---------cccC--cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 0001 13345688999999999999999 8888854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=313.18 Aligned_cols=244 Identities=18% Similarity=0.235 Sum_probs=189.7
Q ss_pred CccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 61 KVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
+.||+|+||.||+|+. +++.||+|.+..... .....+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999998 667899999876422 2334567888888777 799999999999999999999999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
|+|..++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~- 151 (329)
T cd05618 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD- 151 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-
Confidence 99998886543 5889999999999999999999 99999999999999999999999999999875432211
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPI 294 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (344)
......||..|+|||++.+..++.++||||||+++|+|++|..||................+........
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-------- 221 (329)
T cd05618 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------- 221 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--------
Confidence 1124578999999999999999999999999999999999999996322211111111111111111111
Q ss_pred cccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCH
Q 048160 295 IVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM 330 (344)
Q Consensus 295 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 330 (344)
...|. ..+..+.+++.+||+.||++||++
T Consensus 222 -----~~~p~--~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 222 -----IRIPR--SLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -----CCCCC--CCCHHHHHHHHHHhcCCHHHcCCC
Confidence 00111 234457899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=306.34 Aligned_cols=259 Identities=18% Similarity=0.300 Sum_probs=199.8
Q ss_pred HhcCCCCCCccccCCCceEEEEEEC-------CccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCc
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFLQ-------DRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETEL 124 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~~-------~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~ 124 (344)
..++|+..+.||+|+||.||+|.+. +..||+|++..... .....+.+|+.+++.++||||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999999863 35699998764422 234567899999999999999999999999999
Q ss_pred cEEEEeecCCCCccccccCCCCC-----CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceE
Q 048160 125 PILVFEFVACGTLADRIHDPNGS-----QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKF 199 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 199 (344)
.++||||+++++|.+++...... ....+++.++..++.|++.||.||| +.+++|+||||+||+++.++.+++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence 99999999999999988653211 0124677888999999999999999 999999999999999999999999
Q ss_pred eeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHH
Q 048160 200 FDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELV 278 (344)
Q Consensus 200 ~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~ 278 (344)
+|||++.......... ......++..|+|||++.+..++.++||||||+++|||++ |..||.... .......+
T Consensus 161 ~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-----~~~~~~~~ 234 (277)
T cd05062 161 GDFGMTRDIYETDYYR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-----NEQVLRFV 234 (277)
T ss_pred CCCCCccccCCcceee-cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH
Confidence 9999987654332211 1112345778999999988889999999999999999999 566764321 11111111
Q ss_pred HHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048160 279 RKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338 (344)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~ 338 (344)
. ...... .+ ...+..+.+++.+||+.||++|||+.++++.|+
T Consensus 235 ---~-~~~~~~------------~~--~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 235 ---M-EGGLLD------------KP--DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ---H-cCCcCC------------CC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0 111000 01 123456899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=299.97 Aligned_cols=247 Identities=22% Similarity=0.318 Sum_probs=193.8
Q ss_pred CccccCCCceEEEEEE--CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCCc
Q 048160 61 KVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTL 137 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL 137 (344)
+.||+|+||.||+|.. +++.||+|.+...... ....+.+|+.++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3699999999999998 6788999987654332 345688999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCccccc
Q 048160 138 ADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217 (344)
Q Consensus 138 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~ 217 (344)
.+++.... ..+++.++..++.|++.||.||| +.+++||||||+||+++.++.++++|||++......... ..
T Consensus 81 ~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~ 152 (252)
T cd05084 81 LTFLRTEG----PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA-ST 152 (252)
T ss_pred HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCccccccccc-cc
Confidence 99986543 25789999999999999999999 999999999999999999999999999998754422111 11
Q ss_pred CCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccc
Q 048160 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIV 296 (344)
Q Consensus 218 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (344)
......+..|+|||.+.+..++.++||||||+++|++++ |..||..... ......+. ...
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-----~~~~~~~~----~~~---------- 213 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-----QQTREAIE----QGV---------- 213 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-----HHHHHHHH----cCC----------
Confidence 111223457999999988889999999999999999998 7777643211 11111111 000
Q ss_pred cCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048160 297 GEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338 (344)
Q Consensus 297 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~ 338 (344)
....+ ...+..+.+++.+||+.+|++|||+.+|++.|.
T Consensus 214 --~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 214 --RLPCP--ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred --CCCCc--ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 00001 133456899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=302.38 Aligned_cols=257 Identities=20% Similarity=0.282 Sum_probs=195.3
Q ss_pred CCCCCccccCCCceEEEEEECC--c--cEEEEEecCCC--CchhhhHhhHHHHHhcCCCCceeeeeeEEeeC------Cc
Q 048160 57 YDPEKVITKDLLYKLYKGFLQD--R--PISVMKFGGNL--NSEEYCCFNCIAFASQMSHKNILKFVGCCLET------EL 124 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~~~--~--~vavk~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~------~~ 124 (344)
|.+.+.||+|+||.||+|.+.+ . .||+|.++... ....+.+.+|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3456889999999999999832 2 58999876542 23346688999999999999999999987542 25
Q ss_pred cEEEEeecCCCCccccccCCC-CCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeee
Q 048160 125 PILVFEFVACGTLADRIHDPN-GSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFC 203 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg 203 (344)
.++++||+++|+|.+++.... +.....+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998763211 111235889999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
+++......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||..... ..+.+.+
T Consensus 158 ~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~~~~~---- 227 (272)
T cd05075 158 LSKKIYNGDYYR-QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-----SEIYDYL---- 227 (272)
T ss_pred cccccCccccee-cCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHH----
Confidence 998765432211 1112345678999999988889999999999999999999 6777643211 1111111
Q ss_pred ccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 283 ESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
...... +.....+..+.+++.+||+.||++|||+.+|++.|+++
T Consensus 228 ~~~~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 228 RQGNRL--------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HcCCCC--------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111100 00013345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=305.53 Aligned_cols=260 Identities=22% Similarity=0.304 Sum_probs=202.4
Q ss_pred CCCCCCccccCCCceEEEEEECC-------ccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 56 NYDPEKVITKDLLYKLYKGFLQD-------RPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~~~-------~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
+|...+.||+|+||.||+|.... ..+++|.+..... .....+.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47778999999999999998722 4588887765533 234568899999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCC-------------------CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccc
Q 048160 128 VFEFVACGTLADRIHDPNG-------------------SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPST 188 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N 188 (344)
|+||+.+++|.+++..... ....++++.+++.++.|++.||.||| +.+++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 9999999999998754211 11135788999999999999999999 9999999999999
Q ss_pred eEeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCcc
Q 048160 189 ILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFE 267 (344)
Q Consensus 189 ill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~ 267 (344)
|+++.++.++|+|||+++.......... .....++..|+|||.+.+..++.++||||||+++++|++ |..||....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-- 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVK-RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA-- 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhc-ccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC--
Confidence 9999999999999999876543222111 112345678999999988889999999999999999998 888875321
Q ss_pred CcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 268 NGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
...+.+... ... .++.....+.++.+++..||+.+|++||++.+|++.|+++..
T Consensus 235 ---~~~~~~~~~----~~~--------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 235 ---PERLFNLLK----TGY--------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ---HHHHHHHHh----CCC--------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 111111111 100 000111334568999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=303.14 Aligned_cols=256 Identities=20% Similarity=0.320 Sum_probs=202.2
Q ss_pred cCCCCCCccccCCCceEEEEEE--CC---ccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QD---RPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~---~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
++|...+.||+|+||.||+|.+ .+ ..+|+|.+..... ...+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 4688889999999999999987 22 3689998865432 2345688999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||+++++|.+++.... ..+++.++..++.|++.||.||| +.+++||||||+||+++.++.++++|||++...
T Consensus 84 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 84 TEYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 99999999999997654 25788999999999999999999 999999999999999999999999999998876
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
..............++..|+|||++.+..++.++|+||||+++|++++ |..||..... ......+. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-----~~~~~~~~---~~~~- 227 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-----QDVIKAIE---EGYR- 227 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH-----HHHHHHHh---CCCc-
Confidence 543222111112233567999999988889999999999999999886 8888854321 11111111 0000
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
.+.....+..+.+++.+||+.+|++||++.+|++.|.++
T Consensus 228 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 --------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 011113345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=307.22 Aligned_cols=245 Identities=21% Similarity=0.278 Sum_probs=204.9
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchh---hhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEE---YCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~---~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
...|.+.+.||+|+||.|-++.. .|+.||||.+.++.-.+. --+.+|+++|+.|+||||+++|.+|+..+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 34578889999999999999987 789999999877633332 3356999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||..+|.|++++...+ .|++.++..+++||++|+.|+| .++++|||||.+|||+|.++++||+|||++..+
T Consensus 132 MEYaS~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEecCCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhh
Confidence 99999999999998875 6999999999999999999999 999999999999999999999999999999877
Q ss_pred CCCCcccccCCccccccccccccccCcCCCC-cccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCN-EKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
....... +++|++.|++||.+.+.+|. +.+|-||||+++|-|..|..||++...
T Consensus 204 ~~~kfLq----TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--------------------- 258 (668)
T KOG0611|consen 204 ADKKFLQ----TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--------------------- 258 (668)
T ss_pred ccccHHH----HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---------------------
Confidence 6544332 67899999999999999985 789999999999999999999976421
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..++.++..|.+.. | ..+.+..-||..||-.||++|.|+.+|..
T Consensus 259 k~lvrQIs~GaYrE-P---~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 259 KRLVRQISRGAYRE-P---ETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred HHHHHHhhcccccC-C---CCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 11111222222111 1 22334568999999999999999999875
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=300.77 Aligned_cols=249 Identities=20% Similarity=0.269 Sum_probs=197.2
Q ss_pred CCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 56 NYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
+|+..+.||+|+||.||+|.+ .+..+|+|.+..... ..+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 477789999999999999998 556799998765432 345678899999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
++|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++++|||+++........
T Consensus 84 ~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 84 GCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999987544 25789999999999999999999 999999999999999999999999999998765432211
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDP 293 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (344)
.. ....++..|+|||.+.+..++.++||||||+++|++++ |..||..... . .....+.. ..
T Consensus 157 ~~--~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~-~~~~~~~~---~~-------- 218 (256)
T cd05059 157 SS--QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN----S-EVVESVSA---GY-------- 218 (256)
T ss_pred cc--CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH----H-HHHHHHHc---CC--------
Confidence 11 11123457999999988889999999999999999999 7777754311 1 11111100 00
Q ss_pred ccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048160 294 IIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337 (344)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L 337 (344)
....+. ..+..+.+++.+||+.+|++|||+.+|++.|
T Consensus 219 -----~~~~~~--~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 219 -----RLYRPK--LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -----cCCCCC--CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 000011 2445689999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=321.80 Aligned_cols=252 Identities=15% Similarity=0.161 Sum_probs=195.3
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
.|...+.||+|+||+||+|+. ++..||+|++.... ......+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999998 67789999986542 2234567899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|+++|+|.+++.... .+++..+..++.|++.||.||| ..+|+||||||+|||++.++.++|+|||++.....
T Consensus 82 ~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 82 YIPGGDMMSLLIRME-----VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 999999999987643 5888889999999999999999 99999999999999999999999999999754311
Q ss_pred CCcc--------------------------------------------cccCCccccccccccccccCcCCCCcccchHH
Q 048160 211 GKTH--------------------------------------------VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYS 246 (344)
Q Consensus 211 ~~~~--------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~s 246 (344)
.... ........||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 0000 00011346899999999998888999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHH--ccccCC
Q 048160 247 FGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIK--CLSKSE 324 (344)
Q Consensus 247 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP 324 (344)
|||++|||++|..||..... ........ .... ....|.....+.++.+|+.+ |+..+|
T Consensus 234 lG~il~elltG~~Pf~~~~~----~~~~~~i~----~~~~------------~~~~~~~~~~s~~~~dli~~ll~~~~~~ 293 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTP----TETQLKVI----NWEN------------TLHIPPQVKLSPEAVDLITKLCCSAEER 293 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCH----HHHHHHHH----cccc------------ccCCCCCCCCCHHHHHHHHHHccCcccc
Confidence 99999999999999975321 11111110 0000 00011111234557888887 666677
Q ss_pred CCCCCHHHHHH
Q 048160 325 QDRPTMVQVAK 335 (344)
Q Consensus 325 ~~RPs~~ei~~ 335 (344)
..||++.+|+.
T Consensus 294 ~~R~~~~~~l~ 304 (381)
T cd05626 294 LGRNGADDIKA 304 (381)
T ss_pred cCCCCHHHHhc
Confidence 77999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=309.40 Aligned_cols=258 Identities=20% Similarity=0.270 Sum_probs=199.3
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCc--cEEEEEecCCCC-chhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDR--PISVMKFGGNLN-SEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~--~vavk~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv 128 (344)
++|+..+.||+|+||.||+|.+ ++. .+++|.+..... .....+.+|+.++.++ +|+||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 5688889999999999999998 333 457777664332 2345678999999999 899999999999999999999
Q ss_pred EeecCCCCccccccCCCC-----------CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcc
Q 048160 129 FEFVACGTLADRIHDPNG-----------SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA 197 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 197 (344)
|||+++++|.+++..... .....+++.+++.++.|++.||+||| +.+++||||||+||+++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcE
Confidence 999999999999864321 01125788999999999999999999 9999999999999999999999
Q ss_pred eEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHH
Q 048160 198 KFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQE 276 (344)
Q Consensus 198 kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~ 276 (344)
+|+|||++........ .....++..|+|||++.+..++.++||||||+++|+|+| |..||..... .....
T Consensus 164 kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~ 234 (303)
T cd05088 164 KIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYE 234 (303)
T ss_pred EeCccccCcccchhhh----cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-----HHHHH
Confidence 9999999864321111 112234567999999988889999999999999999998 8888854321 11111
Q ss_pred HHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 277 LVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.. .... . ++.....+..+.+|+.+||+.+|++||++.++++.|..+.+
T Consensus 235 ---~~-~~~~------------~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 235 ---KL-PQGY------------R--LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred ---HH-hcCC------------c--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11 0000 0 00001234468899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=300.41 Aligned_cols=251 Identities=22% Similarity=0.309 Sum_probs=204.8
Q ss_pred hcCCCCCCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
.++|...+.||+|+||.||+|...++.||+|.+..... ..+.+.+|+.++++++|+||+++++++...+..++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 35688889999999999999999999999999876654 45678899999999999999999999998999999999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||.+........
T Consensus 84 ~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 84 KGSLVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred CCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 9999999875432 25889999999999999999999 99999999999999999999999999999876632221
Q ss_pred ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
....+..|+|||++....++.++||||||++++++++ |..||.... ...+...+.. .....
T Consensus 158 ------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~~~~----~~~~~--- 219 (256)
T cd05039 158 ------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPHVEK----GYRME--- 219 (256)
T ss_pred ------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHhc----CCCCC---
Confidence 2234567999999988889999999999999999997 888875431 1111111110 00000
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
.+ ...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 220 ---------~~--~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 ---------AP--EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ---------Cc--cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 00 12345689999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=322.66 Aligned_cols=252 Identities=16% Similarity=0.248 Sum_probs=198.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
..++|...+.||+|+||.||+++. ++..||+|++.... ......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 346799999999999999999998 67889999986431 1223446789999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
||||+++|+|.+++... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 121 v~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 99999999999998653 4788889999999999999999 99999999999999999999999999999876
Q ss_pred cCCCCcccccCCccccccccccccccCcC----CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhc
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTA----NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE 283 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (344)
....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||..... ...+... ..
T Consensus 192 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~~~~i----~~ 261 (370)
T cd05596 192 MDANGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGTYSKI----MD 261 (370)
T ss_pred ccCCCcc--cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH----HHHHHHH----Hc
Confidence 5432221 11245789999999998653 378999999999999999999999975321 1111111 11
Q ss_pred cCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 048160 284 SNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQD--RPTMVQVAK 335 (344)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ei~~ 335 (344)
.. ....+|.....+..+.+|+..||+.+|++ |||+.++++
T Consensus 262 ~~------------~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 262 HK------------NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CC------------CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 00 00111111133456889999999999988 999999865
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=305.38 Aligned_cols=246 Identities=16% Similarity=0.224 Sum_probs=191.8
Q ss_pred cccCCCceEEEEEE--CCccEEEEEecCCCCc---hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCCc
Q 048160 63 ITKDLLYKLYKGFL--QDRPISVMKFGGNLNS---EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTL 137 (344)
Q Consensus 63 ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL 137 (344)
||+|+||+||++.. +++.||+|++...... ..+.+..|+.++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999998 6788999998654221 234567899999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCccccc
Q 048160 138 ADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217 (344)
Q Consensus 138 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~ 217 (344)
.+++...... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--- 153 (280)
T cd05608 81 RYHIYNVDEE-NPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--- 153 (280)
T ss_pred HHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc---
Confidence 8876432111 135889999999999999999999 999999999999999999999999999998765433221
Q ss_pred CCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccccccc
Q 048160 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVG 297 (344)
Q Consensus 218 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (344)
.....|++.|+|||++.+..++.++||||||+++|+|++|..||........ ......... ..
T Consensus 154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~----~~~~~~~~~-~~------------ 216 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----NKELKQRIL-ND------------ 216 (280)
T ss_pred ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh----HHHHHHhhc-cc------------
Confidence 1134688999999999999999999999999999999999999865322111 111111100 00
Q ss_pred CCCCChhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048160 298 EEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-----TMVQVAK 335 (344)
Q Consensus 298 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ei~~ 335 (344)
. ...+ ...+..+.+++.+||+.||++|| +++++++
T Consensus 217 ~-~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 217 S-VTYP--DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred C-CCCc--ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 0 0001 13445688999999999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=302.30 Aligned_cols=260 Identities=22% Similarity=0.346 Sum_probs=205.7
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|+..+.||+|+||.||+|.. +++.+|||.+..... .....+.+|+.+++.++||||+++++++..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999997 788999998764322 23356789999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++++|.+++...... ...+++.++..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQ-KRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 999999999988632211 135889999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
...... ....++..|+|||++.+..++.++|+||||+++|+|++|..||..... + ..........
T Consensus 158 ~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~----~~~~~~~~~~------ 222 (267)
T cd08229 158 SKTTAA---HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--N----LYSLCKKIEQ------ 222 (267)
T ss_pred cCCccc---ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc--h----HHHHhhhhhc------
Confidence 332211 134578899999999888899999999999999999999999864321 0 1111110000
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLH 341 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~ 341 (344)
...+..+. ...+..+.+++.+||+.||++|||+.+|++.++++.
T Consensus 223 -------~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 223 -------CDYPPLPS-DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -------CCCCCCCc-ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00010111 135567899999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=300.41 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=199.5
Q ss_pred cCCCCCCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEe-eCCccEEEEeecC
Q 048160 55 NNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCL-ETELPILVFEFVA 133 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~-~~~~~~lv~e~~~ 133 (344)
++|...+.||+|+||.||++...+..||+|.+.... ..+.+.+|+.++++++|+|++++++++. .++..++|+||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 458888999999999999999999999999986543 3456889999999999999999999865 4567899999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+++|.+++..... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++++|||++........
T Consensus 84 ~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 157 (256)
T cd05082 84 KGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 157 (256)
T ss_pred CCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccCC
Confidence 9999999876442 24788999999999999999999 99999999999999999999999999999875433221
Q ss_pred ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
...++..|+|||++.+..++.++||||||+++|+|++ |+.||.... +....... ....
T Consensus 158 ------~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~~-~~~~------ 216 (256)
T cd05082 158 ------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRV-EKGY------ 216 (256)
T ss_pred ------CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHH-hcCC------
Confidence 2234568999999988889999999999999999997 888775321 11111111 1100
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
....+ +.++..+.+++.+||+.+|++|||+.++++.|.++
T Consensus 217 ------~~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 217 ------KMDAP--DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ------CCCCC--CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00000 13445689999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=314.62 Aligned_cols=250 Identities=19% Similarity=0.209 Sum_probs=194.5
Q ss_pred CCCCCCccccCCCceEEEEEE-----CCccEEEEEecCCC----CchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCcc
Q 048160 56 NYDPEKVITKDLLYKLYKGFL-----QDRPISVMKFGGNL----NSEEYCCFNCIAFASQM-SHKNILKFVGCCLETELP 125 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~-----~~~~vavk~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~ 125 (344)
+|+..+.||+|+||.||+++. .++.||+|.+.... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999886 46789999986431 12234567899999999 489999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
++||||+++|+|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 99999999999999987643 5889999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES 284 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (344)
+......... .....||+.|+|||++.+. .++.++|||||||++|||++|..||.......... .........
T Consensus 153 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~----~~~~~~~~~ 226 (332)
T cd05614 153 KEFLSEEKER--TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS----EVSRRILKC 226 (332)
T ss_pred ccccccCCCc--cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH----HHHHHHhcC
Confidence 7654322211 1135689999999998765 47889999999999999999999986432211111 111111100
Q ss_pred CCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048160 285 NSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-----TMVQVAK 335 (344)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ei~~ 335 (344)
. +..+. ..+..+.+++.+||+.||++|| ++.++++
T Consensus 227 -------------~-~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 -------------D-PPFPS--FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -------------C-CCCCC--CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 0 00111 2344578999999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=299.68 Aligned_cols=249 Identities=20% Similarity=0.306 Sum_probs=195.7
Q ss_pred CccccCCCceEEEEEE--CC---ccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 61 KVITKDLLYKLYKGFL--QD---RPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~--~~---~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
+.||+|+||.||+|.+ .+ ..+|+|.+...... ..+.+.+|+.+++++.|+||+++++++. ++..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 4699999999999988 22 57999998766442 3466889999999999999999999876 5567999999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
|+|.+++.... .+++..+..++.|++.||.||| ..+++|+||||+||+++.++.++|+|||+++........
T Consensus 80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 80 GPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 99999997653 5889999999999999999999 999999999999999999999999999998866443322
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDP 293 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (344)
........++..|+|||.+.+..++.++||||||+++|++++ |..||.... .......+.. ...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~-----~~~~~~~~~~----~~~------ 216 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-----GAEVIAMLES----GER------ 216 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC-----HHHHHHHHHc----CCc------
Confidence 111111223467999999988889999999999999999998 888775321 1111121111 100
Q ss_pred ccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 048160 294 IIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLH 341 (344)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~ 341 (344)
. +....++..+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus 217 ------~--~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 217 ------L--PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ------C--CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0 011133456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=322.26 Aligned_cols=252 Identities=15% Similarity=0.200 Sum_probs=197.5
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|+..+.||+|+||+||+|+. +++.||||++.... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4688899999999999999999 67889999986532 122345678999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++|+|.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++....
T Consensus 81 E~~~~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 9999999999987643 5899999999999999999999 9999999999999999999999999999987653
Q ss_pred CCCcccc-----------------------------------cCCccccccccccccccCcCCCCcccchHHHHHHHHHH
Q 048160 210 EGKTHVN-----------------------------------DNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLEL 254 (344)
Q Consensus 210 ~~~~~~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el 254 (344)
....... ......||+.|+|||++....++.++|||||||++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 2211000 00123689999999999988999999999999999999
Q ss_pred HcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCC---HH
Q 048160 255 LTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT---MV 331 (344)
Q Consensus 255 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~ 331 (344)
++|..||..... ...... ...... ....|.....+..+.+++.+|+. +|.+|++ +.
T Consensus 233 ~~G~~Pf~~~~~----~~~~~~----i~~~~~------------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~ 291 (364)
T cd05599 233 LVGYPPFCSDNP----QETYRK----IINWKE------------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVN 291 (364)
T ss_pred hcCCCCCCCCCH----HHHHHH----HHcCCC------------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence 999999965321 111111 110000 00001111234467899999996 9999998 88
Q ss_pred HHHH
Q 048160 332 QVAK 335 (344)
Q Consensus 332 ei~~ 335 (344)
++++
T Consensus 292 ~ll~ 295 (364)
T cd05599 292 EIKS 295 (364)
T ss_pred HHhc
Confidence 8765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=317.11 Aligned_cols=266 Identities=18% Similarity=0.283 Sum_probs=205.0
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEECC-------ccEEEEEecCCCCch-hhhHhhHHHHHhcCC-CCceeeeeeEEe
Q 048160 50 LKAATNNYDPEKVITKDLLYKLYKGFLQD-------RPISVMKFGGNLNSE-EYCCFNCIAFASQMS-HKNILKFVGCCL 120 (344)
Q Consensus 50 i~~~~~~~~~~~~ig~G~~g~V~~~~~~~-------~~vavk~~~~~~~~~-~~~~~~E~~~l~~l~-H~niv~~~~~~~ 120 (344)
+....++|...+.||+|+||.||+|++.+ ..||+|++....... .+.+.+|+.++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 34444568888999999999999999732 579999997653332 346889999999997 999999999999
Q ss_pred eCCccEEEEeecCCCCccccccCCCC------------------------------------------------------
Q 048160 121 ETELPILVFEFVACGTLADRIHDPNG------------------------------------------------------ 146 (344)
Q Consensus 121 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 146 (344)
.....++||||+++|+|.+++.....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999998864321
Q ss_pred ---------------------------------------CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccccc
Q 048160 147 ---------------------------------------SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPS 187 (344)
Q Consensus 147 ---------------------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~ 187 (344)
.....+++..++.++.|++.||.||| +.+|+||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcc
Confidence 01124677788899999999999999 999999999999
Q ss_pred ceEeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCc
Q 048160 188 TILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCF 266 (344)
Q Consensus 188 Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~ 266 (344)
|||++.++.++++|||+++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYI-SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccc-cCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 9999999999999999987653322111 1112356788999999988889999999999999999998 7777753211
Q ss_pred cCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 048160 267 ENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLH 341 (344)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~ 341 (344)
.......+. ... ....| ...+..+.+|+.+||..+|++||++.+|++.|+++.
T Consensus 348 ----~~~~~~~~~----~~~------------~~~~p--~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 ----NEQFYNAIK----RGY------------RMAKP--AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ----hHHHHHHHH----cCC------------CCCCC--CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111111111 100 00001 123456899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=312.02 Aligned_cols=243 Identities=19% Similarity=0.235 Sum_probs=190.4
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHH---hcCCCCceeeeeeEEeeCCccEEE
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFA---SQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l---~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
|+..+.||+|+||.||+|.+ +++.||+|.+.... ....+.+.+|..++ +.++||||+++++++..+...|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 55678999999999999998 67889999987542 12234456666554 567899999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||+++++|..++... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 81 ~E~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 9999999998887642 5889999999999999999999 999999999999999999999999999998654
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
..... ......|++.|+|||.+.+..++.++|||||||++|+|++|..||..... ........ .. .
T Consensus 152 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~----~~~~~~i~----~~-~-- 217 (324)
T cd05589 152 MGFGD---RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE----EEVFDSIV----ND-E-- 217 (324)
T ss_pred CCCCC---cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH----HHHHHHHH----hC-C--
Confidence 32221 11245789999999999988999999999999999999999999864321 11111111 00 0
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT-----MVQVAK 335 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ei~~ 335 (344)
...|. ..+..+.+++.+||+.||.+||+ +.++++
T Consensus 218 -----------~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 -----------VRYPR--FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -----------CCCCC--CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 00111 23456789999999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=308.10 Aligned_cols=264 Identities=20% Similarity=0.283 Sum_probs=204.3
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEECC-------ccEEEEEecCCCC-chhhhHhhHHHHHhcC-CCCceeeeeeEEee
Q 048160 51 KAATNNYDPEKVITKDLLYKLYKGFLQD-------RPISVMKFGGNLN-SEEYCCFNCIAFASQM-SHKNILKFVGCCLE 121 (344)
Q Consensus 51 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~-------~~vavk~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~ 121 (344)
....++|+..+.||+|+||.||++.+.+ ..+|+|.+..... .....+.+|+.++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 3445668888999999999999999732 5689998875432 2335577999999999 79999999999999
Q ss_pred CCccEEEEeecCCCCccccccCCCC-----------CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceE
Q 048160 122 TELPILVFEFVACGTLADRIHDPNG-----------SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTIL 190 (344)
Q Consensus 122 ~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil 190 (344)
+...+++|||+++|+|.+++..... .....+++..++.++.|++.||.||| +.+|+||||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEE
Confidence 9999999999999999999864310 11236889999999999999999999 999999999999999
Q ss_pred eecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCc
Q 048160 191 FQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENG 269 (344)
Q Consensus 191 l~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~ 269 (344)
++.++.++|+|||+++......... ......++..|+|||++.+..++.++|||||||++||+++ |..||.....
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--- 240 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYR-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--- 240 (293)
T ss_pred EcCCCeEEeCcccccccccccccee-ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH---
Confidence 9999999999999998765432211 1112234567999999988889999999999999999997 7777753211
Q ss_pred chhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 048160 270 EEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLH 341 (344)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~ 341 (344)
........ ... .. +....++..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 241 --~~~~~~~~---~~~-------------~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 --EELFKLLK---EGY-------------RM--EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --HHHHHHHH---cCC-------------cC--CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111110 000 00 001133456889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=323.15 Aligned_cols=242 Identities=23% Similarity=0.333 Sum_probs=200.3
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
|....-||.|+||.||-++. +...||||+++..-. .....+.+|+.+|.+++|||+|.+-|++..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 66778899999999999998 778899999875433 3346678999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
|- ||-.+++.... .++.+-++..|..+.+.||.||| +.+.||||||+.|||+...|.+||+|||.|.....
T Consensus 108 Cl-GSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 108 CL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred Hh-ccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 96 78888887655 47889999999999999999999 99999999999999999999999999999876533
Q ss_pred CcccccCCccccccccccccccC---cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMS---TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
.+.++||+.|||||++. .+.|+-++||||||++..||..+++|.+... .-..++.+..+
T Consensus 179 ------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN----AMSALYHIAQN-------- 240 (948)
T KOG0577|consen 179 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSALYHIAQN-------- 240 (948)
T ss_pred ------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch----HHHHHHHHHhc--------
Confidence 33689999999999875 4789999999999999999999999987531 11111111110
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+.+..+. ...+..+..|+..||+.-|++|||..++++
T Consensus 241 ---------esPtLqs-~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 241 ---------ESPTLQS-NEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred ---------CCCCCCC-chhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1111111 156667999999999999999999998764
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=299.50 Aligned_cols=252 Identities=21% Similarity=0.304 Sum_probs=198.5
Q ss_pred cCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
++|+..+.||+|+||.||+|.. .+..||+|.+..... ..+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 4578889999999999999998 566799998876543 3456889999999999999999999875 456789999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+++|.+++..... ..+++.++..++.+++.||.||| +.+++|+||||+||+++.++.++++|||++........
T Consensus 84 ~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 84 KGSLLDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999865332 35789999999999999999999 99999999999999999999999999999976643322
Q ss_pred ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
... ....++..|+|||++.+..++.++||||||+++|++++ |..||.... .......+. . .
T Consensus 158 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-----~~~~~~~~~---~-~------- 219 (260)
T cd05070 158 TAR--QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-----NREVLEQVE---R-G------- 219 (260)
T ss_pred ccc--cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHH---c-C-------
Confidence 111 12234668999999988889999999999999999999 777775321 111111111 0 0
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQ 339 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~ 339 (344)
... +.....+..+.+|+.+||+.+|++|||+.++.+.|+.
T Consensus 220 -----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 -----YRM--PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -----CCC--CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 000 0111344568999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=330.92 Aligned_cols=259 Identities=21% Similarity=0.270 Sum_probs=207.9
Q ss_pred hcCCCCCCccccCCCceEEEEEE-CC-ccEEEEEecCCCCchhhhHhhHHHHHhcCC-CCceeeeeeEE-ee------CC
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL-QD-RPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCC-LE------TE 123 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~-~~-~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~-~~------~~ 123 (344)
..+.++.+.|.+|||+.||.|.. .+ ..||+|++........+.+.+|+++|++|+ |+|||.+++.. .. .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34567788999999999999999 44 899999988877777888999999999997 99999999942 21 13
Q ss_pred ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeee
Q 048160 124 LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFC 203 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg 203 (344)
..+|.||||.||+|-+++..+.. ..|++.++++|+.|++.|+.+||.. ..+|||||||.+||||+.++..||||||
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence 57899999999999999976543 2499999999999999999999943 5569999999999999999999999999
Q ss_pred cccccCCCCcccc------cCCcccccccccccccc---CcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHH
Q 048160 204 VSISIPEGKTHVN------DNNKVIGTFGFIAPEYM---STANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFL 274 (344)
Q Consensus 204 ~a~~~~~~~~~~~------~~~~~~g~~~y~aPE~~---~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 274 (344)
.+...-....... ..-....|+-|+|||.+ .+.+.++|+|||||||+||.|+....||.....
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------- 263 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------- 263 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--------
Confidence 9875433221100 00012458999999975 567899999999999999999999999964311
Q ss_pred HHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 275 QELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
. +++.+.+ ..|..+..+..|.+||..||+.||.+||++-+|+..+-++..
T Consensus 264 -------------l----aIlng~Y-~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 264 -------------L----AILNGNY-SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred -------------e----eEEeccc-cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 1 1222222 233334677789999999999999999999999999888753
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=306.51 Aligned_cols=258 Identities=19% Similarity=0.269 Sum_probs=199.2
Q ss_pred cCCCCCCccccCCCceEEEEEE--CC--ccEEEEEecCCC-CchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QD--RPISVMKFGGNL-NSEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~--~~vavk~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv 128 (344)
++|+..+.||+|+||.||+|.. ++ ..+++|.++... ....+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 4688889999999999999988 22 246888876432 22345688999999999 799999999999999999999
Q ss_pred EeecCCCCccccccCCCCC-----------CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcc
Q 048160 129 FEFVACGTLADRIHDPNGS-----------QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA 197 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 197 (344)
+||+++++|.+++...... ....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 9999999999998653210 1125788999999999999999999 9999999999999999999999
Q ss_pred eEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHH
Q 048160 198 KFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQE 276 (344)
Q Consensus 198 kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~ 276 (344)
||+|||++........ ......+..|+|||++....++.++||||||+++|||++ |..||..... . .
T Consensus 159 kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-----~---~ 226 (297)
T cd05089 159 KIADFGLSRGEEVYVK----KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-----A---E 226 (297)
T ss_pred EECCcCCCccccceec----cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----H---H
Confidence 9999999864322111 111223557999999988889999999999999999997 8888854321 1 1
Q ss_pred HHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 277 LVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
....... . .....+ ..++..+.+|+.+||+.+|.+|||+.+|++.|..+.+
T Consensus 227 ~~~~~~~-~------------~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 227 LYEKLPQ-G------------YRMEKP--RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HHHHHhc-C------------CCCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111100 0 000001 1334568899999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=315.10 Aligned_cols=240 Identities=18% Similarity=0.216 Sum_probs=192.5
Q ss_pred CccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCC
Q 048160 61 KVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACG 135 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 135 (344)
+.||+|+||.||++.. ++..||+|.+.... ......+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999998 67889999987542 123345678999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCC-CCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 136 TLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFS-RPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 136 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
+|..++.... .+++.++..++.|++.||.||| + .+|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 152 (325)
T cd05594 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 152 (325)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc
Confidence 9998886543 5889999999999999999999 7 79999999999999999999999999998754322211
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPI 294 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (344)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+. ...
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-----~~~~~~i~----~~~-------- 212 (325)
T cd05594 153 ---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELIL----MEE-------- 212 (325)
T ss_pred ---cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-----HHHHHHHh----cCC--------
Confidence 1134689999999999988999999999999999999999999965321 11111110 000
Q ss_pred cccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048160 295 IVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-----TMVQVAK 335 (344)
Q Consensus 295 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ei~~ 335 (344)
...|. ..+.++.+|+.+||+.||++|+ ++.++++
T Consensus 213 -----~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 213 -----IRFPR--TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred -----CCCCC--CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 00011 2344688999999999999996 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=299.40 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=193.4
Q ss_pred CccccCCCceEEEEEEC-----CccEEEEEecCCC-CchhhhHhhHHHHHhcCCCCceeeeeeEEe-eCCccEEEEeecC
Q 048160 61 KVITKDLLYKLYKGFLQ-----DRPISVMKFGGNL-NSEEYCCFNCIAFASQMSHKNILKFVGCCL-ETELPILVFEFVA 133 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~-----~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~-~~~~~~lv~e~~~ 133 (344)
+.||+|+||.||+|.+. ...||+|++.... ....+.+.+|+.+++.++||||+++++++. .++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999872 2468999875432 233466789999999999999999999876 4556889999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+|+|.+++.... ..+.+..++.++.|++.||.||| ..+++||||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 81 HGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 999999987543 23567778889999999999999 99999999999999999999999999999876543221
Q ss_pred c-cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 214 H-VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 214 ~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
. ........++..|+|||.+.+..++.++||||||+++|||++|..|++.... ...+... ....
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~----~~~~~~~---~~~~-------- 218 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD----SFDITVY---LLQG-------- 218 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHH---HhcC--------
Confidence 1 1111123456789999999888899999999999999999997666543321 1111111 1111
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.....+ ...+..+.+++.+||+.+|++||++.+|++.|+++..
T Consensus 219 -----~~~~~~--~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 219 -----RRLLQP--EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred -----CCCCCC--CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 000001 1234568899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=303.99 Aligned_cols=257 Identities=19% Similarity=0.261 Sum_probs=201.4
Q ss_pred cCCCCCCccccCCCceEEEEEE-------CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL-------QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~-------~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
.+|+....||+|+||.||++.. ++..+|+|.+..........+.+|+.+++.++|+||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 3577789999999999999974 345788898876655556778899999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCCC----------CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcc
Q 048160 128 VFEFVACGTLADRIHDPNGS----------QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA 197 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 197 (344)
||||+++++|.+++...... ....+++.++..++.|++.||.||| +.+++||||||+||+++.++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence 99999999999988654310 0124788999999999999999999 9999999999999999999999
Q ss_pred eEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHH
Q 048160 198 KFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQE 276 (344)
Q Consensus 198 kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~ 276 (344)
+|+|||++......... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||..... ...
T Consensus 162 kL~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~--- 233 (280)
T cd05092 162 KIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN----TEA--- 233 (280)
T ss_pred EECCCCceeEcCCCcee-ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH----HHH---
Confidence 99999998765432211 11112345678999999998899999999999999999998 7887754321 101
Q ss_pred HHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048160 277 LVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338 (344)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~ 338 (344)
........ .. .....++..+.+|+.+||+.||++||++.+|++.|+
T Consensus 234 -~~~~~~~~-------------~~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 234 -IECITQGR-------------EL--ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -HHHHHcCc-------------cC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11110000 00 000133456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=306.10 Aligned_cols=256 Identities=15% Similarity=0.236 Sum_probs=198.4
Q ss_pred CCCCCccccCCCceEEEEEEC-------CccEEEEEecCCCCch-hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 57 YDPEKVITKDLLYKLYKGFLQ-------DRPISVMKFGGNLNSE-EYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~~-------~~~vavk~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
|...+.||+|+||.||+|.+. +..||+|++....... .+.+.+|+.++++++||||+++++++......+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 556688999999999999872 3679999987654332 35577999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCC-----------CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcc
Q 048160 129 FEFVACGTLADRIHDPNG-----------SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA 197 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 197 (344)
+||+.+++|.+++..... .....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCce
Confidence 999999999998742210 00124788889999999999999999 9999999999999999999999
Q ss_pred eEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHH
Q 048160 198 KFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQE 276 (344)
Q Consensus 198 kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~ 276 (344)
||+|||+++........ .......+++.|+|||++.+..++.++||||||+++|||++ |..||..... .+
T Consensus 164 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~ 234 (283)
T cd05091 164 KISDLGLFREVYAADYY-KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--------QD 234 (283)
T ss_pred Eecccccccccccchhe-eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--------HH
Confidence 99999998765433221 11123345778999999988889999999999999999998 6666643211 11
Q ss_pred HHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048160 277 LVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQ 339 (344)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~ 339 (344)
...... ... ....+ ..++..+.+|+.+||+.+|++||++.+|+..|++
T Consensus 235 ~~~~i~-~~~------------~~~~~--~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIR-NRQ------------VLPCP--DDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHH-cCC------------cCCCC--CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111 111 11111 1455668999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=284.78 Aligned_cols=246 Identities=21% Similarity=0.305 Sum_probs=204.5
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|.+.+.||.|.||.||.|+. ++..||+|++.+.. ..-..++.+|+++.+.|+||||.++|+++.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 5699999999999999999999 56789999976542 122456789999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||.++|+|...|..... ..+.+.....++.|+|.||.|+| .++|+||||||+|+|++.++.+|++|||-+...+
T Consensus 102 Eya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999985443 36888889999999999999999 9999999999999999999999999999987765
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
.+. ..+..||.-|.+||...+..++..+|+|++|++.||++.|.+||.+.. ...+.+-+....
T Consensus 176 ~~k-----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-----~~etYkrI~k~~------- 238 (281)
T KOG0580|consen 176 SNK-----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-----HSETYKRIRKVD------- 238 (281)
T ss_pred CCC-----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-----hHHHHHHHHHcc-------
Confidence 322 226789999999999999999999999999999999999999997642 112222221110
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+. .| ...+.+..+++.+|+..+|.+|.+..++++
T Consensus 239 ~~----------~p--~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 239 LK----------FP--STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred cc----------CC--cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 00 11 144456789999999999999999999875
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=299.27 Aligned_cols=252 Identities=21% Similarity=0.280 Sum_probs=200.4
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc-----hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS-----EEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
++|...+.||+|++|.||+|.. .+..||+|.+...... ....+.+|+.++++++||||+++++++..+...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5789999999999999999987 6789999987644221 23457789999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
|+||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 82 v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEECCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 999999999999887643 5788889999999999999999 99999999999999999999999999999876
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
...............++..|+|||++.+..++.++||||||+++|++++|+.||..... ..... ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~----~~~~~~~~ 225 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAIF----KIATQPTN 225 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch----HHHHH----HHhccCCC
Confidence 54322211111234577899999999988899999999999999999999999864311 10111 11111000
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
...+ ...+..+.+++.+||+.+|++|||+.++++.
T Consensus 226 ------------~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 ------------PQLP--SHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ------------CCCC--ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0011 1344568899999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=309.81 Aligned_cols=239 Identities=20% Similarity=0.287 Sum_probs=188.3
Q ss_pred CccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhc-CCCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 61 KVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQ-MSHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
+.||+|+||.||+|+. +++.||+|.++... ....+.+..|..++.. .+||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999998 56789999987542 2233445567666665 4899999999999999999999999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
|+|..++.... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 81 g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~- 151 (316)
T cd05592 81 GDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG- 151 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC-
Confidence 99999887643 5889999999999999999999 99999999999999999999999999999876433221
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPI 294 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (344)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....... ...
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~----~~~~~~i----~~~---------- 211 (316)
T cd05592 152 --KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE----DELFDSI----LND---------- 211 (316)
T ss_pred --ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH----HHHHHHH----HcC----------
Confidence 12245789999999999988899999999999999999999999865321 1111111 100
Q ss_pred cccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 048160 295 IVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMV-QVA 334 (344)
Q Consensus 295 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-ei~ 334 (344)
.+..|. ..+.++.+++.+||+.||++||++. +++
T Consensus 212 ----~~~~~~--~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 212 ----RPHFPR--WISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred ----CCCCCC--CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 000111 2344578999999999999999875 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=303.93 Aligned_cols=246 Identities=20% Similarity=0.331 Sum_probs=211.1
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
|.+..+||+|+||.||++.+ .|..||+|++..+ ++.+++.+|+.+|++...|++|++||.+.....+|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 77788999999999999998 7889999998655 4688899999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
||+.+.++.++ .+|.+.++..++.+.++||+||| ...-+|||||+.|||++.+|..||+|||+|..+....
T Consensus 113 GSiSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-- 183 (502)
T KOG0574|consen 113 GSISDIMRARR----KPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-- 183 (502)
T ss_pred CcHHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhH--
Confidence 99999998776 58999999999999999999999 9999999999999999999999999999998776433
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPI 294 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (344)
...+++.||+.|||||++..-.|+.++||||||++..||..|++|+...- .++.++- +
T Consensus 184 -AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH--------------------PMRAIFM-I 241 (502)
T KOG0574|consen 184 -AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH--------------------PMRAIFM-I 241 (502)
T ss_pred -HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc--------------------ccceeEe-c
Confidence 23447899999999999999999999999999999999999999875421 1111111 1
Q ss_pred cccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 295 IVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 295 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
....++-+..++..+.++.+++..||-..|++|-|+..+++
T Consensus 242 PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 242 PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 11123333344577888999999999999999999988765
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=317.66 Aligned_cols=202 Identities=17% Similarity=0.207 Sum_probs=173.2
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|+..+.||+|+||+||++.. .++.||+|++.... ......+.+|+.++.+++|+||+++++.+.++...++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4688899999999999999998 67889999986542 122345678999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++|+|.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 9999999999997643 5889999999999999999999 9999999999999999999999999999987543
Q ss_pred CCCcc--------------------------------cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcC
Q 048160 210 EGKTH--------------------------------VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257 (344)
Q Consensus 210 ~~~~~--------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 257 (344)
..... ........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 21100 0001134789999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 048160 258 KRISYSS 264 (344)
Q Consensus 258 ~~p~~~~ 264 (344)
..||...
T Consensus 233 ~~Pf~~~ 239 (363)
T cd05628 233 YPPFCSE 239 (363)
T ss_pred CCCCCCC
Confidence 9999653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=311.10 Aligned_cols=240 Identities=20% Similarity=0.247 Sum_probs=191.1
Q ss_pred CccccCCCceEEEEEE-----CCccEEEEEecCCC----CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 61 KVITKDLLYKLYKGFL-----QDRPISVMKFGGNL----NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~-----~~~~vavk~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
+.||+|+||.||+++. .++.||+|.+.... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999986 45789999986431 12234467899999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+++++|.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 99999999987653 5778888999999999999999 999999999999999999999999999998754322
Q ss_pred CcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
... .....|++.|+|||++.+..++.++||||||+++|||++|..||..... .. ....... ..
T Consensus 154 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~----~~----~~~~~~~-~~----- 216 (323)
T cd05584 154 GTV---THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR----KK----TIDKILK-GK----- 216 (323)
T ss_pred CCc---ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH----HH----HHHHHHc-CC-----
Confidence 211 1235689999999999888899999999999999999999999864321 11 1111111 00
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-----TMVQVAK 335 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ei~~ 335 (344)
. ..|. ..+..+.+++.+||+.||++|| ++.++++
T Consensus 217 -------~-~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 217 -------L-NLPP--YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -------C-CCCC--CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 0 0010 2334578999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=320.34 Aligned_cols=252 Identities=19% Similarity=0.235 Sum_probs=201.3
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||+||+|+. +++.||+|++.... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 4688889999999999999999 58899999987542 123456778999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++++|.+++.... .+++..+..++.|++.||.||| ..+|+||||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 81 EYMPGGDLMNLLIRKD-----VFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred cCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 9999999999997653 5889999999999999999999 9999999999999999999999999999987664
Q ss_pred CCCc--------------------------ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCC
Q 048160 210 EGKT--------------------------HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYS 263 (344)
Q Consensus 210 ~~~~--------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 263 (344)
.... .........||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 4320 00112245689999999999999999999999999999999999999975
Q ss_pred CCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 048160 264 SCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT-MVQVAK 335 (344)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~ei~~ 335 (344)
... ...... ..... .....|.....+..+.+|+.+||. ||.+||+ +.++++
T Consensus 233 ~~~----~~~~~~----i~~~~------------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 233 DTL----QETYNK----IINWK------------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred CCH----HHHHHH----HhccC------------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 421 111111 11100 000011111234568899999997 9999999 999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=311.14 Aligned_cols=235 Identities=21% Similarity=0.282 Sum_probs=188.1
Q ss_pred CccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 61 KVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
+.||+|+||.||+|+. +++.||+|.+.... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999998 57789999986542 22345567888888876 699999999999999999999999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.........
T Consensus 81 g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~ 152 (320)
T cd05590 81 GDLMFHIQKSR-----RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT 152 (320)
T ss_pred chHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc
Confidence 99999887653 5889999999999999999999 999999999999999999999999999998754322211
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPI 294 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (344)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||..... . ..... .. ...
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~----~-~~~~~---i~-~~~-------- 212 (320)
T cd05590 153 ---TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE----D-DLFEA---IL-NDE-------- 212 (320)
T ss_pred ---ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----H-HHHHH---Hh-cCC--------
Confidence 1245689999999999988899999999999999999999999864321 1 11111 11 000
Q ss_pred cccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCH
Q 048160 295 IVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM 330 (344)
Q Consensus 295 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 330 (344)
...|. ..+.++.+++.+||+.||++||++
T Consensus 213 -----~~~~~--~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 213 -----VVYPT--WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -----CCCCC--CCCHHHHHHHHHHcccCHHHCCCC
Confidence 00011 234467899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=299.01 Aligned_cols=248 Identities=21% Similarity=0.295 Sum_probs=201.0
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCC--CCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGN--LNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
+|...+.||+|++|.||+|.. ++..|++|.+... .....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477788999999999999998 6788999987643 233456688999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+++++|.+++....+ ..+++.++..++.+++.||.||| +.+++|+||+|+||+++.++.++++|||++......
T Consensus 81 ~~~~~L~~~l~~~~~---~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 999999999876422 35888999999999999999999 999999999999999999999999999998766543
Q ss_pred CcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
.... ....++..|+|||++.+..++.++|+||||+++++|++|..||..... .... .... ..
T Consensus 155 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~----~~~~-~~------ 216 (256)
T cd08529 155 TNFA---NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ----GALI----LKII-RG------ 216 (256)
T ss_pred cchh---hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----HHHH----HHHH-cC------
Confidence 2211 134678899999999988899999999999999999999999864321 1111 1110 00
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+..+. ..+..+.+++.+||+.+|++||++.++++
T Consensus 217 ------~~~~~~~--~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 217 ------VFPPVSQ--MYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred ------CCCCCcc--ccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1111111 33456899999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=305.21 Aligned_cols=248 Identities=19% Similarity=0.293 Sum_probs=201.5
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
.+|...+.||+|+||.||+|.. ++..|++|.+........+.+.+|+.+++.+.|+||+++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4688889999999999999987 67899999987765555677889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++++|.+++... .+++.++..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++.......
T Consensus 100 ~~~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 100 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred CCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999998642 4788899999999999999999 9999999999999999999999999999987654322
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..||..... ....... ....
T Consensus 171 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~----~~~~~~~----~~~~------- 232 (296)
T cd06654 171 SK---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----LRALYLI----ATNG------- 232 (296)
T ss_pred cc---cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH----HHhHHHH----hcCC-------
Confidence 11 1134678899999999888889999999999999999999999864321 0001000 0000
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+..+.....+..+.+++.+||+.||++|||+.+|++
T Consensus 233 ------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 233 ------TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ------CCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 0001111133456889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=310.73 Aligned_cols=240 Identities=18% Similarity=0.269 Sum_probs=190.5
Q ss_pred CccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 61 KVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
+.||+|+||.||+|+. .+..||+|.+.... ....+.+..|..++..+ +||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999998 56789999987542 22334566888888866 799999999999999999999999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
|+|..++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 152 (321)
T cd05591 81 GDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT 152 (321)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc
Confidence 99998886543 5888999999999999999999 999999999999999999999999999998754322211
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPI 294 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (344)
.....|++.|+|||++.+..++.++||||||+++|+|++|..||..... ...... .....
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~----~~~~~~----i~~~~--------- 212 (321)
T cd05591 153 ---TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE----DDLFES----ILHDD--------- 212 (321)
T ss_pred ---ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH----HHHHHH----HHcCC---------
Confidence 1245689999999999888999999999999999999999999964321 111111 11100
Q ss_pred cccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-------CHHHHHH
Q 048160 295 IVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-------TMVQVAK 335 (344)
Q Consensus 295 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-------s~~ei~~ 335 (344)
...|. ..+.++.+++..||+.||++|| ++.++++
T Consensus 213 -----~~~p~--~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 213 -----VLYPV--WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred -----CCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 00111 2335688999999999999999 6777653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=316.92 Aligned_cols=251 Identities=16% Similarity=0.176 Sum_probs=199.2
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||+||+++. +++.||+|.+..... .....+.+|+.+++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688889999999999999998 678899999875422 23355778999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 81 EYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred CCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 9999999999997653 25889999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCcccccCCccccccccccccccC------cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMS------TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE 283 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (344)
...... .....||+.|+|||++. ...++.++||||||+++|+|++|..||..... ...+... ..
T Consensus 154 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~----~~~~~~i----~~ 223 (330)
T cd05601 154 ANKMVN--SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS----AKTYNNI----MN 223 (330)
T ss_pred CCCcee--eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH----HHHHHHH----Hc
Confidence 433221 11346899999999986 45678999999999999999999999864321 1111111 11
Q ss_pred cCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 284 SNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
... ....|.....+..+.+|+..||+ +|++|||+.++++
T Consensus 224 ~~~------------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 224 FQR------------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCC------------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 100 00111111334568899999998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=287.91 Aligned_cols=267 Identities=17% Similarity=0.206 Sum_probs=211.1
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCC-----
Q 048160 51 KAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETE----- 123 (344)
Q Consensus 51 ~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~----- 123 (344)
....+.|++.+.+|+|||+-||.++. +++.+|+|++......+.+..++|++..++++|||+++++++...+.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 33456799999999999999999997 88999999998888778888999999999999999999999876443
Q ss_pred ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCC--eeeecccccceEeecCCcceEee
Q 048160 124 LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRP--IVFRDIKPSTILFQEQNVAKFFD 201 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~d 201 (344)
..||+++|...|||.+.+....-.. ..+++.+.+.++.++++||++|| +.. ..||||||.|||+...+.+++.|
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg-~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKG-NFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEEe
Confidence 4899999999999999886543221 36899999999999999999999 665 99999999999999999999999
Q ss_pred eecccccCCCCcccc------cCCccccccccccccccCc---CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchh
Q 048160 202 FCVSISIPEGKTHVN------DNNKVIGTFGFIAPEYMST---ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEY 272 (344)
Q Consensus 202 fg~a~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 272 (344)
||.++..+..-.... .-.....|..|.|||.+.- ...+.++|||||||++|.|+.|..||......
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~----- 247 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ----- 247 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-----
Confidence 999887653211100 0001245889999999853 45789999999999999999999999754331
Q ss_pred HHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 048160 273 FLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLH 341 (344)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~ 341 (344)
.+++.-++ .. ....+|...-.+..+.+++..|++.||.+||++.+++..+..+.
T Consensus 248 -----------GgSlaLAv---~n-~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 -----------GGSLALAV---QN-AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -----------CCeEEEee---ec-cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 12211111 11 11223332235667999999999999999999999999988764
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=298.81 Aligned_cols=254 Identities=20% Similarity=0.275 Sum_probs=199.1
Q ss_pred cCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
+.|...+.||+|+||.||+|++ .+..||+|++..... ..+.+.+|+.++++++||||+++++++. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 4588899999999999999998 445799998875432 3456889999999999999999999875 456799999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+|+|.+++....+ ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||.+........
T Consensus 84 ~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 84 KGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCcHHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 9999999975332 25788899999999999999999 99999999999999999999999999999976643322
Q ss_pred ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
... ....++..|+|||+..+..++.++||||||+++|++++ |..||..... . +.........
T Consensus 158 ~~~--~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~----~----~~~~~~~~~~------- 220 (262)
T cd05071 158 TAR--QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----R----EVLDQVERGY------- 220 (262)
T ss_pred ccc--cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh----H----HHHHHHhcCC-------
Confidence 111 12345678999999988889999999999999999999 6666643211 1 1111110000
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLH 341 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~ 341 (344)
..+.....+..+.+|+.+||+.||++||++.++++.|+...
T Consensus 221 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 221 --------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred --------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 00111134567899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=301.90 Aligned_cols=263 Identities=22% Similarity=0.294 Sum_probs=204.5
Q ss_pred CCCCCCccccCCCceEEEEEEC------CccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEee--CCccE
Q 048160 56 NYDPEKVITKDLLYKLYKGFLQ------DRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLE--TELPI 126 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~~------~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~ 126 (344)
.|...+.||+|+||.||+|+++ +..||+|.+...... ....+.+|+..+++++|+||+++++++.. +...+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4666789999999999999973 568999998766543 45678899999999999999999999877 56789
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
+||||+++++|.+++.... ..+++.++..++.|++.||.||| +.+++|+||||+||+++.++.++++|||.+.
T Consensus 85 lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999997654 25889999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcc-------hhHHHHHHH
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGE-------EYFLQELVR 279 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------~~~~~~~~~ 279 (344)
................++..|+|||.+.+..++.++||||||++++||++|..|+......... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 7653322211111223456799999998888999999999999999999999988653221100 000000000
Q ss_pred HHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 280 KSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
.... ....+....++..+.+|+.+||+.+|++|||+.+|++.|+++
T Consensus 238 -~~~~--------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 -LLKE--------------GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred -HHHc--------------CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0000 001111123456789999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=320.85 Aligned_cols=252 Identities=16% Similarity=0.191 Sum_probs=195.1
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||+||++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688889999999999999998 77889999986432 123355778999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.++|+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 81 EFLPGGDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred eCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 9999999999987543 5888899999999999999999 9999999999999999999999999999986432
Q ss_pred CCCcc------------c--------------------------------ccCCccccccccccccccCcCCCCcccchH
Q 048160 210 EGKTH------------V--------------------------------NDNNKVIGTFGFIAPEYMSTANCNEKSDVY 245 (344)
Q Consensus 210 ~~~~~------------~--------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~ 245 (344)
..... . .......||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 11000 0 000124689999999999888999999999
Q ss_pred HHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCC
Q 048160 246 SFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQ 325 (344)
Q Consensus 246 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 325 (344)
||||++|||++|..||..... ...+.... .... ...+|.....+.++.+|+.+|+. +|.
T Consensus 233 SlGvil~elltG~~Pf~~~~~----~~~~~~i~----~~~~------------~~~~p~~~~~s~~~~dli~~lL~-~~~ 291 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENS----HETYRKII----NWRE------------TLYFPDDIHLSVEAEDLIRRLIT-NAE 291 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCH----HHHHHHHH----ccCC------------ccCCCCCCCCCHHHHHHHHHHhc-CHh
Confidence 999999999999999864321 11111111 1000 00111111234567899999997 776
Q ss_pred CC---CCHHHHHH
Q 048160 326 DR---PTMVQVAK 335 (344)
Q Consensus 326 ~R---Ps~~ei~~ 335 (344)
+| +|+.+++.
T Consensus 292 ~r~~r~~~~~~l~ 304 (377)
T cd05629 292 NRLGRGGAHEIKS 304 (377)
T ss_pred hcCCCCCHHHHhc
Confidence 65 59988875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=295.86 Aligned_cols=246 Identities=24% Similarity=0.359 Sum_probs=194.8
Q ss_pred CccccCCCceEEEEEE-CCccEEEEEecCCCCch-hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCCcc
Q 048160 61 KVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSE-EYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLA 138 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 138 (344)
++||+|+||.||+|.. ++..||+|.+....... ...+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999988 66789999887654332 345779999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcccccC
Q 048160 139 DRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDN 218 (344)
Q Consensus 139 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~ 218 (344)
+++.... ..+.+.++..++.|++.||.||| ..+++|+||+|+||+++.++.++++|||++...........
T Consensus 81 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~-- 151 (250)
T cd05085 81 SFLRKKK----DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSS-- 151 (250)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccC--
Confidence 9886543 25788999999999999999999 99999999999999999999999999999876543222111
Q ss_pred CccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccccccccccc
Q 048160 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVG 297 (344)
Q Consensus 219 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (344)
....++..|+|||++.+..++.++||||||+++|++++ |..||..... ......+ .......
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-----~~~~~~~----~~~~~~~-------- 214 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-----QQAREQV----EKGYRMS-------- 214 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHHH----HcCCCCC--------
Confidence 12234567999999988889999999999999999998 8888754311 1111111 1110000
Q ss_pred CCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048160 298 EEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338 (344)
Q Consensus 298 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~ 338 (344)
.+ ...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 215 ----~~--~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 215 ----CP--QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ----CC--CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 00 023456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=309.82 Aligned_cols=240 Identities=22% Similarity=0.295 Sum_probs=191.7
Q ss_pred CccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 61 KVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
+.||+|+||.||+|++ ++..||+|.+.... ......+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999 56789999987542 22345567888888888 699999999999999999999999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
|+|..++.... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++........
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 152 (318)
T cd05570 81 GDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT 152 (318)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc
Confidence 99998887653 5889999999999999999999 999999999999999999999999999998653222211
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPI 294 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (344)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||..... ....... .. ..
T Consensus 153 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~----~~~~~~i----~~-~~-------- 212 (318)
T cd05570 153 ---TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE----DELFQSI----LE-DE-------- 212 (318)
T ss_pred ---ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH----HHHHHHH----Hc-CC--------
Confidence 1234689999999999999999999999999999999999999864321 1111111 10 00
Q ss_pred cccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 048160 295 IVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM-----VQVAK 335 (344)
Q Consensus 295 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~ei~~ 335 (344)
...|. ..+..+.+|+.+||+.||++|||+ .++++
T Consensus 213 -----~~~~~--~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 213 -----VRYPR--WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -----CCCCC--cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 00111 234568899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=301.83 Aligned_cols=258 Identities=19% Similarity=0.307 Sum_probs=199.2
Q ss_pred hcCCCCCCccccCCCceEEEEEECC-------ccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCcc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQD-------RPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELP 125 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~~-------~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~ 125 (344)
+++|...+.||+|+||.||+|.+.+ ..|++|.+...... ....+.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678889999999999999999933 56888887644322 335688999999999999999999999999999
Q ss_pred EEEEeecCCCCccccccCCCC--CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC---cceEe
Q 048160 126 ILVFEFVACGTLADRIHDPNG--SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN---VAKFF 200 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~ 200 (344)
++||||+++++|.+++..... .....+++.+++.++.|++.||.||| +.+++|+||||+||+++.++ .++++
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence 999999999999999865431 11135889999999999999999999 99999999999999998764 68999
Q ss_pred eeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHH
Q 048160 201 DFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVR 279 (344)
Q Consensus 201 dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 279 (344)
|||+++......... .......+..|+|||++.+..++.++|||||||++|+|++ |..||..... ..+...+.
T Consensus 162 dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-----~~~~~~~~ 235 (277)
T cd05036 162 DFGMARDIYRASYYR-KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-----QEVMEFVT 235 (277)
T ss_pred cCccccccCCcccee-cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHH
Confidence 999988763322111 1112233568999999988889999999999999999997 8887754321 11111111
Q ss_pred HHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048160 280 KSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338 (344)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~ 338 (344)
.... ...| ...+..+.+++.+||+.+|++|||+.+|++.|.
T Consensus 236 ---~~~~-------------~~~~--~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 ---GGGR-------------LDPP--KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ---cCCc-------------CCCC--CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0000 0001 133456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=307.96 Aligned_cols=239 Identities=22% Similarity=0.289 Sum_probs=189.2
Q ss_pred CccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhc-CCCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 61 KVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQ-MSHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
+.||+|+||+||+|+. .+..||+|.+.... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999998 56789999987542 2234456677778776 4899999999999999999999999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
|+|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++........
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 151 (316)
T cd05619 81 GDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA- 151 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-
Confidence 99999987543 5888999999999999999999 99999999999999999999999999999875322211
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPI 294 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (344)
......||..|+|||++.+..++.++|||||||++|+|++|..||..... ..+...+. ..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~i~----~~--------- 211 (316)
T cd05619 152 --KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-----EELFQSIR----MD--------- 211 (316)
T ss_pred --ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHH----hC---------
Confidence 11245689999999999988999999999999999999999999865321 11111110 00
Q ss_pred cccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 048160 295 IVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMV-QVA 334 (344)
Q Consensus 295 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-ei~ 334 (344)
.+..|. ..+.++.+++.+||+.||++||++. ++.
T Consensus 212 ----~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 212 ----NPCYPR--WLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ----CCCCCc--cCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 000111 2334578999999999999999996 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=305.61 Aligned_cols=264 Identities=19% Similarity=0.270 Sum_probs=204.2
Q ss_pred HhcCCCCCCccccCCCceEEEEEE---------CCccEEEEEecCCC-CchhhhHhhHHHHHhcC-CCCceeeeeeEEee
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL---------QDRPISVMKFGGNL-NSEEYCCFNCIAFASQM-SHKNILKFVGCCLE 121 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~---------~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~ 121 (344)
..++|.+...||+|+||.||+|++ ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 345688899999999999999975 12468999886543 23346688999999999 79999999999999
Q ss_pred CCccEEEEeecCCCCccccccCCCCC-----------CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceE
Q 048160 122 TELPILVFEFVACGTLADRIHDPNGS-----------QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTIL 190 (344)
Q Consensus 122 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil 190 (344)
....++||||+++|+|.+++...... ....+++.++..++.|++.||.||| +.+++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEE
Confidence 99999999999999999998654211 0125788889999999999999999 999999999999999
Q ss_pred eecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCc
Q 048160 191 FQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENG 269 (344)
Q Consensus 191 l~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~ 269 (344)
++.++.++|+|||+++.......... .....++..|+|||++.+..++.++||||||+++|++++ |..||....
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---- 244 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKK-TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 244 (304)
T ss_pred EcCCCcEEECCCccceeccccccccc-ccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----
Confidence 99999999999999987643322111 112345678999999988889999999999999999998 666664321
Q ss_pred chhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 270 EEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
..+.......... ...+ ..++..+.+++.+||+.+|++|||+.+|++.|.++...
T Consensus 245 ----~~~~~~~~~~~~~-------------~~~~--~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 245 ----VEELFKLLKEGHR-------------MDKP--ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred ----HHHHHHHHHcCCc-------------CCCC--CCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1111111111100 0001 13455689999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=300.13 Aligned_cols=255 Identities=19% Similarity=0.267 Sum_probs=201.5
Q ss_pred cCCCCCCccccCCCceEEEEEECC-----ccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFLQD-----RPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~~~-----~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
++|...+.||+|+||.||+|.+.+ ..|++|....... ...+.+.+|+.++++++||||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788999999999999999822 3689998876652 344668899999999999999999998875 567899
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||+++|+|.+++.... ..+++.++..++.+++.||.||| +.+++|+||||+||+++.++.++++|||++...
T Consensus 85 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 85 MELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999997643 25889999999999999999999 999999999999999999999999999998766
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
........ ....++..|+|||.+....++.++||||||++++++++ |..||..... ..... .+ ....
T Consensus 158 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~----~~~~~-~~---~~~~-- 225 (270)
T cd05056 158 EDESYYKA--SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN----NDVIG-RI---ENGE-- 225 (270)
T ss_pred ccccceec--CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHH-HH---HcCC--
Confidence 54322111 12234567999999988889999999999999999986 8888854321 11111 11 0000
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.. +....++..+.+++.+||..+|++|||+.++++.|.++..
T Consensus 226 -----------~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 226 -----------RL--PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -----------cC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00 0111344578999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=308.94 Aligned_cols=239 Identities=22% Similarity=0.277 Sum_probs=189.5
Q ss_pred CccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 61 KVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
+.||+|+||.||+|+. ++..||+|.++... .........|..++... +||||+++++++...+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999 67789999987542 22344566787777754 899999999999999999999999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
|+|..++.... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++.......
T Consensus 81 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 151 (316)
T cd05620 81 GDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN- 151 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-
Confidence 99999887643 5888999999999999999999 99999999999999999999999999999865322211
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPI 294 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (344)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..+.+.+. ..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-----~~~~~~~~----~~--------- 211 (316)
T cd05620 152 --RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-----DELFESIR----VD--------- 211 (316)
T ss_pred --ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHH----hC---------
Confidence 11245689999999999999999999999999999999999999965321 11111111 00
Q ss_pred cccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 048160 295 IVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMV-QVA 334 (344)
Q Consensus 295 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-ei~ 334 (344)
.+..|. ..+.++.+++.+||+.||++||++. +++
T Consensus 212 ----~~~~~~--~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 212 ----TPHYPR--WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ----CCCCCC--CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 000111 2334578999999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=300.47 Aligned_cols=256 Identities=18% Similarity=0.308 Sum_probs=200.2
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCc----cEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDR----PISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~----~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
++|...+.||+|+||+||+|++ ++. .||+|.+...... ....+.+|+.+++.++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 4588889999999999999997 444 4899988755332 34567899999999999999999999875 45679
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
++||+++|+|.+++.... ..+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++.
T Consensus 86 ~~~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceee
Confidence 999999999999987643 25889999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
.......... ....++..|+|||.+.+..++.++||||||+++||+++ |..||.... ...+...+. ...
T Consensus 159 ~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~~~----~~~ 228 (279)
T cd05109 159 LDIDETEYHA-DGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-----AREIPDLLE----KGE 228 (279)
T ss_pred cccccceeec-CCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHH----CCC
Confidence 6533221111 11234678999999988889999999999999999998 777764321 111111111 100
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
. .+....++..+.+++.+||+.||+.||++.++++.|.++..
T Consensus 229 ~--------------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 229 R--------------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred c--------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 0 00111344568899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=312.56 Aligned_cols=262 Identities=17% Similarity=0.233 Sum_probs=210.2
Q ss_pred CCCCCCccccCCCceEEEEEECC-ccEEEEEecCCCCchh-hhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 56 NYDPEKVITKDLLYKLYKGFLQD-RPISVMKFGGNLNSEE-YCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~~~-~~vavk~~~~~~~~~~-~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
.....++||+|-||+|..+...+ ..||||.++.+..... .+|.+|+++|.+++|||||+++|+|..++++++++|||+
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence 35567899999999999999966 8999999998866555 789999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+|+|.+++..+.- +.+.-..-+.|+.||++|++||. +.++||||+.++|+|+|.++++||+|||+++.+.....
T Consensus 619 nGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 619 NGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred cCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 9999999987642 12344556779999999999999 99999999999999999999999999999997765543
Q ss_pred ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc--CCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT--GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
.. -....+-+.+|||+|.+..+++++++|+|+||+++||+++ ...||....+ . ...+......+......++
T Consensus 693 y~-vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~----e-~vven~~~~~~~~~~~~~l 766 (807)
T KOG1094|consen 693 YR-VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD----E-QVVENAGEFFRDQGRQVVL 766 (807)
T ss_pred ee-eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH----H-HHHHhhhhhcCCCCcceec
Confidence 32 1224566889999999999999999999999999999864 5566643221 1 1112222222222222211
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
+.+.-|+..+.++|..||..|-.+|||++++..-|+..
T Consensus 767 -----------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 -----------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -----------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 12226777899999999999999999999999888764
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=312.43 Aligned_cols=236 Identities=23% Similarity=0.264 Sum_probs=186.3
Q ss_pred CccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHH-HHhcCCCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 61 KVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIA-FASQMSHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
+.||+|+||+||+|+. +++.||+|++..... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999999 678899999865421 12234445544 56789999999999999999999999999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
|+|..++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 151 (323)
T cd05575 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK- 151 (323)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-
Confidence 99999887643 5888999999999999999999 99999999999999999999999999999875432211
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPI 294 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (344)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..... . +....... .
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~----~~~~~i~~-~--------- 211 (323)
T cd05575 152 --TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT----A----EMYDNILN-K--------- 211 (323)
T ss_pred --ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH----H----HHHHHHHc-C---------
Confidence 11245689999999999998999999999999999999999999965321 1 11111110 0
Q ss_pred cccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHH
Q 048160 295 IVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMV 331 (344)
Q Consensus 295 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 331 (344)
.....+ ..+..+.+++.+||+.||++||++.
T Consensus 212 ---~~~~~~---~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 212 ---PLRLKP---NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ---CCCCCC---CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 000001 2244688999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=306.80 Aligned_cols=266 Identities=17% Similarity=0.239 Sum_probs=197.2
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
++|...+.||+|+||.||+|+. .+..||+|.+...... ....+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 4688889999999999999998 6778999998755332 234567899999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
++ ++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++......
T Consensus 86 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 86 LD-KDLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 97 58888876543 24788889999999999999999 999999999999999999999999999998764332
Q ss_pred CcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc--CCcc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES--NSFK 288 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 288 (344)
.... ....++..|+|||++.+ ..++.++||||||+++|+|++|+.||...... ..+.........+ ..+.
T Consensus 158 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07872 158 TKTY---SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE----DELHLIFRLLGTPTEETWP 230 (309)
T ss_pred cccc---ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCCHHHHh
Confidence 2111 13457889999998865 46889999999999999999999998654221 1111111100000 0000
Q ss_pred c------cccccccc--CCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 E------IVDPIIVG--EEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~------~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. ..+..... ...........+.++.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0 00000000 00000011123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=309.85 Aligned_cols=240 Identities=20% Similarity=0.280 Sum_probs=190.9
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCC-CceeeeeeEEeeCCccEEEE
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSH-KNILKFVGCCLETELPILVF 129 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H-~niv~~~~~~~~~~~~~lv~ 129 (344)
+|...+.||+|+||.||+|.. .++.||+|++.... ....+.+..|..++..+.| ++|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 477889999999999999998 45789999987542 2334567789999999976 56889999999899999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++....
T Consensus 81 E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 9999999999887543 5888999999999999999999 9999999999999999999999999999986532
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...... .... .
T Consensus 153 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~~~~----i~~~-~--- 217 (324)
T cd05587 153 FGGK---TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----DELFQS----IMEH-N--- 217 (324)
T ss_pred CCCC---ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHH----HHcC-C---
Confidence 2111 11135689999999999999999999999999999999999999864321 111111 1100 0
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM 330 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 330 (344)
...|. ..+..+.+++.+||+.||.+||+.
T Consensus 218 ----------~~~~~--~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 ----------VSYPK--SLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ----------CCCCC--CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00111 233457899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=299.70 Aligned_cols=264 Identities=18% Similarity=0.309 Sum_probs=206.4
Q ss_pred hcCCCCCCccccCCCceEEEEEE-C-----CccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEee-CCcc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL-Q-----DRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLE-TELP 125 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~-~-----~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-~~~~ 125 (344)
.++|...+.||+|+||.||+|.+ . +..|++|++..... .....+.+|+.++++++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 46788899999999999999998 3 47788888765433 234557899999999999999999999876 4678
Q ss_pred EEEEeecCCCCccccccCCCCC---CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeee
Q 048160 126 ILVFEFVACGTLADRIHDPNGS---QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF 202 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~df 202 (344)
++++||+++++|.+++...... ....+++.++..++.|++.||.||| +.+++|+||||+||+++.++.++++||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999988653211 0135889999999999999999999 999999999999999999999999999
Q ss_pred ecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHH
Q 048160 203 CVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKS 281 (344)
Q Consensus 203 g~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 281 (344)
|+++........... ....++..|+|||++.+..++.++||||||+++|++++ |+.||.... ...+...+..
T Consensus 162 g~~~~~~~~~~~~~~-~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~- 234 (280)
T cd05043 162 ALSRDLFPMDYHCLG-DNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID-----PFEMAAYLKD- 234 (280)
T ss_pred CCcccccCCceEEeC-CCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC-----HHHHHHHHHc-
Confidence 999865433222111 12345678999999988889999999999999999998 888885421 1112221111
Q ss_pred hccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhC
Q 048160 282 IESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKSI 344 (344)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~l 344 (344)
... .+....++..+.+++.+||+.||++|||+.+|++.|+.+.+.+
T Consensus 235 --~~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 280 (280)
T cd05043 235 --GYR---------------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQL 280 (280)
T ss_pred --CCC---------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhcC
Confidence 000 0011133456899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=302.21 Aligned_cols=258 Identities=21% Similarity=0.312 Sum_probs=201.4
Q ss_pred hcCCCCCCccccCCCceEEEEEECC-------ccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCcc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQD-------RPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELP 125 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~~-------~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~ 125 (344)
.++|...+.||+|+||.||+|.+.+ ..||+|.+..... .....+.+|+.+++.++||||+++++++..+...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3568888999999999999999832 5699999865532 2345678999999999999999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCC-----CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEe
Q 048160 126 ILVFEFVACGTLADRIHDPNGS-----QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFF 200 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 200 (344)
++||||+++|+|.+++...... ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence 9999999999999998653221 1124678889999999999999999 9999999999999999999999999
Q ss_pred eeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHH
Q 048160 201 DFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVR 279 (344)
Q Consensus 201 dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 279 (344)
|||+++........ .......++..|+|||.+.+..++.++||||||+++||+++ |..||.... .....+.+.
T Consensus 162 dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-----~~~~~~~~~ 235 (277)
T cd05032 162 DFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-----NEEVLKFVI 235 (277)
T ss_pred CcccchhhccCccc-ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-----HHHHHHHHh
Confidence 99998765433221 11123456788999999988889999999999999999998 777764321 111111111
Q ss_pred HHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048160 280 KSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338 (344)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~ 338 (344)
..... ..|. .++..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 236 ----~~~~~------------~~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 ----DGGHL------------DLPE--NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ----cCCCC------------CCCC--CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11100 0011 23456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=306.96 Aligned_cols=263 Identities=19% Similarity=0.255 Sum_probs=203.4
Q ss_pred hcCCCCCCccccCCCceEEEEEEC---------CccEEEEEecCCC-CchhhhHhhHHHHHhcC-CCCceeeeeeEEeeC
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQ---------DRPISVMKFGGNL-NSEEYCCFNCIAFASQM-SHKNILKFVGCCLET 122 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~---------~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~ 122 (344)
.++|.+.+.||+|+||.||++++. ...+|+|.+.... ......+.+|+.+++++ +||||+++++++..+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 456899999999999999999862 1359999987553 23345677899999999 799999999999999
Q ss_pred CccEEEEeecCCCCccccccCCCCC-----------CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe
Q 048160 123 ELPILVFEFVACGTLADRIHDPNGS-----------QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF 191 (344)
Q Consensus 123 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 191 (344)
...++||||+++|+|.+++...... ....+++.+++.++.|++.||+||| +.+++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence 9999999999999999999754311 0125788999999999999999999 9999999999999999
Q ss_pred ecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcc
Q 048160 192 QEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGE 270 (344)
Q Consensus 192 ~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~ 270 (344)
+.++.++|+|||.+............ ....++..|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~----- 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKT-TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----- 247 (307)
T ss_pred cCCCcEEECCCcccccccccchhhcc-ccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-----
Confidence 99999999999998765432211111 11223568999999988889999999999999999998 777764321
Q ss_pred hhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 271 EYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
.......+. .... .+.....+.++.+|+.+||+.+|++|||+.+|++.|.++.+.
T Consensus 248 ~~~~~~~~~----~~~~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 248 VEELFKLLK----EGHR--------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHHHH----cCCC--------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 111111111 1000 001113445788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=302.97 Aligned_cols=258 Identities=19% Similarity=0.314 Sum_probs=203.1
Q ss_pred hcCCCCCCccccCCCceEEEEEE-------CCccEEEEEecCCCC-chhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL-------QDRPISVMKFGGNLN-SEEYCCFNCIAFASQM-SHKNILKFVGCCLETEL 124 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~-------~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~ 124 (344)
.++|...+.||+|+||.||++.. .+..||+|.++.... ...+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 35688999999999999999975 234689998875532 2345688999999999 79999999999999999
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeec
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV 204 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~ 204 (344)
.++||||+++|+|.+++..... ..+++.++..++.|++.||.||| +.+|+|+||||+||+++.++.++++|||+
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 9999999999999999865432 23789999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhc
Q 048160 205 SISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIE 283 (344)
Q Consensus 205 a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (344)
+.......... ......++..|+|||++.+..++.++||||||+++|++++ |..||..... .......+..
T Consensus 188 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~----~~~~~~~~~~--- 259 (302)
T cd05055 188 ARDIMNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV----DSKFYKLIKE--- 259 (302)
T ss_pred cccccCCCcee-ecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc----hHHHHHHHHc---
Confidence 87664332211 1112345778999999988889999999999999999998 8888764321 1111111111
Q ss_pred cCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 284 SNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
. ... +.....+..+.+++.+||+.+|++|||+.+|++.|.++
T Consensus 260 -~-~~~-------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 -G-YRM-------------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -C-CcC-------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 000 00002234689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=297.31 Aligned_cols=253 Identities=19% Similarity=0.296 Sum_probs=200.6
Q ss_pred hcCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
.++|...++||+|+||.||+|.. +++.||+|.+..... ....+.+|+.++++++|+||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 45688899999999999999998 678899998875543 3467889999999999999999999864 55789999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++++|.+++....+ ..+++.++..++.|++.||.||| +.+++|+||||+||+++.++.++++|||++.......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 83 ENGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999998865432 35788999999999999999999 9999999999999999999999999999987765322
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
.... ....++..|+|||++....++.++||||||+++|++++ |..||..... ....... .....
T Consensus 157 ~~~~--~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~---~~~~~----- 221 (260)
T cd05067 157 YTAR--EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-----PEVIQNL---ERGYR----- 221 (260)
T ss_pred cccc--cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-----HHHHHHH---HcCCC-----
Confidence 2111 12345678999999988889999999999999999998 8888753211 1111111 00000
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQ 339 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~ 339 (344)
.+.....+.++.+++.+||+.+|++|||+++++..|+.
T Consensus 222 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 ----------MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 00011234568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=300.31 Aligned_cols=255 Identities=19% Similarity=0.300 Sum_probs=200.9
Q ss_pred CCCCCCccccCCCceEEEEEE--CC---ccEEEEEecCCC-CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QD---RPISVMKFGGNL-NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~---~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
.|+..+.||+|+||.||+|.+ ++ ..||+|.+.... ......+..|+.++++++||||+++++++..+...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 467789999999999999998 23 259999987653 233467889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++++|.+++.... ..+++.+++.++.|++.||.||| +.+++|+||||+||+++.++.++++|||++....
T Consensus 85 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 85 EFMENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred ecCCCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999987644 25788999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCcccccCCccc--cccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 210 EGKTHVNDNNKVI--GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 210 ~~~~~~~~~~~~~--g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
............. .+..|+|||.+.+..++.++||||||+++||+++ |..||..... ......+.. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-----~~~~~~i~~---~~- 228 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----QDVINAIEQ---DY- 228 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-----HHHHHHHHc---CC-
Confidence 3322111111111 2357999999988899999999999999999886 8888864321 111111110 00
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
..+....++..+.+++.+||+.+|++||++.+|+..|+++
T Consensus 229 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 --------------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0111113455688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=298.80 Aligned_cols=256 Identities=20% Similarity=0.280 Sum_probs=200.8
Q ss_pred HHHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccE
Q 048160 49 ELKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPI 126 (344)
Q Consensus 49 ~i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~ 126 (344)
|++..++++.....||+|+||.||+|.. ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 3455677888888999999999999997 56779999987766556677889999999999999999999999999999
Q ss_pred EEEeecCCCCccccccCCCCCCCccc--cHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec-CCcceEeeee
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPF--LMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE-QNVAKFFDFC 203 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~dfg 203 (344)
+|+||+++++|.+++..... ++ ++..+..++.|++.||.||| +.+|+||||||+||+++. ++.++|+|||
T Consensus 82 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg 154 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWG----PLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFG 154 (268)
T ss_pred EEEecCCCCCHHHHHHHhcc----cCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecch
Confidence 99999999999999875431 34 77888899999999999999 999999999999999976 6799999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCcCC--CCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHH
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTAN--CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS 281 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 281 (344)
++......... .....++..|+|||++.... ++.++||||||+++|+|++|..||........ .. +...
T Consensus 155 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~--~~~~- 225 (268)
T cd06624 155 TSKRLAGINPC---TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AM--FKVG- 225 (268)
T ss_pred hheecccCCCc---cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hH--hhhh-
Confidence 98765432211 11335788999999986643 78999999999999999999999854211000 00 0000
Q ss_pred hccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 282 IESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.....+..|. .....+.+++.+||+.+|++|||+.+|+.
T Consensus 226 -------------~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 226 -------------MFKIHPEIPE--SLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -------------hhccCCCCCc--ccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0000111111 34456889999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=299.52 Aligned_cols=251 Identities=22% Similarity=0.284 Sum_probs=198.5
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
++|...+.||+|+||.||+|+. +++.||+|.+..........+.+|+.+++.++||||+++++++..+...++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4577778899999999999998 67889999987665445566788999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++++|.+++...+ .+++.++..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 89 GGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 9999999987553 5889999999999999999999 9999999999999999999999999999987654321
Q ss_pred cccccCCccccccccccccccC---cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMS---TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
. ......|+..|+|||++. ...++.++|+|||||++|+|++|..||..... ........ . ....
T Consensus 161 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~----~~~~~~~~----~-~~~~- 227 (267)
T cd06645 161 A---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP----MRALFLMT----K-SNFQ- 227 (267)
T ss_pred c---ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc----hhhHHhhh----c-cCCC-
Confidence 1 112446889999999874 45688999999999999999999999864321 00000000 0 0000
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. +........+..+.+++.+||+.+|++|||+++|++
T Consensus 228 --~-------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 228 --P-------PKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --C-------CcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0 000000022345789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=297.68 Aligned_cols=249 Identities=20% Similarity=0.293 Sum_probs=195.8
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
+|...+.||+|+||.||+|.. ++..||+|.+..... .....+.+|+.++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577789999999999999998 678899999865532 23456889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++++|..+. .+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 82 DGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 999986542 3677888899999999999999 9999999999999999999999999999987654321
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
.....++..|+|||++.+..++.++|+||||+++|+|++|+.||........... ....... .....
T Consensus 150 -----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~-~~~~~------ 216 (279)
T cd06619 150 -----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM-PLQLLQC-IVDED------ 216 (279)
T ss_pred -----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc-hHHHHHH-HhccC------
Confidence 1234688999999999988899999999999999999999999865322111110 0011110 00000
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
....+. ...+.++.+++.+||+.+|++||++.++++.
T Consensus 217 ------~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 217 ------PPVLPV-GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ------CCCCCC-CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000010 0233468899999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=317.60 Aligned_cols=254 Identities=17% Similarity=0.258 Sum_probs=197.5
Q ss_pred HHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccE
Q 048160 52 AATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPI 126 (344)
Q Consensus 52 ~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~ 126 (344)
...++|+..+.||+|+||.||+++. +++.||+|.+.... ......+.+|+.+++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 3456799999999999999999999 57789999886421 122345778999999999999999999999999999
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
+||||+++|+|.+++... .+++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.
T Consensus 120 lv~Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccce
Confidence 999999999999998653 4788899999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCcccccCCccccccccccccccCcC----CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTA----NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
........ ......||+.|+|||++... .++.++|||||||++|+|++|..||..... ....... .
T Consensus 191 ~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~----~~~~~~i----~ 260 (370)
T cd05621 191 KMDETGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL----VGTYSKI----M 260 (370)
T ss_pred ecccCCce--ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH----HHHHHHH----H
Confidence 76432221 11245789999999998654 378899999999999999999999975321 1111111 1
Q ss_pred ccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 048160 283 ESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQD--RPTMVQVAKQ 336 (344)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ei~~~ 336 (344)
.... ...+|.....+..+.+++..||+.+|.+ ||++.++++.
T Consensus 261 ~~~~------------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 261 DHKN------------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred hCCc------------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1000 0111221133456788999999855543 8899998763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=304.46 Aligned_cols=263 Identities=17% Similarity=0.258 Sum_probs=201.2
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
++|+..+.||+|+||.||++.. ++..+|+|.+...... ....+.+|++++.+++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 4688899999999999999998 5677888887655332 235578999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCC-CCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFS-RPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
+++++|.+++.... .+++..+..++.|++.||.||| + .+++|+||||+||+++.++.++++|||++.....
T Consensus 81 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 81 MDGGSLDQVLKKAG-----RIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 99999999997653 5888999999999999999999 6 5899999999999999999999999999865532
Q ss_pred CCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc---
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF--- 287 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 287 (344)
.. .....++..|+|||++.+..++.++|+||||+++|+|++|..||..... ................
T Consensus 153 ~~-----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~ 222 (308)
T cd06615 153 SM-----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-----KELEAMFGRPVSEGEAKES 222 (308)
T ss_pred cc-----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch-----hhHHHhhcCccccccccCC
Confidence 21 1245678999999999888899999999999999999999999864321 1111111110000000
Q ss_pred -----------------ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 288 -----------------KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 288 -----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
....+.......+..|.. ..+.++.+|+.+||+.||++|||+.+|++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 223 HRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSG-AFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cccccCCCCCccchhhHHHHHHHHhcCCCccCcCc-ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000111111111111 244568999999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=317.65 Aligned_cols=268 Identities=16% Similarity=0.173 Sum_probs=200.1
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
..+|.+...||+|+||.||+|.+ .+..||+|... ...+.+|+.++++++|+|||++++++..+...++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 44688999999999999999999 56789999632 23456899999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+. ++|.+++.... ..+++.+++.++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+++.....
T Consensus 242 ~~-~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 242 YR-SDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred cC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 95 78988886543 26899999999999999999999 999999999999999999999999999999765432
Q ss_pred CcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcch---hHHHHHHHHHhc-cCCc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEE---YFLQELVRKSIE-SNSF 287 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~-~~~~ 287 (344)
.... ......||..|+|||++.+..++.++|||||||++|||++|..|++......... ..+...+..... ...+
T Consensus 314 ~~~~-~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 314 WSTP-FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392 (461)
T ss_pred cccc-cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence 2111 1113468999999999999999999999999999999999988776543322111 112222221110 0000
Q ss_pred ccccc--------------cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 288 KEIVD--------------PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 288 ~~~~~--------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
..... .........|.........+.+|+..||+.||++|||+.|+++.
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 00000111222222233468899999999999999999999863
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=308.67 Aligned_cols=240 Identities=20% Similarity=0.272 Sum_probs=191.2
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEEE
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~ 129 (344)
+|...+.||+|+||.||+|+. ++..||+|.+..... .....+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 477889999999999999998 567899999875422 2234456778888777 5899999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++|+|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+++...
T Consensus 81 E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 9999999999886543 5889999999999999999999 9999999999999999999999999999987543
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
.... ......||+.|+|||++.+..++.++|||||||++|||++|..||..... ........ . ..
T Consensus 153 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~----~-~~--- 217 (323)
T cd05616 153 WDGV---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIM----E-HN--- 217 (323)
T ss_pred CCCC---ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH----HHHHHHHH----h-CC---
Confidence 2221 11245689999999999999999999999999999999999999864321 11111111 1 00
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM 330 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 330 (344)
..+|. ..+.++.+++.+||+.||++|+++
T Consensus 218 ----------~~~p~--~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 ----------VAYPK--SMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ----------CCCCC--cCCHHHHHHHHHHcccCHHhcCCC
Confidence 00111 234567899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=299.51 Aligned_cols=239 Identities=21% Similarity=0.331 Sum_probs=185.6
Q ss_pred CccccCCCceEEEEEEC--------------------------CccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceee
Q 048160 61 KVITKDLLYKLYKGFLQ--------------------------DRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILK 114 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~--------------------------~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 114 (344)
..||+|+||.||+|.+. +..|++|.+..........+.+|+.++++++||||++
T Consensus 1 ~~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 1 AHLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CCcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeee
Confidence 36999999999999861 1247888876554444566888999999999999999
Q ss_pred eeeEEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC
Q 048160 115 FVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ 194 (344)
Q Consensus 115 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 194 (344)
+++++..++..++||||+++|+|..++.... ..+++.++..++.|++.||.||| +.+|+||||||+||+++..
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEecc
Confidence 9999999999999999999999999886543 25788999999999999999999 9999999999999999765
Q ss_pred C-------cceEeeeecccccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHH-cCCCCCCCCC
Q 048160 195 N-------VAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELL-TGKRISYSSC 265 (344)
Q Consensus 195 ~-------~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~-~g~~p~~~~~ 265 (344)
+ .++++|||++....... ...++..|+|||.+.+ ..++.++||||||+++||++ +|..||....
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~~-------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSRE-------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred CcccCccceeeecCCcccccccccc-------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 4 47999999875442211 2356788999998865 56899999999999999985 6887775431
Q ss_pred ccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048160 266 FENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338 (344)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~ 338 (344)
. ......... ... .|. .....+.+++.+||+.+|++|||+.+|++.|.
T Consensus 227 ~-----~~~~~~~~~---~~~---------------~~~--~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 227 P-----SEKERFYEK---KHR---------------LPE--PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred h-----HHHHHHHHh---ccC---------------CCC--CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 001111100 000 000 11235789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=298.52 Aligned_cols=238 Identities=21% Similarity=0.360 Sum_probs=186.0
Q ss_pred CccccCCCceEEEEEECC--------------ccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccE
Q 048160 61 KVITKDLLYKLYKGFLQD--------------RPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPI 126 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~~--------------~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~ 126 (344)
+.||+|+||.||+|.+.+ ..|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998622 248888876655445567788999999999999999999999999999
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCc-------ceE
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNV-------AKF 199 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-------~kl 199 (344)
+||||+++|+|..++.... .++++.+++.++.|++.||.||| +.+|+||||||+||+++.++. +++
T Consensus 81 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 9999999999998886543 35889999999999999999999 999999999999999987664 899
Q ss_pred eeeecccccCCCCcccccCCccccccccccccccC-cCCCCcccchHHHHHHHHHHH-cCCCCCCCCCccCcchhHHHHH
Q 048160 200 FDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMS-TANCNEKSDVYSFGALLLELL-TGKRISYSSCFENGEEYFLQEL 277 (344)
Q Consensus 200 ~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~-~g~~p~~~~~~~~~~~~~~~~~ 277 (344)
+|||++....... ...++..|+|||++. +..++.++||||||+++|+|+ +|..|+..... .+.
T Consensus 154 ~d~g~~~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~ 218 (262)
T cd05077 154 SDPGIPITVLSRQ-------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL--------AEK 218 (262)
T ss_pred CCCCCCccccCcc-------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch--------hHH
Confidence 9999886543211 345688899999886 466899999999999999998 56666543211 000
Q ss_pred HHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048160 278 VRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337 (344)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L 337 (344)
..... .... ... .....+.+|+.+||+.||++||++.+|++.+
T Consensus 219 -~~~~~-~~~~-----------~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 219 -ERFYE-GQCM-----------LVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -HHHHh-cCcc-----------CCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00000 0000 000 1124578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=301.53 Aligned_cols=248 Identities=21% Similarity=0.255 Sum_probs=195.7
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
|+..+.||+|+||.||+|.. .+..+++|.+........+.+.+|+.+++.++||||+++++++..+...++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 45668899999999999999 4677888888665545566788999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
++|..++.... .++++..+..++.|++.||.||| +.+++||||||+||+++.++.++++|||++........
T Consensus 87 ~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 87 GAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 99988876533 25889999999999999999999 99999999999999999999999999999876533221
Q ss_pred cccCCccccccccccccccC-----cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMS-----TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
......++..|+|||++. +..++.++|||||||++|+|++|..||..... ........ .... ..
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~~~~~~~~----~~~~-~~ 227 (282)
T cd06643 159 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP----MRVLLKIA----KSEP-PT 227 (282)
T ss_pred --ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH----HHHHHHHh----hcCC-CC
Confidence 112356789999999874 34578899999999999999999998864311 11111110 0000 00
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+.....+..+.+++.+||+.||.+||++.++++
T Consensus 228 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 228 ------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001123456899999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=300.92 Aligned_cols=249 Identities=20% Similarity=0.284 Sum_probs=197.2
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc---hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS---EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
|+..+.||+|+||.||++.. .++.||+|.+...... ....+.+|+.++++++|+||+.+++.+..++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 67778999999999999999 6789999998654221 224467899999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+++++|.+++..... ..+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++++|||++......
T Consensus 82 ~~g~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 82 MNGGDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred cCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 999999998854332 25888999999999999999999 999999999999999999999999999998765432
Q ss_pred CcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
... ....|+..|+|||++.+..++.++||||||+++|+|++|..||......... .......... ...
T Consensus 156 ~~~----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~~~~~~~~~------~~~- 223 (285)
T cd05630 156 QTI----KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVKEV------QEE- 223 (285)
T ss_pred ccc----cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-HHHHhhhhhh------hhh-
Confidence 211 1346899999999999888999999999999999999999999753221110 0111111000 000
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT-----MVQVAK 335 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ei~~ 335 (344)
.+ ...+..+.+|+..||+.||++||| +.++++
T Consensus 224 ----------~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 224 ----------YS--EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ----------cC--ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 00 023345789999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=301.98 Aligned_cols=250 Identities=19% Similarity=0.233 Sum_probs=198.3
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
++|+..+.||+|+||.||+|+. ++..|++|.+........+.+.+|+.++++++|+||+++++++..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 5688889999999999999998 57889999987765555677889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++++|..++.... ..+++.++..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 92 ~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 92 PGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred CCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 9999988775543 25889999999999999999999 9999999999999999999999999999876543221
Q ss_pred cccccCCccccccccccccccC-----cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMS-----TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
. ......++..|+|||++. ...++.++||||||+++|+|++|..||..... ....... ....
T Consensus 165 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~~----~~~~-- 231 (292)
T cd06644 165 Q---RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP----MRVLLKI----AKSE-- 231 (292)
T ss_pred c---ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH----HHHHHHH----hcCC--
Confidence 1 112346788999999884 34578899999999999999999999854211 1111111 0000
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+..+.....+.++.+++.+||+.||++||++.+|++
T Consensus 232 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 232 -----------PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -----------CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000111133456889999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=297.61 Aligned_cols=249 Identities=20% Similarity=0.279 Sum_probs=199.8
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCC-CCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGN-LNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
+|...+.||+|+||.||++.. ++..+|+|.+... .....+.+.+|+.+++.++|+||+++++++.+++..++|+||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 467789999999999999998 6788999988643 2334466778999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++++|.+++....+ ..+++.....++.|++.||.||| +.+|+|+||||+||+++.++.++++|||.+.......
T Consensus 81 ~~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 81 DGGDLMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred CCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 99999998865332 35788899999999999999999 9999999999999999999999999999987654322
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
.. .....++..|+|||++.+..++.++|+||||+++|+|++|..||..... . ....... .....
T Consensus 155 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~----~----~~~~~~~-~~~~~---- 218 (255)
T cd08219 155 AY---ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW----K----NLILKVC-QGSYK---- 218 (255)
T ss_pred cc---cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH----H----HHHHHHh-cCCCC----
Confidence 21 1134678899999999888899999999999999999999999864311 1 1111110 11111
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
..+ ...+..+.+++.+||+.||++|||+.+|+.+
T Consensus 219 --------~~~--~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 --------PLP--SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --------CCC--cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 001 1234468899999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=299.81 Aligned_cols=264 Identities=18% Similarity=0.241 Sum_probs=201.7
Q ss_pred cCCCCCCccccCCCceEEEEEECC------------------ccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFLQD------------------RPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKF 115 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~~~------------------~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~ 115 (344)
+.|+..+.||+|+||.||+|...+ ..||+|.+...... ..+.+.+|+.++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 468889999999999999998732 34899998765433 34668899999999999999999
Q ss_pred eeEEeeCCccEEEEeecCCCCccccccCCCCC------CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccce
Q 048160 116 VGCCLETELPILVFEFVACGTLADRIHDPNGS------QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTI 189 (344)
Q Consensus 116 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 189 (344)
++++..++..++|+||+++++|.+++...... ....+++..+..++.|++.||.||| +.+++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhce
Confidence 99999999999999999999999998654311 1125889999999999999999999 99999999999999
Q ss_pred EeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc--CCCCCCCCCcc
Q 048160 190 LFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT--GKRISYSSCFE 267 (344)
Q Consensus 190 ll~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~--g~~p~~~~~~~ 267 (344)
+++.++.++++|||++......... .......++..|+|||++.+..++.++||||||+++|||++ +..||....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYY-RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eecCCCceEEccccceeecccCcce-eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999998765433221 11123456778999999988889999999999999999998 556654321
Q ss_pred CcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048160 268 NGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338 (344)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~ 338 (344)
....+ ............... .+.....+.++.+++.+||+.||++|||+.+|++.|+
T Consensus 239 --~~~~~-~~~~~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 --DQQVI-ENAGHFFRDDGRQIY-----------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --hHHHH-HHHHhcccccccccc-----------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11111 111111111110000 0011123456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=295.35 Aligned_cols=248 Identities=23% Similarity=0.340 Sum_probs=202.1
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
++|+..+.||+|+||.||+|.+ ++..+++|.+..... .+.+.+|+.++++++|+||+++++++..+...++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 5788999999999999999999 468899999865532 567889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 81 GAGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred CCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 9999999986544 36889999999999999999999 9999999999999999999999999999988765432
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
.. .....++..|+|||++.+..++.++||||||+++|+|++|+.||........ . .. ...
T Consensus 154 ~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~----~-~~----~~~-------- 213 (256)
T cd06612 154 AK---RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA----I-FM----IPN-------- 213 (256)
T ss_pred cc---cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh----h-hh----hcc--------
Confidence 11 1234578899999999888899999999999999999999999864321000 0 00 000
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
............+..+.+++.+||+.||++|||+.+|++
T Consensus 214 ----~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 214 ----KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred ----CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 001111111234456899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=306.62 Aligned_cols=242 Identities=19% Similarity=0.217 Sum_probs=189.5
Q ss_pred CccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 61 KVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
+.||+|+||.||+|+. +++.||+|.+..... ...+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999998 667899999876422 2334577899999888 699999999999999999999999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
|+|..++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 152 (327)
T cd05617 81 GDLMFHMQRQR-----KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT 152 (327)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc
Confidence 99998886543 5899999999999999999999 999999999999999999999999999998753222111
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPI 294 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (344)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||......... ..............
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~-------- 219 (327)
T cd05617 153 ---TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM--NTEDYLFQVILEKP-------- 219 (327)
T ss_pred ---eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc--ccHHHHHHHHHhCC--------
Confidence 12457899999999999999999999999999999999999999643221110 01111111111110
Q ss_pred cccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCH
Q 048160 295 IVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM 330 (344)
Q Consensus 295 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 330 (344)
...|. ..+..+.+++.+||+.||++||++
T Consensus 220 -----~~~p~--~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 220 -----IRIPR--FLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred -----CCCCC--CCCHHHHHHHHHHhccCHHHcCCC
Confidence 01111 233457899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=302.68 Aligned_cols=252 Identities=21% Similarity=0.249 Sum_probs=201.1
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
.++|.+.+.||+|+||.||+|.+ ++..||+|.+........+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 35688889999999999999998 5788999998766555566788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.++++|||++......
T Consensus 84 ~~~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 84 CDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred cCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99999999987644 35889999999999999999999 999999999999999999999999999987665332
Q ss_pred CcccccCCccccccccccccccC-----cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMS-----TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
... .....++..|+|||++. ...++.++|+||||+++|+|++|..||..... ....... . ...
T Consensus 157 ~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~----~~~~~~~----~-~~~ 224 (280)
T cd06611 157 LQK---RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP----MRVLLKI----L-KSE 224 (280)
T ss_pred ccc---cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH----HHHHHHH----h-cCC
Confidence 211 12346788999999874 34578899999999999999999999864311 1111111 0 000
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
.+........+..+.+++.+||+.+|.+||++.+|++.
T Consensus 225 ------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 225 ------------PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ------------CCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00001111334568899999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=318.89 Aligned_cols=251 Identities=15% Similarity=0.164 Sum_probs=192.8
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
.|...+.||+|+||+||+|+. .+..||+|++.... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 478889999999999999998 67789999986542 1233557789999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
||++|+|.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++.....
T Consensus 82 ~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 82 YIPGGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred CCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 999999999987643 5788889999999999999999 99999999999999999999999999999753210
Q ss_pred CCc--------------------------------------------ccccCCccccccccccccccCcCCCCcccchHH
Q 048160 211 GKT--------------------------------------------HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYS 246 (344)
Q Consensus 211 ~~~--------------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~s 246 (344)
... .........||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 000 000011346899999999999989999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCC
Q 048160 247 FGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQD 326 (344)
Q Consensus 247 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 326 (344)
|||++|||++|..||..... ........ ... .....|.....+.++.+++.+++ .+|.+
T Consensus 234 lGvil~elltG~~Pf~~~~~----~~~~~~i~----~~~------------~~~~~p~~~~~s~~~~~li~~l~-~~p~~ 292 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTP----LETQMKVI----NWQ------------TSLHIPPQAKLSPEASDLIIKLC-RGPED 292 (382)
T ss_pred chHHHHHHHhCCCCCCCCCH----HHHHHHHH----ccC------------CCcCCCCcccCCHHHHHHHHHHc-cCHhH
Confidence 99999999999999975321 11111111 000 00001111123445678887765 49999
Q ss_pred CCC---HHHHHH
Q 048160 327 RPT---MVQVAK 335 (344)
Q Consensus 327 RPs---~~ei~~ 335 (344)
|++ +.++++
T Consensus 293 R~~~~~~~ei~~ 304 (382)
T cd05625 293 RLGKNGADEIKA 304 (382)
T ss_pred cCCCCCHHHHhc
Confidence 987 777664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=295.25 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=198.4
Q ss_pred CccccCCCceEEEEEEC---C--ccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 61 KVITKDLLYKLYKGFLQ---D--RPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~---~--~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
+.||+|++|.||+|.+. + ..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 46899999999999982 2 2589999887765 455678899999999999999999999988 889999999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++.........
T Consensus 80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 999999876532 25889999999999999999999 999999999999999999999999999999877543322
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDP 293 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (344)
........++..|+|||++.+..++.++||||||+++|+|++ |..||..... ....... .. ..
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~-~~---~~-------- 217 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG----SQILKKI-DK---EG-------- 217 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH-Hh---cC--------
Confidence 222223456788999999988889999999999999999998 9988753211 1111111 10 00
Q ss_pred ccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048160 294 IIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338 (344)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~ 338 (344)
..++.....+..+.+++.+||+.+|++|||+.+|++.|.
T Consensus 218 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 ------ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ------CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 000111133456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=295.08 Aligned_cols=252 Identities=21% Similarity=0.278 Sum_probs=197.5
Q ss_pred cCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
+.|.....||+|++|.||+|.+ .+..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....++||||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4577888999999999999998 445789998765432 3456789999999999999999999875 456789999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+++|.+++....+ ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 84 KGSLLDFLKEGDG---KYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 9999999975432 24788899999999999999999 99999999999999999999999999999976643322
Q ss_pred ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
.. .....++..|+|||+..+..++.++||||||+++|++++ |..||..... ........ ....
T Consensus 158 ~~--~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~~~---~~~~------ 221 (260)
T cd05069 158 TA--RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-----REVLEQVE---RGYR------ 221 (260)
T ss_pred cc--cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHH---cCCC------
Confidence 11 112345678999999988889999999999999999999 7777754211 11111111 0000
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQ 339 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~ 339 (344)
. +.....+..+.+++.+||+.||++||++.+|++.|+.
T Consensus 222 -------~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 -------M--PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -------C--CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0 0111344568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=297.23 Aligned_cols=252 Identities=20% Similarity=0.283 Sum_probs=193.5
Q ss_pred CccccCCCceEEEEEEC--Cc--cEEEEEecCCC-CchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 61 KVITKDLLYKLYKGFLQ--DR--PISVMKFGGNL-NSEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~--~~--~vavk~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
+.||+|+||.||+|.+. +. .+++|.++... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999982 33 46888876443 23345688999999999 799999999999999999999999999
Q ss_pred CCccccccCCCC-----------CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeee
Q 048160 135 GTLADRIHDPNG-----------SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFC 203 (344)
Q Consensus 135 gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg 203 (344)
|+|.+++..... .....+++.++..++.|++.||+||| +.+++||||||+||+++.++.++++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 999999865321 01124788999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
++....... .......+..|+|||++....++.++||||||+++|||++ |..||..... . +......
T Consensus 158 l~~~~~~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~---~~~~~~~ 225 (270)
T cd05047 158 LSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----A---ELYEKLP 225 (270)
T ss_pred Cccccchhh----hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-----H---HHHHHHh
Confidence 985332111 1112233567999999988889999999999999999997 8888854211 1 1111110
Q ss_pred ccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 283 ESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
..... ..+ ...+.++.+++.+||+.||.+|||+.++++.|.++.+
T Consensus 226 ~~~~~-------------~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~ 270 (270)
T cd05047 226 QGYRL-------------EKP--LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270 (270)
T ss_pred CCCCC-------------CCC--CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence 00000 000 0233468899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=296.39 Aligned_cols=255 Identities=22% Similarity=0.335 Sum_probs=202.8
Q ss_pred HhcCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
..++|.+.+.||+|+||.||+|.. ++..||+|.+..... ..+.+.+|+.++++++|+||+++++++..+...++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 346789999999999999999998 557799998875432 346788999999999999999999999988899999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+++++|.+++....+ ..+++.++..++.+++.||.||| +++++|+||+|+||+++.++.++++|||.+......
T Consensus 83 ~~~~~L~~~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 83 MSKGSLLDFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred cCCCCHHHHHhcccc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 999999999976442 35889999999999999999999 999999999999999999999999999998766432
Q ss_pred CcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcccc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEI 290 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (344)
..... ....++..|+|||.+.+..++.++|+||||++++++++ |+.||.... ....+.... ....
T Consensus 157 ~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~----~~~~~~~~~----~~~~---- 222 (261)
T cd05034 157 EYTAR--EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT----NREVLEQVE----RGYR---- 222 (261)
T ss_pred hhhhh--hccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHH----cCCC----
Confidence 21111 12234568999999988889999999999999999998 888774321 111111111 0000
Q ss_pred cccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048160 291 VDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQ 339 (344)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~ 339 (344)
.+.....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 223 -----------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 -----------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00111234568999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=301.65 Aligned_cols=248 Identities=19% Similarity=0.292 Sum_probs=201.8
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
.+|...+.||+|+||.||+|.. +++.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5688899999999999999997 68899999987665555667889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++++|.+++... .+++.++..++.|++.||.||| +.+++||||||+||+++.++.++++|||++.......
T Consensus 99 ~~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 99 AGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred CCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999998653 4788899999999999999999 9999999999999999999999999999987654322
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
.. .....+++.|+|||.+.+..++.++|+||||+++|++++|..||........ ...
T Consensus 170 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--------------------~~~ 226 (297)
T cd06656 170 SK---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--------------------LYL 226 (297)
T ss_pred cC---cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--------------------eee
Confidence 11 1134678899999999888899999999999999999999999865321000 000
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
......+........+..+.+++.+||+.+|++||++.+|++
T Consensus 227 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 227 -IATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred -eccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000001111111133455789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=301.22 Aligned_cols=259 Identities=22% Similarity=0.342 Sum_probs=201.5
Q ss_pred hcCCCCCCccccCCCceEEEEEE-------CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCcc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL-------QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELP 125 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~-------~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~ 125 (344)
.++|+..+.||+|+||.||+|.. .+..||+|.+..... .....+.+|+.++++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 35688899999999999999987 346799998876543 2345688999999999999999999999999999
Q ss_pred EEEEeecCCCCccccccCCCC-----------------CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccc
Q 048160 126 ILVFEFVACGTLADRIHDPNG-----------------SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPST 188 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N 188 (344)
++|+||+++|+|.+++..... .....+++.+++.++.|++.||.||| ..+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 999999999999999864321 01124778889999999999999999 9999999999999
Q ss_pred eEeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCcc
Q 048160 189 ILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFE 267 (344)
Q Consensus 189 ill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~ 267 (344)
|+++.++.++++|||++........... ......+..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKA-SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccc-cCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 9999999999999999876543321111 112234667999999988899999999999999999997 7778754321
Q ss_pred CcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048160 268 NGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQ 339 (344)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~ 339 (344)
. +.... ...... ...+ ...+..+.+++.+||+.||++|||+.||++.|++
T Consensus 239 ---~----~~~~~-~~~~~~------------~~~~--~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ---E----EVIYY-VRDGNV------------LSCP--DNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ---H----HHHHH-HhcCCC------------CCCC--CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 11111 111111 0011 1334568999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=312.12 Aligned_cols=264 Identities=18% Similarity=0.227 Sum_probs=195.5
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCC-----ccE
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETE-----LPI 126 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-----~~~ 126 (344)
+|+..+.||+|+||.||++.. +++.||+|++..... ...+.+.+|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999997 788999999865422 23456789999999999999999999998766 789
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
+|+||+. ++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+++
T Consensus 81 lv~e~~~-~~l~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ-----PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEeeccc-cCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEecccccee
Confidence 9999996 67888775543 5889999999999999999999 9999999999999999999999999999997
Q ss_pred ccCCCCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
......... .....++..|+|||++.+. .++.++|||||||++|||++|+.||..... ...+... .......
T Consensus 152 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i-~~~~g~~ 224 (372)
T cd07853 152 VEEPDESKH--MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP----IQQLDLI-TDLLGTP 224 (372)
T ss_pred ecccCcccc--CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH----HHHHHHH-HHHcCCC
Confidence 654322211 1134578899999998774 478999999999999999999999865321 1111111 1100000
Q ss_pred Ccccc-------cccccccC--CCCC----hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 SFKEI-------VDPIIVGE--EGLW----PEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ~~~~~-------~~~~~~~~--~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..... ........ .+.. ......+.++.+|+.+||+.||++|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 225 SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred CHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00000 00000000 0000 000122456889999999999999999999885
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=315.94 Aligned_cols=259 Identities=16% Similarity=0.249 Sum_probs=199.5
Q ss_pred HHHHHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEee
Q 048160 47 AQELKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLE 121 (344)
Q Consensus 47 ~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~ 121 (344)
..++....++|...+.||+|+||.||+++. .++.||+|.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 334455567899999999999999999999 67789999885421 1223456789999999999999999999999
Q ss_pred CCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEee
Q 048160 122 TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFD 201 (344)
Q Consensus 122 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~d 201 (344)
+...++||||+++|+|.+++... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~D 185 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLAD 185 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999998653 4788888999999999999999 99999999999999999999999999
Q ss_pred eecccccCCCCcccccCCccccccccccccccCcC----CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHH
Q 048160 202 FCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA----NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL 277 (344)
Q Consensus 202 fg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 277 (344)
||++......... ......||+.|+|||++.+. .++.++|||||||++|||++|..||..... .....
T Consensus 186 fG~a~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~~~-- 257 (371)
T cd05622 186 FGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGTYS-- 257 (371)
T ss_pred CCceeEcCcCCcc--cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH----HHHHH--
Confidence 9999876433221 11245789999999998653 378999999999999999999999975321 11111
Q ss_pred HHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 048160 278 VRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQD--RPTMVQVAKQ 336 (344)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ei~~~ 336 (344)
....... ...+|.....+..+.+++..||+.++.+ ||++.+|++.
T Consensus 258 --~i~~~~~------------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 258 --KIMNHKN------------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred --HHHcCCC------------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 1111100 0011111134456789999999844433 7788888763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=310.73 Aligned_cols=262 Identities=19% Similarity=0.236 Sum_probs=195.0
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCC-----
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETE----- 123 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~----- 123 (344)
..++|...+.||+|+||.||++.. .+..||+|++..... .....+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999988 678999999875432 23456779999999999999999999986543
Q ss_pred -ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeee
Q 048160 124 -LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF 202 (344)
Q Consensus 124 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~df 202 (344)
..|+||||+. ++|.+.+.. .++...+..++.|++.||.||| +.+|+||||||+||+++.++.++|+||
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecC
Confidence 4699999997 466666532 4778888999999999999999 999999999999999999999999999
Q ss_pred ecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHH---
Q 048160 203 CVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR--- 279 (344)
Q Consensus 203 g~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--- 279 (344)
|+++....... .....||..|+|||++.+..++.++||||||+++|+|++|..||...... ..+.....
T Consensus 168 g~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~----~~~~~~~~~~~ 239 (359)
T cd07876 168 GLARTACTNFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI----DQWNKVIEQLG 239 (359)
T ss_pred CCccccccCcc----CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcC
Confidence 99876433221 11346789999999999989999999999999999999999999754211 01111110
Q ss_pred ---------------HHhccC------CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 280 ---------------KSIESN------SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 280 ---------------~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
...... ...+.+....... ...........+.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPS--ESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred CCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhcccccccc--ccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 0000000000000 00000012356889999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=297.37 Aligned_cols=255 Identities=20% Similarity=0.237 Sum_probs=188.4
Q ss_pred CccccCCCceEEEEEEC----CccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCC
Q 048160 61 KVITKDLLYKLYKGFLQ----DRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACG 135 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~----~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 135 (344)
+.||+|+||.||+|.+. +..+|+|++...... ....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 35899999999999873 246899987665432 2346788999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCccc
Q 048160 136 TLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHV 215 (344)
Q Consensus 136 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~ 215 (344)
+|.+++...........++..+..++.|++.||.||| +.+++|+||||+||+++.++.++++|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986533211124566778889999999999999 9999999999999999999999999999986543322111
Q ss_pred ccCCccccccccccccccCcC-------CCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 216 NDNNKVIGTFGFIAPEYMSTA-------NCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 216 ~~~~~~~g~~~y~aPE~~~~~-------~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
......++..|+|||++... .++.++||||||+++|||++ |..||..... ....... ... ..
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----~~~~~~~----~~~-~~ 227 (269)
T cd05087 158 -TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD----EQVLTYT----VRE-QQ 227 (269)
T ss_pred -cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh----HHHHHHH----hhc-cc
Confidence 11234567889999988542 35789999999999999996 8888854321 1111110 000 00
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~ 338 (344)
.....+... ...+..+.+++..|| .+|++|||+++|++.|+
T Consensus 228 ~~~~~~~~~---------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 228 LKLPKPRLK---------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCccC---------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 001110000 012345788999999 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=304.05 Aligned_cols=262 Identities=21% Similarity=0.278 Sum_probs=201.9
Q ss_pred hcCCCCCCccccCCCceEEEEEE---------CCccEEEEEecCCCC-chhhhHhhHHHHHhcC-CCCceeeeeeEEeeC
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL---------QDRPISVMKFGGNLN-SEEYCCFNCIAFASQM-SHKNILKFVGCCLET 122 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~---------~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~ 122 (344)
.++|...+.||+|+||.||+|+. ....+|+|.+..... .....+.+|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 35688899999999999999975 234689998775432 2345678999999999 699999999999998
Q ss_pred CccEEEEeecCCCCccccccCCCCC-----------CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe
Q 048160 123 ELPILVFEFVACGTLADRIHDPNGS-----------QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF 191 (344)
Q Consensus 123 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 191 (344)
...++||||+++|+|.+++...... ....+++.++..++.|++.||.||| +.+++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence 9999999999999999998653210 0135888999999999999999999 9999999999999999
Q ss_pred ecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcc
Q 048160 192 QEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGE 270 (344)
Q Consensus 192 ~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~ 270 (344)
+.++.++|+|||+++.......... .....++..|+|||++.+..++.++||||||+++|++++ |..||....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~----- 241 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKK-TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP----- 241 (314)
T ss_pred cCCCcEEEccccccccccccccccc-cccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC-----
Confidence 9999999999999976643221111 111233467999999988889999999999999999999 777764321
Q ss_pred hhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 271 EYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
...+...+. ..... .....++.++.+++.+||+.||++|||+.++++.|.++..
T Consensus 242 ~~~~~~~~~----~~~~~--------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 242 VEELFKLLR----EGHRM--------------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHHHHHHH----cCCCC--------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 111111111 11000 0001334568899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=295.05 Aligned_cols=254 Identities=19% Similarity=0.284 Sum_probs=186.2
Q ss_pred ccccCCCceEEEEEE-C---CccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCC
Q 048160 62 VITKDLLYKLYKGFL-Q---DRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGT 136 (344)
Q Consensus 62 ~ig~G~~g~V~~~~~-~---~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gs 136 (344)
.||+|+||.||+|.. . ...+++|.+..... .....+.+|+..++.++|+||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 589999999999976 2 24678887654432 223567899999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcccc
Q 048160 137 LADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN 216 (344)
Q Consensus 137 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~ 216 (344)
|.+++..........+++.....++.|++.||.||| +.+|+||||||+||+++.++.++++|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999987654322223567778899999999999999 99999999999999999999999999999865433221111
Q ss_pred cCCccccccccccccccCc-------CCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 217 DNNKVIGTFGFIAPEYMST-------ANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 217 ~~~~~~g~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||..... ...+...+. ... .
T Consensus 159 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~~~~~~~~----~~~-~ 228 (269)
T cd05042 159 -KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD----EQVLKQVVR----EQD-I 228 (269)
T ss_pred -cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH----HHHHHHHhh----ccC-c
Confidence 112345678999998743 356789999999999999999 5566543211 111111111 110 0
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~ 338 (344)
....+. . ....+..+.+++..|| .||++|||+++|++.|.
T Consensus 229 ~~~~~~-------~--~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPKPQ-------L--DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCCCc-------c--cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 000000 0 0133455778999999 49999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=308.75 Aligned_cols=240 Identities=23% Similarity=0.251 Sum_probs=187.1
Q ss_pred CccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHH-HHHhcCCCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 61 KVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCI-AFASQMSHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~-~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
+.||+|+||+||+|+. +++.||+|.+..... .....+..|. .+++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999998 567899999865321 1223344444 456788999999999999999999999999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~- 151 (325)
T cd05602 81 GELFYHLQRER-----CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG- 151 (325)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-
Confidence 99999987643 4778888899999999999999 99999999999999999999999999999875432211
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPI 294 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (344)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...+.... . ..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~----~-~~-------- 212 (325)
T cd05602 152 --TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT----AEMYDNIL----N-KP-------- 212 (325)
T ss_pred --CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH----HHHHHHHH----h-CC--------
Confidence 11245789999999999999999999999999999999999999974321 11111111 0 00
Q ss_pred cccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 295 IVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 295 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... +..+..+.+++.+||+.||.+||++.+.+.
T Consensus 213 ----~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 213 ----LQLK---PNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred ----cCCC---CCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 0000 023345789999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=294.25 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=200.3
Q ss_pred CccccCCCceEEEEEEC-----CccEEEEEecCCCCch-hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 61 KVITKDLLYKLYKGFLQ-----DRPISVMKFGGNLNSE-EYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~-----~~~vavk~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
+.||+|+||.||+|... +..|++|.+....... .+.+.+|+..++.++|+||+++++++..+...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 46999999999999994 7789999987765443 56788999999999999999999999999999999999999
Q ss_pred CCccccccCCCCC----CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 135 GTLADRIHDPNGS----QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 135 gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
++|.+++...... ....+++.++..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999765110 0136899999999999999999999 99999999999999999999999999999987754
Q ss_pred CCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
.... .......++..|+|||.+....++.++||||||+++|+|++ |..||.... ...+... ... .
T Consensus 158 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~---~~~-~---- 223 (262)
T cd00192 158 DDYY-RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-----NEEVLEY---LRK-G---- 223 (262)
T ss_pred cccc-ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH---HHc-C----
Confidence 4321 11123456889999999988889999999999999999999 577775431 1111111 111 0
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~ 338 (344)
... +.....+.++.+++.+||+.+|.+|||+.++++.|+
T Consensus 224 --------~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 --------YRL--PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --------CCC--CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 000 111133567899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=298.73 Aligned_cols=240 Identities=19% Similarity=0.344 Sum_probs=188.0
Q ss_pred CccccCCCceEEEEEEC---------CccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 61 KVITKDLLYKLYKGFLQ---------DRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~---------~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
+.||+|+||.||+|... ...|++|.+........+.+..|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 36999999999999872 234888887655444556788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCc--------ceEeeee
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNV--------AKFFDFC 203 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~kl~dfg 203 (344)
+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++. ++++|||
T Consensus 81 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 81 VKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred CCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 99999999997654 25788899999999999999999 999999999999999987765 5899999
Q ss_pred cccccCCCCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
.+...... ....++..|+|||++.+. .++.++||||||+++|++++|..+++.... .........
T Consensus 154 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~----~~~~~~~~~--- 219 (258)
T cd05078 154 ISITVLPK-------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD----SQKKLQFYE--- 219 (258)
T ss_pred cccccCCc-------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc----HHHHHHHHH---
Confidence 87654321 134578889999999764 578999999999999999999655443221 000000000
Q ss_pred ccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048160 283 ESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338 (344)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~ 338 (344)
.... .|. ....++.+|+.+||+.||++|||+.+|++.|+
T Consensus 220 ~~~~---------------~~~--~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 DRHQ---------------LPA--PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cccc---------------CCC--CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 010 12245789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=307.16 Aligned_cols=263 Identities=19% Similarity=0.316 Sum_probs=200.0
Q ss_pred cCCCCCCccccCCCceEEEEEE-------CCccEEEEEecCCCC-chhhhHhhHHHHHhcC-CCCceeeeeeEEee-CCc
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL-------QDRPISVMKFGGNLN-SEEYCCFNCIAFASQM-SHKNILKFVGCCLE-TEL 124 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~-------~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~-~~~ 124 (344)
++|+..+.||+|+||.||+|.+ .++.||||++..... .....+.+|+.++.++ +||||+++++++.. +..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5688999999999999999974 357899999876432 2345678999999999 68999999998865 456
Q ss_pred cEEEEeecCCCCccccccCCCCCC--------------------------------------------------------
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQ-------------------------------------------------------- 148 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~-------------------------------------------------------- 148 (344)
.++||||+++|+|.+++....+..
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999999886432100
Q ss_pred ------CccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcccccCCccc
Q 048160 149 ------LEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVI 222 (344)
Q Consensus 149 ------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~ 222 (344)
...+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++++|||++.......... ......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~ 242 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-RKGDAR 242 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchh-hcCCCC
Confidence 023677888999999999999999 9999999999999999999999999999987654322111 111234
Q ss_pred cccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCC
Q 048160 223 GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGL 301 (344)
Q Consensus 223 g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (344)
++..|+|||.+.+..++.++||||||+++|++++ |..||..... ...... ....... ..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~----~~~~~~~------------~~ 302 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----DEEFCR----RLKEGTR------------MR 302 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc----cHHHHH----HHhccCC------------CC
Confidence 5677999999988889999999999999999997 7777754211 001111 1111100 00
Q ss_pred ChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 302 WPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 302 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
.|. ..+..+.+++..||+.||++|||+.+|++.|+.+.+.
T Consensus 303 ~~~--~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 303 APD--YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCC--CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 011 1234588999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=310.77 Aligned_cols=241 Identities=24% Similarity=0.265 Sum_probs=188.6
Q ss_pred CccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHH-HHhcCCCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 61 KVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIA-FASQMSHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
+.||+|+||.||+|+. ++..||+|.+.... ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999998 67899999986542 122344555554 57789999999999999999999999999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
|+|..++.... .+++.++..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+++.......
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 151 (325)
T cd05604 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD- 151 (325)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-
Confidence 99998886543 5889999999999999999999 99999999999999999999999999999875432211
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPI 294 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (344)
......|++.|+|||++.+..++.++|||||||++|+|++|..||..... . +........
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~----~----~~~~~~~~~---------- 211 (325)
T cd05604 152 --TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV----A----EMYDNILHK---------- 211 (325)
T ss_pred --CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH----H----HHHHHHHcC----------
Confidence 11245689999999999999999999999999999999999999975321 1 111111110
Q ss_pred cccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 295 IVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 295 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
.....+ ..+..+.+++.+||+.||++||++.+.++.
T Consensus 212 ---~~~~~~---~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 212 ---PLVLRP---GASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred ---CccCCC---CCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 000000 223457899999999999999988644333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=311.29 Aligned_cols=237 Identities=20% Similarity=0.211 Sum_probs=189.7
Q ss_pred CccccCCCceEEEEEE-----CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 61 KVITKDLLYKLYKGFL-----QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~-----~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
+.||+|+||.||+++. .++.||+|++..... .....+.+|+.++++++||||+++++++..+...|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999876 467899999875422 123446689999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 82 GGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 999999986543 5889999999999999999999 99999999999999999999999999999876543211
Q ss_pred ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDP 293 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (344)
. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ..... .... ...
T Consensus 154 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~---~i~~-~~~------ 215 (318)
T cd05582 154 K---AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----KETMT---MILK-AKL------ 215 (318)
T ss_pred c---eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----HHHHH---HHHc-CCC------
Confidence 1 1135689999999999888899999999999999999999999864321 11111 1110 000
Q ss_pred ccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHH
Q 048160 294 IIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQ 332 (344)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 332 (344)
..| ...+..+.+|+.+||+.||++||++.+
T Consensus 216 -------~~p--~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 -------GMP--QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -------CCC--CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 001 023446789999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=301.09 Aligned_cols=199 Identities=21% Similarity=0.297 Sum_probs=160.7
Q ss_pred CCccccCCCceEEEEEE----CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEee--CCccEEEEeecC
Q 048160 60 EKVITKDLLYKLYKGFL----QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLE--TELPILVFEFVA 133 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~----~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~~ 133 (344)
..+||+|+||+||+|+. .++.||+|.+.... ....+.+|+.++++++||||+++++++.. +...++|+||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 46899999999999996 34679999986542 23456789999999999999999998864 456789999996
Q ss_pred CCCccccccCCCC----CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe----ecCCcceEeeeecc
Q 048160 134 CGTLADRIHDPNG----SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF----QEQNVAKFFDFCVS 205 (344)
Q Consensus 134 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~dfg~a 205 (344)
++|.+++..... .....+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 588777643211 11135888999999999999999999 9999999999999999 45678999999999
Q ss_pred cccCCCCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCC
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSS 264 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~ 264 (344)
+................+|+.|+|||++.+. .++.++||||+||++|+|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 8765433222222345789999999998764 5899999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=301.24 Aligned_cols=262 Identities=18% Similarity=0.277 Sum_probs=201.2
Q ss_pred HhcCCCCCCccccCCCceEEEEEEC-------CccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCc
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFLQ-------DRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETEL 124 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~~-------~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~ 124 (344)
..++|.+.+.||+|+||.||+|... +..||+|.+..... .....+.+|+.+++.++||||+++++++..+..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567899999999999999999762 34799998765432 223457789999999999999999999999999
Q ss_pred cEEEEeecCCCCccccccCCCCC-----CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceE
Q 048160 125 PILVFEFVACGTLADRIHDPNGS-----QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKF 199 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 199 (344)
.++||||+++|+|.+++...... .....+...+..++.|++.||.||| +++|+||||||+||+++.++.+++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999653211 1124566788899999999999999 999999999999999999999999
Q ss_pred eeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHH
Q 048160 200 FDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELV 278 (344)
Q Consensus 200 ~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~ 278 (344)
+|||+++......... ......++..|+|||.+.+..++.++|||||||++||+++ |..||..... . ...+.
T Consensus 161 ~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~----~-~~~~~- 233 (288)
T cd05061 161 GDFGMTRDIYETDYYR-KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN----E-QVLKF- 233 (288)
T ss_pred CcCCcccccccccccc-ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH----H-HHHHH-
Confidence 9999987654332211 1112345678999999988889999999999999999998 6667654211 1 11111
Q ss_pred HHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 048160 279 RKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLH 341 (344)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~ 341 (344)
...... ...+ ...+..+.+++.+||+.||++|||+.++++.|.+..
T Consensus 234 --~~~~~~-------------~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 --VMDGGY-------------LDQP--DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred --HHcCCC-------------CCCC--CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 111100 0001 123456899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=288.40 Aligned_cols=251 Identities=20% Similarity=0.319 Sum_probs=204.5
Q ss_pred HHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC----ch----hhhHhhHHHHHhcCC-CCceeeeeeEEe
Q 048160 52 AATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN----SE----EYCCFNCIAFASQMS-HKNILKFVGCCL 120 (344)
Q Consensus 52 ~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~----~~----~~~~~~E~~~l~~l~-H~niv~~~~~~~ 120 (344)
...++|...+.||.|..++|-++.. .++.+|+|++..... .. .++-.+|+.+|+++. ||||+++.+++.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3446788899999999999998887 778899998743211 11 234458999999995 999999999999
Q ss_pred eCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEe
Q 048160 121 ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFF 200 (344)
Q Consensus 121 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 200 (344)
.+..+++|+|.|+.|.|.++|...- .+++.....|+.|+..|++||| .++||||||||+|||+|++.+++|+
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~V-----tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKV-----TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhhe-----eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEe
Confidence 9999999999999999999998764 7999999999999999999999 9999999999999999999999999
Q ss_pred eeecccccCCCCcccccCCccccccccccccccC------cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHH
Q 048160 201 DFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMS------TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFL 274 (344)
Q Consensus 201 dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 274 (344)
|||.|..+..+.... ..+||++|+|||.+. ...|+..+|+||+|++||.|+.|.+||+.... +..
T Consensus 166 DFGFa~~l~~GekLr----elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-----mlM 236 (411)
T KOG0599|consen 166 DFGFACQLEPGEKLR----ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-----MLM 236 (411)
T ss_pred ccceeeccCCchhHH----HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-----HHH
Confidence 999999988766543 468999999999873 24689999999999999999999999974210 000
Q ss_pred HHHHHHHhccCCcccccccccccCCC-CChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 275 QELVRKSIESNSFKEIVDPIIVGEEG-LWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+ .. +..|... ..|+..+.+....+|+.+||+.||.+|.|++|+++
T Consensus 237 ---L-R~------------ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 237 ---L-RM------------IMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ---H-HH------------HHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 0 11 1111111 12333455667889999999999999999999875
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=331.35 Aligned_cols=263 Identities=18% Similarity=0.248 Sum_probs=202.4
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||.||+|.. .++.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4688899999999999999998 578999999875432 22356889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCC------CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeee
Q 048160 130 EFVACGTLADRIHDPNG------SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFC 203 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg 203 (344)
||++||+|.+++..... .....+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++++|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998854210 01124566778899999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCc---------------ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccC
Q 048160 204 VSISIPEGKT---------------HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFEN 268 (344)
Q Consensus 204 ~a~~~~~~~~---------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 268 (344)
+++....... .........||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~-- 236 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG-- 236 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch--
Confidence 9986621110 00111235689999999999999999999999999999999999999864211
Q ss_pred cchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHH
Q 048160 269 GEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-TMVQVAKQLRQLH 341 (344)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~ei~~~L~~l~ 341 (344)
....... . ... ..........+..+.+++.+||+.||++|| +++++.+.|+...
T Consensus 237 -~ki~~~~---------~---i~~------P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 237 -RKISYRD---------V---ILS------PIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred -hhhhhhh---------h---ccC------hhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0000000 0 000 000000113445688999999999999995 6777888887754
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=298.46 Aligned_cols=264 Identities=17% Similarity=0.259 Sum_probs=198.6
Q ss_pred cCCCCCCccccCCCceEEEEEECC----------------ccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFLQD----------------RPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVG 117 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~~~----------------~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~ 117 (344)
+.|+..+.||+|+||.||+++..+ ..||+|.+...... ....+.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468888999999999999987622 24899998765332 3356889999999999999999999
Q ss_pred EEeeCCccEEEEeecCCCCccccccCCCC-------CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceE
Q 048160 118 CCLETELPILVFEFVACGTLADRIHDPNG-------SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTIL 190 (344)
Q Consensus 118 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil 190 (344)
++...+..++||||+++++|.+++..... .....+++.++..++.|++.||.||| +.+++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence 99999999999999999999998854321 01124678889999999999999999 999999999999999
Q ss_pred eecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc--CCCCCCCCCccC
Q 048160 191 FQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT--GKRISYSSCFEN 268 (344)
Q Consensus 191 l~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~--g~~p~~~~~~~~ 268 (344)
++.++.+||+|||++......... .......++..|+|||++.+..++.++||||||+++++|++ +..||.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-- 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-- 238 (295)
T ss_pred EcCCCcEEecccccccccccCcce-eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--
Confidence 999999999999998765432211 11123345778999999988889999999999999999998 4556543211
Q ss_pred cchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048160 269 GEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338 (344)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~ 338 (344)
....... ............ ....+ ..+..+.+|+.+||+.||++|||+.+|++.|.
T Consensus 239 --~~~~~~~-~~~~~~~~~~~~-----~~~~~------~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 --EQVIENT-GEFFRNQGRQIY-----LSQTP------LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHHH-HHhhhhcccccc-----CCCCC------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111111 111111100000 00001 23456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=297.75 Aligned_cols=264 Identities=16% Similarity=0.240 Sum_probs=199.4
Q ss_pred cCCCCCCccccCCCceEEEEEEC------------------CccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFLQ------------------DRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKF 115 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~~------------------~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~ 115 (344)
++|+..+.||+|+||.||++.+. ...||+|.+..... .....+.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888999999999999998642 23589998875533 234568899999999999999999
Q ss_pred eeEEeeCCccEEEEeecCCCCccccccCCCCC------CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccce
Q 048160 116 VGCCLETELPILVFEFVACGTLADRIHDPNGS------QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTI 189 (344)
Q Consensus 116 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 189 (344)
++++..++..++||||+++|+|.+++...... ....+++.++..++.|++.||.||| +.+++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence 99999999999999999999999988653321 1124778889999999999999999 99999999999999
Q ss_pred EeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc--CCCCCCCCCcc
Q 048160 190 LFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT--GKRISYSSCFE 267 (344)
Q Consensus 190 ll~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~--g~~p~~~~~~~ 267 (344)
+++.++.++|+|||++.......... ......++..|++||+...+.++.++||||||+++|||++ |..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYR-IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD- 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCccee-ccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-
Confidence 99999999999999987654322111 1112344678999999888889999999999999999998 6667653211
Q ss_pred CcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048160 268 NGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338 (344)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~ 338 (344)
...... ............ ..+....++..+.+|+.+||+.||++|||+.+|.+.|+
T Consensus 240 ---~~~~~~-~~~~~~~~~~~~-----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 ---EQVIEN-TGEFFRDQGRQV-----------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ---HHHHHH-HHHHHhhccccc-----------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 111111 111110000000 00111134457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=298.39 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=196.5
Q ss_pred HHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcC-CCCceeeeeeEEeeC------
Q 048160 52 AATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQM-SHKNILKFVGCCLET------ 122 (344)
Q Consensus 52 ~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~------ 122 (344)
.+++.|+..+.||+|+||.||+|.. .+..||+|.+.... .....+.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3556788889999999999999998 67789999986543 2345678899999998 699999999998753
Q ss_pred CccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeee
Q 048160 123 ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF 202 (344)
Q Consensus 123 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~df 202 (344)
...++||||+++++|.+++....+ ..+++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.++|+||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccC
Confidence 357899999999999999876432 35888999999999999999999 999999999999999999999999999
Q ss_pred ecccccCCCCcccccCCccccccccccccccC-----cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHH
Q 048160 203 CVSISIPEGKTHVNDNNKVIGTFGFIAPEYMS-----TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL 277 (344)
Q Consensus 203 g~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 277 (344)
|++........ ......|+..|+|||++. ...++.++||||||+++|+|++|..||..... . ...
T Consensus 156 g~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-----~--~~~ 225 (272)
T cd06637 156 GVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-----M--RAL 225 (272)
T ss_pred CCceecccccc---cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-----H--HHH
Confidence 99876543221 122456888999999986 33578899999999999999999999854321 0 000
Q ss_pred HHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 278 VRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. .... ...... .....+..+.+|+.+||+.||.+|||+.+|++
T Consensus 226 ~-~~~~-~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 226 F-LIPR-NPAPRL-------------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred H-HHhc-CCCCCC-------------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 0000 000000 00123446889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=296.64 Aligned_cols=256 Identities=18% Similarity=0.324 Sum_probs=201.5
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCc----cEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDR----PISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~----~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
++|...+.||+|+||.||+|.+ ++. .||+|.+..... .....+.+|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 4577889999999999999997 332 588888765543 234567899999999999999999999987 78899
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
|+||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||+++.
T Consensus 86 v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 999999999999997654 25889999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
.......... ....++..|+|||.+....++.++|+||||+++||+++ |..||..... ..+...+. ....
T Consensus 159 ~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~---~~~~ 229 (279)
T cd05057 159 LDVDEKEYHA-EGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-----VEIPDLLE---KGER 229 (279)
T ss_pred ccCcccceec-CCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHHHh---CCCC
Confidence 6533222111 11223567999999988889999999999999999998 8888854311 11111111 0000
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.+.+..++..+.+++.+||..||++||++.++++.|.++.+
T Consensus 230 ---------------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 ---------------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 01111233458899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=318.16 Aligned_cols=263 Identities=17% Similarity=0.214 Sum_probs=189.4
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeC--------C
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLET--------E 123 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--------~ 123 (344)
..+|...+.||+|+||.||+|.. .++.||||++.... ....+|+.++++++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 45799999999999999999998 67889999885442 2345799999999999999999886432 2
Q ss_pred ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC-cceEeee
Q 048160 124 LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN-VAKFFDF 202 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~df 202 (344)
.+++||||++ ++|.+++...... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++ .+||+||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARN-NHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 4679999997 5776665421100 035889999999999999999999 99999999999999998665 7999999
Q ss_pred ecccccCCCCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHH
Q 048160 203 CVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS 281 (344)
Q Consensus 203 g~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 281 (344)
|+++......... ...||+.|+|||++.+. .++.++|||||||++|||++|..||..... ...+...+...
T Consensus 216 Gla~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~----~~~~~~i~~~~ 287 (440)
T PTZ00036 216 GSAKNLLAGQRSV----SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS----VDQLVRIIQVL 287 (440)
T ss_pred ccchhccCCCCcc----cCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHh
Confidence 9998765432211 34678999999998664 689999999999999999999999865321 11122111111
Q ss_pred hcc---------CCcccccccccccCCCCCh--hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 282 IES---------NSFKEIVDPIIVGEEGLWP--EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 282 ~~~---------~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+ .......-+... ...+. .....+.++.+|+.+||++||.+|||+.++++
T Consensus 288 ~~p~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 288 GTPTEDQLKEMNPNYADIKFPDVK--PKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CCCCHHHHHHhchhhhcccCCccC--chhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000 000000000000 00000 00023457899999999999999999999874
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=311.77 Aligned_cols=266 Identities=17% Similarity=0.212 Sum_probs=199.7
Q ss_pred hcCCCCCCccccCCCceEEEEEE----CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL----QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~----~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
...|...+.||+|+||.||++.. .+..||+|.+... ....+|+.++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 34699999999999999999986 3467899987543 23468999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
|++. ++|.+++... ..+++.+++.++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++....
T Consensus 166 e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 166 PKYK-CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred hhcC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 9995 7888888543 26899999999999999999999 9999999999999999999999999999987665
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCC-cc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNS-FK 288 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 288 (344)
...... ......||..|+|||++.+..++.++|||||||++|||++|+.||+...... ....+...+........ ..
T Consensus 237 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 237 AHPDTP-QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cccccc-cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHHHhccCccccC
Confidence 432211 1124578999999999999999999999999999999999999997654322 12222222221110000 00
Q ss_pred --------cccccccccCCCCCh--h---hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 --------EIVDPIIVGEEGLWP--E---KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 --------~~~~~~~~~~~~~~~--~---~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+........+.++ . ......++.+++.+||..||++|||+.+++.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000000000 0 0123456789999999999999999999986
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=301.78 Aligned_cols=248 Identities=19% Similarity=0.299 Sum_probs=201.1
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
.+|+..+.||.|+||.||+|.. +++.|++|.+........+.+.+|+..++.++||||+++++++..+...++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 3588889999999999999987 77899999987665555667889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++++|..++... .+++.++..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 99 AGGSLTDVVTET------CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred CCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 999999988643 4789999999999999999999 9999999999999999999999999999987654332
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
.. .....++..|+|||.+.+..++.++||||||+++|++++|+.||..... ...... .. . ...
T Consensus 170 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~----~~~~~~-~~---~-~~~----- 232 (296)
T cd06655 170 SK---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP----LRALYL-IA---T-NGT----- 232 (296)
T ss_pred cc---CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHH-HH---h-cCC-----
Confidence 11 1134678899999999888899999999999999999999999865321 000000 00 0 000
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+........+..+.+++.+||..||++|||+.+|++
T Consensus 233 -------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 233 -------PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -------cccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000011133456889999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=299.07 Aligned_cols=249 Identities=18% Similarity=0.275 Sum_probs=195.4
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
|+..+.||+|+||+||+|.+ +++.||+|.+..... .....+.+|+.++++++|+||+.+.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66678899999999999999 678899999865422 1224467899999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+++++|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 82 MNGGDLKFHIYNMGN---PGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred ccCccHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 999999988864322 25899999999999999999999 999999999999999999999999999998765432
Q ss_pred CcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
... ....|+..|+|||++.+..++.++|+||||+++|+|++|..||..... ....... ........ .
T Consensus 156 ~~~----~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~----~~~~~~~-~~~~~~~~--~-- 222 (285)
T cd05632 156 ESI----RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE----KVKREEV-DRRVLETE--E-- 222 (285)
T ss_pred Ccc----cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH-HHhhhccc--c--
Confidence 211 134689999999999888899999999999999999999999864321 1011111 11111000 0
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT-----MVQVAK 335 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ei~~ 335 (344)
..+ ...+..+.+|+..||+.||++||+ +.+++.
T Consensus 223 ---------~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 ---------VYS--AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ---------ccC--ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 000 123345789999999999999999 566655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=307.37 Aligned_cols=264 Identities=16% Similarity=0.232 Sum_probs=196.3
Q ss_pred HHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCC----
Q 048160 52 AATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETE---- 123 (344)
Q Consensus 52 ~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~---- 123 (344)
...++|...+.||+|+||.||++.. .++.||+|++..... .....+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 4557899999999999999999987 678899999876532 23456778999999999999999999886432
Q ss_pred --ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEee
Q 048160 124 --LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFD 201 (344)
Q Consensus 124 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~d 201 (344)
..++||||++ ++|.+.+.. .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~D 162 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEee
Confidence 4689999996 567766642 4778888999999999999999 99999999999999999999999999
Q ss_pred eecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHH
Q 048160 202 FCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS 281 (344)
Q Consensus 202 fg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 281 (344)
||+++........ ....||..|+|||++.+..++.++|||||||++|+|++|+.||..... .......+...
T Consensus 163 fg~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~~~~~~ 234 (355)
T cd07874 163 FGLARTAGTSFMM----TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY----IDQWNKVIEQL 234 (355)
T ss_pred CcccccCCCcccc----CCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHh
Confidence 9999765432211 135689999999999988999999999999999999999999865321 11111111100
Q ss_pred ------------------hccC-Cc-----ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 282 ------------------IESN-SF-----KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 282 ------------------~~~~-~~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
.... .. ...+.......... ........+.+|+.+||+.||++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSE--HNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccc--cccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 00 00000000000000 001123567899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=316.73 Aligned_cols=251 Identities=16% Similarity=0.160 Sum_probs=193.5
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
+|+..+.||+|+||.||+++. .++.||+|.+.... ......+.+|+.++++++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 588899999999999999998 67889999986432 1223457789999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|+++|+|.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++.....
T Consensus 82 ~~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 82 YIPGGDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred CCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 999999999997643 5788888999999999999999 99999999999999999999999999999753210
Q ss_pred CCc----------------------------------------ccccCCccccccccccccccCcCCCCcccchHHHHHH
Q 048160 211 GKT----------------------------------------HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGAL 250 (344)
Q Consensus 211 ~~~----------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~i 250 (344)
... .........||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 000 0000113468999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCC--
Q 048160 251 LLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-- 328 (344)
Q Consensus 251 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-- 328 (344)
+|||++|+.||..... ..... ........ ...+.....+..+.+++.+|+ .+|.+|+
T Consensus 234 lyell~G~~Pf~~~~~-----~~~~~---~i~~~~~~------------~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~ 292 (376)
T cd05598 234 LYEMLVGQPPFLADTP-----AETQL---KVINWETT------------LHIPSQAKLSREASDLILRLC-CGAEDRLGK 292 (376)
T ss_pred eeehhhCCCCCCCCCH-----HHHHH---HHhccCcc------------ccCCCCCCCCHHHHHHHHHHh-cCHhhcCCC
Confidence 9999999999975321 11100 00000000 000010123345678888876 4999999
Q ss_pred -CHHHHHH
Q 048160 329 -TMVQVAK 335 (344)
Q Consensus 329 -s~~ei~~ 335 (344)
++.++++
T Consensus 293 ~t~~ell~ 300 (376)
T cd05598 293 NGADEIKA 300 (376)
T ss_pred CCHHHHhC
Confidence 8888874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=293.73 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=203.1
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
++|...+.||+|+||.||+|.. .+..+++|.+........+.+.+|+.++++++||||+++++++..+...+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 5788889999999999999998 56789999987765556677889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++++|.+++.... .++++.++..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||.+.......
T Consensus 83 ~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 83 GGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 9999999887653 25889999999999999999999 9999999999999999999999999999987654322
Q ss_pred cccccCCccccccccccccccCcC---CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTA---NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
.. .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... ........ ....
T Consensus 156 ~~---~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~----~~~~~~~~-----~~~~-- 221 (262)
T cd06613 156 AK---RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP----MRALFLIS-----KSNF-- 221 (262)
T ss_pred hc---cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH-----hccC--
Confidence 11 1234678899999998776 789999999999999999999999864321 00000000 0000
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
...........+.++.+++.+||+.+|.+|||+.+|+.
T Consensus 222 --------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 222 --------PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --------CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000111244567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=290.18 Aligned_cols=250 Identities=22% Similarity=0.300 Sum_probs=200.3
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCC--CCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGN--LNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
.+++|+..+.||+|.|+.||++.. .|+.+|+|.+... ...+.+.+.+|+++-+.|+||||+++...+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 345677788899999999999888 7888888876533 333567788999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC---CcceEeeeecc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ---NVAKFFDFCVS 205 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~dfg~a 205 (344)
+|+|.|++|..-+-.+ ..+++.-+-..+.||+.+|.|+| .++|||||+||+|+++.+. .-+||+|||+|
T Consensus 89 Fe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceE
Confidence 9999999997655333 35778888889999999999999 9999999999999999643 46899999999
Q ss_pred cccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
..+.... -.. -+.||+.|+|||++...+|+..+|||+.|+++|-|+.|..||+.... ..+.+.
T Consensus 161 i~l~~g~-~~~---G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-----~rlye~-------- 223 (355)
T KOG0033|consen 161 IEVNDGE-AWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRLYEQ-------- 223 (355)
T ss_pred EEeCCcc-ccc---cccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-----HHHHHH--------
Confidence 9887322 221 46899999999999999999999999999999999999999986321 112211
Q ss_pred CcccccccccccCCC-CChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 SFKEIVDPIIVGEEG-LWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+..+... +.|..+...++..+|+.+||..||.+|.|+.|.++
T Consensus 224 --------I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 224 --------IKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred --------HhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1111111 11122345566889999999999999999998764
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=293.90 Aligned_cols=247 Identities=21% Similarity=0.319 Sum_probs=197.6
Q ss_pred cCCCCCCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 55 NNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
++|...+.||+|+||.||+|...++.||+|.+.... ..+.+.+|+.++++++||||+++++++..+ ..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 458888999999999999999999999999986543 345688999999999999999999998755 47899999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
++|.+++..... ..+++.++..++.|++.||.||| +.+++||||||+||+++.++.++|+|||.+........
T Consensus 83 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~- 155 (254)
T cd05083 83 GNLVNFLRTRGR---ALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD- 155 (254)
T ss_pred CCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccCC-
Confidence 999999875432 35788899999999999999999 99999999999999999999999999999876432211
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDP 293 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (344)
....+..|+|||.+.+..++.++|+||||+++|+|++ |..||..... ......+. ....
T Consensus 156 -----~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~----~~~~------ 215 (254)
T cd05083 156 -----NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-----KEVKECVE----KGYR------ 215 (254)
T ss_pred -----CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-----HHHHHHHh----CCCC------
Confidence 1233567999999988889999999999999999997 8877754311 11111111 1000
Q ss_pred ccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048160 294 IIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQ 339 (344)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~ 339 (344)
.. .....+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 216 ------~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 216 ------ME--PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ------CC--CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 00 001334568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=293.07 Aligned_cols=248 Identities=22% Similarity=0.320 Sum_probs=197.5
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch---------hhhHhhHHHHHhcCCCCceeeeeeEEeeCCcc
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE---------EYCCFNCIAFASQMSHKNILKFVGCCLETELP 125 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~---------~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~ 125 (344)
|.....||+|++|.||+|.. .+..||+|.+....... .+.+.+|+.++++++||||+++++++......
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 66778999999999999998 56889999886543221 24577899999999999999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
++|+||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||.+
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred EEEEEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 99999999999999997643 5788899999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCccc---ccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 206 ISIPEGKTHV---NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 206 ~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
+......... .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ....... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~----~ 225 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----LQAIFKI----G 225 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH----HHHHHHH----h
Confidence 8765322111 111134578899999999888899999999999999999999999864311 1111100 0
Q ss_pred ccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. . ..+..+ ...+..+.+++.+||+.||++||++.+|++
T Consensus 226 ~-~------------~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 E-N------------ASPEIP--SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred c-c------------CCCcCC--cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 0 000001 133456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=304.35 Aligned_cols=266 Identities=16% Similarity=0.201 Sum_probs=192.8
Q ss_pred CCccccC--CCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 60 EKVITKD--LLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 60 ~~~ig~G--~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
..+||+| +|++||++.. ++..||+|++..... ...+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4679999 6789999998 678899999876532 223456689999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+|+|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++++||+..........
T Consensus 83 ~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 83 YGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999865332 24788999999999999999999 99999999999999999999999999986544322111
Q ss_pred cc----ccCCccccccccccccccCc--CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh----c
Q 048160 214 HV----NDNNKVIGTFGFIAPEYMST--ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI----E 283 (344)
Q Consensus 214 ~~----~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~ 283 (344)
.. .......++..|+|||++.+ ..++.++|||||||++|||++|..||...... ........... .
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~ 232 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT----QMLLEKLNGTVPCLLD 232 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh----HHHHHHhcCCcccccc
Confidence 10 01112356778999999876 45899999999999999999999998643211 11111000000 0
Q ss_pred c-----C-----Cccccccccc------------ccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 284 S-----N-----SFKEIVDPII------------VGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 284 ~-----~-----~~~~~~~~~~------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. . ......+... .......+........+.+|+.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0 0 0000000000 0000011111234567899999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=304.14 Aligned_cols=240 Identities=18% Similarity=0.271 Sum_probs=191.0
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCC-CCceeeeeeEEeeCCccEEEE
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMS-HKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~ 129 (344)
+|...+.||+|+||.||+|.. +++.||+|.+.... ....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 367778999999999999998 67889999987542 223355678888888885 578889999999889999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++|+|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 9999999999887643 5889999999999999999999 9999999999999999999999999999987543
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ........ . ..
T Consensus 153 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~~~~i~----~-~~--- 217 (323)
T cd05615 153 VDGV---TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE----DELFQSIM----E-HN--- 217 (323)
T ss_pred CCCc---cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHH----h-CC---
Confidence 2221 11245689999999999988899999999999999999999999865321 11111111 0 00
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM 330 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 330 (344)
...|. ..+..+.+++.+||+.||.+|++.
T Consensus 218 ----------~~~p~--~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 ----------VSYPK--SLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----------CCCCc--cCCHHHHHHHHHHcccCHhhCCCC
Confidence 00111 233467899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=292.76 Aligned_cols=253 Identities=19% Similarity=0.297 Sum_probs=199.3
Q ss_pred hcCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
.+.|...+.||+|+||.||++.+ .+..+|+|.+.... ...+.+.+|+.++++++|+||+++++++.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 45688899999999999999998 55678998876542 234568899999999999999999999877 7789999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++++|.+++....+ ..+++.++..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||.+.......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 83 AKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCcHHHHHHhCCc---cccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999976432 35788889999999999999999 9999999999999999999999999999987654332
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
... .....++..|+|||++....++.++|+||||+++|++++ |..||..... . .....+. ....
T Consensus 157 ~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~----~-~~~~~~~---~~~~----- 221 (260)
T cd05073 157 YTA--REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----P-EVIRALE---RGYR----- 221 (260)
T ss_pred ccc--ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH----H-HHHHHHh---CCCC-----
Confidence 211 112345677999999988889999999999999999998 7877753211 1 1111110 0000
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQ 339 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~ 339 (344)
.+.....+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus 222 ----------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 ----------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00011334568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=315.92 Aligned_cols=245 Identities=22% Similarity=0.315 Sum_probs=203.2
Q ss_pred CCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCCc
Q 048160 60 EKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTL 137 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL 137 (344)
.-+||+|+||+||-|+. +...+|||-+........+-++.|+.+.++|+|.|||+++|.+.+++++-|.||-.+||||
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 45699999999999999 4456799988777666677788999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccc--cHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEee-cCCcceEeeeecccccCCCCcc
Q 048160 138 ADRIHDPNGSQLEPF--LMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ-EQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 138 ~~~l~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
.++|+..=| |+ .+.+.-.+..||+.||.||| ++.|||||||.+|+|++ -.|.+||+|||.++.+..-...
T Consensus 660 SsLLrskWG----PlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 660 SSLLRSKWG----PLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred HHHHHhccC----CCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 999987554 45 78888899999999999999 99999999999999996 5789999999999877543322
Q ss_pred cccCCccccccccccccccCcC--CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTA--NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
.+++.||.-|||||++..+ .|...+|||||||++.||.||++||..... ++ ...+.
T Consensus 733 ---TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs----pq---------------AAMFk 790 (1226)
T KOG4279|consen 733 ---TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS----PQ---------------AAMFK 790 (1226)
T ss_pred ---ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC----hh---------------Hhhhh
Confidence 2367899999999999876 489999999999999999999999974321 11 11122
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
-..-+.+++.|. ..+.+...++.+|+.+||.+||++.++++
T Consensus 791 VGmyKvHP~iPe--elsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 791 VGMYKVHPPIPE--ELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred hcceecCCCCcH--HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 222224444444 66778899999999999999999999875
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=313.70 Aligned_cols=249 Identities=19% Similarity=0.299 Sum_probs=204.3
Q ss_pred CCCccccCCCceEEEEEE---CC--ccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 59 PEKVITKDLLYKLYKGFL---QD--RPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 59 ~~~~ig~G~~g~V~~~~~---~~--~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
..++||+|.||.|++|.| .| -.||||.+..+... ..+.|++|+.+|.+|+|+|+++|||+..+ ....+|+|++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 347899999999999999 33 36899999877554 56889999999999999999999999887 7788999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
+.|||.+.|.+... ..|.......++.|||.|+.||. .+++|||||.++|+|+.....+||+|||+.+.+..+.
T Consensus 193 plGSLldrLrka~~---~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKK---AILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred ccchHHHHHhhccc---cceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999987221 46888899999999999999999 9999999999999999999999999999999887765
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcC-CCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG-KRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
..........-+..|+|||.+....++.++|||+|||++|||+|+ ..||-+.. ...+.+ .+
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~-----g~qIL~-------------~i 328 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR-----GIQILK-------------NI 328 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC-----HHHHHH-------------hc
Confidence 543322233446789999999999999999999999999999984 45664321 111111 11
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L 337 (344)
| ..++.+....|+.++++++.+||..+|++|||+..|.+.+
T Consensus 329 D-----~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 329 D-----AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred c-----ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 1 2233444448899999999999999999999999997544
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=304.00 Aligned_cols=250 Identities=22% Similarity=0.296 Sum_probs=206.6
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch---hhhHhhHHHHHhcCC-CCceeeeeeEEeeCCccE
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE---EYCCFNCIAFASQMS-HKNILKFVGCCLETELPI 126 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~---~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~ 126 (344)
....|...+.||+|.||.||+++. +|+.+|+|.+.+..... .+.+.+|+.+|++++ |||||.+++++.+.+..+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 345688889999999999999999 68899999987664432 357889999999998 999999999999999999
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC----CcceEeee
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ----NVAKFFDF 202 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~df 202 (344)
+|||+|.||.|.+.+... .+++..+..++.|++.++.||| +.+|+||||||+|+|+... +.++++||
T Consensus 113 lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 999999999999998764 2899999999999999999999 9999999999999999643 47999999
Q ss_pred ecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 203 CVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 203 g~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
|++........ ....+||+.|+|||++....|+..+||||+|+++|.|++|..||........ ....
T Consensus 184 Gla~~~~~~~~----~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~----~~~i----- 250 (382)
T KOG0032|consen 184 GLAKFIKPGER----LHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI----FLAI----- 250 (382)
T ss_pred CCceEccCCce----EeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH----HHHH-----
Confidence 99998876222 1257899999999999999999999999999999999999999986532111 1111
Q ss_pred ccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
....+ .-..+.|+ ..+..+.+++..|+..||.+|+|+.++++
T Consensus 251 ~~~~~--------~f~~~~w~---~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 251 LRGDF--------DFTSEPWD---DISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HcCCC--------CCCCCCcc---ccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 01111 11222333 34567889999999999999999999986
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=306.18 Aligned_cols=265 Identities=17% Similarity=0.244 Sum_probs=194.3
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
...+|...+.||+|+||.||+|+. .+..||+|..... ....|+.++++++||||+++++++..+...++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 345799999999999999999999 4567888874332 23568999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
++. ++|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+++....
T Consensus 138 ~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 138 HYS-SDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred ccC-CcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 995 68888886544 36889999999999999999999 99999999999999999999999999999875332
Q ss_pred CCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchh------HHHHHHHHHh-c
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEY------FLQELVRKSI-E 283 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~------~~~~~~~~~~-~ 283 (344)
.... ....||..|+|||++.+..++.++|||||||++|||+++..|++.......... .+...+.... .
T Consensus 210 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 285 (357)
T PHA03209 210 APAF----LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH 285 (357)
T ss_pred Cccc----ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence 2111 134689999999999998999999999999999999997777654322211111 1111111100 0
Q ss_pred cCCcc-----cc----cccc--cccCCCCChh--hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 284 SNSFK-----EI----VDPI--IVGEEGLWPE--KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 284 ~~~~~-----~~----~~~~--~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+..+. .. ++.. .......++. ....+.++.+|+.+||+.||++|||+.||++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 286 PEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred hhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 00000 00 0000 0000000000 0122345678999999999999999999975
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=295.79 Aligned_cols=258 Identities=19% Similarity=0.311 Sum_probs=200.7
Q ss_pred cCCCCCCccccCCCceEEEEEEC-------CccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFLQ-------DRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPI 126 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~~-------~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~ 126 (344)
.+|+....||+|+||.||+|+.. ...|++|.+...... ..+.+.+|+.++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46888899999999999999972 356888887654433 3467889999999999999999999999989999
Q ss_pred EEEeecCCCCccccccCCCCCC----CccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeee
Q 048160 127 LVFEFVACGTLADRIHDPNGSQ----LEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF 202 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~df 202 (344)
+||||+++|+|.+++....... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999987543211 125889999999999999999999 999999999999999999999999999
Q ss_pred ecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHH
Q 048160 203 CVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKS 281 (344)
Q Consensus 203 g~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 281 (344)
|++......... ......++..|+|||.+.+..++.++||||||+++|++++ |..||..... ...... .
T Consensus 162 ~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~----~~~~~~----~ 231 (275)
T cd05046 162 SLSKDVYNSEYY--KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD----EEVLNR----L 231 (275)
T ss_pred ccccccCccccc--ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch----HHHHHH----H
Confidence 998654322211 1113356778999999988888999999999999999998 6677643211 111111 1
Q ss_pred hccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048160 282 IESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQ 339 (344)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~ 339 (344)
..... .++....++..+.+++.+||+.+|++|||+.++++.|.+
T Consensus 232 -~~~~~-------------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 232 -QAGKL-------------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred -HcCCc-------------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 00010 011111344568999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=288.88 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=196.0
Q ss_pred CccccCCCceEEEEEE-CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCCcc
Q 048160 61 KVITKDLLYKLYKGFL-QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLA 138 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 138 (344)
++||+|+||.||++.. +++.|++|++...... ....+.+|+.++++++|+||+++++++......++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 4699999999999998 5789999988765443 4456889999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcccccC
Q 048160 139 DRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDN 218 (344)
Q Consensus 139 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~ 218 (344)
+++.... ..+++..+..++.+++.||.||| +++++||||+|+||+++.++.++|+|||++........... .
T Consensus 81 ~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~-~ 152 (251)
T cd05041 81 TFLRKKK----NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS-D 152 (251)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec-c
Confidence 9986543 25788899999999999999999 99999999999999999999999999999876543221111 1
Q ss_pred CccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccccccccccc
Q 048160 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVG 297 (344)
Q Consensus 219 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (344)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |..||..... ......+.. ..
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-----~~~~~~~~~----~~----------- 212 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-----QQTRERIES----GY----------- 212 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-----HHHHHHHhc----CC-----------
Confidence 12233567999999988889999999999999999999 6666643211 111111110 00
Q ss_pred CCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048160 298 EEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338 (344)
Q Consensus 298 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~ 338 (344)
. .+.....+..+.+++.+||+.+|++|||+.+|++.|.
T Consensus 213 -~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 213 -R--MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -C--CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 0 0001134557899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=291.42 Aligned_cols=237 Identities=22% Similarity=0.396 Sum_probs=186.3
Q ss_pred CccccCCCceEEEEEECCc------------cEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 61 KVITKDLLYKLYKGFLQDR------------PISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~~~------------~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
+.||+|+||.||+|.+.+. .|++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 4689999999999999332 3777776555332 5678899999999999999999999988 778999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC-------cceEee
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN-------VAKFFD 201 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-------~~kl~d 201 (344)
|||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++ .++++|
T Consensus 79 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 79 EEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 99999999999997654 25888999999999999999999 99999999999999999888 799999
Q ss_pred eecccccCCCCcccccCCccccccccccccccCcC--CCCcccchHHHHHHHHHHHcC-CCCCCCCCccCcchhHHHHHH
Q 048160 202 FCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA--NCNEKSDVYSFGALLLELLTG-KRISYSSCFENGEEYFLQELV 278 (344)
Q Consensus 202 fg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g-~~p~~~~~~~~~~~~~~~~~~ 278 (344)
||++...... ....++..|+|||++... .++.++||||||+++|+|++| ..|+..... .. ....
T Consensus 152 fg~a~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-~~----~~~~- 218 (259)
T cd05037 152 PGIPITVLSR-------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-SE----KERF- 218 (259)
T ss_pred CCcccccccc-------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-hh----HHHH-
Confidence 9998765431 123567789999998776 789999999999999999995 555543211 00 0000
Q ss_pred HHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048160 279 RKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338 (344)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~ 338 (344)
..... ..+. .....+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 219 ---~~~~~--------------~~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 ---YQDQH--------------RLPM--PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ---HhcCC--------------CCCC--CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 0000 00146889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=291.74 Aligned_cols=250 Identities=23% Similarity=0.362 Sum_probs=198.0
Q ss_pred cCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
.+|+..+.||+|+||.||+|.+ ++..+|+|.+..... ....+.+|+.++++++||||+++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3577789999999999999998 578899998865432 34568899999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+++|.+++.... .++++..+..++.+++.||.||| +.+++|+||||+||+++.++.++++|||++........
T Consensus 83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 83 HGCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999999987544 25788899999999999999999 99999999999999999999999999999876543221
Q ss_pred ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
.. .....++..|+|||++.+..++.++||||||+++|||++ |..||..... ......... . ..
T Consensus 156 ~~--~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~-~-~~---- 219 (256)
T cd05112 156 TS--STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--------SEVVETINA-G-FR---- 219 (256)
T ss_pred cc--cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHhC-C-CC----
Confidence 11 112234678999999988889999999999999999998 8888753211 111111100 0 00
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L 337 (344)
...+. ..+..+.+|+.+||+.+|++|||+.++++.|
T Consensus 220 -------~~~~~--~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 220 -------LYKPR--LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -------CCCCC--CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 00000 1235689999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=292.33 Aligned_cols=250 Identities=20% Similarity=0.279 Sum_probs=193.3
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-----chhhhHhhHHHHHhcCCCCceeeeeeEEee--CCcc
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-----SEEYCCFNCIAFASQMSHKNILKFVGCCLE--TELP 125 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~ 125 (344)
.+|...+.||+|+||.||+|.. .+..|++|++..... .....+.+|+.++++++||||+++++++.. +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688999999999999999998 678899998764321 123457789999999999999999998865 3577
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
++++||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 89999999999999987543 4788889999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
.................++..|+|||++.+..++.++||||||+++|+|++|..||..... . ..+.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----~----~~~~~~~~~~ 225 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----M----AAIFKIATQP 225 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----H----HHHHHHhcCC
Confidence 7654322111111234578899999999888899999999999999999999999864311 1 1111110000
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+..| ......+.+++ .||..+|++||++.+|++
T Consensus 226 ------------~~~~~~--~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 ------------TNPQLP--SHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ------------CCCCCc--hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 000011 12334566777 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=305.57 Aligned_cols=262 Identities=16% Similarity=0.234 Sum_probs=195.6
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeC------
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLET------ 122 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~------ 122 (344)
..++|...+.||+|+||.||++.. .++.||||++..... .....+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457899999999999999999998 678899999876432 2345677999999999999999999987643
Q ss_pred CccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeee
Q 048160 123 ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF 202 (344)
Q Consensus 123 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~df 202 (344)
...++||||++ ++|.+.+.. .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeC
Confidence 35699999996 577776642 4778888999999999999999 999999999999999999999999999
Q ss_pred ecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 203 CVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 203 g~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
|+++........ ....+|..|+|||++.+..++.++|||||||++|+|++|+.||..... .......+....
T Consensus 171 G~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~~~~~~~ 242 (364)
T cd07875 171 GLARTAGTSFMM----TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH----IDQWNKVIEQLG 242 (364)
T ss_pred CCccccCCCCcc----cCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcC
Confidence 999765432211 134689999999999999999999999999999999999999965321 111111111000
Q ss_pred ------------------ccC-C-----cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ------------------ESN-S-----FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ------------------~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
... . ....+......... .........+.+|+.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 243 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADS--EHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred CCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccc--cccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 0 00000000000000 000012346789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=293.59 Aligned_cols=247 Identities=22% Similarity=0.291 Sum_probs=200.2
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC-CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL-NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
++|+..+.||.|++|.||+|.. ++..||+|.+.... ......+.+|+.++++++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 3577889999999999999998 67889999987553 23345678999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+++++|.+++... ++++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++......
T Consensus 81 ~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 9999999998753 5889999999999999999999 999999999999999999999999999998776543
Q ss_pred CcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
.. ......++..|+|||++.+..++.++||||||+++|+|++|..||..... ......+ ....
T Consensus 152 ~~---~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~----~~~~----- 214 (274)
T cd06609 152 MS---KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-----MRVLFLI----PKNN----- 214 (274)
T ss_pred cc---ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-----HHHHHHh----hhcC-----
Confidence 21 11234678899999999888899999999999999999999999854321 0000000 0000
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+..+.. ..+..+.+++.+||..+|++|||+.++++
T Consensus 215 -------~~~~~~~-~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 215 -------PPSLEGN-KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred -------CCCCccc-ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0000110 13456889999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=296.58 Aligned_cols=199 Identities=20% Similarity=0.291 Sum_probs=159.8
Q ss_pred CCccccCCCceEEEEEE----CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEee--CCccEEEEeecC
Q 048160 60 EKVITKDLLYKLYKGFL----QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLE--TELPILVFEFVA 133 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~----~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~~ 133 (344)
..+||+|+||.||+|+. .+..||+|.+.... ....+.+|+.++++++||||+++++++.. +...++|+||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 36799999999999997 23679999886543 23457789999999999999999998854 457799999996
Q ss_pred CCCccccccCCCC----CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe----ecCCcceEeeeecc
Q 048160 134 CGTLADRIHDPNG----SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF----QEQNVAKFFDFCVS 205 (344)
Q Consensus 134 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~dfg~a 205 (344)
++|.+++..... .....+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 577776642211 11135888899999999999999999 9999999999999999 46678999999999
Q ss_pred cccCCCCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCC
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSS 264 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~ 264 (344)
+................+|..|+|||++.+. .++.++|||||||++|||+||..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 8765433222222345789999999998764 5789999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=295.85 Aligned_cols=251 Identities=28% Similarity=0.432 Sum_probs=196.8
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhh--hHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEY--CCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~--~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
|+..+.||+|+||+||+++. ++..||+|.+......... ...+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 44567899999999999999 5567999999877543332 2356999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++++|.+++... ..+++.++..++.|++.||.+|| +.+++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN 152 (260)
T ss_dssp TTEBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred cccccccccccc-----ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 988999999733 26899999999999999999999 9999999999999999999999999999987642111
Q ss_pred cccccCCccccccccccccccC-cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMS-TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
. ......++..|+|||++. +..++.++||||+|+++++|++|..||..... .+..................
T Consensus 153 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~---- 224 (260)
T PF00069_consen 153 E---NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS-DDQLEIIEKILKRPLPSSSQ---- 224 (260)
T ss_dssp S---EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH-HHHHHHHHHHHHTHHHHHTT----
T ss_pred c---ccccccccccccccccccccccccccccccccccccccccccccccccccc-hhhhhhhhhccccccccccc----
Confidence 1 112456788999999998 78899999999999999999999999875411 01111111111111100000
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
........+.+++.+||+.||++|||+.++++
T Consensus 225 ------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 ------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011257899999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=292.52 Aligned_cols=246 Identities=23% Similarity=0.311 Sum_probs=199.3
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC-CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL-NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
.|+..+.||+|+||.||+|.. .+..||+|.+.... ......+.+|+.+++++.|+||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 477778999999999999998 57889999876543 334466789999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++++|.+++... ++++.++..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++.......
T Consensus 85 ~~~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 85 GGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999988642 4788899999999999999999 9999999999999999999999999999987664332
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
.. .....++..|+|||++.+..++.++|+||||+++|+|++|..||..... ...... ....
T Consensus 156 ~~---~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-----~~~~~~----~~~~------- 216 (277)
T cd06640 156 IK---RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP-----MRVLFL----IPKN------- 216 (277)
T ss_pred cc---cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh-----HhHhhh----hhcC-------
Confidence 11 1234678899999999888899999999999999999999999864311 000000 0000
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
..+ ......+..+.+++.+||+.+|++||++.++++.
T Consensus 217 -----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 217 -----NPP--TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -----CCC--CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 000 1112456678999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=296.36 Aligned_cols=265 Identities=17% Similarity=0.204 Sum_probs=192.2
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch--hhhHhhHHHHHhcC---CCCceeeeeeEEee-----CC
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE--EYCCFNCIAFASQM---SHKNILKFVGCCLE-----TE 123 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~--~~~~~~E~~~l~~l---~H~niv~~~~~~~~-----~~ 123 (344)
+|...+.||+|+||+||+|+. +++.||+|.+....... ...+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 477889999999999999998 67889999987543222 23455777777665 69999999998864 24
Q ss_pred ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeee
Q 048160 124 LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFC 203 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg 203 (344)
..++|+||+. ++|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccC
Confidence 5789999997 588888865432 24889999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhc
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE 283 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (344)
++........ .....++..|+|||++.+..++.++|||||||++|+|++|..||..... ...+.+.......
T Consensus 154 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~----~~~~~~~~~~~~~ 225 (288)
T cd07863 154 LARIYSCQMA----LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE----ADQLGKIFDLIGL 225 (288)
T ss_pred ccccccCccc----CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH----HHHHHHHHHHhCC
Confidence 9876543221 1134678899999999888899999999999999999999988854321 1122222211100
Q ss_pred c--CCcccc---cccccccCCC-CCh-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 284 S--NSFKEI---VDPIIVGEEG-LWP-EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 284 ~--~~~~~~---~~~~~~~~~~-~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. ..+... .......... ... ..+..+..+.+++.+||+.||++|||+.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 226 PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 000000 0000000000 000 00123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=293.94 Aligned_cols=252 Identities=22% Similarity=0.264 Sum_probs=203.9
Q ss_pred CCCCCCccccCCCceEEEEEECC--ccEEEEEecCCCCch---hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 56 NYDPEKVITKDLLYKLYKGFLQD--RPISVMKFGGNLNSE---EYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~~~--~~vavk~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
.|+..+.||.|.-|+||+++..+ ..+|+|++.+..-.. ......|-.+|+.+.||-++.+|+.+..+...|+|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 46667889999999999999944 789999987664332 3445678889999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
||+||+|..+++...+ ..|++..+..++.+++.||+||| -.|||.|||||+|||+-++|++-|+||.++.....
T Consensus 158 yCpGGdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred cCCCccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999877665 47999999999999999999999 99999999999999999999999999998765421
Q ss_pred CCc------------------------------c-c----------------------ccCCccccccccccccccCcCC
Q 048160 211 GKT------------------------------H-V----------------------NDNNKVIGTFGFIAPEYMSTAN 237 (344)
Q Consensus 211 ~~~------------------------------~-~----------------------~~~~~~~g~~~y~aPE~~~~~~ 237 (344)
..+ . . ...+.++||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 100 0 0 0112467999999999999999
Q ss_pred CCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHH
Q 048160 238 CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAI 317 (344)
Q Consensus 238 ~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 317 (344)
.+..+|+|+||+++|||+.|..||.+... ...+..+ +. +....|..+..+..+.+||.
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~----~~Tl~NI-------------v~-----~~l~Fp~~~~vs~~akDLIr 369 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNN----KETLRNI-------------VG-----QPLKFPEEPEVSSAAKDLIR 369 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCc----hhhHHHH-------------hc-----CCCcCCCCCcchhHHHHHHH
Confidence 99999999999999999999999986532 1112211 11 22333443355667899999
Q ss_pred HccccCCCCCCC----HHHHHH
Q 048160 318 KCLSKSEQDRPT----MVQVAK 335 (344)
Q Consensus 318 ~cl~~dP~~RPs----~~ei~~ 335 (344)
+.|.+||++|.- +.||.+
T Consensus 370 ~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 370 KLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHhccChhhhhccccchHHhhc
Confidence 999999999987 666643
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=298.16 Aligned_cols=255 Identities=21% Similarity=0.284 Sum_probs=201.1
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
++|+..+.||+|+||+||++.. ++..||+|++..... .....+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 4577778999999999999998 478899998765432 2346688999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCC-CCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFS-RPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
+++++|.+++...+ .+++..+..++.+++.||.||| + .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 85 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 85 MDCGSLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred CCCCCHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHH---HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 99999999886643 5889999999999999999999 6 5899999999999999999999999998765422
Q ss_pred CCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcc---hhHHHHHHHHHhccCCc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGE---EYFLQELVRKSIESNSF 287 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 287 (344)
.. .....|+..|+|||++.+..++.++|||||||++|++++|..||......... .....+........
T Consensus 157 ~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 228 (284)
T cd06620 157 SI-----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE--- 228 (284)
T ss_pred hc-----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc---
Confidence 11 11356889999999998888999999999999999999999999754322111 01111111111110
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
..+..+. ...+..+.+|+.+||+.||++|||+.||++.
T Consensus 229 ----------~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 229 ----------PPPRLPS-SDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred ----------cCCCCCc-hhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1111111 1245568999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=297.62 Aligned_cols=264 Identities=20% Similarity=0.229 Sum_probs=201.9
Q ss_pred cccHHHHHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcC-CCCceeeeeeEEe
Q 048160 44 NFTAQELKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQM-SHKNILKFVGCCL 120 (344)
Q Consensus 44 ~~~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~ 120 (344)
.+.++.+..+.++|...+.||+|+||.||++.. .++.+|+|.+.... .....+.+|+.+++++ +||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred eEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 355677777889999999999999999999988 67789999876432 2335677899999999 6999999999874
Q ss_pred -----eCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC
Q 048160 121 -----ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN 195 (344)
Q Consensus 121 -----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 195 (344)
.+...++||||+++++|.+++...... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEG 161 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCC
Confidence 345689999999999999887532111 135788889999999999999999 99999999999999999999
Q ss_pred cceEeeeecccccCCCCcccccCCccccccccccccccCc-----CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcc
Q 048160 196 VAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-----ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGE 270 (344)
Q Consensus 196 ~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 270 (344)
.++++|||++......... .....|+..|+|||++.. ..++.++||||||+++|+|++|..||.....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~---- 234 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRLR---RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP---- 234 (286)
T ss_pred CEEEccCCceeecccCCCc---cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch----
Confidence 9999999998766432211 113468899999998753 4478899999999999999999999864311
Q ss_pred hhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 271 EYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
...+.. .. .... .........+..+.+++.+||+.||++|||+.+|++.
T Consensus 235 ~~~~~~----~~-~~~~------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 235 MRALFK----IP-RNPP------------PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred hHHHhh----cc-ccCC------------CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000000 00 0000 0000001233468899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=289.94 Aligned_cols=249 Identities=26% Similarity=0.329 Sum_probs=201.4
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC--CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL--NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
+|+..+.||+|+||.||.++. ++..+++|.+.... ......+.+|+.++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477889999999999988887 67889999876442 33446688999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+++++|.+++....+ ..+++.++..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 999999999976432 35889999999999999999999 999999999999999999999999999998766443
Q ss_pred CcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
.. ......++..|+|||++.+..++.++|+||||+++|+|++|..||..... . +...... .....
T Consensus 155 ~~---~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~----~----~~~~~~~-~~~~~--- 219 (256)
T cd08221 155 YS---MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP----L----NLVVKIV-QGNYT--- 219 (256)
T ss_pred cc---cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH----H----HHHHHHH-cCCCC---
Confidence 32 11245688999999999888889999999999999999999998854211 1 1111111 11111
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
+.....+..+.+++.+||+.+|++||++.++++.
T Consensus 220 -----------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 -----------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -----------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 0111345568999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=291.49 Aligned_cols=248 Identities=22% Similarity=0.278 Sum_probs=199.7
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC--CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL--NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
+|+..+.||+|+||.||.+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999998 67889999986432 23345688999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+++++|.+++....+ ..+++.++..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++......
T Consensus 81 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 81 CEGGDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 999999998865432 24788899999999999999999 999999999999999999999999999998766443
Q ss_pred CcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
.... ....|+..|+|||++.+..++.++|+||||++++++++|+.||.... .. +.......
T Consensus 155 ~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~----~~----~~~~~~~~-------- 215 (256)
T cd08218 155 VELA---RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN----MK----NLVLKIIR-------- 215 (256)
T ss_pred hhhh---hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC----HH----HHHHHHhc--------
Confidence 2211 13457888999999988889999999999999999999999986431 11 11111111
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+..+..+ ...+.++.+++.+||+.+|++||++.+|++
T Consensus 216 -----~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 216 -----GSYPPVS--SHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -----CCCCCCc--ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1111111 134456899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.97 Aligned_cols=262 Identities=24% Similarity=0.370 Sum_probs=207.8
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
..|...+.||+|+||.||+|++ ++..||||++..... ....|+..+++++|||||+++|+|.++...++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4578889999999999999997 678999998864432 1235688999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++|+|.++++ .+++.++..++.|++.||+|||+..+.+|+||||||+||+++.++..++. ||.+......
T Consensus 766 ~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~- 835 (968)
T PLN00113 766 EGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD- 835 (968)
T ss_pred CCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence 9999999995 27788999999999999999996556799999999999999988887765 6554332211
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
....++..|+|||++.+..++.++|||||||++|||++|+.||..... ......+|.............++
T Consensus 836 ------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 906 (968)
T PLN00113 836 ------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG---VHGSIVEWARYCYSDCHLDMWID 906 (968)
T ss_pred ------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC---CCCcHHHHHHHhcCccchhheeC
Confidence 123678999999999999999999999999999999999999854322 22234444444443444444555
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
+.+.... +.......++.+++.+||+.||++|||+.+|++.|+++.+
T Consensus 907 ~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 907 PSIRGDV---SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred ccccCCC---CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 5443221 1223455678899999999999999999999999998865
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=292.07 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=197.2
Q ss_pred CCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCc------hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 56 NYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNS------EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
+|...+.||+|+||.||+|.. ++..+|+|.+...... ....+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 367789999999999999988 7788999987654221 124477899999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
+||+++++|.+++.... ++++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.++++|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 99999999999997643 5788899999999999999999 999999999999999999999999999998765
Q ss_pred CCCCcc---cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 209 PEGKTH---VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 209 ~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
...... ........++..|+|||++.+..++.++||||||+++|++++|..||..... ........ ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~----~~~ 224 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR----LAAMFYIG----AHR 224 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh----HHHHHHhh----hcc
Confidence 321111 1111134578899999999888899999999999999999999999864321 00000000 000
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.. . +. .....+..+.+++.+||+.+|++||++.++++
T Consensus 225 ~~---~--------~~--~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 GL---M--------PR--LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CC---C--------CC--CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 0 00 00123456889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=303.95 Aligned_cols=236 Identities=22% Similarity=0.274 Sum_probs=185.0
Q ss_pred CccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHH-HHHhcCCCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 61 KVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCI-AFASQMSHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~-~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
+.||+|+||.||+|+. ++..||+|.+..... .....+.+|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999 677899999865421 1233445554 467889999999999999999999999999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
|+|...+.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 151 (321)
T cd05603 81 GELFFHLQRER-----CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE- 151 (321)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-
Confidence 99988886543 5788889999999999999999 99999999999999999999999999999875322211
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPI 294 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (344)
......|++.|+|||++.+..++.++|||||||++|||++|..||..... . ... ..... ..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~-~~~---~~i~~-~~-------- 212 (321)
T cd05603 152 --TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV----S-QMY---DNILH-KP-------- 212 (321)
T ss_pred --ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH----H-HHH---HHHhc-CC--------
Confidence 11245689999999999988899999999999999999999999975321 1 111 11110 00
Q ss_pred cccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHH
Q 048160 295 IVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMV 331 (344)
Q Consensus 295 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 331 (344)
...|. ..+..+.+++.+||+.||.+||++.
T Consensus 213 -----~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 213 -----LQLPG--GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -----CCCCC--CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 00010 2234578999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=295.35 Aligned_cols=249 Identities=20% Similarity=0.304 Sum_probs=201.8
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
++|...+.||+|+||.||+|.. ++..||+|.+........+.+.+|+.++++++||||+++++++..+...++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6788999999999999999987 67889999987655555567889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++++|.+++... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 99 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999998653 4778889999999999999999 9999999999999999999999999999887654332
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
.. .....+++.|+|||.+....++.++|+||||+++|++++|..||........ ..
T Consensus 170 ~~---~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~----~~----------------- 225 (293)
T cd06647 170 SK---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LY----------------- 225 (293)
T ss_pred cc---cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh----ee-----------------
Confidence 21 1234678899999999888899999999999999999999999865321000 00
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
.......+..+.....+..+.+++.+||+.+|++||++.+++..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 226 LIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000111111122344568899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=299.64 Aligned_cols=247 Identities=19% Similarity=0.295 Sum_probs=197.2
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
|.....||+|+||.||++.. ++..||+|.+........+.+.+|+..+++++|+||+++++.+..++..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 33346799999999999998 6788999998766555566788999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
++|.+++... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++........
T Consensus 104 ~~L~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~- 173 (292)
T cd06658 104 GALTDIVTHT------RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP- 173 (292)
T ss_pred CcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence 9999988542 4788899999999999999999 99999999999999999999999999999875533221
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPI 294 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (344)
......++..|+|||++.+..++.++||||||+++||+++|..||..... ..... .+... ....
T Consensus 174 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~~~~~-~~~~~---------~~~~ 237 (292)
T cd06658 174 --KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP----LQAMR-RIRDN---------LPPR 237 (292)
T ss_pred --cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHH-HHHhc---------CCCc
Confidence 11234678899999999888899999999999999999999999864311 11111 11000 0000
Q ss_pred cccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 295 IVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 295 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
. +.....+..+.+++..||..||++|||+.+|++.
T Consensus 238 ~-------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 238 V-------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred c-------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0 0111234457899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=311.52 Aligned_cols=202 Identities=17% Similarity=0.216 Sum_probs=172.7
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|+..+.||+|+||.||++.. .++.||+|.+.... ......+.+|+.++.+++|+||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688889999999999999998 67889999986432 223455678999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++....
T Consensus 81 E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 9999999999987653 5889999999999999999999 9999999999999999999999999999987543
Q ss_pred CCCcc--------------------------------cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcC
Q 048160 210 EGKTH--------------------------------VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257 (344)
Q Consensus 210 ~~~~~--------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 257 (344)
..... ........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 21100 0001134689999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 048160 258 KRISYSS 264 (344)
Q Consensus 258 ~~p~~~~ 264 (344)
..||...
T Consensus 233 ~~Pf~~~ 239 (360)
T cd05627 233 YPPFCSE 239 (360)
T ss_pred CCCCCCC
Confidence 9999653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=297.50 Aligned_cols=256 Identities=20% Similarity=0.351 Sum_probs=198.8
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCc----cEEEEEecCCCCch-hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDR----PISVMKFGGNLNSE-EYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~----~vavk~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
++|+..+.||+|+||.||+|.+ ++. .||+|.+....... ...+.+|+.++++++||||++++|++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 4577889999999999999988 443 46888876553322 34578999999999999999999998754 4678
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
++||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||+++.
T Consensus 86 v~e~~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eehhcCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEcccccccc
Confidence 999999999999987644 25788899999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
......... .....++..|+|||++.+..++.++||||||+++||+++ |..||.... .....+++. ...
T Consensus 159 ~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-----~~~~~~~~~----~~~ 228 (303)
T cd05110 159 LEGDEKEYN-ADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-----TREIPDLLE----KGE 228 (303)
T ss_pred ccCcccccc-cCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHH----CCC
Confidence 653322111 112345678999999988889999999999999999997 888875421 111111111 110
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
. .+....++..+.+++..||..+|++||++.++++.|..+.+
T Consensus 229 ~--------------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 229 R--------------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred C--------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 00001233468899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=301.69 Aligned_cols=254 Identities=17% Similarity=0.220 Sum_probs=193.4
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCC---CCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGN---LNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||.||+++. +++.||+|.+... .....+.+.+|..++..++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4688899999999999999998 6788999998642 1223355778999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.++|+|||++....
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred ecCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 9999999999996543 25889999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCcccccCCccccccccccccccCc-----CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMST-----ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES 284 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (344)
...... .....||+.|+|||++.. ..++.++|||||||++|+|++|..||..... . +........
T Consensus 154 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~----~----~~~~~i~~~ 223 (331)
T cd05597 154 ADGTVQ--SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL----V----ETYGKIMNH 223 (331)
T ss_pred CCCCcc--ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH----H----HHHHHHHcC
Confidence 322211 113468999999999863 4578899999999999999999999864321 1 111111111
Q ss_pred CCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCC--CCCCCHHHHHHH
Q 048160 285 NSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSE--QDRPTMVQVAKQ 336 (344)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP--~~RPs~~ei~~~ 336 (344)
..... ..+.....+..+.+++.+|+..++ ..||++.++++.
T Consensus 224 ~~~~~-----------~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 224 KEHFQ-----------FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCccc-----------CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00000 000001234567888888776543 347898888753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=292.86 Aligned_cols=269 Identities=19% Similarity=0.251 Sum_probs=198.1
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
++|+....||+|+||.||+|.. +++.||+|++..... ...+.+.+|+.++++++|+||+++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4688889999999999999998 578999998764422 223457799999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|+++++|..+..... .+++.++..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 81 YCDHTVLNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred ccCccHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 999988887765443 5889999999999999999999 99999999999999999999999999999887654
Q ss_pred CCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc----C
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES----N 285 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~ 285 (344)
.... .....++..|+|||++.+ ..++.++||||||+++|+|++|..||....... ............... .
T Consensus 153 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 153 PGDD---YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred Cccc---ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChHHhhhc
Confidence 3321 113456788999999876 457899999999999999999999886432211 000111110000000 0
Q ss_pred Ccccccccc-cccCCCCCh---hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 SFKEIVDPI-IVGEEGLWP---EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ~~~~~~~~~-~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
......... ........+ ..+..+..+.+|+.+||+.+|++|||+.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000000 000000000 01123466899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=295.73 Aligned_cols=251 Identities=19% Similarity=0.284 Sum_probs=197.2
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
++|+..+.||+|+||.||++.+ .+..||+|.+..... .....+.+|+.++++++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 3577889999999999999999 578999998875432 2346688999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCC-CCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFS-RPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
+++++|..++..... ...+++..+..++.+++.||.||| + .+|+|+||||+||+++.++.++++|||++.....
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 81 MDAGSLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLK---EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred cCCCCHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHH---hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 999999988865311 125889999999999999999999 6 5999999999999999999999999999876532
Q ss_pred CCcccccCCccccccccccccccCcC------CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTA------NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES 284 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (344)
... ....++..|+|||++.+. .++.++|+|||||++|+|++|..||..... ...........
T Consensus 156 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~-- 223 (286)
T cd06622 156 SLA-----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-----ANIFAQLSAIV-- 223 (286)
T ss_pred Ccc-----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-----hhHHHHHHHHh--
Confidence 211 134578899999998554 357899999999999999999999864321 01111110000
Q ss_pred CCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 285 NSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+..+..+ ...+.++.+++.+||+.+|++||++.+++.
T Consensus 224 -----------~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 224 -----------DGDPPTLP--SGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -----------hcCCCCCC--cccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 00111111 135567889999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=294.69 Aligned_cols=259 Identities=22% Similarity=0.303 Sum_probs=201.3
Q ss_pred ccHHHHHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcC-CCCceeeeeeEEee
Q 048160 45 FTAQELKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQM-SHKNILKFVGCCLE 121 (344)
Q Consensus 45 ~~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~ 121 (344)
.+..++....+.|+....||+|+||.||+|.. .+..+|+|.+.... .....+..|+.+++++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 46666666778899999999999999999999 66789999875543 2345677899999998 69999999999853
Q ss_pred ------CCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC
Q 048160 122 ------TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN 195 (344)
Q Consensus 122 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 195 (344)
+...++||||+++|+|.+++....+ ..+++..+..++.|++.||.||| +.+|+|+||+|+||+++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENA 158 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCC
Confidence 4578999999999999998875432 24778888999999999999999 99999999999999999999
Q ss_pred cceEeeeecccccCCCCcccccCCccccccccccccccC-----cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcc
Q 048160 196 VAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMS-----TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGE 270 (344)
Q Consensus 196 ~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 270 (344)
.++|+|||++........ ......|+..|+|||.+. ...++.++||||||+++|+|++|..||.....
T Consensus 159 ~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~---- 231 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP---- 231 (282)
T ss_pred CEEEeeCcchhhhhcccc---CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH----
Confidence 999999999876532211 112456889999999875 34578899999999999999999999864321
Q ss_pred hhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 271 EYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
...... ..... .........+..+.+|+.+||+.||.+|||+.+|++
T Consensus 232 ~~~~~~----~~~~~--------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 232 MRALFL----IPRNP--------------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred Hhhhhh----HhhCC--------------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000000 00000 000000134456899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=301.31 Aligned_cols=262 Identities=19% Similarity=0.270 Sum_probs=201.7
Q ss_pred hcCCCCCCccccCCCceEEEEEEC---------CccEEEEEecCCCC-chhhhHhhHHHHHhcC-CCCceeeeeeEEeeC
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQ---------DRPISVMKFGGNLN-SEEYCCFNCIAFASQM-SHKNILKFVGCCLET 122 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~---------~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~ 122 (344)
..+|.+.+.||+|+||.||++.+. +..||+|.+..... ...+.+.+|+.+++++ +||||+++++++..+
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 345888999999999999999861 12589998765432 2346788999999999 799999999999999
Q ss_pred CccEEEEeecCCCCccccccCCCCC-----------CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe
Q 048160 123 ELPILVFEFVACGTLADRIHDPNGS-----------QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF 191 (344)
Q Consensus 123 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 191 (344)
...++++||+++|+|.+++...... ....+++.+++.++.|++.||.||| +.+++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEE
Confidence 9999999999999999998653210 1135788889999999999999999 9999999999999999
Q ss_pred ecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcc
Q 048160 192 QEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGE 270 (344)
Q Consensus 192 ~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~ 270 (344)
+.++.++|+|||+++......... ......++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----- 241 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP----- 241 (334)
T ss_pred cCCCcEEECCcccceecccccccc-cccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-----
Confidence 999999999999987654322111 1112234567999999988889999999999999999998 677764321
Q ss_pred hhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 271 EYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
..+......... .. +....++..+.+++.+||+.+|++|||+.+|++.|.++..
T Consensus 242 ---~~~~~~~~~~~~-~~--------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 242 ---VEELFKLLKEGH-RM--------------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred ---HHHHHHHHHcCC-CC--------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 111111111100 00 0001334568899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=294.63 Aligned_cols=244 Identities=23% Similarity=0.312 Sum_probs=196.3
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCC-CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL-NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
|+..+.||+|+||.||+|.+ .+..||+|.+.... ....+.+.+|+.++++++||||+++++++..++..++|+||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 55567899999999999988 56789999876443 2334567899999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+++|.+++... .+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||++........
T Consensus 86 ~~~L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 86 GGSALDLLKPG------PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999988642 4788999999999999999999 99999999999999999999999999999876543221
Q ss_pred ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDP 293 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (344)
. .....++..|+|||++.+..++.++|+||||+++|+|++|..|+..... . . .... .....
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~----~-~---~~~~-~~~~~------- 217 (277)
T cd06642 157 K---RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP----M-R---VLFL-IPKNS------- 217 (277)
T ss_pred h---hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch----h-h---HHhh-hhcCC-------
Confidence 1 1134578899999999888899999999999999999999999753211 0 0 0000 00000
Q ss_pred ccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 294 IIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+.. ....+.++.+++.+||+.+|++|||+.+|++
T Consensus 218 -----~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 218 -----PPTL--EGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred -----CCCC--CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0000 0134456889999999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=309.38 Aligned_cols=198 Identities=21% Similarity=0.269 Sum_probs=170.2
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCC-C-----CceeeeeeEEeeCCccEE
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-H-----KNILKFVGCCLETELPIL 127 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~~~~~~~~~~~~~l 127 (344)
.|.+.+.||+|+||.|-+|.. ++..||||++++.-. -.++...|+.+|..|+ | -|+|++++++...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 467789999999999999999 688999999987632 3455667999999997 4 479999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC--CcceEeeeecc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ--NVAKFFDFCVS 205 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~dfg~a 205 (344)
|+|.+. .+|+++++.+.- ..|+...+..++.||+.||.+|| ..+|||+||||+||||... ..+||+|||.|
T Consensus 266 VfELL~-~NLYellK~n~f---~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKF---RGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eehhhh-hhHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccc
Confidence 999995 799999987654 46889999999999999999999 9999999999999999644 37999999999
Q ss_pred cccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccC
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFEN 268 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 268 (344)
........ ..+.+..|+|||++.+.+|+.+.||||||||+.||++|.+. +++..+.
T Consensus 339 c~~~q~vy------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PL-fpG~ne~ 394 (586)
T KOG0667|consen 339 CFESQRVY------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPL-FPGDNEY 394 (586)
T ss_pred cccCCcce------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccc-cCCCCHH
Confidence 87654332 45678999999999999999999999999999999999554 4544433
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=297.53 Aligned_cols=266 Identities=17% Similarity=0.234 Sum_probs=196.7
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
+.|...+.||+|+||.||+|+. .+..||+|.+...... ....+.+|+.++++++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 4588889999999999999988 5788999998654322 234567899999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
++ ++|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++......
T Consensus 86 ~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 86 LD-KDLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred cc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 97 68988886543 25788899999999999999999 999999999999999999999999999998764332
Q ss_pred CcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh--ccCCcc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI--ESNSFK 288 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 288 (344)
.... ....+++.|+|||++.+ ..++.++||||||+++|+|++|..||..... ............ ....+.
T Consensus 158 ~~~~---~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~----~~~~~~~~~~~~~~~~~~~~ 230 (301)
T cd07873 158 TKTY---SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV----EEQLHFIFRILGTPTEETWP 230 (301)
T ss_pred CCcc---cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHcCCCChhhch
Confidence 2111 12356889999998865 3578899999999999999999999865321 111111110000 000011
Q ss_pred ccccccc--ccCCCCCh------hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 EIVDPII--VGEEGLWP------EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~~~~~~~--~~~~~~~~------~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
....... ....+.+. .....+..+.+|+.+||+.||.+|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 231 GILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1000000 00000000 00123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=290.35 Aligned_cols=250 Identities=20% Similarity=0.267 Sum_probs=194.3
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-----chhhhHhhHHHHHhcCCCCceeeeeeEEeeC--Ccc
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-----SEEYCCFNCIAFASQMSHKNILKFVGCCLET--ELP 125 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~ 125 (344)
++|...+.||+|+||.||.|.. ++..||+|.+..... ...+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4788899999999999999998 578899998753321 1234677899999999999999999988763 467
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccc
Confidence 89999999999999987543 4788889999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
.................++..|+|||++.+..++.++||||||+++|+|++|+.||..... . .... ......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~---~~~~-~~~~~~ 225 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----M---AAIF-KIATQP 225 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch----H---HHHH-HHhcCC
Confidence 7654322111112234678899999999888899999999999999999999999853211 1 1111 110000
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+..| ......+.+++.+||. +|++||++++|++
T Consensus 226 ------------~~~~~~--~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 ------------TNPVLP--PHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ------------CCCCCc--hhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 001111 1334567889999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=298.44 Aligned_cols=243 Identities=20% Similarity=0.285 Sum_probs=195.7
Q ss_pred CCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCCc
Q 048160 60 EKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTL 137 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL 137 (344)
...||+|+||.||++.. ++..||+|.+........+.+.+|+..++.++||||+++++++..+...++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 45799999999999988 6788999998665444556688999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCccccc
Q 048160 138 ADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217 (344)
Q Consensus 138 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~ 217 (344)
..++... .+++.++..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 106 ~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--- 173 (297)
T cd06659 106 TDIVSQT------RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--- 173 (297)
T ss_pred HHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc---
Confidence 9887542 4788999999999999999999 999999999999999999999999999998755432211
Q ss_pred CCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccccccc
Q 048160 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVG 297 (344)
Q Consensus 218 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (344)
.....++..|+|||++.+..++.++||||||+++++|++|..||..... ...+. .+. .....
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~-~~~----~~~~~--------- 235 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP----VQAMK-RLR----DSPPP--------- 235 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHH-HHh----ccCCC---------
Confidence 1234678999999999888899999999999999999999999874321 11111 110 00000
Q ss_pred CCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 298 EEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 298 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+......+..+.+++.+||+.+|++||++.+|++
T Consensus 236 ---~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 236 ---KLKNAHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred ---CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000123345789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=289.05 Aligned_cols=248 Identities=23% Similarity=0.303 Sum_probs=197.0
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEee-CCccEEEEe
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLE-TELPILVFE 130 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-~~~~~lv~e 130 (344)
+|+..+.||+|++|.||++.. +++.||+|++..... ...+.+.+|+.++++++|+|++++++.+.. +...++|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 477889999999999999998 667899999865432 234567899999999999999999998764 446789999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|+++++|.+++....+ ..+++.++..++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~l~~~~~---~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQKG---KLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 9999999999875332 35889999999999999999999 99999999999999999999999999999876643
Q ss_pred CCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEI 290 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (344)
.... .....+++.|+|||++.+..++.++||||||++++++++|..||..... ......... ....
T Consensus 155 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--------~~~~~~~~~-~~~~-- 220 (257)
T cd08223 155 QCDM---ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM--------NSLVYRIIE-GKLP-- 220 (257)
T ss_pred cCCc---cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHh-cCCC--
Confidence 2211 1234678899999999888899999999999999999999998864311 111111111 1100
Q ss_pred cccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 291 VDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+ ...+..+.+++.+||+.||++|||+.++++
T Consensus 221 ----------~~~--~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 ----------PMP--KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ----------CCc--cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 134456899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=296.34 Aligned_cols=266 Identities=15% Similarity=0.169 Sum_probs=196.1
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
+|...+.||+|+||.||+|+. ++..||+|++...... ....+.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 367788999999999999999 6788999998654222 234567899999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+. ++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 81 CD-QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 97 58888776543 25889999999999999999999 999999999999999999999999999998765432
Q ss_pred CcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC-----
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN----- 285 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 285 (344)
.... ....++..|+|||++.+. .++.++||||||+++|+|++|..|++..... ...+...........
T Consensus 153 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07839 153 VRCY---SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV---DDQLKRIFRLLGTPTEESWP 226 (284)
T ss_pred CCCc---CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH---HHHHHHHHHHhCCCChHHhH
Confidence 2111 134568899999998664 4789999999999999999999998654321 111111111000000
Q ss_pred Cccccccccccc---CCCCCh-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 SFKEIVDPIIVG---EEGLWP-EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ~~~~~~~~~~~~---~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
......+..... ....|. ..+..+.++.+++.+||+.||.+|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000000000 000000 01124467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=298.69 Aligned_cols=255 Identities=19% Similarity=0.224 Sum_probs=198.6
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||.||++.. .++.|++|.+..... .....+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 4688889999999999999998 567899998875532 22356778999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.++++|||+++...
T Consensus 81 e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 81 EYVEGGDCATLLKNIG-----ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred ecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 9999999999997643 5888999999999999999999 9999999999999999999999999999886421
Q ss_pred CCCcc------------cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHH
Q 048160 210 EGKTH------------VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL 277 (344)
Q Consensus 210 ~~~~~------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 277 (344)
..... ........++..|+|||.+....++.++|+||||+++|++++|..||..... .......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~----~~~~~~~ 228 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP----EELFGQV 228 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Confidence 11000 0011123567889999999888899999999999999999999999864311 1111111
Q ss_pred HHHHhccCCcccccccccccCCCCChhh-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048160 278 VRKSIESNSFKEIVDPIIVGEEGLWPEK-EKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQ 339 (344)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~ 339 (344)
... .. .+|.. ...+..+.+++.+||+.||++||++.++.+.|+.
T Consensus 229 ~~~-----~~-------------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 ISD-----DI-------------EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred Hhc-----cc-------------CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 100 00 00000 0234568999999999999999997666665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=296.28 Aligned_cols=262 Identities=20% Similarity=0.238 Sum_probs=201.8
Q ss_pred ccHHHHHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcC-CCCceeeeeeEEee
Q 048160 45 FTAQELKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQM-SHKNILKFVGCCLE 121 (344)
Q Consensus 45 ~~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~ 121 (344)
++..++..++++|.....||+|+||.||++.. +++.+|+|.+.... .....+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 56677777889999999999999999999998 57789999876542 2335577899999999 79999999999875
Q ss_pred C-----CccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCc
Q 048160 122 T-----ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNV 196 (344)
Q Consensus 122 ~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 196 (344)
. ...++|+||+++++|.+++...... ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCC
Confidence 4 3579999999999999987532110 135888999999999999999999 999999999999999999999
Q ss_pred ceEeeeecccccCCCCcccccCCccccccccccccccCcC-----CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcch
Q 048160 197 AKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA-----NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEE 271 (344)
Q Consensus 197 ~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 271 (344)
++|+|||++.......... ....++..|+|||++... .++.++||||||+++|+|++|+.||..... .
T Consensus 167 ~kl~dfg~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~----~ 239 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLRR---NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP----V 239 (291)
T ss_pred EEEeecccchhcccccccc---cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH----H
Confidence 9999999987654322211 134578899999987543 368999999999999999999999864321 1
Q ss_pred hHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 272 YFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+... .. ..... ..........+.+++.+||+.+|++||++.+|++
T Consensus 240 ~~~~~~----~~-~~~~~------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 240 KTLFKI----PR-NPPPT------------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHHH----hc-CCCCC------------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111 00 00000 0011123346899999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=293.71 Aligned_cols=265 Identities=18% Similarity=0.215 Sum_probs=195.0
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
+|+..+.||+|++|.||+|+. ++..||+|++..... .....+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 477788999999999999998 678899999865432 2235677899999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
++ ++|.+++...... ..+++.++..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 81 LS-MDLKKYLDSLPKG--QYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred CC-CCHHHHHhcCCCC--CcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 97 6888887543321 25889999999999999999999 999999999999999999999999999998755322
Q ss_pred CcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc--C---
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES--N--- 285 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~--- 285 (344)
... .....++..|+|||++.+. .++.++||||||+++|+|++|+.||....... ............ .
T Consensus 155 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 227 (285)
T cd07861 155 VRV---YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID----QLFRIFRILGTPTEDVWP 227 (285)
T ss_pred ccc---ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHHhCCCChhhhh
Confidence 111 1123568899999988654 57899999999999999999999986532211 111111000000 0
Q ss_pred ------CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 ------SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.....+.....+. ........+.++.+++.+||+.||++|||+.+|+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 228 GVTSLPDYKNTFPKWKKGS--LRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred cchhhHHHHhhccccCcch--hHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000000 00000123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=302.31 Aligned_cols=252 Identities=16% Similarity=0.212 Sum_probs=194.2
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCC---CCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGN---LNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||+||+++. .++.||+|.+... .......+.+|..++..++|+||+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688899999999999999998 6678999998642 1122344678899999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++....
T Consensus 81 Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred eCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999997643 25888899999999999999999 9999999999999999999999999999987664
Q ss_pred CCCcccccCCccccccccccccccCc-----CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMST-----ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES 284 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (344)
...... .....|++.|+|||++.+ ..++.++||||||+++|+|++|+.||..... ..... .....
T Consensus 154 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~----~~~~~----~i~~~ 223 (331)
T cd05624 154 QDGTVQ--SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYG----KIMNH 223 (331)
T ss_pred CCCcee--eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH----HHHHH----HHHcC
Confidence 332211 113468999999999865 4678999999999999999999999965321 11111 11110
Q ss_pred CCcccccccccccCCCCChh-hHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 048160 285 NSFKEIVDPIIVGEEGLWPE-KEKQLLSYTELAIKCLSKSEQD--RPTMVQVAK 335 (344)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~--RPs~~ei~~ 335 (344)
... ...|. ....+..+.+++.+|+..++++ |+++.++++
T Consensus 224 ~~~------------~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 224 EER------------FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred CCc------------ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 000 00010 1123456889999999876544 467877764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=302.28 Aligned_cols=262 Identities=17% Similarity=0.251 Sum_probs=194.2
Q ss_pred HHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeC-----
Q 048160 52 AATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLET----- 122 (344)
Q Consensus 52 ~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~----- 122 (344)
...++|...+.||+|+||.||+|.. .++.||||++...... ....+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457799999999999999999988 6678999998764322 234567899999999999999999987543
Q ss_pred -CccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEee
Q 048160 123 -ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFD 201 (344)
Q Consensus 123 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~d 201 (344)
...+++++++ +++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcC
Confidence 3468999998 68998887542 4889999999999999999999 99999999999999999999999999
Q ss_pred eecccccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHH
Q 048160 202 FCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280 (344)
Q Consensus 202 fg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 280 (344)
||++....... ....||..|+|||++.+ ..++.++|||||||++|+|++|..||..... ...+..+...
T Consensus 162 fg~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~~~~~ 231 (343)
T cd07878 162 FGLARQADDEM------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY----IDQLKRIMEV 231 (343)
T ss_pred CccceecCCCc------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHH
Confidence 99987654321 13468999999999876 5689999999999999999999999864321 1111111110
Q ss_pred HhccCCccccccccc-------ccCCCCChhh------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 281 SIESNSFKEIVDPII-------VGEEGLWPEK------EKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 281 ~~~~~~~~~~~~~~~-------~~~~~~~~~~------~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.. ........... ....+..+.. ....+.+.+|+.+||+.||++|||+.++++
T Consensus 232 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 232 VG--TPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred hC--CCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 00000000000 0000000000 012235789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=291.80 Aligned_cols=251 Identities=22% Similarity=0.354 Sum_probs=194.3
Q ss_pred CccccCCCceEEEEEECC--------ccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 61 KVITKDLLYKLYKGFLQD--------RPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~~--------~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
+.||+|+||.||+|++.+ ..+|+|.+..... .....+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999999832 4688898765432 3456688999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCC--CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC-----cceEeeeec
Q 048160 132 VACGTLADRIHDPNGS--QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN-----VAKFFDFCV 204 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-----~~kl~dfg~ 204 (344)
+++++|.+++...... ....+++.+++.++.|++.||.||| +.+++|+||+|+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998643211 1124788899999999999999999 99999999999999999887 899999999
Q ss_pred ccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhc
Q 048160 205 SISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIE 283 (344)
Q Consensus 205 a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (344)
+......... .......++..|+|||++.+..++.++||||||+++|+|++ |..||..... . .....+ .
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~----~-~~~~~~----~ 227 (269)
T cd05044 158 ARDIYKSDYY-RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN----Q-EVLQHV----T 227 (269)
T ss_pred cccccccccc-ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH----H-HHHHHH----h
Confidence 8765432211 11112345678999999998899999999999999999998 8888753211 1 111111 0
Q ss_pred cCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048160 284 SNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338 (344)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~ 338 (344)
... . .......+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 228 ~~~------------~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 228 AGG------------R--LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cCC------------c--cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 000 0 0011134567899999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=288.57 Aligned_cols=258 Identities=23% Similarity=0.301 Sum_probs=202.9
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC-CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL-NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
++|+..+.||.|+||+||+|.. ++..+++|++.... ....+.+.+|+..++.++|+||+++++.+..+...++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688899999999999999998 66789999986543 23456788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+++++|.+++...... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 81 LSGGSLLDIMKSSYPR--GGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred cCCCcHHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 9999999998653210 25788999999999999999999 999999999999999999999999999998776544
Q ss_pred Cccc-ccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 212 KTHV-NDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 212 ~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
.... .......++..|+|||++... .++.++|+||||+++++|++|..||..... .....+... ... .
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~----~~~~~~~~~----~~~-~- 225 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP----MKVLMLTLQ----NDP-P- 225 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh----hhhHHHHhc----CCC-C-
Confidence 3221 112244688899999998776 789999999999999999999999864321 111111111 000 0
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
...........+..+.+++..||+.||++|||+.+|++
T Consensus 226 --------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 --------SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred --------CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000001134567899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=288.62 Aligned_cols=252 Identities=22% Similarity=0.339 Sum_probs=200.5
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
.|...+.||+|+||.||+|.. +++.|++|.+...... ..+.+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 367789999999999999998 6788999998766443 456788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+++++|.+++.... .+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 99999999987643 4778889999999999999999 999999999999999999999999999998876543
Q ss_pred Cccccc-CCccccccccccccccCcCC---CCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 212 KTHVND-NNKVIGTFGFIAPEYMSTAN---CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 212 ~~~~~~-~~~~~g~~~y~aPE~~~~~~---~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
...... .....++..|+|||++.+.. ++.++||||||++++++++|..||..... .......+. .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~----~~~~~~~~~----~--- 221 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN----EFQIMFHVG----A--- 221 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc----hHHHHHHHh----c---
Confidence 322111 11345688999999988766 88999999999999999999999864321 000000000 0
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+..+..|.....+..+.+++.+||+.+|++|||+.+++.
T Consensus 222 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 222 ---------GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---------CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 011111221133556789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=300.68 Aligned_cols=253 Identities=17% Similarity=0.224 Sum_probs=193.6
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||+||+++. .++.+|+|.+.... ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4688889999999999999998 56779999885421 122344678899999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++....
T Consensus 81 ey~~~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 9999999999997643 25888899999999999999999 9999999999999999999999999999987653
Q ss_pred CCCcccccCCccccccccccccccC-----cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMS-----TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES 284 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (344)
...... .....||+.|+|||++. ...++.++|||||||++|||++|+.||..... . +........
T Consensus 154 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~----~----~~~~~i~~~ 223 (332)
T cd05623 154 EDGTVQ--SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL----V----ETYGKIMNH 223 (332)
T ss_pred cCCcce--ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH----H----HHHHHHhCC
Confidence 322211 11356899999999986 34588999999999999999999999964321 1 111111110
Q ss_pred CCcccccccccccCCCCChh-hHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 048160 285 NSFKEIVDPIIVGEEGLWPE-KEKQLLSYTELAIKCLSKSEQD--RPTMVQVAKQ 336 (344)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~--RPs~~ei~~~ 336 (344)
.. ....|. ....+.++.+|+.+|+..+|++ |+++.++++.
T Consensus 224 ~~------------~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 224 KE------------RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred Cc------------cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 000111 1134556889999988655444 6889888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=291.07 Aligned_cols=252 Identities=20% Similarity=0.298 Sum_probs=201.4
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
++|+..+.||+|+||.||++.. +++.||+|.+..... .....+.+|+.++++++||||+++++++..++..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 3577788999999999999999 578899999876643 3345678999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCC-CCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFS-RPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
+++++|.+++.... .++++..+..++.|++.||.||| + .+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 81 MDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred cCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 99999999997643 36888999999999999999999 8 9999999999999999999999999999865532
Q ss_pred CCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEI 290 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (344)
.... ...++..|+|||.+.+..++.++||||||++++++++|..||......... ...........
T Consensus 154 ~~~~-----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~------ 219 (265)
T cd06605 154 SLAK-----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG---IFELLQYIVNE------ 219 (265)
T ss_pred HHhh-----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc---HHHHHHHHhcC------
Confidence 2111 246788999999998889999999999999999999999998654221111 11111111110
Q ss_pred cccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 291 VDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+..+.. ..+.++.+++.+||..||++|||+.+++.
T Consensus 220 -------~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 220 -------PPPRLPSG-KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -------CCCCCChh-hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11111111 14566899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=298.31 Aligned_cols=271 Identities=22% Similarity=0.301 Sum_probs=203.3
Q ss_pred CCCCCCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcC--CCCceeeeeeEEeeCC----ccEEEE
Q 048160 56 NYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQM--SHKNILKFVGCCLETE----LPILVF 129 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~~~~~~~~~~----~~~lv~ 129 (344)
+.....+||+|.||.||+|.++++.||||+|... +.+.|..|-++++-. +|+||++++++-..++ .++||+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred chhhHHHhhcCccceeehhhccCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 3445578999999999999999999999998765 566788787777664 7999999999977665 889999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhc------CCCCCeeeecccccceEeecCCcceEeeee
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHV------GFSRPIVFRDIKPSTILFQEQNVAKFFDFC 203 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~------~~~~~ivH~dlk~~Nill~~~~~~kl~dfg 203 (344)
||.+.|||.++|..+ .++|.....++..+++||+|||+ +...+|+|||||+.|||+.+|+.+.|+|||
T Consensus 288 ~fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eeccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999875 58999999999999999999993 347799999999999999999999999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCcCC-CC-----cccchHHHHHHHHHHHcCCCCCCCCCccCcchhH-HHH
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTAN-CN-----EKSDVYSFGALLLELLTGKRISYSSCFENGEEYF-LQE 276 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-----~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~~~ 276 (344)
+|..+.......... -.+||.+|||||++.+.. +. ...||||+|.++||++++..-+++... ...+. +..
T Consensus 362 LAl~~~p~~~~~d~~-~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~v--p~Yqlpfe~ 438 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTH-GQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPV--PEYQLPFEA 438 (534)
T ss_pred eeEEecCCCCCcchh-hhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCC--CcccCchhH
Confidence 999887544332222 368999999999997643 21 469999999999999998765543111 11110 111
Q ss_pred HHHHHhccCCccccccccc-ccCCCCChh----hHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 277 LVRKSIESNSFKEIVDPII-VGEEGLWPE----KEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.+.. ..++.+.-+-.+ .+.++.+|. . ....-+.+.+..||+.||+.|.|+.-|-+++..+..
T Consensus 439 evG~---hPt~e~mq~~VV~kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 439 EVGN---HPTLEEMQELVVRKKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred HhcC---CCCHHHHHHHHHhhccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 1111 111111100000 111222222 1 234558899999999999999999999999988754
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=305.42 Aligned_cols=239 Identities=19% Similarity=0.217 Sum_probs=183.7
Q ss_pred cccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcC---CCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 63 ITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQM---SHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 63 ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l---~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
||+|+||+||+|+. .++.||+|++..... ........|..++... .||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999998 678999999864321 1222344566666655 699999999999999999999999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++........
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~- 151 (330)
T cd05586 81 GELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK- 151 (330)
T ss_pred ChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-
Confidence 99999887543 5889999999999999999999 99999999999999999999999999999875432221
Q ss_pred cccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDP 293 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (344)
......||..|+|||++.+. .++.++|||||||++|+|++|..||..... . +...... ....
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~----~----~~~~~i~-~~~~------ 214 (330)
T cd05586 152 --TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT----Q----QMYRNIA-FGKV------ 214 (330)
T ss_pred --CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH----H----HHHHHHH-cCCC------
Confidence 11245789999999998764 488999999999999999999999975321 1 1111111 1100
Q ss_pred ccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 048160 294 IIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT----MVQVAK 335 (344)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~ei~~ 335 (344)
..+.. ..+..+.+++.+||+.||++||+ +.++++
T Consensus 215 -------~~~~~-~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 215 -------RFPKN-VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -------CCCCc-cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 00110 22345789999999999999984 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=287.32 Aligned_cols=247 Identities=22% Similarity=0.328 Sum_probs=197.5
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC--CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL--NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
+|+..+.||+|+||.||++.. ++..+|+|.+.... ......+.+|+.++++++||||+++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999988 67889999986542 22345688999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC-CcceEeeeecccccCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ-NVAKFFDFCVSISIPE 210 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~dfg~a~~~~~ 210 (344)
+++++|.+++....+ ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.+ +.++++|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKRCN---SLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 999999999976432 35788999999999999999999 9999999999999999855 4689999999877643
Q ss_pred CCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEI 290 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (344)
.... ....++..|+|||.+.+..++.++||||||+++|+|++|..||..... ....... .. .....
T Consensus 155 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~----~~~~~~~----~~-~~~~~- 220 (256)
T cd08220 155 KSKA----YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL----PALVLKI----MS-GTFAP- 220 (256)
T ss_pred Cccc----cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch----HHHHHHH----Hh-cCCCC-
Confidence 3221 134678899999999888889999999999999999999999854311 1111111 00 00000
Q ss_pred cccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 291 VDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+ ...+..+.+++.+||+.+|++|||+.++++
T Consensus 221 -----------~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 -----------IS--DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -----------CC--CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 00 123456899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=286.44 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=198.0
Q ss_pred CCCCCccccCCCceEEEEEECC------ccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 57 YDPEKVITKDLLYKLYKGFLQD------RPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~~~------~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
|...+.||.|+||.||++.+.+ ..||+|.+...... ..+.+.+|+.++..++|+||+++++++...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456889999999999999943 77999998766443 4567889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++++|.+++..... ..+++.++..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++....
T Consensus 81 e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 99999999999876442 12889999999999999999999 9999999999999999999999999999987765
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
........ ...++..|+|||.+.+..++.++||||||+++++|++ |..||... . ...+...+. ....
T Consensus 155 ~~~~~~~~--~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~----~-~~~~~~~~~----~~~~- 222 (258)
T smart00219 155 DDDYYKKK--GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM----S-NEEVLEYLK----KGYR- 222 (258)
T ss_pred cccccccc--cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----C-HHHHHHHHh----cCCC-
Confidence 44222111 1236788999999988889999999999999999998 66665432 1 111111111 0000
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L 337 (344)
. +.....+.++.+++.+||+.||++|||+.++++.|
T Consensus 223 -----------~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 -----------L--PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----------C--CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0 00112455689999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=291.28 Aligned_cols=255 Identities=23% Similarity=0.297 Sum_probs=198.7
Q ss_pred HHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCC-----
Q 048160 52 AATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQM-SHKNILKFVGCCLETE----- 123 (344)
Q Consensus 52 ~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~----- 123 (344)
..+++|...+.||+|++|.||+|.. ++..+++|.+..... ..+.+.+|+.+++++ .|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4568899999999999999999999 567899998765543 346688999999999 6999999999997644
Q ss_pred -ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeee
Q 048160 124 -LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF 202 (344)
Q Consensus 124 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~df 202 (344)
..++||||+++++|.+++...... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCC
Confidence 489999999999999987643200 035889999999999999999999 999999999999999999999999999
Q ss_pred ecccccCCCCcccccCCccccccccccccccCc-----CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHH
Q 048160 203 CVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-----ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL 277 (344)
Q Consensus 203 g~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 277 (344)
|.+......... .....++..|+|||++.. ..++.++||||||++++++++|..||..... .......
T Consensus 158 ~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~ 230 (275)
T cd06608 158 GVSAQLDSTLGR---RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP----MRALFKI 230 (275)
T ss_pred ccceecccchhh---hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch----HHHHHHh
Confidence 998765432211 123467889999998753 3467899999999999999999999864211 1111111
Q ss_pred HHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 278 VRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. . ...+........+..+.+|+.+||+.||++|||+.+|++
T Consensus 231 ~----~-------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 P----R-------------NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred h----c-------------cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 0 011111111234567899999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=289.04 Aligned_cols=257 Identities=19% Similarity=0.308 Sum_probs=195.3
Q ss_pred CCCCCccccCCCceEEEEEE-----CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCC------
Q 048160 57 YDPEKVITKDLLYKLYKGFL-----QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETE------ 123 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~-----~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------ 123 (344)
|...+.||+|+||.||+|.+ .+..||+|.+..... ...+.+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 55678899999999999987 257799999876532 23456789999999999999999999886532
Q ss_pred ccEEEEeecCCCCccccccCCC-CCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeee
Q 048160 124 LPILVFEFVACGTLADRIHDPN-GSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF 202 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~df 202 (344)
..++++||+.+|+|.+++.... +.....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999988764221 111135788899999999999999999 999999999999999999999999999
Q ss_pred ecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHH
Q 048160 203 CVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKS 281 (344)
Q Consensus 203 g~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 281 (344)
|.++.......... .....++..|++||.+....++.++||||||+++|+|++ |..||.... ...+...+.
T Consensus 158 g~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~-----~~~~~~~~~-- 229 (273)
T cd05074 158 GLSKKIYSGDYYRQ-GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-----NSEIYNYLI-- 229 (273)
T ss_pred cccccccCCcceec-CCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC-----HHHHHHHHH--
Confidence 99886643321111 112345678999999988889999999999999999999 677764321 111111111
Q ss_pred hccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 282 IESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
..... ..+ ...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 230 -~~~~~-------------~~~--~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 -KGNRL-------------KQP--PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -cCCcC-------------CCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00000 000 12345689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=287.06 Aligned_cols=253 Identities=19% Similarity=0.297 Sum_probs=199.4
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC------chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN------SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
+|+..+.||+|+||.||+|.. ++..||+|.+..... ...+.+.+|+.++++++|+||+++++++.+++..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 578889999999999999987 778999999864431 123567899999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC-cceEeeeeccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN-VAKFFDFCVSI 206 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~dfg~a~ 206 (344)
|+||+++++|.+++.... ++++..+..++.|++.||.||| +.+++|+||+|+||+++.++ .++|+|||.+.
T Consensus 81 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEeccCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 999999999999987543 5888999999999999999999 99999999999999998776 69999999987
Q ss_pred ccCCCCccc-ccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 207 SIPEGKTHV-NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 207 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
......... .......++..|+|||.+.+..++.++|+||+|++++++++|..||........ ...........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~ 227 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-----LALIFKIASAT 227 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-----HHHHHHHhccC
Confidence 765432111 111234678899999999888899999999999999999999999854321100 01110000000
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+ ......+.++.+++.+||+.+|++|||+.++++
T Consensus 228 ------------~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 ------------TAP--SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ------------CCC--CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000 111144567899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=296.16 Aligned_cols=253 Identities=21% Similarity=0.247 Sum_probs=200.5
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc---hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS---EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||.||+|.. .+..||+|.+...... ..+.+..|+.+++.++|+||+++++.+..+...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3588889999999999999999 5789999998765322 3455778999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+.+++|.+++....+ ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQPG---KCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhCCC---CccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 99999999999875432 36889999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCccc--------------------------ccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCC
Q 048160 210 EGKTHV--------------------------NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYS 263 (344)
Q Consensus 210 ~~~~~~--------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 263 (344)
...... ...+...|+..|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 321110 011234678899999999888899999999999999999999999864
Q ss_pred CCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 048160 264 SCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT----MVQVAK 335 (344)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~ei~~ 335 (344)
... ...+.... . ....++.....+..+.+++.+||+.||++||| +.+++.
T Consensus 235 ~~~----~~~~~~~~----~--------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 235 SNR----DETFSNIL----K--------------KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred Cch----HHHHHHHh----c--------------CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 321 11111111 0 01111111124567899999999999999999 666654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=287.16 Aligned_cols=253 Identities=19% Similarity=0.251 Sum_probs=184.0
Q ss_pred ccccCCCceEEEEEE-CCc---cEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCC
Q 048160 62 VITKDLLYKLYKGFL-QDR---PISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGT 136 (344)
Q Consensus 62 ~ig~G~~g~V~~~~~-~~~---~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gs 136 (344)
.||+|+||.||+|.. ++. .+++|.+..... ...+.+.+|+..++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999987 332 356666654432 234678899999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcccc
Q 048160 137 LADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN 216 (344)
Q Consensus 137 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~ 216 (344)
|.+++...... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++........ ..
T Consensus 82 L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~-~~ 156 (268)
T cd05086 82 LKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY-IE 156 (268)
T ss_pred HHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchh-hh
Confidence 99998754221 124666778889999999999999 99999999999999999999999999998754322111 11
Q ss_pred cCCccccccccccccccCc-------CCCCcccchHHHHHHHHHHHcCC-CCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 217 DNNKVIGTFGFIAPEYMST-------ANCNEKSDVYSFGALLLELLTGK-RISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 217 ~~~~~~g~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
......++..|+|||++.. ..++.++||||||+++|||+++. .||.... ....+..... .. ..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~----~~~~~~~~~~----~~-~~ 227 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS----DREVLNHVIK----DQ-QV 227 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHHh----hc-cc
Confidence 1123467889999998743 24578999999999999999754 4543221 1111111111 11 11
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~ 338 (344)
...++.+. . .....+.+++..|| .+|++||++++|++.|.
T Consensus 228 ~~~~~~~~-------~--~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 228 KLFKPQLE-------L--PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCCCccC-------C--CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11111111 0 12345788999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=294.12 Aligned_cols=266 Identities=23% Similarity=0.290 Sum_probs=197.4
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
++|+..+.||+|+||.||+|.+ .++.||+|++...... ..+.+.+|+.+++.++||||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4688889999999999999999 5788999987654322 24567799999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|+++++|..+..... .+++.++..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++.....
T Consensus 81 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 999988888765432 4889999999999999999999 99999999999999999999999999999876544
Q ss_pred CCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc-CCcc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES-NSFK 288 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 288 (344)
.... .....++..|+|||++.+ ..++.++||||||+++|+|++|..||..... .............. ....
T Consensus 153 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07846 153 PGEV---YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD----IDQLYHIIKCLGNLIPRHQ 225 (286)
T ss_pred Cccc---cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch----HHHHHHHHHHhCCCchhhH
Confidence 3211 113467889999998865 4478899999999999999999988754321 11111111100000 0000
Q ss_pred cccc------cccccC----CCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 EIVD------PIIVGE----EGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~~~~------~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..++ ...... .+.....+..+..+.+++.+||+.+|++||++.+|++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000 000000 0000001123466899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=324.56 Aligned_cols=256 Identities=20% Similarity=0.258 Sum_probs=194.4
Q ss_pred HHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeC--Ccc
Q 048160 52 AATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLET--ELP 125 (344)
Q Consensus 52 ~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~ 125 (344)
...++|.+.+.||+|+||+||+++. .+..||+|.+..... .....+.+|+.++++++|||||++++++... ..+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3456799999999999999999999 567789998865422 2345688999999999999999999988653 568
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCC----CCCeeeecccccceEeecC-------
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGF----SRPIVFRDIKPSTILFQEQ------- 194 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----~~~ivH~dlk~~Nill~~~------- 194 (344)
||||||+++|+|.+++...... ...+++..++.|+.||+.||.|||... ..+|+||||||+|||++..
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 9999999999999988642110 125899999999999999999999211 1459999999999999642
Q ss_pred ----------CcceEeeeecccccCCCCcccccCCccccccccccccccCc--CCCCcccchHHHHHHHHHHHcCCCCCC
Q 048160 195 ----------NVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST--ANCNEKSDVYSFGALLLELLTGKRISY 262 (344)
Q Consensus 195 ----------~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~ 262 (344)
..+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~----~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc----ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 3589999999976543221 124578999999999854 458899999999999999999999996
Q ss_pred CCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 263 SSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... . ...+....... ..+. ...+.++.+||..||+.+|.+||++.+++.
T Consensus 245 ~~~~----~---~qli~~lk~~p---------------~lpi-~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 245 KANN----F---SQLISELKRGP---------------DLPI-KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cCCc----H---HHHHHHHhcCC---------------CCCc-CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 4321 1 11111111100 0000 023456889999999999999999999984
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=291.67 Aligned_cols=247 Identities=19% Similarity=0.273 Sum_probs=197.9
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
.|...+.||+|++|.||++.. ++..+++|++........+.+.+|+.+++.++||||+++++++..++..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 355568999999999999987 677899998865554455668899999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+++|.+++... .+++.++..++.|++.||.||| +.+++||||+|+||+++.++.++++|||.+........
T Consensus 100 ~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 100 GGALTDIVTHT------RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred CCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 99999998762 4788899999999999999999 99999999999999999999999999998765543221
Q ss_pred ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDP 293 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (344)
. .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.... .......+.. ...
T Consensus 171 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-----~~~~~~~~~~----~~~------ 232 (285)
T cd06648 171 R---RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-----PLQAMKRIRD----NLP------ 232 (285)
T ss_pred c---cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC-----HHHHHHHHHh----cCC------
Confidence 1 113467889999999988889999999999999999999999986431 1111111110 000
Q ss_pred ccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 294 IIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+........+..+.+++.+||+.+|++|||+.++++
T Consensus 233 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 233 ------PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ------CCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 000001123456899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=289.66 Aligned_cols=266 Identities=18% Similarity=0.192 Sum_probs=198.4
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
+|...+.||+|+||.||+|.+ ++..||+|++..... .....+.+|+.++++++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 477788999999999999998 678999999876542 2346688999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+ +++|.+++.... .++++.++..++.|++.||.||| +.+++|+||||+||+++.++.++++|||++......
T Consensus 81 ~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 999999886544 36899999999999999999999 999999999999999999999999999998776543
Q ss_pred CcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC--C--
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN--S-- 286 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~-- 286 (344)
... ......++..|+|||.+.+. .++.++||||+|+++++|++|..||..... ...+........... .
T Consensus 153 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07832 153 EPR--LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND----IEQLAIVFRTLGTPNEETWP 226 (286)
T ss_pred CCC--ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH----HHHHHHHHHHcCCCChHHHh
Confidence 221 11134678899999988654 468999999999999999999766643221 111111111100000 0
Q ss_pred -ccccc--ccccccCCC--CCh-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 287 -FKEIV--DPIIVGEEG--LWP-EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 287 -~~~~~--~~~~~~~~~--~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..... ......... .+. ..+.....+.+++.+||+.||++|||+++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000 000000000 000 00123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=291.07 Aligned_cols=251 Identities=21% Similarity=0.285 Sum_probs=192.1
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHH-HhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAF-ASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~-l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
++|+..+.||+|+||.||+|.. +++.||+|++..... .....+..|+.. ++.++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4688889999999999999998 688999999876533 223445556554 666789999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCC-CeeeecccccceEeecCCcceEeeeecccccC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSR-PIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
|++ |+|.+++....... ..+++.++..++.|++.||.||| +. +++||||||+||+++.++.++|+|||++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKG-LTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 996 78887775422111 36899999999999999999999 76 99999999999999999999999999987654
Q ss_pred CCCcccccCCccccccccccccccCc----CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMST----ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
.... .....++..|+|||++.+ ..++.++|+||||+++|+|++|..||..... ....+.... . .
T Consensus 156 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~----~-~ 223 (283)
T cd06617 156 DSVA----KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT---PFQQLKQVV----E-E 223 (283)
T ss_pred cccc----cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc---CHHHHHHHH----h-c
Confidence 3211 113467889999998865 4568899999999999999999999853211 111111111 0 0
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.....+. ...+.++.+++.+||+.+|++||++.+|++
T Consensus 224 ------------~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 ------------PSPQLPA-EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ------------CCCCCCc-cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001111 134456899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=286.04 Aligned_cols=253 Identities=18% Similarity=0.264 Sum_probs=195.3
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc----------hhhhHhhHHHHHhcCCCCceeeeeeEEeeCC
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS----------EEYCCFNCIAFASQMSHKNILKFVGCCLETE 123 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~----------~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~ 123 (344)
+|...+.||+|+||.||+|.. ++..||+|.+...... ..+.+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 366788999999999999987 6788999987542111 1235678999999999999999999999999
Q ss_pred ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeee
Q 048160 124 LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFC 203 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg 203 (344)
..++|+||+++++|.+++...+ ++++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecc
Confidence 9999999999999999987653 5888899999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCcCC--CCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHH
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTAN--CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS 281 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 281 (344)
++......... .......++..|+|||++.... ++.++|+||||+++|++++|..||..... .....+ .
T Consensus 154 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~----~ 224 (272)
T cd06629 154 ISKKSDDIYDN-DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----IAAMFK----L 224 (272)
T ss_pred ccccccccccc-cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----HHHHHH----h
Confidence 98765432111 1112345788999999987654 78999999999999999999999853211 000110 0
Q ss_pred hccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 282 IESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... ....+... .....+..+.+++.+||+.+|++|||+.+|++
T Consensus 225 ~~~~-~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 225 GNKR-SAPPIPPD---------VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred hccc-cCCcCCcc---------ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 0000 00000000 00123457899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=285.63 Aligned_cols=251 Identities=20% Similarity=0.292 Sum_probs=204.7
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
++|+..+.||+|++|.||+|.. +++.|++|++..... .....+.+|+..+++++|+||+++++++..+...++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 4688899999999999999999 578899999876654 3456788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCC-CCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFS-RPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
+++++|.+++.... ++++..+..++.|++.||.||| + .+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 81 MDGGSLADLLKKVG-----KIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred cCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999997653 5899999999999999999999 8 9999999999999999999999999999877654
Q ss_pred CCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEI 290 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (344)
..... ....++..|+|||.+....++.++|+||||+++|+|++|..||..... .........+ .. ...
T Consensus 153 ~~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~---~~-~~~--- 220 (264)
T cd06623 153 TLDQC---NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAI---CD-GPP--- 220 (264)
T ss_pred CCCcc---cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHH---hc-CCC---
Confidence 33221 134678899999999888899999999999999999999999865432 0111111111 11 000
Q ss_pred cccccccCCCCChhhHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 291 VDPIIVGEEGLWPEKEK-QLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 291 ~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
...+. . .+..+.+++.+||+.+|++|||+.++++.
T Consensus 221 ---------~~~~~--~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 ---------PSLPA--EEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---------CCCCc--ccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00011 2 45568999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=287.68 Aligned_cols=260 Identities=21% Similarity=0.209 Sum_probs=198.4
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeC--CccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLET--ELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~ 129 (344)
++|...+.||.|++|.||++.. .+..+|+|.+..... .....+.+|++++++++||||+++++++... +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3577888999999999999999 678899998875433 2346688999999999999999999988653 4689999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++++|.+++..... ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999999887643211 1135788899999999999999999 9999999999999999999999999999986543
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
.... ....++..|+|||.+.+..++.++||||||+++|+|++|..||.....+.........++.. .....
T Consensus 157 ~~~~-----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~ 227 (287)
T cd06621 157 NSLA-----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPE 227 (287)
T ss_pred cccc-----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchh
Confidence 2221 13356788999999988889999999999999999999999987553211111111111111 00000
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+ . .+.....+..+.+++.+||+.+|.+|||+.||++
T Consensus 228 ~~~-~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 228 LKD-E-------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hcc-C-------CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 000 0 0000123456899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=311.83 Aligned_cols=200 Identities=17% Similarity=0.240 Sum_probs=163.4
Q ss_pred HHHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCC------CceeeeeeEEe
Q 048160 49 ELKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSH------KNILKFVGCCL 120 (344)
Q Consensus 49 ~i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~~~~~~~ 120 (344)
++...+++|.+.+.||+|+||+||+|.. .++.||||++.... .....+..|+.+++.++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3444567899999999999999999998 67789999986432 123445567777777754 45889998887
Q ss_pred eC-CccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCC-CCeeeecccccceEeecCC---
Q 048160 121 ET-ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFS-RPIVFRDIKPSTILFQEQN--- 195 (344)
Q Consensus 121 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlk~~Nill~~~~--- 195 (344)
.. ...++|||++ +++|.+++...+ .+++..+..++.|++.||.||| . .+|+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCccc
Confidence 54 5788999988 688988886543 5889999999999999999999 7 5999999999999998765
Q ss_pred -------------cceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCC
Q 048160 196 -------------VAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISY 262 (344)
Q Consensus 196 -------------~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 262 (344)
.+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~~------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERHS------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCccc------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 4899999987543211 124578999999999999999999999999999999999999996
Q ss_pred CC
Q 048160 263 SS 264 (344)
Q Consensus 263 ~~ 264 (344)
..
T Consensus 347 ~~ 348 (467)
T PTZ00284 347 TH 348 (467)
T ss_pred CC
Confidence 53
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=290.27 Aligned_cols=267 Identities=22% Similarity=0.250 Sum_probs=198.4
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
++|+..+.||+|+||.||+|.. ++..||+|++..... ...+.+.+|+.++++++|+||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3688889999999999999998 567899998765422 234668899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|++++.+..+..... .+++.++..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 81 YVERTLLELLEASPG-----GLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred cCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 999877766554432 4889999999999999999999 99999999999999999999999999999887654
Q ss_pred CCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh--ccCCc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI--ESNSF 287 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 287 (344)
..... .....++..|+|||++.+. .++.++||||||+++|+|++|..||..... ...+........ .....
T Consensus 153 ~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd07833 153 RPASP--LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD----IDQLYLIQKCLGPLPPSHQ 226 (288)
T ss_pred Ccccc--ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHHh
Confidence 43211 1134678889999999887 789999999999999999999988864321 111111111000 00000
Q ss_pred -cccccccccc-C--CCCChh------hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 288 -KEIVDPIIVG-E--EGLWPE------KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 288 -~~~~~~~~~~-~--~~~~~~------~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
....+....+ . ....+. ....+..+.+|+.+||+.+|++|||+++|++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred hhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000000 0 000000 0012567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=286.15 Aligned_cols=253 Identities=20% Similarity=0.354 Sum_probs=196.0
Q ss_pred CCCCCCccccCCCceEEEEEEC---CccEEEEEecCCC----------CchhhhHhhHHHHHhc-CCCCceeeeeeEEee
Q 048160 56 NYDPEKVITKDLLYKLYKGFLQ---DRPISVMKFGGNL----------NSEEYCCFNCIAFASQ-MSHKNILKFVGCCLE 121 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~~---~~~vavk~~~~~~----------~~~~~~~~~E~~~l~~-l~H~niv~~~~~~~~ 121 (344)
+|+..+.||+|+||.||+|.+. +..+|+|.+.... ......+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4778899999999999999993 4779999875321 1223446678887765 799999999999999
Q ss_pred CCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCC-CCeeeecccccceEeecCCcceEe
Q 048160 122 TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFS-RPIVFRDIKPSTILFQEQNVAKFF 200 (344)
Q Consensus 122 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~ 200 (344)
++..++||||+++++|.+++...... ...+++..++.++.|++.||.||| + .+++|+||+|+||+++.++.++|+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~ 156 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTIT 156 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEe
Confidence 99999999999999999887431110 135888999999999999999999 6 689999999999999999999999
Q ss_pred eeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHH
Q 048160 201 DFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280 (344)
Q Consensus 201 dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 280 (344)
|||++....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... . ... ..
T Consensus 157 dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~----~-~~~---~~ 224 (269)
T cd08528 157 DFGLAKQKQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM----L-SLA---TK 224 (269)
T ss_pred cccceeeccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH----H-HHH---HH
Confidence 999987755432 11245678899999999888899999999999999999999999864311 1 111 11
Q ss_pred HhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048160 281 SIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338 (344)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~ 338 (344)
... ...... +. ...+..+.+++.+||+.||++||++.+|..+|.
T Consensus 225 ~~~-~~~~~~------------~~-~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 225 IVE-AVYEPL------------PE-GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred Hhh-ccCCcC------------Cc-ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 100 000000 00 023356889999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=305.72 Aligned_cols=275 Identities=19% Similarity=0.285 Sum_probs=207.3
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeC------CccEE
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLET------ELPIL 127 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~------~~~~l 127 (344)
+...+.||+|+||.||+|+. .|+.||||.++.... ...+.+.+|+++|++++|+|||+++++-.+. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 44567899999999999997 899999999887543 3456678999999999999999999986543 35689
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEee--c--CCcceEeeee
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ--E--QNVAKFFDFC 203 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~--~--~~~~kl~dfg 203 (344)
|||||.||||+..++++.+.. -|++.+.+.++.+++.||.||| .++|+||||||.||++. . ....||+|||
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~--GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAY--GLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEeecCCCcHHHHhcCccccc--CCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 999999999999998866432 4899999999999999999999 99999999999999983 3 3367999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
.|+.++.+.... ..+||..|.+||++.. ..|+..+|.|||||++|+++||..||-+.....+.....+..+...
T Consensus 170 ~Arel~d~s~~~----S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkk- 244 (732)
T KOG4250|consen 170 AARELDDNSLFT----SLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKK- 244 (732)
T ss_pred ccccCCCCCeee----eecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccC-
Confidence 999988766332 6799999999999984 7889999999999999999999999987654433222222222111
Q ss_pred ccCCcccccccccccC-----CCCChh--hHHHHHHHHHHHHHccccCCCCCC--CHHHHHHHHHHHHh
Q 048160 283 ESNSFKEIVDPIIVGE-----EGLWPE--KEKQLLSYTELAIKCLSKSEQDRP--TMVQVAKQLRQLHK 342 (344)
Q Consensus 283 ~~~~~~~~~~~~~~~~-----~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RP--s~~ei~~~L~~l~~ 342 (344)
+........+.-+|+ .-+.|. .+.....+...+..+|..+|++|. .+.+....+..|.+
T Consensus 245 -p~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 245 -PSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred -CCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 111111111111111 111111 122334567788889999999998 77777777666553
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=282.78 Aligned_cols=246 Identities=23% Similarity=0.288 Sum_probs=197.2
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-----chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-----SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
+|+..+.||+|+||.||+|.. ++..|++|.+..... ...+.+.+|+.+++.++|+||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 367788999999999999998 578899998765431 2345678999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
+||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 99999999999987543 5788899999999999999999 999999999999999999999999999998765
Q ss_pred CCCCcccccCCccccccccccccccCcCC-CCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTAN-CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
.... ......++..|+|||.+.... ++.++|+||||+++|++++|..||..... . ............
T Consensus 153 ~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----~----~~~~~~~~~~~~ 220 (258)
T cd06632 153 VEFS----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----V----AAVFKIGRSKEL 220 (258)
T ss_pred cccc----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH----H----HHHHHHHhcccC
Confidence 4332 112456788999999987766 89999999999999999999999864321 1 111111110111
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.. .+ ......+.+++.+||+.+|++||++.+++.
T Consensus 221 ~~------------~~--~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 PP------------IP--DHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CC------------cC--CCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 00 00 123456789999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=295.03 Aligned_cols=246 Identities=20% Similarity=0.268 Sum_probs=204.9
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch--hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE--EYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
+-|...+.||+|-|+.|-.+++ .|..||||++-+..-.. ...+++|++.|+-++|||||++|.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4477789999999999999998 99999999986553222 2447799999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe-ecCCcceEeeeecccccC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF-QEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~dfg~a~~~~ 209 (344)
+-++|+|.+|+-... .-+.+..+.+++.||+.|+.|+| ..++|||||||+|+.+ ...|-+||.|||++..+.
T Consensus 98 LGD~GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred ecCCchHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999999999997655 35889999999999999999999 9999999999999876 567899999999998776
Q ss_pred CCCcccccCCccccccccccccccCcCCCC-cccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCN-EKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
.+.... +..|+..|-|||.+.+..|+ +.+||||||||+|-|.+|..||....+ . .++-
T Consensus 171 PG~kL~----TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND----S-------------ETLT 229 (864)
T KOG4717|consen 171 PGKKLT----TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND----S-------------ETLT 229 (864)
T ss_pred Ccchhh----cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc----h-------------hhhh
Confidence 655433 56899999999999999997 779999999999999999999965422 1 1122
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.++|-.. ..+...+.+.++||..||..||++|.|.++|..
T Consensus 230 mImDCKY-------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 230 MIMDCKY-------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hhhcccc-------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 2222211 111256677899999999999999999999874
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=289.79 Aligned_cols=265 Identities=19% Similarity=0.195 Sum_probs=196.4
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc-----hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS-----EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
+|...+.||+|+||.||+|.. ++..||+|++...... ....+..|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 367788999999999999998 5789999998765332 234466899999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||+ +++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred Eccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 9999 899999997643 25889999999999999999999 999999999999999999999999999999776
Q ss_pred CCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc--C
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES--N 285 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~ 285 (344)
....... ....++..|+|||.+.+ ..++.++||||||+++++|++|..||..... ...+.......... .
T Consensus 153 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~ 225 (298)
T cd07841 153 GSPNRKM---THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD----IDQLGKIFEALGTPTEE 225 (298)
T ss_pred cCCCccc---cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc----HHHHHHHHHHcCCCchh
Confidence 5432111 12345778999998854 4578999999999999999999666543211 11111111110000 0
Q ss_pred ---CcccccccccccCCCCCh---hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 ---SFKEIVDPIIVGEEGLWP---EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ---~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
......+..........+ .....+..+.+++.+||++||++|||+.+|++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 226 NWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000000000000000 00123467899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=286.24 Aligned_cols=246 Identities=20% Similarity=0.296 Sum_probs=196.4
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHHHhcCC---CCceeeeeeEEeeCCccEEEE
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMS---HKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~~~lv~ 129 (344)
.|+..+.||+|+||.||+|.+ +++.||+|.+..... .....+.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999998 678899998865532 33456788999999996 999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++++|.+++... ++++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.++++|||++....
T Consensus 82 e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 82 EYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred ecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 999999999988652 5889999999999999999999 9999999999999999999999999999987765
Q ss_pred CCCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
..... .....|+..|+|||.+.++ .++.++|+||||+++|+|++|..||..... ...... ....
T Consensus 153 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--------~~~~~~-~~~~--- 217 (277)
T cd06917 153 QNSSK---RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA--------FRAMML-IPKS--- 217 (277)
T ss_pred CCccc---cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh--------hhhhhc-cccC---
Confidence 43321 1234678899999988654 468999999999999999999999864321 000000 0000
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+..+.. ..+.++.+++.+||+.||++||++.+++.
T Consensus 218 ---------~~~~~~~~-~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 218 ---------KPPRLEDN-GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ---------CCCCCCcc-cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 00111110 13456889999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=291.77 Aligned_cols=244 Identities=22% Similarity=0.317 Sum_probs=193.3
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
..|...+.||+|+||.||+|.. ++..||+|++..... .....+.+|+.+++.++||||+++++++..+...++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 3488889999999999999998 678899998864422 22356789999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+. |+|.+++.... .++++.++..++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||++....
T Consensus 95 e~~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 95 EYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HhhC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9997 67777765433 25889999999999999999999 9999999999999999999999999999986553
Q ss_pred CCCcccccCCccccccccccccccC---cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMS---TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
... ...++..|+|||++. ...++.++||||||+++|+|++|..||..... ....... . ...
T Consensus 167 ~~~-------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~----~~~~~~~----~-~~~ 230 (307)
T cd06607 167 PAN-------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHI----A-QND 230 (307)
T ss_pred CCC-------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH----HHHHHHH----h-cCC
Confidence 221 345788999999874 35688999999999999999999999864321 0000000 0 000
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+..+ ....+..+.+++.+||+.||++||++.+|+.
T Consensus 231 ------------~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 231 ------------SPTLS-SNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred ------------CCCCC-chhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 1134556899999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=288.68 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=202.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
.+++|+....||+|++|.||+|.+ .+..|++|.+..... ..+.+.+|+..+++++|+||+++++++..+...++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 456688889999999999999999 478899999876544 45678899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|+++++|.+++.... ..+++..+..++.+++.||.||| ..+++|+||+|+||+++.++.++|+|||++.....
T Consensus 96 ~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 96 YMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred ccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 999999999998653 26889999999999999999999 99999999999999999999999999998866543
Q ss_pred CCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEI 290 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (344)
.... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ........ ..
T Consensus 169 ~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~----~~~~~~~~-----~~----- 231 (286)
T cd06614 169 EKSK---RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP----LRALFLIT-----TK----- 231 (286)
T ss_pred chhh---hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH-----hc-----
Confidence 2211 1234578899999999888899999999999999999999999753211 11111100 00
Q ss_pred cccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 291 VDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.....+.....+..+.+++.+||+.+|.+|||+.+|+.
T Consensus 232 -------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 232 -------GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -------CCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 00111111124556899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=289.92 Aligned_cols=267 Identities=16% Similarity=0.198 Sum_probs=195.0
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch-hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE-EYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
+++|...+.||+|+||.||+|.. +++.||+|.+....... ...+.+|+.+++.++|+||+++++++..+...++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46799999999999999999987 67899999986553322 2356789999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|+. ++|.+++.... ..+++.++..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||+++....
T Consensus 84 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 84 YMH-TDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred ccc-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 996 67777665432 24678888899999999999999 99999999999999999999999999999875433
Q ss_pred CCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhc------
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE------ 283 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------ 283 (344)
.... .....++..|+|||++.+. .++.++||||||+++|+|++|..||..... ....+.+.......
T Consensus 156 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~---~~~~~~~~~~~~~~~~~~~~ 229 (291)
T cd07870 156 PSQT---YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD---VFEQLEKIWTVLGVPTEDTW 229 (291)
T ss_pred CCCC---CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh---HHHHHHHHHHHcCCCChhhh
Confidence 2211 1133568899999998754 578899999999999999999999864322 11111111110000
Q ss_pred ------cCCcccccccccccC-CCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 284 ------SNSFKEIVDPIIVGE-EGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 284 ------~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+.............. ...+... .....+.+++.+|+..||.+|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRL-SRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhhcccccchhccccCCcchhhhcccc-CCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000 0000000 12346789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=288.59 Aligned_cols=265 Identities=17% Similarity=0.259 Sum_probs=194.8
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
++|+..+.||+|++|.||+|.. ++..||+|.+...... ....+.+|+.++++++|+||+++++++.++...++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 5688889999999999999998 6788999998654322 234467899999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+. ++|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++.....
T Consensus 85 ~~-~~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 85 LD-TDLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred CC-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 97 59999887554 25788999999999999999999 999999999999999999999999999998654322
Q ss_pred CcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC---Cc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN---SF 287 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 287 (344)
... .....++..|+|||++.+ ..++.++||||||+++|+|++|..||...... ...+. .+....... .+
T Consensus 157 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~~ 229 (291)
T cd07844 157 SKT---YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV---EDQLH-KIFRVLGTPTEETW 229 (291)
T ss_pred Ccc---ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH---HHHHH-HHHHhcCCCChhhh
Confidence 111 112345788999998865 45889999999999999999999998643211 11111 111111000 00
Q ss_pred cccc------ccccc--cCCC---CChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 288 KEIV------DPIIV--GEEG---LWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 288 ~~~~------~~~~~--~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... ..... .... ..+.. .....+.+++.+||+.+|++|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 230 PGVSSNPEFKPYSFPFYPPRPLINHAPRL-DRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhhccccccccccccCChhHHHhCcCC-CCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 00000 0000 00000 11146789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=290.50 Aligned_cols=242 Identities=17% Similarity=0.244 Sum_probs=196.9
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||.||++.+ +++.||+|.+..... ...+.+.+|+.++++++||||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4688889999999999999999 678999998864321 23456779999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 81 EYVPGGELFSHLRKSG-----RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred ecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 9999999999987653 5889999999999999999999 9999999999999999999999999999987764
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
.. .....+++.|+|||.+.+..++.++||||||+++|+|++|..||..... ........ ...
T Consensus 153 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~-----~~~--- 214 (290)
T cd05580 153 GR------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP----IQIYEKIL-----EGK--- 214 (290)
T ss_pred CC------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHh-----cCC---
Confidence 33 1234678999999999888889999999999999999999999865321 11111110 000
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-----TMVQVA 334 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ei~ 334 (344)
...|. ..+..+.+++.+||+.||.+|| ++.+++
T Consensus 215 ----------~~~~~--~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 215 ----------VRFPS--FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ----------ccCCc--cCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 00011 2245688999999999999998 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=287.51 Aligned_cols=264 Identities=16% Similarity=0.191 Sum_probs=195.4
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
+|+..+.||.|++|.||+|+. ++..||+|++...... ....+.+|++++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 578889999999999999998 6788999988654322 235678999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+. ++|..++....+ ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++......
T Consensus 81 ~~-~~l~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 81 LH-QDLKKFMDASPL---SGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred cc-cCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 96 688888765332 35888999999999999999999 999999999999999999999999999998765432
Q ss_pred CcccccCCccccccccccccccCcCC-CCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCC----
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTAN-CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNS---- 286 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---- 286 (344)
... .....++..|+|||++.+.. ++.++||||||+++|+|+||+.||...... ...............
T Consensus 154 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07860 154 VRT---YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI----DQLFRIFRTLGTPDEVVWP 226 (284)
T ss_pred ccc---cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHhCCCChhhhh
Confidence 211 11234678899999886644 688999999999999999999998654321 111111111000000
Q ss_pred ----c---ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 287 ----F---KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 287 ----~---~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. ...+....... .....+..+..+.+++.+||+.||.+|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 227 GVTSLPDYKPSFPKWARQD--FSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhHHHHHHhhcccccccC--HHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0 00000000000 00000123356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=285.22 Aligned_cols=245 Identities=22% Similarity=0.315 Sum_probs=196.8
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCC-CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL-NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
|+..+.||+|+||.||+|.. ++..||+|.+.... ......+.+|+..+++++||||+++++++..+...++|+||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 77788999999999999987 66789999875432 2234567899999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+++|.+++... .+++..+..++.+++.|+.||| +.+++|+||+|+||+++.++.++++|||++........
T Consensus 86 ~~~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 86 GGSALDLLEPG------PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999988642 4788999999999999999999 99999999999999999999999999999876543221
Q ss_pred ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDP 293 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (344)
......++..|+|||.+.+..++.++|+||||+++|++++|..||.... .......+ .......
T Consensus 157 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~----~~~~~~~---- 220 (277)
T cd06641 157 ---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH-----PMKVLFLI----PKNNPPT---- 220 (277)
T ss_pred ---hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc-----hHHHHHHH----hcCCCCC----
Confidence 1123467889999999988888999999999999999999999985321 11111110 0110000
Q ss_pred ccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 294 IIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
. ....+.++.+++.+||+.+|.+||++.++++.
T Consensus 221 --------~--~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 --------L--EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred --------C--CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 01334568899999999999999999999883
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=311.38 Aligned_cols=275 Identities=16% Similarity=0.166 Sum_probs=189.5
Q ss_pred HhcCCCCCCccccCCCceEEEEEEC---CccEEEE------------------EecCCCCchhhhHhhHHHHHhcCCCCc
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFLQ---DRPISVM------------------KFGGNLNSEEYCCFNCIAFASQMSHKN 111 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~~---~~~vavk------------------~~~~~~~~~~~~~~~E~~~l~~l~H~n 111 (344)
..++|.+.+.||+|+||+||++.+. +..++.| ++.. .......+.+|+.++++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCC
Confidence 4568999999999999999998762 1112222 1111 1122345779999999999999
Q ss_pred eeeeeeEEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe
Q 048160 112 ILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF 191 (344)
Q Consensus 112 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 191 (344)
|+++++++...+..|+|++++. ++|..++..............++..++.|++.||.||| +.+|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence 9999999999999999999985 67777665432111122345667889999999999999 9999999999999999
Q ss_pred ecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcch
Q 048160 192 QEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEE 271 (344)
Q Consensus 192 ~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 271 (344)
+.++.+||+|||+++......... .....||..|+|||++.+..++.++|||||||++|||++|..+++..... ...
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~-~~~ 377 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAF--DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG-KPG 377 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccc--cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC-CHH
Confidence 999999999999998765332211 11357899999999999999999999999999999999998765543221 111
Q ss_pred hHHHHHHHHHh-ccCCccc----ccccc----cccCCCCChhh---HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 272 YFLQELVRKSI-ESNSFKE----IVDPI----IVGEEGLWPEK---EKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 272 ~~~~~~~~~~~-~~~~~~~----~~~~~----~~~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+.+.+.... ....+.. +++.+ ........+.. ...+..+.+++.+||+.||++|||+.|++.
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 12222221110 0000000 00000 00000000000 012345788899999999999999999986
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=279.15 Aligned_cols=248 Identities=26% Similarity=0.359 Sum_probs=202.1
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
+|...+.||+|++|.||++.. ++..+++|++..........+.+|+..+++++|+||+++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 367788999999999999999 478899999877655456778899999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+++|.+++.... ..+++..+..++.+++.||.+|| ..+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 81 GGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 999999987653 36899999999999999999999 99999999999999999999999999999877654332
Q ss_pred ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDP 293 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (344)
.....++..|+|||.+.+..++.++|+||||++++++++|..||..... .... .... ......
T Consensus 154 ----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~-~~~~----~~~~~~---- 216 (253)
T cd05122 154 ----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP----MKAL-FKIA----TNGPPG---- 216 (253)
T ss_pred ----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch----HHHH-HHHH----hcCCCC----
Confidence 1245678899999999888889999999999999999999999864321 0000 0000 011111
Q ss_pred ccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 294 IIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+.....+..+.+++.+||+.||++|||+.++++
T Consensus 217 --------~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 217 --------LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred --------cCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111112456899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=289.62 Aligned_cols=251 Identities=20% Similarity=0.252 Sum_probs=190.5
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHHHhcCC-CCceeeeeeEEeeCCccEEEEee
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMS-HKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
+|.....||+|+||.||++.. ++..||+|++..... .....+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 355567899999999999998 678999999875432 33456789999999996 99999999999999999999999
Q ss_pred cCCCCcccccc---CCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCC-CCeeeecccccceEeecCCcceEeeeecccc
Q 048160 132 VACGTLADRIH---DPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFS-RPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 132 ~~~gsL~~~l~---~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
+. +++.++.. .... ..+++..+..++.+++.||+||| + .+++||||||+||+++.++.++|+|||++..
T Consensus 85 ~~-~~l~~l~~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLK---SVIPEEILGKIAVATVKALNYLK---EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred cc-CCHHHHHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh---hcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 86 46555332 1111 35889999999999999999999 5 5999999999999999999999999999876
Q ss_pred cCCCCcccccCCccccccccccccccCcC---CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTA---NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES 284 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (344)
....... ....|+..|+|||++... .++.++||||||+++|+|++|+.||.... ...+........
T Consensus 158 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~ 226 (288)
T cd06616 158 LVDSIAK----TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVKG 226 (288)
T ss_pred hccCCcc----ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcCC
Confidence 5432211 133578899999998766 68999999999999999999999985421 011111111110
Q ss_pred CCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 285 NSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... +. .......+..+.+|+.+||+.||++|||+.+|++
T Consensus 227 -~~~~-----~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 227 -DPPI-----LS-----NSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred -CCCc-----CC-----CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00 0000134567899999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=286.72 Aligned_cols=265 Identities=18% Similarity=0.232 Sum_probs=196.4
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch--hhhHhhHHHHHhcCCCCceeeeeeEEeeC--CccEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE--EYCCFNCIAFASQMSHKNILKFVGCCLET--ELPILV 128 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv 128 (344)
++|+..+.||+|+||.||+|.+ +++.+++|+++...... ...+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 5688889999999999999999 57789999987543222 23466899999999999999999999877 889999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
+||+. ++|.+++.... ..+++.++..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++...
T Consensus 85 ~e~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 85 MEYVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred ehhcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 99997 58988886544 25899999999999999999999 999999999999999999999999999998876
Q ss_pred CCCCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc---
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES--- 284 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 284 (344)
...... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... .............+
T Consensus 157 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~----~~~~~~~~~~~~~~~~~ 229 (293)
T cd07843 157 GSPLKP---YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE----IDQLNKIFKLLGTPTEK 229 (293)
T ss_pred cCCccc---cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCchH
Confidence 543211 1134568889999988664 468999999999999999999999864322 11111111110000
Q ss_pred -----CCccccccccccc-C----CCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 285 -----NSFKEIVDPIIVG-E----EGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 285 -----~~~~~~~~~~~~~-~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+.......... . ....+.. ..+..+.+++.+||+.||++|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 230 IWPGFSELPGAKKKTFTKYPYNQLRKKFPAL-SLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHHHhhccchhcccccccccchhhhcccccc-CCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000000000 0 0001110 02456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=287.49 Aligned_cols=206 Identities=24% Similarity=0.321 Sum_probs=168.4
Q ss_pred CCCCCccccCCCceEEEEEE----CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeC--CccEE
Q 048160 57 YDPEKVITKDLLYKLYKGFL----QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLET--ELPIL 127 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~----~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~l 127 (344)
|...+.||+|+||.||+|.. .+..||+|.+.... ....+.+.+|+.++++++||||+++++++... ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 67778899999999999999 35789999988743 33345677899999999999999999999987 78999
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec----CCcceEeeee
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE----QNVAKFFDFC 203 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~dfg 203 (344)
||||++ ++|.+++..........+++..+..++.|++.||.||| +.+|+||||||+||+++. ++.+|++|||
T Consensus 82 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 999997 46776664322111136888999999999999999999 999999999999999999 9999999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCc
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCF 266 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~ 266 (344)
++.................++..|+|||++.+. .++.++||||||+++++|++|..||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 988764433222222244678899999988664 578999999999999999999999875443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=281.47 Aligned_cols=253 Identities=18% Similarity=0.253 Sum_probs=198.0
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEee--CCccEEEE
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLE--TELPILVF 129 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~lv~ 129 (344)
+|+..+.||.|+||.||++.. ++..||+|.+..... ...+.+..|+.++++++|+||+++++++.. +...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477789999999999999988 667899998865422 234557789999999999999999998764 45679999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCC--CCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGF--SRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
||+++++|.+++...... ..++++..++.++.+++.||.|||... +.+++|+||+|+||+++.++.++++|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKE-RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999998653211 136889999999999999999999332 56899999999999999999999999999887
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
........ ....++..|+|||++.+..++.++|+||||+++++|++|..||.... .......+ .....
T Consensus 160 ~~~~~~~~---~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~----~~~~~ 227 (265)
T cd08217 160 LGHDSSFA---KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLASKI----KEGKF 227 (265)
T ss_pred ccCCcccc---cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHHHHH----hcCCC
Confidence 65433211 13467889999999988889999999999999999999999986432 11111111 11111
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+..+ ...+..+.+++.+||+.+|++|||+.+|++
T Consensus 228 ------------~~~~--~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 228 ------------RRIP--YRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ------------CCCc--cccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1111 134456899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=290.33 Aligned_cols=264 Identities=20% Similarity=0.258 Sum_probs=191.8
Q ss_pred CccccCCCceEEEEEECCccEEEEEecCC--CCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCCcc
Q 048160 61 KVITKDLLYKLYKGFLQDRPISVMKFGGN--LNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLA 138 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 138 (344)
+.+|.|+++.|+++..+++.||+|++... .....+.+.+|+.+++.++|+||+++++++......+++|||+++|+|.
T Consensus 8 ~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 8 KCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred HhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 44555566666666668899999998765 2334467889999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc----
Q 048160 139 DRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH---- 214 (344)
Q Consensus 139 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~---- 214 (344)
+++....+ ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++++|||.+.........
T Consensus 88 ~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 88 DLLKTHFP---EGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 99875432 24788889999999999999999 999999999999999999999999999988765432211
Q ss_pred cccCCccccccccccccccCc--CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh----ccCC--
Q 048160 215 VNDNNKVIGTFGFIAPEYMST--ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI----ESNS-- 286 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~-- 286 (344)
........++..|+|||++.. ..++.++|+||||+++|+|++|..||...... ...... ..... ....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~---~~~~~~-~~~~~~~~~~~~~~~ 237 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT---QMLLEK-VRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH-HhccCccccccCchh
Confidence 111123456778999999866 35889999999999999999999999754211 111111 10000 0000
Q ss_pred -----ccc----ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 287 -----FKE----IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 287 -----~~~----~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
... ..+... ......+.......++.+|+..||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNN-RDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhcCCcCcccccccccch-hhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000 000000 000111111234567899999999999999999999886
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=294.74 Aligned_cols=268 Identities=17% Similarity=0.192 Sum_probs=195.8
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCC-----cc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETE-----LP 125 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-----~~ 125 (344)
+++|...+.||+|+||.||+|.. ++..||+|++..... .....+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46799999999999999999988 678899999864322 23455778999999999999999999876543 57
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
++|+||+. ++|..++... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEehhcc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccce
Confidence 99999996 5888777542 5889999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES 284 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (344)
.................|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... .............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-----~~~~~~~~~~~~~ 228 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-----LHQLNLILGVLGT 228 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCC
Confidence 766433222222223567889999998754 4688999999999999999999998854321 0001111110100
Q ss_pred CC---cccccccc--------cccCCCCChh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 285 NS---FKEIVDPI--------IVGEEGLWPE-KEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 285 ~~---~~~~~~~~--------~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
.. .....+.. .......+.. .+..+..+.+++.+||+.||++|||+.++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 00000000 0000000000 01234568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=302.42 Aligned_cols=244 Identities=20% Similarity=0.269 Sum_probs=197.5
Q ss_pred CccccCCCceEEEEEEC--CccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCCcc
Q 048160 61 KVITKDLLYKLYKGFLQ--DRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLA 138 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~--~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 138 (344)
.-||.|+||.||++... +-..|.|.+........+.++-|+.+|+...||+||++++.+.-.+.+|+..|||.||-++
T Consensus 38 GELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVD 117 (1187)
T KOG0579|consen 38 GELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVD 117 (1187)
T ss_pred hhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHh
Confidence 45899999999999983 3345777777777778888999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcccccC
Q 048160 139 DRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDN 218 (344)
Q Consensus 139 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~ 218 (344)
.++-..+ .+|++.++..++.|++.||.||| +.+|||||||+.|||+.-+|.++|+|||++....... ...
T Consensus 118 aimlEL~----r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~---qkR 187 (1187)
T KOG0579|consen 118 AIMLELG----RVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR---QKR 187 (1187)
T ss_pred HHHHHhc----cccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHH---hhh
Confidence 8876655 47999999999999999999999 9999999999999999999999999999986543322 222
Q ss_pred Ccccccccccccccc-----CcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccc
Q 048160 219 NKVIGTFGFIAPEYM-----STANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDP 293 (344)
Q Consensus 219 ~~~~g~~~y~aPE~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (344)
..++||++|||||+. ...+|+.++||||||+++.||..+.+|-.... ... .+.++.
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln---pMR-VllKia--------------- 248 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN---PMR-VLLKIA--------------- 248 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc---hHH-HHHHHh---------------
Confidence 368999999999975 35689999999999999999999998753210 000 011110
Q ss_pred ccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 294 IIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
...++-.-.+...+..+.+++..||..||..||++.++++
T Consensus 249 --KSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 249 --KSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred --hcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1111111222256667999999999999999999999875
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=285.09 Aligned_cols=246 Identities=21% Similarity=0.235 Sum_probs=198.6
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
+|...+.||+|+||.||+|.. .+..||+|.+..... ...+.+.+|+.++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 477889999999999999999 478899999875432 234678899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|+.+++|.+++.... ++++.++..++.|++.||.||| +.+++|+||+|+||++++++.++++|||.+.....
T Consensus 81 ~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQKV-----KFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 999999999997652 5889999999999999999999 99999999999999999999999999999876544
Q ss_pred CCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEI 290 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (344)
.... ....++..|+|||.+.+..++.++|+||||+++|++++|..||...... ............
T Consensus 153 ~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~----- 217 (258)
T cd05578 153 DTLT----TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------IRDQIRAKQETA----- 217 (258)
T ss_pred Cccc----cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc------HHHHHHHHhccc-----
Confidence 3211 1346788999999998888999999999999999999999998754321 111111111100
Q ss_pred cccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 048160 291 VDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM--VQVA 334 (344)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~--~ei~ 334 (344)
..+.....+..+.+++.+||+.||.+||++ .+++
T Consensus 218 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 ----------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ----------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 000111334568899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=281.03 Aligned_cols=250 Identities=21% Similarity=0.268 Sum_probs=194.9
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC-----CchhhhHhhHHHHHhcCCCCceeeeeeEEeeC--Ccc
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL-----NSEEYCCFNCIAFASQMSHKNILKFVGCCLET--ELP 125 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~ 125 (344)
.+|...+.||+|+||.||+|.. ++..||+|.+.... ......+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999998 67889999875321 12335677999999999999999999998764 457
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
++|+||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccc
Confidence 89999999999999987543 4788889999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
+................++..|+|||++.+..++.++|+||||++++++++|..||..... ....... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~----~~~~ 225 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MAAIFKI----ATQP 225 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HHHHHHH----HcCC
Confidence 7654321111111234678899999999888889999999999999999999999864211 1111111 1000
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+..| ......+.+++.+||+ +|..|||+.+++.
T Consensus 226 ------------~~~~~p--~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 ------------TKPMLP--DGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ------------CCCCCC--cccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 001111 1344568999999999 5799999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=287.97 Aligned_cols=270 Identities=16% Similarity=0.174 Sum_probs=195.0
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCC-CCceeeeeeEEeeCCc-----
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMS-HKNILKFVGCCLETEL----- 124 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~----- 124 (344)
++|+..+.||+|+||.||+|.. +++.||+|++...... ....+.+|+.++++++ |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688899999999999999998 6788999987654322 2356778999999995 6999999999887665
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec-CCcceEeeee
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE-QNVAKFFDFC 203 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~dfg 203 (344)
.++||||++ ++|.+++..........+++..+..++.|++.||.||| +.+|+||||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 799999998 48888875433221135889999999999999999999 999999999999999998 8899999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
++......... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||..... ...+.+......
T Consensus 157 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~ 229 (295)
T cd07837 157 LGRAFSIPVKS---YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE----LQQLLHIFKLLG 229 (295)
T ss_pred cceecCCCccc---cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHHhC
Confidence 98765332111 112346788999998865 4578999999999999999999998865321 111222211110
Q ss_pred ccCC--cccccccccccCCCCCh-h-----hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ESNS--FKEIVDPIIVGEEGLWP-E-----KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ~~~~--~~~~~~~~~~~~~~~~~-~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+.. .............+.+. . .+..+..+.+++.+||++||++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 00000000000000000 0 0124466899999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=287.61 Aligned_cols=243 Identities=19% Similarity=0.282 Sum_probs=194.6
Q ss_pred CCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCCc
Q 048160 60 EKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTL 137 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL 137 (344)
...||+|+||.||++.. ++..||+|++..........+.+|+.+++.++|+||+++++.+..++..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 36799999999999988 6788999998655444556688999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCccccc
Q 048160 138 ADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217 (344)
Q Consensus 138 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~ 217 (344)
.+++... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++........ .
T Consensus 105 ~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~---~ 172 (292)
T cd06657 105 TDIVTHT------RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP---R 172 (292)
T ss_pred HHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc---c
Confidence 9987542 4788899999999999999999 99999999999999999999999999998876543221 1
Q ss_pred CCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccccccc
Q 048160 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVG 297 (344)
Q Consensus 218 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (344)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ......+.....
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~-----~~~~~~~~~~~~-------------- 233 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMKMIRDNLP-------------- 233 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhhCC--------------
Confidence 1234678899999999888889999999999999999999999864311 111111111000
Q ss_pred CCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 298 EEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 298 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
...+.....+..+.+++.+||+.||.+||++.+|++
T Consensus 234 --~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 234 --PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred --cccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 000011123445789999999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=283.31 Aligned_cols=243 Identities=20% Similarity=0.263 Sum_probs=189.7
Q ss_pred cccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCCc
Q 048160 63 ITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTL 137 (344)
Q Consensus 63 ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL 137 (344)
||+|+||+||++.. +++.||+|.+.... ......+.+|+.++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999987 67899999886432 12234467899999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCccccc
Q 048160 138 ADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217 (344)
Q Consensus 138 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~ 217 (344)
.+++..... ..+++.++..++.|++.||.||| ..+++|+||+|+||+++.++.++++|||.+........
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---- 150 (277)
T cd05577 81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---- 150 (277)
T ss_pred HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc----
Confidence 998875442 25889999999999999999999 99999999999999999999999999999876543211
Q ss_pred CCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccccccc
Q 048160 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVG 297 (344)
Q Consensus 218 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (344)
.....++..|+|||++.+..++.++||||||+++++|++|+.||.......... .. ......
T Consensus 151 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~-~~~~~~------------- 212 (277)
T cd05577 151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE----EL-KRRTLE------------- 212 (277)
T ss_pred cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH----HH-Hhcccc-------------
Confidence 113456789999999988889999999999999999999999986543211100 00 000000
Q ss_pred CCCCChhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048160 298 EEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-----TMVQVAK 335 (344)
Q Consensus 298 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ei~~ 335 (344)
.....+ ...+..+.+++.+||+.||.+|| ++.+++.
T Consensus 213 ~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 213 MAVEYP--DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccccCC--ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 000000 12345688999999999999999 6655653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=288.03 Aligned_cols=244 Identities=22% Similarity=0.323 Sum_probs=193.3
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
|...+.||+|+||.||+|+. ++..||+|++..... .....+.+|+.++++++|||++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 77788999999999999998 678899999864422 2234577899999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+. |+|.+.+.... .++++.++..++.+++.||.||| +.+|+||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 107 CL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 97 57877775433 35889999999999999999999 999999999999999999999999999987654321
Q ss_pred CcccccCCccccccccccccccC---cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMS---TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
....++..|+|||++. ...++.++||||||+++|+|++|..||..... ......... .. .
T Consensus 179 -------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~~~~~~~~~----~~-~- 241 (317)
T cd06635 179 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQ----NE-S- 241 (317)
T ss_pred -------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHh----cc-C-
Confidence 1346788999999873 45688999999999999999999999865311 111111111 00 0
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L 337 (344)
.. ......+..+.+++.+||+.+|.+||++.+|++.+
T Consensus 242 -----------~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 242 -----------PT-LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred -----------CC-CCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 00 00113345689999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=294.32 Aligned_cols=252 Identities=20% Similarity=0.216 Sum_probs=198.8
Q ss_pred hcCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCC--chhhhHhhHHHHHhcCC-CCceeeeeeEEeeCCccEEEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMS-HKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~ 129 (344)
...|++.+.||.||.+.||++.. +.+.+|+|++..... ...+-+..|+.+|.+|+ |.+||++++|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 34688899999999999999999 667889988765433 33466889999999996 899999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||-+ .+|..+|+.... ..+...+..+..|++.++.++| ..+|||.||||.|+|+- .|.+||+|||.|..+.
T Consensus 440 E~Gd-~DL~kiL~k~~~----~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 440 ECGD-IDLNKILKKKKS----IDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred eccc-ccHHHHHHhccC----CCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 9874 799999987653 2332377889999999999999 99999999999999984 6789999999999887
Q ss_pred CCCcccccCCccccccccccccccCcC-----------CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHH
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTA-----------NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELV 278 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 278 (344)
.+...... ...+||+.||+||.+... +.++++||||+|||+|+|+.|+.||..... .
T Consensus 511 ~DTTsI~k-dsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~---- 578 (677)
T KOG0596|consen 511 PDTTSIVK-DSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------Q---- 578 (677)
T ss_pred ccccceee-ccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------H----
Confidence 76655432 356899999999987432 257899999999999999999999853210 0
Q ss_pred HHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 279 RKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
...+..+.++....+.+..|.. .++.++|..||.+||++|||..++++
T Consensus 579 -----~aKl~aI~~P~~~Iefp~~~~~----~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 579 -----IAKLHAITDPNHEIEFPDIPEN----DELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -----HHHHHhhcCCCccccccCCCCc----hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1122333333332233333332 22899999999999999999999875
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=281.81 Aligned_cols=248 Identities=24% Similarity=0.332 Sum_probs=197.1
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
+|...+.||+|+||.||+|.. ++..||+|.+..... ...+.+.+|+.++++++|+||+++++.+..+...++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 477788999999999999999 678899998765421 2345677999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC-cceEeeeecccccCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN-VAKFFDFCVSISIPE 210 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~dfg~a~~~~~ 210 (344)
+++++|.+++....+ ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++ .++++|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 999999999865432 25788999999999999999999 99999999999999998875 569999999876643
Q ss_pred CCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEI 290 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (344)
..... ....|+..|+|||++.+..++.++|+||||++++++++|..||.... ..+.+..... .....
T Consensus 155 ~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~~~- 221 (257)
T cd08225 155 SMELA---YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--------LHQLVLKICQ-GYFAP- 221 (257)
T ss_pred Ccccc---cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHhc-ccCCC-
Confidence 32211 13457889999999988889999999999999999999999985431 1111111111 10000
Q ss_pred cccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 291 VDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.....+.++.+++.+||+.+|++|||+.+|++
T Consensus 222 -------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 -------------ISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 00123346889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=278.79 Aligned_cols=249 Identities=18% Similarity=0.190 Sum_probs=191.5
Q ss_pred HHHHHHHhcCCCCCCcc--ccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcC-CCCceeeeeeEEee
Q 048160 47 AQELKAATNNYDPEKVI--TKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQM-SHKNILKFVGCCLE 121 (344)
Q Consensus 47 ~~~i~~~~~~~~~~~~i--g~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~ 121 (344)
..++....++|...+.+ |+|+||.||++.. ++..+|+|.+........ |+.....+ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 34455556677777776 9999999999998 677888888765422111 22222222 69999999999999
Q ss_pred CCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC-cceEe
Q 048160 122 TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN-VAKFF 200 (344)
Q Consensus 122 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~ 200 (344)
.+..++||||+++++|.+++.... ++++.++..++.|++.||.||| +.+++||||+|+||+++.++ .++++
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEe
Confidence 999999999999999999997653 5899999999999999999999 99999999999999999998 99999
Q ss_pred eeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHH
Q 048160 201 DFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280 (344)
Q Consensus 201 dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 280 (344)
|||++....... ...++..|+|||++.+..++.++||||||+++|+|++|..||.....+ ......+...
T Consensus 153 dfg~~~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~ 222 (267)
T PHA03390 153 DYGLCKIIGTPS-------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE---ELDLESLLKR 222 (267)
T ss_pred cCccceecCCCc-------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc---hhhHHHHHHh
Confidence 999987653221 235788999999998888999999999999999999999998743221 1111111111
Q ss_pred HhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 048160 281 SIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT-MVQVAK 335 (344)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~ei~~ 335 (344)
. ... .+.....+..+.+++.+||+.+|.+||+ ++++++
T Consensus 223 ~--~~~---------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 223 Q--QKK---------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred h--ccc---------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1 000 0011134456899999999999999996 588874
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=287.28 Aligned_cols=266 Identities=17% Similarity=0.209 Sum_probs=194.8
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch--hhhHhhHHHHHhcCCCCceeeeeeEEeeC--CccEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE--EYCCFNCIAFASQMSHKNILKFVGCCLET--ELPIL 127 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~l 127 (344)
.++|+..+.||+|+||.||+|.. ++..||+|++....... ...+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46799999999999999999998 67899999986543222 23456899999999999999999998755 46899
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
||||+. ++|.+++.... ..+++.++..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++..
T Consensus 86 v~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEecCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeee
Confidence 999996 58888876543 36889999999999999999999 99999999999999999999999999999887
Q ss_pred cCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc-C
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES-N 285 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~ 285 (344)
........ ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||..... ...+.........+ .
T Consensus 158 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~----~~~~~~~~~~~~~~~~ 230 (309)
T cd07845 158 YGLPAKPM---TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE----IEQLDLIIQLLGTPNE 230 (309)
T ss_pred cCCccCCC---CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCCh
Confidence 65432111 12345778999999865 4578999999999999999999998864321 11111111110000 0
Q ss_pred C-cccc-----cccccccCCCCChhh----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 S-FKEI-----VDPIIVGEEGLWPEK----EKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ~-~~~~-----~~~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. +... ...... ........ ...+..+.+++.+||++||++|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 231 SIWPGFSDLPLVGKFTL-PKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhchhhhcccccccccc-cCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 0000 000000 00000000 012456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=276.36 Aligned_cols=212 Identities=22% Similarity=0.293 Sum_probs=176.9
Q ss_pred HHhcCCCCCCccccCCCceEEEEEE----C--CccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEee-C
Q 048160 52 AATNNYDPEKVITKDLLYKLYKGFL----Q--DRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLE-T 122 (344)
Q Consensus 52 ~~~~~~~~~~~ig~G~~g~V~~~~~----~--~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-~ 122 (344)
.....|+....||+|+||.||+|.. + ++.+|+|+|+.... .-....-||+.+++.++||||+.+..++.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 3345588889999999999999966 2 34799999986633 234667799999999999999999999887 7
Q ss_pred CccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC----Ccce
Q 048160 123 ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ----NVAK 198 (344)
Q Consensus 123 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~k 198 (344)
...++++||.+ -+|.+.++-........++...+..|++||++|+.||| ++=|+||||||.|||+..+ |.+|
T Consensus 101 ~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeE
Confidence 78999999997 48998886544433357889999999999999999999 9999999999999999877 8999
Q ss_pred EeeeecccccCCCCcccccCCccccccccccccccCcCC-CCcccchHHHHHHHHHHHcCCCCCCCCCcc
Q 048160 199 FFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTAN-CNEKSDVYSFGALLLELLTGKRISYSSCFE 267 (344)
Q Consensus 199 l~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~ 267 (344)
|+|||+++.+...-........++-|++|.|||++.+.. |+...||||.|||+.||+|-.+.|...+..
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k 246 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEK 246 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhh
Confidence 999999998865544333333567899999999998864 899999999999999999999888765443
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=282.77 Aligned_cols=240 Identities=18% Similarity=0.229 Sum_probs=183.9
Q ss_pred ccccCCCceEEEEEE--CCccEEEEEecCCCCc---hhhhHhhHHHHH---hcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 62 VITKDLLYKLYKGFL--QDRPISVMKFGGNLNS---EEYCCFNCIAFA---SQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 62 ~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~---~~~~~~~E~~~l---~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
.||+|+||.||++.. ++..+|+|.+...... ....+.+|..++ ....||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999998 5788999988654221 122234444333 34479999999999999999999999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+++|.+++...+ .+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++++|||++........
T Consensus 81 ~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 152 (279)
T cd05633 81 GGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (279)
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc
Confidence 999999887543 5899999999999999999999 99999999999999999999999999999865432211
Q ss_pred ccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
....|+..|+|||.+.. ..++.++||||||+++|+|++|..||....... ........ ...
T Consensus 153 -----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~----~~~------- 214 (279)
T cd05633 153 -----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMT----LTV------- 214 (279)
T ss_pred -----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC--HHHHHHHh----hcC-------
Confidence 13468999999998864 568999999999999999999999996542211 11111110 000
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-----TMVQVAK 335 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ei~~ 335 (344)
.... ....+.++.+++.+||+.||++|| |+.++++
T Consensus 215 ------~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 215 ------NVEL--PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred ------CcCC--ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 0000 113445688999999999999999 5888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=279.73 Aligned_cols=264 Identities=20% Similarity=0.234 Sum_probs=191.3
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCC-CCceeeeeeEEeeC--CccEEEEe
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMS-HKNILKFVGCCLET--ELPILVFE 130 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~--~~~~lv~e 130 (344)
|+..+.||+|+||.||+|.. +++.||+|++...... ......+|+..+.++. |+||+++++++.++ +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 45678899999999999998 6788999998765322 2233457899999995 99999999999887 88999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|+. ++|.+.+.... ..+++.++..++.|++.||.||| +.+++||||+|+||+++. +.++|+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 997 68888876543 25889999999999999999999 999999999999999999 9999999999876643
Q ss_pred CCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHH-------HHHh
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELV-------RKSI 282 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~ 282 (344)
.... ....++..|+|||++.. ..++.++|||||||++|||++|..||..... ........... ....
T Consensus 152 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 152 KPPY----TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE-LDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred CCCc----CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH-HHHHHHHHHHcCCCCHHHHHhh
Confidence 2221 13457889999997644 5578899999999999999999988854321 00000000000 0000
Q ss_pred ccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..........+... ....++.....+..+.+++.+||+.+|++|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 227 RKSRHMNYNFPSKK-GTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccccCcccc-cccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000000000 00001111234577999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=289.83 Aligned_cols=263 Identities=17% Similarity=0.245 Sum_probs=195.6
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeC------
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLET------ 122 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~------ 122 (344)
..+.|+..+.||+|+||.||+|.. +++.||+|.+..... .....+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457799999999999999999998 778999999865422 2335577899999999999999999988643
Q ss_pred CccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeee
Q 048160 123 ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF 202 (344)
Q Consensus 123 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~df 202 (344)
...++||||+. ++|.+.+.. .++...+..++.|++.||.||| ..+|+||||||+||+++.++.++|+||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccC
Confidence 35699999996 688887753 3778888999999999999999 999999999999999999999999999
Q ss_pred ecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHH--
Q 048160 203 CVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK-- 280 (344)
Q Consensus 203 g~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-- 280 (344)
|+++....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ..........
T Consensus 163 g~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~ 234 (353)
T cd07850 163 GLARTAGTSFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH----IDQWNKIIEQLG 234 (353)
T ss_pred ccceeCCCCCC----CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHhcC
Confidence 99976543221 1134578899999999998999999999999999999999999864321 1111111110
Q ss_pred ----------------HhccC------CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 281 ----------------SIESN------SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 281 ----------------~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..... .+...+.......... ......+..+.+++.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSE-SHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred CCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccc-cccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000 0001110000000000 000123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=277.21 Aligned_cols=241 Identities=19% Similarity=0.252 Sum_probs=193.6
Q ss_pred cccCCCceEEEEEEC--CccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCCc
Q 048160 63 ITKDLLYKLYKGFLQ--DRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTL 137 (344)
Q Consensus 63 ig~G~~g~V~~~~~~--~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL 137 (344)
||.|++|.||+++.. +..||+|.+..... ...+.+.+|+.+++.++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999994 88999999865422 2345678999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCccccc
Q 048160 138 ADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217 (344)
Q Consensus 138 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~ 217 (344)
.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---- 148 (262)
T cd05572 81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---- 148 (262)
T ss_pred HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc----
Confidence 99997653 4888999999999999999999 99999999999999999999999999999887654321
Q ss_pred CCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccccccc
Q 048160 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVG 297 (344)
Q Consensus 218 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (344)
.....++..|++||.+.+..++.++|+||||+++|++++|..||..... +....... .....
T Consensus 149 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~----~~~~~------------ 210 (262)
T cd05572 149 TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE--DPMEIYND----ILKGN------------ 210 (262)
T ss_pred cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC--CHHHHHHH----HhccC------------
Confidence 1134678899999999888899999999999999999999999875432 11111111 11000
Q ss_pred CCCCChhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 048160 298 EEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT-----MVQVAK 335 (344)
Q Consensus 298 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ei~~ 335 (344)
.....|. ..+..+.+++.+||+.+|++||+ +.|+++
T Consensus 211 ~~~~~~~--~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 211 GKLEFPN--YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCCCCc--ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 0001111 22456899999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=282.84 Aligned_cols=257 Identities=13% Similarity=0.105 Sum_probs=182.2
Q ss_pred cCCCCCCccccCCCceEEEEEECC-----ccEEEEEecCCCCchh-----------hhHhhHHHHHhcCCCCceeeeeeE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFLQD-----RPISVMKFGGNLNSEE-----------YCCFNCIAFASQMSHKNILKFVGC 118 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~~~-----~~vavk~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~~~~~ 118 (344)
+.|.+.+.||+|+||.||+|.+.+ ..+|+|.......... .....+...+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 568899999999999999999832 3455554322221110 011233345566789999999997
Q ss_pred EeeCC----ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC
Q 048160 119 CLETE----LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ 194 (344)
Q Consensus 119 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 194 (344)
+.... ..++++|++. .++.+.+.... ..++..+..++.|++.||.||| +.+|+||||||+|||++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGN 162 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCC
Confidence 66543 3367788764 46666654432 3567788899999999999999 9999999999999999999
Q ss_pred CcceEeeeecccccCCCCccc----ccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcc
Q 048160 195 NVAKFFDFCVSISIPEGKTHV----NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGE 270 (344)
Q Consensus 195 ~~~kl~dfg~a~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 270 (344)
+.++|+|||+|+......... .......||+.|+|||+..+..++.++|||||||+++||++|..||.........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 999999999998764322111 1112346899999999999999999999999999999999999999654221111
Q ss_pred hhH-HHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048160 271 EYF-LQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337 (344)
Q Consensus 271 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L 337 (344)
... ..+++..... +.. ....++..+.+++..||+.+|++||++.+|++.|
T Consensus 243 ~~~~~~~~~~~~~~-~~~----------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IHAAKCDFIKRLHE-GKI----------------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhHHHHHHHhhh-hhh----------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 100 1111111111 000 0012345689999999999999999999999876
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=288.15 Aligned_cols=246 Identities=22% Similarity=0.285 Sum_probs=204.6
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
+.|+.-.+||+|+||.||-++. +|+.+|.|++.+.. .......+.|-.++++++.+.||.+--++.+.+.+++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 5688889999999999999887 88999999875431 122344668999999999999999988899999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
..|.||+|.-+|.+.++ +-|++..++.++.+|+.||++|| ..+||.|||||+|||+|+.|+++|+|+|+|..++
T Consensus 265 tlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 99999999999987764 35899999999999999999999 9999999999999999999999999999999887
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
.+.... .++||.+|||||++.+..|+.+.|.||+||++|||+.|..||....+-. ..+
T Consensus 339 ~g~~~~----~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv------------------k~e 396 (591)
T KOG0986|consen 339 EGKPIR----GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV------------------KRE 396 (591)
T ss_pred CCCccc----cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh------------------hHH
Confidence 765433 4589999999999999999999999999999999999999996532211 111
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM 330 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 330 (344)
-+|+.+......++ +..+++..+|....|+.||.+|.-.
T Consensus 397 Evdrr~~~~~~ey~--~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 397 EVDRRTLEDPEEYS--DKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHHHHhcchhhcc--cccCHHHHHHHHHHHccCHHHhccC
Confidence 22222222333333 2677889999999999999999654
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=280.91 Aligned_cols=265 Identities=15% Similarity=0.167 Sum_probs=195.3
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
|+..+.||.|++|.||+|.. ++..||+|++...... ....+.+|+.++++++|||++++++++.+++..++|+||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56678899999999999998 6889999998655322 2355778999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
. ++|.+++..... ..+++.++..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 81 D-LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred C-cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 5 689998865432 25889999999999999999999 9999999999999999999999999999987653322
Q ss_pred cccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCC-----
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNS----- 286 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 286 (344)
.. .....++..|+|||++.+. .++.++||||||+++|+|++|..||..... ................
T Consensus 154 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07835 154 RT---YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE----IDQLFRIFRTLGTPDEDVWPG 226 (283)
T ss_pred cc---cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCChHHhhh
Confidence 11 1123567889999987664 578999999999999999999999864321 1111111111100000
Q ss_pred ---cccccccccccCCCCC-hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 287 ---FKEIVDPIIVGEEGLW-PEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 287 ---~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+............. ......+..+.+++.+||+.||++|||+.+|++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 227 VTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000000000 001123356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=283.20 Aligned_cols=263 Identities=20% Similarity=0.236 Sum_probs=195.9
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCC--CchhhhHhhHHHHHhcCCCCceeeeeeEEeeC--CccEEEEe
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL--NSEEYCCFNCIAFASQMSHKNILKFVGCCLET--ELPILVFE 130 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~e 130 (344)
|...+.||+|+||.||+|.. ++..+|+|++.... ......+.+|+.++++++|+|++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 55678899999999999999 46889999987663 22345677899999999999999999999887 78999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|++ ++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++.....
T Consensus 81 ~~~-~~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 81 YMD-HDLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred ccc-ccHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 997 58988886543 25889999999999999999999 99999999999999999999999999999887654
Q ss_pred CCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC---C
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN---S 286 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~ 286 (344)
..... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||..... ......... ..... .
T Consensus 153 ~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~----~~~~~~~~~-~~~~~~~~~ 225 (287)
T cd07840 153 RNSAD--YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE----LEQLEKIFE-LCGSPTDEN 225 (287)
T ss_pred CCccc--ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHH-HhCCCchhh
Confidence 33211 113356788999997764 4578999999999999999999998864321 111111111 11100 0
Q ss_pred cccccc----cccccCCCCChh-----hHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 287 FKEIVD----PIIVGEEGLWPE-----KEK-QLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 287 ~~~~~~----~~~~~~~~~~~~-----~~~-~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+....+ .... .....+. ... ++..+.+++.+||+.+|.+||++.++++
T Consensus 226 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 226 WPGVSKLPWFENLK-PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccccccchhhhhcc-ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000 0000 0000000 001 2567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=280.90 Aligned_cols=267 Identities=15% Similarity=0.221 Sum_probs=197.0
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
+|+..+.||+|++|.||+|+. ++..||+|++...... ....+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 578889999999999999999 6788999998765332 2355678999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
+ ++|.+++...... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++++|||++.......
T Consensus 81 ~-~~l~~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 81 D-KDLKKYMDTHGVR--GALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred C-ccHHHHHHhcCCC--CCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 8 5888887653311 25889999999999999999999 9999999999999999999999999999987654322
Q ss_pred cccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc--CCccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES--NSFKE 289 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 289 (344)
.. .....++..|++||++.+. .++.++||||||+++|++++|..||..... .............+ ..+..
T Consensus 155 ~~---~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07836 155 NT---FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN----EDQLLKIFRIMGTPTESTWPG 227 (284)
T ss_pred cc---cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCChhhHHH
Confidence 11 1123567889999988654 578999999999999999999998865422 11111111110000 00000
Q ss_pred ccc-cccccCCCCCh------hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 IVD-PIIVGEEGLWP------EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ~~~-~~~~~~~~~~~------~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+.+ +......+..+ ..+..+..+.+++.+||+.||.+||++.+|++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 228 ISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 00000000000 01123456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=281.30 Aligned_cols=245 Identities=21% Similarity=0.245 Sum_probs=193.7
Q ss_pred cccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCCc
Q 048160 63 ITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTL 137 (344)
Q Consensus 63 ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL 137 (344)
||+|+||.||++.. ++..+++|.+..... ...+.+.+|+.++++++||||+++++.+..+...++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999 488999999865533 3345678999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc---
Q 048160 138 ADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH--- 214 (344)
Q Consensus 138 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~--- 214 (344)
.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++.........
T Consensus 81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 99987643 5889999999999999999999 999999999999999999999999999998765433211
Q ss_pred --cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 215 --VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 215 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
........++..|+|||......++.++||||||++++++++|..||..... . +....... .
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~----~~~~~~~~-~------- 216 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP----E----EIFQNILN-G------- 216 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----H----HHHHHHhc-C-------
Confidence 0111234577889999999888889999999999999999999999864321 1 11111110 0
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L 337 (344)
...++.....+..+.+++.+||+.+|.+|||+.++.+.|
T Consensus 217 ------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 217 ------KIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred ------CcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 011111111255689999999999999999995555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=273.14 Aligned_cols=250 Identities=22% Similarity=0.287 Sum_probs=202.2
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeC--CccEEEE
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLET--ELPILVF 129 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~ 129 (344)
+|...+.||+|++|.||+|.. ++..|++|.+..... ...+.+.+|+.++++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 477789999999999999999 478899999876543 3456788999999999999999999999988 8899999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++++|.+++.... .+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 9999999999987653 5889999999999999999999 9999999999999999999999999999988776
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
..... .......++..|+|||.+....++.++||||||+++++|++|..||..... .............
T Consensus 153 ~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~--- 221 (260)
T cd06606 153 DIETG-EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-------PMAALYKIGSSGE--- 221 (260)
T ss_pred ccccc-ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHhccccCC---
Confidence 54321 011234678899999999888899999999999999999999999865431 1111111110000
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
....+ ...+..+.+++.+||+.||++||++.++++
T Consensus 222 ---------~~~~~--~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 222 ---------PPEIP--EHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ---------CcCCC--cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 01111 133567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=284.91 Aligned_cols=269 Identities=18% Similarity=0.239 Sum_probs=193.1
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch--hhhHhhHHHHHhcCCCCceeeeeeEEeeCCc-----
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE--EYCCFNCIAFASQMSHKNILKFVGCCLETEL----- 124 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~----- 124 (344)
.++|...+.||+|+||.||+|.. +++.||+|.+....... ...+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 35689999999999999999998 67899999886543222 2345689999999999999999999876543
Q ss_pred ---cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEee
Q 048160 125 ---PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFD 201 (344)
Q Consensus 125 ---~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~d 201 (344)
.++||||+. ++|.+++.... ..+++.++..++.|++.||.||| +.+++|+||||+||+++.++.++|+|
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECc
Confidence 499999996 58888776543 25889999999999999999999 99999999999999999999999999
Q ss_pred eecccccCCCCccc-ccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHH
Q 048160 202 FCVSISIPEGKTHV-NDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR 279 (344)
Q Consensus 202 fg~a~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 279 (344)
||++.......... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||..... ......+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~-----~~~~~~~~ 237 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE-----QHQLTLIS 237 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHH
Confidence 99987664332211 111234567889999988664 478899999999999999999988854321 11111111
Q ss_pred HHhc---cCCcc-----cccccccccCCC--CChh---hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 280 KSIE---SNSFK-----EIVDPIIVGEEG--LWPE---KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 280 ~~~~---~~~~~-----~~~~~~~~~~~~--~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... ..... ...+........ ..+. .......+.+|+.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 1110 00000 000000000000 0000 0011245679999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=285.11 Aligned_cols=265 Identities=17% Similarity=0.178 Sum_probs=191.3
Q ss_pred CccccC--CCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 61 KVITKD--LLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 61 ~~ig~G--~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
..||+| +||+||.+++ .++.||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456776 8999999998 789999999875432 2235678999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
++|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 999998876432 24788889999999999999999 999999999999999999999999999765433221111
Q ss_pred ----cccCCccccccccccccccCcC--CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHH-HhccC--
Q 048160 215 ----VNDNNKVIGTFGFIAPEYMSTA--NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK-SIESN-- 285 (344)
Q Consensus 215 ----~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~-- 285 (344)
........++..|+|||++.+. .++.++|||||||++|+|++|..||...... ......... ...+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~ 233 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT----QMLLQKLKGPPYSPLDI 233 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH----HHHHHHhcCCCCCCccc
Confidence 0011112345679999998763 4789999999999999999999998653211 111111000 00000
Q ss_pred ---------------Cc-----ccccc----cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 ---------------SF-----KEIVD----PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ---------------~~-----~~~~~----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.. ..... ..........+....++..+.+|+.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00 00000 0000011112222356678999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=283.39 Aligned_cols=269 Identities=19% Similarity=0.199 Sum_probs=195.5
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCC-----
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETE----- 123 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~----- 123 (344)
..++|+..+.||+|+||.||+|.. ++..||+|++..... .....+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 456799999999999999999999 578899999865432 22345678999999999999999999987654
Q ss_pred -----ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcce
Q 048160 124 -----LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAK 198 (344)
Q Consensus 124 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 198 (344)
..++|+||+++ ++...+.... ..+++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.++
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEE
Confidence 78999999975 7777765543 35889999999999999999999 99999999999999999999999
Q ss_pred EeeeecccccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHH
Q 048160 199 FFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL 277 (344)
Q Consensus 199 l~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 277 (344)
|+|||++.......... .....++..|+|||.+.+ ..++.++||||||+++++|++|+.||..... ...+...
T Consensus 157 l~dfg~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~----~~~~~~~ 230 (302)
T cd07864 157 LADFGLARLYNSEESRP--YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE----LAQLELI 230 (302)
T ss_pred eCcccccccccCCcccc--cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHH
Confidence 99999987665433211 112345778999998865 3578999999999999999999988864321 1111111
Q ss_pred HHHHhcc--CCccccc--------ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 278 VRKSIES--NSFKEIV--------DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 278 ~~~~~~~--~~~~~~~--------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
....... ..+..+. +................+..+.+++.+||+.||.+|||+.+|+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1110000 0000000 00000000000001123456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=285.24 Aligned_cols=251 Identities=21% Similarity=0.307 Sum_probs=192.1
Q ss_pred hcCCCCCCccccCCCceEEEEEEC--CccEEEEEecCCCC-chhhhHhhHHHHHhcCC-CCceeeeeeEEeeCCccEEEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQ--DRPISVMKFGGNLN-SEEYCCFNCIAFASQMS-HKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~--~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~ 129 (344)
.++|...+.||+|+||.||+|.+. +..||||.+..... .....+.+|+.++.+.. ||||+++++++.++...++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 356888899999999999999994 88999999875432 23345667777777775 999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCC-CCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFS-RPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
||+. ++|.+++.... .++++..+..++.|++.||.||| + .+|+||||+|+||+++.++.++|+|||++...
T Consensus 94 e~~~-~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 94 ELMS-TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred eccC-cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 9985 57777665533 26888999999999999999999 6 59999999999999999999999999998765
Q ss_pred CCCCcccccCCccccccccccccccCcCC----CCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTAN----CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES 284 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (344)
...... ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||..... ....+... ...
T Consensus 166 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~----~~~ 234 (296)
T cd06618 166 VDSKAK----TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT---EFEVLTKI----LQE 234 (296)
T ss_pred cCCCcc----cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh---HHHHHHHH----hcC
Confidence 432211 1235678899999987553 78999999999999999999999854211 01111111 111
Q ss_pred CCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 285 NSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
. ....+.....+.++.+|+.+||+.||++||++.+|++.
T Consensus 235 ~-------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 235 E-------------PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C-------------CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 00111111234568999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=276.06 Aligned_cols=250 Identities=26% Similarity=0.356 Sum_probs=201.2
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
+|...+.||.|+||.||++.. ++..|++|++..... .....+.+|++++++++|+|++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 477788999999999999999 478999999876543 3456678999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+++++|.+++...... ...+++.++..++.+++.||.||| +.+++|+||+|+||+++.++.++++|||.+......
T Consensus 81 ~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKE-GKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhcc-CCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 9999999998764210 036899999999999999999999 999999999999999999999999999998776543
Q ss_pred CcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
... .....++..|+|||.+.+..++.++|+||+|+++++|++|..||.... . ......... .....
T Consensus 157 ~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~----~----~~~~~~~~~-~~~~~-- 222 (258)
T cd08215 157 VDL---AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN----L----LELALKILK-GQYPP-- 222 (258)
T ss_pred cce---ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc----H----HHHHHHHhc-CCCCC--
Confidence 311 123467889999999988889999999999999999999999885432 1 111111111 11100
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+. ..+..+.+++.+||+.+|++|||+.++++
T Consensus 223 ----------~~~--~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 ----------IPS--QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ----------CCC--CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 011 33456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=293.52 Aligned_cols=247 Identities=22% Similarity=0.239 Sum_probs=206.5
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch--hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE--EYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
-..+|.+..+||+|.|++|..|++ .+..||+|.+.+..-.. ...+.+|+++|+.++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 346799999999999999999999 78999999887653322 24467999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||+.+|.+.+++.+.+ ...+..+..++.|+++|++||| ...|+|||||++|+|++.+.++||+|||++..+
T Consensus 134 ~eya~~ge~~~yl~~~g-----r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG-----RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred EEeccCchhHHHHHhcc-----cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceee
Confidence 99999999999998776 3566888999999999999999 999999999999999999999999999999988
Q ss_pred CCCCcccccCCccccccccccccccCcCCCC-cccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCN-EKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
....... +..|++.|+|||++.+..|+ +.+|+||+|+++|-|..|..||.... +
T Consensus 206 ~~~~~lq----t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~---------------------l 260 (596)
T KOG0586|consen 206 DYGLMLQ----TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN---------------------L 260 (596)
T ss_pred ccccccc----ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc---------------------c
Confidence 7544333 57899999999999998875 78999999999999999999997532 2
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+-.+.+.+... .|. ..+.+..+++.++|-.+|.+|++.++|.+
T Consensus 261 k~Lr~rvl~gk~r-Ip~--~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 261 KELRPRVLRGKYR-IPF--YMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ccccchheeeeec-ccc--eeechhHHHHHHhhccCccccCCHHHhhh
Confidence 2222223322211 111 33345789999999999999999998864
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=289.08 Aligned_cols=269 Identities=16% Similarity=0.240 Sum_probs=197.8
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEee----CCcc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLE----TELP 125 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----~~~~ 125 (344)
.++|...+.||+|+||.||+|.. ++..||+|++..... .....+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 46799999999999999999998 688999999876432 234557789999999999999999998753 3467
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
++|+||+. ++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEehhh-hhHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccc
Confidence 99999995 68999886543 5889999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCccc-ccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhc
Q 048160 206 ISIPEGKTHV-NDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE 283 (344)
Q Consensus 206 ~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (344)
.......... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... ...+.........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~----~~~~~~~~~~~g~ 230 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY----VHQLKLILSVLGS 230 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh----HHHHHHHHHHhCC
Confidence 7664332211 11123467889999998765 4588999999999999999999999864321 1111111110000
Q ss_pred ----------cCCcccccccccccCCCCChh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 284 ----------SNSFKEIVDPIIVGEEGLWPE-KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 284 ----------~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
........+..-......+.. .+..+..+.+++.+||+.+|++|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000000000000000111111 0134567999999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=274.82 Aligned_cols=246 Identities=24% Similarity=0.398 Sum_probs=200.3
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
+|+..+.||+|++|.||++.. .++.|++|.+..... ...+.+.+|+.++++++|+|++++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 477789999999999999988 567899999876643 3456788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+++++|.+++.... .+++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKKFG-----PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 99999999987653 5889999999999999999999 999999999999999999999999999998876543
Q ss_pred CcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
... .....++..|+|||...+..++.++||||||++++++++|..||..... ....... . ..
T Consensus 153 ~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~----~-~~------ 214 (254)
T cd06627 153 SKD---DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRI----V-QD------ 214 (254)
T ss_pred ccc---ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHH----h-cc------
Confidence 321 1234678899999998887789999999999999999999999864321 1111110 0 00
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.....+. ..+..+.+++.+||+.+|++|||+.+++.
T Consensus 215 ------~~~~~~~--~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 215 ------DHPPLPE--GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ------CCCCCCC--CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0000111 23456889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=278.37 Aligned_cols=242 Identities=21% Similarity=0.187 Sum_probs=186.3
Q ss_pred CccccCCCceEEEEEE--CCccEEEEEecCCCCc---hhhhHhhHHHH-HhcCCCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 61 KVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS---EEYCCFNCIAF-ASQMSHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~---~~~~~~~E~~~-l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
+.||+|+||.||+|.. .++.||+|.+...... ....+..|..+ ....+|+||+++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999998 6789999998654221 12233445443 4455899999999999999999999999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
++|.+++.... ++++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++.....
T Consensus 82 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 82 GDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 99999997643 5889999999999999999999 99999999999999999999999999998875432
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPI 294 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (344)
.....++..|+|||.+.+..++.++||||||+++|++++|..||..... ........ ..... .
T Consensus 150 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~-----~~~~~-~---- 212 (260)
T cd05611 150 ---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP----DAVFDNIL-----SRRIN-W---- 212 (260)
T ss_pred ---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHH-----hcccC-C----
Confidence 1134578899999999888889999999999999999999999854321 11111110 00000 0
Q ss_pred cccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048160 295 IVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337 (344)
Q Consensus 295 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L 337 (344)
. .......+..+.+++.+||+.+|++||++.++.+.|
T Consensus 213 ---~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 213 ---P---EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ---C---CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 0 000113456689999999999999999876555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=307.00 Aligned_cols=268 Identities=22% Similarity=0.298 Sum_probs=209.1
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEEC---------CccEEEEEecCCCCc-hhhhHhhHHHHHhcC-CCCceeeeeeE
Q 048160 50 LKAATNNYDPEKVITKDLLYKLYKGFLQ---------DRPISVMKFGGNLNS-EEYCCFNCIAFASQM-SHKNILKFVGC 118 (344)
Q Consensus 50 i~~~~~~~~~~~~ig~G~~g~V~~~~~~---------~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~~~~~ 118 (344)
++...++....+.+|+|.||.|++|... ...||||.++..... +.+.+..|+.+|+.+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 4444555666679999999999999872 346999998866443 456788999999999 59999999999
Q ss_pred EeeCCccEEEEeecCCCCccccccCCC---C------CCC--ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccccc
Q 048160 119 CLETELPILVFEFVACGTLADRIHDPN---G------SQL--EPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPS 187 (344)
Q Consensus 119 ~~~~~~~~lv~e~~~~gsL~~~l~~~~---~------~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~ 187 (344)
|......++|+||+..|+|..+++... . ... ..++....+.++.|||.|++||+ +.+++||||.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhh
Confidence 999999999999999999999998765 0 000 13888899999999999999999 999999999999
Q ss_pred ceEeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCcc
Q 048160 188 TILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFE 267 (344)
Q Consensus 188 Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 267 (344)
|||+..+..+|++|||+|+................-+..|||||.+....|+.++||||||+++||++|...++|+..
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~-- 525 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI-- 525 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC--
Confidence 999999999999999999866544332211111113566999999999999999999999999999998666655431
Q ss_pred CcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 048160 268 NGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLH 341 (344)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~ 341 (344)
.....+.+ ..+.+. . ...+..|..++.++|+.||+.+|++||++.++.+.+.+..
T Consensus 526 -~~~~~l~~----~l~~G~------------r--~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 526 -PPTEELLE----FLKEGN------------R--MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred -CcHHHHHH----HHhcCC------------C--CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 10111111 222221 1 1122256778999999999999999999999999999854
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=281.57 Aligned_cols=253 Identities=18% Similarity=0.199 Sum_probs=195.6
Q ss_pred CCCCCCccccCCCceEEEEEE-----CCccEEEEEecCCC----CchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCcc
Q 048160 56 NYDPEKVITKDLLYKLYKGFL-----QDRPISVMKFGGNL----NSEEYCCFNCIAFASQM-SHKNILKFVGCCLETELP 125 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~-----~~~~vavk~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~ 125 (344)
+|...+.||+|++|.||+++. ++..||+|.+.... ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467788999999999999986 45679999886432 12234577899999999 599999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
++||||+++|+|.+++.... .+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.++++|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE-----HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC-----CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccc
Confidence 99999999999999886543 5788899999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCcccccCCccccccccccccccCcCC--CCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhc
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTAN--CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE 283 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (344)
.......... .....++..|+|||.+.+.. .+.++||||||+++|+|++|..||...... .. ..........
T Consensus 153 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~---~~~~~~~~~~ 226 (288)
T cd05583 153 KEFLAEEEER--AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NS---QSEISRRILK 226 (288)
T ss_pred cccccccccc--cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-ch---HHHHHHHHHc
Confidence 7654332211 11345788999999987654 788999999999999999999998542211 11 1111111111
Q ss_pred cCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048160 284 SNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338 (344)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~ 338 (344)
. ....+ ...+..+.+++.+||+.||++|||+.++.+.|.
T Consensus 227 ~--------------~~~~~--~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 227 S--------------KPPFP--KTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred c--------------CCCCC--cccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 0 00011 123456889999999999999999888877664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=302.01 Aligned_cols=255 Identities=19% Similarity=0.312 Sum_probs=208.2
Q ss_pred CCCCCccccCCCceEEEEEE--CC----ccEEEEEecCC-CCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QD----RPISVMKFGGN-LNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~----~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
.+..++||+|+||+||+|.| .+ .+||+|.+... ......+++.|+-.|.++.|||+++++|+|.... +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 44458899999999999999 43 46899987654 3344678999999999999999999999998766 77999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
+|++.|+|.++++...+ ++.....+.+..|||+|+.||| ...++||||-++|||+.+-..+|+.|||+++...
T Consensus 777 q~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HhcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 99999999999987663 6788888999999999999999 9999999999999999999999999999999887
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
......... ...-.+.|+|-|.++...|+.++|||||||++||++| |..|++.... +.+....+.
T Consensus 850 ~d~~ey~~~-~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~---------~eI~dlle~---- 915 (1177)
T KOG1025|consen 850 PDEKEYSAP-GGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA---------EEIPDLLEK---- 915 (1177)
T ss_pred ccccccccc-ccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH---------HHhhHHHhc----
Confidence 665443221 1122567999999999999999999999999999998 6667654321 111111111
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
..+.+.++.|+.++.-++.+||..|++.||+++++...+.+..+.
T Consensus 916 ----------geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 916 ----------GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ----------cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 222444557888899999999999999999999999999887653
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=278.33 Aligned_cols=264 Identities=19% Similarity=0.203 Sum_probs=197.7
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
|...+.||+|++|.||+|.. ++..+++|++...... ....+.+|+.++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 45678899999999999998 6788999998765433 3456778999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
+ ++|.+++.... ..+++.++..++.|++.||.||| ..+|+|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~-~~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 D-TDLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred C-CCHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 7 58888886643 26889999999999999999999 9999999999999999999999999999987765433
Q ss_pred cccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc--CCccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES--NSFKE 289 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 289 (344)
.. .....++..|+|||.+.+. .++.++|+||||+++|++++|+.||..... ...+.......... ..+..
T Consensus 153 ~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd05118 153 RP---YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE----IDQLFKIFRTLGTPDPEVWPK 225 (283)
T ss_pred cc---ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHcCCCchHhccc
Confidence 11 1123567889999998776 789999999999999999999988854321 11111111110000 00000
Q ss_pred ccc---c----ccccCCCCCh-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 IVD---P----IIVGEEGLWP-EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ~~~---~----~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+ . .........+ ..+..+..+.+++.+||++||.+||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 226 FTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred chhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 0 0000000000 11235677999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=290.42 Aligned_cols=268 Identities=17% Similarity=0.199 Sum_probs=194.1
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeC---------
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLET--------- 122 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--------- 122 (344)
..+|...+.||.|+||.||+|.. ++..||+|++........+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36788899999999999999998 6788999998766555566788999999999999999999876543
Q ss_pred -----CccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec-CCc
Q 048160 123 -----ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE-QNV 196 (344)
Q Consensus 123 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~ 196 (344)
...++|+||+. ++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||+++. ++.
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCce
Confidence 35789999997 6888877542 4888999999999999999999 999999999999999974 557
Q ss_pred ceEeeeecccccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHH
Q 048160 197 AKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQ 275 (344)
Q Consensus 197 ~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 275 (344)
++++|||++.................++..|+|||.+.. ..++.++|||||||++|+|++|..||..... .....
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~----~~~~~ 229 (342)
T cd07854 154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE----LEQMQ 229 (342)
T ss_pred EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHH
Confidence 899999998765432222211123357889999998654 5578999999999999999999999964321 11111
Q ss_pred HHHHHHhcc-----CCcccccccccc--cCCCCChh---hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 276 ELVRKSIES-----NSFKEIVDPIIV--GEEGLWPE---KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 276 ~~~~~~~~~-----~~~~~~~~~~~~--~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
......... ............ ......+. ....+..+.+++.+||+.||++|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 111110000 000000000000 00000110 0123356889999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=277.16 Aligned_cols=240 Identities=18% Similarity=0.229 Sum_probs=184.8
Q ss_pred ccccCCCceEEEEEE--CCccEEEEEecCCCCc---hhhhHhhHH---HHHhcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 62 VITKDLLYKLYKGFL--QDRPISVMKFGGNLNS---EEYCCFNCI---AFASQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 62 ~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~---~~~~~~~E~---~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
.||+|+||.||++.. .++.||+|.+...... ....+..|. ..++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999988 5789999988654221 112233343 34555679999999999999999999999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++........
T Consensus 81 g~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~ 152 (278)
T cd05606 81 GGDLHYHLSQHG-----VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (278)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC
Confidence 999999886543 5899999999999999999999 99999999999999999999999999999875532211
Q ss_pred ccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
....|+..|+|||++.++ .++.++||||+|+++|+|++|..||........ .... .....
T Consensus 153 -----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~~----~~~~~-------- 213 (278)
T cd05606 153 -----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEID----RMTLT-------- 213 (278)
T ss_pred -----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHHH----HHhhc--------
Confidence 134688999999998754 589999999999999999999999865421111 0000 00000
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-----TMVQVAK 335 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ei~~ 335 (344)
....+|. ..+..+.+++.+||+.+|.+|| ++.++++
T Consensus 214 -----~~~~~~~--~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 214 -----MAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -----cCCCCCC--cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 0011111 2345689999999999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=279.26 Aligned_cols=250 Identities=19% Similarity=0.235 Sum_probs=193.1
Q ss_pred CCCCCCccccCCCceEEEEEE-----CCccEEEEEecCCCC----chhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCcc
Q 048160 56 NYDPEKVITKDLLYKLYKGFL-----QDRPISVMKFGGNLN----SEEYCCFNCIAFASQM-SHKNILKFVGCCLETELP 125 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~-----~~~~vavk~~~~~~~----~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~ 125 (344)
+|+..+.||+|+||.||.++. ++..||+|.+..... ...+.+.+|+.+++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999987 567899999865321 2235577899999999 589999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
++|+||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccc
Confidence 99999999999999987643 5788889999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCcccccCCccccccccccccccCcC--CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhc
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA--NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE 283 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (344)
......... ......|+..|+|||.+... .++.++||||||+++|+|++|..||........ ..........
T Consensus 153 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~----~~~~~~~~~~ 226 (290)
T cd05613 153 KEFHEDEVE--RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS----QAEISRRILK 226 (290)
T ss_pred eeccccccc--ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc----HHHHHHHhhc
Confidence 765432211 11134678899999998653 467899999999999999999999864221111 1111111110
Q ss_pred cCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048160 284 SNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-----TMVQVAK 335 (344)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ei~~ 335 (344)
. ....+. .....+.+++.+||+.||++|| ++.+++.
T Consensus 227 ~--------------~~~~~~--~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 227 S--------------EPPYPQ--EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred c--------------CCCCCc--cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0 011111 2345678999999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=287.46 Aligned_cols=267 Identities=19% Similarity=0.207 Sum_probs=200.2
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC--CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCC-----ccE
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL--NSEEYCCFNCIAFASQMSHKNILKFVGCCLETE-----LPI 126 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-----~~~ 126 (344)
+|...+.||+|++|.||+|+. .+..||+|++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 477889999999999999998 47889999987654 233466889999999999999999999988765 789
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
+||||++ ++|.+++.... ++++..+..++.+++.||.||| +.+|+|+||||+||+++.++.++|+|||++.
T Consensus 81 lv~e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 9999997 58988887543 6889999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh---
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI--- 282 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 282 (344)
................++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... ............
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~~~~ 227 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY----IDQLNLIVEVLGTPS 227 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH----HHHHHHHHHhcCCCC
Confidence 765443211112234678899999999877 789999999999999999999999865431 111111111000
Q ss_pred -------ccCCcccccccccccCCCCCh-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 -------ESNSFKEIVDPIIVGEEGLWP-EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 -------~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
........+..........+. ..+..+..+.+++.+||+.+|++|||+.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 000000000000000000000 01123566899999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=285.97 Aligned_cols=270 Identities=20% Similarity=0.238 Sum_probs=196.0
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC--CchhhhHhhHHHHHhcC-CCCceeeeeeEEeeC--Ccc
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL--NSEEYCCFNCIAFASQM-SHKNILKFVGCCLET--ELP 125 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~--~~~ 125 (344)
..++|...+.||+|+||.||+|.. .+..+|+|++.... ......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 456788889999999999999998 57889999885432 22345577899999999 999999999988653 367
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
++||||++ ++|..++... .+.+..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++
T Consensus 85 ~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred EEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccch
Confidence 99999997 6898888653 4778888899999999999999 999999999999999999999999999998
Q ss_pred cccCCCCccc--ccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 206 ISIPEGKTHV--NDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 206 ~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
.......... .......|+..|+|||++.+ ..++.++||||||+++|+|++|..||...... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~----~~~~~~~~~~~ 230 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL----NQLEKIIEVIG 230 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhC
Confidence 8765432210 11123467889999998755 45789999999999999999999998543211 11111110000
Q ss_pred ----------ccCCcccccccccccCCCC-ChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 283 ----------ESNSFKEIVDPIIVGEEGL-WPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 283 ----------~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
........++......... .......+..+.+++..||+.||++|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000111000000000 00011235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=280.38 Aligned_cols=265 Identities=18% Similarity=0.221 Sum_probs=192.9
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
++|+..+.||+|++|.||+|.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++..+...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4688889999999999999998 577899998765432 223567789999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec-CCcceEeeeecccccC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE-QNVAKFFDFCVSISIP 209 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~dfg~a~~~~ 209 (344)
|++ ++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++. ++.+|++|||++....
T Consensus 82 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhCCC---CCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 996 688887754432 23577888899999999999999 999999999999999985 5578999999987553
Q ss_pred CCCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc--CC
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES--NS 286 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~ 286 (344)
..... .....++..|+|||++.+. .++.++||||||+++|+|++|..||..... .............+ ..
T Consensus 155 ~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~----~~~~~~~~~~~~~~~~~~ 227 (294)
T PLN00009 155 IPVRT---FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE----IDELFKIFRILGTPNEET 227 (294)
T ss_pred CCccc---cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCChhh
Confidence 32111 1123568899999988664 578999999999999999999999865322 11111111110000 00
Q ss_pred c---ccccccccccCCCCChh------hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 287 F---KEIVDPIIVGEEGLWPE------KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 287 ~---~~~~~~~~~~~~~~~~~------~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+ ..+.+.. ...+.++. .+..+..+.+++.+||+.+|++||++.++++
T Consensus 228 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 228 WPGVTSLPDYK--SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccccccchhhh--hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0000000 00000000 0123355889999999999999999999875
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=281.79 Aligned_cols=243 Identities=23% Similarity=0.326 Sum_probs=190.7
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCC---CCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGN---LNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
|...+.||+|+||.||+|.. ++..+|+|.+... .......+.+|+.+++.++|+|++++++++......++|+||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 66678899999999999998 6678999988643 222234577899999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+. |+|.+++.... .++++.++..++.|++.||.||| +.+++||||+|+||+++.++.++++|||++......
T Consensus 97 ~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 97 CL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred cC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 96 68877765433 25888999999999999999999 999999999999999999999999999998654321
Q ss_pred CcccccCCccccccccccccccC---cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMS---TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
....++..|+|||++. ...++.++||||||+++|+|++|..||..... ........ . ...
T Consensus 169 -------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~----~-~~~- 231 (308)
T cd06634 169 -------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIA----Q-NES- 231 (308)
T ss_pred -------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH----HHHHHHHh----h-cCC-
Confidence 1345788999999874 35678899999999999999999999864211 00111110 0 000
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
+ .......+..+.+|+.+||+.+|++||++.+|+..
T Consensus 232 -----------~-~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 232 -----------P-ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred -----------C-CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 0 00011344568899999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=286.26 Aligned_cols=261 Identities=17% Similarity=0.244 Sum_probs=190.5
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCC------
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETE------ 123 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------ 123 (344)
.++|.....||+|+||.||+|.. ++..||+|++..... .....+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 37899999999999999999997 678999999875422 22345779999999999999999999987543
Q ss_pred ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeee
Q 048160 124 LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFC 203 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg 203 (344)
..++|+||+. .+|..+.. ..+++..+..++.|++.||.||| ..+++||||||+||+++.++.++|+|||
T Consensus 94 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred eEEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCC
Confidence 4589999996 46766553 14788899999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHH-
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS- 281 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~- 281 (344)
++....... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...+.......
T Consensus 163 ~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~----~~~~~~~~~~~~ 232 (342)
T cd07879 163 LARHADAEM------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY----LDQLTQILKVTG 232 (342)
T ss_pred CCcCCCCCC------CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcC
Confidence 987543211 13456888999999866 4588999999999999999999999965321 11111111100
Q ss_pred ---------hccCCcccccccccccCCCCCh-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 282 ---------IESNSFKEIVDPIIVGEEGLWP-EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 282 ---------~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
...............-....+. ..+..+..+.+++.+||+.||++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000000000000000000000 00123456889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=287.60 Aligned_cols=266 Identities=17% Similarity=0.225 Sum_probs=196.6
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC--CchhhhHhhHHHHHhcCCCCceeeeeeEEeeC-----Cc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL--NSEEYCCFNCIAFASQMSHKNILKFVGCCLET-----EL 124 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----~~ 124 (344)
.+.|...+.||+|+||+||+|.. ++..||+|++.... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35688899999999999999998 67899999986542 22334567899999999999999999987654 34
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeec
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV 204 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~ 204 (344)
.++|+||+. ++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ-----TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcc
Confidence 799999996 78988887543 5889999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhc
Q 048160 205 SISIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE 283 (344)
Q Consensus 205 a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (344)
+......... .....++..|+|||.+.. ..++.++||||||+++|+|++|..||..... ......+.....
T Consensus 155 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~ 226 (337)
T cd07858 155 ARTTSEKGDF---MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-----VHQLKLITELLG 226 (337)
T ss_pred ccccCCCccc---ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHHHHhC
Confidence 8766443211 113467889999998765 4688999999999999999999999854311 000111111100
Q ss_pred c-----------CCcccccccccccCCCCCh-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 284 S-----------NSFKEIVDPIIVGEEGLWP-EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 284 ~-----------~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
. ......+............ ..+..+..+.+++.+||+.+|++|||+.++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 227 SPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred CCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0 0000000000000000000 011345678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=248.24 Aligned_cols=263 Identities=17% Similarity=0.240 Sum_probs=201.6
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch--hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE--EYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
+|...++||+|+||+||+|+. .+..||+|++.-+...+ .....+|+.+++.++|.|||+++++...+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 466678999999999999998 66789999987664433 35678999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
|. .+|..+...-+| .+....+..++.|+++||.++| +.+++|||+||+|.|++.+|.+|++|||+++.+...
T Consensus 83 cd-qdlkkyfdslng----~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNG----DLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred hh-HHHHHHHHhcCC----cCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 96 689888877664 5888899999999999999999 999999999999999999999999999999987644
Q ss_pred CcccccCCccccccccccccccCcCC-CCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc--CCc-
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTAN-CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES--NSF- 287 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~- 287 (344)
.... +..+-|.+|.+|.++-+.+ |+++.|+||.||++.|+.....|.++..+..+ .+..+++....+ ..+
T Consensus 155 vrcy---saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd---qlkrif~~lg~p~ed~wp 228 (292)
T KOG0662|consen 155 VRCY---SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKRIFRLLGTPTEDQWP 228 (292)
T ss_pred eEee---eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH---HHHHHHHHhCCCccccCC
Confidence 3222 1345689999999988765 89999999999999999876666665543222 233333322211 111
Q ss_pred --ccccccccccCCCCChhh-------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 288 --KEIVDPIIVGEEGLWPEK-------EKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 288 --~~~~~~~~~~~~~~~~~~-------~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+.|-. ..+.+|.. +.....=+++++..+.-+|.+|.++++.++
T Consensus 229 s~t~lpdyk---~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 229 SMTKLPDYK---PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccccCCCCc---ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1111111 11222221 122223478999999999999999998765
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=277.76 Aligned_cols=264 Identities=19% Similarity=0.228 Sum_probs=194.1
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCC-CCceeeeeeEEeeCCccEEEEeec
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMS-HKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
|...+.||+|++|+||+|.. .++.|++|++...... ......+|+..+.+++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 55678899999999999999 5678999998765432 2233457999999999 999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
+|+|.+++....+ ..+++.++..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 -~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 81 -EGNLYQLMKDRKG---KPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred -CCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 7899988866432 25789999999999999999999 9999999999999999999999999999987654332
Q ss_pred cccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc-------
Q 048160 213 THVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES------- 284 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 284 (344)
.. ....++..|+|||++.. ..++.++|+||||+++++|++|..||...... ..+.+........
T Consensus 154 ~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07830 154 PY----TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEI----DQLYKICSVLGTPTKQDWPE 225 (283)
T ss_pred Cc----CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChH----HHHHHHHHhcCCCChhhhhh
Confidence 21 13457889999998754 45789999999999999999999888544211 1111111000000
Q ss_pred -CCcccccccccccCCCCChh--hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 285 -NSFKEIVDPIIVGEEGLWPE--KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 285 -~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.......+............ ....+..+.+++.+||+.||++|||+.||+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 226 GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred HhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000000000000000 0011356899999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=280.53 Aligned_cols=242 Identities=22% Similarity=0.326 Sum_probs=190.1
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
|...+.||+|+||+||+|+. .+..|++|++..... .....+.+|+.+++.++|||++++++++.++...|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999998 678899999865422 2234577899999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+. |+|.+++.... .++++.++..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 103 CL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence 96 67877775543 35889999999999999999999 99999999999999999999999999998754321
Q ss_pred CcccccCCccccccccccccccC---cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMS---TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
.....|+..|+|||++. ...++.++||||||+++|+|++|..||..... ....... ... ...
T Consensus 174 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~----~~~~~~~----~~~-~~~ 238 (313)
T cd06633 174 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHI----AQN-DSP 238 (313)
T ss_pred ------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHH----Hhc-CCC
Confidence 12346788999999974 45688999999999999999999999865321 1111111 000 000
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.. ... ..+..+.+|+.+||+.+|++||++.+++.
T Consensus 239 ~~-------~~~------~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 239 TL-------QSN------EWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred CC-------Ccc------ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 000 22345789999999999999999999885
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=273.68 Aligned_cols=264 Identities=20% Similarity=0.227 Sum_probs=192.9
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch--hhhHhhHHHHHhcC---CCCceeeeeeEEeeCCc-----
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE--EYCCFNCIAFASQM---SHKNILKFVGCCLETEL----- 124 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~--~~~~~~E~~~l~~l---~H~niv~~~~~~~~~~~----- 124 (344)
|+..+.||+|+||.||+|++ ++..||+|.+....... ...+.+|+.+++++ .|+||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 55678899999999999999 47899999987543221 23455787777666 59999999999987766
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeec
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV 204 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~ 204 (344)
.+++|||+. ++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCc
Confidence 899999997 589888865432 25889999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc
Q 048160 205 SISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES 284 (344)
Q Consensus 205 a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (344)
+......... ....++..|+|||++.+..++.++|+||||+++|+|++|..||..... ...+..........
T Consensus 154 ~~~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~ 225 (287)
T cd07838 154 ARIYSFEMAL----TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE----ADQLDKIFDVIGLP 225 (287)
T ss_pred ceeccCCccc----ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh----HHHHHHHHHHcCCC
Confidence 8776433221 123468889999999888899999999999999999999888764321 11122222111110
Q ss_pred CCcc--ccc---cccccc-CCCCCh-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 285 NSFK--EIV---DPIIVG-EEGLWP-EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 285 ~~~~--~~~---~~~~~~-~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... ... ...... ...... ..+..+..+.+++.+||+.||.+||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 226 SEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred ChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000 000 000000 000000 01134467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=273.66 Aligned_cols=248 Identities=19% Similarity=0.238 Sum_probs=199.1
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC--CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL--NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
+|+..+.||+|+||.||++.. ++..+++|.+.... ......+.+|+.++++++|+||+++++++..+...++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 477789999999999999988 66789999986543 22345677899999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+++++|.+++...... ...+++..+..++.|++.||.||| +.+++|+||+|.||+++.++.++++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKK-RKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999988652211 135788899999999999999999 999999999999999999999999999998776543
Q ss_pred CcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
.. ....++..|+|||.+.+..++.++|+||||++++++++|..||..... ..+... .......
T Consensus 157 ~~-----~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~----~~~~~~~--- 219 (256)
T cd08530 157 MA-----KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-----QDLRYK----VQRGKYP--- 219 (256)
T ss_pred Cc-----ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH----HhcCCCC---
Confidence 11 134578899999999888899999999999999999999999854321 111111 1111110
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. .....+.++.+++.+||+.+|++|||+.++++
T Consensus 220 ---------~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 ---------P--IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ---------C--CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 11144567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=284.95 Aligned_cols=270 Identities=19% Similarity=0.203 Sum_probs=196.8
Q ss_pred HHHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC--CchhhhHhhHHHHHhcCCCCceeeeeeEEee-CC
Q 048160 49 ELKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL--NSEEYCCFNCIAFASQMSHKNILKFVGCCLE-TE 123 (344)
Q Consensus 49 ~i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-~~ 123 (344)
++..++++|...+.||+|+||.||++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.. +.
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 4455778899999999999999999987 67889999876432 2234567789999999999999999999865 56
Q ss_pred ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeee
Q 048160 124 LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFC 203 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg 203 (344)
..++|+||+ +++|..++... ++++..+..++.|++.||.||| +.+|+||||+|.||+++.++.++++|||
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg 153 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFG 153 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccc
Confidence 789999998 57898888642 4778888899999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHH-----
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL----- 277 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----- 277 (344)
.+....... ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...... .....+.+.
T Consensus 154 ~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~-~~~~~~~~~~~~~~ 226 (328)
T cd07856 154 LARIQDPQM------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV-NQFSIITDLLGTPP 226 (328)
T ss_pred cccccCCCc------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCC
Confidence 987543211 12356788999998766 56899999999999999999999988543210 000001110
Q ss_pred ---HHHHhccCCcccccccccccCCCCCh-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 278 ---VRKSIESNSFKEIVDPIIVGEEGLWP-EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 278 ---~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
....... .....+............ ..+..+..+.+++.+||+.+|++|||+.+++..
T Consensus 227 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 227 DDVINTICSE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHHhccch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 000000000000000000 001234678999999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=277.86 Aligned_cols=249 Identities=20% Similarity=0.263 Sum_probs=199.3
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCC-CCceeeeeeEEeeCCccEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMS-HKNILKFVGCCLETELPILV 128 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv 128 (344)
++|...+.||+|+||.||+|.. ++..||+|.+.... ....+.+.+|..++++++ |+||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 3688889999999999999998 67889999886532 122356778999999998 99999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 99999999999997653 6899999999999999999999 999999999999999999999999999998766
Q ss_pred CCCCcc-----------------cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcch
Q 048160 209 PEGKTH-----------------VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEE 271 (344)
Q Consensus 209 ~~~~~~-----------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 271 (344)
...... ........++..|+|||.+....++.++|+||||++++++++|..||..... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~ 228 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----Y 228 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH----H
Confidence 433211 0112234678899999999888899999999999999999999999864321 1
Q ss_pred hHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 048160 272 YFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM----VQVAK 335 (344)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~----~ei~~ 335 (344)
..+.... . .. ...+ ...+..+.+++.+||+.+|.+|||+ .++++
T Consensus 229 ~~~~~~~----~-~~-------------~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 LTFQKIL----K-LE-------------YSFP--PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHH----h-cC-------------CCCC--CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1111111 0 00 0000 1224568899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=318.89 Aligned_cols=255 Identities=21% Similarity=0.282 Sum_probs=203.5
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccE
Q 048160 51 KAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPI 126 (344)
Q Consensus 51 ~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~ 126 (344)
...+-++....+||.|.||.||.|.. +|...|+|-++-+.. ...+.+.+|..++..++|||+|+++|+-.+....+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 34455677889999999999999998 778889998765432 23456679999999999999999999999999999
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
|.||||.+|+|.+.+...+ ..++.-...+-.|++.|+.||| +.+||||||||.||+++.+|.+|++|||.|.
T Consensus 1311 IFMEyC~~GsLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHhccCcHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeeccccee
Confidence 9999999999999997653 3566666778899999999999 9999999999999999999999999999998
Q ss_pred ccCCCCcc-cccCCccccccccccccccCcC---CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 207 SIPEGKTH-VNDNNKVIGTFGFIAPEYMSTA---NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 207 ~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
.+..+... ....+...||+.|||||++.+. .-..+.||||+||++.||+||+.||..... ......+.
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---e~aIMy~V----- 1454 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---EWAIMYHV----- 1454 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---hhHHHhHH-----
Confidence 88655322 1222356899999999999763 345789999999999999999999964321 11111111
Q ss_pred ccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
-.|..+..|+ ..+++=.+++.+||..||++|+++.++++
T Consensus 1455 ------------~~gh~Pq~P~--~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1455 ------------AAGHKPQIPE--RLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ------------hccCCCCCch--hhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 1122333333 35666789999999999999999988775
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=280.96 Aligned_cols=270 Identities=16% Similarity=0.185 Sum_probs=193.7
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch--hhhHhhHHHHHhcCCCCceeeeeeEEeeCC------
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE--EYCCFNCIAFASQMSHKNILKFVGCCLETE------ 123 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------ 123 (344)
.++|...+.||+|+||.||+|.. ++..||+|++....... ...+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47899999999999999999998 57889999886543222 245678999999999999999999875433
Q ss_pred --ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEee
Q 048160 124 --LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFD 201 (344)
Q Consensus 124 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~d 201 (344)
..++|+||+. ++|...+.... ..+++.++..++.|++.||.||| +.+|+|+||||+||++++++.++++|
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPS----VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECc
Confidence 4699999996 57777665543 35899999999999999999999 99999999999999999999999999
Q ss_pred eecccccCCCCcccc--------cCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchh
Q 048160 202 FCVSISIPEGKTHVN--------DNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEY 272 (344)
Q Consensus 202 fg~a~~~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 272 (344)
||++........... ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||..... ..
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~----~~ 234 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD----ID 234 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH----HH
Confidence 999876543322111 11233567889999987654 578999999999999999999988864322 11
Q ss_pred HHHHHHHHHhcc--------CCcccccccccccCCCCCh--hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 273 FLQELVRKSIES--------NSFKEIVDPIIVGEEGLWP--EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 273 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
............ .......+.......+... ........+.+++.+||+.||.+|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111111110000 0000000000000000000 00122356889999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=280.63 Aligned_cols=268 Identities=17% Similarity=0.187 Sum_probs=194.0
Q ss_pred cCCCC-CCccccCCCceEEEEEE--CCccEEEEEecCCCCch--------------hhhHhhHHHHHhcCCCCceeeeee
Q 048160 55 NNYDP-EKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE--------------EYCCFNCIAFASQMSHKNILKFVG 117 (344)
Q Consensus 55 ~~~~~-~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~~~~ 117 (344)
++|.. .+.||+|+||+||+|.. .+..||+|++....... ...+.+|+.++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 44553 47799999999999997 67889999986543222 124678999999999999999999
Q ss_pred EEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcc
Q 048160 118 CCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA 197 (344)
Q Consensus 118 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 197 (344)
++..++..++||||+. |+|.+++.... .+++.....++.|++.||.||| +.+++|+||+|+||+++.++.+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI-----RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCE
Confidence 9999999999999997 68999886543 5888999999999999999999 9999999999999999999999
Q ss_pred eEeeeecccccCCCCc-----------ccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCC
Q 048160 198 KFFDFCVSISIPEGKT-----------HVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSC 265 (344)
Q Consensus 198 kl~dfg~a~~~~~~~~-----------~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~ 265 (344)
+++|||++........ .........++..|+|||.+.+. .++.++||||||+++|+|++|..||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999876541110 00111123457789999998764 46899999999999999999999886542
Q ss_pred ccCcchhHHHHHHHHHhccC--Ccccccc-----cccccCCCC-ChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 266 FENGEEYFLQELVRKSIESN--SFKEIVD-----PIIVGEEGL-WPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~-----~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. ...+........... .+....+ +........ .......+..+.+++.+||+.+|++|||+.+++.
T Consensus 239 ~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 239 E----IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred H----HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 2 111111111110000 0000000 000000000 0001123456889999999999999999999975
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=290.27 Aligned_cols=242 Identities=22% Similarity=0.333 Sum_probs=191.9
Q ss_pred CCccccCCCceEEEEEEC--CccEEEEEe--c--CCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCc--cEEEEee
Q 048160 60 EKVITKDLLYKLYKGFLQ--DRPISVMKF--G--GNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETEL--PILVFEF 131 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~~--~~~vavk~~--~--~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~--~~lv~e~ 131 (344)
...||+|+|-+||+|.+. |..||=-.+ . .+.....+.|..|+.+|+.|+|||||++|.+|.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 466999999999999994 444432111 1 1122334778899999999999999999999987765 7799999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEee-cCCcceEeeeecccccCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ-EQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~dfg~a~~~~~ 210 (344)
+..|+|..|+++.+ .+.......+++||++||.|||++ ..+|+|||||-+||+|+ ..|.+||+|+|+|.....
T Consensus 125 ~TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ccCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999998875 578888999999999999999966 78999999999999996 568999999999987654
Q ss_pred CCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEI 290 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (344)
.... ..+|||.|||||++. ..|+..+||||||.+|+||+|+..|+.-. .+..+.+.+.. .+..+..
T Consensus 199 s~ak-----svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC---~n~AQIYKKV~-----SGiKP~s 264 (632)
T KOG0584|consen 199 SHAK-----SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC---TNPAQIYKKVT-----SGIKPAA 264 (632)
T ss_pred cccc-----eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh---CCHHHHHHHHH-----cCCCHHH
Confidence 3322 478999999999996 88999999999999999999999997532 23333333332 2223333
Q ss_pred cccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 291 VDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+.++- -+++.+||.+|+.. ..+|||+.|+++
T Consensus 265 l~kV~-------------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 265 LSKVK-------------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred hhccC-------------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 33221 13578999999999 999999999986
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=266.40 Aligned_cols=245 Identities=20% Similarity=0.299 Sum_probs=194.7
Q ss_pred CCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHHHhcCC-CCceeeeeeEEeeCCccEEEEeecCCC
Q 048160 60 EKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMS-HKNILKFVGCCLETELPILVFEFVACG 135 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~g 135 (344)
...||.|+.|.|+++++ .|...|||.+....+ .+.+.++..+.++.+-+ .|.||+.+|+|..+...++.||.|. -
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-T 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-H
Confidence 45699999999999999 568999999976643 44566778888887775 7999999999999999999999984 4
Q ss_pred CccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCccc
Q 048160 136 TLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHV 215 (344)
Q Consensus 136 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~ 215 (344)
.+..++.... .++++.-+-.+...+++||.||-. ..+|+|||+||+|||+|+.|++|+||||.+..+.....+.
T Consensus 176 C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht 249 (391)
T KOG0983|consen 176 CAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT 249 (391)
T ss_pred HHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccccc
Confidence 4555555544 368887777788899999999995 7799999999999999999999999999998776544332
Q ss_pred ccCCccccccccccccccCc---CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 216 NDNNKVIGTFGFIAPEYMST---ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 216 ~~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
..-|.+.|||||.+.. ..|+..+||||||+.++||.||..||..... +...+.+.
T Consensus 250 ----rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t---dFe~ltkv--------------- 307 (391)
T KOG0983|consen 250 ----RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT---DFEVLTKV--------------- 307 (391)
T ss_pred ----cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc---cHHHHHHH---------------
Confidence 4468899999999864 3689999999999999999999999875321 11112222
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
++.+++..|.....++.+.+++..||+.|+.+||...++++
T Consensus 308 --ln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 308 --LNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred --HhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 22233444444457788999999999999999999988764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=306.47 Aligned_cols=256 Identities=21% Similarity=0.286 Sum_probs=189.9
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC-CchhhhHhhHHHHHhcCCCCceeeeeeEEeeC-----
Q 048160 51 KAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL-NSEEYCCFNCIAFASQMSHKNILKFVGCCLET----- 122 (344)
Q Consensus 51 ~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~----- 122 (344)
.....+|+....||+||||.||+++. +|+.||||++.... ......+.+|+.++++|+|||||+++..|.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 34556788999999999999999998 99999999987664 22235577999999999999999998877540
Q ss_pred --------------------------------------------------------------------------------
Q 048160 123 -------------------------------------------------------------------------------- 122 (344)
Q Consensus 123 -------------------------------------------------------------------------------- 122 (344)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHH
Q 048160 123 ----------------------------------ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAV 168 (344)
Q Consensus 123 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l 168 (344)
..+||-||||+...|.+++..+.... .....+.++.+|+.||
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGL 710 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHH
Confidence 01378899998877777776654110 3567789999999999
Q ss_pred HHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC---------------CCcccccCCcccccccccccccc
Q 048160 169 AYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE---------------GKTHVNDNNKVIGTFGFIAPEYM 233 (344)
Q Consensus 169 ~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~---------------~~~~~~~~~~~~g~~~y~aPE~~ 233 (344)
.|+| +.+||||||||.||+++.+..+||+|||+|..... ........+..+||..|+|||++
T Consensus 711 aYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 9999 99999999999999999999999999999987220 01111133456899999999998
Q ss_pred CcC---CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHH
Q 048160 234 STA---NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLL 310 (344)
Q Consensus 234 ~~~---~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (344)
.+. .|+.|+|+||+|++++||+. ||....+ =...+... +.+.++.- +.. .. ...+
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME-------Ra~iL~~L-R~g~iP~~---------~~f-~~-~~~~ 845 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME-------RASILTNL-RKGSIPEP---------ADF-FD-PEHP 845 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCchHH-------HHHHHHhc-ccCCCCCC---------ccc-cc-ccch
Confidence 764 49999999999999999986 4543321 11111111 12222111 000 00 1122
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 048160 311 SYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 311 ~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.-..++..+++.||.+||||.|++.
T Consensus 846 ~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 846 EEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHHHHhcCCCccCCCHHHHhh
Confidence 3478999999999999999999885
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=282.82 Aligned_cols=266 Identities=16% Similarity=0.203 Sum_probs=195.9
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeCC--
Q 048160 50 LKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLETE-- 123 (344)
Q Consensus 50 i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-- 123 (344)
+....++|...+.||+|+||.||+|.. ++..||+|++...... ....+.+|+.++++++||||+++++++..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 444567899999999999999999988 6788999998654322 2345779999999999999999999987654
Q ss_pred ----ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceE
Q 048160 124 ----LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKF 199 (344)
Q Consensus 124 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 199 (344)
..++||||+ +++|.+++... .+++..+..++.|++.||.||| ..+|+||||||+||+++.++.+++
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl 159 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKI 159 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEE
Confidence 348999999 67998887642 5889999999999999999999 999999999999999999999999
Q ss_pred eeeecccccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHH
Q 048160 200 FDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELV 278 (344)
Q Consensus 200 ~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 278 (344)
+|||++....... ....+++.|+|||.+.+ ..++.++|+||||+++|++++|..||..... ...+.+..
T Consensus 160 ~dfg~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~----~~~~~~~~ 229 (343)
T cd07880 160 LDFGLARQTDSEM------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH----LDQLMEIM 229 (343)
T ss_pred eecccccccccCc------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Confidence 9999987653221 13356889999999876 4578999999999999999999999864321 11111111
Q ss_pred HHH----------hccCCcccccccccccCCCCCh-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 279 RKS----------IESNSFKEIVDPIIVGEEGLWP-EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 279 ~~~----------~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
... ...................... .....+..+.+++.+|++.||++|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 230 KVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 100 0000000000000000000000 00123446889999999999999999999883
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=283.87 Aligned_cols=271 Identities=18% Similarity=0.220 Sum_probs=198.1
Q ss_pred ccHHHHHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEe
Q 048160 45 FTAQELKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCL 120 (344)
Q Consensus 45 ~~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~ 120 (344)
....++....++|...+.||+|+||.||+|.. ++..||+|++...... ..+.+.+|+.++++++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34556677889999999999999999999987 6788999998754322 2355778999999999999999999886
Q ss_pred eC------CccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC
Q 048160 121 ET------ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ 194 (344)
Q Consensus 121 ~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 194 (344)
.. ...+++++++ +++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||+++.+
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~ 156 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNED 156 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCC
Confidence 43 3467888887 68998887642 4888999999999999999999 9999999999999999999
Q ss_pred CcceEeeeecccccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhH
Q 048160 195 NVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYF 273 (344)
Q Consensus 195 ~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 273 (344)
+.++|+|||++....... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... ...
T Consensus 157 ~~~kl~dfg~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~----~~~ 226 (345)
T cd07877 157 CELKILDFGLARHTDDEM------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH----IDQ 226 (345)
T ss_pred CCEEEecccccccccccc------cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHH
Confidence 999999999987643211 13467889999998866 4688999999999999999999999854321 111
Q ss_pred HHHHHHHHhcc----------CCcccccccccccCCCCChh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 274 LQELVRKSIES----------NSFKEIVDPIIVGEEGLWPE-KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 274 ~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+.......... ......+............. ....+..+.+++.+||+.||++|||+.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 227 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 11111110000 00000000000000000000 0012456889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=271.98 Aligned_cols=249 Identities=19% Similarity=0.228 Sum_probs=190.4
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC-----CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL-----NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
.|.+.+.||+|+||.||++.+ .+..+++|.++... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 377789999999999999998 33445555544321 12233466889999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
+||+++++|.+++...... ...+++.++..++.|++.||.||| +.+++|+||+|+||+++. +.++++|||.+...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeec
Confidence 9999999999887532111 136889999999999999999999 999999999999999975 56999999998765
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
...... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.... . ......... .
T Consensus 156 ~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~---~~~~~~~~~-~--- 220 (260)
T cd08222 156 MGSCDL---ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----F---LSVVLRIVE-G--- 220 (260)
T ss_pred CCCccc---ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----H---HHHHHHHHc-C---
Confidence 433221 113457889999999988888999999999999999999999985321 1 111111111 0
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+..+ ...+.++.+++.+||+.+|++||++.++++
T Consensus 221 ---------~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 221 ---------PTPSLP--ETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---------CCCCCc--chhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 111111 144567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=279.48 Aligned_cols=267 Identities=17% Similarity=0.183 Sum_probs=190.7
Q ss_pred CCCCCCccccCCCceEEEEEE--C--CccEEEEEecCCCCc--hhhhHhhHHHHHhcC-CCCceeeeeeEEeeC----Cc
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--Q--DRPISVMKFGGNLNS--EEYCCFNCIAFASQM-SHKNILKFVGCCLET----EL 124 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~--~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~----~~ 124 (344)
+|...+.||+|+||.||++.. . +..||+|++...... ....+.+|+.+++++ .||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 367778999999999999999 3 568999998654222 235577899999999 599999999976433 35
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeec
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV 204 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~ 204 (344)
.++++||+. ++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 688899985 78998886543 5889999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCccc-ccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 205 SISIPEGKTHV-NDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 205 a~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
+.......... .......|+..|+|||++.+ ..++.++||||||+++|++++|..||..... ...+...+....
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~ 227 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY----VDQLNQILQVLG 227 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH----HHHHHHHHHHhC
Confidence 98665332211 11123468899999998765 4689999999999999999999988864321 111111111000
Q ss_pred cc----------CCcccccccccccCCCCChh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ES----------NSFKEIVDPIIVGEEGLWPE-KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ~~----------~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+ ..................+. .+..+..+.+++.+||+.||++|||+.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred CCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 00000000000000000000 0012456899999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=263.85 Aligned_cols=251 Identities=21% Similarity=0.255 Sum_probs=198.3
Q ss_pred HhcCCCC-CCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcC-CCCceeeeeeEEee----CCc
Q 048160 53 ATNNYDP-EKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQM-SHKNILKFVGCCLE----TEL 124 (344)
Q Consensus 53 ~~~~~~~-~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~----~~~ 124 (344)
++++|++ ..+||-|-.|.|-.+.. .+..+|+|.+.. .....+|+++.-.. .|||||++++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 4566765 46789999999999888 788899998643 24456788866555 59999999999864 246
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec---CCcceEee
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE---QNVAKFFD 201 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~d 201 (344)
+.+|||.|+||.|...++.++. ..|++.++..|+.||..|+.||| +.+|.||||||+|+|... |..+||+|
T Consensus 134 LLiVmE~meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eEeeeecccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecc
Confidence 7899999999999999988765 47999999999999999999999 999999999999999964 55899999
Q ss_pred eecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHH
Q 048160 202 FCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS 281 (344)
Q Consensus 202 fg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 281 (344)
||+|+......... +..-|+.|.|||++...+|+.+.|+||+||++|-|+.|.+|||+.-.. .+
T Consensus 208 fGFAK~t~~~~~L~----TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~-----ai------- 271 (400)
T KOG0604|consen 208 FGFAKETQEPGDLM----TPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-----AI------- 271 (400)
T ss_pred cccccccCCCcccc----CCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc-----cC-------
Confidence 99998876433322 345699999999999999999999999999999999999999975320 00
Q ss_pred hccCCcccccccccccCCC-CChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 282 IESNSFKEIVDPIIVGEEG-LWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.++. -.++..|... +.|+..+.+....++++..|..+|.+|.|+.++.+
T Consensus 272 -spgM----k~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 272 -SPGM----KRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred -ChhH----HhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 0000 0111122221 22344566788999999999999999999998864
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=272.15 Aligned_cols=264 Identities=19% Similarity=0.227 Sum_probs=195.9
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCC--CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL--NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
|+....||+|++|.||+|.. ++..||+|.+.... ....+.+.+|+.++++++|+||+++++++......++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 45668899999999999999 57899999987653 223456778999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
. ++|.+++.... ..+++..+..++.+++.||.||| +.+|+||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 81 D-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred C-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 7 69999997653 25889999999999999999999 9999999999999999999999999999987664332
Q ss_pred cccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc--CCc--
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES--NSF-- 287 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~-- 287 (344)
.. .....++..|+|||.+.+. .++.++||||||++++|+++|..||..... ...+.......... ..+
T Consensus 153 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07829 153 RT---YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE----IDQLFKIFQILGTPTEESWPG 225 (282)
T ss_pred cc---cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHHHhCCCcHHHHHh
Confidence 11 1123456789999998766 789999999999999999999888754321 11111111100000 000
Q ss_pred -ccc--cccccccCCC--CChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 288 -KEI--VDPIIVGEEG--LWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 288 -~~~--~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
... .+........ .....+..+..+.+++..||+.||++||++.+|+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 226 VTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred hcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000 0000000000 00000122457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=282.45 Aligned_cols=264 Identities=19% Similarity=0.246 Sum_probs=195.5
Q ss_pred HHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCc---
Q 048160 52 AATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETEL--- 124 (344)
Q Consensus 52 ~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~--- 124 (344)
...++|.....||+|++|.||+|+. ++..||+|++..... .....+.+|+.+++++.|+||+++.+++.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 4467899999999999999999999 577899998865422 233556789999999999999999998766554
Q ss_pred ---cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEee
Q 048160 125 ---PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFD 201 (344)
Q Consensus 125 ---~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~d 201 (344)
.++|+||+ +++|.+++... .+++..+..++.|++.||.||| +.+|+||||+|+||+++.++.++|+|
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ------KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcc
Confidence 89999999 57999988652 5889999999999999999999 99999999999999999999999999
Q ss_pred eecccccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHH
Q 048160 202 FCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280 (344)
Q Consensus 202 fg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 280 (344)
||++....... ....++..|+|||.+.+ ..++.++||||||+++|++++|..||..... ...+......
T Consensus 162 fg~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~----~~~~~~i~~~ 231 (343)
T cd07851 162 FGLARHTDDEM------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH----IDQLKRIMNL 231 (343)
T ss_pred ccccccccccc------cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHh
Confidence 99987654321 13456888999998865 3678999999999999999999999864321 1111111110
Q ss_pred Hh----------ccCCcccccccccccCCCCChh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 281 SI----------ESNSFKEIVDPIIVGEEGLWPE-KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 281 ~~----------~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.. ........+..........+.. ....+..+.+++.+||+.||++|||+.+|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 232 VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred cCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00 0000000000000000000110 0123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=264.42 Aligned_cols=239 Identities=20% Similarity=0.226 Sum_probs=197.9
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhh---HhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYC---CFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~---~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...++||+|+||.|-.++- .++.+|+|++++..-...++ -+.|-++|+.-+||.+..+--.+...+.+|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 5688899999999999999988 78999999998775444333 347889999999999999988888999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||..||.|.-+|.+.. .+++.....+...|+.||.||| +.+||.||||.+|.|+|.+|.+||.|||+.+..-
T Consensus 248 eyanGGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 248 EYANGGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEccCceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcc
Confidence 9999999999998754 6899999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
..+.. ..+++||+.|+|||++....|...+|.|.+|+++|||++|+.||+.... ..+-+++--
T Consensus 320 ~~g~t---~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-----~kLFeLIl~--------- 382 (516)
T KOG0690|consen 320 KYGDT---TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-----EKLFELILM--------- 382 (516)
T ss_pred cccce---eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch-----hHHHHHHHh---------
Confidence 43332 2368999999999999999999999999999999999999999986422 122221110
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCC
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP 328 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 328 (344)
+.-..|. ..+++...|+...|..||.+|.
T Consensus 383 --------ed~kFPr--~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 383 --------EDLKFPR--TLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred --------hhccCCc--cCCHHHHHHHHHHhhcChHhhc
Confidence 0001111 3445678899999999999995
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=265.36 Aligned_cols=235 Identities=24% Similarity=0.271 Sum_probs=189.8
Q ss_pred cccCCCceEEEEEE--CCccEEEEEecCCCCc---hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCCc
Q 048160 63 ITKDLLYKLYKGFL--QDRPISVMKFGGNLNS---EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTL 137 (344)
Q Consensus 63 ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL 137 (344)
||+|+||.||++.. ++..+++|.+...... ....+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999 5788999988665322 345678999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCccccc
Q 048160 138 ADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217 (344)
Q Consensus 138 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~ 217 (344)
.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++........ .
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~ 149 (250)
T cd05123 81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---R 149 (250)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC---c
Confidence 99997653 5889999999999999999999 99999999999999999999999999999876644321 1
Q ss_pred CCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccccccc
Q 048160 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVG 297 (344)
Q Consensus 218 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (344)
.....++..|+|||...+...+.++|+||||+++|++++|..||..... ..... .... ..
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~----~~~~-~~----------- 209 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYE----KILK-DP----------- 209 (250)
T ss_pred ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHH----HHhc-CC-----------
Confidence 1234678899999999888889999999999999999999999864321 11111 1111 00
Q ss_pred CCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHH
Q 048160 298 EEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQ 332 (344)
Q Consensus 298 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 332 (344)
...+. ..+..+.+++.+||..||++||++.+
T Consensus 210 --~~~~~--~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 210 --LRFPE--FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred --CCCCC--CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 00011 22456889999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=297.92 Aligned_cols=144 Identities=21% Similarity=0.203 Sum_probs=129.0
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|.+.+.||+|+||.||+|.+ .++.||+|++..... .....+.+|+.++..++||||+++++++......|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 5788899999999999999999 488999999865422 12356778999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
||+.+++|.+++...+ .+++..++.++.||+.||.||| ..+|+||||||+|||++.++.++|+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999987543 5788889999999999999999 8999999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=298.66 Aligned_cols=257 Identities=18% Similarity=0.249 Sum_probs=204.9
Q ss_pred HHHHHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCC---CCchhhhHhhHHHHHhcCCCCceeeeeeEEee
Q 048160 47 AQELKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGN---LNSEEYCCFNCIAFASQMSHKNILKFVGCCLE 121 (344)
Q Consensus 47 ~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~ 121 (344)
..++....++|.+.++||+|+||.|..++. .++.||+|++++- ......-|+.|=.+|..-+.+.|+++.-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 344555567899999999999999999999 6788999998763 22334557778888988889999999999999
Q ss_pred CCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEee
Q 048160 122 TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFD 201 (344)
Q Consensus 122 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~d 201 (344)
...+|+|||||+||+|..++.+.. ++++..+..++..|+.||.-|| ..|+|||||||+|||+|..|++||+|
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeecc
Confidence 999999999999999999998764 6999999999999999999999 99999999999999999999999999
Q ss_pred eecccccCCCCcccccCCccccccccccccccCc-----CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHH
Q 048160 202 FCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-----ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQE 276 (344)
Q Consensus 202 fg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 276 (344)
||.+..+..++.... ...+|||-|.+||++.. +.|++.+|.||+||++|||+.|..|||.... ...+.+
T Consensus 219 FGsClkm~~dG~V~s--~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl----veTY~K 292 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRS--SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL----VETYGK 292 (1317)
T ss_pred chhHHhcCCCCcEEe--ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH----HHHHHH
Confidence 999887775554332 36799999999999853 4689999999999999999999999986421 111111
Q ss_pred HHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCC---HHHHH
Q 048160 277 LVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT---MVQVA 334 (344)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~ei~ 334 (344)
+ ... . ..-.+|.....+.+..+||...+. +|+.|.. ++++.
T Consensus 293 I----m~h---k---------~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 293 I----MNH---K---------ESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred H----hch---h---------hhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 1 111 1 111122222456678889988776 7888876 66654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=285.91 Aligned_cols=260 Identities=22% Similarity=0.325 Sum_probs=211.5
Q ss_pred ccHHHHHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcC-CCCceeeeeeEEee
Q 048160 45 FTAQELKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQM-SHKNILKFVGCCLE 121 (344)
Q Consensus 45 ~~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~ 121 (344)
..++.+...++.|.+.+.||.|.+|.||+++. +++.+|+|++....+ ..+++..|..+++.+ .|||++.++|++.-
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 44555666678899999999999999999888 788899998766643 446677788888888 59999999999863
Q ss_pred -----CCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCc
Q 048160 122 -----TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNV 196 (344)
Q Consensus 122 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 196 (344)
++.+|||||||.+||..++++...+ ..+.|..+..|++.++.||.+|| .+.++|||+|-.|||+..++.
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g---~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~ 161 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKG---NRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAE 161 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcc---cchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCc
Confidence 5789999999999999999987765 46889999999999999999999 999999999999999999999
Q ss_pred ceEeeeecccccCCCCcccccCCccccccccccccccCc-----CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcch
Q 048160 197 AKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-----ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEE 271 (344)
Q Consensus 197 ~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 271 (344)
+|++|||++..++... ...++.+||+.|||||++.- ..|+..+|+||||++..||..|.+|+...
T Consensus 162 VKLvDFGvSaQldsT~---grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm------- 231 (953)
T KOG0587|consen 162 VKLVDFGVSAQLDSTV---GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM------- 231 (953)
T ss_pred EEEeeeeeeeeeeccc---ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc-------
Confidence 9999999998876543 34447899999999999853 23778899999999999999999997642
Q ss_pred hHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 272 YFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+..++. +....++....+...++.+.++|..||..|-++||++.++++
T Consensus 232 -------------HPmraLF~-IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 232 -------------HPMRALFL-IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -------------chhhhhcc-CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11111111 111122222233477889999999999999999999998764
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=260.25 Aligned_cols=266 Identities=17% Similarity=0.241 Sum_probs=194.1
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCC--CchhhhHhhHHHHHhcCCCCceeeeeeEEeeC--------Cc
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL--NSEEYCCFNCIAFASQMSHKNILKFVGCCLET--------EL 124 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--------~~ 124 (344)
|....+||+|.||+||+|+. .++.||+|++.-+. ..-.....+|+.++..++|+|++.++..|... ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 55668899999999999998 67788998754322 12234567999999999999999999887642 34
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeec
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV 204 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~ 204 (344)
+|+|+.+|+ -+|..+|.+.. ..++..++..++.+++.||.|+| .+.|+|||+|+.|+||+.++.+||+|||+
T Consensus 99 ~ylVf~~ce-hDLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 99 FYLVFDFCE-HDLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeHHHhh-hhHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccc
Confidence 799999997 48988887765 46899999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCcccc-cCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 205 SISIPEGKTHVN-DNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 205 a~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
++.+........ ....++-|.+|.+||.+.+. .|+++.|||+.||++.||+|+.+.+....+ +.....+....
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte-----qqql~~Is~Lc 245 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE-----QQQLHLISQLC 245 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH-----HHHHHHHHHHh
Confidence 987654332221 11234569999999998875 589999999999999999999988765432 22222222211
Q ss_pred ---ccCCccccccccccc--CCCCChh-----hHHH------HHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ---ESNSFKEIVDPIIVG--EEGLWPE-----KEKQ------LLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ---~~~~~~~~~~~~~~~--~~~~~~~-----~~~~------~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+..+++...--+-. +.++.|. ..+. -.+..+|+..++..||.+|+++++++.
T Consensus 246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 111121111000000 0000111 0011 125679999999999999999998764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=259.99 Aligned_cols=219 Identities=18% Similarity=0.131 Sum_probs=174.8
Q ss_pred CCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCCccccccC
Q 048160 66 DLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHD 143 (344)
Q Consensus 66 G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 143 (344)
|.+|.||+++. +++.||+|++.... .+.+|...+....||||+++++++.+....++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999999 77889999986653 233455556666799999999999999999999999999999998865
Q ss_pred CCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcccccCCcccc
Q 048160 144 PNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIG 223 (344)
Q Consensus 144 ~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g 223 (344)
.. .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++++|||.+........ ...+
T Consensus 79 ~~-----~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~------~~~~ 144 (237)
T cd05576 79 FL-----NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD------GEAV 144 (237)
T ss_pred hc-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccccc------cCCc
Confidence 43 4889999999999999999999 99999999999999999999999999998765543211 2244
Q ss_pred ccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCCh
Q 048160 224 TFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWP 303 (344)
Q Consensus 224 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (344)
+..|+|||...+..++.++|+||+|+++|++++|..|+...... .... .....|
T Consensus 145 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-------------------~~~~-------~~~~~~ 198 (237)
T cd05576 145 ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-------------------INTH-------TTLNIP 198 (237)
T ss_pred CccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-------------------cccc-------cccCCc
Confidence 66799999998888899999999999999999999876422100 0000 000001
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHH
Q 048160 304 EKEKQLLSYTELAIKCLSKSEQDRPTMV 331 (344)
Q Consensus 304 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 331 (344)
...+..+.+++.+||+.||++||++.
T Consensus 199 --~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 199 --EWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred --ccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 12345688999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=267.29 Aligned_cols=265 Identities=19% Similarity=0.224 Sum_probs=200.2
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCC-C-Cc----eeeeeeEEeeCCcc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-H-KN----ILKFVGCCLETELP 125 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-H-~n----iv~~~~~~~~~~~~ 125 (344)
++.|.+..++|+|+||.|-.+.. .+..||+|+++... ...+..+-|+.+++++. + |+ +|++.+|+.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 66799999999999999999988 56789999886553 24566778999999994 2 33 78888889889999
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec------------
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE------------ 193 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~------------ 193 (344)
|||+|.+ |.|+.+++..++- .+++..++..++.|++.++++|| ++.++|-||||+|||+-+
T Consensus 167 Civfell-G~S~~dFlk~N~y---~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNY---IPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred EEEEecc-ChhHHHHhccCCc---cccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCc
Confidence 9999999 5699999987553 58999999999999999999999 999999999999999842
Q ss_pred --------CCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCC
Q 048160 194 --------QNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSC 265 (344)
Q Consensus 194 --------~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 265 (344)
+..++++|||.|+...... ...+.|..|.|||++.+.++++++||||+||||+|+++|...|+..+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 1257899999997754433 35688999999999999999999999999999999999999998875
Q ss_pred ccCcchhHHHHHHHH--------------HhccCCccccccccccc-----CCCCChh------hHHHHHHHHHHHHHcc
Q 048160 266 FENGEEYFLQELVRK--------------SIESNSFKEIVDPIIVG-----EEGLWPE------KEKQLLSYTELAIKCL 320 (344)
Q Consensus 266 ~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~-----~~~~~~~------~~~~~~~l~~l~~~cl 320 (344)
+. .+....+.+-. +...+ ..++-.....+ -.+..|- .+....+|++|+..||
T Consensus 314 n~--EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 314 NL--EHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred cH--HHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 31 11111111111 11111 00000000000 0000010 1133456999999999
Q ss_pred ccCCCCCCCHHHHHH
Q 048160 321 SKSEQDRPTMVQVAK 335 (344)
Q Consensus 321 ~~dP~~RPs~~ei~~ 335 (344)
..||.+|+|+.|++.
T Consensus 391 ~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 391 EFDPARRITLREALS 405 (415)
T ss_pred ccCccccccHHHHhc
Confidence 999999999999875
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=260.79 Aligned_cols=268 Identities=21% Similarity=0.296 Sum_probs=206.1
Q ss_pred cHHHHHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCC-CCceeeeeeEEeeC
Q 048160 46 TAQELKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCCLET 122 (344)
Q Consensus 46 ~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~ 122 (344)
++.++.+.++ +.||+|+|+.|..+.. +|..+|||++.+.-......+++|++++.+.+ |+||++++.+++++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4667766664 6799999999999887 89999999998886667788999999999996 99999999999999
Q ss_pred CccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC---cceE
Q 048160 123 ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN---VAKF 199 (344)
Q Consensus 123 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl 199 (344)
+.+|||||-|.||+|..++..+. .|++.++..+..+|+.||.+|| .++|.||||||+|||..+.. -+||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceee
Confidence 99999999999999999998765 6999999999999999999999 99999999999999986544 5799
Q ss_pred eeeecccccCCCCccc----ccCCccccccccccccccCc-----CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcc
Q 048160 200 FDFCVSISIPEGKTHV----NDNNKVIGTFGFIAPEYMST-----ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGE 270 (344)
Q Consensus 200 ~dfg~a~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 270 (344)
+||.+........... ....+.+|+..|||||+..- ..|+.+.|.||||+|+|-|++|..||-+....+=.
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG 300 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG 300 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence 9998876543222111 11224678999999997632 35899999999999999999999999876543211
Q ss_pred hh--HHHHHHHHHhccCCcccccccccccCCCCChhh--HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 271 EY--FLQELVRKSIESNSFKEIVDPIIVGEEGLWPEK--EKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 271 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+. ...... -..++..+-.|.. .+|+. ...+.+..+++...|..|+..|.++..++.
T Consensus 301 WdrGe~Cr~C--------Q~~LFesIQEGkY-eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 301 WDRGEVCRVC--------QNKLFESIQEGKY-EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCCccHHH--------HHHHHHHHhccCC-cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 00 000000 0112222222222 22322 234566788898999999999999988765
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=265.79 Aligned_cols=252 Identities=20% Similarity=0.229 Sum_probs=188.3
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEEEeec
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
.+....||.|+||+|++-.+ .|+..|||++..... .+...++.|.....+- +.||||++||.+...+..|+.||+|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 33456799999999999888 788999999987654 4456677887766555 6799999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
. .||+.+.+.-..-....++++-.-.|..-.+.||.||-. ...|+|||+||+|||++..|.+||||||.+..+..+-
T Consensus 146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence 6 677764421100001246776666777788999999985 7899999999999999999999999999987664432
Q ss_pred cccccCCccccccccccccccCc--CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMST--ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEI 290 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (344)
... .-.|...|+|||.+.. ..|+.++||||||++|+|+.||+.|+..- ...-+.+...
T Consensus 223 AkT----~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w-------~svfeql~~V--------- 282 (361)
T KOG1006|consen 223 AKT----VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW-------DSVFEQLCQV--------- 282 (361)
T ss_pred Hhh----hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH-------HHHHHHHHHH---------
Confidence 221 2357889999999864 35999999999999999999999997531 1111111111
Q ss_pred cccccccCCCCChhh---HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 291 VDPIIVGEEGLWPEK---EKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 291 ~~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..|..+..-.. ...+..+..++..||..|-..||...++++
T Consensus 283 ----v~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 283 ----VIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ----HcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 11222111111 134567899999999999999999988764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=275.21 Aligned_cols=238 Identities=21% Similarity=0.238 Sum_probs=191.9
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEEEe
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e 130 (344)
++.|.....+|.|+|+.|..+.. .+...++|++.... ....+|+.++... +||||+++.+++.++...|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 56677788899999999999998 77889999987662 2233466555554 79999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe-ecCCcceEeeeecccccC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF-QEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~dfg~a~~~~ 209 (344)
.+.++-+.+.+.... ....++..++.+|+.|+.||| ..++|||||||+|||+ ++.+.++|+|||.++...
T Consensus 397 ~l~g~ell~ri~~~~------~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP------EFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hccccHHHHHHHhcc------hhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 999988877665432 333778889999999999999 9999999999999999 699999999999998876
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
.... +..-|..|.|||++....|+..+||||||++||+|++|+.||...... .. +...+..+...
T Consensus 468 ~~~~------tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~e----i~~~i~~~~~s- 532 (612)
T KOG0603|consen 468 RSCD------TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IE----IHTRIQMPKFS- 532 (612)
T ss_pred hhhc------ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HH----HHHhhcCCccc-
Confidence 5511 223488999999999999999999999999999999999999765431 11 11111111111
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
...+.+..+|+.+||+.||.+||++.++..
T Consensus 533 ----------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 ----------------ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ----------------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 255567899999999999999999999864
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=288.40 Aligned_cols=248 Identities=23% Similarity=0.312 Sum_probs=191.8
Q ss_pred CCCCCccccCCCce-EEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 57 YDPEKVITKDLLYK-LYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 57 ~~~~~~ig~G~~g~-V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
|...+++|.|+-|+ ||+|.+.++.||||++-... .+-..+|+..++.- .|||||++++.-.+..+.||+.|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~- 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA- 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-
Confidence 55567789999886 89999999999999986552 34567999999988 59999999999888999999999996
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec---C--CcceEeeeecccccC
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE---Q--NVAKFFDFCVSISIP 209 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~--~~~kl~dfg~a~~~~ 209 (344)
.+|.++++..... .........+.++.|++.||.||| +.+||||||||+||||+. + ..++|+|||+++...
T Consensus 587 ~sL~dlie~~~~d-~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 CSLQDLIESSGLD-VEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhHHHHHhccccc-hhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 7999999874111 011111335778999999999999 999999999999999976 3 478999999999998
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcC-CCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG-KRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
.+...........||-+|+|||++....-+..+||||+||++|+.++| +.||........ +....+.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~----------NIl~~~~-- 730 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA----------NILTGNY-- 730 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh----------hhhcCcc--
Confidence 877666666677899999999999998888999999999999999987 667754321000 0000000
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+ . ...+.. ++ +..+||.+|++++|..||+|.+|+.
T Consensus 731 ~L-~-------~L~~~~-d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 731 TL-V-------HLEPLP-DC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ce-e-------eeccCc-hH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00 0 000111 22 6789999999999999999999873
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=273.70 Aligned_cols=241 Identities=20% Similarity=0.248 Sum_probs=193.6
Q ss_pred CCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCC
Q 048160 60 EKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACG 135 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 135 (344)
.+.||+|-||+||-|.+ +|+.||||.+.+-.- .....+..|+.+|++++||.||.+...|+..+..++|||-+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 68899999999999998 899999999754421 233567799999999999999999999999999999999996 6
Q ss_pred Cccccc-cCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC---cceEeeeecccccCCC
Q 048160 136 TLADRI-HDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN---VAKFFDFCVSISIPEG 211 (344)
Q Consensus 136 sL~~~l-~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~dfg~a~~~~~~ 211 (344)
++.+.+ .... ..|++.....++.||+.||.||| .++|+|+||||+|||+.+.. ++||||||.|+.+...
T Consensus 648 DMLEMILSsEk----gRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 648 DMLEMILSSEK----GRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred hHHHHHHHhhc----ccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 666654 3333 26888888999999999999999 99999999999999997553 7999999999998765
Q ss_pred CcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
.... ..+||+.|+|||++.+..|+.+-|+||.|+++|--++|..||...++ +.+.+.+....-
T Consensus 721 sFRr----sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-------IndQIQNAaFMy------ 783 (888)
T KOG4236|consen 721 SFRR----SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-------INDQIQNAAFMY------ 783 (888)
T ss_pred hhhh----hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-------hhHHhhcccccc------
Confidence 4332 67999999999999999999999999999999999999999965432 222222111000
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVA 334 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~ 334 (344)
...+|. ..+...++||...|+..-.+|-|.+.-+
T Consensus 784 ------Pp~PW~---eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 784 ------PPNPWS---EISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred ------CCCchh---hcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 111222 3345678999999999999998887644
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=249.96 Aligned_cols=237 Identities=24% Similarity=0.288 Sum_probs=191.0
Q ss_pred CCceEEEEEE--CCccEEEEEecCCCCch-hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCCccccccC
Q 048160 67 LLYKLYKGFL--QDRPISVMKFGGNLNSE-EYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHD 143 (344)
Q Consensus 67 ~~g~V~~~~~--~~~~vavk~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 143 (344)
+||.||+|.+ ++..+++|++....... .+.+.+|+..+++++|+||+++++++..+...++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 5899999999 46889999987765444 67788999999999999999999999999999999999999999999876
Q ss_pred CCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcccccCCcccc
Q 048160 144 PNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIG 223 (344)
Q Consensus 144 ~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g 223 (344)
.. .+++..+..++.+++.++.||| ..+++|+||+|.||+++.++.++++|||.+........ .....+
T Consensus 81 ~~-----~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~ 148 (244)
T smart00220 81 RG-----RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL----LTTFVG 148 (244)
T ss_pred cc-----CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeeccccc----cccccC
Confidence 43 3788999999999999999999 99999999999999999999999999999887654321 113457
Q ss_pred ccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCCh
Q 048160 224 TFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWP 303 (344)
Q Consensus 224 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (344)
+..|++||.+....++.++||||||++++++++|..||..... .....+... ... ....+
T Consensus 149 ~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~----~~~~~~~~~----~~~------------~~~~~ 208 (244)
T smart00220 149 TPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ----LLELFKKIG----KPK------------PPFPP 208 (244)
T ss_pred CcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHh----ccC------------CCCcc
Confidence 8899999999888889999999999999999999999864211 111111111 000 00000
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 304 EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 304 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.....+.++.+++.+||..+|++||++.++++
T Consensus 209 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 209 PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 00014456899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=260.10 Aligned_cols=240 Identities=20% Similarity=0.261 Sum_probs=194.1
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv 128 (344)
.+|....+||+|+||.|-.|.. .+..+|||+++++.- .+.+.-+.|-++|+-. +-|.++++..++..-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 3477889999999999999999 557899999988733 2334445677777665 578899999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||+.||+|-..++.-+ .+.+..++.++..||-||-+|| +.+|+.||||.+||++|.+|.+||+|||+++..
T Consensus 429 MEyvnGGDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEecCchhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999888765 5888889999999999999999 999999999999999999999999999998764
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
--... ...++.||+.|+|||.+..++|..++|.||||+++|||+.|.+||....+ ......+. +.
T Consensus 501 i~~~~---TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE----~elF~aI~----eh---- 565 (683)
T KOG0696|consen 501 IFDGV---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----DELFQAIM----EH---- 565 (683)
T ss_pred ccCCc---ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHH----Hc----
Confidence 33222 22368999999999999999999999999999999999999999976532 11111111 11
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCC
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT 329 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 329 (344)
.-.+|. ..+.+..++....|...|.+|..
T Consensus 566 ----------nvsyPK--slSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 566 ----------NVSYPK--SLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ----------cCcCcc--cccHHHHHHHHHHhhcCCccccC
Confidence 111222 45567789999999999999954
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=259.87 Aligned_cols=259 Identities=21% Similarity=0.313 Sum_probs=196.8
Q ss_pred HHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEe--cCCCCchh-----hhHhhHHHHHhcCCCCceeeeeeEEe-e
Q 048160 52 AATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKF--GGNLNSEE-----YCCFNCIAFASQMSHKNILKFVGCCL-E 121 (344)
Q Consensus 52 ~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~--~~~~~~~~-----~~~~~E~~~l~~l~H~niv~~~~~~~-~ 121 (344)
...+.|-..++||+|||+.||++.. ..+-||||+- ++...... +-..+|-++.+.|.||-||++|+++. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3345566788999999999999998 6778899873 33332222 22348999999999999999999985 5
Q ss_pred CCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEee---cCCcce
Q 048160 122 TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ---EQNVAK 198 (344)
Q Consensus 122 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~k 198 (344)
.+.+|-|+|||+|.+|+-+|+.+. .+++.++..|+.||+.||.||..- ..+|||-||||.|||+- ..|.+|
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeE
Confidence 568899999999999999998764 689999999999999999999854 67999999999999995 347899
Q ss_pred EeeeecccccCCCCcc----cccCCccccccccccccccCcC----CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcc
Q 048160 199 FFDFCVSISIPEGKTH----VNDNNKVIGTFGFIAPEYMSTA----NCNEKSDVYSFGALLLELLTGKRISYSSCFENGE 270 (344)
Q Consensus 199 l~dfg~a~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 270 (344)
|.|||+++........ ..-.....||.+|++||.+.-+ ..+.|+||||.||++|.++.|+.||.....
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs---- 689 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS---- 689 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh----
Confidence 9999999998754432 1223345789999999987543 478999999999999999999999964321
Q ss_pred hhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 048160 271 EYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVA 334 (344)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~ 334 (344)
-.+++ ..+++..+ ..-.+|..+..+.+..++|.+||++.-++|..+.++.
T Consensus 690 ---QQdIL----qeNTIlkA-------tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 690 ---QQDIL----QENTILKA-------TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ---HHHHH----hhhchhcc-------eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 11111 11111111 1111222234556678999999999999998877664
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=279.73 Aligned_cols=268 Identities=18% Similarity=0.154 Sum_probs=167.1
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--C----CccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeE------Ee
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--Q----DRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGC------CL 120 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~----~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~------~~ 120 (344)
..++|...+.||+|+||.||+|++ + +..||+|++..... .+.+..+ .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 567899999999999999999999 4 67899998764321 1111111 1122222333322221 23
Q ss_pred eCCccEEEEeecCCCCccccccCCCCCCC---------------ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccc
Q 048160 121 ETELPILVFEFVACGTLADRIHDPNGSQL---------------EPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIK 185 (344)
Q Consensus 121 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk 185 (344)
.+...++|+||+.+++|.+++........ .......+..++.|++.||.||| +.+|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 56688999999999999998865431000 01112335678999999999999 9999999999
Q ss_pred ccceEeec-CCcceEeeeecccccCCCCcccccCCccccccccccccccCcC----------------------CCCccc
Q 048160 186 PSTILFQE-QNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA----------------------NCNEKS 242 (344)
Q Consensus 186 ~~Nill~~-~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~ 242 (344)
|+|||++. ++.+||+|||+|+......... .....+++.|+|||.+... .++.++
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~--~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYI--PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccC--CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 99999986 5799999999997654332221 1245788999999965321 234567
Q ss_pred chHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhc-cCCcccccccccccC-CCCChhhHHHHHHHHHHHHHcc
Q 048160 243 DVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE-SNSFKEIVDPIIVGE-EGLWPEKEKQLLSYTELAIKCL 320 (344)
Q Consensus 243 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl 320 (344)
|||||||++|||+++..++... ...+...+..... ...+........... ...............+|+.+||
T Consensus 361 DVwSlGviL~el~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSN------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchH------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 9999999999999876554221 1111111110000 000000000000000 0000000011223568999999
Q ss_pred ccCCCCCCCHHHHHH
Q 048160 321 SKSEQDRPTMVQVAK 335 (344)
Q Consensus 321 ~~dP~~RPs~~ei~~ 335 (344)
+.||++|||+.++++
T Consensus 435 ~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 435 RFKGRQRISAKAALA 449 (566)
T ss_pred cCCcccCCCHHHHhC
Confidence 999999999999875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=266.22 Aligned_cols=267 Identities=15% Similarity=0.174 Sum_probs=179.8
Q ss_pred HhcCCCCCCccccCCCceEEEEEE------------------CCccEEEEEecCCCCchhhh--------------HhhH
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL------------------QDRPISVMKFGGNLNSEEYC--------------CFNC 100 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~------------------~~~~vavk~~~~~~~~~~~~--------------~~~E 100 (344)
..++|++.++||+|+||+||+|.+ .++.||||++........+. ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 23579999987553322222 3346
Q ss_pred HHHHhcCCCCce-----eeeeeEEee--------CCccEEEEeecCCCCccccccCCCCCC-------------------
Q 048160 101 IAFASQMSHKNI-----LKFVGCCLE--------TELPILVFEFVACGTLADRIHDPNGSQ------------------- 148 (344)
Q Consensus 101 ~~~l~~l~H~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------- 148 (344)
+.++.+++|.++ ++++++|.. ....++|+||+++++|.+++....+..
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 677887753 346799999999999999886532110
Q ss_pred CccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcccccCCccccccccc
Q 048160 149 LEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFI 228 (344)
Q Consensus 149 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~ 228 (344)
...+++..+..++.|++.||.||| ..+|+||||||+||+++.++.++|+|||++.......... .....+++.|+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~g~~tp~Y~ 377 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN--PLYGMLDPRYS 377 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC--ccccCCCccee
Confidence 013456778889999999999999 9999999999999999999999999999987554322111 11224478999
Q ss_pred cccccCcCC--------------------C--CcccchHHHHHHHHHHHcCCC-CCCCCCccCcchhHHHHHHHHHhccC
Q 048160 229 APEYMSTAN--------------------C--NEKSDVYSFGALLLELLTGKR-ISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 229 aPE~~~~~~--------------------~--~~~~Di~slG~il~el~~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
|||.+.... + ..+.||||+||++++|+++.. |+..... .+............++.
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~-f~~~~~~~~~~~~~~r~- 455 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRL-FNTELRQYDNDLNRWRM- 455 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhh-hhhHHhhccchHHHHHh-
Confidence 999875322 1 134799999999999999886 4432110 00000000000000000
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCC---CCCCCHHHHHH
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSE---QDRPTMVQVAK 335 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~ei~~ 335 (344)
..+....++..........+|+.++|..+| .+|+|+.|+++
T Consensus 456 ---------~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 456 ---------YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ---------hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 000111111122344567899999999766 68999999875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=259.94 Aligned_cols=240 Identities=18% Similarity=0.254 Sum_probs=195.6
Q ss_pred CCCCCCccccCCCceEEEEEECCcc--EEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 56 NYDPEKVITKDLLYKLYKGFLQDRP--ISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~~~~~--vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
++.....||-|+||.|=.+..++.. +|+|.+++.. +...+-+..|-.+|...+.|.||++|..+.+....|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4555678999999999999995544 7888776542 2223346688899999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
-|-||.|...+.+++ .|...+...++..++.|++||| ..+||.|||||+|.++|.+|-+||.|||.|+.+..
T Consensus 501 aClGGElWTiLrdRg-----~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 501 ACLGGELWTILRDRG-----SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhcCchhhhhhhhcC-----CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 999999999999876 6889999999999999999999 99999999999999999999999999999999877
Q ss_pred CCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEI 290 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (344)
+.... ++.||+.|.|||.+.+...+.++|.||||+++|||++|++||... +++..+..+-.-+..-.
T Consensus 573 g~KTw----TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~-----dpmktYn~ILkGid~i~---- 639 (732)
T KOG0614|consen 573 GRKTW----TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV-----DPMKTYNLILKGIDKIE---- 639 (732)
T ss_pred CCcee----eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC-----chHHHHHHHHhhhhhhh----
Confidence 66554 689999999999999999999999999999999999999998653 23333322222111111
Q ss_pred cccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCC
Q 048160 291 VDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT 329 (344)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 329 (344)
+| ........+|+.+....+|.+|.-
T Consensus 640 -----------~P--r~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 640 -----------FP--RRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -----------cc--cccchhHHHHHHHHHhcCcHhhhc
Confidence 11 123334678888888889999965
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=242.04 Aligned_cols=249 Identities=18% Similarity=0.252 Sum_probs=196.3
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~l 127 (344)
.++|....+||+|+|+.|-.+++ .++.+|+|++++.. ..+.+....|-.+..+- +||.+|-+..++...+.+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 35788999999999999999999 77889999987652 23344556776666665 69999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
|.||.+||+|--+++... +++++.+..+...|..||.||| +.+|+.||||.+|+|+|..|.+|+.|+|+.+.
T Consensus 329 vieyv~ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEecCcceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhc
Confidence 999999999998887654 7999999999999999999999 99999999999999999999999999999887
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
.-..+.. .+++.||+.|.|||.+.+..|..++|.|++|++++||..|+.||.-....+. .+...+.+.+.+-...
T Consensus 401 ~l~~gd~---tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~-d~ntedylfqvilekq- 475 (593)
T KOG0695|consen 401 GLGPGDT---TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNP-DMNTEDYLFQVILEKQ- 475 (593)
T ss_pred CCCCCcc---cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCc-ccchhHHHHHHHhhhc-
Confidence 6544432 2368999999999999999999999999999999999999999975432221 1111111111111110
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCC
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT 329 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 329 (344)
+ +.|. ..+.....+++.-|+.||.+|..
T Consensus 476 -------i-----ripr--slsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 476 -------I-----RIPR--SLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred -------c-----cccc--eeehhhHHHHHHhhcCCcHHhcC
Confidence 0 0011 23333567888889999999853
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=246.09 Aligned_cols=268 Identities=19% Similarity=0.260 Sum_probs=204.3
Q ss_pred HHHHHhcCCCCCCccccCCCceEEEEEE-------CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEe
Q 048160 49 ELKAATNNYDPEKVITKDLLYKLYKGFL-------QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCL 120 (344)
Q Consensus 49 ~i~~~~~~~~~~~~ig~G~~g~V~~~~~-------~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~ 120 (344)
++......++...++.+|+||.||.|.| +.+.|.+|.++.... -....++.|..++.-++|||+.++.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 3444556677888899999999999977 224577777665432 23355779999999999999999999986
Q ss_pred e-CCccEEEEeecCCCCccccccCCCC---CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCc
Q 048160 121 E-TELPILVFEFVACGTLADRIHDPNG---SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNV 196 (344)
Q Consensus 121 ~-~~~~~lv~e~~~~gsL~~~l~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 196 (344)
. ...+++.+.++.-|+|..++..-.+ .....++-.+.+.++.|++.|+.||| ..+|||.||.++|.+||+.-+
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhee
Confidence 5 4678889999999999999972111 12245777788899999999999999 999999999999999999999
Q ss_pred ceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHH
Q 048160 197 AKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQ 275 (344)
Q Consensus 197 ~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~ 275 (344)
+|++|=.+++-+-..+.+.-..+ ...+..||+||.+....|+..+|+||||+++|||+| |+.|+.... +....
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDn-EnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID-----PfEm~ 508 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDN-ENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID-----PFEME 508 (563)
T ss_pred EEeccchhccccCcccccccCCC-CCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC-----HHHHH
Confidence 99999999887654443321111 123778999999999999999999999999999987 666654321 11111
Q ss_pred HHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 276 ELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
..+. + ..+..++-+|+.++..+|.-||..+|++||+++++...|.....+
T Consensus 509 ~ylk----d--------------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 509 HYLK----D--------------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred HHHh----c--------------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 1111 1 111122227888899999999999999999999999999887654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-34 Score=238.87 Aligned_cols=262 Identities=17% Similarity=0.224 Sum_probs=194.3
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeC-----CccE
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLET-----ELPI 126 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----~~~~ 126 (344)
+.+..+-||-|.||.||.++. +|+.||.|++..-.. ...+.+++|..++..++|.|+...++..... ...|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 456678899999999999999 889999999876533 2346788999999999999999998876543 2568
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
+++|.|. .+|...+-... +++...+.-++.||++||+||| +.+|+||||||.|.|++++..+||||||+++
T Consensus 134 V~TELmQ-SDLHKIIVSPQ-----~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVSPQ-----ALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHH-hhhhheeccCC-----CCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEeccccccc
Confidence 8999995 68888887654 6888999999999999999999 9999999999999999999999999999999
Q ss_pred ccCCCCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
........... ..+-|..|.|||.+.+. .|+...||||.||++.||+.++..|.... +..-.+.+.......
T Consensus 205 vee~d~~~hMT--qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~-----PiqQL~lItdLLGTP 277 (449)
T KOG0664|consen 205 TWDQRDRLNMT--HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG-----PIEQLQMIIDLLGTP 277 (449)
T ss_pred ccchhhhhhhH--HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC-----hHHHHHHHHHHhCCC
Confidence 87655433322 34568899999999885 59999999999999999999888775421 111112222222211
Q ss_pred Cccc-----------ccccccccCCCCCh------hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 SFKE-----------IVDPIIVGEEGLWP------EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ~~~~-----------~~~~~~~~~~~~~~------~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+.+. ++..... .+..+ .......+...+...++..||++|.+..+.+.
T Consensus 278 s~EaMr~ACEGAk~H~LR~~~k--~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 278 SQEAMKYACEGAKNHVLRAGLR--APDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred cHHHHHHHhhhhHHHhhccCCC--CCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence 1111 1000000 00000 00122234678888999999999999887654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-33 Score=230.44 Aligned_cols=262 Identities=16% Similarity=0.235 Sum_probs=196.2
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCC-CCceeeeeeEEeeC--CccEEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCCLET--ELPILV 128 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~--~~~~lv 128 (344)
.++|++.+++|+|.|++||.|.. ++..++||.+++. ..+.+.+|+.+|..|+ ||||++++++..+. ..+.||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 46788889999999999999996 7788999998765 3566789999999998 99999999998764 456799
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC-CcceEeeeecccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ-NVAKFFDFCVSIS 207 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~dfg~a~~ 207 (344)
+||..+.+...+.. .|+...+..++.+++.||.|+| +.||.|||+||.|+++|.. -.++++|+|+|.+
T Consensus 114 FE~v~n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP--------TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred hhhhccccHHHHhh--------hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhh
Confidence 99998877666553 5777778899999999999999 9999999999999999865 4799999999988
Q ss_pred cCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHH-----HH
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR-----KS 281 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----~~ 281 (344)
.-.+..-. -++.+..|--||.+.. ..|+.+-|+|||||++..|+..+.||+.+.+..+....+.+.+. .+
T Consensus 183 YHp~~eYn----VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Y 258 (338)
T KOG0668|consen 183 YHPGKEYN----VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAY 258 (338)
T ss_pred cCCCceee----eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHH
Confidence 75543322 4567888899998765 45899999999999999999999999876543332222222111 11
Q ss_pred hccCCccccccccccc-----CCCCChh-----hH-HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 282 IESNSFKEIVDPIIVG-----EEGLWPE-----KE-KQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 282 ~~~~~~~~~~~~~~~~-----~~~~~~~-----~~-~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
...-.+ .+++...+ ...+|.. .. -..++.++|+...|.+|.++|||+.|...
T Consensus 259 l~KY~i--~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 259 LNKYQI--DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHcc--CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 111110 01111111 1111111 01 12367899999999999999999998753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-33 Score=256.92 Aligned_cols=252 Identities=22% Similarity=0.282 Sum_probs=204.2
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
.++|.....||.|+||.||+++. .+...|+|.++-.-........+|+-+++.-+|||||-++|.+...+.+|++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 46788889999999999999999 7889999999887666677788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
|.+|+|.+.-...+ ++.+.++..+.+..+.||.||| +.+-+|||||-.||++...|.+|++|||.+..+...
T Consensus 94 cgggslQdiy~~Tg-----plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred cCCCcccceeeecc-----cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhh
Confidence 99999999887765 7999999999999999999999 999999999999999999999999999998776543
Q ss_pred CcccccCCccccccccccccccC---cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMS---TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
......+.||+.|||||+.. .+.|++++|||++|+...|+..-.+|-+..- .+...... . .
T Consensus 166 ---i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh-----pmr~l~Lm----T----k 229 (829)
T KOG0576|consen 166 ---IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH-----PMRALFLM----T----K 229 (829)
T ss_pred ---hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc-----hHHHHHHh----h----c
Confidence 23333679999999999863 4679999999999999999987777644210 00000000 0 0
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+++... .+.....+.+.+|++.|+..+|++|||++.+++
T Consensus 230 S~~qpp~l------kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 230 SGFQPPTL------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cCCCCCcc------cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11111111 111245556899999999999999999987654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=220.61 Aligned_cols=209 Identities=25% Similarity=0.403 Sum_probs=180.9
Q ss_pred cccCCCceEEEEEEC--CccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCCccc
Q 048160 63 ITKDLLYKLYKGFLQ--DRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLAD 139 (344)
Q Consensus 63 ig~G~~g~V~~~~~~--~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 139 (344)
||+|.+|.||++... +..+++|++...... ..+.+.+|+..++.++|++|+++++++......++++||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999995 889999998766432 24668899999999999999999999999899999999999999999
Q ss_pred cccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec-CCcceEeeeecccccCCCCcccccC
Q 048160 140 RIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE-QNVAKFFDFCVSISIPEGKTHVNDN 218 (344)
Q Consensus 140 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~dfg~a~~~~~~~~~~~~~ 218 (344)
++.... ..+++..+..++.+++.++.+|| ..+++|+||+|.||+++. ++.++++|||.+........ ..
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~ 150 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LL 150 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hh
Confidence 987642 25788999999999999999999 999999999999999999 89999999999876654321 11
Q ss_pred CccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccccccc
Q 048160 219 NKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVG 297 (344)
Q Consensus 219 ~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (344)
....+...|++||.+... .++.++|+|++|++++++
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 134567889999998776 788999999999999998
Q ss_pred CCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 298 EEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 298 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 136799999999999999999998864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=246.58 Aligned_cols=196 Identities=18% Similarity=0.230 Sum_probs=168.7
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--------chhhhHhhHHHHHhcCC---CCceeeeeeEEee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--------SEEYCCFNCIAFASQMS---HKNILKFVGCCLE 121 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--------~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~ 121 (344)
.+|...+.+|.|+||.|+.|.+ +...|++|-+.+..- ...-.+-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 4588899999999999999999 556788887765411 11122347999999997 9999999999999
Q ss_pred CCccEEEEeec-CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEe
Q 048160 122 TELPILVFEFV-ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFF 200 (344)
Q Consensus 122 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 200 (344)
++.+||+||-. ++.+|.+++.... .+++.++..|+.|++.|+++|| +.+|||||||-+|++++.+|.+||+
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEe
Confidence 99999999985 4668999997654 6899999999999999999999 9999999999999999999999999
Q ss_pred eeecccccCCCCcccccCCccccccccccccccCcCCCC-cccchHHHHHHHHHHHcCCCCCCC
Q 048160 201 DFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCN-EKSDVYSFGALLLELLTGKRISYS 263 (344)
Q Consensus 201 dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~ 263 (344)
|||.|.....+... .++||..|+|||++.+.+|- ..-|||++|+++|.+.....|||.
T Consensus 713 dfgsaa~~ksgpfd-----~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 713 DFGSAAYTKSGPFD-----VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eccchhhhcCCCcc-----eeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99998776554432 57899999999999998874 668999999999999999999874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=229.69 Aligned_cols=264 Identities=20% Similarity=0.246 Sum_probs=191.4
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC--CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCC------cc
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL--NSEEYCCFNCIAFASQMSHKNILKFVGCCLETE------LP 125 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------~~ 125 (344)
.|...+.+|.|.. .|..+.. .+++||+|++.... ....+...+|..++..++|+||++++.++.... ..
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4666778888887 6766666 78999999987652 334566779999999999999999999987643 56
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
|+|||+|. ++|...+.- .++=.+...++.|++.|++||| +.+|+||||||+||++..+..+||.|||+|
T Consensus 97 y~v~e~m~-~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 97 YLVMELMD-ANLCQVILM-------ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHhhh-hHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhh
Confidence 99999996 789888763 2555678899999999999999 999999999999999999999999999999
Q ss_pred cccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCc-----------chhH-
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENG-----------EEYF- 273 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----------~~~~- 273 (344)
+..... ...+..+.|..|.|||++.+..|.+.+||||+||++.||++|...|.+...-++ ....
T Consensus 166 r~e~~~----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 166 RTEDTD----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred cccCcc----cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 875543 112246789999999999998899999999999999999999988764211000 0000
Q ss_pred --HHHHHHHHhccCCcccccccccccCCCCChhh----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 274 --LQELVRKSIESNSFKEIVDPIIVGEEGLWPEK----EKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 274 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+......+.+...-...+...-.-....|+.. ......+.+++.+||-.||++|.|++++++
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 11112222221110000000000011111111 122334789999999999999999999875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=234.71 Aligned_cols=131 Identities=15% Similarity=0.244 Sum_probs=109.8
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCC-----C---CceeeeeeEEee---
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-----H---KNILKFVGCCLE--- 121 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~~~~~~~~--- 121 (344)
..|...++||.|-|++||++.. ..+-||+|+++.. ....+..+.|+.+|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 4577899999999999999999 6678999987644 234566789999999994 3 359999999864
Q ss_pred -CCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEee
Q 048160 122 -TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ 192 (344)
Q Consensus 122 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 192 (344)
+.+.|+|+|++ |-+|..++...+. .-++...+.+|+.||+.||.|||. ..+|||-||||+|||+.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeee
Confidence 56899999999 6789888865443 347889999999999999999996 78999999999999984
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=243.47 Aligned_cols=201 Identities=16% Similarity=0.197 Sum_probs=168.0
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchh---hhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEE---YCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~---~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
-|...+.||-|+||+|.+++. ....+|+|.+.+..--.. .-+..|-.+|..-..+.||+||-.|.+.+.+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 477889999999999999988 345688888765422111 224477889999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC-
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP- 209 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~- 209 (344)
|++||++-.+|-+.+ .|.+..+..++.++..|+++.| ..|+|||||||+|||||.+|.+||.|||+..-+-
T Consensus 710 YIPGGDmMSLLIrmg-----IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMG-----IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred ccCCccHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeecccccccee
Confidence 999999999887765 6888899999999999999999 9999999999999999999999999999976441
Q ss_pred -------CCCcccc-------------------------------cCCccccccccccccccCcCCCCcccchHHHHHHH
Q 048160 210 -------EGKTHVN-------------------------------DNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALL 251 (344)
Q Consensus 210 -------~~~~~~~-------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il 251 (344)
..+.+.. .....+||+.|+|||++....|+..+|.||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 0000000 01135799999999999999999999999999999
Q ss_pred HHHHcCCCCCCCC
Q 048160 252 LELLTGKRISYSS 264 (344)
Q Consensus 252 ~el~~g~~p~~~~ 264 (344)
|||+.|..||...
T Consensus 862 ~em~~g~~pf~~~ 874 (1034)
T KOG0608|consen 862 YEMLVGQPPFLAD 874 (1034)
T ss_pred HHHhhCCCCccCC
Confidence 9999999999754
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=216.06 Aligned_cols=201 Identities=18% Similarity=0.214 Sum_probs=160.3
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch-hhhHhhHHHHHhc-CCCCceeeeeeEEeeCCccEEEEe
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE-EYCCFNCIAFASQ-MSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~-~~~~~~E~~~l~~-l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
+.......||+|+||.|-+-++ +|...|+|++....... ....++|+.+..+ ...|.+|.+||........|+.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 4445567799999999877777 88999999987665433 3446677775544 468999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
.|. -||+.+-..--... ...++.-.=+|+..++.||.|||+ ...++|||+||+|||++.+|++|+||||.+..+..
T Consensus 126 ~M~-tSldkfy~~v~~~g-~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 126 LMD-TSLDKFYRKVLKKG-GTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred Hhh-hhHHHHHHHHHhcC-CcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 996 67876543211000 257777788899999999999996 78999999999999999999999999999977654
Q ss_pred CCcccccCCccccccccccccccCc----CCCCcccchHHHHHHHHHHHcCCCCCCC
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMST----ANCNEKSDVYSFGALLLELLTGKRISYS 263 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Di~slG~il~el~~g~~p~~~ 263 (344)
+-... .-.|...|+|||.+.. ..|+.++||||||+++.||.+++.|+.+
T Consensus 202 SiAkt----~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 202 SIAKT----MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred hhHHH----HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 33222 2246778999998754 3699999999999999999999999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=241.92 Aligned_cols=268 Identities=19% Similarity=0.222 Sum_probs=200.8
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCC------CCceeeeeeEEeeCCcc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMS------HKNILKFVGCCLETELP 125 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~~~~~~~~~~~~ 125 (344)
.+.|.+....|+|-|++|.+|.. .+..||||++.+.. ...+.=++|+++|++|+ --|+++++..|...+++
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL 509 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL 509 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence 34577777889999999999999 67799999987652 22344568999999995 35799999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC-CcceEeeeec
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ-NVAKFFDFCV 204 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~dfg~ 204 (344)
|||+|-+. -+|.++|+..+.+- -|....+..++.|+..||..|- ..+|+|.||||.|||++.. ..+||||||.
T Consensus 510 ClVFE~Ls-lNLRevLKKyG~nv--GL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 510 CLVFEPLS-LNLREVLKKYGRNV--GLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred EEEehhhh-chHHHHHHHhCccc--ceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCcc
Confidence 99999884 79999998765432 3777889999999999999999 9999999999999999854 5789999999
Q ss_pred ccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHH----
Q 048160 205 SISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK---- 280 (344)
Q Consensus 205 a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---- 280 (344)
|......... ...-+..|.|||.+.+.+|+...|+||.||+||||+||+..|.+..+. ...-+..+...+
T Consensus 584 A~~~~eneit-----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN-~MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 584 ASFASENEIT-----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN-QMLRLFMELKGKFPNK 657 (752)
T ss_pred cccccccccc-----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH-HHHHHHHHhcCCCcHH
Confidence 9877654432 234577899999999999999999999999999999999988765331 111111111111
Q ss_pred HhccCCccc-ccc-----------cc---------------------cccCCCCChh-hHHHHHHHHHHHHHccccCCCC
Q 048160 281 SIESNSFKE-IVD-----------PI---------------------IVGEEGLWPE-KEKQLLSYTELAIKCLSKSEQD 326 (344)
Q Consensus 281 ~~~~~~~~~-~~~-----------~~---------------------~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~ 326 (344)
.++.+.+.+ -|| ++ +. ..+.+|. .+....+|.+|+..||..||++
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~-~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELI-AVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHh-ccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 111111100 000 00 11 1122332 2356678999999999999999
Q ss_pred CCCHHHHHH
Q 048160 327 RPTMVQVAK 335 (344)
Q Consensus 327 RPs~~ei~~ 335 (344)
|.|..+.++
T Consensus 737 Rit~nqAL~ 745 (752)
T KOG0670|consen 737 RITVNQALK 745 (752)
T ss_pred cCCHHHHhc
Confidence 999988764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=219.24 Aligned_cols=250 Identities=18% Similarity=0.209 Sum_probs=183.8
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCC-CCceeeeeeE-EeeCCccEEEEe
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGC-CLETELPILVFE 130 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~-~~~~~~~~lv~e 130 (344)
+.|.+.+.+|+|-||.+-.+++ ....+++|-+..... ....|.+|...--.|. |.||+.-|++ +...+.+.+++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 5588899999999999999999 445688887766643 4577889988777774 8999998876 445567789999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEee-c-CCcceEeeeeccccc
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ-E-QNVAKFFDFCVSISI 208 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~-~~~~kl~dfg~a~~~ 208 (344)
|++.|+|..-+...+ +.+..-..++.|+++||.|+| +.++||||||.+|||+. . ...+||||||.++..
T Consensus 103 ~aP~gdL~snv~~~G------igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAAG------IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred cCccchhhhhcCccc------ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 999999999887654 677778899999999999999 99999999999999984 2 338999999998765
Q ss_pred CCCCcccccCCccccccccccccccCc-----CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMST-----ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE 283 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (344)
...-. ...-+..|.+||+... ...++.+|||.||++++.++||+.||......+........|.....
T Consensus 174 g~tV~------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~- 246 (378)
T KOG1345|consen 174 GTTVK------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN- 246 (378)
T ss_pred Cceeh------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC-
Confidence 32211 2233667899997643 23578999999999999999999999855443333333333322111
Q ss_pred cCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 284 SNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
...+..+. -.++.+..+..+-|.++|++|=-..++.+.
T Consensus 247 -~~~P~~F~--------------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 247 -PALPKKFN--------------PFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred -ccCchhhc--------------ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 01111111 223457788899999999999444444433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=215.56 Aligned_cols=198 Identities=26% Similarity=0.341 Sum_probs=170.5
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
|...+.||+|++|.||++.. .+..+++|.+...... ..+.+.+|+..+.+++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 45668899999999999999 3688999998876554 56778899999999999999999999999899999999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+++|.+++..... .+++..+..++.+++.++.+|| ..+++|+|++|.||+++.++.++++|||.+........
T Consensus 81 ~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 81 GGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 9999999876531 1788899999999999999999 89999999999999999999999999999887654321
Q ss_pred ccccCCcccccccccccccc-CcCCCCcccchHHHHHHHHHHHcCCCCCCC
Q 048160 214 HVNDNNKVIGTFGFIAPEYM-STANCNEKSDVYSFGALLLELLTGKRISYS 263 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~p~~~ 263 (344)
. ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 154 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 A--LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred c--cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 0 11134567889999998 666788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=225.11 Aligned_cols=273 Identities=19% Similarity=0.242 Sum_probs=200.0
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEE-C----CccEEEEEecCCCCchhhhHhhHHHHHhcCC-CCceeeeeeEEeeCC
Q 048160 50 LKAATNNYDPEKVITKDLLYKLYKGFL-Q----DRPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCCLETE 123 (344)
Q Consensus 50 i~~~~~~~~~~~~ig~G~~g~V~~~~~-~----~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~ 123 (344)
+....+.|...++||.|+|++||++.. . ++.||+|.+...+ ....+..|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 344556789999999999999999998 2 4679999987664 3345788999999995 899999999999999
Q ss_pred ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec-CCcceEeee
Q 048160 124 LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE-QNVAKFFDF 202 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~df 202 (344)
...+|+||+++-+..++... ++...+..+++.+..||.++| .+|||||||||.|+|.+. .+.-.|.||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred eeEEEecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEec
Confidence 99999999999888888753 667888999999999999999 999999999999999974 467789999
Q ss_pred ecccccCCCC------c------cc-----------------------------ccCCccccccccccccccCcCC-CCc
Q 048160 203 CVSISIPEGK------T------HV-----------------------------NDNNKVIGTFGFIAPEYMSTAN-CNE 240 (344)
Q Consensus 203 g~a~~~~~~~------~------~~-----------------------------~~~~~~~g~~~y~aPE~~~~~~-~~~ 240 (344)
|+|....... . .. .....+.||++|.|||++...+ .++
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 9998321100 0 00 0000245899999999987654 689
Q ss_pred ccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHH-Hhc-----cCC------------------cccccccccc
Q 048160 241 KSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK-SIE-----SNS------------------FKEIVDPIIV 296 (344)
Q Consensus 241 ~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~-----~~~------------------~~~~~~~~~~ 296 (344)
++||||.|+++..++++..||+...+.-.....+..++.. .++ .+. +..+....+.
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 9999999999999999999999876655444433322221 111 011 0001000000
Q ss_pred cCCC----CChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 297 GEEG----LWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 297 ~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... .....+..+..+.+|+.+|+..||.+|.|+++.++
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0000 11111123446899999999999999999999875
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-29 Score=250.59 Aligned_cols=198 Identities=18% Similarity=0.222 Sum_probs=140.3
Q ss_pred hcCCC-CceeeeeeEE-------eeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCC
Q 048160 105 SQMSH-KNILKFVGCC-------LETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFS 176 (344)
Q Consensus 105 ~~l~H-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 176 (344)
+.++| +||+++++++ ..+..++.++||+ +++|.+++.... ..+++.+++.++.||+.||.||| +
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~ 98 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAH---S 98 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHH---h
Confidence 45566 6888888887 2334677889988 579999997543 35899999999999999999999 9
Q ss_pred CCeeeecccccceEeec-------------------CCcceEeeeecccccCCCCcc-------------cccCCccccc
Q 048160 177 RPIVFRDIKPSTILFQE-------------------QNVAKFFDFCVSISIPEGKTH-------------VNDNNKVIGT 224 (344)
Q Consensus 177 ~~ivH~dlk~~Nill~~-------------------~~~~kl~dfg~a~~~~~~~~~-------------~~~~~~~~g~ 224 (344)
++|+||||||+|||++. ++.+|++|||+++........ ........||
T Consensus 99 ~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 99 QGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred CCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 99999999999999954 445666777766542210000 0000123578
Q ss_pred cccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChh
Q 048160 225 FGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPE 304 (344)
Q Consensus 225 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (344)
+.|+|||++.+..++.++|||||||++|||++|..|+... ............ . +.
T Consensus 179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~------~~~~~~~~~~~~---------~----------~~ 233 (793)
T PLN00181 179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK------SRTMSSLRHRVL---------P----------PQ 233 (793)
T ss_pred cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH------HHHHHHHHHhhc---------C----------hh
Confidence 8999999999999999999999999999999987765321 001111110000 0 00
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 305 KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 305 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..........++..||+++|.+||++.+|++
T Consensus 234 ~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 234 ILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred hhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 0011233568889999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-28 Score=199.85 Aligned_cols=169 Identities=21% Similarity=0.186 Sum_probs=126.8
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
|||.+++...+ .++++.++..++.|++.||.||| +.+ ||+||+++.++.+++ ||++......
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--- 62 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE--- 62 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc---
Confidence 68888887644 36999999999999999999999 665 999999999999999 9998765432
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPI 294 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (344)
...|++.|+|||++.+..++.++|||||||++|||++|..||..... ....+..........
T Consensus 63 -----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~---~~~~~~~~~~~~~~~---------- 124 (176)
T smart00750 63 -----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE---LSAILEILLNGMPAD---------- 124 (176)
T ss_pred -----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch---hcHHHHHHHHHhccC----------
Confidence 12578999999999999999999999999999999999999854321 111122222111100
Q ss_pred cccCCCCChhhHHHHH--HHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 295 IVGEEGLWPEKEKQLL--SYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 295 ~~~~~~~~~~~~~~~~--~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.....+....... .+.+++.+||+.||++||++.++++.+..+..
T Consensus 125 ---~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 125 ---DPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ---CccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 0000011112222 68999999999999999999999998877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=191.49 Aligned_cols=265 Identities=17% Similarity=0.202 Sum_probs=201.5
Q ss_pred HHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCC-CCceeeeeeEEeeCCccEEE
Q 048160 52 AATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCCLETELPILV 128 (344)
Q Consensus 52 ~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv 128 (344)
...-+|.+.++||+|+||+++.|+. ++.+||||.-... +....+..|.+..+.|. .++|+.+|-+...+-.-.||
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 3445799999999999999999998 9999999974433 35567888999999996 59999999998889899999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC-----CcceEeeee
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ-----NVAKFFDFC 203 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~dfg 203 (344)
+|++ |.||.+++.--+ ..|+..++..+|.|++.-++|+| +..+|.|||||+|+||..- ..+.++|||
T Consensus 103 idLL-GPSLEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG 174 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFG 174 (449)
T ss_pred hhhh-CcCHHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEecc
Confidence 9998 789998875444 46999999999999999999999 9999999999999999754 368899999
Q ss_pred cccccCCCCcccc----cCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHH
Q 048160 204 VSISIPEGKTHVN----DNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR 279 (344)
Q Consensus 204 ~a~~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 279 (344)
+|+.+-+..+... ......||.+||+-....+..-+...|+-|+|-++++.+-|..||.+..-...-. .+ +-+.
T Consensus 175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~-kY-eKIG 252 (449)
T KOG1165|consen 175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE-KY-EKIG 252 (449)
T ss_pred chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH-HH-HHhc
Confidence 9998865543321 2235679999999998888888999999999999999999999998753322110 01 1111
Q ss_pred HHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 280 KSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
..-+.-.+.++ ....+.++..-+...-..+-.+-|..+-+...+..+.+
T Consensus 253 e~Kr~T~i~~L--------------c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 253 ETKRSTPIEVL--------------CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred cccccCCHHHH--------------HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 11111111111 11334556666666666777778888777777766654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.8e-25 Score=199.40 Aligned_cols=261 Identities=17% Similarity=0.165 Sum_probs=194.3
Q ss_pred CCCCCCccccCCCceEEEEEECC---ccEEEEEecCCCCchhhhHhhHHHHHhcCCC----CceeeeeeEE-eeCCccEE
Q 048160 56 NYDPEKVITKDLLYKLYKGFLQD---RPISVMKFGGNLNSEEYCCFNCIAFASQMSH----KNILKFVGCC-LETELPIL 127 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~~~---~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~~~~~~-~~~~~~~l 127 (344)
+|.+...||+|+||.||.+.... ..+|+|............+..|..++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 69999999999999999999833 3578887655433333367788999988873 6899999888 47778899
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC-----CcceEeee
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ-----NVAKFFDF 202 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~df 202 (344)
||+.+ |.||.++...... ..++..+++.++.|++.+|++|| +.+++||||||.|++++.. ..+.+.||
T Consensus 99 VM~l~-G~sL~dl~~~~~~---~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPP---GRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEecc-CccHHHHHHhCCC---CCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 99998 7899998755442 36999999999999999999999 9999999999999999765 46899999
Q ss_pred eccc--ccCCCCc----cccc-CCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHH
Q 048160 203 CVSI--SIPEGKT----HVND-NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQ 275 (344)
Q Consensus 203 g~a~--~~~~~~~----~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 275 (344)
|+++ ....... .... .....||..|+++....+...+.+.|+||++.++.++..|..||........ .....
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~ 250 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFE 250 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHH
Confidence 9998 3322211 1111 1235699999999999999999999999999999999999999855432111 11111
Q ss_pred HHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 276 ELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
....... ... .....+..+.++...+-+.+...+|....+...|..+..
T Consensus 251 ~~~~~~~----~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 251 KDPRKLL----TDR--------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred HHhhhhc----ccc--------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 1100000 000 000233456677777777899999999999998877654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=205.00 Aligned_cols=171 Identities=13% Similarity=0.135 Sum_probs=130.8
Q ss_pred cHHHHHHHhcCCCCCCccccCCCceEEEEEE---CCccEEEEEecCCC-----CchhhhHhhHHHHHhcCCCCceee-ee
Q 048160 46 TAQELKAATNNYDPEKVITKDLLYKLYKGFL---QDRPISVMKFGGNL-----NSEEYCCFNCIAFASQMSHKNILK-FV 116 (344)
Q Consensus 46 ~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~---~~~~vavk~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~-~~ 116 (344)
..+.+....++|...+.||+|+||+||+|.+ ++..||||++.... ......+.+|+.++++++|+|++. ++
T Consensus 9 ~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~ 88 (365)
T PRK09188 9 PGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLL 88 (365)
T ss_pred cccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEE
Confidence 3445566678899999999999999999987 35667999865331 112455889999999999999985 44
Q ss_pred eEEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecc-cccceEeecCC
Q 048160 117 GCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDI-KPSTILFQEQN 195 (344)
Q Consensus 117 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-k~~Nill~~~~ 195 (344)
++ ...++||||++|++|.. +.. .. ...++.+++.||.||| +.+|+|||| ||+|||++.++
T Consensus 89 ~~----~~~~LVmE~~~G~~L~~-~~~--------~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~ 149 (365)
T PRK09188 89 AT----GKDGLVRGWTEGVPLHL-ARP--------HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDG 149 (365)
T ss_pred Ec----CCcEEEEEccCCCCHHH-hCc--------cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCC
Confidence 32 45799999999999963 211 11 1357889999999999 999999999 99999999999
Q ss_pred cceEeeeecccccCCCCcccc-----cCCccccccccccccccCc
Q 048160 196 VAKFFDFCVSISIPEGKTHVN-----DNNKVIGTFGFIAPEYMST 235 (344)
Q Consensus 196 ~~kl~dfg~a~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~ 235 (344)
.++|+|||+|+.......... .-....+++.|+|||.+..
T Consensus 150 ~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 150 EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999999999997754332111 1123567888999998854
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=186.22 Aligned_cols=264 Identities=15% Similarity=0.197 Sum_probs=200.2
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCC-CceeeeeeEEeeCCccEEEEe
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSH-KNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~~~~~~~~~~~~~lv~e 130 (344)
.++|...++||.|+||.+|.|.. .|..||+|.-+... ....+..|..+...|+| ..|+.+..+..+...-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 46799999999999999999998 88999999865543 34567789999999986 788888888888889999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec---CCcceEeeeecccc
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE---QNVAKFFDFCVSIS 207 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~dfg~a~~ 207 (344)
.. |+||.+++.--. ..++..+++-++-|++.-++|+| ..+.+||||||+|+|.+- ..++.++|||+|+.
T Consensus 92 LL-GPsLEdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS----RRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred cc-CccHHHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhh
Confidence 98 799999875433 36899999999999999999999 999999999999999863 45789999999998
Q ss_pred cCCCCcccc----cCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhc
Q 048160 208 IPEGKTHVN----DNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE 283 (344)
Q Consensus 208 ~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (344)
+.+..+... ......||.+|++-....+-..+...|+-|+|.++.++..|..||........ .+.+.+ +.
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk-~QKyEk-----I~ 237 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK-KQKYEK-----IS 237 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH-HHHHHH-----HH
Confidence 765432211 12245789999988877777778899999999999999999999976532111 111111 11
Q ss_pred cCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 284 SNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
...+...+...+. ..|.++.-.+..|-..--++-|...-+.+.+.-+...
T Consensus 238 EkK~s~~ie~LC~----------G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ 287 (341)
T KOG1163|consen 238 EKKMSTPIEVLCK----------GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT 287 (341)
T ss_pred HhhcCCCHHHHhC----------CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence 1111111111111 3455677788888888888889888777776665543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-25 Score=187.45 Aligned_cols=245 Identities=17% Similarity=0.191 Sum_probs=182.4
Q ss_pred CCccccCCCceEEEEEECCccEEEEEecCC--CCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCCc
Q 048160 60 EKVITKDLLYKLYKGFLQDRPISVMKFGGN--LNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTL 137 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~~~~~vavk~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL 137 (344)
..+|.+.-.|+.|+|+|.|..+++|+++-. .....+.|..|.-.++-+.||||..++|.|.+...+.++..||+.|||
T Consensus 195 ~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 345777888999999999998888887644 223346788899999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCee-eecccccceEeecCCcceEe--eeecccccCCCCcc
Q 048160 138 ADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIV-FRDIKPSTILFQEQNVAKFF--DFCVSISIPEGKTH 214 (344)
Q Consensus 138 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv-H~dlk~~Nill~~~~~~kl~--dfg~a~~~~~~~~~ 214 (344)
+..+....+ ...+-.+++.++.++++|+.|||+- .+++ .-.|.+..+++|++...+|+ |--.+-+.
T Consensus 275 ynvlhe~t~---vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltarismad~kfsfqe------ 343 (448)
T KOG0195|consen 275 YNVLHEQTS---VVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE------ 343 (448)
T ss_pred HHHHhcCcc---EEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhheecccceeeeec------
Confidence 999976543 3567788999999999999999942 2333 33688899999999877654 32222110
Q ss_pred cccCCccccccccccccccCcCCC---CcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANC---NEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~---~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
. -..-.+.|++||.+...+- -..+|+|||++++|||-|+..||..... ..-.+.
T Consensus 344 ~----gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp-mecgmk------------------ 400 (448)
T KOG0195|consen 344 V----GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP-MECGMK------------------ 400 (448)
T ss_pred c----ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc-hhhhhh------------------
Confidence 0 1122678999999977553 3579999999999999999999964321 000000
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLH 341 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~ 341 (344)
-.+.|-.. ..++..+..+-.|+.-|.+.||.+||.++.|+-.|+++.
T Consensus 401 -ialeglrv--~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 401 -IALEGLRV--HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -hhhccccc--cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 00111111 111245566889999999999999999999999998864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-23 Score=184.71 Aligned_cols=262 Identities=24% Similarity=0.320 Sum_probs=195.9
Q ss_pred CCCCCccccCCCceEEEEEECCccEEEEEecCCCCch---hhhHhhHHHHHhcCCCC-ceeeeeeEEeeCCccEEEEeec
Q 048160 57 YDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSE---EYCCFNCIAFASQMSHK-NILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~---~~~~~~E~~~l~~l~H~-niv~~~~~~~~~~~~~lv~e~~ 132 (344)
|.....||.|+||.||.+... ..+++|.+....... ...+.+|+..++.+.|+ +|+++.+++......+++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 556678999999999999988 788999887664433 56688999999999988 7999999997777789999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC-cceEeeeecccccCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN-VAKFFDFCVSISIPEG 211 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~dfg~a~~~~~~ 211 (344)
.++++.+++...... ..+.......++.|++.++.|+| ..+++|||+||+||+++..+ .++++|||.++.....
T Consensus 81 ~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 81 DGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999777654211 15788899999999999999999 99999999999999999988 7999999999865543
Q ss_pred Ccccc---cCCccccccccccccccCc---CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 212 KTHVN---DNNKVIGTFGFIAPEYMST---ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 212 ~~~~~---~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
..... ......|+..|++||.+.+ ..++...|+||+|++++++++|..||...... .......+.+......
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~- 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTLKIILELPTP- 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHHHHHHhcCCc-
Confidence 32211 2235688999999999987 57889999999999999999999996543211 0011122222211111
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
...... ....+ ......+.+++..|+..+|..|.+..+...
T Consensus 234 ~~~~~~-------~~~~~--~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 234 SLASPL-------SPSNP--ELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred cccccc-------Ccccc--chhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 000000 00000 122346789999999999999998887665
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=211.10 Aligned_cols=254 Identities=17% Similarity=0.173 Sum_probs=186.4
Q ss_pred CCCccccCCCceEEEEEE--CCccEEEEEecC---CCCch---hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 59 PEKVITKDLLYKLYKGFL--QDRPISVMKFGG---NLNSE---EYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 59 ~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~---~~~~~---~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
....+|.|.+|.|+.... .....+.|.+.. ..... ...+..|..+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 467899999998777766 334444443321 11111 1224567778888999999888877776665556699
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
||++ +|..++.... .+....+-.++.|++.|++|+| ..+|.|||+|++|+++..++.+|++|||.+.....
T Consensus 402 ~~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred cccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeecc
Confidence 9998 9999997753 4778888899999999999999 99999999999999999999999999999887654
Q ss_pred CCcc-cccCCccccccccccccccCcCCCCc-ccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 211 GKTH-VNDNNKVIGTFGFIAPEYMSTANCNE-KSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 211 ~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
.... ........|+-.|+|||++.+..|++ ..||||.|+++..|++|+.||.......... ..
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---------------~~ 537 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---------------KT 537 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---------------hh
Confidence 4332 12222467899999999999999985 5999999999999999999997654322211 00
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
.....-.....+.++.....+..-+.++.++|+.||.+|.|+.+|++.
T Consensus 538 ~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 538 NNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred hccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 000000011222333334556678899999999999999999999863
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-23 Score=193.77 Aligned_cols=215 Identities=24% Similarity=0.398 Sum_probs=162.0
Q ss_pred HhcCCCCceeeeeeEEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCe-eee
Q 048160 104 ASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPI-VFR 182 (344)
Q Consensus 104 l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i-vH~ 182 (344)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.... ..+++.....++.+++.||.||| +.+| .|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~----~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED----IKLDYFFILSFIRDISKGLAYLH---NSPIGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc----cCccHHHHHHHHHHHHHHHHHHh---cCcceeee
Confidence 467889999999999999999999999999999999998743 36788888899999999999999 5555 999
Q ss_pred cccccceEeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcC---C----CCcccchHHHHHHHHHHH
Q 048160 183 DIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA---N----CNEKSDVYSFGALLLELL 255 (344)
Q Consensus 183 dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~----~~~~~Di~slG~il~el~ 255 (344)
.+++.|.++|....+|+.|||+.......... ..........-|.|||.+... . .+.+.||||||++++|++
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~-~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEP-EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred eeccccceeeeeEEEEechhhhcccccccccc-cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 99999999999999999999998776531111 111111234579999998763 1 467899999999999999
Q ss_pred cCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhH---HHHHHHHHHHHHccccCCCCCCCHHH
Q 048160 256 TGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKE---KQLLSYTELAIKCLSKSEQDRPTMVQ 332 (344)
Q Consensus 256 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~l~~~cl~~dP~~RPs~~e 332 (344)
+.+.||............... +.. . +.....|... ....++..++.+||..+|.+||++..
T Consensus 153 ~r~~~~~~~~~~~~~~eii~~-~~~-----~----------~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~ 216 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDPDEIILR-VKK-----G----------GSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQ 216 (484)
T ss_pred hccCccccccccCChHHHHHH-HHh-----c----------CCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHH
Confidence 999999865443332111111 111 0 1111111111 23346899999999999999999999
Q ss_pred HHHHHHHHHh
Q 048160 333 VAKQLRQLHK 342 (344)
Q Consensus 333 i~~~L~~l~~ 342 (344)
|...+..+..
T Consensus 217 i~~~~~~~~~ 226 (484)
T KOG1023|consen 217 IRSKLLTINK 226 (484)
T ss_pred HHhhhhhhcc
Confidence 9988877654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=178.49 Aligned_cols=169 Identities=15% Similarity=0.118 Sum_probs=133.2
Q ss_pred hcCCCCCCccccCCCceEEEEEECCccEEEEEecCCCCchhhh---------HhhHHHHHhcCCCCceeeeeeEEeeC--
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYC---------CFNCIAFASQMSHKNILKFVGCCLET-- 122 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~---------~~~E~~~l~~l~H~niv~~~~~~~~~-- 122 (344)
.++|+..+.+|.|+||.||....+++.+|+|.+.......... +.+|+..+.++.|+||+.+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 5789999999999999999987788899999997664433222 57899999999999999998886532
Q ss_pred ------CccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCc
Q 048160 123 ------ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNV 196 (344)
Q Consensus 123 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 196 (344)
...++||||++|.+|.++.. ++. ..+.+++.++..+| ..+++|||++|+||+++.++
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-
Confidence 35789999999999987632 222 24569999999999 99999999999999999988
Q ss_pred ceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHH
Q 048160 197 AKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLEL 254 (344)
Q Consensus 197 ~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el 254 (344)
++++|||............ .++....|+.++|+||||+++.-+
T Consensus 173 i~liDfg~~~~~~e~~a~d---------------~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAKD---------------RIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred EEEEECCCcccccchhhHH---------------HHHHHhHhcccccccceeEeehHH
Confidence 9999999876553222111 123344567899999999987754
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=170.73 Aligned_cols=138 Identities=12% Similarity=0.136 Sum_probs=106.8
Q ss_pred CCccccCCCceEEEEEE-CCccEEEEEecCCCCchh---------hh-----------------HhhHHHHHhcCCCCce
Q 048160 60 EKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEE---------YC-----------------CFNCIAFASQMSHKNI 112 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~---------~~-----------------~~~E~~~l~~l~H~ni 112 (344)
...||+|+||.||+|.. +|+.||+|+++....... .. ..+|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999998 789999999875532111 11 1349999999988776
Q ss_pred eeeeeEEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHh-hcCCCCCeeeecccccceEe
Q 048160 113 LKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYL-HVGFSRPIVFRDIKPSTILF 191 (344)
Q Consensus 113 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~dlk~~Nill 191 (344)
.....+.. ...++||||++++++....... .+++..+...++.|++.+|.++ | ..+|+||||||+||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEE
Confidence 44333222 2348999999987776543222 2578889999999999999999 7 8899999999999999
Q ss_pred ecCCcceEeeeeccccc
Q 048160 192 QEQNVAKFFDFCVSISI 208 (344)
Q Consensus 192 ~~~~~~kl~dfg~a~~~ 208 (344)
+ ++.++++|||+|...
T Consensus 152 ~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H-DGKLYIIDVSQSVEH 167 (190)
T ss_pred E-CCcEEEEEccccccC
Confidence 8 578999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=164.32 Aligned_cols=139 Identities=12% Similarity=0.128 Sum_probs=109.4
Q ss_pred CCccccCCCceEEEEEE-CCccEEEEEecCCCCch--------------------------hhhHhhHHHHHhcCCCCce
Q 048160 60 EKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSE--------------------------EYCCFNCIAFASQMSHKNI 112 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~--------------------------~~~~~~E~~~l~~l~H~ni 112 (344)
...||+|++|.||+|.. +|+.||||.+....... ...+.+|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999998 68999999987653210 1113478999999999987
Q ss_pred eeeeeEEeeCCccEEEEeecCCCCcccc-ccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCC-CCeeeecccccceE
Q 048160 113 LKFVGCCLETELPILVFEFVACGTLADR-IHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFS-RPIVFRDIKPSTIL 190 (344)
Q Consensus 113 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlk~~Nil 190 (344)
.....+... ..++||||++++++... +.. ..++..+...++.+++.++.++| . .+|+||||||+||+
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIl 150 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNIL 150 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEE
Confidence 544433322 34899999988755443 332 14677888999999999999999 8 99999999999999
Q ss_pred eecCCcceEeeeecccccCC
Q 048160 191 FQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 191 l~~~~~~kl~dfg~a~~~~~ 210 (344)
++ ++.++++|||++.....
T Consensus 151 l~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EE-CCCEEEEEcccceecCC
Confidence 98 88999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-22 Score=196.13 Aligned_cols=251 Identities=17% Similarity=0.177 Sum_probs=180.1
Q ss_pred CCCCCCccccCCCceEEEEEECCccEEEEEecCCC-CchhhhHh---hHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 56 NYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNL-NSEEYCCF---NCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~-~~~~~~~~---~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
++...+.+|.+.|=.|.+|+++...|+||+|.++. .-..+.+. +|++ ..-++|||++.+--+-..+.-.|||=+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 56677889999999999999977779999987664 33345554 4444 5555899999998887777778888888
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
.. -+|+|.+..+. -+...+..-|+-|++.||.-+| ..+|+|||||.+|||+.+-.-+.|+||..-+...-.
T Consensus 103 vk-hnLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 103 VK-HNLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred Hh-hhhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 86 59999997763 4677778889999999999999 999999999999999999999999999765544322
Q ss_pred CcccccCCcc----ccccccccccccCc----------CC-CCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHH
Q 048160 212 KTHVNDNNKV----IGTFGFIAPEYMST----------AN-CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQE 276 (344)
Q Consensus 212 ~~~~~~~~~~----~g~~~y~aPE~~~~----------~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 276 (344)
.........+ .....|.|||.+-. .+ .+++-||||+||++.||++-..|.+. +.+
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----------LSQ 243 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----------LSQ 243 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----------HHH
Confidence 2222211122 22357999998743 12 57889999999999999876444432 111
Q ss_pred HHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 048160 277 LVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338 (344)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~ 338 (344)
.+ .+.. +. .....+.+.+- ....++.++..|++.||.+|.|+++.++.-.
T Consensus 244 L~-aYr~-~~-~~~~e~~Le~I---------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 244 LL-AYRS-GN-ADDPEQLLEKI---------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred HH-hHhc-cC-ccCHHHHHHhC---------cCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 11 1111 11 11111111100 0014789999999999999999999988643
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=160.70 Aligned_cols=191 Identities=10% Similarity=0.048 Sum_probs=141.0
Q ss_pred CCCCCccccCCCceEEEEEECCccEEEEEecCCCCchh----hhHhhHHHHHhcCC-CCceeeeeeEEeeCCccEEEEee
Q 048160 57 YDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEE----YCCFNCIAFASQMS-HKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~----~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
+.....|++|+||+||.+...+..++.+.+........ ..+.+|+++|++|+ |++|++++++ +..+++|||
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred cccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 34567899999999998888888898887765543221 24679999999995 5889999886 345899999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecc-cccceEeecCCcceEeeeecccccCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDI-KPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
+.|.+|.+.+.. ....++.+++.+|.++| ..+|+|||| ||+|||++.++.++|+|||++.....
T Consensus 80 I~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 80 LAGAAMYQRPPR------------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred ecCccHHhhhhh------------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 998888654311 11346789999999999 999999999 79999999999999999999986554
Q ss_pred CCcc----c-c-----cCCccccccccccccccCcC-CCC-cccchHHHHHHHHHHHcCCCCCCCCCc
Q 048160 211 GKTH----V-N-----DNNKVIGTFGFIAPEYMSTA-NCN-EKSDVYSFGALLLELLTGKRISYSSCF 266 (344)
Q Consensus 211 ~~~~----~-~-----~~~~~~g~~~y~aPE~~~~~-~~~-~~~Di~slG~il~el~~g~~p~~~~~~ 266 (344)
.... . . .......++.|++|+..... ..+ ...+.++-|.-+|.++|+..++++..+
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 3310 0 0 00011245666666643322 233 556777999999999999999877644
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.6e-21 Score=162.53 Aligned_cols=137 Identities=13% Similarity=0.119 Sum_probs=107.5
Q ss_pred CCCCCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcC-----CCCceeeeeeEEeeCC---c-cEE
Q 048160 57 YDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQM-----SHKNILKFVGCCLETE---L-PIL 127 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~~~~~~~~~~---~-~~l 127 (344)
+.....||+|+||.||. .......+||++........+.+.+|+.+++.+ .||||++++|++.++. . ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 44568899999999996 324444579988765444567789999999999 5799999999998763 3 337
Q ss_pred EEee--cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHH-HHhhcCCCCCeeeecccccceEeecC----CcceEe
Q 048160 128 VFEF--VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAV-AYLHVGFSRPIVFRDIKPSTILFQEQ----NVAKFF 200 (344)
Q Consensus 128 v~e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~ 200 (344)
|+|| +.+|+|.+++... .+++. ..++.+++.++ +||| +.+|+||||||+||+++.. ..++|+
T Consensus 83 I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 8999 5579999999653 24444 35678888888 9999 9999999999999999743 379999
Q ss_pred eeecc
Q 048160 201 DFCVS 205 (344)
Q Consensus 201 dfg~a 205 (344)
||+.+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95433
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-20 Score=165.51 Aligned_cols=198 Identities=20% Similarity=0.266 Sum_probs=141.6
Q ss_pred CCCceeeeeeEEee---------------------------CCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHH
Q 048160 108 SHKNILKFVGCCLE---------------------------TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160 (344)
Q Consensus 108 ~H~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 160 (344)
+|||||++.++|.+ +..+|+||...+ .+|.+++..+. .+..+..-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~------~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH------RSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC------CchHHHHHH
Confidence 49999999988765 235689999886 58999987653 567778889
Q ss_pred HHHHHHHHHHhhcCCCCCeeeecccccceEe--ecCC--cceEeeeecccccCCCCcccc---cCCcccccccccccccc
Q 048160 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILF--QEQN--VAKFFDFCVSISIPEGKTHVN---DNNKVIGTFGFIAPEYM 233 (344)
Q Consensus 161 ~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill--~~~~--~~kl~dfg~a~~~~~~~~~~~---~~~~~~g~~~y~aPE~~ 233 (344)
+.|++.|+.||| ..+|.|||+|++|||+ |.|+ .+.++|||++-..+..+.... ......|...-||||+.
T Consensus 347 laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 999999999999 9999999999999998 4444 567999998755443222211 11123466778999987
Q ss_pred CcC--C---C-CcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHH
Q 048160 234 STA--N---C-NEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEK 307 (344)
Q Consensus 234 ~~~--~---~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (344)
..- + . -.|+|.|+.|.+.||+++...|||...+. .+ ...+.+ +.+..+-++.
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-----~L--------~~r~Yq---------e~qLPalp~~ 481 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-----LL--------DTRTYQ---------ESQLPALPSR 481 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-----ee--------chhhhh---------hhhCCCCccc
Confidence 542 2 2 26899999999999999999999973210 00 000000 1111112225
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048160 308 QLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337 (344)
Q Consensus 308 ~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L 337 (344)
+++.+.+++...|+.||.+|+++.-....|
T Consensus 482 vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 482 VPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred CChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 667789999999999999999986555544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.5e-21 Score=178.71 Aligned_cols=224 Identities=19% Similarity=0.165 Sum_probs=175.0
Q ss_pred ccccCCCceEEEEEE-----CCccEEEEEecCCCCchh--hhHhhHHHHHhcCC-CCceeeeeeEEeeCCccEEEEeecC
Q 048160 62 VITKDLLYKLYKGFL-----QDRPISVMKFGGNLNSEE--YCCFNCIAFASQMS-HKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 62 ~ig~G~~g~V~~~~~-----~~~~vavk~~~~~~~~~~--~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
.+|+|.||.|+.++- .+..+|.|..++...... .-...|..++...+ ||.+|++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999987554 566788887655432221 12346777888887 9999999999999999999999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+|.|...+.... .+.+.....+...++.+++++| ..+|++||+|++||+++.+|.+++.|||+++..-...
T Consensus 81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~- 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK- 151 (612)
T ss_pred cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhh-
Confidence 999999887664 5777778888999999999999 9999999999999999999999999999998754322
Q ss_pred ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDP 293 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (344)
...||..|||||++. .....+|.||||++++||+||..||... ....+..
T Consensus 152 ------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~---------~~~~Il~------------- 201 (612)
T KOG0603|consen 152 ------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD---------TMKRILK------------- 201 (612)
T ss_pred ------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH---------HHHHHhh-------------
Confidence 127899999999997 5678899999999999999999999751 1111100
Q ss_pred ccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCH
Q 048160 294 IIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM 330 (344)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 330 (344)
.. .+.+........+++.+++..+|..|.-.
T Consensus 202 ----~~--~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 202 ----AE--LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred ----hc--cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 00 11112445567788888999999888644
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.3e-20 Score=156.69 Aligned_cols=134 Identities=19% Similarity=0.186 Sum_probs=114.0
Q ss_pred CccccCCCceEEEEEECCccEEEEEecCCCCch--------hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 61 KVITKDLLYKLYKGFLQDRPISVMKFGGNLNSE--------EYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~--------~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
+.||+|++|.||+|.+.+..|++|+........ ...+.+|+.++..+.|+||+....++......++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 579999999999999999999999866442211 134668999999999999887777777778889999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
+|++|.+++.... . ++..++.+++.+|.++| ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 82 ~G~~L~~~~~~~~--------~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG--------M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc--------H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999886421 2 77889999999999999 99999999999999999 78899999998865
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.1e-20 Score=183.28 Aligned_cols=200 Identities=19% Similarity=0.184 Sum_probs=157.3
Q ss_pred HHHHHHhcCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCC---CCceeeeeeEEeeCC
Q 048160 48 QELKAATNNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMS---HKNILKFVGCCLETE 123 (344)
Q Consensus 48 ~~i~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~ 123 (344)
.++......|.+.+.||+|+||.||+|.. +++.||+|.-+..+..+. --..+++.+|+ -+.|..+..++.-.+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 34455566788999999999999999999 888999998766654432 22334555555 245666666666677
Q ss_pred ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec-------CCc
Q 048160 124 LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE-------QNV 196 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-------~~~ 196 (344)
.-+||+||.+.|+|.++++... .+++.-++.+..|++.-+++|| ..+|||+||||+|.||.. ...
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~~-----~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTNK-----VMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred cceeeeeccccccHHHhhccCC-----CCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccc
Confidence 7789999999999999998543 5788889999999999999999 999999999999999942 346
Q ss_pred ceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCC
Q 048160 197 AKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKR 259 (344)
Q Consensus 197 ~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 259 (344)
++|+|||.+.-+..-... .......+|-.+-++|...+.+++...|.|.|+.+++.|+-|+.
T Consensus 840 l~lIDfG~siDm~lfp~~-~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEEEecccceeeeEcCCC-cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 899999998654321111 11124567888999999999999999999999999999999875
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-19 Score=157.12 Aligned_cols=232 Identities=18% Similarity=0.133 Sum_probs=142.1
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch---hhhHhhHHHHHhcCCC----------CceeeeeeEEe-
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE---EYCCFNCIAFASQMSH----------KNILKFVGCCL- 120 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~---~~~~~~E~~~l~~l~H----------~niv~~~~~~~- 120 (344)
+.....||.|+++.||.+++ .+..+|+|.+....... .+.+.+|.-....+.+ -.++.-++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 34457799999999999999 56899999976543322 3445566544444332 11111111111
Q ss_pred --------eC---C-----ccEEEEeecCCCCccccccC---CCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeee
Q 048160 121 --------ET---E-----LPILVFEFVACGTLADRIHD---PNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVF 181 (344)
Q Consensus 121 --------~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 181 (344)
.. + ..+++|+-+. ++|.+++.. .... ...+...-++.+..|+++.+++|| +.+++|
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVH 168 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLH---SYGLVH 168 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHh---hcceEe
Confidence 11 1 1246677664 688776532 1110 123444556777799999999999 999999
Q ss_pred ecccccceEeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCc--------CCCCcccchHHHHHHHHH
Q 048160 182 RDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST--------ANCNEKSDVYSFGALLLE 253 (344)
Q Consensus 182 ~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Di~slG~il~e 253 (344)
+||+|+|++++.+|.+.|+||+........... ...+..|.+||.... -.++.+.|.|++|+++|.
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 999999999999999999999876554322111 123567899997633 247889999999999999
Q ss_pred HHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCC
Q 048160 254 LLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDR 327 (344)
Q Consensus 254 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 327 (344)
|+++..||........... .+ ... ...+..+..||..+|++||++|
T Consensus 243 lWC~~lPf~~~~~~~~~~~-----------------~f----~~C-------~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW-----------------DF----SRC-------RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG-----------------GG----TTS-------S---HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc-----------------cc----hhc-------CCcCHHHHHHHHHHccCCcccC
Confidence 9999999975432211110 01 101 1455668999999999999988
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.3e-19 Score=153.46 Aligned_cols=140 Identities=12% Similarity=0.104 Sum_probs=109.2
Q ss_pred CCCCCCccccCCCceEEEEE-E--CCccEEEEEecCCCCch------------------------hhhHhhHHHHHhcCC
Q 048160 56 NYDPEKVITKDLLYKLYKGF-L--QDRPISVMKFGGNLNSE------------------------EYCCFNCIAFASQMS 108 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~-~--~~~~vavk~~~~~~~~~------------------------~~~~~~E~~~l~~l~ 108 (344)
-|.+.+.||+|+||.||+|. . +|..||+|.+....... ...+.+|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 3 78999999987542110 012458999999997
Q ss_pred CC--ceeeeeeEEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCC-eeeeccc
Q 048160 109 HK--NILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRP-IVFRDIK 185 (344)
Q Consensus 109 H~--niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~dlk 185 (344)
+. .+++++++ ...++||||+++++|........ .+...+...++.|++.++.+|| ..+ |+|||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dik 176 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-----EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLS 176 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-----CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCC
Confidence 53 34455543 23589999999888876553222 3555667889999999999999 999 9999999
Q ss_pred ccceEeecCCcceEeeeeccccc
Q 048160 186 PSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 186 ~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|+||+++ ++.++++|||.+...
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999 889999999998654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.9e-19 Score=150.17 Aligned_cols=130 Identities=19% Similarity=0.192 Sum_probs=107.3
Q ss_pred ccccCCCceEEEEEECCccEEEEEecCCCCc--------hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 62 VITKDLLYKLYKGFLQDRPISVMKFGGNLNS--------EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 62 ~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
.||+|+||.||+|.+++..|++|........ ....+.+|+.++..++|+++.....++...+..++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 4899999999999999999999986543211 12446689999999998876655555566777899999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
|++|.+++.... . .++.+++.+|.+|| ..+++|+|++|.||+++ ++.++++|||++..
T Consensus 81 g~~l~~~~~~~~-----~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGN-----D-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcH-----H-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999988775421 1 78999999999999 99999999999999999 88999999998755
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-18 Score=169.72 Aligned_cols=138 Identities=17% Similarity=0.151 Sum_probs=113.7
Q ss_pred hcCCCCCCccccCCCceEEEEEECCccEEEEEecCCC-C-------chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCcc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNL-N-------SEEYCCFNCIAFASQMSHKNILKFVGCCLETELP 125 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~-~-------~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~ 125 (344)
...|...+.||+|+||+||+|.+.+..+++|+..... . ...+.+.+|+.+++.++|++++....++......
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3445668899999999999999977777776543221 1 1124577999999999999999888888777788
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
++||||+++++|.+++. ....++.+++.+|.+|| ..+++|||+||+||++ .++.++++|||++
T Consensus 412 ~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred EEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 99999999999987764 24578999999999999 9999999999999999 6788999999998
Q ss_pred ccc
Q 048160 206 ISI 208 (344)
Q Consensus 206 ~~~ 208 (344)
+..
T Consensus 475 ~~~ 477 (535)
T PRK09605 475 KYS 477 (535)
T ss_pred ccC
Confidence 653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-19 Score=174.66 Aligned_cols=210 Identities=24% Similarity=0.351 Sum_probs=145.1
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEC--CccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 52 AATNNYDPEKVITKDLLYKLYKGFLQ--DRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 52 ~~~~~~~~~~~ig~G~~g~V~~~~~~--~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
....+|...++|..|+||.||..++. ...+|+ +++++.- +++ ||..+.+ +. +.|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l-----------ilR-----nilt~a~-----np-fvv- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL-----------ILR-----NILTFAG-----NP-FVV- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhh-cccccch-----------hhh-----ccccccC-----Cc-cee-
Confidence 34467999999999999999999883 567888 4444321 111 2222221 11 111
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
|+=...++..+ +++. +++.+++||| +-+|+|||+||+|.+|..-|.+|+.|||+++...
T Consensus 136 -----gDc~tllk~~g-----~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 -----GDCATLLKNIG-----PLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred -----chhhhhcccCC-----CCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhh
Confidence 44444554433 3443 2388999999 9999999999999999999999999999987653
Q ss_pred CCCcc------------cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHH
Q 048160 210 EGKTH------------VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL 277 (344)
Q Consensus 210 ~~~~~------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 277 (344)
..... .-....+.||+.|.|||++....|...+|+|++|+++||.+-|+.||+.... +..+...
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp----eelfg~v 270 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP----EELFGQV 270 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH----HHHHhhh
Confidence 22111 1122246899999999999999999999999999999999999999986521 1222222
Q ss_pred HHHHhccCCcccccccccccCCCCChhh-HHHHHHHHHHHHHccccCCCCCC
Q 048160 278 VRKSIESNSFKEIVDPIIVGEEGLWPEK-EKQLLSYTELAIKCLSKSEQDRP 328 (344)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RP 328 (344)
+... -.||+. ...+.+..+++.+.|+.+|..|-
T Consensus 271 isd~------------------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 271 ISDD------------------IEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhh------------------ccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 2211 112221 13345688999999999999994
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.1e-18 Score=144.46 Aligned_cols=144 Identities=13% Similarity=0.073 Sum_probs=111.4
Q ss_pred HHHHHHhcCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCc----------------------hhhhHhhHHHHH
Q 048160 48 QELKAATNNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNS----------------------EEYCCFNCIAFA 104 (344)
Q Consensus 48 ~~i~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~----------------------~~~~~~~E~~~l 104 (344)
.++......|...+.||+|+||.||++.. +++.||||++...... ......+|..++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 34444444577889999999999999998 7899999987543210 012256788899
Q ss_pred hcCCCCc--eeeeeeEEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeee
Q 048160 105 SQMSHKN--ILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFR 182 (344)
Q Consensus 105 ~~l~H~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 182 (344)
.++.|++ ++..++. ...++||||+++++|...... .....++.+++.++.++| ..+|+||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh---~~gi~H~ 149 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAY---KHGIIHG 149 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHH---HCCCCcC
Confidence 9998774 4555442 345899999999988765431 223568899999999999 9999999
Q ss_pred cccccceEeecCCcceEeeeecccccC
Q 048160 183 DIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 183 dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+|+||+++.++.++|+|||++....
T Consensus 150 Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 150 DLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCcccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999999986554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2e-18 Score=158.16 Aligned_cols=174 Identities=26% Similarity=0.387 Sum_probs=126.9
Q ss_pred ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeee
Q 048160 124 LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFC 203 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg 203 (344)
.+|+.|++|...+|.+++..+... ..-++.....++.|++.|++| ++.+|+|+||.||+...+..+||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~--e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG--EERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc--cccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence 478999999999999999754422 345667778899999999987 678999999999999999999999999
Q ss_pred cccccCCCCcc---cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHH
Q 048160 204 VSISIPEGKTH---VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVR 279 (344)
Q Consensus 204 ~a~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 279 (344)
+........+. ........||..||+||.+.+..|+.++||||||++++|++. -...+..
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---------------- 465 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---------------- 465 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------------
Confidence 98776554411 112235589999999999999999999999999999999987 2322211
Q ss_pred HHhccCCcccccccccccCCCCCh-hhHHHHHHHHHHHHHccccCCCCCCCHHH
Q 048160 280 KSIESNSFKEIVDPIIVGEEGLWP-EKEKQLLSYTELAIKCLSKSEQDRPTMVQ 332 (344)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 332 (344)
-..+.++-+.. +| ..-..-+.-..|+++++...|.+||++.+
T Consensus 466 ----~~t~~d~r~g~-------ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 466 ----IATLTDIRDGI-------IPPEFLQDYPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred ----HHhhhhhhcCC-------CChHHhhcCcHHHHHHHHhcCCCcccCchHHH
Confidence 11111111111 11 00011122468999999999999995444
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=2e-16 Score=127.38 Aligned_cols=135 Identities=15% Similarity=0.125 Sum_probs=112.6
Q ss_pred CCCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCC--CceeeeeeEEeeCCccEEEEeecCCCC
Q 048160 59 PEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSH--KNILKFVGCCLETELPILVFEFVACGT 136 (344)
Q Consensus 59 ~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~~~~~~~~~~~~~lv~e~~~~gs 136 (344)
+.+.||+|.++.||++..++..+++|.+..... ...+.+|+.++..++| .++++++++....+..++++||+++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 356799999999999999888999999766543 4568899999999976 589999998888788999999998877
Q ss_pred ccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 137 LADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 137 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
+..+ +......++.+++.++.++|.....+++|+|++|.||+++..+.++++|||.+..
T Consensus 80 ~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7543 3345567889999999999932225799999999999999989999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-16 Score=133.53 Aligned_cols=136 Identities=14% Similarity=0.156 Sum_probs=97.7
Q ss_pred CCccccCCCceEEEEEE-CCccEEEEEecCCCCchh--hh----------------------HhhHHHHHhcCCCC--ce
Q 048160 60 EKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEE--YC----------------------CFNCIAFASQMSHK--NI 112 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~--~~----------------------~~~E~~~l~~l~H~--ni 112 (344)
.+.||+|+||.||+|.. ++..||||.+........ .. ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998 589999998765422111 11 12455555555433 24
Q ss_pred eeeeeEEeeCCccEEEEeecCCCCcccc-ccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCC-CCeeeecccccceE
Q 048160 113 LKFVGCCLETELPILVFEFVACGTLADR-IHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFS-RPIVFRDIKPSTIL 190 (344)
Q Consensus 113 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlk~~Nil 190 (344)
++.++. ...++||||++++++... +.... . ......++.+++.++.++| . .+|+|+||||+||+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~-~~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nil 147 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------L-LEDPEELYDQILELMRKLY---REAGLVHGDLSEYNIL 147 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh------h-cccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEE
Confidence 444443 346899999998654322 22111 1 1566789999999999999 8 99999999999999
Q ss_pred eecCCcceEeeeecccccCC
Q 048160 191 FQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 191 l~~~~~~kl~dfg~a~~~~~ 210 (344)
++ ++.++++|||.+.....
T Consensus 148 i~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred EE-CCcEEEEECcccccccC
Confidence 99 89999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-16 Score=137.45 Aligned_cols=136 Identities=11% Similarity=0.088 Sum_probs=106.6
Q ss_pred CCccc-cCCCceEEEEEECCccEEEEEecCCC-------------CchhhhHhhHHHHHhcCCCCce--eeeeeEEeeCC
Q 048160 60 EKVIT-KDLLYKLYKGFLQDRPISVMKFGGNL-------------NSEEYCCFNCIAFASQMSHKNI--LKFVGCCLETE 123 (344)
Q Consensus 60 ~~~ig-~G~~g~V~~~~~~~~~vavk~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~~~~~~~~~~ 123 (344)
...|| .|+.|+||.+...+..+++|.+.... ......+.+|+.++.+++|++| +..+++.....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 46687 89999999999989999999875321 0122456789999999998775 77777654322
Q ss_pred ----ccEEEEeecCC-CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcce
Q 048160 124 ----LPILVFEFVAC-GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAK 198 (344)
Q Consensus 124 ----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 198 (344)
..++|||+++| .+|.+++... +++.. .+.+++.+|.+|| ..+|+||||||+|||++.++.++
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEE
Confidence 23599999997 6888887542 34443 3578999999999 99999999999999999989999
Q ss_pred Eeeeeccccc
Q 048160 199 FFDFCVSISI 208 (344)
Q Consensus 199 l~dfg~a~~~ 208 (344)
|+|||.+...
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999988653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.4e-17 Score=160.19 Aligned_cols=256 Identities=17% Similarity=0.196 Sum_probs=185.5
Q ss_pred cCCCCCCccccCCCceEEEEEE---CCccEEEEEecCCC--CchhhhHhhHHHHHhcCC-CCceeeeeeEEeeCCccEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL---QDRPISVMKFGGNL--NSEEYCCFNCIAFASQMS-HKNILKFVGCCLETELPILV 128 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~---~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv 128 (344)
..|.....||+|+|+.|-.... ....+|+|.+.... .........|..+-..+. |.|++.+++...+....+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 4577778899999999988777 33456666655443 122233446787888887 99999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC-cceEeeeecccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN-VAKFFDFCVSIS 207 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~dfg~a~~ 207 (344)
++|..++++...+..... ...+...+-.++.|+..++.|+|. ..++.|+|+||+|.+++..+ ..+++|||+|..
T Consensus 100 ~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988832221 124455567789999999999996 67899999999999999999 999999999988
Q ss_pred cCCCCcccccCCcccc-ccccccccccCcCC-CCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 208 IPEGKTHVNDNNKVIG-TFGFIAPEYMSTAN-CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g-~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
...............| ++.|+|||...+.. ..+..|+||.|+++.-+++|..|+.......+......+. .
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~---~---- 247 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSN---K---- 247 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccc---c----
Confidence 7662222222334567 99999999988744 4688999999999999999999987654433211111000 0
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVA 334 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~ 334 (344)
..+ ....|. .......+++.+++..+|..|.+.+++.
T Consensus 248 ---~~~------~~~~~~---~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 248 ---GRF------TQLPWN---SISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ---ccc------ccCccc---cCChhhhhcccccccCCchhcccccccc
Confidence 000 000111 2223467888899999999999987764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.5e-15 Score=138.67 Aligned_cols=246 Identities=16% Similarity=0.155 Sum_probs=181.6
Q ss_pred CCCCCcccc--CCCceEEEEEE----CCccEEEEEecCCCCchh--hhHhhHHHHHhcCC-CCceeeeeeEEeeCCccEE
Q 048160 57 YDPEKVITK--DLLYKLYKGFL----QDRPISVMKFGGNLNSEE--YCCFNCIAFASQMS-HKNILKFVGCCLETELPIL 127 (344)
Q Consensus 57 ~~~~~~ig~--G~~g~V~~~~~----~~~~vavk~~~~~~~~~~--~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~l 127 (344)
|...+.+|. |.+|.||.+.. ....+|+|+-+....... ..-.+|+....++. |+|.++.+..+..++..++
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 666788999 99999999887 567889988555444333 33457888888884 9999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHH----HHHHhhcCCCCCeeeecccccceEeecC-CcceEeee
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIAN----AVAYLHVGFSRPIVFRDIKPSTILFQEQ-NVAKFFDF 202 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~df 202 (344)
-+|+|. .+|.++..... ..++.......+.+... ||.++| +.+++|-|+||.||+...+ ..+++.||
T Consensus 196 qtE~~~-~sl~~~~~~~~----~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 196 QTELCG-ESLQSYCHTPC----NFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eecccc-chhHHhhhccc----ccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCc
Confidence 999995 78888887665 34777778888888888 999999 9999999999999999999 89999999
Q ss_pred ecccccCCCCcccc-cCC-ccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHH
Q 048160 203 CVSISIPEGKTHVN-DNN-KVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280 (344)
Q Consensus 203 g~a~~~~~~~~~~~-~~~-~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 280 (344)
|+...+........ ... ...|...|++||+. .+.++...|+|++|.++.+..++..++-....... .
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W----------~ 336 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW----------S 336 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCc----------c
Confidence 99877765442211 111 12567789999988 45668899999999999999998887654321000 0
Q ss_pred HhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 048160 281 SIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVA 334 (344)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~ 334 (344)
..+..-+. +..+ ..-...+...+.++++.+|..|+++..+.
T Consensus 337 ~~r~~~ip---~e~~----------~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 337 QLRQGYIP---LEFC----------EGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred ccccccCc---hhhh----------cCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 00000000 0000 01223455688999999999999987764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.1e-13 Score=130.52 Aligned_cols=141 Identities=15% Similarity=0.152 Sum_probs=99.5
Q ss_pred CCccccCCCceEEEEEE-CCccEEEEEecCCCCchh----------------------------------------hhHh
Q 048160 60 EKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEE----------------------------------------YCCF 98 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~----------------------------------------~~~~ 98 (344)
.+.||.|++|.||+|++ +|+.||||+......... -.+.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46799999999999999 889999999866532110 0234
Q ss_pred hHHHHHhcCC----CCceeeeeeEEe-eCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHH-HHHHhh
Q 048160 99 NCIAFASQMS----HKNILKFVGCCL-ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIAN-AVAYLH 172 (344)
Q Consensus 99 ~E~~~l~~l~----H~niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH 172 (344)
+|+..+.+++ |.+-+.+-.++. ..+..+|||||++|++|.++...... .. .+..++..++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHHH
Confidence 5665555552 333333333332 23457899999999999887643211 11 12345666655 467889
Q ss_pred cCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 173 VGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 173 ~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
..+++|+|++|.||+++.++.++++|||++...+.
T Consensus 275 ---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 ---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 89999999999999999999999999999877653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.6e-14 Score=125.44 Aligned_cols=204 Identities=24% Similarity=0.319 Sum_probs=135.8
Q ss_pred HHhcCCCCceeeeeeEEeeC-----CccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCC
Q 048160 103 FASQMSHKNILKFVGCCLET-----ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSR 177 (344)
Q Consensus 103 ~l~~l~H~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 177 (344)
-+-++-|.|||+++.++.+. ....+++|||..|+|.++|++..... ..++...-.+++.||++||.|||++ +.
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 44455699999999998753 35789999999999999998654322 2456666678999999999999966 88
Q ss_pred CeeeecccccceEeecCCcceEeeeecccccCCCCcccc-cCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc
Q 048160 178 PIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN-DNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT 256 (344)
Q Consensus 178 ~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 256 (344)
.|+|+++..+-|++..++-+|+.--.-....+....... ......+-++|.+||+=.....+..+|||+||....+|..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 999999999999999998888664322111111111110 0011234578899997666667889999999999999987
Q ss_pred CCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 048160 257 GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVA 334 (344)
Q Consensus 257 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~ 334 (344)
+..-...... .... +......+.+.... .=++++..|++..|+.||+|.+++
T Consensus 278 lEiq~tnseS----~~~~-------------ee~ia~~i~~len~---------lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 278 LEIQSTNSES----KVEV-------------EENIANVIIGLENG---------LQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred heeccCCCcc----eeeh-------------hhhhhhheeeccCc---------cccCcCcccccCCCCCCcchhhhh
Confidence 7653211110 0000 00111111111000 014678899999999999998865
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=6.7e-14 Score=130.87 Aligned_cols=257 Identities=18% Similarity=0.191 Sum_probs=185.5
Q ss_pred CCccccccHHH-HHHHhcCCCCCCccccCCCceEEEEEE---CCccEEEEEecCCCCchhhhH--hhHHHHHhcC-CCCc
Q 048160 39 YNPIQNFTAQE-LKAATNNYDPEKVITKDLLYKLYKGFL---QDRPISVMKFGGNLNSEEYCC--FNCIAFASQM-SHKN 111 (344)
Q Consensus 39 ~~~~~~~~~~~-i~~~~~~~~~~~~ig~G~~g~V~~~~~---~~~~vavk~~~~~~~~~~~~~--~~E~~~l~~l-~H~n 111 (344)
..+.++|...+ ..-...+|.....||.|.|+.|+.... ++..+++|-+.+......... +.|+.+...+ .|.+
T Consensus 248 ~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 248 LKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred cchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccc
Confidence 44555565555 444556788999999999999998776 567889988777655444443 3777777777 5999
Q ss_pred eeeeeeEEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe
Q 048160 112 ILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF 191 (344)
Q Consensus 112 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 191 (344)
++..+..|......|+-.|||.++++.....-. ..+.+..++.+..+++.++.++| +..++|+|++|.||++
T Consensus 328 ~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i 399 (524)
T KOG0601|consen 328 SVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILI 399 (524)
T ss_pred cCCCCCCccccccccCchhhhcCcchhhhhHHH-----HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceee
Confidence 999999888888888999999999887665222 35777888999999999999999 9999999999999999
Q ss_pred ecC-CcceEeeeecccccCCCCcccccCCccccccccc--cccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccC
Q 048160 192 QEQ-NVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFI--APEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFEN 268 (344)
Q Consensus 192 ~~~-~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 268 (344)
.++ +..++.|||++..+.-... ...+..++. ++.......+..+.|++|||..+.+.+++.........
T Consensus 400 ~~~~~~~~~~~~~~~t~~~~~~~------~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-- 471 (524)
T KOG0601|consen 400 SNDGFFSKLGDFGCWTRLAFSSG------VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-- 471 (524)
T ss_pred ccchhhhhccccccccccceecc------cccccccccccchhhccccccccccccccccccccccccCcccCccccc--
Confidence 886 7889999998864321111 111222333 55556667788999999999999999998865432211
Q ss_pred cchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 269 GEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
+..+ ..+..+..+ .....+..+...+..+++..||++.++...
T Consensus 472 ------------------~~~i----~~~~~p~~~---~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~ 514 (524)
T KOG0601|consen 472 ------------------SLTI----RSGDTPNLP---GLKLQLQVLLKVMINPDRKRRPSAVELSLH 514 (524)
T ss_pred ------------------ceee----ecccccCCC---chHHhhhhhhhhhcCCccccchhhhhhccc
Confidence 0000 011112222 222556778888999999999998876544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.8e-12 Score=106.83 Aligned_cols=126 Identities=17% Similarity=0.127 Sum_probs=95.7
Q ss_pred CccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCc-eeeeeeEEeeCCccEEEEeecCCCCccc
Q 048160 61 KVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKN-ILKFVGCCLETELPILVFEFVACGTLAD 139 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~~~~~~~~~~~~~lv~e~~~~gsL~~ 139 (344)
+.|+.|.++.||+++..++.|++|....... ....+.+|+.++..+.+.+ +++++++. ....++||||++|.++..
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 5688999999999999999999998655432 2234578999999886544 44565543 334689999999888764
Q ss_pred cccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCC-----eeeecccccceEeecCCcceEeeeeccc
Q 048160 140 RIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRP-----IVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 140 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
.- . ....++.+++.+|..|| ..+ ++|+|++|.||+++ ++.++++||+.+.
T Consensus 81 ~~----------~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 81 ED----------F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cc----------c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 30 0 01235678999999999 666 59999999999999 6789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=7.1e-12 Score=118.72 Aligned_cols=166 Identities=17% Similarity=0.193 Sum_probs=125.4
Q ss_pred CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHH
Q 048160 77 QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKH 156 (344)
Q Consensus 77 ~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~ 156 (344)
++.+|.|...+...........+-+..|+.++||||++++..+...+..|||+|-+. .|..+++. +....
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------l~~~~ 105 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------LGKEE 105 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------hHHHH
Confidence 677888877665544334556678999999999999999999999999999999884 67777764 33455
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcC
Q 048160 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA 236 (344)
Q Consensus 157 ~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 236 (344)
+...+.||+.||.|||+ ..+++|++|.-..|+++..|.-||++|-+....+.... .......-..|..|+.+...
T Consensus 106 v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---ccccchhhhcccChhhcCcc
Confidence 66678999999999986 88999999999999999999999999987755443221 00011122345566654332
Q ss_pred CCCcccchHHHHHHHHHHHcCCC
Q 048160 237 NCNEKSDVYSFGALLLELLTGKR 259 (344)
Q Consensus 237 ~~~~~~Di~slG~il~el~~g~~ 259 (344)
. -..|.|.||++++|++.|..
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred c--cchhhhhHHHHHHHHhCccc
Confidence 2 34699999999999999943
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.3e-11 Score=103.10 Aligned_cols=135 Identities=13% Similarity=0.124 Sum_probs=98.7
Q ss_pred CccccCCCceEEEEEEC--------CccEEEEEecCCCC----------------------chhhhHh----hHHHHHhc
Q 048160 61 KVITKDLLYKLYKGFLQ--------DRPISVMKFGGNLN----------------------SEEYCCF----NCIAFASQ 106 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~--------~~~vavk~~~~~~~----------------------~~~~~~~----~E~~~l~~ 106 (344)
..||.|.-+.||.|... +..+|||..+.... ...+.+. +|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 56899999999999863 36899997532210 1122233 89999999
Q ss_pred CC--CCceeeeeeEEeeCCccEEEEeecCCCCccc-cccCCCCCCCccccHHHHHHHHHHHHHHHHHh-hcCCCCCeeee
Q 048160 107 MS--HKNILKFVGCCLETELPILVFEFVACGTLAD-RIHDPNGSQLEPFLMKHRLKVAMEIANAVAYL-HVGFSRPIVFR 182 (344)
Q Consensus 107 l~--H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~ 182 (344)
+. .-++++.+++ ..-+|||||+.+..+.. .+.+. .++..+...+..+++.+|..+ | ..+++|+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~------~~~~~~~~~i~~~i~~~l~~l~H---~~glVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA------KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc------ccCHHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 95 4677777765 45679999997644422 22221 244456677889999999998 8 8999999
Q ss_pred cccccceEeecCCcceEeeeecccccC
Q 048160 183 DIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 183 dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||++.||+++ ++.+.++|||.+....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 9999999996 5789999999886553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.34 E-value=5.3e-12 Score=120.80 Aligned_cols=143 Identities=14% Similarity=0.148 Sum_probs=94.4
Q ss_pred CCCCCCccccCCCceEEEEEE-C-CccEEEEEecCCCCch----------------------------------hh----
Q 048160 56 NYDPEKVITKDLLYKLYKGFL-Q-DRPISVMKFGGNLNSE----------------------------------EY---- 95 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~-~-~~~vavk~~~~~~~~~----------------------------------~~---- 95 (344)
+|+. +.||+|++|.||+|++ + |+.||||+..+..... .+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4665 7899999999999999 4 8999999987652110 01
Q ss_pred --hHhhHHHHHhcCC----CCceeeeeeEEee-CCccEEEEeecCCCCcccc--ccCCCCCCCccccHHHHHHHHHHHHH
Q 048160 96 --CCFNCIAFASQMS----HKNILKFVGCCLE-TELPILVFEFVACGTLADR--IHDPNGSQLEPFLMKHRLKVAMEIAN 166 (344)
Q Consensus 96 --~~~~E~~~l~~l~----H~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~~l~~~~~~~i~~~i~~ 166 (344)
.+.+|+..+.+++ +.+.+.+-.++.+ .+..+|||||++|+++.++ +...+ .....+....+..++.|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-TDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-CCHHHHHHHHHHHHHHH---
Confidence 1335555555552 3333444343332 4567899999999999874 22221 01112222222223333
Q ss_pred HHHHhhcCCCCCeeeecccccceEeecCC----cceEeeeecccccCC
Q 048160 167 AVAYLHVGFSRPIVFRDIKPSTILFQEQN----VAKFFDFCVSISIPE 210 (344)
Q Consensus 167 ~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~dfg~a~~~~~ 210 (344)
+. ..+++|+|++|.||+++.++ .++++|||+...++.
T Consensus 276 ----if---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 ----VF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34 67899999999999999888 999999999987754
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=5.5e-11 Score=96.31 Aligned_cols=131 Identities=17% Similarity=0.200 Sum_probs=96.8
Q ss_pred CccccCCCceEEEEEECCccEEEEEe-cCCCC-ch------hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 61 KVITKDLLYKLYKGFLQDRPISVMKF-GGNLN-SE------EYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~~~~vavk~~-~~~~~-~~------~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
..+++|+-+.+|.+.+.|.++++|.= .+.-. .. ...-.+|+.++.++.--.|..-+-+..+.+...|+|||.
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 45889999999999998888777753 22211 11 133458999999986444433333445666778999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
+|..|.+.+... ...++..+-.-+.-|| ..+|+|+||.++||++.... +.++|||++..
T Consensus 82 ~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA------------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc------------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 988888888653 1345566666677899 99999999999999997665 99999999864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=5.7e-11 Score=95.86 Aligned_cols=143 Identities=15% Similarity=0.146 Sum_probs=102.5
Q ss_pred CCCccccCCCceEEEEEECCccEEEEE-ecCCCCch-------hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 59 PEKVITKDLLYKLYKGFLQDRPISVMK-FGGNLNSE-------EYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 59 ~~~~ig~G~~g~V~~~~~~~~~vavk~-~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
....|-||+-+.|+++.+.|+..+||. +.+....+ .....+|++.+.++.--.|.--.-++.+...-.|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 567889999999999999999988885 33332211 2445689999999864444333334455566679999
Q ss_pred ecCC-CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC---cceEeeeeccc
Q 048160 131 FVAC-GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN---VAKFFDFCVSI 206 (344)
Q Consensus 131 ~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~dfg~a~ 206 (344)
|.+| .++.+++...... .....-...++..+-..+.-|| .++|+|+||..+||++..++ .+.++|||++.
T Consensus 91 ~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred eccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 9985 3777777544321 1112222677888888899999 99999999999999997655 45799999985
Q ss_pred c
Q 048160 207 S 207 (344)
Q Consensus 207 ~ 207 (344)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.9e-10 Score=98.85 Aligned_cols=141 Identities=16% Similarity=0.166 Sum_probs=108.5
Q ss_pred CccccCCCceEEEEEECC-ccEEEEEecCCCC-chhhhHhhHHHHHhcCCC--CceeeeeeEEeeCC---ccEEEEeecC
Q 048160 61 KVITKDLLYKLYKGFLQD-RPISVMKFGGNLN-SEEYCCFNCIAFASQMSH--KNILKFVGCCLETE---LPILVFEFVA 133 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~~-~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H--~niv~~~~~~~~~~---~~~lv~e~~~ 133 (344)
+.|+.|.++.||++...+ ..+++|....... .....+.+|+.+++.+++ .++++++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 568999999999999855 8899998655432 134567899999999975 45677888776542 5689999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVG--------------------------------------- 174 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------------------------------------- 174 (344)
|.++.+.+.. ..++......++.+++.+|..||+.
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9888876532 1366777778888888888888831
Q ss_pred --------------CCCCeeeecccccceEeec--CCcceEeeeecccc
Q 048160 175 --------------FSRPIVFRDIKPSTILFQE--QNVAKFFDFCVSIS 207 (344)
Q Consensus 175 --------------~~~~ivH~dlk~~Nill~~--~~~~kl~dfg~a~~ 207 (344)
....++|+|+.+.||+++. ++.+.++||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1256799999999999988 56789999987754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=5.2e-12 Score=124.60 Aligned_cols=249 Identities=16% Similarity=0.172 Sum_probs=168.2
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCC---CCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGN---LNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
..+.|.+.+-+.+|.++.++.+.- .+...+.+..... .....+...++-.++-..+||-++...-.+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 446677778888999999998776 3323333322111 11112233333333333455666665555566778899
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
|++|..+++|...++..+ +....-....+..+..++++|| ...+.|+|++|.|.+...++..++.|||....
T Consensus 882 ~~~~~~~~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG-----CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred hhHHhccCCchhhhhcCC-----CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccc
Confidence 999999999999887765 3445555667788899999999 88899999999999999999999999983332
Q ss_pred cCC------C--C-------------c---c----cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCC
Q 048160 208 IPE------G--K-------------T---H----VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKR 259 (344)
Q Consensus 208 ~~~------~--~-------------~---~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 259 (344)
... . . . . ........+|+.|.+||...+......+|+|++|++++|.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 210 0 0 0 0 011224578999999999999988999999999999999999999
Q ss_pred CCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhH-HHHHHHHHHHHHccccCCCCCCCHH
Q 048160 260 ISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKE-KQLLSYTELAIKCLSKSEQDRPTMV 331 (344)
Q Consensus 260 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~ 331 (344)
||..... +..++.++. ....||..+ .......+++...+..+|.+|..+.
T Consensus 1034 p~na~tp---------------------q~~f~ni~~-~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETP---------------------QQIFENILN-RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCcch---------------------hhhhhcccc-CCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9865321 112221221 222333322 3344567888888999999997654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=9.9e-10 Score=96.77 Aligned_cols=141 Identities=13% Similarity=0.006 Sum_probs=103.1
Q ss_pred CCccccCCCceEEEEEECCccEEEEEecCCCCc-----------hhhhHhhHHHHHhcCCCC--ceeeeeeEEee-----
Q 048160 60 EKVITKDLLYKLYKGFLQDRPISVMKFGGNLNS-----------EEYCCFNCIAFASQMSHK--NILKFVGCCLE----- 121 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~-----------~~~~~~~E~~~l~~l~H~--niv~~~~~~~~----- 121 (344)
.+.+-......|.++.++|+.+.||+....... ....+.+|...+.++.-. .++..+++...
T Consensus 27 ~e~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 27 GEVFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred CcEEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 355555555667888889999999987544311 111367899999888533 34455666543
Q ss_pred CCccEEEEeecCCC-CccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec-------
Q 048160 122 TELPILVFEFVACG-TLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE------- 193 (344)
Q Consensus 122 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~------- 193 (344)
....+||+|++++. +|.+++..... .+.....+..++.+++..+.-|| ..+|+|+|+++.|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCC
Confidence 23468999999875 78888753211 13455667789999999999999 999999999999999985
Q ss_pred CCcceEeeeeccc
Q 048160 194 QNVAKFFDFCVSI 206 (344)
Q Consensus 194 ~~~~kl~dfg~a~ 206 (344)
+..+.++||+.+.
T Consensus 181 ~~~~~LIDl~r~~ 193 (268)
T PRK15123 181 DLKLSVIDLHRAQ 193 (268)
T ss_pred CceEEEEECCccc
Confidence 4688999998774
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.3e-09 Score=89.20 Aligned_cols=125 Identities=14% Similarity=0.159 Sum_probs=80.5
Q ss_pred eEEEEEE-CCccEEEEEecCCCC---------------------ch-----hhhHhhHHHHHhcCCCC--ceeeeeeEEe
Q 048160 70 KLYKGFL-QDRPISVMKFGGNLN---------------------SE-----EYCCFNCIAFASQMSHK--NILKFVGCCL 120 (344)
Q Consensus 70 ~V~~~~~-~~~~vavk~~~~~~~---------------------~~-----~~~~~~E~~~l~~l~H~--niv~~~~~~~ 120 (344)
.||.|.. ++..+|+|....... .. .....+|.+.|.++..- ++++.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899998 788999997543211 00 12345899999999754 677877653
Q ss_pred eCCccEEEEeecC--CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHH-hhcCCCCCeeeecccccceEeecCCcc
Q 048160 121 ETELPILVFEFVA--CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAY-LHVGFSRPIVFRDIKPSTILFQEQNVA 197 (344)
Q Consensus 121 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~dlk~~Nill~~~~~~ 197 (344)
.-+|||||++ |..+..+... .+.......++.+++..+.. +| ..+|+|+||.+.||+++.+ .+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-------~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-------DLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-------GGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-------cccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eE
Confidence 4479999998 5455443322 12233455677777775444 58 9999999999999999877 89
Q ss_pred eEeeeecccccC
Q 048160 198 KFFDFCVSISIP 209 (344)
Q Consensus 198 kl~dfg~a~~~~ 209 (344)
.++|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.04 E-value=6.1e-09 Score=96.40 Aligned_cols=169 Identities=17% Similarity=0.196 Sum_probs=124.5
Q ss_pred CceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEe----eCCccEEEEeecCC-CCcccc
Q 048160 68 LYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCL----ETELPILVFEFVAC-GTLADR 140 (344)
Q Consensus 68 ~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~----~~~~~~lv~e~~~~-gsL~~~ 140 (344)
-.+.|++.. +|..|+.|++.............-+++++++.|+|+|.+..++. .+..+++|++|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 356899988 89999999995443333333345688999999999999999876 34578999999874 567664
Q ss_pred ccCCCCC----------CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 141 IHDPNGS----------QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 141 l~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
--..... .-...+++..+.++.|+..||.++| +.|+.-+-|.+.+|+++.+.+++++.-|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 3221110 1135778889999999999999999 99999999999999999888888877666544432
Q ss_pred CCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCC
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKR 259 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 259 (344)
+.. +-+.+ -++-|.-.||.++..|.||..
T Consensus 446 d~~-----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPT-----------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC-----------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 220 00101 245788899999999999964
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=4.5e-08 Score=88.74 Aligned_cols=271 Identities=14% Similarity=0.094 Sum_probs=158.1
Q ss_pred CCCCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcC-CCCceeeeeeEE------eeCC-ccEEEE
Q 048160 58 DPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQM-SHKNILKFVGCC------LETE-LPILVF 129 (344)
Q Consensus 58 ~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~------~~~~-~~~lv~ 129 (344)
....-||+|+-+.+|..---+ ..+.|+.......... +-+..|.+. .||-+-.=+.|= -..+ ...+.|
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~-d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR-DQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCCccccCCccceeeecchhh-chhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 345779999999999644322 2334555444221111 223344444 455433211110 0111 234566
Q ss_pred eecCCC-Ccccccc-CCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 130 EFVACG-TLADRIH-DPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 130 e~~~~g-sL~~~l~-~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
....+. .+..++. ....++.....|.-.+..++.++.+..-|| ..|.+-+|+.++|+|+++++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceee
Confidence 665543 1222221 112234456788889999999999999999 99999999999999999999999998433222
Q ss_pred cCCCCcccccCCccccccccccccccC-----cCCCCcccchHHHHHHHHHHHcC-CCCCCCCCccCcchhHHHHHHHHH
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMS-----TANCNEKSDVYSFGALLLELLTG-KRISYSSCFENGEEYFLQELVRKS 281 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~ 281 (344)
...+.... ..+|...|.+||.-. +..-+...|.|.||+++++++.| +.||.+...-.....-+..-+.
T Consensus 167 ~~ng~~~~----cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia-- 240 (637)
T COG4248 167 NANGTLHL----CPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA-- 240 (637)
T ss_pred ccCCceEe----cccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh--
Confidence 11111111 357889999999754 34457789999999999999876 7777654321111111100000
Q ss_pred hccCCccccccc--ccccCCCCChhhHHHHHHHHHHHHHcccc--CCCCCCCHHHHHHHHHHHHhhC
Q 048160 282 IESNSFKEIVDP--IIVGEEGLWPEKEKQLLSYTELAIKCLSK--SEQDRPTMVQVAKQLRQLHKSI 344 (344)
Q Consensus 282 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--dP~~RPs~~ei~~~L~~l~~~l 344 (344)
.+.+...-++ -.......||- .-.++++..+..+|+.. ++.-|||++.-+..|..+..+|
T Consensus 241 --~g~f~ya~~~~~g~~p~P~~~P~-~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 241 --HGRFAYASDQRRGLKPPPRSIPL-SMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred --cceeeechhccCCCCCCCCCCCh-hhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 0111111111 01111122222 24456788899999986 3678999999888888877654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.9e-08 Score=84.62 Aligned_cols=133 Identities=14% Similarity=0.070 Sum_probs=94.6
Q ss_pred CCCCCccccCCCceEEEEEE-CCccEEEEEecCC--------------------C--CchhhhHhhHHHHHhcCCCC--c
Q 048160 57 YDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGN--------------------L--NSEEYCCFNCIAFASQMSHK--N 111 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~--------------------~--~~~~~~~~~E~~~l~~l~H~--n 111 (344)
..+...||-|.-+.||.|.. .|.++|||.=... + .-......+|..+|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34568899999999999999 7999999942111 0 01123456999999999754 7
Q ss_pred eeeeeeEEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe
Q 048160 112 ILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF 191 (344)
Q Consensus 112 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 191 (344)
+++.+++ +.-.+||||.+|-.|...- +.....-.++..|+.-+.-+- ..|+||+|+++-||++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV 235 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILV 235 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEE
Confidence 7777764 3456999999876665432 112233344555555555555 6899999999999999
Q ss_pred ecCCcceEeeeeccc
Q 048160 192 QEQNVAKFFDFCVSI 206 (344)
Q Consensus 192 ~~~~~~kl~dfg~a~ 206 (344)
+.+|.+.++||--+.
T Consensus 236 ~~dg~~~vIDwPQ~v 250 (304)
T COG0478 236 TEDGDIVVIDWPQAV 250 (304)
T ss_pred ecCCCEEEEeCcccc
Confidence 999999999995543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=2e-07 Score=78.24 Aligned_cols=155 Identities=15% Similarity=0.040 Sum_probs=112.1
Q ss_pred cHHHHHHHhcCCCCCCccccCCCceEEEEEECCccEEEEEecCCC------CchhhhHhhHHHHHhcCCC--Cceeeeee
Q 048160 46 TAQELKAATNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNL------NSEEYCCFNCIAFASQMSH--KNILKFVG 117 (344)
Q Consensus 46 ~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~------~~~~~~~~~E~~~l~~l~H--~niv~~~~ 117 (344)
+++.+-....++...---|.||-+-|++..+.|..+-+|+-.... ......|.+|...+.++.. -.+++.+.
T Consensus 9 ~f~~~w~~~~~wve~pN~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf 88 (216)
T PRK09902 9 EFNHWWATEGDWVEEPNYRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVF 88 (216)
T ss_pred hHHHHHhCCCceecCCCcCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccce
Confidence 344444444445545556779999999999988889999854221 2345789999999999953 33555552
Q ss_pred EEee----CCccEEEEeecCC-CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEee
Q 048160 118 CCLE----TELPILVFEFVAC-GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ 192 (344)
Q Consensus 118 ~~~~----~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 192 (344)
.... ....+||+|-+.+ .||.+++....- .+.+...+..++.+++..+.-|| ..++.|+|+.+.||+++
T Consensus 89 ~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~---~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~ 162 (216)
T PRK09902 89 GEAVKIEGEWRALLVTEDMAGFISIADWYAQHAV---SPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVK 162 (216)
T ss_pred eeeeccCCceEEEEEEEeCCCCccHHHHHhcCCc---CCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeec
Confidence 2222 1246799997753 488888755321 24567778899999999999999 99999999999999998
Q ss_pred cCCc--ceEeeeeccc
Q 048160 193 EQNV--AKFFDFCVSI 206 (344)
Q Consensus 193 ~~~~--~kl~dfg~a~ 206 (344)
.++. +.++||--++
T Consensus 163 ~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 163 TEGKAEAGFLDLEKSR 178 (216)
T ss_pred CCCCeeEEEEEhhccc
Confidence 7776 8999996544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=4.2e-08 Score=83.49 Aligned_cols=106 Identities=16% Similarity=0.082 Sum_probs=83.4
Q ss_pred hhHhhHHHHHhcCC--CCceeeeeeEEeeCC----ccEEEEeecCCC-CccccccCCCCCCCccccHHHHHHHHHHHHHH
Q 048160 95 YCCFNCIAFASQMS--HKNILKFVGCCLETE----LPILVFEFVACG-TLADRIHDPNGSQLEPFLMKHRLKVAMEIANA 167 (344)
Q Consensus 95 ~~~~~E~~~l~~l~--H~niv~~~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~ 167 (344)
....+|...+..+. .=.+++.+++..... ..++|+|++++. +|.+++.... ..+......++.+++..
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALARL 130 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHHH
Confidence 45678888888885 334567777766532 458999999874 7888887532 24556678899999999
Q ss_pred HHHhhcCCCCCeeeecccccceEeecCC---cceEeeeeccccc
Q 048160 168 VAYLHVGFSRPIVFRDIKPSTILFQEQN---VAKFFDFCVSISI 208 (344)
Q Consensus 168 l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~dfg~a~~~ 208 (344)
+.-|| ..+|+|+|+++.|||++.+. .+.++||+-++..
T Consensus 131 i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 99999999999999999887 8999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=4.1e-09 Score=100.69 Aligned_cols=153 Identities=22% Similarity=0.291 Sum_probs=102.0
Q ss_pred HHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcccc------cCCcccccccccccccc
Q 048160 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN------DNNKVIGTFGFIAPEYM 233 (344)
Q Consensus 160 i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~------~~~~~~g~~~y~aPE~~ 233 (344)
=+.++++|+.|+|. +.++||++|.|++|.++..+..|++.|+.+........... -.-.......|.|||++
T Consensus 104 nl~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 104 NLGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 34556699999996 88999999999999999999999999987765544211100 00011235679999999
Q ss_pred CcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHH
Q 048160 234 STANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSY 312 (344)
Q Consensus 234 ~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 312 (344)
.+...+.++|+||+|+++|-+.. |+..+.... .....+.... ..+....+.. ...+.++
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~-----~~~~~~~~~~---------~~~~~~~~~s------~~~p~el 241 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANG-----GLLSYSFSRN---------LLNAGAFGYS------NNLPSEL 241 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhccC-----Ccchhhhhhc---------cccccccccc------ccCcHHH
Confidence 88888899999999999999984 444332211 0011111000 0111111110 1455678
Q ss_pred HHHHHHccccCCCCCCCHHHHH
Q 048160 313 TELAIKCLSKSEQDRPTMVQVA 334 (344)
Q Consensus 313 ~~l~~~cl~~dP~~RPs~~ei~ 334 (344)
++=+.+.+..++..||++.++.
T Consensus 242 ~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 242 RESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred HHHHHHHhcCCcccCcchhhhh
Confidence 8999999999999999776654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.3e-06 Score=75.37 Aligned_cols=133 Identities=8% Similarity=0.017 Sum_probs=85.3
Q ss_pred CccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCCC--ceeeeeeEEeeCCccEEEEeecCCCC-c
Q 048160 61 KVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHK--NILKFVGCCLETELPILVFEFVACGT-L 137 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~~~~~~~~~~~~~lv~e~~~~gs-L 137 (344)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..- .+++++++...+....+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 56899999999984 35567888765432 334568899999998643 35788888877777889999998753 2
Q ss_pred cccccCCCCCCCccccHHHHHHHHHHHHHHH---------------------------------------HHhh-cCCCC
Q 048160 138 ADRIHDPNGSQLEPFLMKHRLKVAMEIANAV---------------------------------------AYLH-VGFSR 177 (344)
Q Consensus 138 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l---------------------------------------~~LH-~~~~~ 177 (344)
...+... ......++..++..+ .+|. .....
T Consensus 83 ~~~~~~~---------~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~ 153 (226)
T TIGR02172 83 SRIISDN---------PSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS 153 (226)
T ss_pred hhhhcCC---------HHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence 2111110 000001111111111 1111 01144
Q ss_pred CeeeecccccceEeecCCcceEeeeecccc
Q 048160 178 PIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 178 ~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
.++|+|+.|.||+++.++ +.++||+.+..
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 668999999999999888 99999987743
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.1e-06 Score=84.15 Aligned_cols=140 Identities=14% Similarity=0.132 Sum_probs=91.4
Q ss_pred CCccccCCCceEEEEEE-CCccEEEEEecCCCCch----------------------------------------hhhHh
Q 048160 60 EKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSE----------------------------------------EYCCF 98 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~----------------------------------------~~~~~ 98 (344)
..-|+.++-|-||+|++ +|+.||||+..++.... .-.+.
T Consensus 130 ~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 130 PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 46789999999999999 69999999865542211 00123
Q ss_pred hHHHHHhcCC----CCceeeeeeEE-eeCCccEEEEeecCCCCcccc--ccCCCCCCCccccHHHHHHHHHHHHHH-HHH
Q 048160 99 NCIAFASQMS----HKNILKFVGCC-LETELPILVFEFVACGTLADR--IHDPNGSQLEPFLMKHRLKVAMEIANA-VAY 170 (344)
Q Consensus 99 ~E~~~l~~l~----H~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~~l~~~~~~~i~~~i~~~-l~~ 170 (344)
+|+..+.+++ +..=+.+-.++ .-.+...|+|||++|..+.+. ++..+ .+... ++.-++.+ +..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g------~d~k~---ia~~~~~~f~~q 280 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG------IDRKE---LAELLVRAFLRQ 280 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC------CCHHH---HHHHHHHHHHHH
Confidence 5555555552 11122222222 224567899999999999987 44422 33222 22222221 222
Q ss_pred hhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 171 LHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 171 LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+- ..+++|.|..|.||+++.++.+.+.|||+....+..
T Consensus 281 ~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 281 LL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HH---hcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 33 568999999999999999999999999998877543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.8e-06 Score=73.69 Aligned_cols=152 Identities=14% Similarity=0.126 Sum_probs=98.7
Q ss_pred ccHHHHHHHhcCCCCCCc---cccCCCceEEEEEE-CCccEEEEEecCCCCch-------------------h-----hh
Q 048160 45 FTAQELKAATNNYDPEKV---ITKDLLYKLYKGFL-QDRPISVMKFGGNLNSE-------------------E-----YC 96 (344)
Q Consensus 45 ~~~~~i~~~~~~~~~~~~---ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~-------------------~-----~~ 96 (344)
.+...+........+... |++|.-+.||+|.. ++..+|||++....... . ..
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 455566666555555444 55666778999987 78899999875432111 1 11
Q ss_pred HhhHHHHHhcCC--CCceeeeeeEEeeCCccEEEEeecCCC-CccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhc
Q 048160 97 CFNCIAFASQMS--HKNILKFVGCCLETELPILVFEFVACG-TLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHV 173 (344)
Q Consensus 97 ~~~E~~~l~~l~--H~niv~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~ 173 (344)
..+|...|.++. +-.+++-+++. .-.|||||+... .-.-.|+.. ++.......+..+++.++.-|-.
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv------~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV------PLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC------CcCchhHHHHHHHHHHHHHHHHH
Confidence 236777777763 44445545443 336999998532 222233322 23333566677788888777762
Q ss_pred CCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 174 GFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 174 ~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
..++||+||+.-|||+. ++.+.++|||-|....
T Consensus 185 --~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 --EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 48999999999999998 8899999999886544
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=9.3e-07 Score=71.48 Aligned_cols=128 Identities=12% Similarity=0.061 Sum_probs=90.0
Q ss_pred CCCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCce-eeeeeEEeeCCccEEEEeecCCCCc
Q 048160 59 PEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNI-LKFVGCCLETELPILVFEFVACGTL 137 (344)
Q Consensus 59 ~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~~~gsL 137 (344)
....|++|++|.||+|.|.+..+|+|+=..+ +....+..|++++..++-.++ .+++.+..+. +.|||..|.+|
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeeccCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechhh----hhhhhhcCcch
Confidence 4577999999999999999999999985554 356789999999999986655 4566654332 55999998788
Q ss_pred cccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccc-ccceEeecCCcceEeeeecccc
Q 048160 138 ADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIK-PSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 138 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk-~~Nill~~~~~~kl~dfg~a~~ 207 (344)
.+..... ...+ +..++..---|- ..+|-|+.|. |...++..+..+.|+||..|+.
T Consensus 100 ~~~~~~~--------~rk~----l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIGG--------DRKH----LLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcc--------cHHH----HHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 7655421 1122 223333333333 7888898886 4445555566999999988763
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.4e-06 Score=73.56 Aligned_cols=137 Identities=15% Similarity=0.080 Sum_probs=91.7
Q ss_pred hcCCCCCCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHh---------hHHHHHhcCCCCc---eeeeeeEEee
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCF---------NCIAFASQMSHKN---ILKFVGCCLE 121 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~---------~E~~~l~~l~H~n---iv~~~~~~~~ 121 (344)
.++|...+.+-......|.+-..+++.+++|..........+.|. +++..+.+++..+ ...++.+...
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 456777777777667778888889999999987765433322221 3333344443322 2232333222
Q ss_pred -----CCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCc
Q 048160 122 -----TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNV 196 (344)
Q Consensus 122 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 196 (344)
....+++|||++|..|.+... +++ .++..++.++.-|| ..|++|+|..|.|+++..+ .
T Consensus 110 k~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 110 KIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-c
Confidence 234568999999988876542 222 24456778899999 9999999999999999855 4
Q ss_pred ceEeeeecccc
Q 048160 197 AKFFDFCVSIS 207 (344)
Q Consensus 197 ~kl~dfg~a~~ 207 (344)
++++||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999977643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.3e-05 Score=67.01 Aligned_cols=104 Identities=18% Similarity=0.229 Sum_probs=81.2
Q ss_pred hHHHHHhcCCC-CceeeeeeEEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCC
Q 048160 99 NCIAFASQMSH-KNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSR 177 (344)
Q Consensus 99 ~E~~~l~~l~H-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 177 (344)
.|.-+++.+++ +++++++|+|-. ++|+||...+++...-.. -. ....-+|..+..|+.+++..+.+++++...
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~-l~-~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRP-LS-QFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccc-cc-cccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 57888899976 699999999933 579999987766432000 00 001357899999999999999999966556
Q ss_pred CeeeecccccceEeecCCcceEeeeeccccc
Q 048160 178 PIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 178 ~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
.+.-.|++++|+-+++++.+|++|.......
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 7888999999999999999999999776544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=7.3e-08 Score=91.52 Aligned_cols=180 Identities=17% Similarity=0.143 Sum_probs=129.0
Q ss_pred CccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCc-eeeeeeEEeeCCccEEEEeecCCC-Cc
Q 048160 61 KVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKN-ILKFVGCCLETELPILVFEFVACG-TL 137 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~~~~~~~~~~~~~lv~e~~~~g-sL 137 (344)
+-+++|+++.+++.+. ..+....+.+... ....-++++|.+++||| .+..++-+..++..+++++++.++ +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 4467889999998887 3333334443322 34456789999999999 777777777788899999999876 33
Q ss_pred cccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCccccc
Q 048160 138 ADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217 (344)
Q Consensus 138 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~ 217 (344)
........ ..+..-+...+.+.-+++++++| +..=+|+| ||+..+ +..+..||+....++... .
T Consensus 323 ~~~~~~se----~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~----~ 386 (829)
T KOG0576|consen 323 ALEMTVSE----IALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM----K 386 (829)
T ss_pred cccCChhh----Hhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc----c
Confidence 32222111 12333444556677778899999 66667888 666644 678999999887766543 2
Q ss_pred CCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCC
Q 048160 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRIS 261 (344)
Q Consensus 218 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~ 261 (344)
.+...+++.++|||+...+.+..+.|.|++|.--.++.-|..|-
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 33568899999999999999999999999998777777776654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.9e-06 Score=69.40 Aligned_cols=134 Identities=19% Similarity=0.203 Sum_probs=94.4
Q ss_pred CCCCccccCCCceEEEEEECCccEEEEEecCCC----------------CchhhhHhhHHHHHhcCC------CCceeee
Q 048160 58 DPEKVITKDLLYKLYKGFLQDRPISVMKFGGNL----------------NSEEYCCFNCIAFASQMS------HKNILKF 115 (344)
Q Consensus 58 ~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~~ 115 (344)
+....||+|+.-.||.-- ++...+||++.... ....++..+|+.....+. +.+|.++
T Consensus 4 ~~~~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCCcccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 345789999999888532 55667888877665 223466778887777776 7889999
Q ss_pred eeEEeeCCccEEEEeecCC------CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccce
Q 048160 116 VGCCLETELPILVFEFVAC------GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTI 189 (344)
Q Consensus 116 ~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 189 (344)
+|+..++--..+|+|...+ .+|.+++... .++. .....+.++ .+||- ..+|+.+|++|.||
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~------~~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~~NI 149 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG------GLTE-ELRQALDEF---KRYLL---DHHIVIRDLNPHNI 149 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC------CccH-HHHHHHHHH---HHHHH---HcCCeecCCCcccE
Confidence 9999998888899998542 3566777543 2444 344444444 44555 78899999999999
Q ss_pred EeecCC----cceEee-eecc
Q 048160 190 LFQEQN----VAKFFD-FCVS 205 (344)
Q Consensus 190 ll~~~~----~~kl~d-fg~a 205 (344)
++..+. .+.++| ||..
T Consensus 150 v~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 150 VVQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EEEecCCCceEEEEEeCCCCc
Confidence 996443 577777 4544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.32 E-value=6.9e-06 Score=71.77 Aligned_cols=75 Identities=8% Similarity=-0.074 Sum_probs=54.2
Q ss_pred cccCCC-ceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCC-CCceeeeeeEEeeCCccEEEEeecCCCCcccc
Q 048160 63 ITKDLL-YKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCCLETELPILVFEFVACGTLADR 140 (344)
Q Consensus 63 ig~G~~-g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~ 140 (344)
|..|.. ..||+....+..+++|...... .....+|+.++..+. +--+++++++...++..++|||+++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 444544 6799998877778888765442 334668898888884 44577888887766678999999998777643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.1e-05 Score=69.65 Aligned_cols=77 Identities=12% Similarity=0.178 Sum_probs=56.3
Q ss_pred CccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCCC--ceeeeeeEEeeC---CccEEEEeecCCC
Q 048160 61 KVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHK--NILKFVGCCLET---ELPILVFEFVACG 135 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~~~~~~~~~---~~~~lv~e~~~~g 135 (344)
+.++.|..+.||+....++.+++|..... .....+.+|+.+++.+... .+++++.+.... ...+++|++++|.
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 45888999999999997789999986554 3456677899998888532 466777755333 3468999999987
Q ss_pred Cccc
Q 048160 136 TLAD 139 (344)
Q Consensus 136 sL~~ 139 (344)
++..
T Consensus 81 ~~~~ 84 (239)
T PF01636_consen 81 PLDD 84 (239)
T ss_dssp EHHH
T ss_pred cccc
Confidence 7766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.14 E-value=9.6e-06 Score=82.33 Aligned_cols=195 Identities=18% Similarity=0.203 Sum_probs=132.5
Q ss_pred HhhHHHHHhcCCCCceeeeeeEEeeCCc----cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhh
Q 048160 97 CFNCIAFASQMSHKNILKFVGCCLETEL----PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLH 172 (344)
Q Consensus 97 ~~~E~~~l~~l~H~niv~~~~~~~~~~~----~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH 172 (344)
..-|...+.++.|+|++.+++|...... ..+..++|..-++.+.++.-+ ..+..+.+.+..++..||.|+|
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~-----~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG-----SIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc-----ccCHHHHHHHHHHHhhhHHHHH
Confidence 4467788999999999999999876432 235567888888888887654 6788899999999999999999
Q ss_pred cCCCCCeeeeccccc---ceEeecCCcceEe--eeecccccCCCCcccccCCccccccccccccccCcCCCC--cccchH
Q 048160 173 VGFSRPIVFRDIKPS---TILFQEQNVAKFF--DFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCN--EKSDVY 245 (344)
Q Consensus 173 ~~~~~~ivH~dlk~~---Nill~~~~~~kl~--dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~--~~~Di~ 245 (344)
+....|.-+... +--.+..+....+ ||+.+.......... ....+..+.++|......+. ...|+|
T Consensus 304 ---~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~----~~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 304 ---SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF----SDLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred ---HhccceeEEecccccccccCccceeecchhhhcccccCCCcccch----hhcCccccccccccccccchhhhhhHHH
Confidence 665555555444 3333444555555 777776655433222 22335567788877665554 447999
Q ss_pred HHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCC
Q 048160 246 SFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQ 325 (344)
Q Consensus 246 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 325 (344)
.+|.....+..+..+.... .....+++. .....+.+....|+..+++
T Consensus 377 ~lgll~~~~~~~~~i~~~~--------------------~~~~~~l~~-------------~~~~~~~d~~~~~~~~~~~ 423 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISEKS--------------------AVPVSLLDV-------------LSTSELLDALPKCLDEDSE 423 (1351)
T ss_pred HHHHHHhhhhhcCcccccc--------------------cchhhhhcc-------------ccchhhhhhhhhhcchhhh
Confidence 9999999998887653211 001111111 1111456788899999999
Q ss_pred CCCCHHHHHHH
Q 048160 326 DRPTMVQVAKQ 336 (344)
Q Consensus 326 ~RPs~~ei~~~ 336 (344)
+|+++.+++..
T Consensus 424 ~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 424 ERLSALELLTH 434 (1351)
T ss_pred hccchhhhhhc
Confidence 99999998764
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.12 E-value=4.8e-05 Score=78.05 Aligned_cols=79 Identities=6% Similarity=0.033 Sum_probs=56.8
Q ss_pred CCccccCCCceEEEEEECC----ccEEEEEecCCCC-chhhhHhhHHHHHhcCC-CCce--eeeeeEEeeC---CccEEE
Q 048160 60 EKVITKDLLYKLYKGFLQD----RPISVMKFGGNLN-SEEYCCFNCIAFASQMS-HKNI--LKFVGCCLET---ELPILV 128 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~~~----~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~-H~ni--v~~~~~~~~~---~~~~lv 128 (344)
...++.|.+..+|+....+ ..+++|+...... .....+.+|+.+++.+. |.++ ++++++|.+. ...++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 4567889999999988743 3677777543321 22346779999999995 6665 8888888764 467899
Q ss_pred EeecCCCCcc
Q 048160 129 FEFVACGTLA 138 (344)
Q Consensus 129 ~e~~~~gsL~ 138 (344)
|||++|..+.
T Consensus 123 ME~v~G~~~~ 132 (822)
T PLN02876 123 MEYLEGRIFV 132 (822)
T ss_pred EEecCCcccC
Confidence 9999876543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.04 E-value=2.6e-05 Score=74.57 Aligned_cols=156 Identities=16% Similarity=0.119 Sum_probs=97.3
Q ss_pred ccccccHHHHHHHh------------cCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCch--------------
Q 048160 41 PIQNFTAQELKAAT------------NNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSE-------------- 93 (344)
Q Consensus 41 ~~~~~~~~~i~~~~------------~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~-------------- 93 (344)
.++.++.+|+.... ..|+ .+.||.-+.|-||+|+. +|..||||+=+++....
T Consensus 136 ~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~ 214 (538)
T KOG1235|consen 136 QAPPFPWEEAFKIFEEELGAPIEDIFSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKV 214 (538)
T ss_pred cCCCCCHHHHHHHHHHHhCCCHHHHHHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHH
Confidence 45666777754432 2233 56799999999999999 78889999744432211
Q ss_pred -----------------------hhhHhhHHHHHhcC----CCCc------eeeeeeEEeeCCccEEEEeecCCCCcccc
Q 048160 94 -----------------------EYCCFNCIAFASQM----SHKN------ILKFVGCCLETELPILVFEFVACGTLADR 140 (344)
Q Consensus 94 -----------------------~~~~~~E~~~l~~l----~H~n------iv~~~~~~~~~~~~~lv~e~~~~gsL~~~ 140 (344)
.=.|.+|++-..+. .|-+ |++++-.+ .+...|+||||+|..+.+.
T Consensus 215 l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl 292 (538)
T KOG1235|consen 215 LQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDL 292 (538)
T ss_pred HHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCH
Confidence 01133444433333 3444 44444322 3467899999999988875
Q ss_pred --ccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec----CCcceEeeeecccccCC
Q 048160 141 --IHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE----QNVAKFFDFCVSISIPE 210 (344)
Q Consensus 141 --l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~dfg~a~~~~~ 210 (344)
+.+.+ ++...+..-+.++..-.- - ..|++|+|=.|.||++.. ++.+.+.|||+......
T Consensus 293 ~~i~~~g------i~~~~i~~~l~~~~~~qI--f---~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 293 DAIDKRG------ISPHDILNKLVEAYLEQI--F---KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHcC------CCHHHHHHHHHHHHHHHH--H---hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 33332 444433333333222222 2 557999999999999984 66899999999876643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.99 E-value=6.5e-05 Score=62.80 Aligned_cols=125 Identities=18% Similarity=0.177 Sum_probs=88.9
Q ss_pred cCCCCCCccccCCC-ceEEEEEECCccEEEEEecC---CCC------------------chhhhHhhHHHHHhcCC---C
Q 048160 55 NNYDPEKVITKDLL-YKLYKGFLQDRPISVMKFGG---NLN------------------SEEYCCFNCIAFASQMS---H 109 (344)
Q Consensus 55 ~~~~~~~~ig~G~~-g~V~~~~~~~~~vavk~~~~---~~~------------------~~~~~~~~E~~~l~~l~---H 109 (344)
.+++..+.||.|.- |.||+++.+|+.+|+|.+.. ... ...+.|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67888899999999 99999999999999999321 100 11234678999888885 4
Q ss_pred Cce--eeeeeEEeeC------------------CccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHH
Q 048160 110 KNI--LKFVGCCLET------------------ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVA 169 (344)
Q Consensus 110 ~ni--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~ 169 (344)
.++ |+++||..=. ....||.||.+... .+.. .-+.+|.+-+.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~~----~~~~~~~~dl~ 178 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQI----RDIPQMLRDLK 178 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccch----hHHHHHHHHHH
Confidence 455 9999997422 11246666654321 1222 23556777788
Q ss_pred HhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 170 YLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 170 ~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
.+| ..+|+-+|+++.|.. .-+|+|||.+
T Consensus 179 ~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 899 999999999999985 3578899754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00014 Score=63.21 Aligned_cols=74 Identities=8% Similarity=-0.001 Sum_probs=46.8
Q ss_pred CccccCCCc-eEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCCC---ceeeeeeEEeeC---CccEEEEeecC
Q 048160 61 KVITKDLLY-KLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHK---NILKFVGCCLET---ELPILVFEFVA 133 (344)
Q Consensus 61 ~~ig~G~~g-~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~~~~~~~~~---~~~~lv~e~~~ 133 (344)
..|+.|+.. .||+. +..+++|..... .....+.+|..++..+... -++++++..... ...+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 457767666 48875 345777764432 2345678899999888532 355555544332 23478999999
Q ss_pred CCCccc
Q 048160 134 CGTLAD 139 (344)
Q Consensus 134 ~gsL~~ 139 (344)
|.++.+
T Consensus 78 G~~l~~ 83 (235)
T cd05155 78 GETATA 83 (235)
T ss_pred CCCCCc
Confidence 877754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00024 Score=64.03 Aligned_cols=76 Identities=9% Similarity=-0.022 Sum_probs=56.9
Q ss_pred CCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCC---CceeeeeeEEeeC---CccEEEEeecC
Q 048160 60 EKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSH---KNILKFVGCCLET---ELPILVFEFVA 133 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~~~~~~~~~---~~~~lv~e~~~ 133 (344)
...||.|..+.||.....+..+.+|..+.. .....+..|+..++.+.- ..++++++++..+ +..+||||+++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGNPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eeecCCccceeEEEEEcCCCCEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 466999999999999875556666764331 133578899999998853 4688999887543 56899999999
Q ss_pred CCCc
Q 048160 134 CGTL 137 (344)
Q Consensus 134 ~gsL 137 (344)
++++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8765
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00025 Score=62.39 Aligned_cols=139 Identities=9% Similarity=0.018 Sum_probs=79.1
Q ss_pred cccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCc-eeeeeeEEeeCCccEEEEeecCCCCcccc-
Q 048160 63 ITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKN-ILKFVGCCLETELPILVFEFVACGTLADR- 140 (344)
Q Consensus 63 ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~~~~~~~~~~~~~lv~e~~~~gsL~~~- 140 (344)
+..|-...+|+...++..+++|..........-...+|..+++.+...+ .+++++... .++|+||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~ 79 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQ 79 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccccc
Confidence 5567788999998888888888754332211123467888888886432 355555432 3689999998766431
Q ss_pred ----------------ccCCCCCCCccccHHHH-HHHHHH---------HHHHHHHhh-----cCCCCCeeeecccccce
Q 048160 141 ----------------IHDPNGSQLEPFLMKHR-LKVAME---------IANAVAYLH-----VGFSRPIVFRDIKPSTI 189 (344)
Q Consensus 141 ----------------l~~~~~~~~~~l~~~~~-~~i~~~---------i~~~l~~LH-----~~~~~~ivH~dlk~~Ni 189 (344)
++...... .++..... ..+..+ +...+..+- ......++|+|+.|.||
T Consensus 80 ~~~~~~~~~la~~l~~lH~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 80 FVALDLLLELAALLHQLHSQPRFG-YPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred ccCchhHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 11110000 11111111 111101 111111111 01134689999999999
Q ss_pred EeecCCcceEeeeecccc
Q 048160 190 LFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 190 ll~~~~~~kl~dfg~a~~ 207 (344)
+++.++ +.++||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999877 78999987643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00024 Score=63.93 Aligned_cols=145 Identities=14% Similarity=0.175 Sum_probs=85.0
Q ss_pred CCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCc--eeeeeeE------EeeCCccEEEEee
Q 048160 60 EKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKN--ILKFVGC------CLETELPILVFEF 131 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~~~~~------~~~~~~~~lv~e~ 131 (344)
...|..|....+|+...++..+++|..... .......|+.++..+.+.+ +++++.. ...++..++|++|
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 455777777889998887778999987542 3345667888888885332 4555442 1223456899999
Q ss_pred cCCCCcccc--------------cc----CCCCC--CCccccHHHHH----------HHHHHHHHHHHHhhc----CCCC
Q 048160 132 VACGTLADR--------------IH----DPNGS--QLEPFLMKHRL----------KVAMEIANAVAYLHV----GFSR 177 (344)
Q Consensus 132 ~~~gsL~~~--------------l~----~~~~~--~~~~l~~~~~~----------~i~~~i~~~l~~LH~----~~~~ 177 (344)
++|.++... ++ ..... ......+.... .....+..++.++.. ....
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 998766430 00 00000 00000111000 011112233333331 1235
Q ss_pred CeeeecccccceEeecCCcceEeeeecccc
Q 048160 178 PIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 178 ~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
+++|+|+.|.|++++.+..+.|+||+.+..
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 799999999999999887788999987643
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0019 Score=58.70 Aligned_cols=144 Identities=12% Similarity=0.104 Sum_probs=77.2
Q ss_pred CccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCC--CceeeeeeE------EeeCCccEEEEeec
Q 048160 61 KVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSH--KNILKFVGC------CLETELPILVFEFV 132 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~~~~~------~~~~~~~~lv~e~~ 132 (344)
+.|+.|....+|....++..+++|++... .......|+.++..|.. -.+++++.. ....+..+++++|.
T Consensus 28 ~~l~~G~~n~~y~v~t~~g~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQGEYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred chhccccccceEEEEeCCCcEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 44666777789999887778999987521 22333445566655532 123444421 12245678999999
Q ss_pred CCCCccc-----------cc---cCCCCCC------CccccH-HHHHH------------HHHHHH-HHHHHhhc----C
Q 048160 133 ACGTLAD-----------RI---HDPNGSQ------LEPFLM-KHRLK------------VAMEIA-NAVAYLHV----G 174 (344)
Q Consensus 133 ~~gsL~~-----------~l---~~~~~~~------~~~l~~-~~~~~------------i~~~i~-~~l~~LH~----~ 174 (344)
+|..+.. .+ +...... ...+.+ ..... .+.+.+ ..+..+.. .
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 8865421 01 0000000 000111 11000 111111 11222210 0
Q ss_pred CCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 175 FSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 175 ~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
-..+++|+|+.+.||+++.+...-++||+.+..
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 245899999999999999776668999988743
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00096 Score=57.78 Aligned_cols=73 Identities=21% Similarity=0.158 Sum_probs=47.6
Q ss_pred CccccCCCceEEEEEEC---CccEEEEEecCCCCchhhhHhhHHHHHhcCC-CCceeeeeeEEeeCCccEEEEeecCCCC
Q 048160 61 KVITKDLLYKLYKGFLQ---DRPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCCLETELPILVFEFVACGT 136 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~---~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~gs 136 (344)
+.|..|-...+|+.... +..|++|....... ..-...+|+.++..+. +.-.+++++.... .+||||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCCCc
Confidence 45677778899998875 46788887654322 1122347888888885 3335566554332 38999999876
Q ss_pred cc
Q 048160 137 LA 138 (344)
Q Consensus 137 L~ 138 (344)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 63
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0017 Score=58.72 Aligned_cols=145 Identities=14% Similarity=0.175 Sum_probs=82.4
Q ss_pred CCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCCC--ceeeeeeEE------eeCCccEEEEee
Q 048160 60 EKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHK--NILKFVGCC------LETELPILVFEF 131 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~~~~~~------~~~~~~~lv~e~ 131 (344)
...++.|....+|+...+++.+++|+..... ..+....|+.++..|... .+++++... ..++..+++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEeCCCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 3456677777899988777778888765432 123445667777777422 245554421 123456899999
Q ss_pred cCCCCcccc--------------ccCCCCCC---C-c--cc-cHHHHH------------HHHHHHHHHHHHhhc----C
Q 048160 132 VACGTLADR--------------IHDPNGSQ---L-E--PF-LMKHRL------------KVAMEIANAVAYLHV----G 174 (344)
Q Consensus 132 ~~~gsL~~~--------------l~~~~~~~---~-~--~l-~~~~~~------------~i~~~i~~~l~~LH~----~ 174 (344)
++|.++... ++...... . . .+ .|.... .....+...++++.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 987654311 11000000 0 0 00 010000 001122334444431 1
Q ss_pred CCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 175 FSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 175 ~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
...+++|+|+.+.|++++.++.+.++||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 25789999999999999988877899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0028 Score=59.09 Aligned_cols=73 Identities=11% Similarity=-0.066 Sum_probs=52.0
Q ss_pred CccccCCCceEEEEEECC--ccEEEEEecCCC-------CchhhhHhhHHHHHhcCC---CCceeeeeeEEeeCCccEEE
Q 048160 61 KVITKDLLYKLYKGFLQD--RPISVMKFGGNL-------NSEEYCCFNCIAFASQMS---HKNILKFVGCCLETELPILV 128 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~~--~~vavk~~~~~~-------~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~~~lv 128 (344)
+.||.|.+..||++...+ +.|+||.-.... .-..+....|...|..+. ..++++++.+. ....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence 468999999999999944 389999843211 123355667888888763 35688888873 3557899
Q ss_pred EeecCCC
Q 048160 129 FEFVACG 135 (344)
Q Consensus 129 ~e~~~~g 135 (344)
|||+++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9998753
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.003 Score=57.01 Aligned_cols=72 Identities=19% Similarity=0.159 Sum_probs=46.9
Q ss_pred ccccCCCceEEEEEEC--------CccEEEEEecCCCCchhhhHhhHHHHHhcCCCC-ceeeeeeEEeeCCccEEEEeec
Q 048160 62 VITKDLLYKLYKGFLQ--------DRPISVMKFGGNLNSEEYCCFNCIAFASQMSHK-NILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 62 ~ig~G~~g~V~~~~~~--------~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~-niv~~~~~~~~~~~~~lv~e~~ 132 (344)
.+..|-...+|+.... ++.+++|...... .......+|..++..+... -.+++++++.. .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 3555666789998874 3678888865543 2223456788888888532 24566666542 3689999
Q ss_pred CCCCcc
Q 048160 133 ACGTLA 138 (344)
Q Consensus 133 ~~gsL~ 138 (344)
+|.++.
T Consensus 80 ~G~~l~ 85 (302)
T cd05156 80 PSRTLT 85 (302)
T ss_pred CCCcCC
Confidence 887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0056 Score=55.70 Aligned_cols=140 Identities=11% Similarity=0.120 Sum_probs=91.3
Q ss_pred CCccccCCCceEEEEEE-CCccEEEEEecCCCC----------------------chhh---h-HhhHHHHHhcCCCCce
Q 048160 60 EKVITKDLLYKLYKGFL-QDRPISVMKFGGNLN----------------------SEEY---C-CFNCIAFASQMSHKNI 112 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~----------------------~~~~---~-~~~E~~~l~~l~H~ni 112 (344)
.-.|..|.-+.||.+.- +|..+|||+.+...- .+.+ . ...|++-|++++...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 45688899999999988 888899997643200 0011 1 2377888888865554
Q ss_pred eeeeeEEeeCCccEEEEeecCCC-CccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe
Q 048160 113 LKFVGCCLETELPILVFEFVACG-TLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF 191 (344)
Q Consensus 113 v~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 191 (344)
+----... ..-.|||+|+... =-...|+. ..++...+..+-.+++.-+.-|-+ ..++||.||+--|+|+
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~aPkLKd------~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWAAPKLKD------ASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLY 298 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCcCccccc------ccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheE
Confidence 32111111 1235899998421 11122332 246666777777777777776654 7899999999999998
Q ss_pred ecCCcceEeeeecccccCC
Q 048160 192 QEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 192 ~~~~~~kl~dfg~a~~~~~ 210 (344)
.+|.+.++|.+-+.....
T Consensus 299 -hdG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 299 -HDGKLYIIDVSQSVEHDH 316 (520)
T ss_pred -ECCEEEEEEccccccCCC
Confidence 578899999987765543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0011 Score=59.07 Aligned_cols=131 Identities=13% Similarity=0.057 Sum_probs=90.1
Q ss_pred CCCCCccccCCCceEEEEEE-CCccEEEEEe----------cCC----------CCch--hhhHhhHHHHHhcCCC--Cc
Q 048160 57 YDPEKVITKDLLYKLYKGFL-QDRPISVMKF----------GGN----------LNSE--EYCCFNCIAFASQMSH--KN 111 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~----------~~~----------~~~~--~~~~~~E~~~l~~l~H--~n 111 (344)
++..+.||-|.-+.||.+-. .|++.++|.= +.. ++-. .-...+|...|+.|.- =-
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 56688999999999999999 6888888741 110 0000 1224588999999852 23
Q ss_pred eeeeeeEEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe
Q 048160 112 ILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF 191 (344)
Q Consensus 112 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 191 (344)
+++.+++ +.-++|||+..+-.|...-+- ....++..-+..+ +.-|- ..|+||+|..-=||++
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v--------~d~~~ly~~lm~~---Iv~la---~~GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV--------EDPPTLYDDLMGL---IVRLA---NHGLIHGDFNEFNIMV 235 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeeec--------CChHHHHHHHHHH---HHHHH---HcCceecccchheeEE
Confidence 5555543 455799999998888775432 2233333333333 33444 8899999999999999
Q ss_pred ecCCcceEeeeecc
Q 048160 192 QEQNVAKFFDFCVS 205 (344)
Q Consensus 192 ~~~~~~kl~dfg~a 205 (344)
+.++.++++||--.
T Consensus 236 ~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQM 249 (465)
T ss_pred ecCCCEEEeechHh
Confidence 99999999999543
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.02 Score=53.47 Aligned_cols=73 Identities=4% Similarity=-0.031 Sum_probs=50.6
Q ss_pred CCccccCCCceEEEEEECCccEEEEEecCCCC-------chhhhHhhHHHHHhcCC---CCceeeeeeEEeeCCccEEEE
Q 048160 60 EKVITKDLLYKLYKGFLQDRPISVMKFGGNLN-------SEEYCCFNCIAFASQMS---HKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~-------~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~~~lv~ 129 (344)
.+.||-|..-.||+....++.++||+-..... .....-..|...|+.+. ..++++++.++. +..+++|
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM 114 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM 114 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence 45678898999999988777899998542111 12333445566666553 358899999886 4457899
Q ss_pred eecCC
Q 048160 130 EFVAC 134 (344)
Q Consensus 130 e~~~~ 134 (344)
|++++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99976
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.007 Score=54.10 Aligned_cols=73 Identities=11% Similarity=0.016 Sum_probs=48.7
Q ss_pred CCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCC---CCceeeeeeEEeeCCccEEEEeecCCC
Q 048160 60 EKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMS---HKNILKFVGCCLETELPILVFEFVACG 135 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~~~lv~e~~~~g 135 (344)
...|+-|....+|+...+++.+.||.-. ......|..|+.-|+.|. --.+++++++....+..+||+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLDTDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEETTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEECCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4568888899999988888889999754 224456788888888883 456889999988777789999998765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.018 Score=53.05 Aligned_cols=141 Identities=14% Similarity=0.122 Sum_probs=78.3
Q ss_pred ccccCCCceEEEEEEC------CccEEEEEecCCCCchhhhHhhHHHHHhcCCCC-ceeeeeeEEeeCCccEEEEeecCC
Q 048160 62 VITKDLLYKLYKGFLQ------DRPISVMKFGGNLNSEEYCCFNCIAFASQMSHK-NILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 62 ~ig~G~~g~V~~~~~~------~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~-niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
.+..|-.-.+|+..+. ++.|++|..........+ -.+|..+++.+..- --+++++.+..+ .|.+|+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 3445677789998862 256888876554322222 25788888888533 334666665433 58999987
Q ss_pred CCcccc-----------------ccCCCCC-CCccccHHHHHHHHHH-----------------HHHHHHH----hhc-C
Q 048160 135 GTLADR-----------------IHDPNGS-QLEPFLMKHRLKVAME-----------------IANAVAY----LHV-G 174 (344)
Q Consensus 135 gsL~~~-----------------l~~~~~~-~~~~l~~~~~~~i~~~-----------------i~~~l~~----LH~-~ 174 (344)
.+|..- ++..... ...+..+.+...++.+ +...+.. +.. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 666421 1111100 0001112222222111 1111111 111 1
Q ss_pred CCCCeeeecccccceEeec-CCcceEeeeecccc
Q 048160 175 FSRPIVFRDIKPSTILFQE-QNVAKFFDFCVSIS 207 (344)
Q Consensus 175 ~~~~ivH~dlk~~Nill~~-~~~~kl~dfg~a~~ 207 (344)
....++|+|+++.||+++. ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2557899999999999986 46899999987743
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.021 Score=51.50 Aligned_cols=130 Identities=12% Similarity=0.101 Sum_probs=81.9
Q ss_pred eEEEEEECCccEEEEEecC--CCCchhhhHhhHHHHHhcCCC--CceeeeeeEEeeCC--ccEEEEeecCCCCccccccC
Q 048160 70 KLYKGFLQDRPISVMKFGG--NLNSEEYCCFNCIAFASQMSH--KNILKFVGCCLETE--LPILVFEFVACGTLADRIHD 143 (344)
Q Consensus 70 ~V~~~~~~~~~vavk~~~~--~~~~~~~~~~~E~~~l~~l~H--~niv~~~~~~~~~~--~~~lv~e~~~~gsL~~~l~~ 143 (344)
.+|.....++.+++. ... ..........+|..+++.+.- .-+...++.|..+. ..+.||+|++|..+...+..
T Consensus 40 ~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~ 118 (321)
T COG3173 40 DTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP 118 (321)
T ss_pred ceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc
Confidence 344444456777777 321 122223445578888887742 34566688887776 77999999987544433321
Q ss_pred CCCCCCccccHHHHHHHHH-HHHHHHHHhhc-------------------------------------------------
Q 048160 144 PNGSQLEPFLMKHRLKVAM-EIANAVAYLHV------------------------------------------------- 173 (344)
Q Consensus 144 ~~~~~~~~l~~~~~~~i~~-~i~~~l~~LH~------------------------------------------------- 173 (344)
. +.. .+++. .++..|.-||+
T Consensus 119 ~--------~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~ 188 (321)
T COG3173 119 E--------SLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE 188 (321)
T ss_pred c--------cch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence 1 111 12222 55555555552
Q ss_pred ------CCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 174 ------GFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 174 ------~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
.....++|+|+.+.|++++...-+-|.||+++...+.
T Consensus 189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 0145789999999999999988899999999876543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.023 Score=50.56 Aligned_cols=32 Identities=22% Similarity=0.389 Sum_probs=26.0
Q ss_pred CCCeeeecccccceEeecCCc-ceEeeeecccc
Q 048160 176 SRPIVFRDIKPSTILFQEQNV-AKFFDFCVSIS 207 (344)
Q Consensus 176 ~~~ivH~dlk~~Nill~~~~~-~kl~dfg~a~~ 207 (344)
...++|+|+.+.||+++.++. .-|+||+.+..
T Consensus 184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 346899999999999987554 56999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.0035 Score=59.28 Aligned_cols=52 Identities=15% Similarity=0.261 Sum_probs=40.2
Q ss_pred chhhhHhhHHHHHhcCCCCceeeeeeEEeeC-CccEEEEeecCCCCccccccCC
Q 048160 92 SEEYCCFNCIAFASQMSHKNILKFVGCCLET-ELPILVFEFVACGTLADRIHDP 144 (344)
Q Consensus 92 ~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~ 144 (344)
.....+..-..+++.+.|+|.-.++.+.... ...++|+|++ +-||.+.+..+
T Consensus 24 ~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 24 PNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred CcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 3445566778899999999999998886543 3578999999 57998887654
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.00047 Score=72.40 Aligned_cols=159 Identities=8% Similarity=-0.075 Sum_probs=109.4
Q ss_pred hhHHHHHhcCCCCceeeeeeEEe--eCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHH-HHHHHHhhc-
Q 048160 98 FNCIAFASQMSHKNILKFVGCCL--ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI-ANAVAYLHV- 173 (344)
Q Consensus 98 ~~E~~~l~~l~H~niv~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i-~~~l~~LH~- 173 (344)
..|..-.+...|+++...+.=.. +....+.+++|+.+|.+.+.+-+.-... .++... ......++ +.+..-+|.
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~-~~ld~~-~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEES-PDLDRS-PVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccC-Ccchhc-hHHHHHHHHHhccchhhhc
Confidence 34555556678998887665433 2346688999999999999875433211 123222 23333444 555555552
Q ss_pred -CCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHH
Q 048160 174 -GFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLL 252 (344)
Q Consensus 174 -~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~ 252 (344)
.-+...+|+++|+-|.+|..+..+++.++|+.+.-....... ....+++.|++|+....-.++.++|+|..|+-+|
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~---Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFF---GLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCchHhhh---hhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 224567899999999999999999999999998322221111 1346677889999887778888899999999999
Q ss_pred HHHcCCCCC
Q 048160 253 ELLTGKRIS 261 (344)
Q Consensus 253 el~~g~~p~ 261 (344)
+...|..+|
T Consensus 1432 ~rs~~n~~f 1440 (2724)
T KOG1826|consen 1432 LRSDGNAYF 1440 (2724)
T ss_pred HHhcccHHH
Confidence 988877654
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.059 Score=50.12 Aligned_cols=72 Identities=11% Similarity=-0.002 Sum_probs=48.7
Q ss_pred CCccccCCCceEEEEEEC--CccEEEEEec------CCCCchhhhHhhHHHHHhcCC---CCceeeeeeEEeeCCccEEE
Q 048160 60 EKVITKDLLYKLYKGFLQ--DRPISVMKFG------GNLNSEEYCCFNCIAFASQMS---HKNILKFVGCCLETELPILV 128 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~~--~~~vavk~~~------~~~~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~~~lv 128 (344)
...||-|.-..||++... ++.|+||+-. .+..-..+...-|..+|+... -.++++++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 346899999999999974 6789999732 122233455666777777663 2367777765 34455688
Q ss_pred EeecC
Q 048160 129 FEFVA 133 (344)
Q Consensus 129 ~e~~~ 133 (344)
||+++
T Consensus 112 MEdL~ 116 (409)
T PRK12396 112 MEDLS 116 (409)
T ss_pred HHhCc
Confidence 99875
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.032 Score=51.21 Aligned_cols=71 Identities=11% Similarity=0.005 Sum_probs=46.6
Q ss_pred ccccCCCceEEEEEECC--ccEEEEEecC-------CCCchhhhHhhHHHHHhcCC---CCceeeeeeEEeeCCccEEEE
Q 048160 62 VITKDLLYKLYKGFLQD--RPISVMKFGG-------NLNSEEYCCFNCIAFASQMS---HKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 62 ~ig~G~~g~V~~~~~~~--~~vavk~~~~-------~~~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~~~lv~ 129 (344)
-||-|....||++...+ +.|+||+-.. ...-..+...-|...|+... -..+++++.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 37889999999999844 5899997321 12223344556777776653 2357777665 344556899
Q ss_pred eecCC
Q 048160 130 EFVAC 134 (344)
Q Consensus 130 e~~~~ 134 (344)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 98853
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.019 Score=48.69 Aligned_cols=117 Identities=14% Similarity=0.056 Sum_probs=72.5
Q ss_pred CCCceEEEEEECCccEEEEEecCC-CCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCCccccccCC
Q 048160 66 DLLYKLYKGFLQDRPISVMKFGGN-LNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDP 144 (344)
Q Consensus 66 G~~g~V~~~~~~~~~vavk~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~ 144 (344)
|+-.+.-.+...=.+..+|++..- ..-....+..+.+++++++ .|+++.-- .+-.+.++.|+|-...
T Consensus 73 ~gNsTl~~~kt~iG~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-------- 140 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-------- 140 (308)
T ss_pred CCceEEEEeccccchhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc--------
Confidence 333444444443355666666433 2213344667888888886 57777621 3335668899885221
Q ss_pred CCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 145 NGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 145 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
..+.. ++..=+++|.-.|+. +.+.+|+|..|+||+-|..|.+|+.|-+.-
T Consensus 141 ------i~~~N----~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 141 ------INFSN----FITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred ------cchhH----HHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence 11111 111113456667733 789999999999999999999999998753
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.028 Score=51.26 Aligned_cols=107 Identities=15% Similarity=0.156 Sum_probs=70.0
Q ss_pred ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeee
Q 048160 124 LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFC 203 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg 203 (344)
..|++|++. |++|.. +. .-.+++...++++.+.-+.-+.. ....-|||+...||||+ +|++.|+||-
T Consensus 300 y~yl~~kdh-gt~is~-ik--------~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 300 YLYLHFKDH-GTPISI-IK--------ADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred EEEEEEecC-Cceeee-ee--------cccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEee
Confidence 445666665 444432 22 23467888999998888777764 56788999999999999 9999999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHH
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLL 252 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~ 252 (344)
+++.-..... . .....--|-.+.|.. +...|||-+--.+.
T Consensus 367 lsRl~~~q~~-i-------sy~rldhp~lF~G~d-d~QFeIYrlMr~l~ 406 (488)
T COG5072 367 LSRLSYSQGI-I-------SYNRLDHPDLFNGVD-DYQFEIYRLMRRLL 406 (488)
T ss_pred eeecccCCce-e-------eccccCchhhhcCcc-ceeeeHHHHHHHHh
Confidence 9984332211 1 111222355555433 66778886654443
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.047 Score=50.00 Aligned_cols=71 Identities=18% Similarity=0.185 Sum_probs=43.8
Q ss_pred ccccCCCceEEEEEECC-----ccEEEEEecCCCCchhhhHhhHHHHHhcCCCCce-eeeeeEEeeCCccEEEEeecCCC
Q 048160 62 VITKDLLYKLYKGFLQD-----RPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNI-LKFVGCCLETELPILVFEFVACG 135 (344)
Q Consensus 62 ~ig~G~~g~V~~~~~~~-----~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~~~g 135 (344)
.|..|-.-.+|+....+ ..|+++....... ..-.-.+|..+++.+..-++ +++++++..+ +|.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence 34446677799887643 2688887655432 11122478888888864443 5666665322 589998766
Q ss_pred Cc
Q 048160 136 TL 137 (344)
Q Consensus 136 sL 137 (344)
+|
T Consensus 96 ~l 97 (330)
T PLN02421 96 TL 97 (330)
T ss_pred CC
Confidence 55
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.059 Score=48.70 Aligned_cols=65 Identities=11% Similarity=0.025 Sum_probs=40.6
Q ss_pred eEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCCC--ceeeeeeE------EeeCCccEEEEeecCCCCcc
Q 048160 70 KLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHK--NILKFVGC------CLETELPILVFEFVACGTLA 138 (344)
Q Consensus 70 ~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~~~~~------~~~~~~~~lv~e~~~~gsL~ 138 (344)
.||+...+++.+++|++... ......|+.++..|... .+++++.. ...++..++++||.+|.++.
T Consensus 11 ~v~~v~t~~g~~~LK~~~~~----~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~~ 83 (313)
T TIGR02906 11 NVYKVETDSGNKCLKKINYP----PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGRECD 83 (313)
T ss_pred cEEEEEeCCCCeEEEEcCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCCC
Confidence 48998887778999987532 23344566666666422 34444432 12345678999999876553
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.12 Score=46.89 Aligned_cols=32 Identities=19% Similarity=0.261 Sum_probs=28.1
Q ss_pred CCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 176 SRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 176 ~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
..+++|+|+.+.|++++.++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 55899999999999999999999999977643
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.99 E-value=0.34 Score=44.20 Aligned_cols=138 Identities=14% Similarity=0.151 Sum_probs=76.7
Q ss_pred CCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCc------eeeeeeE----EeeCCccEEEEeecCCCC
Q 048160 67 LLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKN------ILKFVGC----CLETELPILVFEFVACGT 136 (344)
Q Consensus 67 ~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~~~~~----~~~~~~~~lv~e~~~~gs 136 (344)
.--.+|+....++.+++|..... ....++..|...+..|.-.+ +...=|- ...+....-+++|++|..
T Consensus 37 ~eN~~f~~~~~~g~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~ 114 (331)
T COG2334 37 EENSNFRVQTEDGRYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRP 114 (331)
T ss_pred ccCceEEEEecCCCeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcC
Confidence 34569999997777788877665 34455666777777773211 2222121 111236778999999887
Q ss_pred ccc-cc------------------cCCC---CCCCccccHH----H---------HHHHHHHHHHHHHHhhc----CC-C
Q 048160 137 LAD-RI------------------HDPN---GSQLEPFLMK----H---------RLKVAMEIANAVAYLHV----GF-S 176 (344)
Q Consensus 137 L~~-~l------------------~~~~---~~~~~~l~~~----~---------~~~i~~~i~~~l~~LH~----~~-~ 176 (344)
+.. .. +... ........|. . ......++...+..+.. .. .
T Consensus 115 ~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~ 194 (331)
T COG2334 115 LERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPA 194 (331)
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCc
Confidence 773 10 0000 0000011111 0 01122333333333331 11 2
Q ss_pred CC--eeeecccccceEeecCC-cceEeeeeccc
Q 048160 177 RP--IVFRDIKPSTILFQEQN-VAKFFDFCVSI 206 (344)
Q Consensus 177 ~~--ivH~dlk~~Nill~~~~-~~kl~dfg~a~ 206 (344)
.+ +||+|+-|.||+++.+. .+.++||+-+.
T Consensus 195 ~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 195 LGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred ccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 23 99999999999999887 48899998764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=93.98 E-value=0.016 Score=54.66 Aligned_cols=74 Identities=8% Similarity=0.176 Sum_probs=59.7
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCC
Q 048160 50 LKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETE 123 (344)
Q Consensus 50 i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~ 123 (344)
+....++|.....+|.|+||+|+.+.. ++..+|||++.-... .......+|+..+.++.|++++++...|..++
T Consensus 44 ~sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~~ 120 (516)
T KOG1033|consen 44 TSREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYERP 120 (516)
T ss_pred hhhhhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceecCC
Confidence 444457899999999999999999998 666899999865533 33456789999999999999999988776543
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.63 E-value=1.8 Score=37.23 Aligned_cols=75 Identities=11% Similarity=0.062 Sum_probs=51.5
Q ss_pred CccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcC---CCCceeeeeeEEeeCCccEEEEeecCCCCc
Q 048160 61 KVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQM---SHKNILKFVGCCLETELPILVFEFVACGTL 137 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l---~H~niv~~~~~~~~~~~~~lv~e~~~~gsL 137 (344)
+.+.-|---..|...+...++-||.=. ......|..|+.-|..+ +.-.+.+++.+....+..|+|+||++-+.+
T Consensus 22 ~~v~gG~inea~~v~dg~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 22 EEVSGGDINEAWRLRDGTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred cccCCccccceeEeecCCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 445555445556666567788888622 12335566776655555 456788889998889999999999988776
Q ss_pred c
Q 048160 138 A 138 (344)
Q Consensus 138 ~ 138 (344)
+
T Consensus 99 d 99 (286)
T COG3001 99 D 99 (286)
T ss_pred C
Confidence 6
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.44 E-value=3 Score=38.01 Aligned_cols=96 Identities=11% Similarity=0.077 Sum_probs=52.3
Q ss_pred ccccccHHHHHHHhcCCCCC--C--ccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCc--ee
Q 048160 41 PIQNFTAQELKAATNNYDPE--K--VITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKN--IL 113 (344)
Q Consensus 41 ~~~~~~~~~i~~~~~~~~~~--~--~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv 113 (344)
+...++.+.+..+...+-.. . ..=.+.-..||+... ++..+++|...... .....+..|+..+..|.-.. ++
T Consensus 7 ~~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~ 85 (325)
T PRK11768 7 PFQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVV 85 (325)
T ss_pred CCCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCC
Confidence 44556666666665544221 1 111233456999888 45567777654332 23455667888777774211 22
Q ss_pred ee---ee--EEeeCCccEEEEeecCCCCc
Q 048160 114 KF---VG--CCLETELPILVFEFVACGTL 137 (344)
Q Consensus 114 ~~---~~--~~~~~~~~~lv~e~~~~gsL 137 (344)
.. -| +..-++..+.|+++.+|...
T Consensus 86 ~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 86 APLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred CCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 21 11 11224566789999887643
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.94 E-value=1 Score=42.13 Aligned_cols=73 Identities=18% Similarity=0.171 Sum_probs=43.6
Q ss_pred CccccCCCceEEEEEECC---cc-----EEEEEecCCCCchhhhHhhHHHHHhcCCC-CceeeeeeEEeeCCccEEEEee
Q 048160 61 KVITKDLLYKLYKGFLQD---RP-----ISVMKFGGNLNSEEYCCFNCIAFASQMSH-KNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~~---~~-----vavk~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~~~~~~~~~~~~~lv~e~ 131 (344)
+.|..|-...+|++...+ .. |.+.. ........-.-.+|..+++.+.. ..-+++++.+.. +++.||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~-~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKK-SSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEe-ccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 345557788899997632 12 33333 22211111112468899999864 445667776643 589999
Q ss_pred cCCCCcc
Q 048160 132 VACGTLA 138 (344)
Q Consensus 132 ~~~gsL~ 138 (344)
++|.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9987664
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.32 E-value=0.37 Score=44.88 Aligned_cols=60 Identities=20% Similarity=0.097 Sum_probs=41.1
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHH-HhhcCCCCCeeeecccccceEeec
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVA-YLHVGFSRPIVFRDIKPSTILFQE 193 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~ivH~dlk~~Nill~~ 193 (344)
..++-+|.+|.++..++.... .+++-...++.-.++|+. .|- --+.+|.|+.|.||++--
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~------~pe~l~kkva~lg~~AllkMl~---vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS------QPEALVKKVAKLGVNALLKMLI---VDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhccc------ChHHHHHHHHHHHHHHHHHHHH---hhcceecccCCCcEEEEe
Confidence 357777888889998887654 344444455554555533 333 568899999999999953
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.87 E-value=1.6 Score=41.67 Aligned_cols=73 Identities=16% Similarity=0.180 Sum_probs=43.1
Q ss_pred CccccCCCceEEEEEEC----------CccEEEEEecCCCCchhhhHhhHHHHHhcCCCCce-eeeeeEEeeCCccEEEE
Q 048160 61 KVITKDLLYKLYKGFLQ----------DRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNI-LKFVGCCLETELPILVF 129 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~----------~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~ 129 (344)
+.|..|-.-.+|+.... ++.|+++........- -.-.+|..+++.+...+| .++++.+. -+.|.
T Consensus 111 ~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l-IdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I~ 185 (442)
T PTZ00296 111 NQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL-YNPISEFEVYKTMSKYRIAPQLLNTFS----GGRIE 185 (442)
T ss_pred EEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce-eCHHHHHHHHHHHHHCCCCCceEEEeC----CCEEE
Confidence 33455666678888763 3467777754443222 123467778777754333 35565543 34689
Q ss_pred eecCCCCcc
Q 048160 130 EFVACGTLA 138 (344)
Q Consensus 130 e~~~~gsL~ 138 (344)
||++|.+|.
T Consensus 186 efi~g~~l~ 194 (442)
T PTZ00296 186 EWLYGDPLR 194 (442)
T ss_pred EeeCCccCC
Confidence 999876553
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 344 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-31 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-30 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-27 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-26 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-17 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-17 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-17 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-17 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-08 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-08 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-08 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-08 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-08 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-05 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-05 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-05 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-05 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-04 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-04 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 2e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-04 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 2e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-04 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 3e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-04 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-04 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-04 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 6e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 9e-68
Identities = 87/300 (29%), Positives = 141/300 (47%), Gaps = 21/300 (7%)
Query: 43 QNFTAQELKAATNNYDPEKVITKDLLYKLYKGFLQD-RPISV--MKFGGNLNSEEYCCFN 99
+L+ ATNN+D + +I + K+YKG L+D +++ + EE+
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEF--ET 84
Query: 100 CIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLK 159
I S H +++ +G C E IL+++++ G L ++ + + RL+
Sbjct: 85 EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT-MSMSWEQRLE 143
Query: 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG-KTHVNDN 218
+ + A + YLH I+ RD+K IL E V K DF +S E +TH++
Sbjct: 144 ICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS-- 198
Query: 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKR-ISYSSCFENGEEYFLQEL 277
V GT G+I PEY EKSDVYSFG +L E+L + I S L E
Sbjct: 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS--LPREMVN-LAEW 255
Query: 278 VRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337
+S + ++IVDP + + + L + + A+KCL+ S +DRP+M V +L
Sbjct: 256 AVESHNNGQLEQIVDPNLADK---IRPES--LRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 3e-65
Identities = 74/317 (23%), Positives = 151/317 (47%), Gaps = 38/317 (11%)
Query: 43 QNFTAQELKAATNNYDPEKVITKDLLYKL--------YKGFLQDRPISV--MKFGGNLNS 92
+F+ ELK TNN+D + K+ YKG++ + ++V + ++ +
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGG--NKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT 70
Query: 93 ----EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQ 148
+++ I ++ H+N+++ +G + + LV+ ++ G+L DR+ +G+
Sbjct: 71 EELKQQF--DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 149 LEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208
+ M R K+A AN + +LH + RDIK + IL E AK DF ++ +
Sbjct: 129 PLSWHM--RCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARAS 183
Query: 209 PEG-KTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFE 267
+ +T + ++++GT ++APE + KSD+YSFG +LLE++TG E
Sbjct: 184 EKFAQTVM--TSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD----E 236
Query: 268 NGEEYFLQELVRKSI-ESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQD 326
+ E L ++ + E + ++ +D + + + +A +CL + +
Sbjct: 237 HREPQLLLDIKEEIEDEEKTIEDYIDKKM----NDADSTS--VEAMYSVASQCLHEKKNK 290
Query: 327 RPTMVQVAKQLRQLHKS 343
RP + +V + L+++ S
Sbjct: 291 RPDIKKVQQLLQEMTAS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 2e-63
Identities = 86/300 (28%), Positives = 156/300 (52%), Gaps = 14/300 (4%)
Query: 42 IQNFTAQELKAATNNYDPEKVITKDLLYKLYKGFLQD-RPISV--MKFGGNLNSE-EYCC 97
++ F+ +EL+ A++N+ + ++ + K+YKG L D ++V +K E ++
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ- 75
Query: 98 FNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHR 157
+ S H+N+L+ G C+ +LV+ ++A G++A + + SQ P R
Sbjct: 76 -TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP-PLDWPKR 133
Query: 158 LKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217
++A+ A +AYLH I+ RD+K + IL E+ A DF ++ + THV
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT- 192
Query: 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL 277
V GT G IAPEY+ST +EK+DV+ +G +LLEL+TG+R + N ++ L +
Sbjct: 193 -TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 278 VRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337
V+ ++ + +VD + G K++++ ++A+ C S +RP M +V + L
Sbjct: 252 VKGLLKEKKLEALVDVDLQGN-----YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 7e-46
Identities = 61/325 (18%), Positives = 126/325 (38%), Gaps = 43/325 (13%)
Query: 44 NFTAQELKAATNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNC--- 100
+ + L + +V + ++K L + ++V F ++ +
Sbjct: 13 DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIF----PIQDKQSWQNEYE 68
Query: 101 IAFASQMSHKNILKFVGCC-----LETELPILVFEFVACGTLADRIHDPNGSQLEPFLMK 155
+ M H+NIL+F+G ++ +L L+ F G+L+D +
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLKA------NVVSWN 121
Query: 156 HRLKVAMEIANAVAYLH------VGFSRP-IVFRDIKPSTILFQEQNVAKFFDFCVSISI 208
+A +A +AYLH +P I RDIK +L + A DF +++
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTA-----NCNEKSDVYSFGALLLELLTGKRISYS 263
GK+ + + +V GT ++APE + A + + D+Y+ G +L EL + +
Sbjct: 182 EAGKSAGDTHGQV-GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
Query: 264 SCFENGEEYFLQELVRKSIESNSFKEIV-----DPIIVGEEGLWPEKEKQLLSYTELAIK 318
E + +E + + +E+V P++ W + + E +
Sbjct: 241 PVDEYMLPF--EEEIGQHPSLEDMQEVVVHKKKRPVL---RDYWQKHA-GMAMLCETIEE 294
Query: 319 CLSKSEQDRPTMVQVAKQLRQLHKS 343
C + R + V +++ Q+ +
Sbjct: 295 CWDHDAEARLSAGCVGERITQMQRL 319
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-37
Identities = 61/278 (21%), Positives = 114/278 (41%), Gaps = 38/278 (13%)
Query: 70 KLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129
+ K + + +++ + + + + S+++H NI+K G CL LV
Sbjct: 23 VVCKAKWRAKDVAIKQIESESERKAFI--VELRQLSRVNHPNIVKLYGACLNP--VCLVM 78
Query: 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTI 189
E+ G+L + +H L + H + ++ + VAYLH + ++ RD+KP +
Sbjct: 79 EYAEGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNL 136
Query: 190 LFQEQN-VAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFG 248
L V K DF + I T G+ ++APE +N +EK DV+S+G
Sbjct: 137 LLVAGGTVLKICDFGTACDIQTHMT------NNKGSAAWMAPEVFEGSNYSEKCDVFSWG 190
Query: 249 ALLLELLTGKRISYSSCFEN--GEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKE 306
+L E++T ++ F+ G + + V P ++ + L
Sbjct: 191 IILWEVITRRK-----PFDEIGGPAFRIMWAVHNGTR---------PPLI--KNLPKP-- 232
Query: 307 KQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKSI 344
L +C SK RP+M ++ K + L +
Sbjct: 233 -----IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-36
Identities = 62/329 (18%), Positives = 111/329 (33%), Gaps = 42/329 (12%)
Query: 45 FTAQELKAATNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFA 104
A E +N ++I + +YKG L +RP++V F N + + I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFA-NRQNFINEKNIYRV 61
Query: 105 SQMSHKNILKFVGCCLETELPI-----LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLK 159
M H NI +F+ LV E+ G+L + +
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD------WVSSCR 115
Query: 160 VAMEIANAVAYLH------VGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI-----SI 208
+A + +AYLH + I RD+ +L + DF +S+ +
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTA-------NCNEKSDVYSFGALLLELLTGKRIS 261
N +GT ++APE + A + ++ D+Y+ G + E+
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 262 YSSCFENGEEYFL--QELVRKSIESNSFKEIVD-----PIIVGEEGLWPEKEKQLLSYTE 314
+ E+ EY + Q V + +V P W E + S E
Sbjct: 236 FP--GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA---WKENSLAVRSLKE 290
Query: 315 LAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343
C + + R T +++ +L
Sbjct: 291 TIEDCWDQDAEARLTAQXAEERMAELMMI 319
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-35
Identities = 71/288 (24%), Positives = 114/288 (39%), Gaps = 51/288 (17%)
Query: 70 KLYKGFLQDRPISV---MKFGGNLNSEEYCCFNCIAFA------SQMSHKNILKFVGCCL 120
++KG L V G+ E F S ++H NI+K G
Sbjct: 34 LVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM- 92
Query: 121 ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIV 180
P +V EFV CG L R+ D P +L++ ++IA + Y+ + PIV
Sbjct: 93 -HNPPRMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQ-NQNPPIV 146
Query: 181 FRDIKPSTILFQEQN-----VAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST 235
RD++ I Q + AK DF +S + V+ + ++G F ++APE +
Sbjct: 147 HRDLRSPNIFLQSLDENAPVCAKVADFGLS------QQSVHSVSGLLGNFQWMAPETIGA 200
Query: 236 AN--CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDP 293
EK+D YSF +L +LTG+ F+ S+ +I
Sbjct: 201 EEESYTEKADTYSFAMILYTILTGEGP-----FDE----------------YSYGKIKFI 239
Query: 294 IIVGEEGLWPEKEKQLLS-YTELAIKCLSKSEQDRPTMVQVAKQLRQL 340
++ EEGL P + + C S + RP + K+L +L
Sbjct: 240 NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-34
Identities = 53/281 (18%), Positives = 100/281 (35%), Gaps = 43/281 (15%)
Query: 70 KLYKGFLQDRPISVMKF-GGNLNSEEYCCFNC-IAFASQMSHKNILKFVGCCLETELPIL 127
+L+KG Q I V + ++ + FN SH N+L +G C P
Sbjct: 25 ELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84
Query: 128 --VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIK 185
+ ++ G+L + +H+ ++ +K A+++A +A+LH I +
Sbjct: 85 TLITHWMPYGSLYNVLHEGTNFVVDQ---SQAVKFALDMARGMAFLH-TLEPLIPRHALN 140
Query: 186 PSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYM---STANCNEKS 242
+++ E A+ + + ++APE + +
Sbjct: 141 SRSVMIDEDMTARISMA--------DVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSA 192
Query: 243 DVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLW 302
D++SF LL EL+T E F S EI + V EGL
Sbjct: 193 DMWSFAVLLWELVT------------REVPF---------ADLSNMEIG--MKVALEGLR 229
Query: 303 PEKEKQLLS-YTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342
P + ++L C+++ RP + L ++
Sbjct: 230 PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 60/240 (25%), Positives = 98/240 (40%), Gaps = 30/240 (12%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
++ H NI+ F+G + +V E+++ G+L +H E + RL +A ++
Sbjct: 89 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAR--EQLDERRRLSMAYDV 146
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
A + YLH + PIV R++K +L ++ K DF +S + GT
Sbjct: 147 AKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL---SSKSAAGT 202
Query: 225 FGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES 284
++APE + NEKSDVYSFG +L EL T + +
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ-QPWG-------------------NL 242
Query: 285 NSFKEIVDPIIVGEEGLWPEKEKQLL-SYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343
N + + VG + E + L + C + RP+ + LR L KS
Sbjct: 243 NPAQVVAA---VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-33
Identities = 60/301 (19%), Positives = 119/301 (39%), Gaps = 47/301 (15%)
Query: 70 KLYKGFLQDRPISVMKFGGNLNSEEYCCFNC---IAFASQMSHKNILKFVGCCLETELPI 126
++++G + ++V F +S E + I + H+NIL F+ +
Sbjct: 57 EVWRGKWRGEEVAVKIF----SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112
Query: 127 ----LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLH-----VGFSR 177
LV ++ G+L D ++ ++ +K+A+ A+ +A+LH
Sbjct: 113 TQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 166
Query: 178 PIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND-NNKVIGTFGFIAPE----- 231
I RD+K IL ++ D +++ ++ N +GT ++APE
Sbjct: 167 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 226
Query: 232 -YMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFL--QELVRKSIESNSFK 288
M +++D+Y+ G + E+ I E+Y L +LV S +
Sbjct: 227 INMKHFESFKRADIYAMGLVFWEIARRCSIG-----GIHEDYQLPYYDLVP---SDPSVE 278
Query: 289 EIVDPIIVGEEGLWPE------KEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342
E+ +V E+ L P + L ++ +C + R T +++ K L QL +
Sbjct: 279 EMRK--VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336
Query: 343 S 343
Sbjct: 337 Q 337
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-32
Identities = 54/298 (18%), Positives = 118/298 (39%), Gaps = 47/298 (15%)
Query: 70 KLYKGFLQDRPISVMKFGGNLNSEEYCCFNC---IAFASQMSHKNILKFVGCCLETELPI 126
++++G Q ++V F +S + + + + H+NIL F+ + +
Sbjct: 23 EVWRGSWQGENVAVKIF----SSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78
Query: 127 ----LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLH-----VGFSR 177
L+ + G+L D + L++ + IA+ +A+LH
Sbjct: 79 TQLWLITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132
Query: 178 PIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND-NNKVIGTFGFIAPE----- 231
I RD+K IL ++ D +++ + ++ NN +GT ++APE
Sbjct: 133 AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDET 192
Query: 232 -YMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFL--QELVRKSIESNSFK 288
+ + ++ D+++FG +L E+ E+Y ++V SF+
Sbjct: 193 IQVDCFDSYKRVDIWAFGLVLWEVARRM-----VSNGIVEDYKPPFYDVVP---NDPSFE 244
Query: 289 EIVDPIIVGEEGLWPE------KEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340
++ +V + P + L S +L +C ++ R T +++ K L ++
Sbjct: 245 DMRK--VVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-32
Identities = 56/288 (19%), Positives = 107/288 (37%), Gaps = 41/288 (14%)
Query: 70 KLYKGFLQDRPISV-MKFGGNLNSEEYCCFNC-IAFASQMSHKNILKFVGCCLETELPIL 127
+ K ++ + MK + E F + + H N+LKF+G + +
Sbjct: 25 QAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84
Query: 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPS 187
+ E++ GTL I + + R+ A +IA+ +AYLH S I+ RD+
Sbjct: 85 ITEYIKGGTLRGIIKSMDS----QYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSH 137
Query: 188 TILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK-----------VIGTFGFIAPEYMSTA 236
L +E DF ++ + + KT V+G ++APE ++
Sbjct: 138 NCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR 197
Query: 237 NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIV 296
+ +EK DV+SFG +L E++ + ++ +
Sbjct: 198 SYDEKVDVFSFGIVLCEIIGRVNADP-------DYLPRTMDFGLNVRGFLDRYCPPNC-- 248
Query: 297 GEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKSI 344
P S+ + ++C + RP+ V++ L L +
Sbjct: 249 ------PP------SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-32
Identities = 61/301 (20%), Positives = 115/301 (38%), Gaps = 47/301 (15%)
Query: 70 KLYKGFLQDRPISVMKFGGNLNSEEYCCFNC---IAFASQMSHKNILKFVGCCLETELPI 126
+++ G + ++V F + E + I M H+NIL F+ ++
Sbjct: 52 EVWMGKWRGEKVAVKVF----FTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107
Query: 127 ----LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLH-----VGFSR 177
L+ ++ G+L D + K LK+A + + +LH
Sbjct: 108 TQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKP 161
Query: 178 PIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND-NNKVIGTFGFIAPE----- 231
I RD+K IL ++ D +++ V+ N +GT ++ PE
Sbjct: 162 AIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES 221
Query: 232 -YMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFL--QELVRKSIESNSFK 288
+ +D+YSFG +L E+ EEY L +LV S++
Sbjct: 222 LNRNHFQSYIMADMYSFGLILWEVARRC-----VSGGIVEEYQLPYHDLVP---SDPSYE 273
Query: 289 EIVDPIIVGEEGLWPE------KEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342
++ + IV + L P ++ L +L +C + + R T ++V K L ++ +
Sbjct: 274 DMRE--IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
Query: 343 S 343
S
Sbjct: 332 S 332
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-31
Identities = 60/245 (24%), Positives = 112/245 (45%), Gaps = 38/245 (15%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
+ H NIL F+G +L I V ++ +L +H F MK + +A +
Sbjct: 75 RKTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHASETK----FEMKKLIDIARQT 129
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
A + YLH ++ I+ RD+K + I E N K DF ++ + + + ++ G+
Sbjct: 130 ARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLA-TEKSRWSGSHQFEQLSGS 185
Query: 225 FGFIAPEYMSTAN---CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS 281
++APE + + + +SDVY+FG +L EL+TG ++ YS+
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG-QLPYSNI---------------- 228
Query: 282 IESNSFKEIVDPIIVGEEGLWPEKEKQLLS----YTELAIKCLSKSEQDRPTMVQVAKQL 337
N+ +I++ +VG L P+ K + L +CL K +RP+ ++ ++
Sbjct: 229 ---NNRDQIIE--MVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283
Query: 338 RQLHK 342
+L +
Sbjct: 284 EELAR 288
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 7e-31
Identities = 54/245 (22%), Positives = 88/245 (35%), Gaps = 43/245 (17%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
+ + H NI+ G CL+ LV EF G L + + A++I
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIP------PDILVNWAVQI 114
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQE--------QNVAKFFDFCVSISIPEGKTHVN 216
A + YLH PI+ RD+K S IL + + K DF ++ H
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-----HRT 169
Query: 217 DNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQE 276
G + ++APE + + ++ SDV+S+G LL ELLTG+ + +
Sbjct: 170 TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE-VPFRGI----------- 217
Query: 277 LVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQL-LSYTELAIKCLSKSEQDRPTMVQVAK 335
+ V L + +L C + RP+ +
Sbjct: 218 ---------DGLAVA--YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILD 266
Query: 336 QLRQL 340
QL +
Sbjct: 267 QLTTI 271
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-30
Identities = 41/251 (16%), Positives = 94/251 (37%), Gaps = 45/251 (17%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
Q H+N++ F+G C+ ++ TL + D + ++A EI
Sbjct: 84 RQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEI 139
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS--ISIPEGKTHVNDNNKVI 222
+ YLH ++ I+ +D+K + + V DF + + + +
Sbjct: 140 VKGMGYLH---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQN 195
Query: 223 GTFGFIAPEYMSTAN---------CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYF 273
G +APE + + ++ SDV++ G + EL + +
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE-WPF----------- 243
Query: 274 LQELVRKSIESNSFKEIVDPIIVGEEGLWPEKE--KQLLSYTELAIKCLSKSEQDRPTMV 331
++ + I+ + G + + K++ +++ + C + +++RPT
Sbjct: 244 ---------KTQPAEAIIWQMGTGMKPNLSQIGMGKEI---SDILLFCWAFEQEERPTFT 291
Query: 332 QVAKQLRQLHK 342
++ L +L K
Sbjct: 292 KLMDMLEKLPK 302
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 53/242 (21%), Positives = 92/242 (38%), Gaps = 42/242 (17%)
Query: 101 IAFASQMSHKNILKFVGCCLETELP----ILVFEFVACGTLADRIHDPNGSQLEPFLMKH 156
+ H NI++F T +LV E + GTL + +K
Sbjct: 76 AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKV 130
Query: 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN-VAKFFDFCVSISIPEGKTHV 215
+I + +LH + PI+ RD+K I K D ++
Sbjct: 131 LRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-----LKRA 184
Query: 216 NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQ 275
+ VIGT F+APE +E DVY+FG +LE+ T + YS C +N + +
Sbjct: 185 SFAKAVIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSE-YPYSEC-QNAAQIYR- 240
Query: 276 ELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335
V ++ SF ++ P + K+++ C+ +++ +R + K
Sbjct: 241 -RVTSGVKPASFDKVAIPEV-----------KEIIE------GCIRQNKDERYS----IK 278
Query: 336 QL 337
L
Sbjct: 279 DL 280
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-22
Identities = 48/158 (30%), Positives = 76/158 (48%), Gaps = 14/158 (8%)
Query: 104 ASQMSHKNILKF--VGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVA 161
+SQ+SH+NI+ V E + LV E++ TL++ I +G P + +
Sbjct: 65 SSQLSHQNIVSMIDVDE--EDDCYYLVMEYIEGPTLSEYIES-HG----PLSVDTAINFT 117
Query: 162 MEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKV 221
+I + + + H IV RDIKP IL K FDF I+ +T + N V
Sbjct: 118 NQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDF--GIAKALSETSLTQTNHV 172
Query: 222 IGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKR 259
+GT + +PE +E +D+YS G +L E+L G+
Sbjct: 173 LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 38/162 (23%), Positives = 65/162 (40%), Gaps = 24/162 (14%)
Query: 103 FASQMSHKNILK---FV--GCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHR 157
F +++ H +I++ FV + +V E+V +L L
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPV---AEA 184
Query: 158 LKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217
+ +EI A++YLH S +V+ D+KP I+ E+ + K D + +N
Sbjct: 185 IAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEEQL-KLIDLGAV-------SRINS 233
Query: 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKR 259
+ GT GF APE + +D+Y+ G L L
Sbjct: 234 FGYLYGTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDLP 274
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-21
Identities = 53/238 (22%), Positives = 102/238 (42%), Gaps = 27/238 (11%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
Q++H N++K+ +E +V E G L+ I Q + K +++
Sbjct: 87 KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH-FKKQKRLIPERTVWKYFVQL 145
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
+A+ ++H SR ++ RDIKP+ + V K D + T + ++GT
Sbjct: 146 CSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS---LVGT 199
Query: 225 FGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES 284
+++PE + N KSD++S G LL E+ + F G++ L L +K IE
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS-----PFY-GDKMNLYSLCKK-IEQ 252
Query: 285 NSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342
+ + + E+ +QL++ C++ + RP + V +++H
Sbjct: 253 CDYPPL-------PSDHYSEELRQLVN------MCINPDPEKRPDVTYVYDVAKRMHA 297
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 12/160 (7%)
Query: 104 ASQMSHKNILKF--VGC--CLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLK 159
A+ ++H I+ G LP +V E+V TL D +H G P K ++
Sbjct: 66 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EG----PMTPKRAIE 120
Query: 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNN 219
V + A+ + H I+ RD+KP+ I+ N K DF ++ +I + V
Sbjct: 121 VIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 220 KVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKR 259
VIGT +++PE + + +SDVYS G +L E+LTG+
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 47/233 (20%), Positives = 87/233 (37%), Gaps = 36/233 (15%)
Query: 109 HKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAV 168
H N++++ + + + E A TL + + + + L + + + + +
Sbjct: 77 HPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLG----LEPITLLQQTTSGL 131
Query: 169 AYLHVGFSRPIVFRDIKPSTILFQEQN-----VAKFFDFCVSISIPEGKTHVNDNNKVIG 223
A+LH S IV RD+KP IL N A DF + + G+ + + V G
Sbjct: 132 AHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188
Query: 224 TFGFIAPEYMS---TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280
T G+IAPE +S N D++S G + +++ + G+ Q +
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF------GKSLQRQANILL 242
Query: 281 SIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQV 333
S E ++L+ K ++ Q RP+ V
Sbjct: 243 GACSLDCLHP--------EKHEDVIARELIE------KMIAMDPQKRPSAKHV 281
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 53/267 (19%), Positives = 95/267 (35%), Gaps = 64/267 (23%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPI-------------LVFEFVACGTLADRIHDPNGS 147
+ + ++H+ ++++ LE + + E+ GTL D IH N +
Sbjct: 53 VMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN 112
Query: 148 QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF----- 202
Q ++ +I A++Y+H S+ I+ RD+KP I E K DF
Sbjct: 113 QQR----DEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKN 165
Query: 203 ------CVSISIPEGKTHVNDNNKVIGTFGFIAPEYMS-TANCNEKSDVYSFGALLLELL 255
+ + ++ IGT ++A E + T + NEK D+YS G + E++
Sbjct: 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
Query: 256 TGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWP---EKEKQLLSY 312
F G E N K++ I + EK+++
Sbjct: 226 YP--------FSTGME-----------RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIR- 265
Query: 313 TELAIKCLSKSEQDRPTMVQVAKQLRQ 339
+ RP A+ L
Sbjct: 266 -----LLIDHDPNKRPG----ARTLLN 283
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-20
Identities = 32/158 (20%), Positives = 60/158 (37%), Gaps = 14/158 (8%)
Query: 104 ASQMSHKNILKF--VGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVA 161
A ++ +++ G + + LA + L P + +
Sbjct: 88 AGRLQEPHVVPIHDFGE--IDGQLYVDMRLINGVDLAAMLRR--QGPLAP---PRAVAIV 140
Query: 162 MEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKV 221
+I +A+ H + RD+KP IL + A DF I+ +
Sbjct: 141 RQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDF--GIASATTDEKLTQLGNT 195
Query: 222 IGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKR 259
+GT ++APE S ++ ++D+Y+ +L E LTG
Sbjct: 196 VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-20
Identities = 61/250 (24%), Positives = 104/250 (41%), Gaps = 56/250 (22%)
Query: 105 SQMSHKNILKFVGCCLETELPI----------------LVFEFVACGTLADRIHDPNGSQ 148
+++ H NI+ + GC + + EF GTL I G +
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 149 L-EPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207
L + L++ +I V Y+H S+ ++ RD+KPS I + K DF + S
Sbjct: 119 LDKVLA----LELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171
Query: 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFE 267
+ + + GT +++PE +S+ + ++ D+Y+ G +L ELL + FE
Sbjct: 172 L----KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD----TAFE 223
Query: 268 NGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDR 327
S F ++ D II ++ +KEK LL K LSK +DR
Sbjct: 224 T---------------SKFFTDLRDGII---SDIFDKKEKTLLQ------KLLSKKPEDR 259
Query: 328 PTMVQVAKQL 337
P ++ + L
Sbjct: 260 PNTSEILRTL 269
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-20
Identities = 46/250 (18%), Positives = 88/250 (35%), Gaps = 51/250 (20%)
Query: 105 SQMSHKNILKFVGCCLETELPI------------LVFEFVACGTLADRIHDPNGSQLEPF 152
+++ H I+++ LE + + L D ++ +
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE- 116
Query: 153 LMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF---------C 203
L + ++IA AV +LH S+ ++ RD+KPS I F +V K DF
Sbjct: 117 -RSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYS 263
++ + +GT +++PE + + + K D++S G +L ELL
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP------ 226
Query: 264 SCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKS 323
F E + + + F + E ++ LS S
Sbjct: 227 --FSTQME---RVRTLTDVRNLKFPPLFTQK--------YPCEYVMVQ------DMLSPS 267
Query: 324 EQDRPTMVQV 333
+RP + +
Sbjct: 268 PMERPEAINI 277
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 34/230 (14%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQL-EPFLMKHRLKVAME 163
+ M H NI+++ E +V ++ G L RI+ G E + L ++
Sbjct: 78 ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI----LDWFVQ 133
Query: 164 IANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIG 223
I A+ ++H R I+ RDIK I + + DF ++ + IG
Sbjct: 134 ICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA---RACIG 187
Query: 224 TFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE 283
T +++PE N KSD+++ G +L EL T K FE G ++ LV K I
Sbjct: 188 TPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH-----AFEAGS---MKNLVLK-II 238
Query: 284 SNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQV 333
S SF + + + L + L+S + ++ +DRP++ +
Sbjct: 239 SGSFPPV--SLHYSYD-L-----RSLVS------QLFKRNPRDRPSVNSI 274
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 1e-19
Identities = 48/251 (19%), Positives = 86/251 (34%), Gaps = 39/251 (15%)
Query: 92 SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEP 151
S I S KN + + + + L D ++ +
Sbjct: 103 SPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162
Query: 152 FLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF--------- 202
L + ++IA AV +LH S+ ++ RD+KPS I F +V K DF
Sbjct: 163 H--GVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 203 CVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISY 262
++ + +GT +++PE + N + K D++S G +L ELL
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS----- 272
Query: 263 SSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSK 322
F E + + + + F + +E ++ LS
Sbjct: 273 ---FSTQME---RVRIITDVRNLKFPLLFTQK--------YPQEHMMVQ------DMLSP 312
Query: 323 SEQDRPTMVQV 333
S +RP +
Sbjct: 313 SPTERPEATDI 323
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-19
Identities = 48/253 (18%), Positives = 84/253 (33%), Gaps = 38/253 (15%)
Query: 101 IAFASQMSHKNILKFVGCCLETELP----ILVFEFVACGTLADRIHDPNGSQLEPFLMKH 156
+H NIL+ V CL L+ F GTL + I + +
Sbjct: 77 ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-ERLKDKGNFLTEDQ 135
Query: 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF------CVSISIPE 210
L + + I + +H ++ RD+KP+ IL ++ D C+ +
Sbjct: 136 ILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSR 192
Query: 211 GKTHVNDNNKVIGTFGFIAPEYMST---ANCNEKSDVYSFGALLLELLTGKRISYSSCFE 267
+ D T + APE S +E++DV+S G +L ++ G+ +
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE-----GPY- 246
Query: 268 NGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDR 327
+ F + N P QLL+ ++ R
Sbjct: 247 --DMVFQKGDSVALAVQNQLSIPQSPRH-------SSALWQLLN------SMMTVDPHQR 291
Query: 328 PTMVQVAKQLRQL 340
P + + QL L
Sbjct: 292 PHIPLLLSQLEAL 304
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 5e-19
Identities = 42/231 (18%), Positives = 70/231 (30%), Gaps = 24/231 (10%)
Query: 93 EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPF 152
E Y + +KF L +LV E + GTL + I+ + +
Sbjct: 110 EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVM 169
Query: 153 LMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA-----------KFFD 201
+ AM + + +H I+ DIKP + + D
Sbjct: 170 PQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALID 226
Query: 202 FCVSI---SIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
SI P+G T GF E +S N + D + A + +L G
Sbjct: 227 LGQSIDMKLFPKGTI----FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
Query: 259 RISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQL 309
Y G E + L R+ + + E ++ + L
Sbjct: 283 ---YMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLL 330
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-19
Identities = 48/247 (19%), Positives = 98/247 (39%), Gaps = 37/247 (14%)
Query: 105 SQMSHKNILKFVGCCLETELPIL--VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAM 162
++ H NI+++ ++ L V E+ G LA I + + + L+V
Sbjct: 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK-GTKERQYLDEEFVLRVMT 118
Query: 163 EIANAVAYLH--VGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
++ A+ H ++ RD+KP+ + + K DF ++ + +
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL---NHDTSFAKT 175
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280
+GT +++PE M+ + NEKSD++S G LL EL F +EL K
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP-----FTAFS---QKELAGK 227
Query: 281 SIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQ------VA 334
I F+ I + ++ ++++ + L+ + RP++ + +
Sbjct: 228 -IREGKFRRIPYR--------YSDELNEIIT------RMLNLKDYHRPSVEEILENPLIL 272
Query: 335 KQLRQLH 341
+ H
Sbjct: 273 EHHHHHH 279
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 8e-18
Identities = 40/257 (15%), Positives = 84/257 (32%), Gaps = 48/257 (18%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
A A H +++++ E + ++ E+ G+LAD I + N + F +
Sbjct: 62 YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISE-NYRIMSYFKEAELKDL 120
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK-------- 212
+++ + Y+H S +V DIKPS I ++
Sbjct: 121 LLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 213 ----THVNDNNKVIGTFGFIAPE-YMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFE 267
T ++ G F+A E K+D+++ ++ + +
Sbjct: 178 LGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL-----PR 232
Query: 268 NGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDR 327
NG+++ I I + ++ +LL + + R
Sbjct: 233 NGDQWH-------EIRQGRLPRI--------PQVLSQEFTELLK------VMIHPDPERR 271
Query: 328 PTMVQVAKQLRQLHKSI 344
P+ A L + H +
Sbjct: 272 PS----AMALVK-HSVL 283
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-17
Identities = 40/250 (16%), Positives = 74/250 (29%), Gaps = 64/250 (25%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
+ H ++ E + L E +L S E +
Sbjct: 108 GSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQV----WGY 162
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
+ A+A+LH S+ +V D+KP+ I + K DF + + +
Sbjct: 163 LRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL----GTAGAGEV 215
Query: 221 VIGTFGFIAPEYMS----TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQE 276
G P YM+ + +DV+S G +LE+ + GE + Q+
Sbjct: 216 QEGD-----PRYMAPELLQGSYGTAADVFSLGLTILEVACNMEL-----PHGGEGW--QQ 263
Query: 277 LVRKSIE-------SNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT 329
L + + S+ + ++ L + R T
Sbjct: 264 LRQGYLPPEFTAGLSSELRSVLV-------------------------MMLEPDPKLRAT 298
Query: 330 MVQVAKQLRQ 339
A+ L
Sbjct: 299 ----AEALLA 304
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 81.3 bits (200), Expect = 3e-17
Identities = 25/216 (11%), Positives = 65/216 (30%), Gaps = 41/216 (18%)
Query: 127 LVFEFVAC--GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDI 184
++ + T + + + S + + RL++ +++ +A LH +V +
Sbjct: 182 FLYPRMQSNLQTFGEVLLS-HSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYL 237
Query: 185 KPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMS-----TANCN 239
+P I+ ++ F + +G + V+ + A +
Sbjct: 238 RPVDIVLDQRGGVFLTGF--EHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMT 295
Query: 240 EKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEE 299
D ++ G + + + E + F+ +
Sbjct: 296 FAFDTWTLGLAIYWIWCAD-----LPNTDDAALGGSEWI--------FRSCKNI------ 336
Query: 300 GLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335
P+ + LL L ++DR +Q +
Sbjct: 337 ---PQPVRALLE------GFLRYPKEDRLLPLQAME 363
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 3e-17
Identities = 57/249 (22%), Positives = 101/249 (40%), Gaps = 52/249 (20%)
Query: 106 QMSHKNILKFVGCCLETELPIL-VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
Q SH NI++ +G C + + PI V E V G + G++L +K L++ +
Sbjct: 168 QYSHPNIVRLIGVCTQKQ-PIYIVMELVQGGDFLTFLRT-EGARLR---VKTLLQMVGDA 222
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVI-- 222
A + YL S+ + RD+ L E+NV K DF +S +G + + +
Sbjct: 223 AAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPV 279
Query: 223 -GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS 281
T APE ++ + +SDV+SFG LL E + Y + N + R+
Sbjct: 280 KWT----APEALNYGRYSSESDVWSFGILLWETFSLGASPYPN-LSNQQ-------TREF 327
Query: 282 IESNSFKEIVDPIIVGEEGLW-------PEKEKQLLSYTELAIKCLSKSEQDRPTMVQVA 334
+ E+G P+ +L+ +C + RP+ +
Sbjct: 328 V---------------EKGGRLPCPELCPDAVFRLME------QCWAYEPGQRPSFSTIY 366
Query: 335 KQLRQLHKS 343
++L+ + K
Sbjct: 367 QELQSIRKR 375
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 4e-17
Identities = 33/162 (20%), Positives = 61/162 (37%), Gaps = 11/162 (6%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
+ + +S I+ G E + E + G+L I G E +
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALY----Y 155
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ-NVAKFFDFCVS--ISIPEGKTHVND 217
+ + YLH +R I+ D+K +L + A DF + + +
Sbjct: 156 LGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212
Query: 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKR 259
+ + GT +APE + C+ K D++S ++L +L G
Sbjct: 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-17
Identities = 42/164 (25%), Positives = 66/164 (40%), Gaps = 15/164 (9%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGS--QLEPFLMKHRL 158
IA + HKNI++++G E + E V G+L+ + G E +
Sbjct: 70 IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG---- 125
Query: 159 KVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN-VAKFFDFCVSISIPEGKTHVND 217
+I + YLH IV RDIK +L + V K DF S +
Sbjct: 126 FYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET 182
Query: 218 NNKVIGTFGFIAPE--YMSTANCNEKSDVYSFGALLLELLTGKR 259
GT ++APE + +D++S G ++E+ TGK
Sbjct: 183 ---FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 30/242 (12%), Positives = 71/242 (29%), Gaps = 54/242 (22%)
Query: 107 MSHKNILKFVGCCLETELPILVFEFVAC----GTLADRIHDPNGSQLEPFLMKHRLKVAM 162
K +++ + + F + T + + + S + + RL++ +
Sbjct: 155 PQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS-HSSTHKSLVHHARLQLTL 213
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVI 222
++ +A LH +V ++P I+ ++ F + +G V
Sbjct: 214 QVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGF--EHLVRDGARVV-----SS 263
Query: 223 GTFGFIAPEYMSTANC-----------NEKSDVYSFGALLLELLTGKRISYSSCFENGEE 271
+ GF PE + D ++ G ++ +
Sbjct: 264 VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP-----ITKDAA 318
Query: 272 YFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMV 331
E + +S ++ P+ + LL L ++DR +
Sbjct: 319 LGGSEWIFRSCKN-----------------IPQPVRALLE------GFLRYPKEDRLLPL 355
Query: 332 QV 333
Q
Sbjct: 356 QA 357
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 5e-16
Identities = 28/224 (12%), Positives = 57/224 (25%), Gaps = 31/224 (13%)
Query: 127 LVFEFVAC--GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDI 184
L+ + L + + + + ++ A L S+ +V
Sbjct: 165 LLMPAASVDLELLFSTLDFVYVFR-GDEGILALHILTAQLIRLAANLQ---SKGLVHGHF 220
Query: 185 KPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYM--STANCNEKS 242
P + D S G + E++ STA
Sbjct: 221 TPDNLFIMPDGRLMLGDV--SALWKVGTRG----PASSVPVTYAPREFLNASTATFTHAL 274
Query: 243 DVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLW 302
+ + G + + F R S+ D + G
Sbjct: 275 NAWQLGLSIYRVWCLFLP-----FGLVTPGIKGSWKRPSLRVPGT----DSLAFGSCTPL 325
Query: 303 PEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK--QLRQLHKSI 344
P+ K L+ + L+ + R ++ + + QL I
Sbjct: 326 PDFVKTLIG------RFLNFDRRRRLLPLEAMETPEFLQLQNEI 363
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 9e-16
Identities = 44/157 (28%), Positives = 64/157 (40%), Gaps = 16/157 (10%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIA 165
+ H NI+K + LV E G L D I F + ++
Sbjct: 92 LLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI-----IHRMKFNEVDAAVIIKQVL 146
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILFQ---EQNVAKFFDFCVSISIPEGKTHVNDNNKVI 222
+ V YLH IV RD+KP +L + + + K DF +S K + +
Sbjct: 147 SGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM----KERL 199
Query: 223 GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKR 259
GT +IAPE + +EK DV+S G +L LL G
Sbjct: 200 GTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYP 235
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 16/155 (10%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIA 165
Q+ H NI+K + LV E G L D I + F ++ ++
Sbjct: 82 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-----ISRKRFSEVDAARIIRQVL 136
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILFQ---EQNVAKFFDFCVSISIPEGKTHVNDNNKVI 222
+ + Y+H IV RD+KP +L + + + DF +S K I
Sbjct: 137 SGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM----KDKI 189
Query: 223 GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
GT +IAPE + +EK DV+S G +L LL+G
Sbjct: 190 GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 38/157 (24%), Positives = 72/157 (45%), Gaps = 8/157 (5%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIA 165
++ H N+++ +G C ++ EF+ G L D + + N ++ L +A +I+
Sbjct: 272 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA---VVLLYMATQIS 328
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTF 225
+A+ YL + + R++ L E ++ K DF +S + + K
Sbjct: 329 SAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PI 383
Query: 226 GFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISY 262
+ APE ++ + KSDV++FG LL E+ T Y
Sbjct: 384 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 50/249 (20%), Positives = 96/249 (38%), Gaps = 47/249 (18%)
Query: 109 HKNILKFVGCCLETELPI-LVFEFVACGTLADRI--HDPNGSQLEPFLMKHRLKVAMEIA 165
H N++++ C T+ + + E L D + + + L+ + + + +IA
Sbjct: 68 HPNVIRYY-CSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILF-------------QEQNVAKFFDFCVSISIPEGK 212
+ VA+LH S I+ RD+KP IL E DF + + G+
Sbjct: 126 SGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 213 THVNDN-NKVIGTFGFIAPEYMSTAN-------CNEKSDVYSFGALLLELLTGKRISYSS 264
+ N N GT G+ APE + +N D++S G + +L+ + +
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF-- 240
Query: 265 CFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSE 324
G++Y + + + I S + + + E L+S + +
Sbjct: 241 ----GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEA------TDLIS------QMIDHDP 284
Query: 325 QDRPTMVQV 333
RPT ++V
Sbjct: 285 LKRPTAMKV 293
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 45/157 (28%), Positives = 64/157 (40%), Gaps = 16/157 (10%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIA 165
+ H NI+K + + LV EF G L ++I F + +I
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-----INRHKFDECDAANIMKQIL 156
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILFQ---EQNVAKFFDFCVSISIPEGKTHVNDNNKVI 222
+ + YLH IV RDIKP IL + K DF +S + +
Sbjct: 157 SGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL----RDRL 209
Query: 223 GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKR 259
GT +IAPE + NEK DV+S G ++ LL G
Sbjct: 210 GTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYP 245
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-15
Identities = 21/156 (13%), Positives = 44/156 (28%), Gaps = 40/156 (25%)
Query: 104 ASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAME 163
S++ + + + ++V E++ G+L + P ++
Sbjct: 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSP---VGAIRAMQS 137
Query: 164 IANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIG 223
+A A H + PS + +S D + V+
Sbjct: 138 LAAAADAAH---RAGVALSIDHPSRVR---------------VS--------IDGDVVLA 171
Query: 224 TFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKR 259
+ N + D+ GA L LL +
Sbjct: 172 YPATMPDA-------NPQDDIRGIGASLYALLVNRW 200
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-15
Identities = 43/162 (26%), Positives = 64/162 (39%), Gaps = 19/162 (11%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDPNGSQLEPFLMKHRLKVAM 162
S+ +H+NI++ +G L++ ++ E +A G L R P SQ M L VA
Sbjct: 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTIL---FQEQNVAKFFDFCVSISIPEGKTHVNDNN 219
+IA YL + RDI L VAK DF ++ I +
Sbjct: 148 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY----- 199
Query: 220 KVIGTFGFI-----APEYMSTANCNEKSDVYSFGALLLELLT 256
G + PE K+D +SFG LL E+ +
Sbjct: 200 -RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-15
Identities = 38/205 (18%), Positives = 77/205 (37%), Gaps = 22/205 (10%)
Query: 61 KVITKDLLYKLYKG-FLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCC 119
K K LL K + IS+ + +E + + + ++ L G
Sbjct: 60 KKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNE-------LQIITDIKNEYCLTCEGI- 111
Query: 120 LETELPI-LVFEFVACGTLADRIHDP---NGSQLEPFLMKHRLKVAMEIANAVAYLHVGF 175
+ + +++E++ ++ + + ++ + + N+ +Y+H
Sbjct: 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--N 169
Query: 176 SRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST 235
+ I RD+KPS IL + K DF S + + K GT+ F+ PE+ S
Sbjct: 170 EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-----GSRGTYEFMPPEFFSN 224
Query: 236 ANC--NEKSDVYSFGALLLELLTGK 258
+ K D++S G L +
Sbjct: 225 ESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 5e-15
Identities = 33/161 (20%), Positives = 59/161 (36%), Gaps = 22/161 (13%)
Query: 109 HKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAV 168
I++ + + +V E L + S + + AV
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK-KKSIDPWERKSY----WKNMLEAV 140
Query: 169 AYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFI 228
+H IV D+KP+ L + + K DF ++ + T V ++ +GT ++
Sbjct: 141 HTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS-QVGTVNYM 195
Query: 229 APE-----------YMSTANCNEKSDVYSFGALLLELLTGK 258
PE S + + KSDV+S G +L + GK
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 6e-15
Identities = 45/281 (16%), Positives = 82/281 (29%), Gaps = 61/281 (21%)
Query: 101 IAFASQMSHKNILKFVGCCL-ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLK 159
+ + +H NI+ + + + EL + V F+A G+ D L+
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWV-VTSFMAYGSAKD-------------LICTHFM 122
Query: 160 VAME---IA-------NAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209
M IA A+ Y+H V R +K S IL ++S+
Sbjct: 123 DGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179
Query: 210 EG----KTHVNDNNKVIGTFGFIAPEYMSTANC--NEKSDVYSFGALLLELLTGK----- 258
+ + + +++PE + + KSD+YS G EL G
Sbjct: 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239
Query: 259 ----------------RISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLW 302
+ +S E + + P +
Sbjct: 240 MPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPS 299
Query: 303 PEKEKQL-LSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342
+ + +CL ++ RP+ A L H
Sbjct: 300 HPYHRTFSPHFHHFVEQCLQRNPDARPS----ASTLLN-HS 335
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 7e-15
Identities = 45/253 (17%), Positives = 86/253 (33%), Gaps = 48/253 (18%)
Query: 107 MSHKNILKFVGCCLETELP-------ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLK 159
H NI++F + L+ + G L + + P LK
Sbjct: 83 SGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK--KMESRGPLSCDTVLK 140
Query: 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS---------ISIPE 210
+ + AV ++H PI+ RD+K +L Q K DF + +
Sbjct: 141 IFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199
Query: 211 GKTHVNDNNKVIGTFGFIAPEYMSTANC---NEKSDVYSFGALLLELLTGKRISYSSCFE 267
+ V + T + PE + + EK D+++ G +L L + FE
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ-----HPFE 254
Query: 268 NGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDR 327
+G + I + + P + Q + L L + ++R
Sbjct: 255 DG--------AKLRIVNGKYS-------------IPPHDTQYTVFHSLIRAMLQVNPEER 293
Query: 328 PTMVQVAKQLRQL 340
++ +V QL+++
Sbjct: 294 LSIAEVVHQLQEI 306
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 7e-15
Identities = 43/162 (26%), Positives = 64/162 (39%), Gaps = 19/162 (11%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDPNGSQLEPFLMKHRLKVAM 162
S+ +H+NI++ +G L++ ++ E +A G L R P SQ M L VA
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTIL---FQEQNVAKFFDFCVSISIPEGKTHVNDNN 219
+IA YL + RDI L VAK DF ++ I +
Sbjct: 189 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY----- 240
Query: 220 KVIGTFGFI-----APEYMSTANCNEKSDVYSFGALLLELLT 256
G + PE K+D +SFG LL E+ +
Sbjct: 241 -RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 9e-15
Identities = 31/157 (19%), Positives = 63/157 (40%), Gaps = 19/157 (12%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEP---FLMKHRLKVAM 162
+ H ++ + ++++EF++ G L +++ D + E M+
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR------- 262
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA--KFFDFCVSISIPEGKTHVNDNNK 220
++ + ++H V D+KP I+F + K DF ++ + ++
Sbjct: 263 QVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV----KV 315
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
GT F APE +D++S G L LL+G
Sbjct: 316 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 52/261 (19%), Positives = 92/261 (35%), Gaps = 40/261 (15%)
Query: 101 IAFASQMSHKNILKFVGCCL-ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLK 159
+ + + I+ F G + E+ I E + G+L D++ G E L K
Sbjct: 82 LQVLHECNSPYIVGFYGAFYSDGEISI-CMEHMDGGSL-DQVLKKAGRIPEQILGK---- 135
Query: 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNN 219
V++ + + YL I+ RD+KPS IL + K DF VS + + N
Sbjct: 136 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-----N 188
Query: 220 KVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR 279
+GT +++PE + + + +SD++S G L+E+ G R E V
Sbjct: 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG-RYPIPPPDAKELELMFGCQVE 247
Query: 280 KSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIK--------------------- 318
+ + + G+ + + +
Sbjct: 248 GDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK 307
Query: 319 CLSKSEQDRPTMVQVAKQLRQ 339
CL K+ +R KQL
Sbjct: 308 CLIKNPAERAD----LKQLMV 324
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 11/158 (6%)
Query: 106 QMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
++ H+ +++ +E PI +V E+++ G+L D + G L + + +A +I
Sbjct: 318 KLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL---VDMAAQI 372
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
A+ +AY+ V RD++ + IL E V K DF ++ I + + K
Sbjct: 373 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--P 427
Query: 225 FGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISY 262
+ APE KSDV+SFG LL EL T R+ Y
Sbjct: 428 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-14
Identities = 44/212 (20%), Positives = 73/212 (34%), Gaps = 45/212 (21%)
Query: 61 KVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGC-- 118
KV + +Q R V+K +++HKNI+K
Sbjct: 40 KVFNNISFLRPVD--VQMREFEVLK--------------------KLNHKNIVKLFAIEE 77
Query: 119 CLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRP 178
T +L+ EF CG+L + +P S L V ++ + +L
Sbjct: 78 ETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 179 IVFRDIKPSTILFQ----EQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMS 234
IV R+IKP I+ Q+V K DF + + + + + GT ++ P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF----VSLYGTEEYLHPDMYE 188
Query: 235 TANC--------NEKSDVYSFGALLLELLTGK 258
A D++S G TG
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 51/199 (25%), Positives = 78/199 (39%), Gaps = 35/199 (17%)
Query: 61 KVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCL 120
KV+ K L K L E + S + H NIL+ G
Sbjct: 40 KVLFKAQLEK-------------AGVEHQLRRE-------VEIQSHLRHPNILRLYGY-F 78
Query: 121 ETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPI 179
+ L+ E+ GT+ + +L F + E+ANA++Y H S+ +
Sbjct: 79 HDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SKRV 130
Query: 180 VFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCN 239
+ RDIKP +L K DF S+ P + + GT ++ PE + +
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-----LCGTLDYLPPEMIEGRMHD 185
Query: 240 EKSDVYSFGALLLELLTGK 258
EK D++S G L E L GK
Sbjct: 186 EKVDLWSLGVLCYEFLVGK 204
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 43/156 (27%), Positives = 67/156 (42%), Gaps = 18/156 (11%)
Query: 106 QMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
++ H NI+K E +V E G L D I + + F ++ ++
Sbjct: 77 KLDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEI-----IKRKRFSEHDAARIIKQV 130
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQ---EQNVAKFFDFCVSISIPEGKTHVNDNNKV 221
+ + Y+H IV RD+KP IL + + K DF +S +
Sbjct: 131 FSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM----KDR 183
Query: 222 IGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
IGT +IAPE + +EK DV+S G +L LL+G
Sbjct: 184 IGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 11/158 (6%)
Query: 106 QMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
++ H+ +++ +E PI +V E+++ G+L D + G L + + +A +I
Sbjct: 235 KLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL---VDMAAQI 289
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
A+ +AY+ V RD++ + IL E V K DF ++ I + + K
Sbjct: 290 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--P 344
Query: 225 FGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISY 262
+ APE KSDV+SFG LL EL T R+ Y
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 41/210 (19%), Positives = 72/210 (34%), Gaps = 48/210 (22%)
Query: 61 KVITKDLLYKLYKGFLQD--RPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGC 118
K++ +D R S+ + H +I++ +
Sbjct: 55 KIVDVAKFTSSPGLSTEDLKREASICH--------------------MLKHPHIVELLET 94
Query: 119 CLETELPI-LVFEFVACGTLADRIHDPNGSQLEPF-------LMKHRLKVAMEIANAVAY 170
++ + +VFEF+ L I + M+ I A+ Y
Sbjct: 95 Y-SSDGMLYMVFEFMDGADLCFEIVK-RADAGFVYSEAVASHYMRQ-------ILEALRY 145
Query: 171 LHVGFSRPIVFRDIKPSTILFQEQNVA---KFFDFCVSISIPEGKTHVNDNNKVIGTFGF 227
H I+ RD+KP +L + + K F V+I + E +GT F
Sbjct: 146 CH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG---RVGTPHF 199
Query: 228 IAPEYMSTANCNEKSDVYSFGALLLELLTG 257
+APE + + DV+ G +L LL+G
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 41/155 (26%), Positives = 63/155 (40%), Gaps = 15/155 (9%)
Query: 105 SQMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAME 163
S + H NIL+ I L+ EF G L + + F + E
Sbjct: 69 SHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL-----QKHGRFDEQRSATFMEE 122
Query: 164 IANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIG 223
+A+A+ Y H R ++ RDIKP +L + K DF S+ P + + G
Sbjct: 123 LADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT-----MCG 174
Query: 224 TFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
T ++ PE + +EK D++ G L E L G
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 4e-14
Identities = 44/212 (20%), Positives = 72/212 (33%), Gaps = 45/212 (21%)
Query: 61 KVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGC-- 118
KV + Q R V+K +++HKNI+K
Sbjct: 40 KVFNNISFLRPVDV--QMREFEVLK--------------------KLNHKNIVKLFAIEE 77
Query: 119 CLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRP 178
T +L+ EF CG+L + +P S L V ++ + +L
Sbjct: 78 ETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 179 IVFRDIKPSTILFQ----EQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMS 234
IV R+IKP I+ Q+V K DF + + + + + GT ++ P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF----VSLYGTEEYLHPDMYE 188
Query: 235 TANC--------NEKSDVYSFGALLLELLTGK 258
A D++S G TG
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 5e-14
Identities = 39/164 (23%), Positives = 64/164 (39%), Gaps = 22/164 (13%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEP---FLMKH 156
+ Q+ H +IL+ E + LV E G + + + E M
Sbjct: 62 VKIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH- 119
Query: 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF--CVSISIPEGKTH 214
+I + YLH S I+ RD+ S +L K DF + +P K +
Sbjct: 120 ------QIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY 170
Query: 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
+ GT +I+PE + + +SDV+S G + LL G+
Sbjct: 171 T-----LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 5e-14
Identities = 35/171 (20%), Positives = 66/171 (38%), Gaps = 24/171 (14%)
Query: 101 IAFASQMSHKN--ILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRL 158
IA+ +++ + I++ + + +V E L + S +
Sbjct: 58 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK-KKSIDPWERKSY-- 113
Query: 159 KVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDN 218
+ AV +H IV D+KP+ L + + K DF ++ + T V +
Sbjct: 114 --WKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKD 167
Query: 219 NKVIGTFGFIAPE-----------YMSTANCNEKSDVYSFGALLLELLTGK 258
+ +GT ++ PE S + + KSDV+S G +L + GK
Sbjct: 168 S-QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 6e-14
Identities = 39/159 (24%), Positives = 62/159 (38%), Gaps = 24/159 (15%)
Query: 106 QMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEP---FLMKHRLKVA 161
+ H NI++ E I LV E G L +R+ E +MK
Sbjct: 62 SLDHPNIIRLYETF-EDNTDIYLVMELCTGGELFERVVH-KRVFRESDAARIMKD----- 114
Query: 162 MEIANAVAYLHVGFSRPIVFRDIKPSTILFQ---EQNVAKFFDFCVSISIPEGKTHVNDN 218
+ +AVAY H + RD+KP LF + K DF ++ GK
Sbjct: 115 --VLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---- 165
Query: 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
+GT +++P+ + + D +S G ++ LL G
Sbjct: 166 RTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCG 203
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 9e-14
Identities = 34/171 (19%), Positives = 65/171 (38%), Gaps = 24/171 (14%)
Query: 101 IAFASQMSHKN--ILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRL 158
IA+ +++ + I++ + + +V E L + S +
Sbjct: 105 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK-KKSIDPWERKSY-- 160
Query: 159 KVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDN 218
+ AV +H IV D+KP+ L + + K DF ++ + T V +
Sbjct: 161 --WKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKD 214
Query: 219 NKVIGTFGFIAPE-----------YMSTANCNEKSDVYSFGALLLELLTGK 258
+ +G ++ PE S + + KSDV+S G +L + GK
Sbjct: 215 S-QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 41/156 (26%), Positives = 70/156 (44%), Gaps = 14/156 (8%)
Query: 106 QMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
+ H NI+K E + +V E G L +RI ++ + + ++ ++
Sbjct: 76 SLDHPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVS-AQARGKALSEGYVAELMKQM 133
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQ---EQNVAKFFDFCVSISIPEGKTHVNDNNKV 221
NA+AY H S+ +V +D+KP ILFQ + K DF ++ +
Sbjct: 134 MNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS----TNA 186
Query: 222 IGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
GT ++APE + K D++S G ++ LLTG
Sbjct: 187 AGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 70.9 bits (173), Expect = 1e-13
Identities = 45/210 (21%), Positives = 82/210 (39%), Gaps = 44/210 (20%)
Query: 61 KVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCL 120
K ++L K + I +MK +++H N++
Sbjct: 45 KQCRQELSPKNRE--RWCLEIQIMK--------------------KLNHPNVVSAR-EVP 81
Query: 121 ETE-------LPILVFEFVACGTLADRIHDP-NGSQLEPFLMKHRLKVAMEIANAVAYLH 172
+ LP+L E+ G L ++ N L+ + +I++A+ YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE---GPIRTLLSDISSALRYLH 138
Query: 173 VGFSRPIVFRDIKPSTILFQ---EQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIA 229
I+ RD+KP I+ Q ++ + K D + + +G+ + +GT ++A
Sbjct: 139 ---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL----CTEFVGTLQYLA 191
Query: 230 PEYMSTANCNEKSDVYSFGALLLELLTGKR 259
PE + D +SFG L E +TG R
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 37/162 (22%), Positives = 69/162 (42%), Gaps = 19/162 (11%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLAD-----RIHDPNGSQLEPFLMKHRLK 159
+ + ++++ +G + + +++ E + G L R N L P + ++
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNN 219
+A EIA+ +AYL+ + V RD+ + E K DF ++ I E +
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----- 194
Query: 220 KVIGTFGFI-----APEYMSTANCNEKSDVYSFGALLLELLT 256
G G + +PE + SDV+SFG +L E+ T
Sbjct: 195 -RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 12/159 (7%)
Query: 101 IAFASQMSHKNILKFVGCCL-ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLK 159
I+ Q +++K+ G T+L I V E+ G+++D I N + E +
Sbjct: 75 ISIMQQCDSPHVVKYYGSYFKNTDLWI-VMEYCGAGSVSDIIRLRNKTLTEDEIAT---- 129
Query: 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNN 219
+ + YLH + RDIK IL + AK DF V+ + + N
Sbjct: 130 ILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK---RN 183
Query: 220 KVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
VIGT ++APE + N +D++S G +E+ GK
Sbjct: 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 50/241 (20%), Positives = 77/241 (31%), Gaps = 67/241 (27%)
Query: 61 KVITKDLLYKLYKGFLQD--RPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGC 118
K++ K+ + ++ ++ + +MK ++ H NI +
Sbjct: 57 KIMNKNKIRQINPKDVERIKTEVRLMK--------------------KLHHPNIARLYEV 96
Query: 119 CLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAME-------------- 163
E E I LV E G L D+++ M
Sbjct: 97 -YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIH 155
Query: 164 ---------------------IANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA--KFF 200
I +A+ YLH ++ I RDIKP LF K
Sbjct: 156 GFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLV 212
Query: 201 DFCVSISIPEGKTHVNDN-NKVIGTFGFIAPEYMSTA--NCNEKSDVYSFGALLLELLTG 257
DF +S + GT F+APE ++T + K D +S G LL LL G
Sbjct: 213 DFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG 272
Query: 258 K 258
Sbjct: 273 A 273
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 48/207 (23%), Positives = 83/207 (40%), Gaps = 45/207 (21%)
Query: 61 KVITKDLLYKLYKGFLQD---RPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVG 117
K I K L +G ++ R +++++ ++ H NI+
Sbjct: 36 KFIKKRRLSSSRRGVSREEIEREVNILR--------------------EIRHPNIITLHD 75
Query: 118 CCLETELPILVFEFVACGTLADRIHDPNGSQLEP---FLMKHRLKVAMEIANAVAYLHVG 174
+L+ E V+ G L D + + S E +K I + V YLH
Sbjct: 76 IFENKTDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQ-------ILDGVHYLH-- 125
Query: 175 FSRPIVFRDIKPSTILFQEQNVA----KFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAP 230
S+ I D+KP I+ ++NV K DF ++ I G + GT F+AP
Sbjct: 126 -SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF----KNIFGTPEFVAP 180
Query: 231 EYMSTANCNEKSDVYSFGALLLELLTG 257
E ++ ++D++S G + LL+G
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 44/159 (27%), Positives = 65/159 (40%), Gaps = 24/159 (15%)
Query: 106 QMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEP---FLMKHRLKVA 161
++ H NI+K E +V E G L D I E ++K
Sbjct: 77 KLDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQ----- 129
Query: 162 MEIANAVAYLHVGFSRPIVFRDIKPSTILFQ---EQNVAKFFDFCVSISIPEGKTHVNDN 218
+ + + Y+H IV RD+KP IL + + K DF +S +
Sbjct: 130 --VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---- 180
Query: 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
IGT +IAPE + +EK DV+S G +L LL+G
Sbjct: 181 KDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 48/156 (30%), Positives = 66/156 (42%), Gaps = 17/156 (10%)
Query: 106 QMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
++SH NI+K ET I LV E V G L DRI + + + +I
Sbjct: 104 RLSHPNIIKLKEIF-ETPTEISLVLELVTGGELFDRI-----VEKGYYSERDAADAVKQI 157
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQ---EQNVAKFFDFCVSISIPEGKTHVNDNNKV 221
AVAYLH IV RD+KP +L+ K DF +S + V
Sbjct: 158 LEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM----KTV 210
Query: 222 IGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
GT G+ APE + + D++S G + LL G
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-13
Identities = 38/158 (24%), Positives = 68/158 (43%), Gaps = 21/158 (13%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEP---FLMKHRLKVAM 162
++ H NI++ E LVF+ V G L + I E ++
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQ------ 113
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILF---QEQNVAKFFDFCVSISIPEGKTHVNDNN 219
I ++AY H S IV R++KP +L + K DF ++I + + + +
Sbjct: 114 -ILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW----H 165
Query: 220 KVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
GT G+++PE + ++ D+++ G +L LL G
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-13
Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 22/159 (13%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEP---FLMKHRLKVAM 162
++ H N++ IL+ E VA G L D + + S E +K
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLK------- 121
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA----KFFDFCVSISIPEGKTHVNDN 218
+I N V YLH S I D+KP I+ ++NV K DF ++ I G
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---- 174
Query: 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
+ GT F+APE ++ ++D++S G + LL+G
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 39/159 (24%), Positives = 70/159 (44%), Gaps = 14/159 (8%)
Query: 101 IAFASQMSHKNILKFVGCCL-ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLK 159
I + + NI+ ++ L EL + V E++A G+L D + +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWV-VMEYLAGGSLTDVVTE------TCMDEGQIAA 120
Query: 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNN 219
V E A+ +LH S ++ RDIK IL K DF I ++ +
Sbjct: 121 VCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RS 174
Query: 220 KVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
++GT ++APE ++ K D++S G + +E++ G+
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 34/157 (21%), Positives = 62/157 (39%), Gaps = 19/157 (12%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEP---FLMKHRLKVAM 162
Q+ H ++ + +L+ EF++ G L DRI + E M+
Sbjct: 104 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR------- 156
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA--KFFDFCVSISIPEGKTHVNDNNK 220
+ + ++H IV DIKP I+ + + + K DF ++ + +
Sbjct: 157 QACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV----KV 209
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
T F APE + +D+++ G L LL+G
Sbjct: 210 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 43/161 (26%), Positives = 68/161 (42%), Gaps = 23/161 (14%)
Query: 105 SQMSHKNILKFVGCCLETELPIL-VFEFVACGTLAD--RIHDPNGSQLEPFLMKHRLKVA 161
SH N+L +G CL +E L V ++ G L + R N +K +
Sbjct: 81 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFG 134
Query: 162 MEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKV 221
+++A + YL S+ V RD+ + E+ K DF ++ + + + V
Sbjct: 135 LQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-----YDKEYYSV 186
Query: 222 IGTFGF------IAPEYMSTANCNEKSDVYSFGALLLELLT 256
G +A E + T KSDV+SFG LL EL+T
Sbjct: 187 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 4e-13
Identities = 45/164 (27%), Positives = 72/164 (43%), Gaps = 24/164 (14%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEP---FLMKH 156
IA ++ H+NI+ E+ LV + V+ G L DRI + G E +++
Sbjct: 57 IAVLKKIKHENIVTLEDIY-ESTTHYYLVMQLVSGGELFDRILE-RGVYTEKDASLVIQQ 114
Query: 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF---QEQNVAKFFDFCVSISIPEGKT 213
+ +AV YLH IV RD+KP +L+ +E + DF +S G
Sbjct: 115 -------VLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM 164
Query: 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
GT G++APE ++ ++ D +S G + LL G
Sbjct: 165 S-----TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-13
Identities = 40/159 (25%), Positives = 65/159 (40%), Gaps = 26/159 (16%)
Query: 109 HKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEP---FLMKHRLKVAMEI 164
H NI++ ET LVF+ + G L D + + + E +M+ +
Sbjct: 83 HPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRA-------L 133
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
+ LH IV RD+KP IL + K DF S + G+ +V GT
Sbjct: 134 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----REVCGT 186
Query: 225 FGFIAPE------YMSTANCNEKSDVYSFGALLLELLTG 257
++APE + ++ D++S G ++ LL G
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-13
Identities = 43/167 (25%), Positives = 68/167 (40%), Gaps = 24/167 (14%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDP--------NGSQLEPFLM 154
+ + H++I++F G C E ++VFE++ G L R H P P +
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 155 KHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214
L VA ++A + YL V RD+ L + V K DF +S I +
Sbjct: 158 GQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 214
Query: 215 VNDNNKVIGTFGFI-----APEYMSTANCNEKSDVYSFGALLLELLT 256
+G + PE + +SDV+SFG +L E+ T
Sbjct: 215 ------RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-13
Identities = 43/165 (26%), Positives = 72/165 (43%), Gaps = 11/165 (6%)
Query: 101 IAFASQMSHKNILKFVGCCL-ETELPILVFEFVACGTLAD--RIHDPNGSQLEPFLMKHR 157
I SQ H NI+ + + + EL + V + ++ G++ D + G L +
Sbjct: 64 IQAMSQCHHPNIVSYYTSFVVKDELWL-VMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 158 LKVAM-EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN 216
+ + E+ + YLH + RD+K IL E + DF VS + G
Sbjct: 123 IATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179
Query: 217 DN--NKVIGTFGFIAPEYMSTANC-NEKSDVYSFGALLLELLTGK 258
+ +GT ++APE M + K+D++SFG +EL TG
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 6e-13
Identities = 42/166 (25%), Positives = 72/166 (43%), Gaps = 28/166 (16%)
Query: 101 IAFASQMSHKNILKFVGCCL-ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLK 159
I SQ + K+ G L +T+L I + E++ G+ D L++
Sbjct: 71 ITVLSQCDSPYVTKYYGSYLKDTKLWI-IMEYLGGGSALD-------------LLEPGPL 116
Query: 160 VAMEIA-------NAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212
+IA + YLH S + RDIK + +L E K DF V+ + + +
Sbjct: 117 DETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173
Query: 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
N +GT ++APE + + + K+D++S G +EL G+
Sbjct: 174 ---IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 8e-13
Identities = 37/164 (22%), Positives = 67/164 (40%), Gaps = 23/164 (14%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEP---FLMKH 156
I+ ++H++++ F G E + +V E +L + + EP + ++
Sbjct: 66 ISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLR- 122
Query: 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF--CVSISIPEGKTH 214
+I YLH ++ RD+K + E K DF + +
Sbjct: 123 ------QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 173
Query: 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
V + GT +IAPE +S + + DV+S G ++ LL GK
Sbjct: 174 V-----LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 9e-13
Identities = 38/159 (23%), Positives = 69/159 (43%), Gaps = 23/159 (14%)
Query: 106 QMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEP---FLMKHRLKVA 161
++ H NI++ + E LVF+ V G L + I E ++
Sbjct: 84 KLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQ----- 136
Query: 162 MEIANAVAYLHVGFSRPIVFRDIKPSTILF---QEQNVAKFFDFCVSISIPEGKTHVNDN 218
I ++AY H S IV R++KP +L + K DF ++I + + +
Sbjct: 137 --ILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---- 187
Query: 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
+ GT G+++PE + ++ D+++ G +L LL G
Sbjct: 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 59/251 (23%), Positives = 97/251 (38%), Gaps = 39/251 (15%)
Query: 106 QMSHKNILKFVGCCLET-ELPI-LVFEFVACGTLAD--RIHDPNGSQLEPFLMKHRLKVA 161
+ I+K+ G + LV E++ G L D + H L +
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR------LDASRLLLYS 133
Query: 162 MEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH--VNDNN 219
+I + YL SR V RD+ IL + + K DF ++ +P K + V +
Sbjct: 134 SQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 190
Query: 220 KVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR 279
+ + APE +S + +SDV+SFG +L EL T S S E ++
Sbjct: 191 QS--PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE------FLRMMG 242
Query: 280 KSIESNSFKEIVDPIIVGEEG-------LWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQ 332
+ + +++ + EEG P + + EL C + S QDRP+
Sbjct: 243 CERDVPALSRLLELL---EEGQRLPAPPACPAE-----VH-ELMKLCWAPSPQDRPSFSA 293
Query: 333 VAKQLRQLHKS 343
+ QL L
Sbjct: 294 LGPQLDMLWSG 304
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 49/250 (19%), Positives = 101/250 (40%), Gaps = 32/250 (12%)
Query: 105 SQMSHKNILKFVGCCLET-ELPI-LVFEFVACGTLAD--RIHDPNGSQLEPFLMKHRLKV 160
+ H NI+K+ G C + L+ E++ G+L D + H L+
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER------IDHIKLLQY 150
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH--VNDN 218
+I + YL ++ + RD+ IL + +N K DF ++ +P+ K + V +
Sbjct: 151 TSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEP 207
Query: 219 NKVIGTFGF----IAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFL 274
+ APE ++ + + SDV+SFG +L EL T Y ++ F+
Sbjct: 208 GE------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-----YIEKSKSPPAEFM 256
Query: 275 QELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVA 334
+ + +++ + P+ + Y + +C + + RP+ +A
Sbjct: 257 RMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEI-Y-MIMTECWNNNVNQRPSFRDLA 314
Query: 335 KQLRQLHKSI 344
++ Q+ +
Sbjct: 315 LRVDQIRDQM 324
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-12
Identities = 48/257 (18%), Positives = 103/257 (40%), Gaps = 46/257 (17%)
Query: 105 SQMSHKNILKFVGCCLET-ELPI-LVFEFVACGTLAD--RIHDPNGSQLEPFLMKHRLKV 160
+ H NI+K+ G C + L+ E++ G+L D + H L+
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER------IDHIKLLQY 119
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH--VNDN 218
+I + YL ++ + RD+ IL + +N K DF ++ +P+ K V +
Sbjct: 120 TSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEP 176
Query: 219 NKVIGTFGF----IAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFL 274
+ APE ++ + + SDV+SFG +L EL T Y ++ F+
Sbjct: 177 GE------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-----YIEKSKSPPAEFM 225
Query: 275 QELVRKSIESNSFKEIVDPIIVGEEG-------LWPEKEKQLLSYTELAIKCLSKSEQDR 327
+ + +++ + + P++ +++ +C + + R
Sbjct: 226 RMIGNDKQGQMIVFHLIELL---KNNGRLPRPDGCPDEIYMIMT------ECWNNNVNQR 276
Query: 328 PTMVQVAKQLRQLHKSI 344
P+ +A ++ Q+ ++
Sbjct: 277 PSFRDLALRVDQIRDNM 293
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 37/159 (23%), Positives = 69/159 (43%), Gaps = 14/159 (8%)
Query: 101 IAFASQMSHKNILKFVGCCL-ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLK 159
+ H N+++ L EL + + EF+ G L D + +
Sbjct: 93 VVIMRDYQHFNVVEMYKSYLVGEELWV-LMEFLQGGALTDIVSQ------VRLNEEQIAT 145
Query: 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNN 219
V + A+AYLH ++ ++ RDIK +IL K DF I +
Sbjct: 146 VCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---RK 199
Query: 220 KVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
++GT ++APE +S + + D++S G +++E++ G+
Sbjct: 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 37/164 (22%), Positives = 67/164 (40%), Gaps = 23/164 (14%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEP---FLMKH 156
I+ ++H++++ F G E + +V E +L + + EP + ++
Sbjct: 92 ISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLR- 148
Query: 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF--CVSISIPEGKTH 214
+I YLH ++ RD+K + E K DF + +
Sbjct: 149 ------QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 199
Query: 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
V + GT +IAPE +S + + DV+S G ++ LL GK
Sbjct: 200 V-----LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 39/157 (24%), Positives = 67/157 (42%), Gaps = 19/157 (12%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEP---FLMKHRLKVAM 162
Q+ H N+++ +LV E+V G L DRI D + + E MK
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK------- 194
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA--KFFDFCVSISIPEGKTHVNDNNK 220
+I + ++H I+ D+KP IL ++ K DF ++ +
Sbjct: 195 QICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL----KV 247
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
GT F+APE ++ + +D++S G + LL+G
Sbjct: 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 39/159 (24%), Positives = 71/159 (44%), Gaps = 26/159 (16%)
Query: 109 HKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEP---FLMKHRLKVAMEI 164
H +I+ + E+ + LVF+ + G L D + + + E +M+ +
Sbjct: 159 HPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRS-------L 209
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
AV++LH + IV RD+KP IL + + DF S + G+ ++ GT
Sbjct: 210 LEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL----RELCGT 262
Query: 225 FGFIAPE------YMSTANCNEKSDVYSFGALLLELLTG 257
G++APE + ++ D+++ G +L LL G
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 40/159 (25%), Positives = 70/159 (44%), Gaps = 22/159 (13%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEP---FLMKHRLKVAM 162
Q+ H N++ +L+ E V+ G L D + S E +K
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIK------- 122
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA----KFFDFCVSISIPEGKTHVNDN 218
+I + V YLH ++ I D+KP I+ ++N+ K DF ++ I +G
Sbjct: 123 QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---- 175
Query: 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
+ GT F+APE ++ ++D++S G + LL+G
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 51/242 (21%), Positives = 98/242 (40%), Gaps = 48/242 (19%)
Query: 105 SQMSHKNILKFVGCCL-ETELPILVFEFVACGTLADRIHDPNGSQL-EPFLMKHRLKVAM 162
I++ G + T++ I E GT A+++ + E L K + +
Sbjct: 79 KSHDCPYIVQCFGTFITNTDVFI-AMEL--MGTCAEKLKKRMQGPIPERILGK----MTV 131
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVI 222
I A+ YL ++ RD+KPS IL E+ K DF +S + + K ++
Sbjct: 132 AIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK----DRSA 185
Query: 223 GTFGFIAPEYMSTANCNE-----KSDVYSFGALLLELLTGK--RISYSSCFENGEEYFLQ 275
G ++APE + + + ++DV+S G L+EL TG+ + + FE L
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-----VLT 240
Query: 276 ELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335
+++++ +P ++ + + + CL+K + RP
Sbjct: 241 KVLQE-----------EPPLLPGHMGFSGDFQSFVK------DCLTKDHRKRPK----YN 279
Query: 336 QL 337
+L
Sbjct: 280 KL 281
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 35/155 (22%), Positives = 62/155 (40%), Gaps = 14/155 (9%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIA 165
+ H NI++ E L+F+ V G L + I E + +I
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI-----VAREYYSEADASHCIQQIL 120
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILF---QEQNVAKFFDFCVSISIPEGKTHVNDNNKVI 222
AV + H +V R++KP +L + K DF ++I + +
Sbjct: 121 EAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG---FA 174
Query: 223 GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
GT G+++PE + + D+++ G +L LL G
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 42/161 (26%), Positives = 69/161 (42%), Gaps = 23/161 (14%)
Query: 105 SQMSHKNILKFVGCCLETELPIL-VFEFVACGTLAD--RIHDPNGSQLEPFLMKHRLKVA 161
SH N+L +G CL +E L V ++ G L + R N +K +
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFG 198
Query: 162 MEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKV 221
+++A + +L S+ V RD+ + E+ K DF ++ + + + + V
Sbjct: 199 LQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-----YDKEFDSV 250
Query: 222 I-GTFGFI-----APEYMSTANCNEKSDVYSFGALLLELLT 256
T + A E + T KSDV+SFG LL EL+T
Sbjct: 251 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 3e-12
Identities = 34/157 (21%), Positives = 64/157 (40%), Gaps = 19/157 (12%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEP---FLMKHRLKVAM 162
H+NIL E +++FEF++ + +RI+ E +
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH------- 109
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA--KFFDFCVSISIPEGKTHVNDNNK 220
++ A+ +LH S I DI+P I++Q + + K +F + + G
Sbjct: 110 QVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF----RL 162
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
+ + APE + +D++S G L+ LL+G
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-12
Identities = 53/248 (21%), Positives = 93/248 (37%), Gaps = 47/248 (18%)
Query: 109 HKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEP---FLMKHRLKVAMEI 164
H+N+L+ + E E LVFE + G++ IH E +++ +
Sbjct: 70 HRNVLELIEFF-EEEDRFYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQD-------V 120
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQN---VAKFFDFCVSISIPEGKTHVNDNNK- 220
A+A+ +LH ++ I RD+KP IL + N K DF + I +
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 221 ---VIGTFGFIAPE-----YMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEY 272
G+ ++APE + +++ D++S G +L LL+G C +
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC--- 234
Query: 273 FLQELVRKSIESNSFKEIVDPIIVGE----EGLWP---EKEKQLLSYTELAIKCLSKSEQ 325
R + + I G+ + W K L+S K L + +
Sbjct: 235 ---GWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLIS------KLLVRDAK 285
Query: 326 DRPTMVQV 333
R + QV
Sbjct: 286 QRLSAAQV 293
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 4e-12
Identities = 45/161 (27%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 106 QMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
+ H ++K T+ PI ++ EF+A G+L D + GS+ + + +I
Sbjct: 239 TLQHDKLVKLHAVV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL---PKLIDFSAQI 293
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
A +A++ R + RD++ + IL V K DF ++ I + + + K
Sbjct: 294 AEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-- 348
Query: 225 FGFI---APEYMSTANCNEKSDVYSFGALLLELLTGKRISY 262
I APE ++ + KSDV+SFG LL+E++T RI Y
Sbjct: 349 ---IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 386
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 33/165 (20%)
Query: 105 SQMSHKNILKFVGCCLET-ELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV-- 160
+ H++I+K+ GCC + + LV E+V G+L D +L +H + +
Sbjct: 88 RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD------------YLPRHSIGLAQ 135
Query: 161 ----AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH-- 214
A +I +AYLH ++ + RD+ +L + K DF ++ ++PEG +
Sbjct: 136 LLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 192
Query: 215 VNDNNKVIGTFGFI---APEYMSTANCNEKSDVYSFGALLLELLT 256
V ++ + APE + SDV+SFG L ELLT
Sbjct: 193 VREDGDSP-----VFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 5e-12
Identities = 45/162 (27%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 106 QMSHKNILKFVGCCLETELPIL-VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
Q+ H+ +++ T+ PI + E++ G+L D + P+G +L + L +A +I
Sbjct: 64 QLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGIKLT---INKLLDMAAQI 118
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
A +A++ R + RD++ + IL + K DF ++ I + + + K
Sbjct: 119 AEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK---- 171
Query: 225 FGF----IAPEYMSTANCNEKSDVYSFGALLLELLTGKRISY 262
F APE ++ KSDV+SFG LL E++T RI Y
Sbjct: 172 --FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 5e-12
Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 22/159 (13%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEP---FLMKHRLKVAM 162
Q+ H NI+ +L+ E V+ G L D + S E +K
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIK------- 122
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA----KFFDFCVSISIPEGKTHVNDN 218
+I + V YLH ++ I D+KP I+ ++N+ K DF ++ I +G
Sbjct: 123 QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---- 175
Query: 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
+ GT F+APE ++ ++D++S G + LL+G
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 5e-12
Identities = 43/165 (26%), Positives = 69/165 (41%), Gaps = 25/165 (15%)
Query: 108 SHKNILKFVGCCLETELPILVFEFVACGTL-----------ADRIHDPNGSQLEPFLMKH 156
HKNI+ +G C + ++ E+ + G L + +D N E K
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN 216
+ ++A + YL S+ + RD+ +L E NV K DF ++ I +
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI-----NNI 210
Query: 217 DNNKVIGTFGFI-----APEYMSTANCNEKSDVYSFGALLLELLT 256
D K T G + APE + +SDV+SFG L+ E+ T
Sbjct: 211 DYYKK-TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 6e-12
Identities = 47/160 (29%), Positives = 75/160 (46%), Gaps = 17/160 (10%)
Query: 106 QMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
Q+ H N+++ +G +E + + +V E++A G+L D + S L LK ++++
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG---DCLLKFSLDV 298
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
A+ YL V RD+ +L E NVAK DF G T + + G
Sbjct: 299 CEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDF--------GLTKEASSTQDTGK 347
Query: 225 FGF--IAPEYMSTANCNEKSDVYSFGALLLELLTGKRISY 262
APE + + KSDV+SFG LL E+ + R+ Y
Sbjct: 348 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 387
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 7e-12
Identities = 33/159 (20%), Positives = 62/159 (38%), Gaps = 20/159 (12%)
Query: 107 MSHKNILKFVGCCLETELPI-----LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVA 161
+I+ + E ++ E + G L RI + + F + ++
Sbjct: 79 SGGPHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQE---RGDQAFTEREAAEIM 134
Query: 162 MEIANAVAYLHVGFSRPIVFRDIKPSTILFQ---EQNVAKFFDFCVSISIPEGKTHVNDN 218
+I A+ +LH S I RD+KP +L+ + V K DF + +
Sbjct: 135 RDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ---- 187
Query: 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
T ++APE + ++ D++S G ++ LL G
Sbjct: 188 -TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 7e-12
Identities = 40/166 (24%), Positives = 69/166 (41%), Gaps = 26/166 (15%)
Query: 108 SHKNILKFVGCCLETELPI-LVFEFVACGTLAD--RIHDPNGSQL---------EPFLMK 155
H N++ +G C + P+ ++ EF G L+ R + ++
Sbjct: 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 156 HRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHV 215
H + + ++A + +L SR + RD+ IL E+NV K DF ++ I
Sbjct: 149 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDI------Y 199
Query: 216 NDNNKVIGTFGFI-----APEYMSTANCNEKSDVYSFGALLLELLT 256
D + V + APE + +SDV+SFG LL E+ +
Sbjct: 200 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 7e-12
Identities = 38/153 (24%), Positives = 66/153 (43%), Gaps = 16/153 (10%)
Query: 109 HKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANA 167
H NI+K +L LV E + G L +RI + + F + ++ +A
Sbjct: 65 HPNIVKLHEVF-HDQLHTFLVMELLNGGELFERIK-----KKKHFSETEASYIMRKLVSA 118
Query: 168 VAYLHVGFSRPIVFRDIKPSTILF---QEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
V+++H +V RD+KP +LF + K DF + P + T
Sbjct: 119 VSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT---PCFT 172
Query: 225 FGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
+ APE ++ +E D++S G +L +L+G
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 8e-12
Identities = 43/168 (25%), Positives = 67/168 (39%), Gaps = 31/168 (18%)
Query: 108 SHKNILKFVGCCLETELPILVFEFVACGTL-----------ADRIHDPNGSQLEPFLMKH 156
HKNI+ +G C + ++ E+ + G L + +D N E K
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG---KT 213
+ ++A + YL S+ + RD+ +L E NV K DF G
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADF--------GLARDI 253
Query: 214 HVNDNNKVIGTFGFI-----APEYMSTANCNEKSDVYSFGALLLELLT 256
+ D K T G + APE + +SDV+SFG L+ E+ T
Sbjct: 254 NNIDYYKK-TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 9e-12
Identities = 42/161 (26%), Positives = 64/161 (39%), Gaps = 25/161 (15%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEP---FLMKHRLKVAM 162
+++H I+K + E +V E + G L D++ N E
Sbjct: 196 KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQ------ 247
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN---VAKFFDFCVSISIPEGKTHVNDNN 219
+ AV YLH I+ RD+KP +L Q + K DF S + E
Sbjct: 248 -MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM----R 299
Query: 220 KVIGTFGFIAPE---YMSTANCNEKSDVYSFGALLLELLTG 257
+ GT ++APE + TA N D +S G +L L+G
Sbjct: 300 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 33/165 (20%), Positives = 63/165 (38%), Gaps = 23/165 (13%)
Query: 105 SQMSHKNILKFVGCCLETE------LPILVFEFVACGTLAD--RIHDPNGSQLEPFLMKH 156
+ H ++ K VG L + +P+++ F+ G L + ++
Sbjct: 80 KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP-FNLPLQT 138
Query: 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN 216
++ ++IA + YL SR + RD+ + E DF +S I G +
Sbjct: 139 LVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY-- 193
Query: 217 DNNKVIGTFGFI-----APEYMSTANCNEKSDVYSFGALLLELLT 256
G + A E ++ SDV++FG + E++T
Sbjct: 194 ----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 40/161 (24%), Positives = 72/161 (44%), Gaps = 16/161 (9%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIA 165
++ H N+++ +G C ++ EF+ G L D + + N ++ L +A +I+
Sbjct: 65 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS---AVVLLYMATQIS 121
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTF 225
+A+ YL + + RD+ L E ++ K DF +S + + K
Sbjct: 122 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK----- 173
Query: 226 GF----IAPEYMSTANCNEKSDVYSFGALLLELLTGKRISY 262
F APE ++ + KSDV++FG LL E+ T Y
Sbjct: 174 -FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 42/161 (26%), Positives = 64/161 (39%), Gaps = 25/161 (15%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEP---FLMKHRLKVAM 162
+++H I+K + E +V E + G L D++ N E
Sbjct: 71 KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQ------ 122
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN---VAKFFDFCVSISIPEGKTHVNDNN 219
+ AV YLH I+ RD+KP +L Q + K DF S + E
Sbjct: 123 -MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM----R 174
Query: 220 KVIGTFGFIAPE---YMSTANCNEKSDVYSFGALLLELLTG 257
+ GT ++APE + TA N D +S G +L L+G
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 35/164 (21%), Positives = 65/164 (39%), Gaps = 22/164 (13%)
Query: 105 SQMSHKNILKFVGCCLETE-----LPILVFEFVACGTLAD--RIHDPNGSQLEPFLMKHR 157
SH N+++ +G C+E P+++ F+ G L + ++
Sbjct: 91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGP-KHIPLQTL 149
Query: 158 LKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217
LK ++IA + YL +R + RD+ + ++ DF +S I G +
Sbjct: 150 LKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY--- 203
Query: 218 NNKVIGTFGFI-----APEYMSTANCNEKSDVYSFGALLLELLT 256
G + A E ++ KSDV++FG + E+ T
Sbjct: 204 ---RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 36/157 (22%), Positives = 61/157 (38%), Gaps = 19/157 (12%)
Query: 109 HKNILKFVGCCLETELPI-----LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAME 163
+I++ V E +V E + G L RI D + F + ++
Sbjct: 114 CPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKS 169
Query: 164 IANAVAYLHVGFSRPIVFRDIKPSTILFQ---EQNVAKFFDFCVSISIPEGKTHVNDNNK 220
I A+ YLH S I RD+KP +L+ + K DF + +
Sbjct: 170 IGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL----TT 222
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
T ++APE + ++ D++S G ++ LL G
Sbjct: 223 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-11
Identities = 43/168 (25%), Positives = 72/168 (42%), Gaps = 25/168 (14%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDPNGSQL---------EPFL 153
+ + H++I+KF G C + + I+VFE++ G L R H P+ L
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 154 MKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213
+ L +A +IA+ + YL S+ V RD+ L + K DF +S +
Sbjct: 132 LSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188
Query: 214 HVNDNNKVIGTFGFI-----APEYMSTANCNEKSDVYSFGALLLELLT 256
+ +G + PE + +SDV+SFG +L E+ T
Sbjct: 189 Y------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 37/157 (23%), Positives = 58/157 (36%), Gaps = 21/157 (13%)
Query: 108 SHKNILKFVGCCLETELPILVFEFVACGTLADRI-HDPNGSQLEP---FLMKHRLKVAME 163
S ++ T IL+ E+ A G + + E L+K
Sbjct: 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ------- 139
Query: 164 IANAVAYLHVGFSRPIVFRDIKPSTILFQ---EQNVAKFFDFCVSISIPEGKTHVNDNNK 220
I V YLH IV D+KP IL K DF +S I +
Sbjct: 140 ILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL----RE 192
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
++GT ++APE ++ +D+++ G + LLT
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 3e-11
Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 17/162 (10%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
++SH +++ G CLE LV EF+ G L+D + G F + L + +++
Sbjct: 58 MKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL----FAAETLLGMCLDV 113
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
+AYL ++ RD+ L E V K DF ++ + + + + K
Sbjct: 114 CEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK---- 166
Query: 225 FGF----IAPEYMSTANCNEKSDVYSFGALLLELLTGKRISY 262
F +PE S + + KSDV+SFG L+ E+ + +I Y
Sbjct: 167 --FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 206
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 45/165 (27%), Positives = 72/165 (43%), Gaps = 25/165 (15%)
Query: 108 SHKNILKFVGCCLETELPILVFEFVACGTL-----------ADRIHDPNGSQLEPFLMKH 156
HKNI+ +G C + ++ E+ + G L + ++P+ + E K
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN 216
+ A ++A + YL S+ + RD+ +L E NV K DF ++ I H
Sbjct: 193 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHI 244
Query: 217 DNNKVIGTFGFI-----APEYMSTANCNEKSDVYSFGALLLELLT 256
D K T G + APE + +SDV+SFG LL E+ T
Sbjct: 245 DYYKK-TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 50/245 (20%), Positives = 91/245 (37%), Gaps = 53/245 (21%)
Query: 105 SQMSHKNILKFVGCCL-ETELPILVFEFVACGT----LADRIHDPNGSQLEPFLMKHRLK 159
+ + F G E ++ I E T ++ D + E L K
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWI-CMEL--MDTSLDKFYKQVIDKGQTIPEDILGK---- 113
Query: 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK-THVNDN 218
+A+ I A+ +LH ++ RD+KPS +L K DF +S G
Sbjct: 114 IAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGIS-----GYLVDDVAK 166
Query: 219 NKVIGTFGFIAPE----YMSTANCNEKSDVYSFGALLLELLTGK--RISYSSCFENGEEY 272
+ G ++APE ++ + KSD++S G ++EL + S+ + F+
Sbjct: 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ----- 221
Query: 273 FLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQ 332
L+++V +P + + S +CL K+ ++RPT
Sbjct: 222 QLKQVVE------------EPSPQLPADKFSAEFVDFTS------QCLKKNSKERPT--- 260
Query: 333 VAKQL 337
+L
Sbjct: 261 -YPEL 264
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 5e-11
Identities = 36/164 (21%), Positives = 74/164 (45%), Gaps = 21/164 (12%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDPNGSQLEPFLMKHRLKVAM 162
+SH+ +++ G C + ++ E++A G L + R F + L++
Sbjct: 74 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH------RFQTQQLLEMCK 127
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVI 222
++ A+ YL S+ + RD+ L +Q V K DF +S + + + + +K
Sbjct: 128 DVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK-- 182
Query: 223 GTFGF----IAPEYMSTANCNEKSDVYSFGALLLELLTGKRISY 262
F PE + + + KSD+++FG L+ E+ + ++ Y
Sbjct: 183 ----FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 6e-11
Identities = 47/161 (29%), Positives = 74/161 (45%), Gaps = 23/161 (14%)
Query: 105 SQMSHKNILKFVGCCLETEL-PI-LVFEFVACGTLAD--RIHDPNGSQLEPFLMKHRLKV 160
+ H+NI+K+ G C E I L+ EF+ G+L + + +K +LK
Sbjct: 78 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK------INLKQQLKY 131
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT--HVNDN 218
A++I + YL SR V RD+ +L + ++ K DF ++ +I K V D+
Sbjct: 132 AVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD 188
Query: 219 NKVIGTFGFI---APEYMSTANCNEKSDVYSFGALLLELLT 256
+ APE + + SDV+SFG L ELLT
Sbjct: 189 RDSP-----VFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 7e-11
Identities = 39/164 (23%), Positives = 61/164 (37%), Gaps = 28/164 (17%)
Query: 109 HKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDPNGSQL---------EPFLMKHR 157
H NI+ +G C L E+ G L D R + +
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 158 LKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217
L A ++A + YL + + RD+ IL E VAK DF G + +
Sbjct: 145 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADF--------GLSRGQE 193
Query: 218 NNKVIGTFGFI-----APEYMSTANCNEKSDVYSFGALLLELLT 256
T G + A E ++ + SDV+S+G LL E+++
Sbjct: 194 VYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 8e-11
Identities = 32/158 (20%), Positives = 68/158 (43%), Gaps = 16/158 (10%)
Query: 106 QMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
+ + ++ + +G CL + + L+ + + G L D + + + ++ L ++I
Sbjct: 73 SVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQI 126
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
A + YL R +V RD+ +L + K DF ++ + + + G
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG---GK 180
Query: 225 FGF--IAPEYMSTANCNEKSDVYSFGALLLELLT-GKR 259
+A E + +SDV+S+G + EL+T G +
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 37/163 (22%), Positives = 69/163 (42%), Gaps = 23/163 (14%)
Query: 108 SHKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDP-------NGSQLEPFLMKHRL 158
H+NI+ +G C +++ E+ G L + R + L
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 159 KVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDN 218
+ ++A +A+L S+ + RD+ +L +VAK DF ++ I +ND+
Sbjct: 168 HFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI------MNDS 218
Query: 219 NKVIGTFGFI-----APEYMSTANCNEKSDVYSFGALLLELLT 256
N ++ + APE + +SDV+S+G LL E+ +
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 38/157 (24%), Positives = 64/157 (40%), Gaps = 23/157 (14%)
Query: 109 HKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEP---FLMKHRLKVAMEI 164
H NI+ + + +V E + G L D+I E ++ I
Sbjct: 75 HPNIITLKDVY-DDGKYVYVVTELMKGGELLDKILR-QKFFSEREASAVLFT-------I 125
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQN----VAKFFDFCVSISIPEGKTHVNDNNK 220
V YLH ++ +V RD+KPS IL+ +++ + DF + + +
Sbjct: 126 TKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--- 179
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
T F+APE + + D++S G LL +LTG
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 1e-10
Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 17/160 (10%)
Query: 106 QMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
Q+ H N+++ +G +E + + +V E++A G+L D + S L + LK ++++
Sbjct: 70 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL---LKFSLDV 126
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
A+ YL V RD+ +L E NVAK DF G T + + G
Sbjct: 127 CEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDF--------GLTKEASSTQDTGK 175
Query: 225 FGF--IAPEYMSTANCNEKSDVYSFGALLLELLTGKRISY 262
APE + + KSDV+SFG LL E+ + R+ Y
Sbjct: 176 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 37/167 (22%), Positives = 67/167 (40%), Gaps = 27/167 (16%)
Query: 108 SHKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDPNGSQL-----------EPFLM 154
+H NI+ +G C +++ E+ G L + R + +
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 155 KHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214
+ L + ++A +A+L S+ + RD+ IL + K DF ++ I
Sbjct: 145 EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDI------ 195
Query: 215 VNDNNKVIGTFGFI-----APEYMSTANCNEKSDVYSFGALLLELLT 256
ND+N V+ + APE + +SDV+S+G L EL +
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 41/162 (25%), Positives = 67/162 (41%), Gaps = 20/162 (12%)
Query: 101 IAFASQMSHKNILKFVGCCL-ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLK 159
+ F ++ H N +++ GC L E + V E+ G+ +D + E +
Sbjct: 105 VRFLQKLRHPNTIQYRGCYLREHTAWL-VMEYCL-GSASDLLEVHKKPLQEVEIAA---- 158
Query: 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNN 219
V +AYLH S ++ RD+K IL E + K DF + + +
Sbjct: 159 VTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------ 209
Query: 220 KVIGTFGFIAPE---YMSTANCNEKSDVYSFGALLLELLTGK 258
+GT ++APE M + K DV+S G +EL K
Sbjct: 210 -FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 39/167 (23%), Positives = 71/167 (42%), Gaps = 23/167 (13%)
Query: 101 IAFASQMSHKNILKFVGCCL-ETELPILVFEFVACGTLADRIHDPNGSQLEP---FLMKH 156
I + H I+K +G + +L I + EF G + + + + EP + +
Sbjct: 67 IEILATCDHPYIVKLLGAYYHDGKLWI-MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQ 125
Query: 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN 216
L+ A+ +LH S+ I+ RD+K +L + + DF VS +
Sbjct: 126 MLE-------ALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN---LKTLQ 172
Query: 217 DNNKVIGTFGFIAPE-----YMSTANCNEKSDVYSFGALLLELLTGK 258
+ IGT ++APE M + K+D++S G L+E+ +
Sbjct: 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 2e-10
Identities = 37/161 (22%), Positives = 73/161 (45%), Gaps = 15/161 (9%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
++SH ++KF G C + +V E+++ G L + + +G LEP + L++ ++
Sbjct: 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS-HGKGLEPSQL---LEMCYDV 113
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
+A+L S + RD+ L K DF ++ + + + + K
Sbjct: 114 CEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP-- 168
Query: 225 FGFI---APEYMSTANCNEKSDVYSFGALLLELLTGKRISY 262
+ APE + KSDV++FG L+ E+ + ++ Y
Sbjct: 169 ---VKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY 206
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 39/161 (24%), Positives = 61/161 (37%), Gaps = 23/161 (14%)
Query: 105 SQMSHKNILKFVGCCLETELPIL-VFEFVACGTLAD--RIHDPNGSQLEPFLMKHRLKVA 161
++H N+L +G L E + ++ G L R N +K +
Sbjct: 77 RGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN------PTVKDLISFG 130
Query: 162 MEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKV 221
+++A + YL + V RD+ + E K DF ++ I + V
Sbjct: 131 LQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDI-----LDREYYSV 182
Query: 222 IGTFG------FIAPEYMSTANCNEKSDVYSFGALLLELLT 256
+ A E + T KSDV+SFG LL ELLT
Sbjct: 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 2e-10
Identities = 26/168 (15%), Positives = 64/168 (38%), Gaps = 25/168 (14%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDPNGSQL---------EPFL 153
+++ H N++ +G + + ++F + + G L + + P+
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 154 MKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213
+ + +IA + YL S +V +D+ +L ++ K D + +
Sbjct: 127 PPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 183
Query: 214 HVNDNNKVIGTFGFI-----APEYMSTANCNEKSDVYSFGALLLELLT 256
+ + + APE + + SD++S+G +L E+ +
Sbjct: 184 Y------KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 37/155 (23%), Positives = 66/155 (42%), Gaps = 16/155 (10%)
Query: 105 SQMSHKNILKFVGCCLETELPI-LVFEFVACGTLAD--RIHDPNGSQLEPFLMKHRLKVA 161
Q H +I+K +G TE P+ ++ E G L ++ + + A
Sbjct: 446 RQFDHPHIVKLIGVI--TENPVWIIMELCTLGELRSFLQVRKF------SLDLASLILYA 497
Query: 162 MEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKV 221
+++ A+AYL S+ V RDI +L + K DF +S + + + K+
Sbjct: 498 YQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 554
Query: 222 IGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
++APE ++ SDV+ FG + E+L
Sbjct: 555 --PIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 3e-10
Identities = 39/160 (24%), Positives = 74/160 (46%), Gaps = 14/160 (8%)
Query: 106 QMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
+ H+N+++ G L P+ +V E G+L DR+ G FL+ + A+++
Sbjct: 77 SLDHRNLIRLYGVVLTP--PMKMVTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQV 130
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS--ISIPEGKTHVNDNNKVI 222
A + YL S+ + RD+ +L +++ K DF + + + + ++ KV
Sbjct: 131 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV- 186
Query: 223 GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISY 262
F + APE + T + SD + FG L E+ T + +
Sbjct: 187 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 225
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-10
Identities = 52/242 (21%), Positives = 86/242 (35%), Gaps = 43/242 (17%)
Query: 105 SQMSHKNILKFVGCCL-ETELPILVFEFVACGT-LADRIHDPNGSQLEPFLMKHRLKVAM 162
I++F G E + I E T + + K+ +
Sbjct: 76 RSSDCPYIVQFYGALFREGDCWI-CMEL--MSTSFDKFYKYVYSVLDDVIPEEILGKITL 132
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK-THVNDNNKV 221
A+ +L + I+ RDIKPS IL K DF +S G+ +
Sbjct: 133 ATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS-----GQLVDSIAKTRD 185
Query: 222 IGTFGFIAPEYMSTANCNE----KSDVYSFGALLLELLTGK--RISYSSCFENGEEYFLQ 275
G ++APE + + + +SDV+S G L EL TG+ ++S F+ L
Sbjct: 186 AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLT 240
Query: 276 ELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335
++V+ + EE + ++ CL+K E RP K
Sbjct: 241 QVVKG--DPPQLSN-------SEEREFSPSFINFVN------LCLTKDESKRPK----YK 281
Query: 336 QL 337
+L
Sbjct: 282 EL 283
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 43/176 (24%), Positives = 71/176 (40%), Gaps = 33/176 (18%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDP-----------------N 145
++ + NI+K +G C + L+FE++A G L + R P +
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 146 GSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205
P +L +A ++A +AYL R V RD+ L E V K DF +S
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLS 221
Query: 206 ISIPEGKTHVNDNNKVIGTFGFI-----APEYMSTANCNEKSDVYSFGALLLELLT 256
+I + D K I PE + +SDV+++G +L E+ +
Sbjct: 222 RNI-----YSADYYKA-DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 5e-10
Identities = 36/174 (20%), Positives = 66/174 (37%), Gaps = 37/174 (21%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDPNGSQLEPFLMKHRLKVAM 162
S++SHK+++ G C+ + ILV EFV G+L + + + +L+VA
Sbjct: 67 SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN------CINILWKLEVAK 120
Query: 163 EIANAVAYLHVGFSRPIVFRDI--------KPSTILFQEQNVAKFFDFCVSISIPEGKTH 214
++A A+ +L ++ ++ + K D +SI++
Sbjct: 121 QLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP---- 173
Query: 215 VNDNNKVIGTFGFI---APEYMSTANCNE---KSDVYSFGALLLELLTGKRISY 262
D + I PE N +D +SFG L E+ +G
Sbjct: 174 -KDILQER-----IPWVPPE--CIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 6e-10
Identities = 30/100 (30%), Positives = 45/100 (45%), Gaps = 10/100 (10%)
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVI 222
E+ A+ YL ++ I+ RD+KP IL E DF ++ +P +
Sbjct: 123 ELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI----TTMA 175
Query: 223 GTFGFIAPEYMSTANCNEKS---DVYSFGALLLELLTGKR 259
GT ++APE S+ S D +S G ELL G+R
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 8e-10
Identities = 33/157 (21%), Positives = 70/157 (44%), Gaps = 21/157 (13%)
Query: 106 QMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
+ H +I++ +G C + + LV +++ G+L D + G+ + L ++I
Sbjct: 71 SLDHAHIVRLLGLCPGS--SLQLVTQYLPLGSLLDHVRQHRGA----LGPQLLLNWGVQI 124
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
A + YL +V R++ +L + + + DF V+ +P D+ +++ +
Sbjct: 125 AKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP------PDDKQLLYS 175
Query: 225 FGFI-----APEYMSTANCNEKSDVYSFGALLLELLT 256
A E + +SDV+S+G + EL+T
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 31/154 (20%), Positives = 66/154 (42%), Gaps = 15/154 (9%)
Query: 106 QMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
+ + ++ + +G CL + + L+ + + G L D + + + ++ L ++I
Sbjct: 73 SVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQI 126
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
A + YL R +V RD+ +L + K DF ++ + + + G
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG---GK 180
Query: 225 FGF--IAPEYMSTANCNEKSDVYSFGALLLELLT 256
+A E + +SDV+S+G + EL+T
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 1e-09
Identities = 41/179 (22%), Positives = 65/179 (36%), Gaps = 39/179 (21%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDPNGSQLEPFL--------- 153
Q++H +++K G C + +L+ E+ G+L R G
Sbjct: 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 154 --------MKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205
M + A +I+ + YL +V RD+ IL E K DF
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDF--- 194
Query: 206 ISIPEG---KTHVNDNNKVIGTFGFI-----APEYMSTANCNEKSDVYSFGALLLELLT 256
G + D+ + G I A E + +SDV+SFG LL E++T
Sbjct: 195 -----GLSRDVYEEDSYVK-RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 2e-09
Identities = 36/157 (22%), Positives = 60/157 (38%), Gaps = 20/157 (12%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
+ H +I+K +G E E ++ E G L + S + + +++I
Sbjct: 68 KNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNS----LKVLTLVLYSLQI 122
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
A+AYL S V RDI IL K DF +S I D + +
Sbjct: 123 CKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYI-------EDEDYYKAS 172
Query: 225 FGFI-----APEYMSTANCNEKSDVYSFGALLLELLT 256
+ +PE ++ SDV+ F + E+L+
Sbjct: 173 VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 35/133 (26%), Positives = 59/133 (44%), Gaps = 14/133 (10%)
Query: 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKP 186
+ + + G L + SQ F A EI + ++H +R +V+RD+KP
Sbjct: 269 FILDLMNGGDLHYHL-----SQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKP 320
Query: 187 STILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKS-DVY 245
+ IL E + D ++ + K H +GT G++APE + + S D +
Sbjct: 321 ANILLDEHGHVRISDLGLACDFSKKKPH-----ASVGTHGYMAPEVLQKGVAYDSSADWF 375
Query: 246 SFGALLLELLTGK 258
S G +L +LL G
Sbjct: 376 SLGCMLFKLLRGH 388
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 4e-09
Identities = 37/155 (23%), Positives = 67/155 (43%), Gaps = 16/155 (10%)
Query: 105 SQMSHKNILKFVGCCLETELPI-LVFEFVACGTLAD--RIHDPNGSQLEPFLMKHRLKVA 161
Q H +I+K +G TE P+ ++ E G L ++ + + + A
Sbjct: 71 RQFDHPHIVKLIGVI--TENPVWIIMELCTLGELRSFLQVRKYS------LDLASLILYA 122
Query: 162 MEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKV 221
+++ A+AYL S+ V RDI +L + K DF +S + + + K+
Sbjct: 123 YQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 179
Query: 222 IGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
++APE ++ SDV+ FG + E+L
Sbjct: 180 --PIKWMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 39/163 (23%), Positives = 65/163 (39%), Gaps = 24/163 (14%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIA 165
Q H NI++ G L ++V E++ G+L + +G F + + + +
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ----FTIMQLVGMLRGVG 161
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTF 225
+ YL V RD+ +L V K DF +S + + + + T
Sbjct: 162 AGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED-----DPDAAYTTTG 213
Query: 226 GFI-----APEYMSTANCNE---KSDVYSFGALLLELLT-GKR 259
G I APE SDV+SFG ++ E+L G+R
Sbjct: 214 GKIPIRWTAPE---AIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 5e-09
Identities = 46/170 (27%), Positives = 74/170 (43%), Gaps = 21/170 (12%)
Query: 101 IAFASQMS-HKNILKFVGCCLETELPI------LVFEFVACGTLADRIHDPNGSQLEPFL 153
I + S H+NI + G ++ P LV EF G++ D I + G+ L+
Sbjct: 71 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE-- 128
Query: 154 MKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213
+ + EI +++LH ++ RDIK +L E K DF VS +
Sbjct: 129 -EWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DR 181
Query: 214 HVNDNNKVIGTFGFIAPEYMSTANC-----NEKSDVYSFGALLLELLTGK 258
V N IGT ++APE ++ + KSD++S G +E+ G
Sbjct: 182 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 5e-09
Identities = 40/164 (24%), Positives = 66/164 (40%), Gaps = 22/164 (13%)
Query: 107 MSHKNILKFVGC--------CLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHR 157
M K IL V ET+ + LV + G + R H N + P + R
Sbjct: 233 MVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPR 290
Query: 158 LKV-AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF--CVSISIPEGKTH 214
+I + + +LH R I++RD+KP +L + + D V + + KT
Sbjct: 291 AIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK 347
Query: 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
GT GF+APE + + D ++ G L E++ +
Sbjct: 348 -----GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 7e-09
Identities = 40/172 (23%), Positives = 68/172 (39%), Gaps = 32/172 (18%)
Query: 108 SHKNILKFVGCCLETELPILVFEFVACGTL------------------ADRIHDPNGSQL 149
SH+NI+ +G C + L+FE+ G L ++ L
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 150 EPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209
+ L A ++A + +L + V RD+ +L V K DF ++ I
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDI- 222
Query: 210 EGKTHVNDNNKVIGTFGFI-----APEYMSTANCNEKSDVYSFGALLLELLT 256
++D+N V+ + APE + KSDV+S+G LL E+ +
Sbjct: 223 -----MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 9e-09
Identities = 53/223 (23%), Positives = 80/223 (35%), Gaps = 30/223 (13%)
Query: 51 KAATNNYDPE----KVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNC---IAF 103
K A N D KV++K L + + P G IA
Sbjct: 30 KLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89
Query: 104 ASQMSHKNILKFV---GCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
++ H N++K V E L +VFE V G + + +P
Sbjct: 90 LKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTL------KPLSEDQARFY 142
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS--ISIPEGKTHVNDN 218
++ + YLH + I+ RDIKPS +L E K DF VS +
Sbjct: 143 FQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLS---- 195
Query: 219 NKVIGTFGFIAPEYMSTANCN---EKSDVYSFGALLLELLTGK 258
+GT F+APE +S + DV++ G L + G+
Sbjct: 196 -NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 9e-09
Identities = 46/185 (24%), Positives = 79/185 (42%), Gaps = 24/185 (12%)
Query: 107 MSHKNILKFVGC--------CLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHR 157
++ K IL+ V ET+ + LV + G L I+ F
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH---MGQAGFPEARA 288
Query: 158 LKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217
+ A EI + LH IV+RD+KP IL + + D +++ +PEG+T
Sbjct: 289 VFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---- 341
Query: 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL 277
+GT G++APE + D ++ G LL E++ G+ S F+ ++ +E
Sbjct: 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ-----SPFQQRKKKIKREE 396
Query: 278 VRKSI 282
V + +
Sbjct: 397 VERLV 401
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 40/164 (24%), Positives = 70/164 (42%), Gaps = 24/164 (14%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDPNGSQLEPFLMKHRLKVAM 162
Q H NI++ G +++ ++V E++ G+L R HD + ++ M
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM------LR 154
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVI 222
IA+ + YL V RD+ IL V K DF + + + D
Sbjct: 155 GIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED------DPEAAY 205
Query: 223 GTFG------FIAPEYMSTANCNEKSDVYSFGALLLELLT-GKR 259
T G + +PE ++ SDV+S+G +L E+++ G+R
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 40/165 (24%), Positives = 62/165 (37%), Gaps = 37/165 (22%)
Query: 107 MSHKNILKF--VGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRL----- 158
++H NI+K V +ETE + L+ E+ + G + D + R+
Sbjct: 71 LNHPNIVKLFEV---IETEKTLYLIMEYASGGEVFDYLVA-----------HGRMKEKEA 116
Query: 159 -KVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG---KTH 214
+I +AV Y H + IV RD+K +L K DF S G
Sbjct: 117 RSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF 173
Query: 215 VNDNNKVIGTFGFIAPEYMS-TANCNEKSDVYSFGALLLELLTGK 258
G + APE + DV+S G +L L++G
Sbjct: 174 C-------GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 42/167 (25%), Positives = 69/167 (41%), Gaps = 30/167 (17%)
Query: 105 SQMSHKNILKFVGCCLETELPILVFEFVACGTLAD--RIHDPNGSQLEPFLMKHRLKVAM 162
Q SH NI++ G + + +++ E++ G L R D F + + +
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE------FSVLQLVGMLR 154
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVI 222
IA + YL + V RD+ IL V K DF +S + + D
Sbjct: 155 GIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED------DPEATY 205
Query: 223 GTFG------FIAPEYMSTANCNE---KSDVYSFGALLLELLT-GKR 259
T G + APE + + SDV+SFG ++ E++T G+R
Sbjct: 206 TTSGGKIPIRWTAPE---AISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 4e-08
Identities = 33/162 (20%), Positives = 69/162 (42%), Gaps = 21/162 (12%)
Query: 105 SQMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAME 163
Q+ + I++ +G C + LV E G L + + + ++ +
Sbjct: 65 HQLDNPYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQ 118
Query: 164 IANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIG 223
++ + YL + V RD+ +L ++ AK DF +S ++ +D+
Sbjct: 119 VSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA-----DDSYYTAR 170
Query: 224 TFGFI-----APEYMSTANCNEKSDVYSFGALLLELLT-GKR 259
+ G APE ++ + +SDV+S+G + E L+ G++
Sbjct: 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 46/240 (19%), Positives = 93/240 (38%), Gaps = 32/240 (13%)
Query: 106 QMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEI 164
Q+ + I++ +G C + LV E G L + + + ++ ++
Sbjct: 392 QLDNPYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQV 445
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGT 224
+ + YL + V R++ +L ++ AK DF +S ++ ++ +
Sbjct: 446 SMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502
Query: 225 FGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES 284
+ APE ++ + +SDV+S+G + E L+ + Y + E V IE
Sbjct: 503 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK-MKGPE-------VMAFIEQ 554
Query: 285 NSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKSI 344
G+ P + L Y L C +DRP + V +++R + S+
Sbjct: 555 ------------GKRMECPPECPPEL-Y-ALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 8e-08
Identities = 41/211 (19%), Positives = 76/211 (36%), Gaps = 49/211 (23%)
Query: 61 KVITKDLLYKLYKGFLQ-DRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVG-C 118
K++ K L ++ G + I +++ ++ HKN+++ V
Sbjct: 36 KILKKKKLRRIPNGEANVKKEIQLLR--------------------RLRHKNVIQLVDVL 75
Query: 119 CLETELPI-LVFEFVACGT--LADRIHDPNGSQLEPFLMKHRLKVAM------EIANAVA 169
E + + +V E+ CG + D + + R V ++ + +
Sbjct: 76 YNEEKQKMYMVMEYCVCGMQEMLDSV------------PEKRFPVCQAHGYFCQLIDGLE 123
Query: 170 YLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIA 229
YLH S+ IV +DIKP +L K V+ + G+ F
Sbjct: 124 YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVA-EALHPFAADDTCRTSQGSPAFQP 179
Query: 230 PEYMSTANCNE--KSDVYSFGALLLELLTGK 258
PE + + K D++S G L + TG
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 38/166 (22%), Positives = 68/166 (40%), Gaps = 29/166 (17%)
Query: 107 MSHKNILKFVG---------CCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKH 156
+ K++ + C +TE + V E+V G L + + +H
Sbjct: 100 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-----RQRKLPEEH 154
Query: 157 -RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHV 215
R A EI+ A+ YLH R I++RD+K +L + K D+ + K +
Sbjct: 155 ARFYSA-EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC------KEGL 204
Query: 216 NDNNKVI---GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
+ GT +IAPE + + D ++ G L+ E++ G+
Sbjct: 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 37/165 (22%), Positives = 69/165 (41%), Gaps = 30/165 (18%)
Query: 106 QMSHKNILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHR------- 157
Q+ + I++ +G C LV E G L +L ++R
Sbjct: 74 QLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNK------------YLQQNRHVKDKNI 119
Query: 158 LKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217
+++ +++ + YL V RD+ +L Q+ AK DF +S ++ + +
Sbjct: 120 IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 176
Query: 218 NNKVIGTFGF--IAPEYMSTANCNEKSDVYSFGALLLELLT-GKR 259
G + APE ++ + KSDV+SFG L+ E + G++
Sbjct: 177 QTH--GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-07
Identities = 45/205 (21%), Positives = 75/205 (36%), Gaps = 46/205 (22%)
Query: 61 KVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCL 120
K++ + + I + K ++H+N++KF G
Sbjct: 38 KIVDMKRAVDCPENI--KKEICINK--------------------MLNHENVVKFYGH-R 74
Query: 121 ETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVA------MEIANAVAYLHV 173
L E+ + G L DRI + ++ V YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRI-----------EPDIGMPEPDAQRFFHQLMAGVVYLH- 122
Query: 174 GFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYM 233
I RDIKP +L E++ K DF ++ ++ NK+ GT ++APE +
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 234 STANCN-EKSDVYSFGALLLELLTG 257
+ E DV+S G +L +L G
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 38/166 (22%), Positives = 68/166 (40%), Gaps = 29/166 (17%)
Query: 107 MSHKNILKFVG---------CCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKH 156
+ K++ + C +TE + V E+V G L + + +H
Sbjct: 57 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-----RQRKLPEEH 111
Query: 157 -RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHV 215
R A EI+ A+ YLH R I++RD+K +L + K D+ + K +
Sbjct: 112 ARFYSA-EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC------KEGL 161
Query: 216 NDNNK---VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
+ GT +IAPE + + D ++ G L+ E++ G+
Sbjct: 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 38/159 (23%), Positives = 56/159 (35%), Gaps = 44/159 (27%)
Query: 109 HKNILKFVGCCLETELPI-----LVFEFVACGTLADRIHDPNGSQL-EP---FLMKHRLK 159
+I++ V E +V E + G L RI D E +MK
Sbjct: 70 CPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS--- 125
Query: 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNN 219
I A+ YLH S I RD+KP +L+ T N
Sbjct: 126 ----IGEAIQYLH---SINIAHRDVKPENLLY---------------------TSKRPNA 157
Query: 220 KV-IGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
+ + FGF A E ++ D++S G ++ LL G
Sbjct: 158 ILKLTDFGF-AKETTGE-KYDKSCDMWSLGVIMYILLCG 194
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 5e-07
Identities = 26/102 (25%), Positives = 50/102 (49%), Gaps = 12/102 (11%)
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKF--FDFC--VSISIPEGKTHVN 216
EI +A+ YLH + I+ RD+KP IL E + F +S + +
Sbjct: 136 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA--- 189
Query: 217 DNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
N +GT +++PE ++ + + SD+++ G ++ +L+ G
Sbjct: 190 --NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 6e-07
Identities = 38/167 (22%), Positives = 61/167 (36%), Gaps = 32/167 (19%)
Query: 105 SQMSHKNILK----FVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLK 159
H N+++ + E+ + LVFE V L + L +K ++
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 127
Query: 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV--SISIPEGKTHVND 217
+ + +LH + IV RD+KP IL K DF + S T
Sbjct: 128 ---QFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP--- 178
Query: 218 NNKVIGTFGFIAPE------YMSTANCNEKSDVYSFGALLLELLTGK 258
V+ T + APE Y +T D++S G + E+ K
Sbjct: 179 --VVV-TLWYRAPEVLLQSTY-ATP-----VDMWSVGCIFAEMFRRK 216
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 44/168 (26%), Positives = 70/168 (41%), Gaps = 27/168 (16%)
Query: 104 ASQMSHKNILKFVG---------CCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFL 153
M K +L G C +T + V E+V G L I Q+ F
Sbjct: 386 ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-----QVGRFK 440
Query: 154 MKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213
H + A EIA + +L S+ I++RD+K ++ + K DF + K
Sbjct: 441 EPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC------KE 491
Query: 214 HVNDNNKVI---GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
++ D GT +IAPE ++ + D ++FG LL E+L G+
Sbjct: 492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 9e-07
Identities = 24/101 (23%), Positives = 46/101 (45%), Gaps = 11/101 (10%)
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
EI +A+ YLH + +V+RD+K ++ + K DF + K + D
Sbjct: 254 GAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLC------KEGIKDGAT 305
Query: 221 VI---GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
+ GT ++APE + + D + G ++ E++ G+
Sbjct: 306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 45/164 (27%), Positives = 66/164 (40%), Gaps = 27/164 (16%)
Query: 107 MSHKNILKFVG---------CCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKH 156
M K +L C +T+ + V E++ G L I F +
Sbjct: 65 MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-----SCHKFDLSR 119
Query: 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN 216
A EI + +LH S+ IV+RD+K IL + K DF + K ++
Sbjct: 120 ATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMC------KENML 170
Query: 217 DNNKVI---GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
+ K GT +IAPE + N D +SFG LL E+L G
Sbjct: 171 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 45/205 (21%), Positives = 75/205 (36%), Gaps = 46/205 (22%)
Query: 61 KVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCL 120
K++ + + I + K ++H+N++KF G
Sbjct: 38 KIVDMKRAVDCPENI--KKEICINK--------------------MLNHENVVKFYGH-R 74
Query: 121 ETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVA------MEIANAVAYLHV 173
L E+ + G L DRI + ++ V YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRI-----------EPDIGMPEPDAQRFFHQLMAGVVYLH- 122
Query: 174 GFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYM 233
I RDIKP +L E++ K DF ++ ++ NK+ GT ++APE +
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 234 STANCN-EKSDVYSFGALLLELLTG 257
+ E DV+S G +L +L G
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 27/101 (26%), Positives = 48/101 (47%), Gaps = 12/101 (11%)
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
EI +A+ YLH SR +V+RDIK ++ + K DF + K ++D
Sbjct: 111 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC------KEGISDGAT 161
Query: 221 VI---GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
+ GT ++APE + + D + G ++ E++ G+
Sbjct: 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 30/141 (21%), Positives = 50/141 (35%), Gaps = 22/141 (15%)
Query: 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV-AMEIANAVAYLHVGFSRPIVFRDIK 185
LV E+ G L + S+ + + EI A+ +H V RDIK
Sbjct: 138 LVMEYYVGGDLLTLL-----SKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIK 189
Query: 186 PSTILFQEQNVAKFFDF--CVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSD 243
P IL + DF C+ + +G + +GT +++PE + +
Sbjct: 190 PDNILLDRCGHIRLADFGSCLKL-RADGTVR---SLVAVGTPDYLSPEILQAVGGGPGTG 245
Query: 244 VY-------SFGALLLELLTG 257
Y + G E+ G
Sbjct: 246 SYGPECDWWALGVFAYEMFYG 266
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 30/123 (24%), Positives = 53/123 (43%), Gaps = 14/123 (11%)
Query: 139 DRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAK 198
+ P + ++H + + ++A + +L SR + RD+ IL E+NV K
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVK 233
Query: 199 FFDFCVSISIPEGKTHVNDNNKVIGTFGFI-----APEYMSTANCNEKSDVYSFGALLLE 253
DF ++ + D + V + APE + +SDV+SFG LL E
Sbjct: 234 ICDFGLA------RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 287
Query: 254 LLT 256
+ +
Sbjct: 288 IFS 290
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-06
Identities = 37/173 (21%), Positives = 65/173 (37%), Gaps = 38/173 (21%)
Query: 106 QMSHKNILKFVGCCLETELPI--------LVFEFVACGTLADRIHDPNG---SQLEPFLM 154
+ H+N++ + C P LVF+F HD G + L F +
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--------HDLAGLLSNVLVKFTL 123
Query: 155 KHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV--SISIPEGK 212
+V + N + Y+H I+ RD+K + +L V K DF + + S+ +
Sbjct: 124 SEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 213 THVNDNNKVIGTFGFIAPE-------YMSTANCNEKSDVYSFGALLLELLTGK 258
N+V+ T + PE Y D++ G ++ E+ T
Sbjct: 181 QPNRYTNRVV-TLWYRPPELLLGERDY-GPP-----IDLWGAGCIMAEMWTRS 226
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 47.5 bits (114), Expect = 2e-06
Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 12/99 (12%)
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK-- 220
E+A A+ +LH S I++RD+KP IL E+ K DF +S K ++ K
Sbjct: 134 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLS------KESIDHEKKAY 184
Query: 221 -VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
GT ++APE ++ + +D +SFG L+ E+LTG
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 42/226 (18%), Positives = 73/226 (32%), Gaps = 57/226 (25%)
Query: 51 KAATNNYDPEKV----ITKDLLYKLYKGFLQD---RPISVMKFGGNLNSEEYCCFNCIAF 103
A D +V I ++ + ++++
Sbjct: 48 FAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK----------------V 91
Query: 104 ASQMSHKNILKF--VGCCLETELPI-LVFEF-VACGTLADRIHDPNGSQLEPFLMKHRL- 158
+ H +++ ET+ LV E + L D I + K L
Sbjct: 92 GAGGGHPGVIRLLDW---FETQEGFMLVLERPLPAQDLFDYITE-----------KGPLG 137
Query: 159 -----KVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF-QEQNVAKFFDFCVSISIPEGK 212
++ A+ + H SR +V RDIK IL + AK DF + +
Sbjct: 138 EGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP 194
Query: 213 THVNDNNKVIGTFGFIAPEYMSTAN-CNEKSDVYSFGALLLELLTG 257
D GT + PE++S + V+S G LL +++ G
Sbjct: 195 YTDFD-----GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 3e-06
Identities = 37/167 (22%), Positives = 60/167 (35%), Gaps = 32/167 (19%)
Query: 105 SQMSHKNILK----FVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLK 159
H N+++ + E + LVFE V L + + +K +
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMF 127
Query: 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV--SISIPEGKTHVND 217
++ + +LH S +V RD+KP IL K DF + S T
Sbjct: 128 ---QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--- 178
Query: 218 NNKVIGTFGFIAPE------YMSTANCNEKSDVYSFGALLLELLTGK 258
V+ T + APE Y +T D++S G + E+ K
Sbjct: 179 --VVV-TLWYRAPEVLLQSSY-ATP-----VDLWSVGCIFAEMFRRK 216
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 3e-06
Identities = 49/214 (22%), Positives = 81/214 (37%), Gaps = 63/214 (29%)
Query: 58 DPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKF-- 115
+ +K+ + D++ K+ R I +K H +I+K
Sbjct: 45 NRQKIRSLDVVGKIK------REIQNLK--------------------LFRHPHIIKLYQ 78
Query: 116 VGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAM------EIANAV 168
V + T +V E+V+ G L D I R++ +I +AV
Sbjct: 79 V---ISTPTDFFMVMEYVSGGELFDYI-----------CKHGRVEEMEARRLFQQILSAV 124
Query: 169 AYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG---KTHVNDNNKVIGTF 225
Y H +V RD+KP +L AK DF +S + +G +T G+
Sbjct: 125 DYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-------SCGSP 174
Query: 226 GFIAPEYMSTAN-CNEKSDVYSFGALLLELLTGK 258
+ APE +S + D++S G +L LL G
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 3e-06
Identities = 44/165 (26%), Positives = 70/165 (42%), Gaps = 27/165 (16%)
Query: 107 MSHKNILKFVG---------CCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKH 156
M K +L G C +T + V E+V G L I Q+ F H
Sbjct: 68 MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-----QVGRFKEPH 122
Query: 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN 216
+ A EIA + +L S+ I++RD+K ++ + K DF + K ++
Sbjct: 123 AVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC------KENIW 173
Query: 217 DNNKVI---GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
D GT +IAPE ++ + D ++FG LL E+L G+
Sbjct: 174 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 43/165 (26%), Positives = 64/165 (38%), Gaps = 27/165 (16%)
Query: 107 MSHKNILKFVG---------CCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKH 156
M+ K IL CC +T + V EFV G L I + F
Sbjct: 71 MTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ-----KSRRFDEAR 125
Query: 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN 216
A EI +A+ +LH + I++RD+K +L + K DF + K +
Sbjct: 126 ARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMC------KEGIC 176
Query: 217 DNNKVI---GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
+ GT +IAPE + D ++ G LL E+L G
Sbjct: 177 NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 4e-06
Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 12/101 (11%)
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
A EIA+A+ YLH S IV+RD+KP IL Q DF + K ++ N+
Sbjct: 145 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLC------KENIEHNST 195
Query: 221 ---VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
GT ++APE + + D + GA+L E+L G
Sbjct: 196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 8e-06
Identities = 31/99 (31%), Positives = 50/99 (50%), Gaps = 12/99 (12%)
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK-- 220
EI+ A+ +LH + I++RD+KP I+ Q K DF + K ++D
Sbjct: 129 EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLC------KESIHDGTVTH 179
Query: 221 -VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
GT ++APE + + N D +S GAL+ ++LTG
Sbjct: 180 TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 9e-06
Identities = 52/421 (12%), Positives = 116/421 (27%), Gaps = 120/421 (28%)
Query: 5 LGTSESSKKAEKRKFML----KNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNN--YD 58
T S ++ +KF+ N KFL+ + + + Q + +N +
Sbjct: 68 FWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFA 127
Query: 59 PEKVITKDLLYKLYKGFLQDRP---ISV--MK-FG------GNLNSEEY-CCFNC----I 101
V KL + L+ RP + + + G S + C + +
Sbjct: 128 KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWL 187
Query: 102 AFASQMSHKNILKFVGCCLETELPILVFEFVACG----TLADRIHDPNGSQLEPFLMKHR 157
+ S + +L+ L+ L + + + + RIH ++L L
Sbjct: 188 NLKNCNSPETVLEM----LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ-AELRRLLKSKP 242
Query: 158 LKVAMEI------ANAVAYLHVGFSRPIVF-RDIKPSTIL----------------FQEQ 194
+ + + A A ++ + ++ R + + L
Sbjct: 243 YENCLLVLLNVQNAKAWNAFNLS-CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPD 301
Query: 195 NVAKFFDFCVSISIPEGKTHVNDNN----KVIGTF---GFIAPEYMSTANCNEKSDVYSF 247
V + + V N +I G + NC++ + +
Sbjct: 302 EVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIE- 360
Query: 248 GALLLELLTGK--RISYSSCF---------------------ENGEEYFLQELVRKS-IE 283
L +L R + ++ + +L + S +E
Sbjct: 361 --SSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVE 418
Query: 284 SNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343
++ +S + ++ K E + LH+S
Sbjct: 419 KQP-------------------KESTISIPSIYLELKVKLENE-----------YALHRS 448
Query: 344 I 344
I
Sbjct: 449 I 449
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 26/97 (26%), Positives = 44/97 (45%), Gaps = 9/97 (9%)
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
A +I YLH S +++RD+KP +L +Q + DF + K
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWT 197
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
+ GT +APE + + N+ D ++ G L+ E+ G
Sbjct: 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 31/102 (30%), Positives = 44/102 (43%), Gaps = 15/102 (14%)
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVI 222
EI A+ +LH I++RDIK IL DF +S K V D +
Sbjct: 167 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS------KEFVADETERA 217
Query: 223 GTF-G---FIAPEYMSTANCNEKSDV--YSFGALLLELLTGK 258
F G ++AP+ + + V +S G L+ ELLTG
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 39/164 (23%), Positives = 70/164 (42%), Gaps = 27/164 (16%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAM-EI 164
++ H+NI++ LVFEF+ L + L + +K ++
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV--SISIPEGK-THVNDNNKV 221
+A+ H I+ RD+KP +L ++ K DF + + IP + +V
Sbjct: 118 LQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS-----EV 169
Query: 222 IGTFGFIAPE-------YMSTANCNEKSDVYSFGALLLELLTGK 258
+ T + AP+ Y ST+ D++S G +L E++TGK
Sbjct: 170 V-TLWYRAPDVLMGSRTY-STS-----IDIWSCGCILAEMITGK 206
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 34/171 (19%), Positives = 64/171 (37%), Gaps = 29/171 (16%)
Query: 106 QMSHKNILKFVGCCLETELPI--LVFEFVAC---GTLADRIHDPNGSQLEPFLMKHRLKV 160
++ H N++ L L+F++ + + +
Sbjct: 74 ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTIL----FQEQNVAKFFDFCV--SISIPEGKTH 214
+I + + YLH + ++ RD+KP+ IL E+ K D + P K
Sbjct: 134 LYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL-KPL 189
Query: 215 VNDNNKVIGTFGFIAPE-------YMSTANCNEKSDVYSFGALLLELLTGK 258
+ + V+ TF + APE Y + A D+++ G + ELLT +
Sbjct: 190 ADLDPVVV-TFWYRAPELLLGARHY-TKA-----IDIWAIGCIFAELLTSE 233
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-05
Identities = 29/142 (20%), Positives = 50/142 (35%), Gaps = 28/142 (19%)
Query: 126 ILVFEFVA-CGTLADRIHDPNGSQLEPFLMKHRL------KVAMEIANAVAYLHVGFSRP 178
+L+ E L D I + + L ++ AV + H +
Sbjct: 124 VLILERPEPVQDLFDFITE-----------RGALQEELARSFFWQVLEAVRHCH---NCG 169
Query: 179 IVFRDIKPSTILF-QEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTAN 237
++ RDIK IL + K DF + + D GT + PE++
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-----GTRVYSPPEWIRYHR 224
Query: 238 -CNEKSDVYSFGALLLELLTGK 258
+ V+S G LL +++ G
Sbjct: 225 YHGRSAAVWSLGILLYDMVCGD 246
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 48/219 (21%), Positives = 80/219 (36%), Gaps = 45/219 (20%)
Query: 51 KAATNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHK 110
A + ++V+ K + K + + G + E IA S++ H
Sbjct: 41 WTAVDKEKNKEVVVK----FIKKEKVLEDCWIEDPKLGKVTLE-------IAILSRVEHA 89
Query: 111 NILKFVGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKH-RL------KVAM 162
NI+K + E + LV E +G L F+ +H RL +
Sbjct: 90 NIIKVLDI-FENQGFFQLVMEKHG-----------SGLDLFAFIDRHPRLDEPLASYIFR 137
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG---KTHVNDNN 219
++ +AV YL + I+ RDIK I+ E K DF + + G T
Sbjct: 138 QLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---- 190
Query: 220 KVIGTFGFIAPEYMSTAN-CNEKSDVYSFGALLLELLTG 257
GT + APE + + +++S G L L+
Sbjct: 191 ---GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 31/141 (21%), Positives = 49/141 (34%), Gaps = 24/141 (17%)
Query: 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV-AMEIANAVAYLHVGFSRPIVFRDIK 185
LV ++ G L + S+ E L + + E+ A+ +H V RDIK
Sbjct: 151 LVMDYYVGGDLLTLL-----SKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIK 202
Query: 186 PSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTF-G---FIAPEYMSTANCNEK 241
P IL + DF + D G +I+PE + +
Sbjct: 203 PDNILMDMNGHIRLADFGSC------LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKG 256
Query: 242 S-----DVYSFGALLLELLTG 257
D +S G + E+L G
Sbjct: 257 RYGPECDWWSLGVCMYEMLYG 277
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 23/92 (25%), Positives = 41/92 (44%), Gaps = 7/92 (7%)
Query: 167 AVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFG 226
+ +LH S I+ RD+KPS I+ + K DF ++ + + T
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYVVTRY 191
Query: 227 FIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
+ APE + E D++S G ++ E++ G
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 50/214 (23%), Positives = 81/214 (37%), Gaps = 63/214 (29%)
Query: 58 DPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKF-- 115
+ +K+ + D++ K+ R I +K H +I+K
Sbjct: 50 NRQKIRSLDVVGKIR------REIQNLKL--------------------FRHPHIIKLYQ 83
Query: 116 VGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLK--VAM----EIANAV 168
V + T I +V E+V+ G L D I RL + +I + V
Sbjct: 84 V---ISTPSDIFMVMEYVSGGELFDYI-----------CKNGRLDEKESRRLFQQILSGV 129
Query: 169 AYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG---KTHVNDNNKVIGTF 225
Y H +V RD+KP +L AK DF +S + +G +T G+
Sbjct: 130 DYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-------GSP 179
Query: 226 GFIAPEYMSTAN-CNEKSDVYSFGALLLELLTGK 258
+ APE +S + D++S G +L LL G
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 5e-05
Identities = 39/163 (23%), Positives = 64/163 (39%), Gaps = 30/163 (18%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIA 165
++ H NI+ + LVFEF+ L + + ++
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKT----GLQDSQIKIYLYQLL 129
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV--SISIPEGK-THVNDNNKVI 222
VA+ H I+ RD+KP +L K DF + + IP TH +V+
Sbjct: 130 RGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH-----EVV 181
Query: 223 GTFGFIAPE-------YMSTANCNEKSDVYSFGALLLELLTGK 258
T + AP+ Y ST+ D++S G + E++TGK
Sbjct: 182 -TLWYRAPDVLMGSKKY-STS-----VDIWSIGCIFAEMITGK 217
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 28/141 (19%), Positives = 53/141 (37%), Gaps = 27/141 (19%)
Query: 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAM------EIANAVAYLHVGFSRPIV 180
+V E++ G L + + + E+ A+ +H S +
Sbjct: 146 MVMEYM------------PGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH---SMGFI 190
Query: 181 FRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNE 240
RD+KP +L + K DF + + + + +GT +I+PE + + +
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM--VRCDTAVGTPDYISPEVLKSQGGDG 248
Query: 241 K----SDVYSFGALLLELLTG 257
D +S G L E+L G
Sbjct: 249 YYGRECDWWSVGVFLYEMLVG 269
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 7e-05
Identities = 24/96 (25%), Positives = 41/96 (42%), Gaps = 15/96 (15%)
Query: 167 AVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKV----I 222
+ +LH S I+ RD+KPS I+ + K DF G + + +
Sbjct: 176 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF--------GLARTAGTSFMMTPYV 224
Query: 223 GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
T + APE + E D++S G ++ E++ K
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 8e-05
Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIA 165
Q+ H+N++ + C + + LVFEFV T+ D + + + L+ +++ K +I
Sbjct: 80 QLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQ---KYLFQII 134
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF 202
N + + H S I+ RDIKP IL + V K DF
Sbjct: 135 NGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDF 168
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 8e-05
Identities = 41/166 (24%), Positives = 64/166 (38%), Gaps = 39/166 (23%)
Query: 107 MSHKNILKF--VGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVA-- 161
+ H NI++F V + T + ++ E+ + G L +RI R
Sbjct: 73 LRHPNIVRFKEV---ILTPTHLAIIMEYASGGELYERI-----------CNAGRFSEDEA 118
Query: 162 ----MEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA--KFFDFCVSISIPEG---K 212
++ + V+Y H S I RD+K L K DF S S K
Sbjct: 119 RFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175
Query: 213 THVNDNNKVIGTFGFIAPEYMSTANCN-EKSDVYSFGALLLELLTG 257
+ V GT +IAPE + + + +DV+S G L +L G
Sbjct: 176 STV-------GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 9e-05
Identities = 20/119 (16%), Positives = 40/119 (33%), Gaps = 19/119 (15%)
Query: 151 PFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFF--DFCVSISI 208
+ L+VA + +A+ +LH V ++ I ++ ++ + +
Sbjct: 155 VLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
Query: 209 PEGKTHV----NDNNKVIGTFGFIAPEYMS--TANCNEKS---DVYSFGALLLELLTGK 258
HV + G E++S S D+ S G +L+ L G
Sbjct: 212 CPSGKHVAYVEGSRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 1e-04
Identities = 39/163 (23%), Positives = 67/163 (41%), Gaps = 30/163 (18%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIA 165
++ H NI+K + +LVFE + L + G +++
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEG----GLESVTAKSFLLQLL 110
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV--SISIPEGK-THVNDNNKVI 222
N +AY H R ++ RD+KP +L + K DF + + IP K TH +++
Sbjct: 111 NGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-----EIV 162
Query: 223 GTFGFIAPE-------YMSTANCNEKSDVYSFGALLLELLTGK 258
T + AP+ Y ST D++S G + E++ G
Sbjct: 163 -TLWYRAPDVLMGSKKY-STT-----IDIWSVGCIFAEMVNGT 198
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 26/118 (22%), Positives = 42/118 (35%), Gaps = 19/118 (16%)
Query: 152 FLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFF--DFCVSISIP 209
F L++ + + + + Y+H V DIK + +L +N + + D+ +S
Sbjct: 148 FKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYC 204
Query: 210 EGKTHV----NDNNKVIGTFGFIAPEYMS--TANCNEKS---DVYSFGALLLELLTGK 258
H N GT E+ S S DV G +L L GK
Sbjct: 205 PNGNHKQYQENPRKGHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 30/120 (25%), Positives = 48/120 (40%), Gaps = 20/120 (16%)
Query: 151 PFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF---QEQNVAKFFDFCVSIS 207
+K L +A ++ N V ++H S+ + RDIKP L + N DF ++
Sbjct: 99 KLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
Query: 208 I--PEGKTHV--NDNNKVIGTFGFIAPEYMSTAN--CNEKS---DVYSFGALLLELLTGK 258
H+ +N + GT Y S E+S D+ S G +L+ L G
Sbjct: 156 YRDTSTHQHIPYRENKNLTGT-----ARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 1e-04
Identities = 36/163 (22%), Positives = 64/163 (39%), Gaps = 30/163 (18%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIA 165
+ H NI+ + LVFE++ L + D M + ++
Sbjct: 56 DLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGN----IINMHNVKLFLFQLL 110
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV--SISIPEGK-THVNDNNKVI 222
+AY H + ++ RD+KP +L E+ K DF + + SIP + +V+
Sbjct: 111 RGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN-----EVV 162
Query: 223 GTFGFIAPE-------YMSTANCNEKSDVYSFGALLLELLTGK 258
T + P+ Y ST D++ G + E+ TG+
Sbjct: 163 -TLWYRPPDILLGSTDY-STQ-----IDMWGVGCIFYEMATGR 198
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 24/97 (24%), Positives = 40/97 (41%), Gaps = 8/97 (8%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIA 165
Q+ H N++ + LVFE+ T+ + D + L+K + +
Sbjct: 58 QLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVK---SITWQTL 112
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF 202
AV + H + RD+KP IL + +V K DF
Sbjct: 113 QAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDF 146
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 2e-04
Identities = 36/164 (21%), Positives = 62/164 (37%), Gaps = 30/164 (18%)
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIA 165
++ HKNI++ + LVFEF L NG + ++
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG----DLDPEIVKSFLFQLL 111
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV--SISIPEGK-THVNDNNKVI 222
+ + H SR ++ RD+KP +L K +F + + IP + +V+
Sbjct: 112 KGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA-----EVV 163
Query: 223 GTFGFIAPE-------YMSTANCNEKSDVYSFGALLLELLTGKR 259
T + P+ Y ST+ D++S G + EL R
Sbjct: 164 -TLWYRPPDVLFGAKLY-STS-----IDMWSAGCIFAELANAGR 200
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 3e-04
Identities = 35/99 (35%), Positives = 50/99 (50%), Gaps = 13/99 (13%)
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF--CVSISIPEGKTHVNDN 218
A E+ A+ YLH S+ I++RD+KP IL + K DF K +
Sbjct: 112 AAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFA--------KYVPDVT 160
Query: 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG 257
+ GT +IAPE +ST N+ D +SFG L+ E+L G
Sbjct: 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 26/118 (22%), Positives = 46/118 (38%), Gaps = 19/118 (16%)
Query: 152 FLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFF--DFCVSISIP 209
F K L++++ I + + Y+H V DIK S +L +N + + D+ ++
Sbjct: 149 FSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYC 205
Query: 210 EGKTHV----NDNNKVIGTFGFIAPEYMS--TANCNEKS---DVYSFGALLLELLTGK 258
H + GT E+ S N S D+ G +++ LTG
Sbjct: 206 PEGVHKAYAADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 48/214 (22%), Positives = 79/214 (36%), Gaps = 64/214 (29%)
Query: 58 DPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKF-- 115
+ + D+ ++ R IS +K + H +I+K
Sbjct: 43 SRQLLKKSDMHMRVE------REISYLKL--------------------LRHPHIIKLYD 76
Query: 116 VGCCLETELPI-LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLK--VAM----EIANAV 168
V + T I +V E+ G L D I + K R+ +I A+
Sbjct: 77 V---ITTPTDIVMVIEYAG-GELFDYI-----------VEKKRMTEDEGRRFFQQIICAI 121
Query: 169 AYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG---KTHVNDNNKVIGTF 225
Y H IV RD+KP +L + K DF +S + +G KT G+
Sbjct: 122 EYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-------SCGSP 171
Query: 226 GFIAPEYMSTAN-CNEKSDVYSFGALLLELLTGK 258
+ APE ++ + DV+S G +L +L G+
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 33/155 (21%), Positives = 58/155 (37%), Gaps = 19/155 (12%)
Query: 109 HKNILKF--VGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIAN 166
NI+ + + P LVFE V L + ++ + EI
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMY---EILK 141
Query: 167 AVAYLHVGFSRPIVFRDIKPSTILF-QEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTF 225
A+ Y H S I+ RD+KP ++ E + D+ + E + N + +
Sbjct: 142 ALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDW----GLAEFYHPGQEYNVRVASR 194
Query: 226 GFIAPEYMSTANCNEKS-DVYSFGALLLELLTGKR 259
F PE + + S D++S G +L ++ K
Sbjct: 195 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 7e-04
Identities = 28/119 (23%), Positives = 50/119 (42%), Gaps = 20/119 (16%)
Query: 152 FLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF---QEQNVAKFFDFCVSISI 208
F +K L +A ++ + + Y+H S+ + RD+KP L ++ N+ DF ++
Sbjct: 102 FSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
Query: 209 --PEGKTHV--NDNNKVIGTFGFIAPEYMSTAN--CNEKS---DVYSFGALLLELLTGK 258
H+ +N + GT Y S E+S D+ S G +L+ G
Sbjct: 159 RDARTHQHIPYRENKNLTGT-----ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 9e-04
Identities = 27/121 (22%), Positives = 45/121 (37%), Gaps = 22/121 (18%)
Query: 152 FLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF-----QEQNVAKFFDFCVSI 206
F +K A ++ V +H + +V+RDIKP L + N+ DF +
Sbjct: 103 FSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
Query: 207 SIPEGKTHV----NDNNKVIGTFGFIAPEYMSTAN--CNEKS---DVYSFGALLLELLTG 257
+ T + + GT YMS E+S D+ + G + + L G
Sbjct: 160 FYRDPVTKQHIPYREKKNLSGT-----ARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 214
Query: 258 K 258
Sbjct: 215 S 215
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 344 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.73 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.46 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.22 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.97 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.78 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.5 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.47 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.42 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.39 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.36 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.96 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.92 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.85 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.7 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.49 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.46 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.44 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.32 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.24 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.14 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.06 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.93 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.9 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.53 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.47 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.95 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.46 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 90.97 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 81.83 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-61 Score=431.26 Aligned_cols=262 Identities=21% Similarity=0.310 Sum_probs=212.7
Q ss_pred cCCCCCCccccCCCceEEEEEEC-------CccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFLQ-------DRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~~-------~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
++|...+.||+|+||+||+|++. +..||||+++.......+.|.+|+.+|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45777889999999999999972 56799999987766667789999999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCC--------CCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceE
Q 048160 128 VFEFVACGTLADRIHDPN--------GSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKF 199 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 199 (344)
|||||++|||.+++...+ +.....+++.+++.++.|++.||.||| +.+|+||||||+|||++.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence 999999999999996532 111246999999999999999999999 999999999999999999999999
Q ss_pred eeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHH
Q 048160 200 FDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELV 278 (344)
Q Consensus 200 ~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~ 278 (344)
+|||+|+......... ......||+.|+|||++.+..|+.++|||||||++|||+| |+.||..... . .+...+
T Consensus 170 ~DFGla~~~~~~~~~~-~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~----~-~~~~~i 243 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYR-VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN----N-EVIECI 243 (299)
T ss_dssp CCCSCHHHHTGGGCEE-ETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----H-HHHHHH
T ss_pred CCcccceecCCCCcee-ecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH----H-HHHHHH
Confidence 9999998765433221 1224568999999999999999999999999999999999 8998864321 1 111111
Q ss_pred HHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 279 RKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
. .+.....|. .++.++.+|+.+||+.||++|||+.+|.+.|+++.+.
T Consensus 244 ---~-------------~~~~~~~p~--~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 244 ---T-------------QGRVLQRPR--TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp ---H-------------HTCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---H-------------cCCCCCCCc--cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1 111111121 4566789999999999999999999999999988753
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-60 Score=430.63 Aligned_cols=262 Identities=21% Similarity=0.284 Sum_probs=207.3
Q ss_pred cCCCCCCccccCCCceEEEEEEC-------CccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFLQ-------DRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~~-------~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
++|...+.||+|+||+||+|++. +..||||+++.......+.|.+|+.+|++++|||||+++|+|.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34666788999999999999973 56799999987766667889999999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCCC----------CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcc
Q 048160 128 VFEFVACGTLADRIHDPNGS----------QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA 197 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 197 (344)
|||||++|+|.+++...... ...++++.+++.++.|++.||.||| +.+|+||||||+|||++.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence 99999999999998754321 1136899999999999999999999 9999999999999999999999
Q ss_pred eEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHH
Q 048160 198 KFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQE 276 (344)
Q Consensus 198 kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~ 276 (344)
||+|||+|+......... ......||+.|+|||++.+..|+.++|||||||++|||+| |+.||..... . .+..
T Consensus 198 Ki~DFGla~~~~~~~~~~-~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~----~-~~~~ 271 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYR-VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN----T-EAID 271 (329)
T ss_dssp EECCCC-----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH----H-HHHH
T ss_pred EEcccccceeccCCCcce-ecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH----H-HHHH
Confidence 999999998765433211 1224578999999999999999999999999999999999 8999864321 1 1111
Q ss_pred HHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 277 LVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
.+. . +.....|. .++.++.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus 272 ~i~---~-------------g~~~~~p~--~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 272 CIT---Q-------------GRELERPR--ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHH---H-------------TCCCCCCT--TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHH---c-------------CCCCCCcc--cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 111 1 11111121 4556789999999999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-59 Score=419.65 Aligned_cols=262 Identities=22% Similarity=0.294 Sum_probs=204.8
Q ss_pred cCCCCCCccccCCCceEEEEEECCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 55 NNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
+++...+.||+|+||+||+|++.+ .||||+++.... ...+.|.+|+.+|++++|||||+++|++.+ +.++||||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~ 113 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWC 113 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcC
Confidence 457778899999999999999865 599999865432 334678999999999999999999999865 5689999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++|||.+++.... .++++.+++.++.|++.||.||| +.+||||||||+|||++.++.+||+|||+|+......
T Consensus 114 ~gGsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 114 EGSSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp SSCBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred CCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999997654 36999999999999999999999 9999999999999999999999999999998765332
Q ss_pred cccccCCccccccccccccccCc---CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMST---ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
.. .......||+.|+|||++.+ .+|+.++|||||||++|||+||+.||..... ...+...+..........
T Consensus 187 ~~-~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~----~~~~~~~~~~~~~~p~~~- 260 (307)
T 3omv_A 187 GS-QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN----RDQIIFMVGRGYASPDLS- 260 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----HHHHHHHHHTTCCCCCST-
T ss_pred cc-eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh----HHHHHHHHhcCCCCCCcc-
Confidence 21 11224679999999999853 4689999999999999999999999964321 112222221111111000
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhC
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKSI 344 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~l 344 (344)
.....++..+.+|+.+||+.||++|||+.+|++.|+.+.++|
T Consensus 261 -------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 261 -------------KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp -------------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred -------------cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 011145567899999999999999999999999999887654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-60 Score=424.37 Aligned_cols=257 Identities=16% Similarity=0.251 Sum_probs=207.1
Q ss_pred CCCCCccccCCCceEEEEEE-------CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 57 YDPEKVITKDLLYKLYKGFL-------QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~-------~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
++..+.||+|+||+||+|++ +++.||||+++..... ..+.|.+|+.++++++|||||+++|+|.+++..+||
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 44567899999999999997 3467999999765433 346799999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCC-----------CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcc
Q 048160 129 FEFVACGTLADRIHDPNGS-----------QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA 197 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 197 (344)
||||++|||.++|...... ....+++.+++.++.|+|.||.||| +.+||||||||+|||++.++.+
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCCE
Confidence 9999999999999653211 1135899999999999999999999 9999999999999999999999
Q ss_pred eEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHH
Q 048160 198 KFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQE 276 (344)
Q Consensus 198 kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~ 276 (344)
||+|||+|+........ .......||+.|+|||++.+..|+.++|||||||++|||+| |..||.... ...+..
T Consensus 185 Ki~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~-----~~~~~~ 258 (308)
T 4gt4_A 185 KISDLGLFREVYAADYY-KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-----NQDVVE 258 (308)
T ss_dssp EECCSCCBCGGGGGGCB-CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC-----HHHHHH
T ss_pred EECCcccceeccCCCce-eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-----HHHHHH
Confidence 99999999876433221 12224578999999999999999999999999999999998 788886432 111111
Q ss_pred HHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 277 LVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
.+ .. +.....| ..++..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 259 ~i----~~------------~~~~~~p--~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 259 MI----RN------------RQVLPCP--DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HH----HT------------TCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HH----Hc------------CCCCCCc--ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11 11 1111112 25667799999999999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-59 Score=421.68 Aligned_cols=248 Identities=19% Similarity=0.283 Sum_probs=208.3
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
..|+..+.||+|+||+||+|++ +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4588889999999999999999 68899999997665556677889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
+||+|.+++... .+++.++..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 154 ~gg~L~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 154 EGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp TTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 999999999753 4899999999999999999999 9999999999999999999999999999998775433
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
.. ....+||+.|+|||++.+..|+.++|||||||++|||++|..||.... .......+.. .
T Consensus 225 ~~---~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-----~~~~~~~i~~----~------- 285 (346)
T 4fih_A 225 PR---RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-----PLKAMKMIRD----N------- 285 (346)
T ss_dssp CC---BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHH----S-------
T ss_pred Cc---ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHHHHHc----C-------
Confidence 22 225689999999999999999999999999999999999999997531 1111111111 0
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+..+.....+.++.+|+.+||+.||++|||+.|+++
T Consensus 286 -----~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 286 -----LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp -----SCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01111111244567899999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-58 Score=419.19 Aligned_cols=255 Identities=15% Similarity=0.173 Sum_probs=206.0
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
+.|...++||+|+||+||+|++ +|+.||||++.... ...+|+.++++++|||||++++++.+++.+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4566778899999999999998 68899999997542 2357999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC-cceEeeeecccccCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN-VAKFFDFCVSISIPEG 211 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~dfg~a~~~~~~ 211 (344)
+||+|.+++...+ ++++.++..++.|++.||.||| +++|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 133 ~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 133 EGGSLGQLIKQMG-----CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp TTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 9999999997654 6999999999999999999999 99999999999999999998 6999999999887543
Q ss_pred Ccc--cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 212 KTH--VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 212 ~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
... ........||+.|+|||++.+..|+.++|||||||++|||++|..||..... ..........
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~----~~~~~~i~~~--------- 271 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR----GPLCLKIASE--------- 271 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC----SCCHHHHHHS---------
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH----HHHHHHHHcC---------
Confidence 321 1122346799999999999999999999999999999999999999965322 1111111111
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
..+.....+.++..+.+|+.+||+.||++|||+.||++.|......
T Consensus 272 --------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 272 --------PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp --------CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 0000001113456789999999999999999999999999887653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-59 Score=423.82 Aligned_cols=249 Identities=20% Similarity=0.267 Sum_probs=200.5
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
++|...+.||+|+||+||+|+. +++.||||++..... ...+.+.+|+.+|++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5788999999999999999998 688999999976532 234668899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
||+||+|.+++....+ ..+++.+++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+....
T Consensus 104 y~~gg~L~~~i~~~~~---~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG---VLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp CCTTCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred CCCCCcHHHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 9999999999965432 35788999999999999999999 99999999999999999999999999999987643
Q ss_pred CCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEI 290 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (344)
.... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.... ....+.....
T Consensus 178 ~~~~---~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~----~~~~~~~i~~----------- 239 (350)
T 4b9d_A 178 TVEL---ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS----MKNLVLKIIS----------- 239 (350)
T ss_dssp HHHH---HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHH-----------
T ss_pred Cccc---ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHHHHHHc-----------
Confidence 2211 124579999999999999999999999999999999999999996532 1111222111
Q ss_pred cccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 291 VDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+..+..+ ...+.++.+|+.+||+.||++|||+.|+++
T Consensus 240 ------~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 240 ------GSFPPVS--LHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ------TCCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCCCCCC--ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111 134456899999999999999999999975
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-57 Score=406.43 Aligned_cols=269 Identities=18% Similarity=0.240 Sum_probs=201.1
Q ss_pred CCCCCCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCC----ccEEEEee
Q 048160 56 NYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETE----LPILVFEF 131 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~----~~~lv~e~ 131 (344)
+|...+.||+|+||+||+|+++|+.||||++..... ....+..|+..+.+++|||||+++|++.+++ .++|||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 356678899999999999999999999999865421 1122335666778899999999999998654 57999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCC--------CeeeecccccceEeecCCcceEeeee
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSR--------PIVFRDIKPSTILFQEQNVAKFFDFC 203 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~--------~ivH~dlk~~Nill~~~~~~kl~dfg 203 (344)
|++|||.++++.. ++++.++..++.|++.||.||| +. +|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH---~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 83 HEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLH---MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp CTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHH---CCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred CCCCcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---HhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 9999999999763 4899999999999999999999 55 99999999999999999999999999
Q ss_pred cccccCCCCccc-ccCCccccccccccccccCcC------CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcch-----
Q 048160 204 VSISIPEGKTHV-NDNNKVIGTFGFIAPEYMSTA------NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEE----- 271 (344)
Q Consensus 204 ~a~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----- 271 (344)
+|+......... .......||+.|+|||++.+. .++.++|||||||++|||+||..||..........
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 998765443221 122245799999999998764 46789999999999999999988765432211000
Q ss_pred --hHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 272 --YFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 272 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
........... .... ....+.......++..+.+|+.+||+.||++||||.+|++.|+++.++
T Consensus 234 ~~~~~~~~~~~~~-~~~~--------rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 234 SDPSVEEMRKVVC-EQKL--------RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SSCCHHHHHHHHT-TSCC--------CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccchHHHHHHHHh-cccC--------CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 00111111111 1110 001111111125667789999999999999999999999999998753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-57 Score=422.61 Aligned_cols=248 Identities=19% Similarity=0.286 Sum_probs=208.4
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
+.|+..+.||+|+||.||+|++ +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 4588899999999999999999 68899999998776666677899999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
+||+|.+++... .+++.++..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 231 ~gG~L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 231 EGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp TTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCcHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999999753 4899999999999999999999 9999999999999999999999999999998775433
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
.. ....+||+.|+|||++.+..|+.++|||||||++|||++|..||.... .......+....
T Consensus 302 ~~---~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-----~~~~~~~i~~~~---------- 363 (423)
T 4fie_A 302 PR---RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-----PLKAMKMIRDNL---------- 363 (423)
T ss_dssp CC---BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSC----------
T ss_pred cc---ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHHHHHcCC----------
Confidence 22 225689999999999999999999999999999999999999996532 111111111100
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+..+.....+.++.+|+.+||+.||++|||+.|+++
T Consensus 364 ------~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 364 ------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp ------CCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0001111134456899999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-57 Score=416.72 Aligned_cols=271 Identities=18% Similarity=0.308 Sum_probs=216.5
Q ss_pred cHHHHHHHhcCCCCCCccccCCCceEEEEEECC-------ccEEEEEecCCCCc-hhhhHhhHHHHHhcCCC-Cceeeee
Q 048160 46 TAQELKAATNNYDPEKVITKDLLYKLYKGFLQD-------RPISVMKFGGNLNS-EEYCCFNCIAFASQMSH-KNILKFV 116 (344)
Q Consensus 46 ~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~~~-------~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H-~niv~~~ 116 (344)
..++++...++|+..+.||+|+||+||+|++.+ +.||||++...... ..+.|.+|+.+|++++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 445566667889999999999999999999832 46999999766443 34668899999999965 9999999
Q ss_pred eEEeeC-CccEEEEeecCCCCccccccCCCCC-----------CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecc
Q 048160 117 GCCLET-ELPILVFEFVACGTLADRIHDPNGS-----------QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDI 184 (344)
Q Consensus 117 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl 184 (344)
|+|.+. +.++||||||++|+|.++|+..... ....+++.+++.++.|+|.||.||| +.+||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCcc
Confidence 999764 5789999999999999999653210 1135899999999999999999999 999999999
Q ss_pred cccceEeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCC
Q 048160 185 KPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYS 263 (344)
Q Consensus 185 k~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~ 263 (344)
||+|||++.++.+||+|||+|+......... ......||+.|+|||++.+..|+.++|||||||++|||+| |..||..
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~-~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYV-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCce-eeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998775443221 1224578999999999999999999999999999999998 8888864
Q ss_pred CCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 264 SCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
... ...+...+.. + .....|. .+++++.+|+.+||+.||++|||+.+|++.|+++.+
T Consensus 291 ~~~----~~~~~~~i~~----g------------~~~~~p~--~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 291 VKI----DEEFCRRLKE----G------------TRMRAPD--YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp CCC----SHHHHHHHHH----T------------CCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCH----HHHHHHHHHc----C------------CCCCCCc--cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 321 1112211111 1 1111121 445678999999999999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-57 Score=402.02 Aligned_cols=243 Identities=21% Similarity=0.268 Sum_probs=193.9
Q ss_pred CCCCccccCCCceEEEEEE--CCccEEEEEecCCC--CchhhhHhhHHHHHhcCCCCceeeeeeEEee----CCccEEEE
Q 048160 58 DPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL--NSEEYCCFNCIAFASQMSHKNILKFVGCCLE----TELPILVF 129 (344)
Q Consensus 58 ~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----~~~~~lv~ 129 (344)
...+.||+|+||+||+|.+ ++..||+|++.... ....+.|.+|+.+|++++|||||++++++.+ ...+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 4456799999999999999 67889999986543 2334668899999999999999999999875 34579999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCC--eeeecccccceEeec-CCcceEeeeeccc
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRP--IVFRDIKPSTILFQE-QNVAKFFDFCVSI 206 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nill~~-~~~~kl~dfg~a~ 206 (344)
|||++|+|.+++.... .+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+||+|||+|+
T Consensus 109 Ey~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 9999999999997643 6899999999999999999999 877 999999999999974 7899999999998
Q ss_pred ccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
...... .....||+.|+|||++.+ .|+.++|||||||++|||+||..||..... ...+...+ ....
T Consensus 181 ~~~~~~-----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~----~~~~~~~i----~~~~ 246 (290)
T 3fpq_A 181 LKRASF-----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRV----TSGV 246 (290)
T ss_dssp GCCTTS-----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHH----TTTC
T ss_pred eCCCCc-----cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc----HHHHHHHH----HcCC
Confidence 644322 125689999999999864 699999999999999999999999964321 11111111 1111
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... .....++++.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~-------------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 247 KPAS-------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCGG-------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCC-------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 01123346889999999999999999999975
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-57 Score=404.05 Aligned_cols=247 Identities=18% Similarity=0.273 Sum_probs=205.7
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|+..+.||+|+||+||+|+. +++.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+++..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5699999999999999999998 78899999986542 223466889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
|||+||+|.+++...+ .+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+...
T Consensus 112 Ey~~gG~L~~~i~~~~-----~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp CCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 9999999999997654 6999999999999999999999 9999999999999999999999999999998875
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
..... ......+||+.|+|||++.+..|+.++||||+||++|+|++|..||.... ....+......
T Consensus 184 ~~~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~~~~~i~~~--------- 249 (311)
T 4aw0_A 184 PESKQ-ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN----EGLIFAKIIKL--------- 249 (311)
T ss_dssp TTTTC-CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHT---------
T ss_pred CCCCc-ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHcC---------
Confidence 43221 12235689999999999999999999999999999999999999996532 11112221111
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVA 334 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~ 334 (344)
.. .+|. ..++++.+|+.+||+.||++|||+.|++
T Consensus 250 --------~~-~~p~--~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 250 --------EY-DFPE--KFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --------CC-CCCT--TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --------CC-CCCc--ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 10 1111 2345688999999999999999998863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-56 Score=392.74 Aligned_cols=244 Identities=19% Similarity=0.253 Sum_probs=190.1
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|+..+.||+|+||+||+|+. +++.||+|++..... .....+.+|+.++++++|||||++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6799999999999999999998 688999999875532 22456889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||| +|+|.+++...+ ++++.++..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+...
T Consensus 93 Ey~-~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp ECC-CEEHHHHHHHSC-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred eCC-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 999 689999987654 6999999999999999999999 9999999999999999999999999999998764
Q ss_pred CCCcccccCCccccccccccccccCcCCC-CcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANC-NEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
.... .....||+.|+|||++.+..| +.++||||+||++|+|++|+.||.... .......... .
T Consensus 164 ~~~~----~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~----~~~~~~~i~~-----~--- 227 (275)
T 3hyh_A 164 DGNF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES----IPVLFKNISN-----G--- 227 (275)
T ss_dssp ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHH-----T---
T ss_pred CCCc----cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHc-----C---
Confidence 4322 124689999999999998886 579999999999999999999996431 1111111111 0
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. ...|. ..++++.+|+.+||+.||++|||+.|+++
T Consensus 228 ---------~-~~~p~--~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 228 ---------V-YTLPK--FLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ---------C-CCCCT--TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---------C-CCCCC--CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 01111 23456889999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-56 Score=397.85 Aligned_cols=246 Identities=19% Similarity=0.230 Sum_probs=195.1
Q ss_pred cCCCCCCccccCCCceEEEEEE-----CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL-----QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
++|+..+.||+|+||+||+|+. .++.||+|.+..... .....+.+|+.+|++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4699999999999999999987 346799999875532 223457799999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
|||||+||+|.+++...+ .+++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus 104 vmEy~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EECCCTTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEcCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 999999999999997654 6999999999999999999999 99999999999999999999999999999986
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
...... ......||+.|+|||++.+..|+.++|||||||++|||++|..||.... ....+..... .
T Consensus 176 ~~~~~~---~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~----~~~~~~~i~~-----~-- 241 (304)
T 3ubd_A 176 SIDHEK---KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD----RKETMTMILK-----A-- 241 (304)
T ss_dssp -----C---CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHH-----C--
T ss_pred ccCCCc---cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC----HHHHHHHHHc-----C--
Confidence 543322 1225689999999999999999999999999999999999999996532 1111111111 0
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM-----VQVAK 335 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~ei~~ 335 (344)
. ...|. ..++++.+|+.+||+.||++|||+ +|+++
T Consensus 242 ----------~-~~~p~--~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 242 ----------K-LGMPQ--FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ----------C-CCCCT--TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ----------C-CCCCC--cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 0 01111 344568999999999999999985 56653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=389.55 Aligned_cols=251 Identities=18% Similarity=0.292 Sum_probs=188.8
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCC--------
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETE-------- 123 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-------- 123 (344)
++|+..+.||+|+||+||+|++ +++.||||++...... ..+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4588899999999999999998 6889999998755433 3466889999999999999999999987644
Q ss_pred ----ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceE
Q 048160 124 ----LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKF 199 (344)
Q Consensus 124 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 199 (344)
..|+|||||++|+|.+++..... .....+..++.++.|++.||+||| +++|+||||||+|||++.++.+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEE
Confidence 36899999999999999976542 123455668899999999999999 999999999999999999999999
Q ss_pred eeeecccccCCCCccc---------ccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcc
Q 048160 200 FDFCVSISIPEGKTHV---------NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGE 270 (344)
Q Consensus 200 ~dfg~a~~~~~~~~~~---------~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 270 (344)
+|||+|+......... .......||+.|+|||++.+..|+.++|||||||++|||++ ||....
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----- 231 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----- 231 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----
Confidence 9999998775432211 11223579999999999999999999999999999999996 664321
Q ss_pred hhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 271 EYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
... ..+... ... ...+.....++.+.+|+.+||+.||++|||+.+|++
T Consensus 232 -~~~-~~~~~~-~~~--------------~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 -ERV-RTLTDV-RNL--------------KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -HHH-HHHHHH-HTT--------------CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHH-HHHHHH-hcC--------------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001 111110 011 111222244556789999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-52 Score=380.27 Aligned_cols=204 Identities=18% Similarity=0.305 Sum_probs=173.1
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEE-----CCccEEEEEecCCCCchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCC
Q 048160 50 LKAATNNYDPEKVITKDLLYKLYKGFL-----QDRPISVMKFGGNLNSEEYCCFNCIAFASQM-SHKNILKFVGCCLETE 123 (344)
Q Consensus 50 i~~~~~~~~~~~~ig~G~~g~V~~~~~-----~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~ 123 (344)
+....+.|++.+.||+|+||+||+|+. .++.||+|++.... ....+.+|+.+|+.+ +|||||++++++.+.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 334567899999999999999999986 35689999987653 345678999999998 6999999999999999
Q ss_pred ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC-CcceEeee
Q 048160 124 LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ-NVAKFFDF 202 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~df 202 (344)
..|+|||||++|+|.+++. .+++.++..++.|++.||+||| +.+|+||||||+|||++.+ +.+||+||
T Consensus 94 ~~~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcC
Confidence 9999999999999999984 3789999999999999999999 9999999999999999877 79999999
Q ss_pred ecccccCCCCccc-------------------------ccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHc
Q 048160 203 CVSISIPEGKTHV-------------------------NDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLT 256 (344)
Q Consensus 203 g~a~~~~~~~~~~-------------------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~ 256 (344)
|+|+......... ......+||+.|+|||++.+. .|+.++||||+||++|||++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 9998654322110 011235799999999999876 48999999999999999999
Q ss_pred CCCCCCCCCc
Q 048160 257 GKRISYSSCF 266 (344)
Q Consensus 257 g~~p~~~~~~ 266 (344)
|+.||+...+
T Consensus 243 G~~Pf~~~~~ 252 (361)
T 4f9c_A 243 GRYPFYKASD 252 (361)
T ss_dssp TCSSSSCCSS
T ss_pred CCCCCCCCCC
Confidence 9999986543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=381.90 Aligned_cols=268 Identities=16% Similarity=0.223 Sum_probs=201.2
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEee------CCc
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLE------TEL 124 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~------~~~ 124 (344)
++|...+.||+|+||+||+|+. +|+.||||++...... ..+.+.+|+.+|++++|||||++++++.. ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5688899999999999999998 6899999999765432 34567899999999999999999998764 357
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeec
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV 204 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~ 204 (344)
.|||||||. |+|.+++...+ .+++.++..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~-----~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEeCCC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecce
Confidence 899999996 78999997654 6999999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCc-ccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 205 SISIPEGKT-HVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 205 a~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
|+.+..... .........||+.|+|||++.+. .++.++||||+||++|||++|..||..... ...+..+.....
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~----~~~l~~I~~~~g 280 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY----VHQLQLIMMVLG 280 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH----HHHHHHHHHHHC
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH----HHHHHHHHHhcC
Confidence 987643321 12223356899999999998775 468999999999999999999999975421 222222222111
Q ss_pred ccCC--ccc--------ccccccccCCCCChh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ESNS--FKE--------IVDPIIVGEEGLWPE-KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ~~~~--~~~--------~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+.. ... .+..........+.. .+..+.++.+|+.+||..||++|||+.|+++
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1100 000 000000000000000 0123456899999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=367.04 Aligned_cols=290 Identities=29% Similarity=0.513 Sum_probs=235.7
Q ss_pred CCccccccHHHHHHHhcCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeee
Q 048160 39 YNPIQNFTAQELKAATNNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFV 116 (344)
Q Consensus 39 ~~~~~~~~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~ 116 (344)
...++.++..++...+++|...+.||+|+||.||+|+. +++.||||++...... ....+.+|+.++++++||||++++
T Consensus 14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 45678899999999999999999999999999999998 6889999998765432 234688999999999999999999
Q ss_pred eEEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCC---CeeeecccccceEeec
Q 048160 117 GCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSR---PIVFRDIKPSTILFQE 193 (344)
Q Consensus 117 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~---~ivH~dlk~~Nill~~ 193 (344)
+++...+..++||||+++|+|.+++....... .++++..+..++.|++.||.||| +. +|+||||||+||+++.
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil~~~ 169 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQ-PPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVKAANILLDE 169 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTC-CCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCSGGGEEECT
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCchhhEEECC
Confidence 99999999999999999999999997654321 35899999999999999999999 77 9999999999999999
Q ss_pred CCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhH
Q 048160 194 QNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYF 273 (344)
Q Consensus 194 ~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 273 (344)
++.++|+|||++............ ...||+.|+|||++.+..++.++||||||+++|+|++|..||............
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 247 (326)
T 3uim_A 170 EFEAVVGDFGLAKLMDYKDTHVTT--AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247 (326)
T ss_dssp TCCEEECCCSSCEECCSSSSCEEC--CCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred CCCEEeccCccccccCcccccccc--cccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence 999999999999876543322221 346899999999998888999999999999999999999999643222233333
Q ss_pred HHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048160 274 LQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQ 339 (344)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~ 339 (344)
...+..............+...... .....+..+.+++..||+.||++|||+.+|++.|+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 248 LLDWVKGLLKEKKLEALVDVDLQGN-----YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHHHHTTTTSSCCSTTSSCTTCTTS-----CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHHhhchhhhhhcChhhccc-----cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 4455544444444444444333221 223667889999999999999999999999999975
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-51 Score=395.03 Aligned_cols=251 Identities=16% Similarity=0.187 Sum_probs=208.5
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
.++|.+.+.||+|+||+||+|+. +|+.||+|.+........+.+.+|+.+|++++|||||++++++.+...+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 36789999999999999999999 7889999999877666667788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC--CcceEeeeecccccC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ--NVAKFFDFCVSISIP 209 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~dfg~a~~~~ 209 (344)
|+||+|.+++.... ..+++.++..++.||+.||.||| +++|+||||||+|||++.+ +.+||+|||+|+.+.
T Consensus 236 ~~gg~L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 236 MSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp CCCCBHHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred cCCCcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 99999999986544 26999999999999999999999 9999999999999999854 799999999999876
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
...... ...||+.|+|||++.+..|+.++|||||||++|||++|..||..... ...+...... ...+
T Consensus 309 ~~~~~~----~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~----~~~~~~i~~~---~~~~-- 375 (573)
T 3uto_A 309 PKQSVK----VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND----DETLRNVKSC---DWNM-- 375 (573)
T ss_dssp TTSEEE----EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHHHHHHTT---CCCC--
T ss_pred CCCcee----eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HHHHHHHHhC---CCCC--
Confidence 543222 45799999999999999999999999999999999999999975321 1111111100 0000
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+.....+.++.+|+.+||+.||++|||+.|+++
T Consensus 376 -----------~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 376 -----------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp -----------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111133456889999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=360.58 Aligned_cols=288 Identities=28% Similarity=0.426 Sum_probs=231.1
Q ss_pred ccccHHHHHHHhcCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEee
Q 048160 43 QNFTAQELKAATNNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLE 121 (344)
Q Consensus 43 ~~~~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~ 121 (344)
..++..++...+++|...+.||+|+||.||+|++ +++.||+|++........+.+.+|+.++++++||||+++++++..
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 3455666777889999999999999999999998 688999999887766667788999999999999999999999999
Q ss_pred CCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEee
Q 048160 122 TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFD 201 (344)
Q Consensus 122 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~d 201 (344)
++..++||||+++|+|.+++...... ...+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D 182 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLP-TMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITD 182 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCC-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCC-ccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEee
Confidence 99999999999999999999764321 135889999999999999999999 99999999999999999999999999
Q ss_pred eecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHH
Q 048160 202 FCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS 281 (344)
Q Consensus 202 fg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 281 (344)
||++.......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ .....+....
T Consensus 183 fg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~ 259 (321)
T 2qkw_B 183 FGISKKGTELDQTH-LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM--VNLAEWAVES 259 (321)
T ss_dssp CTTCEECSSSSCCC-CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC--CCHHHHTHHH
T ss_pred cccccccccccccc-cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHH--HHHHHHhhhc
Confidence 99998654322211 11244689999999999888999999999999999999999999975433211 1222232222
Q ss_pred hccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 282 IESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.........+++.... ......+..+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 260 ~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 260 HNNGQLEQIVDPNLAD-----KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp HTTTCCCSSSSSSCTT-----CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccccHHHhcChhhcc-----ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 3333333333332211 1223677889999999999999999999999999998875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=387.10 Aligned_cols=246 Identities=17% Similarity=0.257 Sum_probs=197.7
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHh---hHHHHHhcCCCCceeeeeeEEeeCCccE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCF---NCIAFASQMSHKNILKFVGCCLETELPI 126 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~---~E~~~l~~l~H~niv~~~~~~~~~~~~~ 126 (344)
++|...+.||+|+||+||+|+. +|+.||+|++.+.. ......+. .++.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 5788999999999999999999 78899999986431 11122233 3467778889999999999999999999
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
+|||||+||+|.+++...+ .+++..+..++.||+.||.||| +.+||||||||+|||++.+|.+||+|||+|+
T Consensus 269 lVmEy~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceee
Confidence 9999999999999997654 6999999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
...... ....+||+.|+|||++.. ..|+.++|||||||++|||++|..||...... ....+...+ ...
T Consensus 341 ~~~~~~-----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~--~~~~i~~~i---~~~- 409 (689)
T 3v5w_A 341 DFSKKK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRMT---LTM- 409 (689)
T ss_dssp ECSSCC-----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC--CHHHHHHHH---HHC-
T ss_pred ecCCCC-----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhh---cCC-
Confidence 765432 225689999999999964 57999999999999999999999999753221 111111111 100
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHH
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT-----MVQVA 334 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ei~ 334 (344)
....|. ..+.++.+|+.+||+.||++|++ +.||+
T Consensus 410 -------------~~~~p~--~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 410 -------------AVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp -------------CCCCCT--TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred -------------CCCCCc--cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 011111 33456899999999999999998 57765
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=350.49 Aligned_cols=260 Identities=20% Similarity=0.311 Sum_probs=211.5
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
++|...+.||+|+||+||+|.+ ++..||+|++........+.+.+|+.++++++||||+++++++.++...++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 4588889999999999999999 57889999987766566678899999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++|+|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 90 KGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp TTCBHHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 9999999997644 36899999999999999999999 9999999999999999999999999999998765432
Q ss_pred cccc-----------cCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcc-hhHHHHHHHH
Q 048160 213 THVN-----------DNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGE-EYFLQELVRK 280 (344)
Q Consensus 213 ~~~~-----------~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~~ 280 (344)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|..|+......... ..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 2111 111356899999999999999999999999999999999999988653221111 1111111111
Q ss_pred HhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 281 SIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
.. .. .++..+.+|+.+||+.||++|||+.+|++.|+++...
T Consensus 243 ~~----------------~~------~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 243 YC----------------PP------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp TC----------------CT------TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cC----------------CC------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00 00 2233588999999999999999999999999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=351.01 Aligned_cols=249 Identities=19% Similarity=0.295 Sum_probs=207.1
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
.+.|...+.||+|+||+||+|.. +++.||+|++........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999987 7889999998766655667788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+++|+|.+++... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 99 ~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 99 LAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999999753 4889999999999999999999 999999999999999999999999999998876543
Q ss_pred CcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... .......... ..
T Consensus 170 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~~~~~----~~----- 233 (297)
T 3fxz_A 170 QSK---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----LRALYLIATN----GT----- 233 (297)
T ss_dssp TCC---BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHH----CS-----
T ss_pred ccc---cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhC----CC-----
Confidence 322 1245789999999999999999999999999999999999999965321 1111111110 00
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+..+.....+..+.+|+.+||+.||++|||+.++++
T Consensus 234 --------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 234 --------PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp --------CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --------CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 001111134556899999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=352.22 Aligned_cols=270 Identities=21% Similarity=0.301 Sum_probs=210.5
Q ss_pred hcCCCCCCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCc----cEEEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETEL----PILVF 129 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~----~~lv~ 129 (344)
.++|...+.||+|+||+||+|++.++.||||++.... .......+|+.++++++||||+++++++..... .++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEECCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 4568889999999999999999999999999986543 233445679999999999999999999987543 69999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCC----------CeeeecccccceEeecCCcceE
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSR----------PIVFRDIKPSTILFQEQNVAKF 199 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~----------~ivH~dlk~~Nill~~~~~~kl 199 (344)
||+++|+|.+++... .+++..+..++.|++.||.||| +. +|+||||||+|||++.++.+||
T Consensus 102 e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 102 AFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp ECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred ecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 999999999999763 4899999999999999999999 88 9999999999999999999999
Q ss_pred eeeecccccCCCCcccccCCccccccccccccccCcC-----CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhH-
Q 048160 200 FDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA-----NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYF- 273 (344)
Q Consensus 200 ~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~- 273 (344)
+|||+++........ .......||+.|+|||++.+. .++.++||||||+++|||++|+.||............
T Consensus 173 ~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 173 ADFGLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp CCCTTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred ccCCcccccccccCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 999999876543322 112235789999999998763 4667899999999999999999999765432221111
Q ss_pred -------HHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 274 -------LQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 274 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
...+...... ......+.. .+ .....+..+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~-~~~~~~~~~-------~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVH-KKKRPVLRD-------YW-QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHCSSCCHHHHHHHHTT-SCCCCCCCG-------GG-GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhhc-ccCCCCccc-------cc-cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111111111 111110000 01 1125567799999999999999999999999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=343.74 Aligned_cols=288 Identities=25% Similarity=0.417 Sum_probs=227.3
Q ss_pred CccccccHHHHHHHhcCCCCC------CccccCCCceEEEEEECCccEEEEEecCCC----CchhhhHhhHHHHHhcCCC
Q 048160 40 NPIQNFTAQELKAATNNYDPE------KVITKDLLYKLYKGFLQDRPISVMKFGGNL----NSEEYCCFNCIAFASQMSH 109 (344)
Q Consensus 40 ~~~~~~~~~~i~~~~~~~~~~------~~ig~G~~g~V~~~~~~~~~vavk~~~~~~----~~~~~~~~~E~~~l~~l~H 109 (344)
.....|++.++..++++|... +.||+|+||.||+|.+++..||+|++.... ....+.+.+|+.++++++|
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 356789999999999999987 899999999999999999999999987542 2234668899999999999
Q ss_pred CceeeeeeEEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccce
Q 048160 110 KNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTI 189 (344)
Q Consensus 110 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 189 (344)
|||+++++++..++..++||||+++++|.+++...... .++++..+..++.|++.||.||| +.+|+||||||+||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Ni 164 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT--PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANI 164 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGC--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHE
Confidence 99999999999999999999999999999998643221 35889999999999999999999 99999999999999
Q ss_pred EeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCc
Q 048160 190 LFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENG 269 (344)
Q Consensus 190 ll~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 269 (344)
+++.++.++|+|||++.......... ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||........
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 242 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTV-MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCE-ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred EEcCCCcEEEeecccccccccccccc-cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence 99999999999999988765432221 1124568999999998865 578999999999999999999999875433211
Q ss_pred chhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 270 EEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
......... .....+...++..+ . +.....+..+.+++.+||+.||.+|||+.+|++.|+++..+
T Consensus 243 -~~~~~~~~~--~~~~~~~~~~~~~~----~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s 307 (307)
T 2nru_A 243 -LLDIKEEIE--DEEKTIEDYIDKKM----N--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307 (307)
T ss_dssp -TTHHHHHHH--TTSCCHHHHSCSSC----S--CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred -HHHHHHHhh--hhhhhhhhhccccc----c--ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence 111111111 01112222222211 1 11235677899999999999999999999999999998653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=355.86 Aligned_cols=259 Identities=21% Similarity=0.314 Sum_probs=207.2
Q ss_pred cCCCCCCccccCCCceEEEEEE--C---CccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--Q---DRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~---~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
++|...+.||+|+||.||+|++ + +..||||++..... ...+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 4577789999999999999998 2 33599999986643 3346688999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||+++|+|.+++.... ..+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++..
T Consensus 129 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred eeCCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999997654 26899999999999999999999 999999999999999999999999999999877
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
..............+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... . .....+ .....
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~----~-~~~~~~---~~~~~- 272 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN----R-DVISSV---EEGYR- 272 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH----H-HHHHHH---HTTCC-
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH----H-HHHHHH---HcCCC-
Confidence 544322222223356778999999988899999999999999999999 8998864321 1 111111 11100
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
.+....++..+.+|+..||+.||++|||+.+|++.|+.+.++
T Consensus 273 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 273 --------------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp --------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred --------------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 011113455689999999999999999999999999998764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=349.17 Aligned_cols=272 Identities=19% Similarity=0.276 Sum_probs=207.8
Q ss_pred cCCCCCCccccCCCceEEEEEE------CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeC--CccE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL------QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLET--ELPI 126 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~------~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~ 126 (344)
++|+..+.||+|+||+||+|++ ++..||||++........+.+.+|+.++++++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5688889999999999999985 5788999999877666667889999999999999999999998653 5689
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
+||||+++|+|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 90 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEECCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEeCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 9999999999999997654 35899999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
................++..|+|||++.+..++.++||||||+++|+|++|..|+...... ..... .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~------~~~~~---~~~~~ 233 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE------FMRMI---GNDKQ 233 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH------HHHHH---CTTCC
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH------HHhhh---cCccc
Confidence 7654433222222345778899999999999999999999999999999999987643110 00000 00000
Q ss_pred c----ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhC
Q 048160 287 F----KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKSI 344 (344)
Q Consensus 287 ~----~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~l 344 (344)
. .........+. ..+....++.++.+|+.+||+.||++|||+.+|++.|+++.+.+
T Consensus 234 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 234 GQMIVFHLIELLKNNG--RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp THHHHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cchhHHHHHHHHhccC--cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 0 00000000001 11111245567999999999999999999999999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=347.91 Aligned_cols=266 Identities=23% Similarity=0.281 Sum_probs=205.3
Q ss_pred HHHHHHhcCCCCCCccccCCCceEEEEEECCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCcc
Q 048160 48 QELKAATNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLETELP 125 (344)
Q Consensus 48 ~~i~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~ 125 (344)
+++....++|+..+.||+|+||+||+|++++..||||++...... ..+.+.+|+.++++++||||+++++++......
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 333344567888999999999999999999999999998765432 235688999999999999999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCC--eeeecccccceEeecCCcceEeeee
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRP--IVFRDIKPSTILFQEQNVAKFFDFC 203 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~dfg 203 (344)
++||||+++|+|.+++..... ...+++..++.++.|++.||.||| +.+ |+||||||+||+++.++.+||+|||
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg 184 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFG 184 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred EEEEecCCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCC
Confidence 999999999999999976431 124889999999999999999999 888 9999999999999999999999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhc
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE 283 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (344)
+++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... .. .......
T Consensus 185 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~----~~----~~~~~~~ 253 (309)
T 3p86_A 185 LSRLKASTFL---SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP----AQ----VVAAVGF 253 (309)
T ss_dssp --------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH----HH----HHHHHHH
T ss_pred CCcccccccc---ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HH----HHHHHHh
Confidence 9976543221 11245789999999999999999999999999999999999999864321 11 1111100
Q ss_pred cCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 284 SNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
.... ...| ...+..+.+|+.+||+.||++|||+.+|++.|+.+.++
T Consensus 254 ~~~~------------~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 254 KCKR------------LEIP--RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp SCCC------------CCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred cCCC------------CCCC--ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0000 0011 13445689999999999999999999999999998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=350.13 Aligned_cols=260 Identities=20% Similarity=0.270 Sum_probs=213.6
Q ss_pred ccccHHHHHHHhcC----------CCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCC
Q 048160 43 QNFTAQELKAATNN----------YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHK 110 (344)
Q Consensus 43 ~~~~~~~i~~~~~~----------~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~ 110 (344)
..++++++..++++ |...+.||+|+||.||+|+. +++.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 46888888888765 55667899999999999998 6889999999877666667788999999999999
Q ss_pred ceeeeeeEEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceE
Q 048160 111 NILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTIL 190 (344)
Q Consensus 111 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil 190 (344)
||+++++++..++..++||||+++++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIl 173 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV------RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSIL 173 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEE
Confidence 9999999999999999999999999999998753 4889999999999999999999 999999999999999
Q ss_pred eecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcc
Q 048160 191 FQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGE 270 (344)
Q Consensus 191 l~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 270 (344)
++.++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---- 246 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVPK---RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---- 246 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSCC---BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----
T ss_pred ECCCCcEEEeeeeeeeecccCccc---cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----
Confidence 999999999999998876543221 1245789999999999999999999999999999999999999975321
Q ss_pred hhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 271 EYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. .....+.. .. .+........+..+.+++.+||+.||++|||+.++++
T Consensus 247 ~-~~~~~~~~----~~------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 247 V-QAMKRLRD----SP------------PPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp H-HHHHHHHH----SS------------CCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred H-HHHHHHhc----CC------------CCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 11111111 00 0011111133456899999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=358.74 Aligned_cols=258 Identities=19% Similarity=0.311 Sum_probs=197.1
Q ss_pred cCCCCCCccccCCCceEEEEEEC-----CccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFLQ-----DRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~~-----~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
++|...+.||+|+||.||+|++. +..||||++..... ...+.+.+|+.++++++||||+++++++..+...++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 46889999999999999999873 56799999876543 3346688999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||+++|+|.+++.... ..+++.+++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 125 ~e~~~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999997654 36899999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
..............+++.|+|||++.+..++.++||||||+++|||++ |..||..... ......+.....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-----~~~~~~i~~~~~---- 268 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-----QDVIKAVDEGYR---- 268 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-----HHHHHHHHTTEE----
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcCCC----
Confidence 543322211112345678999999998999999999999999999998 9998864321 111111111000
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.+....++..+.+|+.+||+.||++||++.+|++.|+++.+
T Consensus 269 --------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 269 --------------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp --------------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 00011344568999999999999999999999999999865
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=340.60 Aligned_cols=256 Identities=21% Similarity=0.315 Sum_probs=209.6
Q ss_pred cCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
++|...+.||+|+||.||+|.+ +++.||+|++..... ..+.+.+|+.++++++||||+++++++.++...++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 4688889999999999999999 778899999976543 34668899999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++........
T Consensus 89 ~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 89 HGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp TCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCcHHHHHHhcC----cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 999999997654 35889999999999999999999 99999999999999999999999999999986644322
Q ss_pred ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
. ......+++.|+|||++.+..++.++||||||+++|+|++ |..||..... . .... ......
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~----~-~~~~---~~~~~~------- 224 (269)
T 4hcu_A 162 T--SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----S-EVVE---DISTGF------- 224 (269)
T ss_dssp H--STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----H-HHHH---HHHTTC-------
T ss_pred c--cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH----H-HHHH---HHhcCc-------
Confidence 1 1123456788999999988899999999999999999999 8888754321 1 1111 111100
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
....+ ...+..+.+++.+||+.||++|||+.++++.|+++.++
T Consensus 225 ------~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 225 ------RLYKP--RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ------CCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------cCCCC--CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 00000 02345689999999999999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=359.51 Aligned_cols=263 Identities=21% Similarity=0.289 Sum_probs=211.4
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccE
Q 048160 50 LKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPI 126 (344)
Q Consensus 50 i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~ 126 (344)
+....++|...+.||+|+||.||+|++ ++..||||.+...... ..+.+.+|+.++++++||||+++++++..+...+
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 334456788889999999999999999 5788999998765432 2356889999999999999999999999999999
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
+||||+++|+|.+++...+ ..+++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 189 lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSR 261 (377)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence 9999999999999997543 35889999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
........ .......+++.|+|||++.+..++.++||||||+++|||++ |..||..... ......+. ..
T Consensus 262 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-----~~~~~~~~----~~ 331 (377)
T 3cbl_A 262 EEADGVYA-ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-----QQTREFVE----KG 331 (377)
T ss_dssp ECTTSEEE-CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-----HHHHHHHH----TT
T ss_pred ecCCCcee-ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHH----cC
Confidence 65433211 11112345778999999988889999999999999999998 8888754321 11111111 11
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
. .. +....++..+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus 332 ~------------~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 332 G------------RL--PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp C------------CC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C------------CC--CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 0 00 11113455689999999999999999999999999998753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=340.32 Aligned_cols=266 Identities=20% Similarity=0.315 Sum_probs=204.3
Q ss_pred hcCCCCCCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhc--CCCCceeeeeeEEeeC----CccEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQ--MSHKNILKFVGCCLET----ELPIL 127 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~~~~~~~~~----~~~~l 127 (344)
.++|...+.||+|+||+||+|+++++.||||++... ....+.+|.+++.. ++||||+++++++... ...++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 457889999999999999999999999999998654 34455666666666 7999999999997653 45799
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCC-----CCCeeeecccccceEeecCCcceEeee
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGF-----SRPIVFRDIKPSTILFQEQNVAKFFDF 202 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~df 202 (344)
||||+++|+|.+++... .+++..+..++.|++.||.|||... +.+|+||||||+|||++.++.+||+||
T Consensus 84 v~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EECCCTTCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred ehhhccCCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 99999999999999653 5899999999999999999999321 578999999999999999999999999
Q ss_pred ecccccCCCCccc-ccCCccccccccccccccCcC------CCCcccchHHHHHHHHHHHcC----------CCCCCCCC
Q 048160 203 CVSISIPEGKTHV-NDNNKVIGTFGFIAPEYMSTA------NCNEKSDVYSFGALLLELLTG----------KRISYSSC 265 (344)
Q Consensus 203 g~a~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~g----------~~p~~~~~ 265 (344)
|+++......... .......||+.|+|||++.+. .++.++||||||+++|||++| ..||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9997665433221 122245789999999999876 456799999999999999999 77776543
Q ss_pred ccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 266 FENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
............. ......... +........+..+.+|+.+||+.||++|||+.+|++.|++|
T Consensus 238 ~~~~~~~~~~~~~---~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PNDPSFEDMRKVV---CVDQQRPNI---------PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSSCCHHHHHHHH---TTSCCCCCC---------CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcchhhhhHHH---hccCCCCCC---------ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 3222221111111 111100000 00001125677899999999999999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=352.75 Aligned_cols=262 Identities=19% Similarity=0.264 Sum_probs=208.4
Q ss_pred hcCCCCCCccccCCCceEEEEEEC---------CccEEEEEecCCCCc-hhhhHhhHHHHHhcC-CCCceeeeeeEEeeC
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQ---------DRPISVMKFGGNLNS-EEYCCFNCIAFASQM-SHKNILKFVGCCLET 122 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~---------~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~ 122 (344)
.++|...+.||+|+||.||+|++. +..||+|.+...... ..+.+.+|+.+++++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 356788889999999999999872 235999998766432 346688999999999 899999999999999
Q ss_pred CccEEEEeecCCCCccccccCCCCC-----------CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe
Q 048160 123 ELPILVFEFVACGTLADRIHDPNGS-----------QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF 191 (344)
Q Consensus 123 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 191 (344)
+..++||||+++|+|.+++...... ....+++.+++.++.|++.||.||| +.+|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence 9999999999999999998754310 0124788999999999999999999 9999999999999999
Q ss_pred ecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcc
Q 048160 192 QEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGE 270 (344)
Q Consensus 192 ~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~ 270 (344)
+.++.+||+|||+++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~---- 311 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---- 311 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTC-TTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG----
T ss_pred CCCCCEEEccccCCcccCccccee-cccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH----
Confidence 999999999999998765432211 1123456789999999999999999999999999999999 8888764321
Q ss_pred hhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 271 EYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
..+...+. .. .....| ..++..+.+|+.+||+.||++|||+.+|++.|+++..
T Consensus 312 -~~~~~~~~----~~------------~~~~~~--~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 312 -EELFKLLK----EG------------HRMDKP--ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp -GGHHHHHH----TT------------CCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHh----cC------------CCCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111111 01 000111 1344568999999999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=348.51 Aligned_cols=247 Identities=21% Similarity=0.243 Sum_probs=203.7
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
..++|...+.||+|+||.||+|++ +++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 346799999999999999999998 788999999865532 2345678999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||+++|+|.+++...+ .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 93 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp ECCCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EECCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 99999999999987653 5889999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCcccccCCccccccccccccccCcCCCC-cccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCN-EKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
...... ....||+.|+|||++.+..++ .++|||||||++|+|++|..||..... ..+ ....... .
T Consensus 165 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~---~~~i~~~-~- 230 (328)
T 3fe3_A 165 TVGGKL----DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-----KEL---RERVLRG-K- 230 (328)
T ss_dssp SSSCGG----GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH---HHHHHHC-C-
T ss_pred CCCCcc----ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-----HHH---HHHHHhC-C-
Confidence 543322 245789999999999888765 789999999999999999999965321 111 1111111 0
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
...|. ..+.++.+|+.+||+.||.+|||+.++++
T Consensus 231 ------------~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 231 ------------YRIPF--YMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ------------CCCCT--TSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ------------CCCCC--CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00111 23456889999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=362.11 Aligned_cols=252 Identities=21% Similarity=0.302 Sum_probs=206.8
Q ss_pred hcCCCCCCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCC-ccEEEEeec
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETE-LPILVFEFV 132 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-~~~lv~e~~ 132 (344)
.++|...+.||+|+||.||+|.+.++.||||.++... ..+.+.+|+.+|++++||||+++++++.... ..++||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 4567888999999999999999999999999998654 4577899999999999999999999987765 789999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++|+|.+++...+. ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 270 ~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 270 AKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp TTCBHHHHHHHHCT---TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 99999999976432 24788999999999999999999 9999999999999999999999999999997543221
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
. ...++..|+|||++.+..++.++||||||+++|||++ |..||..... .... ..+. .+
T Consensus 344 ~------~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----~~~~-~~i~----~~------ 402 (450)
T 1k9a_A 344 D------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVV-PRVE----KG------ 402 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT----TTHH-HHHH----TT------
T ss_pred c------CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHH-HHHH----cC------
Confidence 1 2356789999999999999999999999999999998 8888864321 1111 1110 11
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.....| ..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 403 ------~~~~~p--~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 403 ------YKMDAP--DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp ------CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCC--CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 011111 1455678999999999999999999999999999865
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=348.73 Aligned_cols=249 Identities=19% Similarity=0.241 Sum_probs=204.1
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc------hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCcc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS------EEYCCFNCIAFASQMSHKNILKFVGCCLETELP 125 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~ 125 (344)
.+.|...+.||+|+||.||+|+. ++..||+|.+...... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 46788999999999999999999 6889999998765332 235688999999999999999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC----cceEee
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN----VAKFFD 201 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~d 201 (344)
++||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++ .+||+|
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS-----CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 99999999999999997653 6899999999999999999999 99999999999999998776 799999
Q ss_pred eecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHH
Q 048160 202 FCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS 281 (344)
Q Consensus 202 fg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 281 (344)
||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||..... ...+....
T Consensus 163 FG~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~----~~~~~~i~--- 231 (361)
T 2yab_A 163 FGLAHEIEDGVEF----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANIT--- 231 (361)
T ss_dssp CSSCEECCTTCCC----CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHHHHHH---
T ss_pred cCCceEcCCCCcc----ccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH---
Confidence 9999876543221 245789999999999998999999999999999999999999975321 11111111
Q ss_pred hccCCcccccccccccCCCCChh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 282 IESNSFKEIVDPIIVGEEGLWPE-KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.. .....+. ....+..+.+|+.+||+.||++|||+.++++
T Consensus 232 --~~------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 232 --AV------------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp --TT------------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --hc------------CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0000000 1123456899999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=337.75 Aligned_cols=256 Identities=18% Similarity=0.240 Sum_probs=208.4
Q ss_pred hcCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
.++|...+.||+|+||.||+|.+ ++..||+|++..... ..+.+.+|+.++.+++||||+++++++..+...++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 45688889999999999999999 556899999876543 3466889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++++|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 86 SNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp TTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred CCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999997643 35899999999999999999999 9999999999999999999999999999998765443
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
.... ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... ..... ......
T Consensus 159 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~----~~~~~~------ 222 (268)
T 3sxs_A 159 YVSS--VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN----SEVVL----KVSQGH------ 222 (268)
T ss_dssp EEEC--CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHHH----HHHTTC------
T ss_pred hhcc--cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh----HHHHH----HHHcCC------
Confidence 2221 13345778999999988889999999999999999999 8888854321 11111 111100
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
....|. ..+..+.+++..||+.||++|||+.+|++.|+.+.+
T Consensus 223 -------~~~~~~--~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 223 -------RLYRPH--LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp -------CCCCCT--TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred -------CCCCCC--cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 000010 233468899999999999999999999999998764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=338.73 Aligned_cols=269 Identities=20% Similarity=0.282 Sum_probs=205.1
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcC--CCCceeeeeeEEeeC----Cc
Q 048160 51 KAATNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQM--SHKNILKFVGCCLET----EL 124 (344)
Q Consensus 51 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~~~~~~~~~----~~ 124 (344)
....++|...+.||+|+||.||+|++.+..||||++... ....+.+|..++..+ +||||+++++++... ..
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cccccceEEEeEeecCCCeEEEEEEECCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 344567999999999999999999999999999998644 334455566666555 899999999999887 67
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCC--------CeeeecccccceEeecCCc
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSR--------PIVFRDIKPSTILFQEQNV 196 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~--------~ivH~dlk~~Nill~~~~~ 196 (344)
.++||||+++|+|.+++... .+++.++..++.|++.||.||| +. +|+||||||+||+++.++.
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred eEEEEeccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCC
Confidence 89999999999999999653 4889999999999999999999 77 9999999999999999999
Q ss_pred ceEeeeecccccCCCCccc-ccCCccccccccccccccCcCCCCcc------cchHHHHHHHHHHHcC----------CC
Q 048160 197 AKFFDFCVSISIPEGKTHV-NDNNKVIGTFGFIAPEYMSTANCNEK------SDVYSFGALLLELLTG----------KR 259 (344)
Q Consensus 197 ~kl~dfg~a~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~------~Di~slG~il~el~~g----------~~ 259 (344)
+||+|||++.......... .......||+.|+|||++.+..++.. +||||||+++|||++| ..
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 9999999997765433221 11224578999999999987766654 9999999999999999 55
Q ss_pred CCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048160 260 ISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQ 339 (344)
Q Consensus 260 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~ 339 (344)
||................ ........ ..+.......++..+.+|+.+||+.||++|||+.+|++.|++
T Consensus 261 p~~~~~~~~~~~~~~~~~----~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 261 PYHDLVPSDPSYEDMREI----VCIKKLRP--------SFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp TTTTTSCSSCCHHHHHHH----HTTSCCCC--------CCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred cHhhhcCCCCchhhhHHH----HhhhccCc--------cccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 554332211111111111 11111110 011111122677889999999999999999999999999999
Q ss_pred HHhh
Q 048160 340 LHKS 343 (344)
Q Consensus 340 l~~~ 343 (344)
+.++
T Consensus 329 l~~~ 332 (337)
T 3mdy_A 329 MSES 332 (337)
T ss_dssp HHHT
T ss_pred HHhh
Confidence 9875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=342.43 Aligned_cols=273 Identities=21% Similarity=0.273 Sum_probs=207.3
Q ss_pred cCCCCCCccccCCCceEEEEEE------CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeC--Ccc
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL------QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLET--ELP 125 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~------~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~ 125 (344)
..|+..+.||+|+||.||+|++ +++.||+|++..... ...+.+.+|+.++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3478889999999999999994 678899999875533 3346788999999999999999999999876 668
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
++||||+++|+|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccc
Confidence 99999999999999995543 35899999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
.................+|..|+|||++.+..++.++||||||+++|+|++|..|+..... .............
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~ 247 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA------LFLKMIGPTHGQM 247 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH------HHHHHHCSCCGGG
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh------HHhhccCCccccc
Confidence 8776554333333345678889999999888899999999999999999999988643210 0000000000000
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
...........+.. .+.....+..+.+|+.+||+.||++|||+.++++.|+++.+
T Consensus 248 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 248 TVTRLVNTLKEGKR--LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CHHHHHHHHhccCC--CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 00000000000011 11111345578999999999999999999999999999863
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=365.93 Aligned_cols=263 Identities=18% Similarity=0.288 Sum_probs=211.2
Q ss_pred HHHHHHHhcCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCcc
Q 048160 47 AQELKAATNNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELP 125 (344)
Q Consensus 47 ~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~ 125 (344)
.+++....++|...+.||+|+||.||+|.+ .+..||||+++... ...+.+.+|+.+|++++||||+++++++. ....
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 344455567788889999999999999999 57789999997654 34677999999999999999999999986 6678
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
++||||+++|+|.+++....+ ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLA 331 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred EEEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence 999999999999999975422 25788899999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhcc
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIES 284 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (344)
+......... .....++..|+|||++....++.++||||||+++|||++ |..||..... . .....+.. .
T Consensus 332 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~----~-~~~~~i~~---~ 401 (454)
T 1qcf_A 332 RVIEDNEYTA--REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----P-EVIRALER---G 401 (454)
T ss_dssp GGBCCHHHHT--TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----H-HHHHHHHH---T
T ss_pred eEcCCCceec--cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH----H-HHHHHHHc---C
Confidence 8765322111 112345788999999988899999999999999999999 8888854311 1 11111111 1
Q ss_pred CCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 285 NSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.. .+....++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 402 ~~---------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 402 YR---------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CC---------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CC---------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 00 01111445678999999999999999999999999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=340.88 Aligned_cols=263 Identities=15% Similarity=0.160 Sum_probs=210.1
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEEEe
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e 130 (344)
.++|...+.||+|+||.||+|+. +++.||||.+.... ..+.+.+|+.+++++ +||||+++++++..+...++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46788999999999999999997 78899999987553 345688999999999 89999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCc-----ceEeeeecc
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNV-----AKFFDFCVS 205 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~dfg~a 205 (344)
|+ +++|.+++.... ..+++.+++.++.|++.||.||| +.+|+||||||+|||++.++. +||+|||++
T Consensus 86 ~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 86 LL-GPSLEDLFDLCD----RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred eC-CCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 99 899999997643 36899999999999999999999 999999999999999998887 999999999
Q ss_pred cccCCCCccc----ccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHH
Q 048160 206 ISIPEGKTHV----NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS 281 (344)
Q Consensus 206 ~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 281 (344)
+......... .......||+.|+|||++.+..++.++||||||+++|||++|..||...... .............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~-~~~~~~~~i~~~~ 236 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD-TLKERYQKIGDTK 236 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS-SHHHHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc-cHHHHHHHHHhhh
Confidence 8765433211 1123567899999999999999999999999999999999999999764221 1111111111111
Q ss_pred hccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 282 IESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
. ....... ....+ ++.+++..||+.||.+||++.+|.+.|..+.+.
T Consensus 237 ~-~~~~~~~--------------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 237 R-ATPIEVL--------------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp H-HSCHHHH--------------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred c-cCCHHHH--------------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 1 0000000 00123 689999999999999999999999999988754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=342.90 Aligned_cols=249 Identities=16% Similarity=0.227 Sum_probs=204.7
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
.++|...+.||+|+||.||+|.. ++..||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 46788899999999999999999 67889999987543 3445678999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec--CCcceEeeeecccccC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE--QNVAKFFDFCVSISIP 209 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~dfg~a~~~~ 209 (344)
+++|+|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||++....
T Consensus 83 ~~g~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 83 ISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 99999999997654 35899999999999999999999 999999999999999987 7899999999998775
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
...... ...||+.|+|||++.+..++.++||||||+++|+|++|..||..... ..........
T Consensus 156 ~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~--------- 218 (321)
T 1tki_A 156 PGDNFR----LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNA--------- 218 (321)
T ss_dssp TTCEEE----EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHT---------
T ss_pred CCCccc----cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH----HHHHHHHHcC---------
Confidence 433221 45789999999999988899999999999999999999999965321 1111111110
Q ss_pred ccccccccCCCCCh-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 IVDPIIVGEEGLWP-EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.....+ .....+.++.+|+.+||+.||++|||+.++++
T Consensus 219 --------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 219 --------EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --------CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --------CCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000000 01133456899999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=337.24 Aligned_cols=258 Identities=17% Similarity=0.250 Sum_probs=206.8
Q ss_pred HhcCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
..++|...+.||+|+||.||+|.+ ++..||+|++..... ..+.+.+|+.++.+++||||+++++++......++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 345688889999999999999999 566899999876543 346788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+++++|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++......
T Consensus 101 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 101 MANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CTTCBHHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred cCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 99999999997643 35899999999999999999999 999999999999999999999999999999876443
Q ss_pred CcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcccc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEI 290 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (344)
... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... ......+. ...
T Consensus 174 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-----~~~~~~~~---~~~----- 238 (283)
T 3gen_A 174 EYT--SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----SETAEHIA---QGL----- 238 (283)
T ss_dssp HHH--STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHHHHHH---TTC-----
T ss_pred ccc--cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-----hHHHHHHh---ccc-----
Confidence 221 1113356788999999998899999999999999999998 8888864321 11111111 000
Q ss_pred cccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 291 VDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
....+. ..+..+.+|+..||+.||++|||+.++++.|..+.+.
T Consensus 239 --------~~~~~~--~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 239 --------RLYRPH--LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp --------CCCCCT--TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCC--cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 000000 2234688999999999999999999999999998763
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=333.47 Aligned_cols=264 Identities=13% Similarity=0.143 Sum_probs=212.1
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEEEe
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e 130 (344)
.++|...+.||+|+||.||+|.. +++.||+|.+.... ..+.+.+|+..++++ +|+|++++++++..+...++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 35688999999999999999996 78899999986543 345678999999999 79999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCc-----ceEeeeecc
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNV-----AKFFDFCVS 205 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~dfg~a 205 (344)
|+ +++|.+++.... .++++.++..++.|++.||.||| +.+|+||||||+||+++.++. ++|+|||++
T Consensus 87 ~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ec-CCCHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 99 899999997654 35899999999999999999999 999999999999999987776 999999999
Q ss_pred cccCCCCccc----ccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHH
Q 048160 206 ISIPEGKTHV----NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS 281 (344)
Q Consensus 206 ~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 281 (344)
.......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||........ ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~ 237 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-KQKYERIGEKK 237 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-HHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc-HHHHHHHHhhc
Confidence 8765433211 112345789999999999999999999999999999999999999976432111 11111111111
Q ss_pred hccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 282 IESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
......... ...+..+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus 238 -~~~~~~~~~--------------~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 238 -QSTPLRELC--------------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp -HHSCHHHHT--------------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -cCccHHHHH--------------hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 111111000 02345689999999999999999999999999998865
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=336.47 Aligned_cols=257 Identities=18% Similarity=0.246 Sum_probs=195.3
Q ss_pred hcCCCCCCccccCCCceEEEEEEC-----CccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQ-----DRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~-----~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
.++|...+.||+|+||.||+|.+. +..||+|.+...... ..+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 356888899999999999999982 345999988765332 3456889999999999999999999974 567899
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
||||+++++|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 93 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccc
Confidence 999999999999997654 25889999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||..... ..... .+. ...
T Consensus 166 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~----~~~~~-~i~----~~~ 234 (281)
T 1mp8_A 166 MEDSTYYK--ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVIG-RIE----NGE 234 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GGHHH-HHH----TTC
T ss_pred cCcccccc--cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH----HHHHH-HHH----cCC
Confidence 65432211 113356788999999988899999999999999999997 8888864321 11111 110 000
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
.. +....++..+.+++.+||+.||++|||+.+|++.|+++.+.
T Consensus 235 ------------~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 235 ------------RL--PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp ------------CC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------CC--CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00 01113445689999999999999999999999999998763
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=349.56 Aligned_cols=274 Identities=18% Similarity=0.299 Sum_probs=215.7
Q ss_pred cccHHHHHHHhcCCCCCCccccCCCceEEEEEE-------CCccEEEEEecCCCCc-hhhhHhhHHHHHhcC-CCCceee
Q 048160 44 NFTAQELKAATNNYDPEKVITKDLLYKLYKGFL-------QDRPISVMKFGGNLNS-EEYCCFNCIAFASQM-SHKNILK 114 (344)
Q Consensus 44 ~~~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~-------~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~ 114 (344)
.+...++....++|...+.||+|+||.||+|++ +++.||||++...... ..+.+.+|+.++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 345666667778899999999999999999985 3478999999765433 345688999999999 7899999
Q ss_pred eeeEEeeCC-ccEEEEeecCCCCccccccCCCCCC---------------------------------------------
Q 048160 115 FVGCCLETE-LPILVFEFVACGTLADRIHDPNGSQ--------------------------------------------- 148 (344)
Q Consensus 115 ~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------- 148 (344)
+++++...+ ..++||||+++|+|.+++.......
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999998754 4899999999999999997654210
Q ss_pred ----------------CccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 149 ----------------LEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 149 ----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
...+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 112889999999999999999999 9999999999999999999999999999998664432
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
.. .......||+.|+|||++.+..++.++||||||+++|+|++ |..||..... .......+.. ...
T Consensus 248 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~~~~~~~----~~~---- 314 (359)
T 3vhe_A 248 DY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----DEEFCRRLKE----GTR---- 314 (359)
T ss_dssp TC-EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC----SHHHHHHHHH----TCC----
T ss_pred cc-hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch----hHHHHHHHHc----CCC----
Confidence 22 11224567889999999999999999999999999999998 9988865322 1111111111 100
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
...+ ...+..+.+++.+||+.||++|||+.+|++.|+++.++
T Consensus 315 --------~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 315 --------MRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp --------CCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCC--CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 0001 12345689999999999999999999999999998764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=342.50 Aligned_cols=246 Identities=19% Similarity=0.239 Sum_probs=202.2
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||.||+|+. +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 5688899999999999999998 68899999986542 223456789999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 85 E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 85 EYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 9999999999987543 5899999999999999999999 9999999999999999999999999999997643
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
..... .....||+.|+|||++.+..++.++||||||+++|||++|..||..... ......... ..
T Consensus 157 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~i~~-----~~--- 221 (337)
T 1o6l_A 157 SDGAT---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELILM-----EE--- 221 (337)
T ss_dssp CTTCC---BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHH-----CC---
T ss_pred cCCCc---ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH----HHHHHHHHc-----CC---
Confidence 32211 1246799999999999999999999999999999999999999975321 111111111 00
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-----TMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ei~~ 335 (344)
..+|. ..+.++.+|+.+||+.||++|| ++.+|++
T Consensus 222 ----------~~~p~--~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 222 ----------IRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----------CCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----------CCCCC--CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 00111 2345689999999999999999 8888865
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=345.78 Aligned_cols=273 Identities=22% Similarity=0.248 Sum_probs=211.5
Q ss_pred cCCCCCCccccCCCceEEEEEE------CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEe--eCCccE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL------QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCL--ETELPI 126 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~------~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~--~~~~~~ 126 (344)
++|+..+.||+|+||.||+|++ .+..||+|++........+.+.+|+.++++++||||+++++++. .....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4688889999999999999995 56789999998776666677899999999999999999999987 456689
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
+||||+++++|.+++.... ..+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.
T Consensus 103 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 9999999999999997643 35899999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
................+|..|+|||++.+..++.++||||||+++|+|++|..||....... .. ..........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~~-~~~~~~~~~~ 249 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF-----LR-MMGCERDVPA 249 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-----HH-HCC----CCH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh-----hh-hccccccccc
Confidence 77654433333334567888999999988889999999999999999999999986532100 00 0000000000
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
..........+... +....++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 250 ~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 250 LSRLLELLEEGQRL--PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHHHHHHhhcccCC--CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00000000011111 1111445678999999999999999999999999998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=363.11 Aligned_cols=257 Identities=20% Similarity=0.292 Sum_probs=209.2
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
..++|...+.||+|+||.||+|.+ .+..||||.+..... ..+.+.+|+.+|++++||||+++++++......++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 345677788999999999999999 478899999876543 45778999999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|+++|+|.+++..... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 297 ~~~~g~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 297 FMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred ccCCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 9999999999975432 35889999999999999999999 99999999999999999999999999999987654
Q ss_pred CCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
..... .....++..|+|||++....++.++||||||+++|||++ |..||..... ......+....
T Consensus 371 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~-----~~~~~~~~~~~------- 436 (495)
T 1opk_A 371 DTYTA--HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLEKDY------- 436 (495)
T ss_dssp CCEEC--CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGHHHHHHTTC-------
T ss_pred Cceee--cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcCC-------
Confidence 33221 113345788999999988899999999999999999999 8888754321 11111111100
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLH 341 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~ 341 (344)
.. +....++..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 437 ---------~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 ---------RM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ---------CC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ---------CC--CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 00 011144567899999999999999999999999998864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=337.60 Aligned_cols=258 Identities=21% Similarity=0.314 Sum_probs=203.1
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||.||+|+. .+..||+|.+..... ...+.+.+|+.++++++||||+++++++..++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 5688899999999999999998 678899999855432 22356789999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++++|.+++.... ++++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 91 e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp ECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred eCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 9999999999997653 5899999999999999999999 9999999999999999999999999999998764
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ..... ..... ....
T Consensus 163 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~----~~~~~----~~~~~-~~~~ 231 (294)
T 4eqm_A 163 ETSLT--QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA----VSIAI----KHIQD-SVPN 231 (294)
T ss_dssp --------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH----HHHHH----HHHSS-CCCC
T ss_pred ccccc--ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh----HHHHH----HHhhc-cCCC
Confidence 33221 12245789999999999999999999999999999999999999965321 11111 11110 0000
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-TMVQVAKQLRQLH 341 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~ei~~~L~~l~ 341 (344)
... .. ....+..+.+++.+||+.||++|| ++.++.+.|.++.
T Consensus 232 ~~~----~~------~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 232 VTT----DV------RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHH----HS------CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred cch----hc------ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 000 00 012345689999999999999998 9999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=345.71 Aligned_cols=266 Identities=21% Similarity=0.328 Sum_probs=210.6
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEECC-------ccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeC
Q 048160 51 KAATNNYDPEKVITKDLLYKLYKGFLQD-------RPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLET 122 (344)
Q Consensus 51 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~-------~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~ 122 (344)
....++|...+.||+|+||.||+|++.+ ..||+|.+...... ..+.+.+|+.++++++||||+++++++..+
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 3345789999999999999999999843 78999998765433 346688999999999999999999999999
Q ss_pred CccEEEEeecCCCCccccccCCCCCC-------------------CccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeec
Q 048160 123 ELPILVFEFVACGTLADRIHDPNGSQ-------------------LEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRD 183 (344)
Q Consensus 123 ~~~~lv~e~~~~gsL~~~l~~~~~~~-------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d 183 (344)
+..++||||+++|+|.+++....... ...+++.+++.++.|++.||.||| +.+|+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence 99999999999999999987532110 136889999999999999999999 99999999
Q ss_pred ccccceEeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCC
Q 048160 184 IKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISY 262 (344)
Q Consensus 184 lk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~ 262 (344)
|||+||+++.++.+||+|||++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccc-cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999765432211 11123467889999999988899999999999999999999 888886
Q ss_pred CCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 263 SSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.... ... ... ....... ..+. .++..+.+|+.+||+.||++|||+.+|++.|+++.+
T Consensus 279 ~~~~-----~~~---~~~-~~~~~~~------------~~~~--~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 279 GMAH-----EEV---IYY-VRDGNIL------------ACPE--NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TSCH-----HHH---HHH-HHTTCCC------------CCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCh-----HHH---HHH-HhCCCcC------------CCCC--CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 4321 111 111 1111110 0111 334568999999999999999999999999999865
Q ss_pred h
Q 048160 343 S 343 (344)
Q Consensus 343 ~ 343 (344)
.
T Consensus 336 ~ 336 (343)
T 1luf_A 336 R 336 (343)
T ss_dssp -
T ss_pred h
Confidence 3
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=340.57 Aligned_cols=249 Identities=20% Similarity=0.241 Sum_probs=203.1
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc------hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS------EEYCCFNCIAFASQMSHKNILKFVGCCLETELPI 126 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~ 126 (344)
+.|...+.||+|+||.||+|.. ++..||+|.+...... ..+.+.+|+.++++++||||+++++++......+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4588899999999999999999 5789999998754322 2466889999999999999999999999999999
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC----cceEeee
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN----VAKFFDF 202 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~df 202 (344)
+||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++ .+||+||
T Consensus 91 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS-----CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEcCCCCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 9999999999999997643 6899999999999999999999 99999999999999998887 7999999
Q ss_pred ecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 203 CVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 203 g~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
|++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||..... ...+......
T Consensus 163 g~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~~~~~-- 232 (326)
T 2y0a_A 163 GLAHKIDFGNEF----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAV-- 232 (326)
T ss_dssp TTCEECCTTSCC----CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHHHHHHHT--
T ss_pred CCCeECCCCCcc----ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH----HHHHHHHHhc--
Confidence 999876543221 245789999999999988999999999999999999999999965321 1111111100
Q ss_pred ccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..... .+.....+..+.+|+.+||+.||++|||+.++++
T Consensus 233 -~~~~~-------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 233 -NYEFE-------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -CCCCC-------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCcC-------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000 0001123456889999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=345.45 Aligned_cols=271 Identities=20% Similarity=0.280 Sum_probs=203.3
Q ss_pred hcCCCCCCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhH--HHHHhcCCCCceeeeeeEEee-----CCccE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNC--IAFASQMSHKNILKFVGCCLE-----TELPI 126 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E--~~~l~~l~H~niv~~~~~~~~-----~~~~~ 126 (344)
.++|...+.||+|+||.||+|+++++.||||++... ....+..| +..+..++||||+++++++.. ....+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEECCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 467888999999999999999999999999998654 23334444 444556899999999986543 23568
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCC---------CeeeecccccceEeecCCcc
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSR---------PIVFRDIKPSTILFQEQNVA 197 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~---------~ivH~dlk~~Nill~~~~~~ 197 (344)
+||||+++|+|.+++... ..++..+..++.|++.||.||| +. +|+||||||+|||++.++.+
T Consensus 89 lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred EEEecCCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcE
Confidence 999999999999999764 3578889999999999999999 88 99999999999999999999
Q ss_pred eEeeeecccccCCCCcc-----cccCCccccccccccccccCc-------CCCCcccchHHHHHHHHHHHcCCCCCCCCC
Q 048160 198 KFFDFCVSISIPEGKTH-----VNDNNKVIGTFGFIAPEYMST-------ANCNEKSDVYSFGALLLELLTGKRISYSSC 265 (344)
Q Consensus 198 kl~dfg~a~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~g~~p~~~~~ 265 (344)
||+|||++......... ........||+.|+|||++.+ ..++.++||||||+++|||++|..||+...
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 99999999876543211 111224468999999999976 356789999999999999999998887654
Q ss_pred ccCcchhHHHHH---------HHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 266 FENGEEYFLQEL---------VRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 266 ~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
............ ............. ....++.....+..+.+|+.+||+.||++|||+.+|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~ 312 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPK-------FPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER 312 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCC-------CCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCC-------CCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence 432211111100 0000000000000 112222233567789999999999999999999999999
Q ss_pred HHHHHhh
Q 048160 337 LRQLHKS 343 (344)
Q Consensus 337 L~~l~~~ 343 (344)
|+++.+.
T Consensus 313 L~~ll~~ 319 (336)
T 3g2f_A 313 MAELMMI 319 (336)
T ss_dssp HHHHHHC
T ss_pred HHHHHHH
Confidence 9998764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=336.96 Aligned_cols=253 Identities=23% Similarity=0.402 Sum_probs=198.8
Q ss_pred cCCCCCCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 55 NNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
++|...+.||+|+||.||+|++.++.||+|++... ...+.+.+|+.++++++||||+++++++. +..++||||+++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~ 83 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEG 83 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTT
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCC
Confidence 45778899999999999999999999999998654 34567889999999999999999999886 458999999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCC---CCeeeecccccceEeecCCc-ceEeeeecccccCC
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFS---RPIVFRDIKPSTILFQEQNV-AKFFDFCVSISIPE 210 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~---~~ivH~dlk~~Nill~~~~~-~kl~dfg~a~~~~~ 210 (344)
|+|.+++..... ...+++..++.++.|++.||.||| + .+|+||||||+||+++.++. +||+|||++.....
T Consensus 84 ~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 84 GSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLH---SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp CBHHHHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHH---TCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCHHHHHhccCC--CCccCHHHHHHHHHHHHHHHHHHH---hCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 999999976432 124778899999999999999999 7 89999999999999998886 79999999875533
Q ss_pred CCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEI 290 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (344)
.. ....||+.|+|||++.+..++.++||||||+++|+|++|..||...... .. ...+... ......
T Consensus 159 ~~------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~---~~~~~~~-~~~~~~- 224 (307)
T 2eva_A 159 HM------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP---AF---RIMWAVH-NGTRPP- 224 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS---HH---HHHHHHH-TTCCCC-
T ss_pred cc------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc---HH---HHHHHHh-cCCCCC-
Confidence 21 1346899999999999989999999999999999999999998643211 11 1111111 111000
Q ss_pred cccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 291 VDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
.+ ...+..+.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 225 -----------~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 225 -----------LI--KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp -----------CB--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred -----------cc--cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 00 13345688999999999999999999999999998754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=332.84 Aligned_cols=258 Identities=17% Similarity=0.256 Sum_probs=207.8
Q ss_pred cCCCCCC-ccccCCCceEEEEEE----CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 55 NNYDPEK-VITKDLLYKLYKGFL----QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 55 ~~~~~~~-~ig~G~~g~V~~~~~----~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
++|.... .||+|+||.||+|.+ .+..||+|.+..... ...+.+.+|+.++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4455555 899999999999986 466799999987543 3346688999999999999999999999 56678999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||+++++|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 99999999999997544 36899999999999999999999 999999999999999999999999999999877
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
..............+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... ......+. ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~~i~----~~~~ 231 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PEVMAFIE----QGKR 231 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----HHHHHHHH----TTCC
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----HHHHHHHh----cCCc
Confidence 544333222234456889999999988889999999999999999998 9999865321 11111111 1110
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
...+ ...+..+.+++..||+.||++|||+.+|++.|+++..+
T Consensus 232 ------------~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 232 ------------MECP--PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp ------------CCCC--TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------CCCC--CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0111 13445689999999999999999999999999998764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=331.92 Aligned_cols=256 Identities=20% Similarity=0.303 Sum_probs=208.6
Q ss_pred cCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
++|...+.||+|+||.||+|.+ ++..||+|.+..... ..+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 4688889999999999999999 777899999976643 34678899999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+++|.+++.... ..+++.++..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 87 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 87 HGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp TCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCcHHHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 999999997654 25889999999999999999999 99999999999999999999999999999987643221
Q ss_pred ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
. ......++..|+|||++.+..++.++||||||+++|+|++ |..||..... . .....+ ....
T Consensus 160 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~-~~~~~i---~~~~------- 222 (267)
T 3t9t_A 160 T--SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----S-EVVEDI---STGF------- 222 (267)
T ss_dssp H--STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----H-HHHHHH---HTTC-------
T ss_pred c--ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH----H-HHHHHH---hcCC-------
Confidence 1 1123456788999999988889999999999999999999 7888754311 1 111111 1100
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
....+. ..+..+.+++.+||+.||++|||+.++++.|+++.++
T Consensus 223 ------~~~~~~--~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 223 ------RLYKPR--LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp ------CCCCCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------cCCCCc--cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 000000 2345688999999999999999999999999998763
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=334.28 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=193.7
Q ss_pred cCCCCCCccccCCCceEEEEEECCccEEEEEecCCCCc----hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 55 NNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNS----EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~----~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
++|...+.||+|+||.||+|.+.+..||+|++...... ..+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 56888899999999999999999999999998654322 23567899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCC---eeeecccccceEeec--------CCcceE
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRP---IVFRDIKPSTILFQE--------QNVAKF 199 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~---ivH~dlk~~Nill~~--------~~~~kl 199 (344)
|+++++|.+++... .+++..+..++.|++.||.||| +.+ |+||||||+||+++. ++.++|
T Consensus 87 ~~~~~~L~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 87 FARGGPLNRVLSGK------RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp CCTTEEHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred cCCCCCHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 99999999998643 5889999999999999999999 777 999999999999986 678999
Q ss_pred eeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHH
Q 048160 200 FDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR 279 (344)
Q Consensus 200 ~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 279 (344)
+|||++......... ...||+.|+|||++.+..++.++||||||+++|+|++|..||..... .... .
T Consensus 158 ~Dfg~~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~----~ 224 (271)
T 3dtc_A 158 TDFGLAREWHRTTKM-----SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG----LAVA----Y 224 (271)
T ss_dssp CCCCC------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH----HHHH----H
T ss_pred ccCCccccccccccc-----CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHH----H
Confidence 999999765433221 34689999999999888899999999999999999999999965321 1111 1
Q ss_pred HHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 280 KSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
..... ... .+....++..+.+++.+||+.||++|||+.++++.|++|
T Consensus 225 ~~~~~-~~~-------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 225 GVAMN-KLA-------------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHTS-CCC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hhhcC-CCC-------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11110 000 001113445689999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=350.53 Aligned_cols=262 Identities=21% Similarity=0.287 Sum_probs=205.8
Q ss_pred hcCCCCCCccccCCCceEEEEEE-------CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCcc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL-------QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELP 125 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~-------~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~ 125 (344)
.++|...+.||+|+||+||+|++ .+..||||++..... .....+.+|+.++++++||||+++++++.++...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35688889999999999999996 345799999875533 3345688999999999999999999999999999
Q ss_pred EEEEeecCCCCccccccCCCC--CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC---cceEe
Q 048160 126 ILVFEFVACGTLADRIHDPNG--SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN---VAKFF 200 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~ 200 (344)
++||||+++|+|.+++..... .....+++.+++.++.|++.||.||| +.+|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999865332 11135889999999999999999999 99999999999999998555 59999
Q ss_pred eeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHH
Q 048160 201 DFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVR 279 (344)
Q Consensus 201 dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 279 (344)
|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.... ...+...+.
T Consensus 227 DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~-----~~~~~~~i~ 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYY-RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----NQEVLEFVT 300 (367)
T ss_dssp CCHHHHHHHHHSSC-TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHHHHHHHH
T ss_pred CCcccccccccccc-ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHH
Confidence 99999755322111 11123567889999999989999999999999999999998 888875432 111111111
Q ss_pred HHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 280 KSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
... ....+ ..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 301 ---~~~-------------~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 301 ---SGG-------------RMDPP--KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp ---TTC-------------CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cCC-------------CCCCC--ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 110 00001 1334568999999999999999999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=333.94 Aligned_cols=275 Identities=16% Similarity=0.223 Sum_probs=212.0
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCC--ccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETE--LPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~--~~~lv~ 129 (344)
+.|...+.||+|+||+||+|++ +++.||||++..... ...+.+.+|+.++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 5688889999999999999999 488999999875432 33466789999999999999999999988765 779999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe----ecCCcceEeeeecc
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF----QEQNVAKFFDFCVS 205 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~dfg~a 205 (344)
||+++++|.+++...... ..+++.++..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||++
T Consensus 89 e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp ECCTTCBHHHHHHSGGGT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred eCCCCCCHHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999764321 23899999999999999999999 9999999999999999 77788999999999
Q ss_pred cccCCCCcccccCCccccccccccccccC--------cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHH
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMS--------TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL 277 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 277 (344)
+......... ...||+.|+|||++. +..++.++||||||+++|||++|..||................
T Consensus 164 ~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 164 RELEDDEQFV----SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp EECCTTCCBC----CCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred eecCCCCcee----ecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 8765443221 356899999999885 4678999999999999999999999997654433333333333
Q ss_pred HHHHhccCCcccc---ccccc--ccC-CCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048160 278 VRKSIESNSFKEI---VDPII--VGE-EGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQ 339 (344)
Q Consensus 278 ~~~~~~~~~~~~~---~~~~~--~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~ 339 (344)
...... ..+..+ ..... ... ..........+..+.+++.+||+.||++|||+.|+++....
T Consensus 240 ~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 240 ITGKPS-GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp HHHCCT-TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred hcCCCc-ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 332111 111100 00000 000 01111223667789999999999999999999999988764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=340.27 Aligned_cols=252 Identities=21% Similarity=0.263 Sum_probs=201.4
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
.++|...+.||+|+||+||+|.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 36788999999999999999998 678999999865433 234668899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|+++|+|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 86 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 86 YCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp CCTTEEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred cCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 999999999997653 5899999999999999999999 99999999999999999999999999999976543
Q ss_pred CCcccccCCccccccccccccccCcCCC-CcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANC-NEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
.... .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||....... .....+... ..
T Consensus 158 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~~~~----~~--- 226 (323)
T 3tki_A 158 NNRE-RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSDWKEK----KT--- 226 (323)
T ss_dssp TTEE-CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS---HHHHHHHTT----CT---
T ss_pred CCcc-cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHHhcc----cc---
Confidence 2211 11224578999999999987765 778999999999999999999997543211 111111100 00
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 227 -----------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 227 -----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp -----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00011133456789999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=330.57 Aligned_cols=252 Identities=18% Similarity=0.214 Sum_probs=204.3
Q ss_pred cCCCCCCccccCCCceEEEEEECCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeC--CccEEEEe
Q 048160 55 NNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLET--ELPILVFE 130 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~e 130 (344)
++|...+.||+|+||.||+|++++..||+|++..... ...+.+.+|+.++++++||||+++++++.+. ...++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 4688889999999999999999999999999876543 2345688999999999999999999999876 78899999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCC--eeeecccccceEeecCCcceEeeeeccccc
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRP--IVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|+++|+|.+++....+ ..+++.++..++.|++.||.||| +.+ |+||||||+||+++.++.++++|||++...
T Consensus 90 ~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CCTTCBHHHHHHSCSS---CCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred ccCCCcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999986542 25899999999999999999999 888 999999999999999999999998876542
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCc---ccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNE---KSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
.. ....||+.|+|||++.+..++. ++||||||+++|+|++|..||..... ...... .....
T Consensus 164 ~~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~----~~~~~ 227 (271)
T 3kmu_A 164 QS--------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN----MEIGMK----VALEG 227 (271)
T ss_dssp SC--------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH----HHHHHH----HHHSC
T ss_pred cc--------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh----HHHHHH----HHhcC
Confidence 21 1346799999999998765544 79999999999999999999864321 111111 11111
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.. +..+ ...+..+.+++..||+.||++|||+.+|++.|+++.+
T Consensus 228 ~~------------~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 228 LR------------PTIP--PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CC------------CCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CC------------CCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 00 0011 1334568999999999999999999999999998864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=334.77 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=194.5
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--------------------------hhhhHhhHHHHHhc
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--------------------------EEYCCFNCIAFASQ 106 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--------------------------~~~~~~~E~~~l~~ 106 (344)
++|...+.||+|+||.||+|+. +++.||+|++...... ..+.+.+|+.++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 5788899999999999999998 6789999998654311 13567899999999
Q ss_pred CCCCceeeeeeEEee--CCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecc
Q 048160 107 MSHKNILKFVGCCLE--TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDI 184 (344)
Q Consensus 107 l~H~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl 184 (344)
++||||+++++++.+ +...++||||+++++|.+++.. .++++.++..++.|++.||.||| +.+|+||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dl 163 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDI 163 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCC
Confidence 999999999999986 5688999999999999987654 25899999999999999999999 999999999
Q ss_pred cccceEeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCC---CCcccchHHHHHHHHHHHcCCCCC
Q 048160 185 KPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTAN---CNEKSDVYSFGALLLELLTGKRIS 261 (344)
Q Consensus 185 k~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Di~slG~il~el~~g~~p~ 261 (344)
||+||+++.++.+||+|||++.......... ....||+.|+|||++.+.. ++.++||||||+++|+|++|..||
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDALL---SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSCEE---CCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CHHHEEECCCCCEEEecCCCccccccccccc---cCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 9999999999999999999998765433221 1357899999999997755 478899999999999999999998
Q ss_pred CCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 262 YSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..... ......+. .... ..+.....+..+.+|+.+||+.||++|||+.+|++
T Consensus 241 ~~~~~-----~~~~~~~~----~~~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 241 MDERI-----MCLHSKIK----SQAL-------------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CCSSH-----HHHHHHHH----HCCC-------------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccH-----HHHHHHHh----cccC-------------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 64321 11111111 0000 00111123446899999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=337.02 Aligned_cols=259 Identities=20% Similarity=0.266 Sum_probs=204.4
Q ss_pred HhcCCCCCC-ccccCCCceEEEEEE----CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCcc
Q 048160 53 ATNNYDPEK-VITKDLLYKLYKGFL----QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLETELP 125 (344)
Q Consensus 53 ~~~~~~~~~-~ig~G~~g~V~~~~~----~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~ 125 (344)
..++|.... .||+|+||.||+|.+ .++.||||.+...... ..+.+.+|+.++++++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 345577766 899999999999976 3578999998765332 246688999999999999999999999 56778
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
++||||+++++|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEeCCCCCHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 99999999999999997653 5889999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhcc
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIES 284 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (344)
.................+++.|+|||++.+..++.++||||||+++|+|++ |..||..... ......+ ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~----~~ 235 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEVTAML----EK 235 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHH----HT
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHH----Hc
Confidence 877544333222223456788999999988889999999999999999999 9998864321 1111111 11
Q ss_pred CCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 285 NSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
... ...+ ...+..+.+++.+||+.||++|||+.+|++.|+++..+
T Consensus 236 ~~~------------~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 236 GER------------MGCP--AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp TCC------------CCCC--TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCC------------CCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 110 0011 13445689999999999999999999999999998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=347.19 Aligned_cols=251 Identities=19% Similarity=0.242 Sum_probs=197.8
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~l 127 (344)
.++|...+.||+|+||.||+|+. +++.||+|+++.... ...+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 35688999999999999999999 578899999876532 2234577899999887 89999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
||||+++|+|..++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 131 V~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEcCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 999999999999987643 5899999999999999999999 99999999999999999999999999999976
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
...... ......||+.|+|||++.+..++.++|||||||++|||++|..||................+.......
T Consensus 203 ~~~~~~---~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-- 277 (396)
T 4dc2_A 203 GLRPGD---TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-- 277 (396)
T ss_dssp CCCTTC---CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC--
T ss_pred cccCCC---ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc--
Confidence 432221 122568999999999999999999999999999999999999999643221111111111111111111
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM 330 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 330 (344)
....|. ..+.++.+|+.+||+.||++||++
T Consensus 278 -----------~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 278 -----------QIRIPR--SLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -----------CCCCCT--TSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -----------ccCCCC--cCCHHHHHHHHHHhcCCHhHcCCC
Confidence 011111 234568899999999999999996
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=340.96 Aligned_cols=256 Identities=18% Similarity=0.298 Sum_probs=201.8
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCcc----EEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRP----ISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~----vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
++|...+.||+|+||.||+|++ ++.. ||+|.+..... .....+.+|+.++++++||||+++++++. +...++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 4588889999999999999998 4444 78887755432 33456779999999999999999999986 566889
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 92 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEECCTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEeCCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 999999999999997654 36888999999999999999999 99999999999999999999999999999988
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
........ ......++..|+|||++.+..++.++||||||+++|+|++ |..||..... ......+.. ..
T Consensus 165 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~----~~ 234 (325)
T 3kex_A 165 LPPDDKQL-LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-----AEVPDLLEK----GE 234 (325)
T ss_dssp SCCCTTCC-C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT-----THHHHHHHT----TC
T ss_pred cCcccccc-cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH-----HHHHHHHHc----CC
Confidence 75443221 1123467889999999998899999999999999999999 9999865321 111111111 10
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
. ...+. .++..+.+++.+||+.||++|||+.+|++.|+++.+
T Consensus 235 ~------------~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 235 R------------LAQPQ--ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp B------------CCCCT--TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred C------------CCCCC--cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 00000 123347899999999999999999999999998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=330.88 Aligned_cols=267 Identities=16% Similarity=0.190 Sum_probs=201.6
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
++|+..+.||+|+||+||+|+. +++.||+|++...... ....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 4688889999999999999999 6788999998755332 23667899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|+++ +|.+.+.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~-~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9974 6666554433 26899999999999999999999 99999999999999999999999999999987643
Q ss_pred CCcccccCCccccccccccccccCcCC-CCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC--Cc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTAN-CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN--SF 287 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 287 (344)
.... .....||+.|+|||++.+.. ++.++||||||+++|+|++|..||+.... ....+........... .+
T Consensus 154 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~---~~~~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 154 PVRC---YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND---VDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp CCSC---CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS---HHHHHHHHHHHHCCCCTTTC
T ss_pred cccc---ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC---HHHHHHHHHHHhCCCChhhh
Confidence 3221 12457899999999987765 89999999999999999999999875432 1122222222111110 00
Q ss_pred cccc---ccc----cccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 288 KEIV---DPI----IVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 288 ~~~~---~~~----~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... +.. ...........+..+..+.+|+.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000 000 00000000111134456889999999999999999999985
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=345.47 Aligned_cols=251 Identities=20% Similarity=0.281 Sum_probs=203.7
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
..++|...+.||+|+||.||+|.. ++..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 356799999999999999999998 678999999876533 2345678999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC---cceEeeeecc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN---VAKFFDFCVS 205 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~dfg~a 205 (344)
|||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++ .+||+|||++
T Consensus 107 ~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE-----FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp ECCCCSCBHHHHHTTCS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 99999999999887653 5899999999999999999999 99999999999999998654 5999999999
Q ss_pred cccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
......... ....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......... .
T Consensus 179 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~----~~~~~~i~~-----~ 245 (362)
T 2bdw_A 179 IEVNDSEAW----HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRLYAQIKA-----G 245 (362)
T ss_dssp BCCTTCCSC----CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHH-----T
T ss_pred eEecCCccc----ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHh-----C
Confidence 876533221 245789999999999998999999999999999999999999975321 111111111 0
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
... ...+.....+..+.+|+.+||+.||++|||+.++++
T Consensus 246 ~~~-----------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 246 AYD-----------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CCC-----------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCC-----------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 001111134456899999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=359.00 Aligned_cols=261 Identities=21% Similarity=0.277 Sum_probs=203.3
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 50 LKAATNNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 50 i~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
+....++|...+.||+|+||.||+|.+ .+..||||++..... ..+.+.+|+.+|++++||||+++++++.+ ...++|
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 344456677888999999999999999 456799999876543 35678999999999999999999999876 678999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||+++|+|.+++....+ ..+++.+++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 257 ~e~~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp ECCCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred ehhhcCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 999999999999974321 24889999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
....... .....++..|+|||++.+..++.++||||||+++|||++ |..||..... . +....... +
T Consensus 331 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----~----~~~~~i~~-~-- 397 (452)
T 1fmk_A 331 EDNEYTA--RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----R----EVLDQVER-G-- 397 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----H----HHHHHHHT-T--
T ss_pred CCCceec--ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH----H----HHHHHHHc-C--
Confidence 5332211 112346788999999988899999999999999999999 8888754311 1 11111111 1
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
... +....++..+.+|+.+||+.||++|||+.+|++.|+.+..+
T Consensus 398 ----------~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 398 ----------YRM--PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp ----------CCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ----------CCC--CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 000 11114456789999999999999999999999999987643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=336.78 Aligned_cols=267 Identities=16% Similarity=0.222 Sum_probs=201.2
Q ss_pred hcCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
.++|...+.||+|+||+||+|+. +++.||+|++...... ....+.+|+.++++++||||+++++++.++...++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 36688899999999999999999 7889999998755332 23567899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|++ |+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 100 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 100 FME-KDLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp CCS-EEHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred CCC-CCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 997 58888876654 35899999999999999999999 99999999999999999999999999999987643
Q ss_pred CCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC--Cc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN--SF 287 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 287 (344)
..... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||...... ..+........... .+
T Consensus 172 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 172 PVRSY---THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD----DQLPKIFSILGTPNPREW 244 (311)
T ss_dssp CCC------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT----THHHHHHHHHCCCCTTTS
T ss_pred Ccccc---cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHHCCCChHHh
Confidence 32211 13467999999999876 56899999999999999999999999754331 12222222111110 00
Q ss_pred ccccc------ccccc-CCCCCh-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 288 KEIVD------PIIVG-EEGLWP-EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 288 ~~~~~------~~~~~-~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
....+ ..... ....+. ..+..+.++.+|+.+||+.||++|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000 00000 000000 01123456899999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=345.50 Aligned_cols=269 Identities=13% Similarity=0.146 Sum_probs=204.6
Q ss_pred hcCCCCCCccccCCCceEEEEEEC-------CccEEEEEecCCCCch-----------hhhHhhHHHHHhcCCCCceeee
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQ-------DRPISVMKFGGNLNSE-----------EYCCFNCIAFASQMSHKNILKF 115 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~-------~~~vavk~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~~ 115 (344)
.++|...+.||+|+||.||+|.+. ++.||+|.+....... ...+.+|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 457999999999999999999982 3689999987654211 1123345667778889999999
Q ss_pred eeEEeeC----CccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe
Q 048160 116 VGCCLET----ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF 191 (344)
Q Consensus 116 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 191 (344)
++++... ...++||||+ +++|.+++.... ..+++.+++.++.|++.||.||| +.+|+||||||+|||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill 185 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEE
Confidence 9998765 4589999999 999999997654 36899999999999999999999 9999999999999999
Q ss_pred e--cCCcceEeeeecccccCCCCccc----ccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCC
Q 048160 192 Q--EQNVAKFFDFCVSISIPEGKTHV----NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSC 265 (344)
Q Consensus 192 ~--~~~~~kl~dfg~a~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 265 (344)
+ .++.+||+|||+++......... .......||+.|+|||++.+..++.++||||||+++|||++|..||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 88999999999998765332211 11123458999999999999999999999999999999999999997432
Q ss_pred ccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 266 FENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
.. ..... ...... ......+++..+... .++.++.+++..||+.||++||++.+|++.|+++.+.
T Consensus 266 ~~---~~~~~-~~~~~~-~~~~~~~~~~~~~~~--------~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 266 KD---PKYVR-DSKIRY-RENIASLMDKCFPAA--------NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp TC---HHHHH-HHHHHH-HHCHHHHHHHHSCTT--------CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cC---HHHHH-HHHHHh-hhhHHHHHHHhcccc--------cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 11 11111 111111 111222222221100 2345689999999999999999999999999998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=340.13 Aligned_cols=264 Identities=22% Similarity=0.305 Sum_probs=207.9
Q ss_pred CCCCCccccCCCceEEEEEE------CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeC--CccEE
Q 048160 57 YDPEKVITKDLLYKLYKGFL------QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLET--ELPIL 127 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~------~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~l 127 (344)
|...+.||+|+||+||++.+ +++.||||++...... ..+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 47889999999999999876 5678999999876432 346688999999999999999999999874 57899
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
||||+++|+|.+++... .+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++..
T Consensus 113 v~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 99999999999999764 3889999999999999999999 99999999999999999999999999999988
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCc------chhHHHHHHHHH
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENG------EEYFLQELVRKS 281 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~ 281 (344)
...............+|..|+|||++.+..++.++||||||+++|+|++|..||........ ............
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 76544332223345678889999999888899999999999999999999999864321000 000000000111
Q ss_pred hccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 282 IESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
.... . ..+....++..+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus 264 ~~~~------------~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 264 LERG------------E--RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp HHTT------------C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred Hhcc------------c--CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 1111 0 0111114456789999999999999999999999999998764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=336.26 Aligned_cols=264 Identities=21% Similarity=0.282 Sum_probs=210.7
Q ss_pred HhcCCCCCCccccCCCceEEEEEE-------CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCc
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL-------QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETEL 124 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~-------~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~ 124 (344)
..++|...+.||+|+||.||+|.. .+..||+|.+..... ...+.+.+|+.++++++||||+++++++..++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 356788889999999999999987 236799999876543 334668899999999999999999999999999
Q ss_pred cEEEEeecCCCCccccccCCCCC-------------------CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccc
Q 048160 125 PILVFEFVACGTLADRIHDPNGS-------------------QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIK 185 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk 185 (344)
.++||||+++++|.+++...... ....+++.++..++.|++.||.||| +.+|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccc
Confidence 99999999999999998754320 0124889999999999999999999 9999999999
Q ss_pred ccceEeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCC
Q 048160 186 PSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSS 264 (344)
Q Consensus 186 ~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~ 264 (344)
|+||+++.++.++|+|||++.......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEE-CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hheEEEcCCCCEEEccccccccccccccce-eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999998765433221 1223456788999999988889999999999999999999 88888643
Q ss_pred CccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 265 CFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
.. ..+...+.. ... ...+ ...+..+.+|+.+||+.||++|||+.+|++.|+++...
T Consensus 257 ~~-----~~~~~~~~~----~~~------------~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 257 PP-----ERLFNLLKT----GHR------------MERP--DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CG-----GGHHHHHHT----TCC------------CCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CH-----HHHHHHhhc----CCc------------CCCC--ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 21 111111111 100 0001 13445689999999999999999999999999998764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=341.44 Aligned_cols=256 Identities=16% Similarity=0.306 Sum_probs=199.1
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCcc----EEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRP----ISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~----vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
++|+..+.||+|+||+||+|++ ++.. ||+|.+..... ...+.+.+|+.++++++||||+++++++..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 4588889999999999999998 4443 58888754432 34467889999999999999999999998754 779
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
|+||+.+|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 94 v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 999999999999997654 36889999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
......... .....+|..|+|||++.+..++.++||||||+++|||++ |..||..... ..+...+.. ..
T Consensus 167 ~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~~~~~----~~ 236 (327)
T 3poz_A 167 LGAEEKEYH-AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSILEK----GE 236 (327)
T ss_dssp HTTTCC--------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHHHT----TC
T ss_pred ccCCccccc-ccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-----HHHHHHHHc----CC
Confidence 654332211 113356789999999999999999999999999999999 8988864321 111111111 00
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
. .+....++..+.+|+.+||+.||++|||+.+|++.|+++.+
T Consensus 237 ------------~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 237 ------------R--LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ------------C--CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred ------------C--CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 00111344568999999999999999999999999998764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=333.01 Aligned_cols=250 Identities=19% Similarity=0.315 Sum_probs=203.6
Q ss_pred cCCCCCCccccCCCceEEEEEE--CC-------ccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCcc
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QD-------RPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELP 125 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~-------~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~ 125 (344)
++|...+.||+|+||.||+|.. .+ ..||+|.+........+.+.+|+.++++++||||+++++++..++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 4688889999999999999998 23 46999998776656667889999999999999999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCc--------c
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNV--------A 197 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~ 197 (344)
++||||+++|+|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+||+++.++. +
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEEEECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999997654 35889999999999999999999 999999999999999998887 9
Q ss_pred eEeeeecccccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHH
Q 048160 198 KFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQE 276 (344)
Q Consensus 198 kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 276 (344)
+|+|||++....... ...+++.|+|||++.+ ..++.++||||||+++|+|++|..|++.... ......
T Consensus 161 kl~Dfg~~~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~----~~~~~~ 229 (289)
T 4fvq_A 161 KLSDPGISITVLPKD-------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD----SQRKLQ 229 (289)
T ss_dssp EECCCCSCTTTSCHH-------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC----HHHHHH
T ss_pred eeccCcccccccCcc-------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc----hHHHHH
Confidence 999999986543221 3457889999999987 6789999999999999999997777665422 111111
Q ss_pred HHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 277 LVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.. ....... . ..+..+.+|+.+||+.||++|||+.++++.|+++..
T Consensus 230 ~~---~~~~~~~-----------~------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 230 FY---EDRHQLP-----------A------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HH---HTTCCCC-----------C------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred Hh---hccCCCC-----------C------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11 0111100 0 112247899999999999999999999999998764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=365.36 Aligned_cols=251 Identities=17% Similarity=0.261 Sum_probs=198.5
Q ss_pred ccccCCCceEEEEEE----CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCC
Q 048160 62 VITKDLLYKLYKGFL----QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGT 136 (344)
Q Consensus 62 ~ig~G~~g~V~~~~~----~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gs 136 (344)
.||+|+||.||+|.+ ++..||||+++.... ...+.+.+|+.+|++++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 699999999999988 345699999876533 345778999999999999999999999876 56899999999999
Q ss_pred ccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcccc
Q 048160 137 LADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN 216 (344)
Q Consensus 137 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~ 216 (344)
|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..........
T Consensus 422 L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 494 (613)
T 2ozo_A 422 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494 (613)
T ss_dssp HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred HHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence 999997654 36899999999999999999999 99999999999999999999999999999987654332222
Q ss_pred cCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccccccccc
Q 048160 217 DNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPII 295 (344)
Q Consensus 217 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (344)
......+++.|+|||++.+..++.++||||||+++|||++ |..||..... ......+. .+
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----~~~~~~i~----~~---------- 555 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PEVMAFIE----QG---------- 555 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-----HHHHHHHH----TT----------
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-----HHHHHHHH----cC----------
Confidence 2122345688999999998999999999999999999998 9998865321 11111111 11
Q ss_pred ccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 296 VGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 296 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
.....| ..++..+.+|+..||+.||++|||+.+|++.|+.+..+
T Consensus 556 --~~~~~p--~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 556 --KRMECP--PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp --CCCCCC--TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCC--CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 111111 14556789999999999999999999999999988654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=340.71 Aligned_cols=257 Identities=21% Similarity=0.328 Sum_probs=198.7
Q ss_pred CCCCCCccccCCCceEEEEEEC--C----ccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 56 NYDPEKVITKDLLYKLYKGFLQ--D----RPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~~--~----~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
+|...+.||+|+||.||+|.+. + ..||+|.+...... ....+.+|+.++++++||||+++++++...+..++|
T Consensus 45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 124 (333)
T 1mqb_A 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 124 (333)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEE
Confidence 4555788999999999999982 2 34999999765433 345688999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||+++|+|.+++.... ..+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 125 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 125 TEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999997654 25889999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
..............+|..|+|||++.+..++.++||||||+++|+|++ |..||..... ......+ .....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~~~~~~~---~~~~~- 268 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVMKAI---NDGFR- 268 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHH---HTTCC-
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-----HHHHHHH---HCCCc-
Confidence 543322211112345778999999988899999999999999999999 9998864321 1111111 11100
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.+....++..+.+|+.+||+.||++||++.+|++.|+++.+
T Consensus 269 --------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 269 --------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp --------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00111344568999999999999999999999999998865
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=352.81 Aligned_cols=252 Identities=19% Similarity=0.250 Sum_probs=202.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
..++|...+.||+|+||+||+|.. +++.||+|++...... ..+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 346699999999999999999998 7889999998765432 345678999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEee---cCCcceEeeeecc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ---EQNVAKFFDFCVS 205 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~dfg~a 205 (344)
|||+.+|+|.+.+.... .+++..+..++.|++.||.||| +.+|+||||||+|||++ .++.+||+|||++
T Consensus 89 ~E~~~gg~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE-----YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp ECCCBCCBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 99999999999887654 5899999999999999999999 99999999999999998 4578999999999
Q ss_pred cccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
.......... ....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......... .
T Consensus 161 ~~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~----~~~~~~i~~-----~ 228 (444)
T 3soa_A 161 IEVEGEQQAW---FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ----HRLYQQIKA-----G 228 (444)
T ss_dssp BCCCTTCCBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHH-----T
T ss_pred EEecCCCcee---ecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHh-----C
Confidence 7765433221 245789999999999998999999999999999999999999965321 111111111 1
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
... ...+.| ...+..+.+|+.+||+.||++|||+.++++
T Consensus 229 ~~~--------~~~~~~---~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 229 AYD--------FPSPEW---DTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCC--------CCTTTT---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC--------CCcccc---ccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 001111 133456899999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=346.58 Aligned_cols=265 Identities=19% Similarity=0.249 Sum_probs=210.9
Q ss_pred HHhcCCCCCCccccCCCceEEEEEECC---------ccEEEEEecCCCCc-hhhhHhhHHHHHhcC-CCCceeeeeeEEe
Q 048160 52 AATNNYDPEKVITKDLLYKLYKGFLQD---------RPISVMKFGGNLNS-EEYCCFNCIAFASQM-SHKNILKFVGCCL 120 (344)
Q Consensus 52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~---------~~vavk~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~~~~~~~ 120 (344)
...++|...+.||+|+||.||+|++.+ ..||+|++...... ....+.+|+.+++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 344678888999999999999999721 46999999766433 336688999999999 8999999999999
Q ss_pred eCCccEEEEeecCCCCccccccCCCCC-----------CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccce
Q 048160 121 ETELPILVFEFVACGTLADRIHDPNGS-----------QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTI 189 (344)
Q Consensus 121 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 189 (344)
.++..++||||+++|+|.+++...... ....+++.+++.++.|++.||.||| +.+|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceE
Confidence 999999999999999999998754311 1135899999999999999999999 99999999999999
Q ss_pred EeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccC
Q 048160 190 LFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFEN 268 (344)
Q Consensus 190 ll~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~ 268 (344)
|++.++.+||+|||+++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~--- 298 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--- 298 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTC-CCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---
T ss_pred EEcCCCcEEEcccCcccccccccccc-cccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---
Confidence 99999999999999998765432211 1123456889999999999999999999999999999999 888875432
Q ss_pred cchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 269 GEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
...+...+. .... ...+ ..++.++.+|+.+||+.||++|||+.+|++.|+++...
T Consensus 299 --~~~~~~~~~----~~~~------------~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 299 --VEELFKLLK----EGHR------------MDKP--SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp --HHHHHHHHH----TTCC------------CCCC--SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHHHH----cCCC------------CCCC--ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 111111111 1100 0001 13345689999999999999999999999999998753
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=331.14 Aligned_cols=259 Identities=21% Similarity=0.302 Sum_probs=206.0
Q ss_pred CCCCCccccCCCceEEEEEE--CCc---cEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCcc-EEEE
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDR---PISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELP-ILVF 129 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~---~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~-~lv~ 129 (344)
|...+.||+|+||+||+|++ ++. .||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 44568899999999999997 222 699999876543 2346688999999999999999999999876654 9999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+.+|+|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++...
T Consensus 103 e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp CCCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred ecccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999997744 36889999999999999999999 9999999999999999999999999999997654
Q ss_pred CCCcc-cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 210 EGKTH-VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 210 ~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
..... ........++..|+|||.+.+..++.++||||||+++|+|++|..||+..... ......+....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~----~~~~~~~~~~~------ 245 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP----FDLTHFLAQGR------ 245 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG----GGHHHHHHTTC------
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH----HHHHHHhhcCC------
Confidence 33211 11222456788999999999999999999999999999999988777654321 11111111100
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhC
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKSI 344 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~l 344 (344)
.. +.....+..+.+++.+||+.||.+|||+.++++.|+++.+.+
T Consensus 246 ----------~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 246 ----------RL--PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp ----------CC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----------CC--CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 00 001123456899999999999999999999999999998764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=335.65 Aligned_cols=260 Identities=20% Similarity=0.295 Sum_probs=211.8
Q ss_pred HHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 52 AATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 52 ~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
...++|...+.||+|+||.||+|.+ .+..||+|.+.... ...+.+.+|+.++++++||||+++++++..+...++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 3456788899999999999999999 47889999987653 34567889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++++|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++....
T Consensus 89 e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp ECCTTEEHHHHHHHCCT---TTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EcCCCCcHHHHHHhccc---CCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999976432 35889999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
....... ....+++.|+|||++.+..++.++||||||+++|+|++ |..||..... ......+.....
T Consensus 163 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~-----~~~~~~~~~~~~----- 230 (288)
T 3kfa_A 163 GDTYTAH--AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLEKDYR----- 230 (288)
T ss_dssp SSSSEEE--TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGHHHHHHTTCC-----
T ss_pred CCccccc--cCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHhccCC-----
Confidence 4432221 13456788999999988899999999999999999999 8888754321 111111111000
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
. +.....+..+.+|+..||+.||.+|||+.+|++.|+++...
T Consensus 231 -----------~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 231 -----------M--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp -----------C--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------C--CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 0 00013345689999999999999999999999999988653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=330.70 Aligned_cols=261 Identities=22% Similarity=0.364 Sum_probs=196.7
Q ss_pred hcCCCCCCccccCCCceEEEEEECCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
.++|...+.||+|+||+||+|++.+ .||+|.+...... ..+.+.+|+.++++++||||+++++++ .....++||||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~ 100 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW 100 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEe
Confidence 4568889999999999999999755 4999998755432 346688999999999999999999965 45678999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+++++|.+++.... ..+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++......
T Consensus 101 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 101 CEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred cCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 99999999997654 36899999999999999999999 999999999999999999999999999998765432
Q ss_pred CcccccCCccccccccccccccC---cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMS---TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
... .......||+.|+|||++. +..++.++||||||+++|+|++|..||..... .......+..........
T Consensus 174 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~ 248 (289)
T 3og7_A 174 SGS-HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN----RDQIIEMVGRGSLSPDLS 248 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC----HHHHHHHHHHTSCCCCTT
T ss_pred ccc-ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch----HHHHHHHhcccccCcchh
Confidence 211 1112456899999999986 56788999999999999999999999965422 112222222111111111
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.. ...++..+.+|+.+||+.||++|||+.+|++.|+++.+
T Consensus 249 ~~--------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 249 KV--------------RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SS--------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hc--------------cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 00 01344568999999999999999999999999998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=329.02 Aligned_cols=251 Identities=27% Similarity=0.425 Sum_probs=199.5
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchh-------hhHhhHHHHHhcCCCCceeeeeeEEeeCCcc
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEE-------YCCFNCIAFASQMSHKNILKFVGCCLETELP 125 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~-------~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~ 125 (344)
++|...+.||+|+||+||+|++ +++.||+|++........ +.+.+|+.++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 5688899999999999999999 678899999865433221 56789999999999999999999986544
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCC--eeeecccccceEeecCCc-----ce
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRP--IVFRDIKPSTILFQEQNV-----AK 198 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~-----~k 198 (344)
++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+ |+||||||+||+++.++. +|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred eEEEEecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 79999999999999886654 36899999999999999999999 888 999999999999987776 99
Q ss_pred EeeeecccccCCCCcccccCCccccccccccccccC--cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHH
Q 048160 199 FFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMS--TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQE 276 (344)
Q Consensus 199 l~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 276 (344)
|+|||++....... ....||+.|+|||++. ...++.++||||||+++|+|++|..||..... . ......
T Consensus 170 l~Dfg~~~~~~~~~------~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~-~~~~~~ 240 (287)
T 4f0f_A 170 VADFGLSQQSVHSV------SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY--G-KIKFIN 240 (287)
T ss_dssp ECCCTTCBCCSSCE------ECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC--C-HHHHHH
T ss_pred eCCCCccccccccc------cccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc--c-HHHHHH
Confidence 99999987543321 1357899999999984 45578999999999999999999999965322 1 111111
Q ss_pred HHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 277 LVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
... ... ... ..+ ..++..+.+|+.+||+.||++|||+.+|++.|+++
T Consensus 241 ~~~---~~~-~~~-----------~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 241 MIR---EEG-LRP-----------TIP--EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHH---HSC-CCC-----------CCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHh---ccC-CCC-----------CCC--cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111 111 000 001 13445689999999999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=343.87 Aligned_cols=251 Identities=18% Similarity=0.224 Sum_probs=205.2
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
.+.|...+.||+|+||.||+|.. +++.||+|.+..........+.+|+.++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 46788999999999999999998 6788999998776555566788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec--CCcceEeeeecccccC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE--QNVAKFFDFCVSISIP 209 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~dfg~a~~~~ 209 (344)
+++|+|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||++....
T Consensus 130 ~~gg~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 130 LSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred CCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 99999999997654 35899999999999999999999 999999999999999974 4679999999998765
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
...... ...||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...+..... ....
T Consensus 203 ~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~~~~~~i~~-----~~~~- 268 (387)
T 1kob_A 203 PDEIVK----VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----LETLQNVKR-----CDWE- 268 (387)
T ss_dssp TTSCEE----EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHHHHHHH-----CCCC-
T ss_pred CCccee----eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH----HHHHHHHHh-----CCCC-
Confidence 433221 34689999999999999999999999999999999999999975321 111111111 0000
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+ ... .....+.++.+|+.+||+.||++|||+.++++
T Consensus 269 -~------~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 269 -F------DED---AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp -C------CSS---TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -C------Ccc---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0 000 00123456899999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=337.46 Aligned_cols=269 Identities=20% Similarity=0.278 Sum_probs=211.4
Q ss_pred cCCCCCCccccCCCceEEEEEE------CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCC--ccE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL------QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETE--LPI 126 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~------~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~--~~~ 126 (344)
++|...+.||+|+||.||+|++ ++..||+|++........+.+.+|+.++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4578889999999999999985 57889999998776666678899999999999999999999987643 789
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
+||||+++++|.+++.... ..+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.
T Consensus 121 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEECCCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEECCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 9999999999999997654 25889999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCcc-------CcchhHHHHHHH
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFE-------NGEEYFLQELVR 279 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~ 279 (344)
................++..|+|||++.+..++.++||||||+++|+|++|..|+.....+ ..........+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 7765433222222345678899999998888999999999999999999999987532100 000000000000
Q ss_pred HHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhC
Q 048160 280 KSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKSI 344 (344)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~l 344 (344)
...... .. .+....++..+.+|+.+||+.||++|||+.+|++.|+++.+++
T Consensus 274 ~~~~~~------------~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 274 ELLKNN------------GR--LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHTT------------CC--CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhhcC------------CC--CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 111100 00 1111144567899999999999999999999999999998753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=339.55 Aligned_cols=267 Identities=17% Similarity=0.253 Sum_probs=195.1
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEEC--Cc---cEEEEEecCC--CCchhhhHhhHHHHHhcCCCCceeeeeeEEeeC
Q 048160 50 LKAATNNYDPEKVITKDLLYKLYKGFLQ--DR---PISVMKFGGN--LNSEEYCCFNCIAFASQMSHKNILKFVGCCLET 122 (344)
Q Consensus 50 i~~~~~~~~~~~~ig~G~~g~V~~~~~~--~~---~vavk~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~ 122 (344)
+....++|...+.||+|+||.||+|++. +. .||+|.+... .....+.+.+|+.++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 3344567999999999999999999982 22 7999998765 334457788999999999999999999999877
Q ss_pred Ccc------EEEEeecCCCCccccccCCCC-CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC
Q 048160 123 ELP------ILVFEFVACGTLADRIHDPNG-SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN 195 (344)
Q Consensus 123 ~~~------~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 195 (344)
... ++||||+++|+|.+++..... .....+++.++..++.|++.||.||| +.+|+||||||+||+++.++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCC
Confidence 655 999999999999998853221 11125889999999999999999999 99999999999999999999
Q ss_pred cceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHH
Q 048160 196 VAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFL 274 (344)
Q Consensus 196 ~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~ 274 (344)
.+||+|||++.......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||..... ....
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~----~~~~ 249 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYR-QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN----AEIY 249 (323)
T ss_dssp CEEECCCCC------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GGHH
T ss_pred CEEEeecccccccccccccc-ccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh----HHHH
Confidence 99999999998764433211 1113356788999999999999999999999999999999 8888764321 1111
Q ss_pred HHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 275 QELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
.... ... .. +.....+..+.+|+.+||+.||++|||+.++++.|+++...
T Consensus 250 ~~~~----~~~-------------~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 250 NYLI----GGN-------------RL--KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp HHHH----TTC-------------CC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHh----cCC-------------CC--CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111 000 00 00113345689999999999999999999999999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=340.61 Aligned_cols=266 Identities=20% Similarity=0.270 Sum_probs=207.7
Q ss_pred HHhcCCCCCCccccCCCceEEEEEE-------CCccEEEEEecCCCC-chhhhHhhHHHHHhcC-CCCceeeeeeEEeeC
Q 048160 52 AATNNYDPEKVITKDLLYKLYKGFL-------QDRPISVMKFGGNLN-SEEYCCFNCIAFASQM-SHKNILKFVGCCLET 122 (344)
Q Consensus 52 ~~~~~~~~~~~ig~G~~g~V~~~~~-------~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~ 122 (344)
...++|...+.||+|+||.||+|++ .+..||+|.+..... ...+.+.+|+.+++++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3456788899999999999999997 345799999876532 3456788999999999 899999999999999
Q ss_pred CccEEEEeecCCCCccccccCCCCCC------------------CccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecc
Q 048160 123 ELPILVFEFVACGTLADRIHDPNGSQ------------------LEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDI 184 (344)
Q Consensus 123 ~~~~lv~e~~~~gsL~~~l~~~~~~~------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl 184 (344)
+..++||||+++|+|.+++....... ...+++..++.++.|++.||.||| +.+|+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCC
Confidence 99999999999999999997654210 124789999999999999999999 999999999
Q ss_pred cccceEeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCC
Q 048160 185 KPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYS 263 (344)
Q Consensus 185 k~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~ 263 (344)
||+||+++.++.++|+|||++.......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYV-VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccce-eccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 9999999999999999999998664332211 1123457889999999988899999999999999999998 8888865
Q ss_pred CCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 264 SCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
... .......+.. ... ...+ ...+..+.+|+.+||+.||++|||+.+|++.|..+...
T Consensus 278 ~~~----~~~~~~~~~~----~~~------------~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 278 IPV----DANFYKLIQN----GFK------------MDQP--FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CCC----SHHHHHHHHT----TCC------------CCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CCc----HHHHHHHHhc----CCC------------CCCC--CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 422 1111111111 100 0001 12345689999999999999999999999999987653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=341.32 Aligned_cols=244 Identities=18% Similarity=0.252 Sum_probs=200.7
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||.||+|.+ +++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788999999999999999998 77899999986442 122356789999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+ +|+|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 89 E~~-~g~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp CCC-CEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred ECC-CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 999 689999886543 5899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCcccccCCccccccccccccccCcCCC-CcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANC-NEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
..... ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||..... .
T Consensus 160 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---------------------~ 214 (336)
T 3h4j_B 160 DGNFL----KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI---------------------P 214 (336)
T ss_dssp TSBTT----CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS---------------------T
T ss_pred CCccc----ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH---------------------H
Confidence 43322 24578999999999988776 6899999999999999999999964321 1
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
........+. ...|. ..+..+.+|+.+||+.||.+|||+.+|++
T Consensus 215 ~~~~~i~~~~-~~~p~--~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 215 NLFKKVNSCV-YVMPD--FLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp TCBCCCCSSC-CCCCT--TSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHcCC-CCCcc--cCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1111111111 11111 34456899999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=331.10 Aligned_cols=256 Identities=18% Similarity=0.277 Sum_probs=202.5
Q ss_pred hcCCCCCCccccCCCceEEEEEECC-----ccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQD-----RPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~~-----~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
.++|...+.||+|+||.||+|.+.+ ..||+|.+..... ...+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4568889999999999999999722 2499999876633 334668899999999999999999999764 45689
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++..
T Consensus 90 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 999999999999997643 35889999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
........ .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||...... .....+... .
T Consensus 163 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-----~~~~~~~~~----~ 231 (281)
T 3cc6_A 163 IEDEDYYK--ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-----DVIGVLEKG----D 231 (281)
T ss_dssp C-----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-----GHHHHHHHT----C
T ss_pred cccccccc--cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-----HHHHHHhcC----C
Confidence 65432211 113456788999999988899999999999999999998 99998653221 111111110 0
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
. . +.....+..+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 232 ~------------~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 232 R------------L--PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp C------------C--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C------------C--CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 0 0 0001234568999999999999999999999999998865
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=342.13 Aligned_cols=251 Identities=19% Similarity=0.211 Sum_probs=193.1
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
.++|...+.||+|+||+||+++. +++.||+|++..... ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 46799999999999999999999 678899999876532 346688999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCc--ceEeeeecccccC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNV--AKFFDFCVSISIP 209 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~dfg~a~~~~ 209 (344)
+++|+|.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+||+++.++. +||+|||+++...
T Consensus 98 ~~~~~L~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 98 ASGGELYERICNAG-----RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 99999999986543 5899999999999999999999 999999999999999987765 9999999987543
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcc-cchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEK-SDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
.... .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ ....+.......
T Consensus 170 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~~~~~~~~~~--- 238 (361)
T 3uc3_A 170 LHSQ----PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD----YRKTIQRILSVK--- 238 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC----HHHHHHHHHTTC---
T ss_pred ccCC----CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH----HHHHHHHHhcCC---
Confidence 2221 124578999999999988887655 8999999999999999999975433222 111111111110
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
...|.....+..+.+|+.+||+.||++|||+.++++
T Consensus 239 -----------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 239 -----------YSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp -----------CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred -----------CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 001111123356889999999999999999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=334.44 Aligned_cols=243 Identities=20% Similarity=0.289 Sum_probs=201.3
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||.||+|+. +++.||+|.+..... ...+.+.+|..+++.++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 5688899999999999999998 688999999865421 23455778999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp CCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 9999999999997653 5889999999999999999999 9999999999999999999999999999998754
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
... ....||+.|+|||++.+..++.++||||||+++|||++|..||..... ......... . .
T Consensus 158 ~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~----~-~--- 219 (318)
T 1fot_A 158 DVT------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----MKTYEKILN----A-E--- 219 (318)
T ss_dssp SCB------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHH----C-C---
T ss_pred Ccc------ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHh----C-C---
Confidence 321 245789999999999999999999999999999999999999975321 111111111 0 0
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-----TMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ei~~ 335 (344)
..+|. ..+.++.+++.+||+.||++|| ++.+|++
T Consensus 220 ----------~~~p~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 220 ----------LRFPP--FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ----------CCCCT--TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----------CCCCC--CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 00111 2334688999999999999999 8888864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=330.46 Aligned_cols=261 Identities=21% Similarity=0.322 Sum_probs=203.9
Q ss_pred cCCCCCCccccCCCceEEEEEECC-----ccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEe-eCCccEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFLQD-----RPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCL-ETELPIL 127 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~~~-----~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~-~~~~~~l 127 (344)
..|...+.||+|+||.||+|++.+ ..||+|.+...... ..+.+.+|+.++++++||||+++++++. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457778999999999999999721 24899988765432 3466889999999999999999999865 4567899
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
||||+++|+|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++..
T Consensus 105 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEECCTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEeCCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccc
Confidence 999999999999997644 35789999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCccc-ccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 208 IPEGKTHV-NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 208 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
........ .......+|+.|+|||.+.+..++.++||||||+++|+|++|..|++....... ...... . .
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~----~~~~~~---~-~- 248 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYLL---Q-G- 248 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT----HHHHHH---T-T-
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH----HHHHHh---c-C-
Confidence 65432211 112234567889999999988999999999999999999997666654432111 111110 0 0
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhC
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKSI 344 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~l 344 (344)
.....+. ..+..+.+++.+||+.||++|||+.++++.|+++...+
T Consensus 249 -----------~~~~~~~--~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 249 -----------RRLLQPE--YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp -----------CCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred -----------CCCCCCc--cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0000111 23456899999999999999999999999999998753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=332.14 Aligned_cols=258 Identities=19% Similarity=0.296 Sum_probs=206.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
..++|...+.||+|+||.||+|.. .+..||+|.+..... ..+.+.+|+.++++++||||+++++++. .+..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 346688899999999999999999 556899999876543 3567889999999999999999999986 4568999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+++++|.+++....+ ..+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++......
T Consensus 89 ~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 89 MENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp CTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred CCCCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 999999999975321 25889999999999999999999 999999999999999999999999999999876543
Q ss_pred CcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcccc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEI 290 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (344)
.... .....++..|+|||++.+..++.++||||||+++|+|++ |..||..... . .....+ .....
T Consensus 163 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~-~~~~~~---~~~~~---- 228 (279)
T 1qpc_A 163 EYTA--REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----P-EVIQNL---ERGYR---- 228 (279)
T ss_dssp CEEC--CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----H-HHHHHH---HTTCC----
T ss_pred cccc--ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH----H-HHHHHH---hcccC----
Confidence 3221 113456788999999988889999999999999999999 8888754321 1 111111 11000
Q ss_pred cccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 291 VDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
...+ ...+..+.+|+..||+.||++|||+.+|++.|+.+...
T Consensus 229 ---------~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 229 ---------MVRP--DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp ---------CCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------CCCc--ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 0000 13345689999999999999999999999999998764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=341.51 Aligned_cols=247 Identities=19% Similarity=0.254 Sum_probs=200.0
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||.||+|+. +++.||+|.+.... ....+.+.+|+.++++++|||||++++++.+....++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 5688899999999999999999 57789999986542 223456789999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+.+|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 95 e~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV-----HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp CCCTTEEHHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 9999999999998653 5899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCcccccCCccccccccccccccCc---CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMST---ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
..... ....||+.|+|||++.. ..++.++|||||||++|+|++|..||....... .......+.. .
T Consensus 167 ~~~~~----~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~~~~~---~-- 235 (384)
T 4fr4_A 167 RETQI----TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIVHTFET---T-- 235 (384)
T ss_dssp TTCCB----CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHHHHHHH---C--
T ss_pred CCCce----eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhh---c--
Confidence 43222 24679999999999864 458999999999999999999999997532211 1111111110 0
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCC-HHHHH
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT-MVQVA 334 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~ei~ 334 (344)
....|. ..+..+.+|+.+||+.||++||+ +.+|+
T Consensus 236 ------------~~~~p~--~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 236 ------------VVTYPS--AWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp ------------CCCCCT--TSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred ------------ccCCCC--cCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 000111 23456899999999999999998 66665
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=332.29 Aligned_cols=265 Identities=18% Similarity=0.301 Sum_probs=211.7
Q ss_pred HhcCCCCCCccccCCCceEEEEEE-------CCccEEEEEecCCCC-chhhhHhhHHHHHhcC-CCCceeeeeeEEeeCC
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL-------QDRPISVMKFGGNLN-SEEYCCFNCIAFASQM-SHKNILKFVGCCLETE 123 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~-------~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~ 123 (344)
..++|...+.||+|+||.||+|++ .+..||+|.+..... ...+.+.+|+.+++++ +||||+++++++..++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346788899999999999999985 346899999976643 2346688999999999 8999999999999999
Q ss_pred ccEEEEeecCCCCccccccCCCCC-------------CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceE
Q 048160 124 LPILVFEFVACGTLADRIHDPNGS-------------QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTIL 190 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil 190 (344)
..++||||+++|+|.+++...... ....+++.++..++.|++.||.||| +.+|+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEE
Confidence 999999999999999998754321 0124889999999999999999999 999999999999999
Q ss_pred eecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCc
Q 048160 191 FQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENG 269 (344)
Q Consensus 191 l~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~ 269 (344)
++.++.+||+|||++.......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--- 253 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--- 253 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSE-ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS---
T ss_pred EcCCCCEEEccccccccccccccce-eccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc---
Confidence 9999999999999998765443221 1123457889999999988899999999999999999999 8888865322
Q ss_pred chhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 270 EEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
.......+...... ..+ ...+..+.+|+.+||+.||++|||+.+|++.|+++..+
T Consensus 254 -~~~~~~~~~~~~~~----------------~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 254 -DSKFYKMIKEGFRM----------------LSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp -SHHHHHHHHHTCCC----------------CCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -hhHHHHHhccCCCC----------------CCc--ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 11111211111100 000 12345689999999999999999999999999998764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=338.38 Aligned_cols=250 Identities=19% Similarity=0.242 Sum_probs=197.6
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv 128 (344)
++|...+.||+|+||.||+|+. +++.||+|++..... ...+.+.+|..++.++ +||||+++++++.+....++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 4688889999999999999999 578999999876532 2234577899999988 899999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~e~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp ECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 99999999999987543 5899999999999999999999 999999999999999999999999999999764
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
...... .....||+.|+|||++.+..++.++|||||||++|||++|..||.........................
T Consensus 161 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-- 235 (345)
T 3a8x_A 161 LRPGDT---TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-- 235 (345)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC--
T ss_pred cCCCCc---ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC--
Confidence 332211 224679999999999999999999999999999999999999996532211111010111111111110
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM 330 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 330 (344)
...|. ..+..+.+|+.+||+.||++||++
T Consensus 236 -----------~~~p~--~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 -----------IRIPR--SLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -----------CCCCT--TSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -----------CCCCC--CCCHHHHHHHHHHhcCCHhHCCCC
Confidence 01111 234568899999999999999996
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=341.53 Aligned_cols=245 Identities=19% Similarity=0.199 Sum_probs=196.0
Q ss_pred CCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCCCCc
Q 048160 60 EKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTL 137 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL 137 (344)
.+.||+|+||.||+|.. ++..||+|++........+.+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56799999999999998 6789999999876655667789999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe--ecCCcceEeeeecccccCCCCccc
Q 048160 138 ADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF--QEQNVAKFFDFCVSISIPEGKTHV 215 (344)
Q Consensus 138 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill--~~~~~~kl~dfg~a~~~~~~~~~~ 215 (344)
.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||+++........
T Consensus 174 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~- 245 (373)
T 2x4f_A 174 FDRIIDES----YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL- 245 (373)
T ss_dssp HHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC-
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc-
Confidence 99886543 36889999999999999999999 9999999999999999 45678999999999876543322
Q ss_pred ccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccccc
Q 048160 216 NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPII 295 (344)
Q Consensus 216 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (344)
....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...+..+....+. ..
T Consensus 246 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~~~i~~~~~~---~~------- 308 (373)
T 2x4f_A 246 ---KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND----AETLNNILACRWD---LE------- 308 (373)
T ss_dssp ---CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHTCCC---SC-------
T ss_pred ---ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhccCC---CC-------
Confidence 134689999999999988999999999999999999999999975421 1122222211100 00
Q ss_pred ccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 296 VGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 296 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+.....+..+.+|+.+||+.||++|||+.++++
T Consensus 309 ------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 309 ------DEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0011133456899999999999999999999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=342.95 Aligned_cols=259 Identities=21% Similarity=0.336 Sum_probs=193.0
Q ss_pred CCCCCccccCCCceEEEEEE--CC---ccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEee-CCccEEEE
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QD---RPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLE-TELPILVF 129 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~---~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-~~~~~lv~ 129 (344)
|...+.||+|+||.||+|++ .+ ..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 44567899999999999998 22 3589998865433 345678899999999999999999998764 46789999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 171 e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp ECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred ECCCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999997654 35788999999999999999999 9999999999999999999999999999998664
Q ss_pred CCCccc-ccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 210 EGKTHV-NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 210 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
...... .......+|+.|+|||++.+..++.++||||||+++|||++|..|++....... ....+. ..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~----~~~~~~----~~--- 312 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYLL----QG--- 312 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC----HHHHHH----TT---
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH----HHHHHH----cC---
Confidence 332111 111234567889999999999999999999999999999995554443322111 111110 00
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhC
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKSI 344 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~l 344 (344)
.....| ..++..+.+++.+||+.||++|||+.+|++.|+++...+
T Consensus 313 ---------~~~~~p--~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 313 ---------RRLLQP--EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp ---------CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ---------CCCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 000111 134456899999999999999999999999999987653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=332.31 Aligned_cols=252 Identities=19% Similarity=0.288 Sum_probs=197.6
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCc------
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETEL------ 124 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~------ 124 (344)
.++|+..+.||+|+||.||+|+. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 35688899999999999999999 688999999875433 345678899999999999999999999866432
Q ss_pred ---------------------------------------------------cEEEEeecCCCCccccccCCCCCCCcccc
Q 048160 125 ---------------------------------------------------PILVFEFVACGTLADRIHDPNGSQLEPFL 153 (344)
Q Consensus 125 ---------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~~~l~ 153 (344)
.++|||||++|+|.+++..... .....
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~ 162 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LEDRE 162 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GGGSC
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--ccchh
Confidence 7999999999999999986542 23456
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCccc---------ccCCccccc
Q 048160 154 MKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHV---------NDNNKVIGT 224 (344)
Q Consensus 154 ~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~---------~~~~~~~g~ 224 (344)
+..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++......... .......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 6678999999999999999 9999999999999999999999999999998776542211 112245689
Q ss_pred cccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChh
Q 048160 225 FGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPE 304 (344)
Q Consensus 225 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (344)
+.|+|||++.+..++.++||||||+++|+|++|..|+.. ........ ... .....
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----------~~~~~~~~-~~~--------------~~~~~ 294 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----------RVRIITDV-RNL--------------KFPLL 294 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----------HHHHHHHH-HTT--------------CCCHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----------HHHHHHHh-hcc--------------CCCcc
Confidence 999999999998999999999999999999998765321 00111110 000 01112
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 305 KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 305 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
....+..+.+|+.+||+.||++|||+.++++
T Consensus 295 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 295 FTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred cccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 2245567899999999999999999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=350.75 Aligned_cols=262 Identities=17% Similarity=0.212 Sum_probs=207.3
Q ss_pred cHHHHHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEe
Q 048160 46 TAQELKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCL 120 (344)
Q Consensus 46 ~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~ 120 (344)
...++....++|...+.||+|+||+||+|++ .++.||+|++.... ......+.+|..++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 3445555678899999999999999999999 56889999986531 122344778999999999999999999999
Q ss_pred eCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEe
Q 048160 121 ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFF 200 (344)
Q Consensus 121 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 200 (344)
+++..|+|||||++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEc
Confidence 9999999999999999999997643 26899999999999999999999 9999999999999999999999999
Q ss_pred eeecccccCCCCcccccCCccccccccccccccC-----cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHH
Q 048160 201 DFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMS-----TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQ 275 (344)
Q Consensus 201 dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 275 (344)
|||+++......... .....||+.|+|||++. ...++.++|||||||++|||++|..||..... .....
T Consensus 218 DFGla~~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~----~~~~~ 291 (437)
T 4aw2_A 218 DFGSCLKLMEDGTVQ--SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYG 291 (437)
T ss_dssp CCTTCEECCTTSCEE--CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHH
T ss_pred chhhhhhcccCCCcc--cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh----hHHHH
Confidence 999997765443322 12457999999999986 45689999999999999999999999975321 11122
Q ss_pred HHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 048160 276 ELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQD--RPTMVQVAK 335 (344)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ei~~ 335 (344)
....... ...+... ....+.++.+|+.+||..+|++ ||++.+|++
T Consensus 292 ~i~~~~~-~~~~p~~--------------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 292 KIMNHKE-RFQFPTQ--------------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHTHHH-HCCCCSS--------------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hhhhccc-cccCCcc--------------cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 2211100 0000000 0023446889999999988888 999999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=344.08 Aligned_cols=276 Identities=16% Similarity=0.171 Sum_probs=202.5
Q ss_pred hcCCCCCCccccC--CCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 54 TNNYDPEKVITKD--LLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 54 ~~~~~~~~~ig~G--~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
.++|...+.||+| +||.||+|+. +++.||||++..... ...+.+.+|+.++++++|||||++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4679999999999 9999999999 588999999876532 223567789999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
||||+++|+|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||.+..
T Consensus 104 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM---DGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEccCCCCHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999999876432 25889999999999999999999 99999999999999999999999999998865
Q ss_pred cCCCCcc----cccCCccccccccccccccCc--CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHH
Q 048160 208 IPEGKTH----VNDNNKVIGTFGFIAPEYMST--ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS 281 (344)
Q Consensus 208 ~~~~~~~----~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 281 (344)
....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||....................
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 4322211 111223478999999999987 5789999999999999999999999975432111110000000000
Q ss_pred hccCC------------------cccccc----cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 282 IESNS------------------FKEIVD----PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 282 ~~~~~------------------~~~~~~----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..... ...... ..........+.....+..+.+|+.+||+.||++|||+.++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00000 000000 0000000111112234567999999999999999999999974
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=343.64 Aligned_cols=247 Identities=20% Similarity=0.278 Sum_probs=197.6
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~l 127 (344)
.++|...+.||+|+||.||+|+. +++.||+|++.... ....+.+.+|..+++.+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 46799999999999999999998 67899999987542 22345577899999988 69999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
||||+++|+|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 102 v~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 999999999999997653 5899999999999999999999 99999999999999999999999999999976
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
...... ......||+.|+|||++.+..++.++|||||||++|||++|..||..... ......... .
T Consensus 174 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----~~~~~~i~~----~--- 239 (353)
T 3txo_A 174 GICNGV---TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE----DDLFEAILN----D--- 239 (353)
T ss_dssp SCC------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHH----C---
T ss_pred cccCCc---cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH----HHHHHHHHc----C---
Confidence 433221 12246799999999999888899999999999999999999999975321 111111111 0
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM------VQVAK 335 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~ei~~ 335 (344)
. ..+|. ..+..+.+|+.+||+.||++||++ .+|++
T Consensus 240 ----------~-~~~p~--~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 240 ----------E-VVYPT--WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ----------C-CCCCT--TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ----------C-CCCCC--CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0 01111 233458899999999999999998 66653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=340.53 Aligned_cols=253 Identities=19% Similarity=0.248 Sum_probs=201.3
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCC-----CCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGN-----LNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPI 126 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~ 126 (344)
.+.|...+.||+|+||+||+|.. +++.||+|++... .....+.+.+|+.++++++||||+++++++...+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35688999999999999999998 6789999998532 1123566889999999999999999999999999999
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCc---ceEeeee
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNV---AKFFDFC 203 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~dfg 203 (344)
+|||||++++|.+++....... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++. +||+|||
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAG-FVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEeCCCCCCHHHHHHHhcccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999988775321100 24889999999999999999999 999999999999999987654 9999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhc
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE 283 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (344)
++......... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.... .........
T Consensus 179 ~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~i~~---- 246 (351)
T 3c0i_A 179 VAIQLGESGLV---AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-----ERLFEGIIK---- 246 (351)
T ss_dssp TCEECCTTSCB---CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-----HHHHHHHHH----
T ss_pred ceeEecCCCee---ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-----HHHHHHHHc----
Confidence 99876543321 124578999999999999999999999999999999999999997531 111111111
Q ss_pred cCCcccccccccccCCCCChh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 284 SNSFKEIVDPIIVGEEGLWPE-KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. .....+. ....+..+.+|+.+||+.||++|||+.++++
T Consensus 247 -~------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 247 -G------------KYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -T------------CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -C------------CCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0000010 1123456899999999999999999999975
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=330.88 Aligned_cols=277 Identities=18% Similarity=0.308 Sum_probs=212.3
Q ss_pred cHHHHHHHhcCCCCCCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhc--CCCCceeeeeeEEeeCC
Q 048160 46 TAQELKAATNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQ--MSHKNILKFVGCCLETE 123 (344)
Q Consensus 46 ~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~~~~~~~~~~ 123 (344)
+..--....++|...+.||+|+||.||+|+++++.||+|.+... ....+.+|+.++.. ++||||+++++++....
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 33333445567999999999999999999999999999998654 34567788888887 78999999999998775
Q ss_pred ----ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCC-----CCCeeeecccccceEeecC
Q 048160 124 ----LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGF-----SRPIVFRDIKPSTILFQEQ 194 (344)
Q Consensus 124 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~ 194 (344)
..++||||+++|+|.+++... .+++.+++.++.|++.||.|||... +.+|+||||||+||+++.+
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~ 183 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 183 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT
T ss_pred CccceeEEEEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC
Confidence 789999999999999999753 4889999999999999999999311 4689999999999999999
Q ss_pred CcceEeeeecccccCCCCccc-ccCCccccccccccccccCcC------CCCcccchHHHHHHHHHHHcC----------
Q 048160 195 NVAKFFDFCVSISIPEGKTHV-NDNNKVIGTFGFIAPEYMSTA------NCNEKSDVYSFGALLLELLTG---------- 257 (344)
Q Consensus 195 ~~~kl~dfg~a~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~g---------- 257 (344)
+.+||+|||++.......... .......||+.|+|||++.+. .++.++||||||+++|||++|
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 999999999997765433221 122345789999999998765 234789999999999999999
Q ss_pred CCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048160 258 KRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337 (344)
Q Consensus 258 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L 337 (344)
..||................ .. .......+. ..+ ....++..+.+|+.+||+.||++|||+.+|++.|
T Consensus 264 ~~p~~~~~~~~~~~~~~~~~---~~-~~~~~~~~~-------~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 264 QLPYYDLVPSDPSVEEMRKV---VC-EQKLRPNIP-------NRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp CCTTTTTSCSSCCHHHHHHH---HT-TSCCCCCCC-------GGG-GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred ccCccccCcCcccHHHHHHH---HH-HHHhCCCCc-------ccc-cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 66776543222211111111 11 111110000 001 1125677899999999999999999999999999
Q ss_pred HHHHhh
Q 048160 338 RQLHKS 343 (344)
Q Consensus 338 ~~l~~~ 343 (344)
+++.++
T Consensus 332 ~~i~~~ 337 (342)
T 1b6c_B 332 SQLSQQ 337 (342)
T ss_dssp HHHHHT
T ss_pred HHHHHH
Confidence 998764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=351.81 Aligned_cols=261 Identities=16% Similarity=0.211 Sum_probs=194.1
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC--CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCC------
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL--NSEEYCCFNCIAFASQMSHKNILKFVGCCLETE------ 123 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------ 123 (344)
.++|...+.||+|+||+||+|.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46788899999999999999998 68899999997652 233466789999999999999999999997553
Q ss_pred ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeee
Q 048160 124 LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFC 203 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg 203 (344)
..|+||||+++ +|.+.+.. .+++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEE
Confidence 46999999974 56666643 3788999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhc
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE 283 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (344)
+++....... .....||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ...+...+.....
T Consensus 210 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~----~~~~~~i~~~lg~ 281 (464)
T 3ttj_A 210 LARTAGTSFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY----IDQWNKVIEQLGT 281 (464)
T ss_dssp CC-----CCC----C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCS
T ss_pred eeeecCCCcc----cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCC
Confidence 9987643321 1245789999999999999999999999999999999999999965421 1112222111100
Q ss_pred c------------------C------CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 284 S------------------N------SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 284 ~------------------~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+ . .+...+..... ..........+.++.+|+.+||+.||++|||+.|+++
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLF--PADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGS--CCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHcchhhhhHhhcccccCCCChHHhCccccc--ccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 0 00000000000 0000011123567899999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=364.90 Aligned_cols=251 Identities=20% Similarity=0.276 Sum_probs=198.5
Q ss_pred CccccCCCceEEEEEE----CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 61 KVITKDLLYKLYKGFL----QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~----~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
+.||+|+||.||+|.+ .++.||||+++..... ..+.+.+|+.++++++|||||++++++.. ...++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 3699999999999977 3467999999765332 24678899999999999999999999864 567899999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
|+|.+++.... .+++.+++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 454 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 99999997643 5889999999999999999999 999999999999999999999999999999877544332
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDP 293 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (344)
........+|+.|+|||++.+..++.++||||||+++|||++ |..||..... ......+. ..
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----~~~~~~i~----~~-------- 588 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEVTAMLE----KG-------- 588 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHH----TT--------
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHH----cC--------
Confidence 222223456788999999998899999999999999999998 9999864321 11111111 11
Q ss_pred ccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 294 IIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
.....|. .++.++.+|+..||+.||++|||+.+|++.|+.+...
T Consensus 589 ----~~~~~p~--~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 589 ----ERMGCPA--GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp ----CCCCCCT--TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCC--CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1111111 4456789999999999999999999999999998764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=352.53 Aligned_cols=257 Identities=16% Similarity=0.249 Sum_probs=205.4
Q ss_pred HHHHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeC
Q 048160 48 QELKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLET 122 (344)
Q Consensus 48 ~~i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~ 122 (344)
.++....++|...+.||+|+||+||+|+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 34445567899999999999999999999 57889999986531 12234577999999999999999999999999
Q ss_pred CccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeee
Q 048160 123 ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF 202 (344)
Q Consensus 123 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~df 202 (344)
...|+||||+++|+|.+++... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEecc
Confidence 9999999999999999999753 4889999999999999999999 999999999999999999999999999
Q ss_pred ecccccCCCCcccccCCccccccccccccccCcCC----CCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHH
Q 048160 203 CVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTAN----CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELV 278 (344)
Q Consensus 203 g~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 278 (344)
|+++......... .....||+.|+|||++.+.. ++.++|||||||++|||++|..||..... ......+.
T Consensus 213 G~a~~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~~~~i~ 286 (410)
T 3v8s_A 213 GTCMKMNKEGMVR--CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGTYSKIM 286 (410)
T ss_dssp TTCEECCTTSEEE--CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHH
T ss_pred ceeEeeccCCccc--ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh----hhHHHHHH
Confidence 9998765443221 22567999999999987655 78999999999999999999999975321 11112211
Q ss_pred HHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 048160 279 RKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQD--RPTMVQVAK 335 (344)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ei~~ 335 (344)
..... . ..|.....+.++.+|+.+||+.+|.+ ||++.+|++
T Consensus 287 ~~~~~-~---------------~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 287 NHKNS-L---------------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp THHHH-C---------------CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred hcccc-c---------------cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 11000 0 01111123456889999999999988 999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=326.22 Aligned_cols=266 Identities=17% Similarity=0.226 Sum_probs=205.1
Q ss_pred HHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEE-eeCCccEEE
Q 048160 52 AATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCC-LETELPILV 128 (344)
Q Consensus 52 ~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~-~~~~~~~lv 128 (344)
...++|...+.||+|+||.||+|+. +++.||+|.+.... ..+.+.+|+.+++.++|++++..++.+ ..++..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3457799999999999999999997 78899999866543 334678999999999988877776665 567788999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe---ecCCcceEeeeecc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF---QEQNVAKFFDFCVS 205 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~dfg~a 205 (344)
|||+ +++|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||++
T Consensus 84 ~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EECC-CCBHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEcc-CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 9999 899999987543 35899999999999999999999 9999999999999999 78899999999999
Q ss_pred cccCCCCccc----ccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHH
Q 048160 206 ISIPEGKTHV----NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS 281 (344)
Q Consensus 206 ~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 281 (344)
.......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||......... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~ 234 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEKK 234 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-SHHHHHHHHH
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh-hhhhhhhccc
Confidence 8765443211 1222457899999999999999999999999999999999999999764332221 1122111111
Q ss_pred hccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 282 IESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
... ..... ....+..+.+|+..||+.||++|||+.+|++.|+++.+.
T Consensus 235 ~~~-~~~~~--------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 235 MST-PIEVL--------------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HHS-CHHHH--------------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccc-hhhhh--------------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 110 00000 002245689999999999999999999999999998764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=339.71 Aligned_cols=260 Identities=21% Similarity=0.334 Sum_probs=195.7
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch---hhhHhhHHHHHhcCCCCceeeeeeEEeeCCcc---
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE---EYCCFNCIAFASQMSHKNILKFVGCCLETELP--- 125 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~--- 125 (344)
.++|...+.||+|+||.||+|+. +++.||+|++....... ...+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 36788999999999999999997 78899999997653322 34578999999999999999999998766544
Q ss_pred -EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeec
Q 048160 126 -ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV 204 (344)
Q Consensus 126 -~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~ 204 (344)
++||||+++++|.+++.... ++++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred cEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 99999999999999997543 5899999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc
Q 048160 205 SISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES 284 (344)
Q Consensus 205 a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (344)
+.................||+.|+|||++.+..++.++||||||+++|+|++|..||..... ..... .....
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~----~~~~~----~~~~~ 234 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP----VSVAY----QHVRE 234 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHH----HHHHC
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh----HHHHH----HHhcC
Confidence 98765443332333345789999999999998999999999999999999999999965321 11111 11111
Q ss_pred CCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHH-HHHHHHHHH
Q 048160 285 NSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQ-VAKQLRQLH 341 (344)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e-i~~~L~~l~ 341 (344)
..... .......+.++.+|+.+||+.||++||++.+ +.+.+.++.
T Consensus 235 ~~~~~------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 235 DPIPP------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp CCCCH------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCCc------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 10000 0000124456899999999999999996554 555555543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=331.41 Aligned_cols=268 Identities=21% Similarity=0.287 Sum_probs=197.8
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEE-C----CccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeC
Q 048160 50 LKAATNNYDPEKVITKDLLYKLYKGFL-Q----DRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLET 122 (344)
Q Consensus 50 i~~~~~~~~~~~~ig~G~~g~V~~~~~-~----~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~ 122 (344)
+....++|...+.||+|+||.||+|.+ . +..||+|.+..... ...+.+.+|+.++++++||||+++++++...
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 334456788889999999999999988 2 23699999875533 2346688999999999999999999999875
Q ss_pred C-----ccEEEEeecCCCCccccccCCC-CCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCc
Q 048160 123 E-----LPILVFEFVACGTLADRIHDPN-GSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNV 196 (344)
Q Consensus 123 ~-----~~~lv~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 196 (344)
. ..++||||+++|+|.+++.... ......+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCc
Confidence 4 3499999999999999883211 011136899999999999999999999 999999999999999999999
Q ss_pred ceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHH
Q 048160 197 AKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQ 275 (344)
Q Consensus 197 ~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~ 275 (344)
+||+|||++.......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... . ...
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~-~~~ 259 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYR-QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN----H-EMY 259 (313)
T ss_dssp EEECSCSCC-----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG----G-GHH
T ss_pred EEEeecCcceecccccccC-cccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH----H-HHH
Confidence 9999999998764432111 1123456789999999998899999999999999999999 7777754321 1 111
Q ss_pred HHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhC
Q 048160 276 ELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKSI 344 (344)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~l 344 (344)
..+. . . .....+ ...+..+.+++.+||+.||++|||+.+|++.|+++.+++
T Consensus 260 ~~~~---~-~------------~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 260 DYLL---H-G------------HRLKQP--EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HHHH---T-T------------CCCCCB--TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHH---c-C------------CCCCCC--ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111 0 0 000011 134456899999999999999999999999999998764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=339.82 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=189.1
Q ss_pred HHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 52 AATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 52 ~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
...+.|...+.||+|+||.||+|+. .++.||+|++.... ..+.+.+|+.++++++||||+++++++......++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 3456789999999999999999999 56789999987653 3456789999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec---CCcceEeeeeccc
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE---QNVAKFFDFCVSI 206 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~dfg~a~ 206 (344)
||+++|+|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||+++
T Consensus 128 e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKG-----YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp CCCCSCBHHHHHTTCS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EeCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 9999999999997653 5899999999999999999999 999999999999999975 8899999999998
Q ss_pred ccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......... . ..
T Consensus 200 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~i~----~-~~ 267 (349)
T 2w4o_A 200 IVEHQVL----MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG---DQFMFRRIL----N-CE 267 (349)
T ss_dssp -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC---HHHHHHHHH----T-TC
T ss_pred ccCcccc----cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc---cHHHHHHHH----h-CC
Confidence 6543221 1245789999999999998999999999999999999999999965422 111111111 1 00
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.. . .. +.....+..+.+|+.+||+.||++|||+.++++
T Consensus 268 ~~-~-------~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 268 YY-F-------IS---PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CC-C-------CT---TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Cc-c-------CC---chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0 00 011133456889999999999999999999876
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=326.80 Aligned_cols=266 Identities=19% Similarity=0.231 Sum_probs=199.2
Q ss_pred cCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
++|...+.||+|+||.||+|+. .++.||+|++...... ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4688889999999999999999 6889999998765332 235678999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
++ ++|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 82 LD-QDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CS-EEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred cC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 97 59999887654 25889999999999999999999 999999999999999999999999999999876432
Q ss_pred CcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc--CCcc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES--NSFK 288 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 288 (344)
... .....||+.|+|||++.+. .++.++||||||+++|+|++|..||..... ...+.......... ..+.
T Consensus 154 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~ 226 (288)
T 1ob3_A 154 VRK---YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE----ADQLMRIFRILGTPNSKNWP 226 (288)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCTTTST
T ss_pred ccc---cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHHCCCChhhch
Confidence 211 1134679999999998764 589999999999999999999999865421 11222222111110 0000
Q ss_pred cc-----ccccccc-CCCCChh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 EI-----VDPIIVG-EEGLWPE-KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~~-----~~~~~~~-~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.. .++.... ....+.. ....+..+.+|+.+||+.||++|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 0000000 0000100 0123456889999999999999999999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=337.18 Aligned_cols=243 Identities=17% Similarity=0.216 Sum_probs=201.5
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||.||+|+. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 5688899999999999999999 68899999986542 123456779999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++|+|.+++...+ .+++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 121 e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceecc
Confidence 9999999999997643 5899999999999999999999 9999999999999999999999999999998764
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
... ....||+.|+|||++.+..++.++||||||+++|+|++|..||..... ......+.. ..
T Consensus 193 ~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~i~~-----~~--- 254 (350)
T 1rdq_E 193 GRT------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP----IQIYEKIVS-----GK--- 254 (350)
T ss_dssp SCB------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHH-----CC---
T ss_pred CCc------ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH----HHHHHHHHc-----CC---
Confidence 321 245789999999999999999999999999999999999999975321 111111111 10
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT-----MVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ei~~ 335 (344)
...|. ..+..+.+|+.+||+.||++||+ +.+|++
T Consensus 255 ----------~~~p~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 255 ----------VRFPS--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----------CCCCT--TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----------CCCCC--CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 00111 23456899999999999999998 777764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=332.29 Aligned_cols=252 Identities=22% Similarity=0.296 Sum_probs=198.7
Q ss_pred hcCCCCCCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeC-CccEEEEeec
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLET-ELPILVFEFV 132 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-~~~~lv~e~~ 132 (344)
.++|...+.||+|+||.||+|++.++.||+|.+.... ..+.+.+|+.++++++||||+++++++... +..++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 4568889999999999999999999999999987553 456788999999999999999999997654 4789999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++++|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 98 AKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp TTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 99999999975421 23788899999999999999999 9999999999999999999999999999987654322
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
. ...+++.|+|||++.+..++.++||||||+++|+|++ |..||..... . .....+ ....
T Consensus 172 ~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----~-~~~~~~----~~~~----- 231 (278)
T 1byg_A 172 D------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----K-DVVPRV----EKGY----- 231 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG----G-GHHHHH----TTTC-----
T ss_pred c------CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH----H-HHHHHH----hcCC-----
Confidence 1 2356889999999988899999999999999999998 8888864321 1 111111 1100
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
....+ ...+..+.+++..||+.||++|||+.++++.|+++..
T Consensus 232 -------~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 232 -------KMDAP--DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp -------CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCCc--ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 00001 1344568999999999999999999999999999865
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=340.22 Aligned_cols=249 Identities=21% Similarity=0.301 Sum_probs=201.0
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCc
Q 048160 51 KAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQM-SHKNILKFVGCCLETEL 124 (344)
Q Consensus 51 ~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~ 124 (344)
....++|...+.||+|+||.||+|+. +++.||+|.+.... ....+.+..|..++..+ +||||+++++++.+...
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 44557899999999999999999999 67889999987542 22345577899999877 89999999999999999
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeec
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV 204 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~ 204 (344)
.|+||||+++|+|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~ 164 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGM 164 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChh
Confidence 999999999999999997643 5899999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc
Q 048160 205 SISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES 284 (344)
Q Consensus 205 a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (344)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|..||..... ........ ..
T Consensus 165 a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~i~----~~ 233 (345)
T 1xjd_A 165 CKENMLGDAK---TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE----EELFHSIR----MD 233 (345)
T ss_dssp CBCCCCTTCC---BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH----HC
T ss_pred hhhcccCCCc---ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHH----hC
Confidence 9764332211 2256799999999999999999999999999999999999999975321 11111111 00
Q ss_pred CCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 048160 285 NSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMV-QVA 334 (344)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-ei~ 334 (344)
. ..+|. ..+.++.+|+.+||+.||++||++. +|+
T Consensus 234 -~-------------~~~p~--~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 234 -N-------------PFYPR--WLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -C-------------CCCCT--TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -C-------------CCCCc--ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0 01111 2345688999999999999999987 554
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=332.04 Aligned_cols=249 Identities=19% Similarity=0.242 Sum_probs=203.4
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc------hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCcc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS------EEYCCFNCIAFASQMSHKNILKFVGCCLETELP 125 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~ 125 (344)
.+.|...+.||+|+||.||+|+. ++..||+|.+...... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 35588899999999999999998 6789999998755322 245688999999999999999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC----cceEee
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN----VAKFFD 201 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~d 201 (344)
++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++ .++|+|
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS-----CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 99999999999999997643 6899999999999999999999 99999999999999999887 799999
Q ss_pred eecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHH
Q 048160 202 FCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS 281 (344)
Q Consensus 202 fg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 281 (344)
||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||..... .......
T Consensus 163 fg~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~i---- 230 (321)
T 2a2a_A 163 FGLAHEIEDGVEF----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANI---- 230 (321)
T ss_dssp CTTCEECCTTCCC----CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHHHHH----
T ss_pred CccceecCccccc----cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH----HHHHHHH----
Confidence 9999876543221 245689999999999988999999999999999999999999965321 1111111
Q ss_pred hccCCcccccccccccCCCCChh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 282 IESNSFKEIVDPIIVGEEGLWPE-KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.. . .....+. ....+..+.+|+.+||+.||++|||+.++++
T Consensus 231 ~~-~------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 231 TS-V------------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HT-T------------CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred Hh-c------------ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 0 0000000 0123456899999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=335.35 Aligned_cols=242 Identities=19% Similarity=0.188 Sum_probs=201.6
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--------hhhhHhhHHHHHhcCCCCceeeeeeEEeeC
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--------EEYCCFNCIAFASQMSHKNILKFVGCCLET 122 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~~~~~~~~~ 122 (344)
..++|...+.||+|+||.||+|+. +++.||||.+...... ....+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 346799999999999999999987 7889999998765321 234577899999999999999999999999
Q ss_pred CccEEEEeecCCC-CccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEee
Q 048160 123 ELPILVFEFVACG-TLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFD 201 (344)
Q Consensus 123 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~d 201 (344)
+..++||||+.+| +|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEee
Confidence 9999999999766 9999997654 5899999999999999999999 99999999999999999999999999
Q ss_pred eecccccCCCCcccccCCccccccccccccccCcCCC-CcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHH
Q 048160 202 FCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANC-NEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280 (344)
Q Consensus 202 fg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 280 (344)
||++.......... ...||+.|+|||++.+..+ +.++||||||+++|+|++|..||.....
T Consensus 174 fg~a~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------- 235 (335)
T 3dls_A 174 FGSAAYLERGKLFY----TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------- 235 (335)
T ss_dssp CTTCEECCTTCCBC----EECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------------
T ss_pred cccceECCCCCcee----ccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------------
Confidence 99998765433221 4568999999999988776 7899999999999999999999864211
Q ss_pred HhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 281 SIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
....... ... ..+.++.+|+.+||+.||++|||+.++++.
T Consensus 236 ---------~~~~~~~-~~~------~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ---------TVEAAIH-PPY------LVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---------GTTTCCC-CSS------CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---------HHhhccC-CCc------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 000 233468999999999999999999999863
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=334.80 Aligned_cols=247 Identities=21% Similarity=0.248 Sum_probs=179.2
Q ss_pred CCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCC-CCceeeeeeEEeeCCccEEEEeecCCCC
Q 048160 60 EKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCCLETELPILVFEFVACGT 136 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~gs 136 (344)
.+.||+|+||.||+|.. +++.||||++... ....+.+|+.+++.+. ||||+++++++.++...++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 47899999999999999 5789999998654 3456779999999997 9999999999999999999999999999
Q ss_pred ccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC---cceEeeeecccccCCCCc
Q 048160 137 LADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN---VAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 137 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~dfg~a~~~~~~~~ 213 (344)
|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++ .+||+|||++........
T Consensus 93 L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 93 LFERIKKKK-----HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp HHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 999997653 6899999999999999999999 99999999999999997765 899999999986654332
Q ss_pred ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDP 293 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (344)
.. ....||+.|+|||++.+..++.++||||||+++|+|++|..||......... ....+.....
T Consensus 165 ~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~i------------ 228 (325)
T 3kn6_A 165 PL---KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-TSAVEIMKKI------------ 228 (325)
T ss_dssp ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C-CCHHHHHHHH------------
T ss_pred cc---cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc-ccHHHHHHHH------------
Confidence 21 2456799999999999999999999999999999999999999754321110 0011111111
Q ss_pred ccccCCCC-ChhhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 048160 294 IIVGEEGL-WPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVA 334 (344)
Q Consensus 294 ~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~ 334 (344)
..+.... .+.....+.++.+|+.+||+.||++|||+.+++
T Consensus 229 -~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 229 -KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp -TTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred -HcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 1111111 111123456789999999999999999998876
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=334.43 Aligned_cols=256 Identities=16% Similarity=0.297 Sum_probs=198.1
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCcc----EEEEEecCCC-CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRP----ISVMKFGGNL-NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~----vavk~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
++|+..+.||+|+||.||+|++ ++.. ||+|.+.... ....+.+.+|+.++++++||||+++++++..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 5688899999999999999998 4444 4777775443 334567889999999999999999999998764 789
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
|+||+.+|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 94 v~~~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EECCCSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 999999999999997654 35889999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
......... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... ..+...+.. ..
T Consensus 167 ~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~~~~~~~~----~~ 236 (327)
T 3lzb_A 167 LGAEEKEYH-AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSILEK----GE 236 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHHHT----TC
T ss_pred ccCcccccc-ccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHc----CC
Confidence 644322211 113356778999999999999999999999999999999 8888864321 111111111 00
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
. .+....++..+.+|+.+||+.||++|||+.+|++.|.++.+
T Consensus 237 ------------~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 ------------R--LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ------------C--CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ------------C--CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 0 01111344568999999999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=325.94 Aligned_cols=247 Identities=20% Similarity=0.255 Sum_probs=203.2
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
.+.|...+.||+|+||.||+|.. ++..||+|++........+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 45688899999999999999999 5568999999876666677889999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe---ecCCcceEeeeeccccc
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF---QEQNVAKFFDFCVSISI 208 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~dfg~a~~~ 208 (344)
+++++|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+||++ +.++.++|+|||++...
T Consensus 88 ~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 88 CTGGELFERVVHKR-----VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred cCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 99999999886543 5889999999999999999999 9999999999999999 78889999999999876
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
...... ....||+.|+|||++.+. ++.++||||||+++|+|++|..||..... ......... ..
T Consensus 160 ~~~~~~----~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~-----~~-- 223 (277)
T 3f3z_A 160 KPGKMM----RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD----SEVMLKIRE-----GT-- 223 (277)
T ss_dssp CTTSCB----CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHH-----CC--
T ss_pred cCccch----hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHh-----CC--
Confidence 543322 145689999999998654 89999999999999999999999865321 111111110 00
Q ss_pred cccccccccCCCCChh--hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPE--KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
...+. ....+..+.+|+.+||+.||++|||+.++++
T Consensus 224 -----------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 224 -----------FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -----------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -----------CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111 0123457899999999999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=341.24 Aligned_cols=278 Identities=16% Similarity=0.217 Sum_probs=213.5
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCC--ccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETE--LPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~--~~~lv~ 129 (344)
+.|...+.||+|+||.||+|++ +++.||||++..... ...+.+.+|+.++++++||||+++++++.... ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 5688889999999999999999 588999999875432 23466789999999999999999999998755 679999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe----ecCCcceEeeeecc
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF----QEQNVAKFFDFCVS 205 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~dfg~a 205 (344)
||+++|+|.+++...... ..+++.+++.++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||++
T Consensus 89 e~~~~g~L~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp CCCTTEEHHHHTTSGGGT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred ecCCCCCHHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999764321 13899999999999999999999 9999999999999999 77778999999999
Q ss_pred cccCCCCcccccCCccccccccccccccCc--------CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHH
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMST--------ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL 277 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 277 (344)
+........ ....||+.|+|||++.+ ..++.++||||||+++|||++|..||................
T Consensus 164 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 164 RELEDDEQF----VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp EECCCGGGS----SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred eEccCCCcc----ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 876543321 24568999999999865 467889999999999999999999997654433333333333
Q ss_pred HHHHhccCCcccc---ccccc--ccC-CCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 278 VRKSIESNSFKEI---VDPII--VGE-EGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 278 ~~~~~~~~~~~~~---~~~~~--~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
..... ...+..+ ....+ ... ..........+..+.+++.+||+.||++|||+.++++.+..+.+
T Consensus 240 ~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 240 ITGKP-SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHSCC-TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred hcCCC-cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 22111 0000000 00000 000 01111124677789999999999999999999999999998865
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=329.94 Aligned_cols=263 Identities=22% Similarity=0.362 Sum_probs=197.9
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
.++|...+.||+|+||.||+|.. ++..||+|++.... ......+.+|+.++++++||||+++++++..++..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 45788999999999999999998 78899999987532 22345678999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||+++++|.+++...... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQ-KRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EECCCSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EecCCCCCHHHHHHHhccc-ccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999988641100 025889999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
...... .....|+..|+|||++.+..++.++||||||+++|+|++|..||..... . ........ ......
T Consensus 187 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~----~~~~~~~~-~~~~~~ 256 (310)
T 2wqm_A 187 SSKTTA---AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--N----LYSLCKKI-EQCDYP 256 (310)
T ss_dssp ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C--C----HHHHHHHH-HTTCSC
T ss_pred cCCCcc---ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch--h----HHHHHHHh-hcccCC
Confidence 433221 1134689999999999999999999999999999999999999875321 1 11111111 111111
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
.. +. ...+..+.+|+..||+.||++|||+.+|++.|+++...
T Consensus 257 ~~------------~~-~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 257 PL------------PS-DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp CC------------CT-TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC------------cc-cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 00 00 13345689999999999999999999999999998753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=346.76 Aligned_cols=245 Identities=21% Similarity=0.246 Sum_probs=202.0
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||.||+|+. +++.||||++..... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5688889999999999999998 688999999865421 22356789999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++|+|.+++...+ .+++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 96 E~~~gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 96 EYVSGGELFDYICKNG-----RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp ECCSSEEHHHHTTSSS-----SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 9999999999997653 5899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCcccccCCccccccccccccccCcCCC-CcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANC-NEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
..... ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||..... ........ . ...
T Consensus 168 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~----~-~~~- 233 (476)
T 2y94_A 168 DGEFL----RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV----PTLFKKIC----D-GIF- 233 (476)
T ss_dssp TTCCB----CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS----HHHHHHHH----T-TCC-
T ss_pred ccccc----cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH----HHHHHHHh----c-CCc-
Confidence 43221 24578999999999988765 6899999999999999999999965321 11111111 0 000
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..|. ..+..+.+|+.+||+.||++|||+.+|++
T Consensus 234 ------------~~p~--~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 ------------YTPQ--YLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ------------CCCT--TCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------------CCCc--cCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0010 23346889999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=361.21 Aligned_cols=262 Identities=21% Similarity=0.280 Sum_probs=208.2
Q ss_pred HHHHHhcCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 49 ELKAATNNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 49 ~i~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
.+....++|...+.||+|+||.||+|.+ .+..||||++..... ..+.+.+|+.+|++++||||+++++++.+ ...++
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 3444456677888999999999999999 456799999986543 35678999999999999999999999876 67899
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
||||+.+|+|.+++....+ ..+++.+++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 339 v~e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp EECCCTTEEHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred eeehhcCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 9999999999999974321 24889999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
....... ......++..|+|||++....++.++||||||+++|||++ |..||..... . +.........
T Consensus 413 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~----~----~~~~~i~~~~- 481 (535)
T 2h8h_A 413 IEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----R----EVLDQVERGY- 481 (535)
T ss_dssp CCCHHHH--TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH----H----HHHHHHHTTC-
T ss_pred cCCCcee--cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----H----HHHHHHHcCC-
Confidence 6432211 1113346788999999988899999999999999999999 8888754311 1 1111111110
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
. .+....++..+.+|+.+||+.||++|||+.+|++.|+.+..+
T Consensus 482 ------------~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 482 ------------R--MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp ------------C--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred ------------C--CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 0 011113455689999999999999999999999999987543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=329.15 Aligned_cols=266 Identities=17% Similarity=0.198 Sum_probs=197.5
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch--hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE--EYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
++|...+.||+|+||+||+|+. +++.||+|++....... .+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 5788899999999999999999 57899999987654332 3557799999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~~l~~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 83 YCDHTVLHELDRYQR-----GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp CCSEEHHHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eCCCchHHHHHhhhc-----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 999999998886543 5889999999999999999999 99999999999999999999999999999987653
Q ss_pred CCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC----
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN---- 285 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 285 (344)
..... ....||..|+|||++.+ ..++.++||||||+++|+|++|..||...... ..............
T Consensus 155 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~ 227 (311)
T 4agu_A 155 PSDYY---DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV----DQLYLIRKTLGDLIPRHQ 227 (311)
T ss_dssp --------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHHCSCCHHHH
T ss_pred ccccc---CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhcccccccc
Confidence 32211 14578999999999876 56899999999999999999999999654321 11111111000000
Q ss_pred ---CcccccccccccCCCC-Ch---hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 ---SFKEIVDPIIVGEEGL-WP---EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ---~~~~~~~~~~~~~~~~-~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
................ .+ ..+..+..+.+|+.+||+.||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000000000000 00 00133456899999999999999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=334.14 Aligned_cols=262 Identities=19% Similarity=0.260 Sum_probs=208.4
Q ss_pred hcCCCCCCccccCCCceEEEEEEC---------CccEEEEEecCCCC-chhhhHhhHHHHHhcC-CCCceeeeeeEEeeC
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQ---------DRPISVMKFGGNLN-SEEYCCFNCIAFASQM-SHKNILKFVGCCLET 122 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~---------~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~ 122 (344)
.++|...+.||+|+||.||+|++. +..||+|++..... ...+.+.+|+.+++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467889999999999999999972 35699999876543 2346688999999999 899999999999999
Q ss_pred CccEEEEeecCCCCccccccCCCCCC-----------CccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe
Q 048160 123 ELPILVFEFVACGTLADRIHDPNGSQ-----------LEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF 191 (344)
Q Consensus 123 ~~~~lv~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 191 (344)
+..++||||+++|+|.+++....... ...+++..++.++.|++.||.||| +.+|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence 99999999999999999997643210 124889999999999999999999 9999999999999999
Q ss_pred ecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcc
Q 048160 192 QEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGE 270 (344)
Q Consensus 192 ~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~ 270 (344)
+.++.+||+|||++.......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~----- 264 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----- 264 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEE-CCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-----
T ss_pred cCCCCEEEcccccccccccccccc-ccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC-----
Confidence 999999999999998765433221 1123456788999999988889999999999999999999 888885432
Q ss_pred hhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 271 EYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
...+...+.. .... ..+ ..++..+.+++.+||+.||++|||+.+|++.|+++..
T Consensus 265 ~~~~~~~~~~----~~~~------------~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 265 VEELFKLLKE----GHRM------------DKP--ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHHHHHHHH----TCCC------------CCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhc----CCCC------------CCC--ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1111111111 1000 000 1334568999999999999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=331.98 Aligned_cols=273 Identities=18% Similarity=0.311 Sum_probs=214.0
Q ss_pred ccHHHHHHHhcCCCCCCccccCCCceEEEEEE-------CCccEEEEEecCCCCc-hhhhHhhHHHHHhcC-CCCceeee
Q 048160 45 FTAQELKAATNNYDPEKVITKDLLYKLYKGFL-------QDRPISVMKFGGNLNS-EEYCCFNCIAFASQM-SHKNILKF 115 (344)
Q Consensus 45 ~~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~-------~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~~ 115 (344)
+....+....++|...+.||+|+||.||+|++ .++.||+|.+...... ..+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 44555556678899999999999999999985 3478999999766443 345688999999999 79999999
Q ss_pred eeEEeeCC-ccEEEEeecCCCCccccccCCCCCC-----------CccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeec
Q 048160 116 VGCCLETE-LPILVFEFVACGTLADRIHDPNGSQ-----------LEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRD 183 (344)
Q Consensus 116 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d 183 (344)
++++...+ ..++||||+++|+|.+++....... ...+++..+..++.|++.||.||| +.+|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence 99987654 5899999999999999997654210 012889999999999999999999 99999999
Q ss_pred ccccceEeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCC
Q 048160 184 IKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISY 262 (344)
Q Consensus 184 lk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~ 262 (344)
|||+||+++.++.+||+|||++.......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYV-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CccceEEECCCCCEEECCCccccccccCccce-eccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 99999999999999999999998765433211 1124567889999999988899999999999999999998 888886
Q ss_pred CCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 263 SSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.... .......+.. .... ..+ ...+..+.+++.+||+.||.+|||+.+|++.|+++.+
T Consensus 253 ~~~~----~~~~~~~~~~----~~~~------------~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 253 GVKI----DEEFCRRLKE----GTRM------------RAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp TCCC----SHHHHHHHHH----TCCC------------CCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccch----hHHHHHHhcc----CccC------------CCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 4321 1111111111 1000 000 0234468999999999999999999999999999875
Q ss_pred h
Q 048160 343 S 343 (344)
Q Consensus 343 ~ 343 (344)
.
T Consensus 311 ~ 311 (316)
T 2xir_A 311 A 311 (316)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=330.92 Aligned_cols=243 Identities=14% Similarity=0.144 Sum_probs=192.9
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch--hhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE--EYCCFNCIAFASQM-SHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~--~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|+..+.||+|+||+||+|++ +++.||||++....... ...+..|+..+.++ +||||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 5688889999999999999999 68899999987654332 23445666666555 8999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+ +++|.+++...+ ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 137 e~~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp ECC-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred ecc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 999 679999887654 36899999999999999999999 9999999999999999999999999999987764
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
..... ....||+.|+|||++.+ .++.++||||||+++|||++|..||+.... . ..........
T Consensus 209 ~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-------~-----~~~~~~~~~~ 271 (311)
T 3p1a_A 209 TAGAG----EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-------W-----QQLRQGYLPP 271 (311)
T ss_dssp ----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-------H-----HHHTTTCCCH
T ss_pred cCCCC----cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------H-----HHHhccCCCc
Confidence 43221 24468999999999875 789999999999999999999887754211 0 0111110000
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
......+..+.+|+.+||+.||++|||+.++++
T Consensus 272 -------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 -------------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 001133467899999999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=323.63 Aligned_cols=264 Identities=17% Similarity=0.228 Sum_probs=207.6
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEE-eeCCccEEEEe
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCC-LETELPILVFE 130 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~-~~~~~~~lv~e 130 (344)
.++|...+.||+|+||.||+|+. +++.||+|.+.... ..+.+.+|+.+++.++|++++..++++ ..+...++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46799999999999999999997 78899999986653 335688999999999988866666655 56778899999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe---ecCCcceEeeeecccc
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF---QEQNVAKFFDFCVSIS 207 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~dfg~a~~ 207 (344)
|+ +++|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||++..
T Consensus 86 ~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 99 899999997443 36899999999999999999999 9999999999999999 5888999999999987
Q ss_pred cCCCCccc----ccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhc
Q 048160 208 IPEGKTHV----NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE 283 (344)
Q Consensus 208 ~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (344)
........ .......||+.|+|||++.+..++.++||||||+++|+|++|..||........ ...+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEKKMS 236 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS-SSHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh-hhhhhhhcccccC
Confidence 65443211 112345789999999999999999999999999999999999999976432211 1111111111111
Q ss_pred cCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 284 SNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
. ..... ....+..+.+|+.+||+.||++|||+.+|++.|+++...
T Consensus 237 ~-~~~~~--------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 237 T-PIEVL--------------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp S-CHHHH--------------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred C-chHHH--------------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 0 00000 002345689999999999999999999999999998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=332.28 Aligned_cols=271 Identities=17% Similarity=0.217 Sum_probs=189.0
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
.++|...+.||+|+||.||+|.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 45789999999999999999998 678999999875533 234668899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCC-CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 131 FVACGTLADRIHDPNG-SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
|++ |+|.+++..... .....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 699988754221 11125889999999999999999999 9999999999999999999999999999998764
Q ss_pred CCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC--C
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN--S 286 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~ 286 (344)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ...+........... .
T Consensus 160 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 160 IPVNT---FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND----EEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp SCCCC---CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCSCCTTT
T ss_pred CCccc---CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCChhH
Confidence 32211 123468999999999876 4689999999999999999999999965422 112222221111100 0
Q ss_pred cccc-----cccccccC-CCCChh------hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 287 FKEI-----VDPIIVGE-EGLWPE------KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 287 ~~~~-----~~~~~~~~-~~~~~~------~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+... ..+..... ...... ....+..+.+|+.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000 00000000 000000 0022356899999999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=337.85 Aligned_cols=212 Identities=20% Similarity=0.252 Sum_probs=183.1
Q ss_pred CCccccccHHHHHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCC-----CCc
Q 048160 39 YNPIQNFTAQELKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-----HKN 111 (344)
Q Consensus 39 ~~~~~~~~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-----H~n 111 (344)
...+..++..+.....++|...+.||+|+||+||+|+. +++.||||++... ....+.+.+|+.+++.++ |||
T Consensus 19 ~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 19 DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp -CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred CccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCC
Confidence 34556667777677778999999999999999999999 7788999998643 233456778999999996 999
Q ss_pred eeeeeeEEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe
Q 048160 112 ILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF 191 (344)
Q Consensus 112 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 191 (344)
|+++++++...+..++||||+ +++|.+++..... ..+++.++..++.|++.||.||| +.+|+||||||+|||+
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll 170 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILL 170 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred eecccceeeECCeeEEEEcCC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEE
Confidence 999999999999999999999 8999999976542 25889999999999999999999 9999999999999999
Q ss_pred ec-------------------------CCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHH
Q 048160 192 QE-------------------------QNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYS 246 (344)
Q Consensus 192 ~~-------------------------~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~s 246 (344)
+. ++.+||+|||++....... ....||+.|+|||++.+..++.++||||
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~Diws 244 (360)
T 3llt_A 171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH------GSIINTRQYRAPEVILNLGWDVSSDMWS 244 (360)
T ss_dssp SCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC------CSCCSCGGGCCHHHHTTCCCCTTHHHHH
T ss_pred ccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC------cCccCcccccCcHHHcCCCCCCccchHH
Confidence 75 7899999999997654322 2457899999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCC
Q 048160 247 FGALLLELLTGKRISYSS 264 (344)
Q Consensus 247 lG~il~el~~g~~p~~~~ 264 (344)
|||++|+|++|..||...
T Consensus 245 lG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 245 FGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp HHHHHHHHHHSSCSCCCS
T ss_pred HHHHHHHHHHCCCCCCCC
Confidence 999999999999999754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=345.31 Aligned_cols=261 Identities=17% Similarity=0.190 Sum_probs=205.8
Q ss_pred cHHHHHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEe
Q 048160 46 TAQELKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCL 120 (344)
Q Consensus 46 ~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~ 120 (344)
...++....++|...+.||+|+||.||+|+. +++.||+|++.+.. ....+.+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3455555678899999999999999999999 68899999986532 122345778999999999999999999999
Q ss_pred eCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEe
Q 048160 121 ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFF 200 (344)
Q Consensus 121 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 200 (344)
+.+..|+||||+++|+|.+++...+ ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEe
Confidence 9999999999999999999997543 25889999999999999999999 9999999999999999999999999
Q ss_pred eeecccccCCCCcccccCCccccccccccccccC-------cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhH
Q 048160 201 DFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMS-------TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYF 273 (344)
Q Consensus 201 dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 273 (344)
|||+++......... .....||+.|+|||++. ...++.++|||||||++|||++|..||..... ...
T Consensus 205 DFGla~~~~~~~~~~--~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~ 278 (412)
T 2vd5_A 205 DFGSCLKLRADGTVR--SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST----AET 278 (412)
T ss_dssp CCTTCEECCTTSCEE--CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHH
T ss_pred echhheeccCCCccc--cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH----HHH
Confidence 999998765433221 12457999999999986 35689999999999999999999999975321 111
Q ss_pred HHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCC---CCHHHHHH
Q 048160 274 LQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDR---PTMVQVAK 335 (344)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~ei~~ 335 (344)
........ ....... .....+.++.+|+.+||. +|++| |++.+|++
T Consensus 279 ~~~i~~~~-~~~~~p~--------------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 279 YGKIVHYK-EHLSLPL--------------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHHTHH-HHCCCC------------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHHhcc-cCcCCCc--------------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 11111100 0000000 001234568999999999 99998 58888864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=349.47 Aligned_cols=247 Identities=18% Similarity=0.218 Sum_probs=193.5
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCC---CCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGN---LNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
.++|...+.||+|+||.||+|+. +++.||+|++... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 35688899999999999999998 6789999998653 222345577899999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCC-CCeeeecccccceEeecCCcceEeeeecccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFS-RPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
|||+++|+|.+++.... .+++..+..++.|++.||.||| + .+|+||||||+|||++.++.+||+|||+++.
T Consensus 227 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp ECCCSSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EeeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 99999999999987543 5899999999999999999999 8 8999999999999999999999999999976
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
....... .....||+.|+|||++.+..++.++|||||||++|||++|..||..... . .+...+. .. .
T Consensus 299 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~-~~~~~i~---~~-~- 365 (446)
T 4ejn_A 299 GIKDGAT---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----E-KLFELIL---ME-E- 365 (446)
T ss_dssp TCC--------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----H-HHHHHHH---HC-C-
T ss_pred ccCCCcc---cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----H-HHHHHHH---hC-C-
Confidence 4332221 2246799999999999999999999999999999999999999965321 1 1111111 00 0
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-----TMVQVAK 335 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ei~~ 335 (344)
...|. ..+..+.+|+.+||+.||++|| |+.++++
T Consensus 366 ------------~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 366 ------------IRFPR--TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ------------CCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------------CCCCc--cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 00111 2345688999999999999999 9999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=332.61 Aligned_cols=259 Identities=20% Similarity=0.272 Sum_probs=202.7
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCcc--EEEEEecCCC-CchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRP--ISVMKFGGNL-NSEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~--vavk~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv 128 (344)
++|...+.||+|+||.||+|+. ++.. ||+|.+.... ....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 4588889999999999999998 5554 4999887542 23346688999999999 899999999999999999999
Q ss_pred EeecCCCCccccccCCCC-----------CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcc
Q 048160 129 FEFVACGTLADRIHDPNG-----------SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA 197 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 197 (344)
|||+++|+|.+++..... .....+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence 999999999999976430 11135889999999999999999999 9999999999999999999999
Q ss_pred eEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHH
Q 048160 198 KFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQE 276 (344)
Q Consensus 198 kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~ 276 (344)
||+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||..... .+
T Consensus 182 kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~ 249 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AE 249 (327)
T ss_dssp EECCTTCEESSCEEC----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HH
T ss_pred EEcccCcCccccccc----cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--------HH
Confidence 999999987432211 1113456788999999988889999999999999999998 9999864321 11
Q ss_pred HHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 277 LVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
...... ... ....+ ...+..+.+|+.+||+.||++|||+.++++.|.++.+.
T Consensus 250 ~~~~~~-~~~------------~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 250 LYEKLP-QGY------------RLEKP--LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp HHHHGG-GTC------------CCCCC--TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHhh-cCC------------CCCCC--CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111111 110 00001 13345689999999999999999999999999998764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=335.60 Aligned_cols=275 Identities=17% Similarity=0.275 Sum_probs=215.6
Q ss_pred CccccccHHHHHHHhcCCCCCCccccCCCceEEEEEEC-------CccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCc
Q 048160 40 NPIQNFTAQELKAATNNYDPEKVITKDLLYKLYKGFLQ-------DRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKN 111 (344)
Q Consensus 40 ~~~~~~~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~~-------~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~n 111 (344)
.....+..+++....++|...+.||+|+||.||+|.+. +..||+|.+...... ....+.+|+.++++++|||
T Consensus 10 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 89 (322)
T 1p4o_A 10 SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89 (322)
T ss_dssp BCCSCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTT
T ss_pred ccccccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCC
Confidence 34455666777777888999999999999999999873 467999998765432 3356889999999999999
Q ss_pred eeeeeeEEeeCCccEEEEeecCCCCccccccCCCC-----CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccc
Q 048160 112 ILKFVGCCLETELPILVFEFVACGTLADRIHDPNG-----SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKP 186 (344)
Q Consensus 112 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~ 186 (344)
|+++++++.+++..++||||+++|+|.+++..... ....++++..++.++.|++.||.||| +.+|+||||||
T Consensus 90 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp 166 (322)
T 1p4o_A 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAA 166 (322)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSG
T ss_pred EeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCcc
Confidence 99999999999999999999999999999864210 01124688999999999999999999 99999999999
Q ss_pred cceEeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCC
Q 048160 187 STILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSC 265 (344)
Q Consensus 187 ~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~ 265 (344)
+||+++.++.+||+|||++.......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 167 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 245 (322)
T 1p4o_A 167 RNCMVAEDFTVKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245 (322)
T ss_dssp GGEEECTTCCEEECCTTCCCGGGGGGCEE-GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred ceEEEcCCCeEEECcCccccccccccccc-cccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence 99999999999999999987654322111 1123456889999999988899999999999999999999 777775431
Q ss_pred ccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 048160 266 FENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLH 341 (344)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~ 341 (344)
. ..... ... ...... .+ ...+..+.+|+.+||+.||++|||+.++++.|+++.
T Consensus 246 ~-----~~~~~---~~~-~~~~~~------------~~--~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 246 N-----EQVLR---FVM-EGGLLD------------KP--DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp H-----HHHHH---HHH-TTCCCC------------CC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred H-----HHHHH---HHH-cCCcCC------------CC--CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 1 11111 111 111100 00 133456899999999999999999999999998764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=336.11 Aligned_cols=247 Identities=19% Similarity=0.254 Sum_probs=199.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccE
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPI 126 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~ 126 (344)
..++|...+.||+|+||.||+|+. +++.||+|.+.... ....+.+.+|..++..+ +||||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 346799999999999999999999 46789999987542 22345677899999988 7999999999999999999
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
+||||+++|+|.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 98 lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 9999999999999997643 5899999999999999999999 9999999999999999999999999999997
Q ss_pred ccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
....... ......||+.|+|||++.+..++.++||||||+++|||++|..||..... ......... . .
T Consensus 170 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----~~~~~~i~~----~-~ 237 (353)
T 2i0e_A 170 ENIWDGV---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIME----H-N 237 (353)
T ss_dssp CCCCTTC---CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHH----C-C
T ss_pred ccccCCc---ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH----HHHHHHHHh----C-C
Confidence 6432221 12246799999999999999999999999999999999999999975321 111111111 0 0
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHH
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT-----MVQVA 334 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ei~ 334 (344)
...|. ..+.++.+|+.+||+.||++||+ +.+|+
T Consensus 238 -------------~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~ 275 (353)
T 2i0e_A 238 -------------VAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 275 (353)
T ss_dssp -------------CCCCT--TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHH
T ss_pred -------------CCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 00111 33456899999999999999996 46654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=334.28 Aligned_cols=266 Identities=20% Similarity=0.168 Sum_probs=203.3
Q ss_pred HHHHHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCC-----CCchhhhHhhHHHHHhcCCCCceeeeeeEE
Q 048160 47 AQELKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGN-----LNSEEYCCFNCIAFASQMSHKNILKFVGCC 119 (344)
Q Consensus 47 ~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~~~~~~ 119 (344)
..++....++|...+.||+|+||.||+|.. ++..||+|.+... .....+.+.+|+.++++++||||+++++++
T Consensus 18 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 97 (345)
T 3hko_A 18 GGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY 97 (345)
T ss_dssp CBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh
Confidence 345666778899999999999999999998 6778999998643 233456788999999999999999999999
Q ss_pred eeCCccEEEEeecCCCCccccccCCCC-----------------------------------CCCccccHHHHHHHHHHH
Q 048160 120 LETELPILVFEFVACGTLADRIHDPNG-----------------------------------SQLEPFLMKHRLKVAMEI 164 (344)
Q Consensus 120 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------------------------------~~~~~l~~~~~~~i~~~i 164 (344)
.+.+..++||||+++|+|.+++..... .....+++..+..++.|+
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 999999999999999999998852100 001235677888999999
Q ss_pred HHHHHHhhcCCCCCeeeecccccceEeecCC--cceEeeeecccccCCCCcc-cccCCccccccccccccccCc--CCCC
Q 048160 165 ANAVAYLHVGFSRPIVFRDIKPSTILFQEQN--VAKFFDFCVSISIPEGKTH-VNDNNKVIGTFGFIAPEYMST--ANCN 239 (344)
Q Consensus 165 ~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~--~~kl~dfg~a~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~--~~~~ 239 (344)
+.||.||| +.+|+||||||+||+++.++ .+||+|||++......... ........||+.|+|||++.+ ..++
T Consensus 178 ~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 254 (345)
T 3hko_A 178 FSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG 254 (345)
T ss_dssp HHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCC
T ss_pred HHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCC
Confidence 99999999 99999999999999998776 8999999999865432211 111224578999999999865 6789
Q ss_pred cccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHc
Q 048160 240 EKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKC 319 (344)
Q Consensus 240 ~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 319 (344)
.++||||||+++|+|++|..||..... ........ .... ....+.....+..+.+|+.+|
T Consensus 255 ~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~~~----~~~~------------~~~~~~~~~~~~~~~~li~~~ 314 (345)
T 3hko_A 255 PKCDAWSAGVLLHLLLMGAVPFPGVND----ADTISQVL----NKKL------------CFENPNYNVLSPLARDLLSNL 314 (345)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH----HCCC------------CTTSGGGGGSCHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCCh----HHHHHHHH----hccc------------ccCCcccccCCHHHHHHHHHH
Confidence 999999999999999999999965421 11111111 1100 001111113455689999999
Q ss_pred cccCCCCCCCHHHHHH
Q 048160 320 LSKSEQDRPTMVQVAK 335 (344)
Q Consensus 320 l~~dP~~RPs~~ei~~ 335 (344)
|+.||++|||+.++++
T Consensus 315 l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 315 LNRNVDERFDAMRALQ 330 (345)
T ss_dssp SCSCTTTSCCHHHHHH
T ss_pred cCCChhHCCCHHHHhc
Confidence 9999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=338.36 Aligned_cols=244 Identities=23% Similarity=0.333 Sum_probs=197.0
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc---hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS---EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
+.|...+.||+|+||.||+|+. +++.||||++...... ..+.+.+|+.++++++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4488889999999999999997 7889999998755322 2356789999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+. |+|.+++.... .++++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 134 e~~~-g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp ECCS-EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred ecCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 9997 68888775433 36899999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCcccccCCccccccccccccccC---cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMS---TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
.. ....||+.|+|||++. ...++.++||||||+++|||++|..||..... ...+... ....
T Consensus 206 ~~-------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~----~~~~~~~----~~~~- 269 (348)
T 1u5q_A 206 PA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHI----AQNE- 269 (348)
T ss_dssp SB-------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHH----HHSC-
T ss_pred CC-------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHH----HhcC-
Confidence 22 1457899999999984 56789999999999999999999999865321 1111111 1111
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... ... ..+..+.+|+..||+.||++|||+.++++
T Consensus 270 ~~~~-------~~~------~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 270 SPAL-------QSG------HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp CCCC-------CCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCC-------CCC------CCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 0000 001 23345889999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=333.83 Aligned_cols=267 Identities=19% Similarity=0.282 Sum_probs=209.4
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEEC--C-----ccEEEEEecCCCCc-hhhhHhhHHHHHhcC-CCCceeeeeeEEe
Q 048160 50 LKAATNNYDPEKVITKDLLYKLYKGFLQ--D-----RPISVMKFGGNLNS-EEYCCFNCIAFASQM-SHKNILKFVGCCL 120 (344)
Q Consensus 50 i~~~~~~~~~~~~ig~G~~g~V~~~~~~--~-----~~vavk~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~~~~~~~ 120 (344)
+....++|...+.||+|+||.||+|.+. + ..||+|.+...... ..+.+.+|+.+++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 4444577888999999999999999982 2 36999998766432 346688999999999 8999999999999
Q ss_pred eCCccEEEEeecCCCCccccccCCCCC---------CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe
Q 048160 121 ETELPILVFEFVACGTLADRIHDPNGS---------QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF 191 (344)
Q Consensus 121 ~~~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 191 (344)
.++..++||||+++|+|.+++...... ....+++..++.++.|++.||.||| +.+|+||||||+||++
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEE
Confidence 999999999999999999988642100 0025789999999999999999999 9999999999999999
Q ss_pred ecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcc
Q 048160 192 QEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGE 270 (344)
Q Consensus 192 ~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~ 270 (344)
+.++.++|+|||++.......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---- 272 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYI-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV---- 272 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSE-ECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS----
T ss_pred CCCCeEEECcccccccccccccee-ecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch----
Confidence 999999999999998654332211 1123457889999999988899999999999999999998 8888754321
Q ss_pred hhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 271 EYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.............. ..+ ...+..+.+|+..||+.||.+|||+.+|++.|+.+..
T Consensus 273 ~~~~~~~~~~~~~~----------------~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 273 NSKFYKLVKDGYQM----------------AQP--AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp SHHHHHHHHHTCCC----------------CCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHhcCCCC----------------CCC--CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 11111221111100 000 0224568999999999999999999999999998765
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=331.85 Aligned_cols=259 Identities=15% Similarity=0.228 Sum_probs=198.3
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch---hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE---EYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
..++|...+.||+|+||.||+|.. +++.||+|.+....... .+.+.+|+.++++++||||+++++++..++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 347899999999999999999998 67889999987553222 3567899999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
||||+++++|.+++.... ++++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++..
T Consensus 112 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EEECCCCEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred EEEecCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 999999999999997643 5889999999999999999999 99999999999999999999999999999876
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
........ .....|++.|+|||++.+..++.++||||||+++|+|++|..||..... ......+.. ....
T Consensus 184 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~---~~~~ 253 (309)
T 2h34_A 184 TTDEKLTQ--LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-----SVMGAHINQ---AIPR 253 (309)
T ss_dssp ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-----HHHHHHHHS---CCCC
T ss_pred cccccccc--ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-----HHHHHHhcc---CCCC
Confidence 64432211 1245689999999999998999999999999999999999999864321 111111110 0000
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHh
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-TMVQVAKQLRQLHK 342 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~ei~~~L~~l~~ 342 (344)
... .. ...+..+.+++.+||+.||++|| |+.++++.|+++..
T Consensus 254 ~~~-------~~------~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 254 PST-------VR------PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp GGG-------TS------TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred ccc-------cC------CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 000 00 12334588999999999999999 99999999987653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=331.79 Aligned_cols=247 Identities=19% Similarity=0.254 Sum_probs=191.9
Q ss_pred hcCCCCCCccccCCCceEEEEEE-----CCccEEEEEecCCC----CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL-----QDRPISVMKFGGNL----NSEEYCCFNCIAFASQMSHKNILKFVGCCLETEL 124 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~-----~~~~vavk~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~ 124 (344)
.++|...+.||+|+||.||+++. .++.||+|++.... ......+.+|+.++++++||||+++++++..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35688999999999999999997 56789999987652 1233557789999999999999999999999999
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeec
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV 204 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~ 204 (344)
.++||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEeCCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 999999999999999997543 5889999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc
Q 048160 205 SISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES 284 (344)
Q Consensus 205 a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (344)
++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... ......... .
T Consensus 168 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~----~ 236 (327)
T 3a62_A 168 CKESIHDGTV---THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR----KKTIDKILK----C 236 (327)
T ss_dssp C-------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHH----T
T ss_pred ccccccCCcc---ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHh----C
Confidence 8764332211 1245789999999999998999999999999999999999999965321 111111111 0
Q ss_pred CCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048160 285 NSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-----TMVQVAK 335 (344)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ei~~ 335 (344)
. ...|. ..+..+.+|+.+||+.||++|| ++.++++
T Consensus 237 -~-------------~~~p~--~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 237 -K-------------LNLPP--YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -C-------------CCCCT--TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -C-------------CCCCC--CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0 00011 2345688999999999999999 6777764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=338.67 Aligned_cols=250 Identities=19% Similarity=0.260 Sum_probs=189.9
Q ss_pred cCCCCC-CccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhc-CCCCceeeeeeEEee----CCccE
Q 048160 55 NNYDPE-KVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQ-MSHKNILKFVGCCLE----TELPI 126 (344)
Q Consensus 55 ~~~~~~-~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~~~~~~~~----~~~~~ 126 (344)
++|... +.||+|+||+||+|.. +++.||||++... ..+.+|+.++.+ .+||||+++++++.. ....|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 455554 6899999999999999 6788999998532 456788888744 589999999999875 56789
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec---CCcceEeeee
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE---QNVAKFFDFC 203 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~dfg 203 (344)
+|||||++|+|.+++..... ..+++.++..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||
T Consensus 136 lv~E~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeCCCCcHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 99999999999999976532 35899999999999999999999 999999999999999987 7899999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhc
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE 283 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (344)
+++........ ....||+.|+|||++.+..++.++|||||||++|+|++|..||..................
T Consensus 210 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~---- 281 (400)
T 1nxk_A 210 FAKETTSHNSL----TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM---- 281 (400)
T ss_dssp TCEECC---------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH----
T ss_pred cccccCCCCcc----ccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc----
Confidence 99866432221 2457899999999999999999999999999999999999999764322111111111110
Q ss_pred cCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 284 SNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... ... +.....+.++.+|+.+||+.||++|||+.+|++
T Consensus 282 -~~~~--------~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 282 -GQYE--------FPN---PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp -TCCC--------CCT---TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -Cccc--------CCC---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 000 011134456899999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=337.15 Aligned_cols=264 Identities=18% Similarity=0.167 Sum_probs=197.4
Q ss_pred cCCCCCCccccCCCceEEEEEE-----CCccEEEEEecCCCCch-----------hhhHhhHHHHHhcCCCCceeeeeeE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL-----QDRPISVMKFGGNLNSE-----------EYCCFNCIAFASQMSHKNILKFVGC 118 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~vavk~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~~~~~ 118 (344)
++|...+.||+|+||.||+|.+ .+..||+|++....... ...+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 5688899999999999999999 34679999987654321 2335678889999999999999999
Q ss_pred Eee----CCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC
Q 048160 119 CLE----TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ 194 (344)
Q Consensus 119 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 194 (344)
+.. ....++||||+ +++|.+++.... .+++.+++.++.|++.||.||| +.+|+||||||+||+++.+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccC
Confidence 988 67899999999 899999997653 6899999999999999999999 9999999999999999988
Q ss_pred C--cceEeeeecccccCCCCccc----ccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccC
Q 048160 195 N--VAKFFDFCVSISIPEGKTHV----NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFEN 268 (344)
Q Consensus 195 ~--~~kl~dfg~a~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 268 (344)
+ .+||+|||+++......... .......||+.|+|||++.+..++.++||||||+++|||++|..||.....
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-- 265 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK-- 265 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT--
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc--
Confidence 7 99999999998764322111 111245789999999999998999999999999999999999999954221
Q ss_pred cchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 269 GEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
.............. . ....+..... ....+..+.+++..||+.||++|||+.+|++.|+++
T Consensus 266 -~~~~~~~~~~~~~~-~-~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 266 -DPVAVQTAKTNLLD-E-LPQSVLKWAP--------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp -CHHHHHHHHHHHHH-T-TTHHHHHHSC--------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred -ccHHHHHHHHhhcc-c-ccHHHHhhcc--------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 11111111111110 0 0000000000 002334689999999999999999999999999865
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=322.86 Aligned_cols=250 Identities=20% Similarity=0.283 Sum_probs=202.5
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
.++|...+.||+|+||.||+|.. ++..||+|++..... ...+.+.+|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46799999999999999999998 578999999865532 23456789999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCc---ceEeeeeccc
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNV---AKFFDFCVSI 206 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~dfg~a~ 206 (344)
||+++++|.+.+.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++. ++|+|||++.
T Consensus 85 e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE-----FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp CCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred ecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 9999999988886543 5889999999999999999999 999999999999999986655 9999999997
Q ss_pred ccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
........ ....||+.|+|||++.+..++.++||||||+++|+|++|..||..... ......... ..
T Consensus 157 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~-----~~ 223 (284)
T 3kk8_A 157 EVNDSEAW----HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRLYAQIKA-----GA 223 (284)
T ss_dssp ECCSSCBC----CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHH-----TC
T ss_pred EcccCccc----cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch----hHHHHHHHh-----cc
Confidence 76543321 135789999999999999999999999999999999999999965321 111111111 00
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.. ...+.....+..+.+|+.+||+.||++|||+.++++
T Consensus 224 ~~-----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 224 YD-----------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CC-----------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cc-----------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 000111133456899999999999999999999976
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=339.83 Aligned_cols=252 Identities=21% Similarity=0.255 Sum_probs=192.6
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC--------CchhhhHhhHHHHHhcCCCCceeeeeeEEe
Q 048160 51 KAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL--------NSEEYCCFNCIAFASQMSHKNILKFVGCCL 120 (344)
Q Consensus 51 ~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~~~~~~~ 120 (344)
....++|...+.||+|+||+||+|.. +++.||+|++.... ......+.+|+.++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34567899999999999999999998 67899999986532 112235779999999999999999999975
Q ss_pred eCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC---cc
Q 048160 121 ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN---VA 197 (344)
Q Consensus 121 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~ 197 (344)
....++||||+++|+|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+|||++.++ .+
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~ 281 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLI 281 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSSSC-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCE
T ss_pred -cCceEEEEEcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceE
Confidence 456799999999999999987654 5899999999999999999999 99999999999999997544 59
Q ss_pred eEeeeecccccCCCCcccccCCccccccccccccccCc---CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHH
Q 048160 198 KFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST---ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFL 274 (344)
Q Consensus 198 kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 274 (344)
||+|||+++........ ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||........ +
T Consensus 282 kl~DFG~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~----~ 353 (419)
T 3i6u_A 282 KITDFGHSKILGETSLM----RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS----L 353 (419)
T ss_dssp EECCSSTTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC----H
T ss_pred EEeecccceecCCCccc----cccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH----H
Confidence 99999999876533221 24578999999999853 5688999999999999999999999965422111 1
Q ss_pred HHHHHHHhccCCcccccccccccCCCCChh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 275 QELVRKSIESNSFKEIVDPIIVGEEGLWPE-KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
...+. .+.....+. ....+..+.+|+.+||+.||++|||+.++++
T Consensus 354 ~~~i~----------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 354 KDQIT----------------SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHHH----------------TTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHh----------------cCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11111 011111111 1123567899999999999999999999886
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=322.57 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=203.5
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEee---------
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLE--------- 121 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--------- 121 (344)
..++|...+.||+|+||.||+|++ +++.||+|++.... +.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 345688899999999999999999 58899999987553 457789999999999999999998864
Q ss_pred -------CCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC
Q 048160 122 -------TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ 194 (344)
Q Consensus 122 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 194 (344)
....++||||+++++|.+++....+ ..+++..+..++.|++.||.||| +.+|+||||||+||+++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEET
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCC
Confidence 3457999999999999999965322 35889999999999999999999 9999999999999999999
Q ss_pred CcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHH
Q 048160 195 NVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFL 274 (344)
Q Consensus 195 ~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 274 (344)
+.++|+|||++......... ....|++.|+|||++.+..++.++||||||+++|+|++|..|+...
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------- 224 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGKR----TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------- 224 (284)
T ss_dssp TEEEECCCTTCEESSCCSCC----CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------
T ss_pred CCEEECcchhheeccccccc----cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------
Confidence 99999999998876543322 1346899999999999888999999999999999999999886421
Q ss_pred HHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 275 QELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
...... ....... . ..+..+.+++.+||+.||++|||+.++++.|..+.++
T Consensus 225 ~~~~~~-~~~~~~~-----------~------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 225 SKFFTD-LRDGIIS-----------D------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHHHH-HHTTCCC-----------T------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred HHHHHH-hhccccc-----------c------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 011111 1111110 0 1234578999999999999999999999999987653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=326.28 Aligned_cols=260 Identities=22% Similarity=0.310 Sum_probs=197.3
Q ss_pred cCCCC-CCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEEEe
Q 048160 55 NNYDP-EKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 55 ~~~~~-~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e 130 (344)
+.|.+ .+.||+|+||.||+|+. +++.||||++........+.+.+|+.++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 45666 47899999999999998 7889999999877655667788999999985 79999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCc---ceEeeeecccc
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNV---AKFFDFCVSIS 207 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~dfg~a~~ 207 (344)
|+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++. +||+|||++..
T Consensus 92 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR-----HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp CCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred cCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999997643 5889999999999999999999 999999999999999988775 99999999876
Q ss_pred cCCCCcc----cccCCccccccccccccccCc-----CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchh------
Q 048160 208 IPEGKTH----VNDNNKVIGTFGFIAPEYMST-----ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEY------ 272 (344)
Q Consensus 208 ~~~~~~~----~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~------ 272 (344)
....... ........||+.|+|||++.. ..++.++||||||+++|+|++|..||...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 5432211 011113458999999999865 4588999999999999999999999976432211000
Q ss_pred HHHHHHHHHhccCCcccccccccccCCCCChhh--HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 273 FLQELVRKSIESNSFKEIVDPIIVGEEGLWPEK--EKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
............. . ...|.. ...+..+.+|+.+||+.||++|||+.++++
T Consensus 244 ~~~~~~~~~i~~~------------~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFESIQEG------------K-YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHC------------C-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHhcc------------C-cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0000011111111 0 011110 123456899999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=337.93 Aligned_cols=248 Identities=22% Similarity=0.248 Sum_probs=192.4
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHH-HhcCCCCceeeeeeEEeeCCccEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAF-ASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~-l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
.++|...+.||+|+||.||+|+. ++..||+|++..... .....+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 35689999999999999999999 567899999875532 223445667666 577899999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 117 v~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 999999999999987643 5889999999999999999999 99999999999999999999999999999986
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
...... ......||+.|+|||++.+..++.++|||||||++|||++|..||..... .......... ..
T Consensus 189 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----~~~~~~i~~~-----~~ 256 (373)
T 2r5t_A 189 NIEHNS---TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT----AEMYDNILNK-----PL 256 (373)
T ss_dssp GBCCCC---CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH----HHHHHHHHHS-----CC
T ss_pred cccCCC---ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHhc-----cc
Confidence 433221 12256799999999999999999999999999999999999999975321 1111111110 00
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
..+. ..+..+.+|+.+||+.||++||++.+.++.
T Consensus 257 -------------~~~~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ 290 (373)
T 2r5t_A 257 -------------QLKP--NITNSARHLLEGLLQKDRTKRLGAKDDFME 290 (373)
T ss_dssp -------------CCCS--SSCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred -------------CCCC--CCCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence 0010 233458899999999999999998644333
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=319.21 Aligned_cols=252 Identities=21% Similarity=0.256 Sum_probs=202.9
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC-CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL-NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
.++|...+.||+|+||.||+|.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 46688899999999999999998 67899999986543 2334678899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|+++++|.+++.... .+++.++..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++.....
T Consensus 86 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 86 YCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp CCTTEEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred ecCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 999999999997643 5899999999999999999999 99999999999999999999999999999876543
Q ss_pred CCcccccCCccccccccccccccCcCCC-CcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANC-NEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
.... .......|++.|+|||++.+..+ +.++||||||+++|+|++|..||....... .....+.. ...
T Consensus 158 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~----~~~--- 226 (276)
T 2yex_A 158 NNRE-RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSDWKE----KKT--- 226 (276)
T ss_dssp TTEE-CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS---HHHHHHHT----TCT---
T ss_pred Ccch-hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHhhh----ccc---
Confidence 2211 11224568999999999987765 788999999999999999999997543211 11111111 000
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+.....+..+.+|+.+||+.||++|||+.+|++
T Consensus 227 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 -----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00011133456889999999999999999999875
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=324.94 Aligned_cols=268 Identities=18% Similarity=0.225 Sum_probs=199.8
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-----chhhhHhhHHHHHhcCC---CCceeeeeeEEeeC
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-----SEEYCCFNCIAFASQMS---HKNILKFVGCCLET 122 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-----~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~ 122 (344)
..++|+..+.||+|+||+||+|+. +++.||+|++..... .....+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 356899999999999999999997 778999999864321 12345668888877775 99999999999876
Q ss_pred C-----ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcc
Q 048160 123 E-----LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA 197 (344)
Q Consensus 123 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 197 (344)
. ..++||||+. ++|.+++..... ..+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCE
Confidence 5 4799999997 699999976543 24899999999999999999999 9999999999999999999999
Q ss_pred eEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHH
Q 048160 198 KFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL 277 (344)
Q Consensus 198 kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 277 (344)
||+|||++......... ....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...+...
T Consensus 160 kl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~i 231 (308)
T 3g33_A 160 KLADFGLARIYSYQMAL----TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE----ADQLGKI 231 (308)
T ss_dssp EECSCSCTTTSTTCCCS----GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH----HHHHHHH
T ss_pred EEeeCccccccCCCccc----CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Confidence 99999999866433222 245789999999999999999999999999999999999999965422 2222222
Q ss_pred HHHHhcc--CCcccccc--cccccCCCCChh---hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 278 VRKSIES--NSFKEIVD--PIIVGEEGLWPE---KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 278 ~~~~~~~--~~~~~~~~--~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
....... ..+..... ..........+. .+..+..+.+|+.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 2211111 00100000 000000000000 0123456899999999999999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=325.61 Aligned_cols=251 Identities=20% Similarity=0.227 Sum_probs=194.0
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
+.|...+.||+|+||.||+++. ++..||+|++..... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 4588899999999999999998 678899999876532 3456788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe---ecCCcceEeeeeccccc
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF---QEQNVAKFFDFCVSISI 208 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~dfg~a~~~ 208 (344)
+++|+|.+++...... ...+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.++|+|||++...
T Consensus 102 ~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 102 CEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred CCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999988532100 025889999999999999999999 9999999999999999 45678999999999765
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
...... ....||+.|+|||++. ..++.++||||||+++|+|++|..||..... ........ .......
T Consensus 178 ~~~~~~----~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~-----~~~~~~~~--~~~~~~~ 245 (285)
T 3is5_A 178 KSDEHS----TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-----EEVQQKAT--YKEPNYA 245 (285)
T ss_dssp -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHH--HCCCCCC
T ss_pred CCcccC----cCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH-----HHHHhhhc--cCCcccc
Confidence 443221 2456899999999985 5689999999999999999999999865321 11111110 0000000
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. ... ..+..+.+|+.+||+.||++|||+.+|++
T Consensus 246 ~--------~~~------~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 246 V--------ECR------PLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp C----------C------CCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred c--------ccC------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000 12345789999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=322.91 Aligned_cols=248 Identities=19% Similarity=0.306 Sum_probs=182.2
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
.++|...+.||+|+||.||+|+. +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35688899999999999999998 788999999864421 1235678999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||+++++|.+++.... .++++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EECCTTEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 99999999999997654 36899999999999999999999 999999999999999999999999999998876
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
...... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.......
T Consensus 163 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------------------- 219 (278)
T 3cok_A 163 KMPHEK---HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-------------------- 219 (278)
T ss_dssp C-------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------
T ss_pred cCCCCc---ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH--------------------
Confidence 533221 113568999999999988889999999999999999999999986532210
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.......... ..|. ..+.++.+|+.+||+.||++|||+.++++
T Consensus 220 -~~~~~~~~~~-~~~~--~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 220 -TLNKVVLADY-EMPS--FLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -----CCSSCC-CCCT--TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -HHHHHhhccc-CCcc--ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0000000000 0111 23456889999999999999999999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=321.95 Aligned_cols=245 Identities=21% Similarity=0.330 Sum_probs=197.6
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
.++|...+.||+|+||.||+|.. ++..||+|.+..... .....+.+|+.++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 45688899999999999999998 566899999854321 1235578999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++...
T Consensus 88 ~e~~~~~~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp ECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 99999999999987543 5889999999999999999999 999999999999999999999999999998654
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
..... ....|++.|+|||++.+..++.++||||||+++|+|++|..||..... ......+.. ..
T Consensus 160 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~----~~-- 223 (279)
T 3fdn_A 160 PSSRR-----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYKRISR----VE-- 223 (279)
T ss_dssp -------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHH----TC--
T ss_pred Ccccc-----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-----HHHHHHHHh----CC--
Confidence 43221 135689999999999998999999999999999999999999864321 111111111 00
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
...|. ..+..+.+|+.+||+.||++|||+.+|++
T Consensus 224 -----------~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 224 -----------FTFPD--FVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp -----------CCCCT--TSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -----------CCCCC--cCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00010 23346889999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=338.45 Aligned_cols=262 Identities=19% Similarity=0.266 Sum_probs=202.6
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
++|...+.||+|+||.||+|.+ ++..||+|++...... ..+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 4688899999999999999999 5788999998766433 346688999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCC-CeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSR-PIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
+++++|.+++.... .+++..+..++.+++.||.||| +. +|+||||||+||+++.++.++|+|||++.....
T Consensus 113 ~~~~~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 113 MDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999997643 5889999999999999999999 75 899999999999999999999999999865432
Q ss_pred CCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHH-----------
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR----------- 279 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----------- 279 (344)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||....... ......
T Consensus 185 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~ 254 (360)
T 3eqc_A 185 S-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE-----LELMFGCQVEGDAAETP 254 (360)
T ss_dssp H-----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH-----HHHHHC-----------
T ss_pred c-----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHhcccccccCCCCC
Confidence 1 1124578999999999999999999999999999999999999997532110 000000
Q ss_pred ---------------HHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 280 ---------------KSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 280 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
............+.......+..+. ...+..+.+|+.+||+.||++|||+.++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPS-GVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -------------------CCCHHHHHHHHHHSCCCCCCT-TTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCc-ccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000011111111111111111 123456899999999999999999999976
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=329.41 Aligned_cols=251 Identities=18% Similarity=0.238 Sum_probs=197.1
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
.+.|++.+.||+|+||.||+|++ ++..||+|.+........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 46688899999999999999999 5788999998877666677889999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+++++|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 98 ~~~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 98 CPGGAVDAIMLELD----RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred CCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999886533 25889999999999999999999 999999999999999999999999999987543211
Q ss_pred CcccccCCcccccccccccccc-----CcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYM-----STANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
. .......|++.|+|||++ ....++.++||||||+++|+|++|..||..... ........ ...
T Consensus 171 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~----~~~- 238 (302)
T 2j7t_A 171 L---QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP----MRVLLKIA----KSD- 238 (302)
T ss_dssp H---HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHH----HSC-
T ss_pred c---cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH----HHHHHHHh----ccC-
Confidence 1 111235689999999988 456789999999999999999999999865321 11111111 110
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+........+..+.+|+.+||+.||++|||+.+|++
T Consensus 239 ------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 239 ------------PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ------------CCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ------------CcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0001111134456899999999999999999999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=350.13 Aligned_cols=252 Identities=20% Similarity=0.283 Sum_probs=204.5
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
.++|...+.||+|+||.||+|+. +++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 45688899999999999999999 68899999986532 12335577999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||++||+|.+++...+. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 263 mEy~~gg~L~~~l~~~~~---~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ---AGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999999876432 24899999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
....... ...||+.|+|||++.+..++.++|||||||++|||++|..||........ ...+...+...
T Consensus 337 ~~~~~~~----~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-~~~i~~~i~~~------- 404 (576)
T 2acx_A 337 PEGQTIK----GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERLVKEV------- 404 (576)
T ss_dssp CTTCCEE----CCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-HHHHHHHHHHC-------
T ss_pred ccCcccc----ccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-HHHHHHHhhcc-------
Confidence 5433221 35789999999999998999999999999999999999999976432111 11111111110
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-----TMVQVAK 335 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ei~~ 335 (344)
...++. ..+.++.+|+.+||+.||++|| ++.+|++
T Consensus 405 ----------~~~~p~--~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 ----------PEEYSE--RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ----------CCCCCT--TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ----------cccCCc--cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 000111 2345689999999999999999 7788764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=327.71 Aligned_cols=258 Identities=19% Similarity=0.330 Sum_probs=196.5
Q ss_pred cCCCCCCccccCCCceEEEEEE---CCc--cEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL---QDR--PISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPI 126 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~---~~~--~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~ 126 (344)
++|...+.||+|+||.||+|++ ++. .||+|.+.... ....+.+.+|+.++++++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 5688899999999999999997 222 58999887542 233467889999999999999999999988665 88
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
+|+||+++++|.+++.... ..+++.++..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++.
T Consensus 97 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccc
Confidence 9999999999999987543 35889999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
................++..|+|||++.+..++.++||||||+++|+|++ |..||..... . ..........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~----~~~~~~~~~~ 241 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG----S----QILHKIDKEG 241 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH----H----HHHHHHHTSC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH----H----HHHHHHHccC
Confidence 77654433222234467888999999988889999999999999999999 8988864321 1 1111111111
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
. ..+.....+..+.+++.+||+.||++|||+.++++.|.++..
T Consensus 242 ~--------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 242 E--------------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp C--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred C--------------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 0 001111344568999999999999999999999999998754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=341.21 Aligned_cols=247 Identities=12% Similarity=0.063 Sum_probs=188.6
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCC---CCchhhhHhhHH---HHHhcCCCCceeeee-------eEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGN---LNSEEYCCFNCI---AFASQMSHKNILKFV-------GCC 119 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~---~~~~~~~~~~E~---~~l~~l~H~niv~~~-------~~~ 119 (344)
++|...+.||+|+||.||+|++ +++.||||++... .....+.+.+|+ ..+++++|||||+++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 5577789999999999999997 6889999998743 223456788999 556666899999998 555
Q ss_pred eeCC-----------------ccEEEEeecCCCCccccccCCCC--CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCee
Q 048160 120 LETE-----------------LPILVFEFVACGTLADRIHDPNG--SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIV 180 (344)
Q Consensus 120 ~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 180 (344)
...+ ..++||||+ +|+|.+++..... .....+++..+..++.|++.||.||| +.+|+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iv 228 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV 228 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 5443 278999999 6899999875321 00124556888899999999999999 99999
Q ss_pred eecccccceEeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcC-----------CCCcccchHHHHH
Q 048160 181 FRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA-----------NCNEKSDVYSFGA 249 (344)
Q Consensus 181 H~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~Di~slG~ 249 (344)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++.+. .++.++||||||+
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR------VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTCE------EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCCc------ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999864321 113467 999999999877 8999999999999
Q ss_pred HHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCC
Q 048160 250 LLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT 329 (344)
Q Consensus 250 il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 329 (344)
++|||++|..||...... .......... . ..+..+.+|+.+||+.||++|||
T Consensus 302 il~elltg~~Pf~~~~~~---------------------~~~~~~~~~~-~------~~~~~~~~li~~~L~~dp~~Rpt 353 (377)
T 3byv_A 302 VIYWIWCADLPITKDAAL---------------------GGSEWIFRSC-K------NIPQPVRALLEGFLRYPKEDRLL 353 (377)
T ss_dssp HHHHHHHSSCCC---------------------------CCSGGGGSSC-C------CCCHHHHHHHHHHTCSSGGGCCC
T ss_pred HHHHHHHCCCCCcccccc---------------------cchhhhhhhc-c------CCCHHHHHHHHHHcCCCchhCCC
Confidence 999999999998643210 0111111100 1 22346889999999999999999
Q ss_pred HHHHHH--HHHHH
Q 048160 330 MVQVAK--QLRQL 340 (344)
Q Consensus 330 ~~ei~~--~L~~l 340 (344)
+.++++ .+..+
T Consensus 354 ~~e~l~hp~f~~~ 366 (377)
T 3byv_A 354 PLQAMETPEYEQL 366 (377)
T ss_dssp HHHHHTSHHHHHH
T ss_pred HHHHhhChHHHHH
Confidence 999985 44443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=334.33 Aligned_cols=251 Identities=22% Similarity=0.272 Sum_probs=198.5
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEEE
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~ 129 (344)
..++|...+.||+|+||.||+|.. +++.||+|.+..... ...+|+.++.++ +||||+++++++.++...|+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 346699999999999999999999 678999999876532 345688888888 7999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC----CcceEeeeecc
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ----NVAKFFDFCVS 205 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~dfg~a 205 (344)
||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||+..+ +.+||+|||++
T Consensus 96 E~~~gg~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK-----FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp CCCCSCBHHHHHHTCT-----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred eCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 9999999999987653 5899999999999999999999 9999999999999998433 35999999999
Q ss_pred cccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... .....+...+. ..
T Consensus 168 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~~~~i~----~~ 238 (342)
T 2qr7_A 168 KQLRAENGL---LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD--DTPEEILARIG----SG 238 (342)
T ss_dssp EECBCTTCC---BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT--SCHHHHHHHHH----HC
T ss_pred ccCcCCCCc---eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc--CCHHHHHHHHc----cC
Confidence 876543221 1245789999999999888899999999999999999999999975322 11111111111 11
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... ....| ...+..+.+|+.+||+.||++|||+.++++
T Consensus 239 ~~~~--------~~~~~---~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 239 KFSL--------SGGYW---NSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CCCC--------CSTTT---TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred Cccc--------Ccccc---ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1100 00011 123456889999999999999999999875
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=329.45 Aligned_cols=266 Identities=17% Similarity=0.248 Sum_probs=195.1
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch-hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE-EYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
++|...+.||+|+||+||+|+. +++.||+|++....... ...+.+|+.++++++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 4688889999999999999999 67889999987554322 23566899999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
++ |+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp CS-EEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred cc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 97 68999887654 35889999999999999999999 999999999999999999999999999999765433
Q ss_pred CcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc--CCcc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES--NSFK 288 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 288 (344)
... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ...+.........+ ..+.
T Consensus 154 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~ 226 (324)
T 3mtl_A 154 TKT---YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV----EEQLHFIFRILGTPTEETWP 226 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCTTTST
T ss_pred ccc---cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCChHhch
Confidence 221 113467999999999876 5689999999999999999999999965421 11122222111110 0111
Q ss_pred ccccccc------cc--CCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 EIVDPII------VG--EEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~~~~~~~------~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
....... .. .....+..+..+.++.+|+.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp TGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 1100000 00 00000001123456899999999999999999999976
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=334.70 Aligned_cols=265 Identities=15% Similarity=0.188 Sum_probs=206.1
Q ss_pred hcCCCCCCccccCCCceEEEEEEC----------CccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceee---------
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQ----------DRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILK--------- 114 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~----------~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~--------- 114 (344)
.++|...+.||+|+||.||+|+.. ++.||+|.+... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 367899999999999999999983 678999998654 46789999999999999988
Q ss_pred ------eeeEEee-CCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccccc
Q 048160 115 ------FVGCCLE-TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPS 187 (344)
Q Consensus 115 ------~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~ 187 (344)
+++++.. +...++||||+ +++|.+++....+ ..+++.+++.++.|++.||.||| +.+|+||||||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~ 188 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK---HVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAE 188 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHH
Confidence 6777776 67889999999 8999999976421 36899999999999999999999 999999999999
Q ss_pred ceEeecCC--cceEeeeecccccCCCCccc----ccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCC
Q 048160 188 TILFQEQN--VAKFFDFCVSISIPEGKTHV----NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRIS 261 (344)
Q Consensus 188 Nill~~~~--~~kl~dfg~a~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~ 261 (344)
||+++.++ .++|+|||+++......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 99999999998765332211 1112447899999999999989999999999999999999999999
Q ss_pred CCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 048160 262 YSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLH 341 (344)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~ 341 (344)
..... ............... .......... + ...+..+.+|+..||+.||++|||+.+|++.|+++.
T Consensus 269 ~~~~~---~~~~~~~~~~~~~~~--~~~~~~~~~~-----~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 269 TNCLP---NTEDIMKQKQKFVDK--PGPFVGPCGH-----W---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp GGGTT---CHHHHHHHHHHHHHS--CCCEECTTSC-----E---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred ccCCc---CHHHHHHHHHhccCC--hhhhhhhccc-----c---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 75421 111122222111111 1111110000 0 022356899999999999999999999999999987
Q ss_pred hh
Q 048160 342 KS 343 (344)
Q Consensus 342 ~~ 343 (344)
+.
T Consensus 336 ~~ 337 (352)
T 2jii_A 336 QD 337 (352)
T ss_dssp HH
T ss_pred Hh
Confidence 65
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=334.17 Aligned_cols=252 Identities=19% Similarity=0.239 Sum_probs=200.1
Q ss_pred cCCCCCCccccCCCceEEEEEE-----CCccEEEEEecCCC----CchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCc
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL-----QDRPISVMKFGGNL----NSEEYCCFNCIAFASQM-SHKNILKFVGCCLETEL 124 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~vavk~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~ 124 (344)
++|...+.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.+++++ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5788999999999999999998 57889999987542 12345677999999999 69999999999999999
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeec
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV 204 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~ 204 (344)
.++||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred EEEEeecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 999999999999999997643 5889999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCcccccCCccccccccccccccCc--CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 205 SISIPEGKTHVNDNNKVIGTFGFIAPEYMST--ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 205 a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
++......... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.......... .......
T Consensus 206 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~----~~~~~~~ 279 (355)
T 1vzo_A 206 SKEFVADETER--AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA----EISRRIL 279 (355)
T ss_dssp EEECCGGGGGG--GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH----HHHHHHH
T ss_pred CeecccCCCCc--ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH----HHHHHHh
Confidence 98664322221 124578999999999975 347899999999999999999999997543222211 1111111
Q ss_pred ccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 048160 283 ESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-----TMVQVAKQ 336 (344)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ei~~~ 336 (344)
.. .+..+. ..+..+.+|+.+||+.||++|| |+.++++.
T Consensus 280 ~~--------------~~~~~~--~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 280 KS--------------EPPYPQ--EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HC--------------CCCCCT--TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred cc--------------CCCCCc--ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 10 000111 2344578999999999999999 89998753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=331.15 Aligned_cols=266 Identities=23% Similarity=0.307 Sum_probs=197.8
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch--hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE--EYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
++|...+.||+|+||.||+|+. +++.||+|++....... .+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 4688889999999999999999 57899999986554332 3457799999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.....
T Consensus 105 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 105 FVDHTILDDLELFPN-----GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp CCSEEHHHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cCCcchHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999999988876543 5889999999999999999999 99999999999999999999999999999976544
Q ss_pred CCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHH--------
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS-------- 281 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 281 (344)
..... ....|++.|+|||++.+. .++.++||||||+++|+|++|..||..... ...+.......
T Consensus 177 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~ 249 (331)
T 4aaa_A 177 PGEVY---DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD----IDQLYHIMMCLGNLIPRHQ 249 (331)
T ss_dssp ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCSCCHHHH
T ss_pred Ccccc---CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCChhhh
Confidence 32211 134689999999998775 689999999999999999999999865432 11111111100
Q ss_pred --hccC-CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 282 --IESN-SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 282 --~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... .......+......+.....+..+..+.+|+.+||+.||++|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 00000000000000000011134567899999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=318.74 Aligned_cols=251 Identities=21% Similarity=0.277 Sum_probs=196.9
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
+|.....||+|+||.||+|.. ++..||+|.+........+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 355566899999999999998 678899999987765566778899999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec-CCcceEeeeecccccCCCC
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE-QNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~dfg~a~~~~~~~ 212 (344)
+++|.+++....+. ..+++..+..++.|++.||.||| +.+|+|+||||+||+++. ++.++|+|||++.......
T Consensus 103 ~~~L~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 103 GGSLSALLRSKWGP--LKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp EEEHHHHHHHTTCC--CTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCHHHHHHhhccC--CCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 99999998764321 24678888999999999999999 999999999999999997 8999999999998764322
Q ss_pred cccccCCccccccccccccccCcCC--CCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTAN--CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEI 290 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (344)
.. .....|++.|+|||++.+.. ++.++||||||+++|+|++|..||...... ....... ... ..
T Consensus 178 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~---~~~-~~---- 243 (295)
T 2clq_A 178 PC---TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP---QAAMFKV---GMF-KV---- 243 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH---HHHHHHH---HHH-CC----
T ss_pred Cc---ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch---hHHHHhh---ccc-cc----
Confidence 11 12456899999999987653 789999999999999999999998643210 0000000 000 00
Q ss_pred cccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 291 VDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+..+. ..+..+.+|+.+||+.||++|||+.++++
T Consensus 244 --------~~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 --------HPEIPE--SMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp --------CCCCCT--TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred --------cccccc--cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000111 33456889999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=328.85 Aligned_cols=269 Identities=14% Similarity=0.179 Sum_probs=195.2
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch--hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccE
Q 048160 51 KAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE--EYCCFNCIAFASQMSHKNILKFVGCCLETELPI 126 (344)
Q Consensus 51 ~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~ 126 (344)
....++|...+.||+|+||+||+|+. +++.||+|++....... .+.+.+|+.++++++||||+++++++..+...+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 34456799999999999999999988 78899999987553322 355779999999999999999999999999999
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEee-----cCCcceEee
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ-----EQNVAKFFD 201 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-----~~~~~kl~d 201 (344)
+||||++ |+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++ .++.+||+|
T Consensus 110 lv~e~~~-~~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp EEEECCS-EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred EEEecCC-CCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECc
Confidence 9999997 59999987654 5889999999999999999999 99999999999999994 455699999
Q ss_pred eecccccCCCCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHH
Q 048160 202 FCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280 (344)
Q Consensus 202 fg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 280 (344)
||++......... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ...+......
T Consensus 181 fg~a~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~~~~~ 253 (329)
T 3gbz_A 181 FGLARAFGIPIRQ---FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE----IDQLFKIFEV 253 (329)
T ss_dssp TTHHHHHC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHH
T ss_pred CCCccccCCcccc---cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH----HHHHHHHHHH
Confidence 9999876433221 1234679999999999774 489999999999999999999999865422 2222222222
Q ss_pred HhccC--Cccccc-----cccccc-CCCCChh--hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 281 SIESN--SFKEIV-----DPIIVG-EEGLWPE--KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 281 ~~~~~--~~~~~~-----~~~~~~-~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..... .+.... ...... ....... ....+.++.+|+.+||+.||++|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 254 LGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 11110 000000 000000 0000000 0013456899999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=330.20 Aligned_cols=265 Identities=17% Similarity=0.199 Sum_probs=203.6
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEee----CCccE
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLE----TELPI 126 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----~~~~~ 126 (344)
..++|...+.||+|+||.||+++. +++.||+|++........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 346799999999999999999997 788999999876655566778899999999999999999999873 34789
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
+||||+++|+|.+++...... ...+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDK-GNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEeCCCCcHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 999999999999988652110 036899999999999999999999 9999999999999999999999999999887
Q ss_pred ccCCCCccc------ccCCccccccccccccccCcCC---CCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHH
Q 048160 207 SIPEGKTHV------NDNNKVIGTFGFIAPEYMSTAN---CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL 277 (344)
Q Consensus 207 ~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~---~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 277 (344)
......... .......||+.|+|||++.+.. ++.++||||||+++|+|++|..||......... ....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~ 259 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS---VALA 259 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC---HHHH
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch---hhHH
Confidence 653211110 0001235689999999987554 689999999999999999999998532110000 0000
Q ss_pred HHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 278 VRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
... . ...+.....+..+.+|+.+||+.||++|||+.+|++.|+++..
T Consensus 260 ~~~---~---------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 260 VQN---Q---------------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HHC---C-----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred hhc---c---------------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 000 0 0001111334568999999999999999999999999998754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=345.94 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=200.5
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC--CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL--NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
.+.|...+.||+|+||+||+|+. +++.||||++.... ......+.+|+.++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 35599999999999999999998 68899999986432 234567889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEee---cCCcceEeeeeccc
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ---EQNVAKFFDFCVSI 206 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~dfg~a~ 206 (344)
|||.+|+|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+|||++ .++.+||+|||++.
T Consensus 101 e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp CCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 9999999999886543 5899999999999999999999 99999999999999995 45679999999998
Q ss_pred ccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
........ ....||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+..... ..
T Consensus 173 ~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~-----~~ 238 (486)
T 3mwu_A 173 CFQQNTKM----KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE----YDILKRVET-----GK 238 (486)
T ss_dssp TBCCC--------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHH-----TC
T ss_pred ECCCCCcc----CCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHh-----CC
Confidence 76543321 24578999999999865 589999999999999999999999975321 111111111 10
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. ....|.....+..+.+|+.+||+.||++|||+.++++
T Consensus 239 ~-----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 239 Y-----------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp C-----------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred C-----------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 0011122234567899999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=337.78 Aligned_cols=268 Identities=22% Similarity=0.272 Sum_probs=190.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCC-CCceeeeeeEEeeCC--cc
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMS-HKNILKFVGCCLETE--LP 125 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~--~~ 125 (344)
..++|...+.||+|+||.||+|.. +++.||+|++..... .....+.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 456799999999999999999998 688999999865432 33455779999999997 999999999997544 68
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
|+|||||+ ++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 87 ~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEecccC-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 99999997 6899988753 4888999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCcc------------------cccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCc
Q 048160 206 ISIPEGKTH------------------VNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCF 266 (344)
Q Consensus 206 ~~~~~~~~~------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 266 (344)
+........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 865431100 011123578999999999876 6789999999999999999999999975422
Q ss_pred cCcchhHHHHHHHHHhccCCcccc---ccc--------c-------cccCCCCChhh----------HHHHHHHHHHHHH
Q 048160 267 ENGEEYFLQELVRKSIESNSFKEI---VDP--------I-------IVGEEGLWPEK----------EKQLLSYTELAIK 318 (344)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~--------~-------~~~~~~~~~~~----------~~~~~~l~~l~~~ 318 (344)
...+...+.. ........+ ..+ . .......++.. ..++..+.+|+.+
T Consensus 237 ----~~~~~~i~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 311 (388)
T 3oz6_A 237 ----MNQLERIIGV-IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDK 311 (388)
T ss_dssp ----HHHHHHHHHH-HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHH
T ss_pred ----HHHHHHHHHh-cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHH
Confidence 1112222211 111000000 000 0 00000000000 0224568999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 048160 319 CLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 319 cl~~dP~~RPs~~ei~~ 335 (344)
||+.||++|||+.++++
T Consensus 312 ~L~~dP~~R~t~~e~l~ 328 (388)
T 3oz6_A 312 LLQFNPNKRISANDALK 328 (388)
T ss_dssp HCCSSGGGSCCHHHHTT
T ss_pred hhccCcccCCCHHHHhC
Confidence 99999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=328.66 Aligned_cols=270 Identities=20% Similarity=0.221 Sum_probs=197.7
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch-----hhhHhhHHHHHhcCCCCceeeeeeEEeeCC
Q 048160 51 KAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE-----EYCCFNCIAFASQMSHKNILKFVGCCLETE 123 (344)
Q Consensus 51 ~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~-----~~~~~~E~~~l~~l~H~niv~~~~~~~~~~ 123 (344)
....++|...+.||+|+||.||+|+. +++.||+|++....... .+.+.+|+.++++++||||+++++++...+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 34457799999999999999999998 57889999987543221 245779999999999999999999999999
Q ss_pred ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeee
Q 048160 124 LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFC 203 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg 203 (344)
..++||||+++ +|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFG 157 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred ceEEEEEcCCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecc
Confidence 99999999984 8988887654 35888899999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
+++........ .....||+.|+|||++.+. .++.++||||||+++|+|++|..||.... ....+........
T Consensus 158 ~a~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~----~~~~~~~i~~~~~ 230 (346)
T 1ua2_A 158 LAKSFGSPNRA---YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS----DLDQLTRIFETLG 230 (346)
T ss_dssp GGSTTTSCCCC---CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHC
T ss_pred cceeccCCccc---CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC----HHHHHHHHHHHcC
Confidence 99876433221 1245789999999998764 58999999999999999999998876532 1222222222211
Q ss_pred cc--CCccc---ccccccccCCCCChhh---HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ES--NSFKE---IVDPIIVGEEGLWPEK---EKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ~~--~~~~~---~~~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.. ..+.. ..+.......+..+.. ...+..+.+|+.+||+.||++|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 11 00110 0010000111111110 123467899999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=347.15 Aligned_cols=249 Identities=22% Similarity=0.285 Sum_probs=203.1
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
.+.|...+.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 35588899999999999999999 68899999986542 23456788999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe---ecCCcceEeeeecc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF---QEQNVAKFFDFCVS 205 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~dfg~a 205 (344)
|||+.+|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 105 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK-----RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp ECCCCSCBHHHHHHTCS-----CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 99999999999887654 5899999999999999999999 9999999999999999 46789999999999
Q ss_pred cccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
.......... ...||+.|+|||++.+ .++.++||||||+++|+|++|..||..... ...+..... .
T Consensus 177 ~~~~~~~~~~----~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~-----~ 242 (484)
T 3nyv_A 177 THFEASKKMK----DKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE----YDILKKVEK-----G 242 (484)
T ss_dssp HHBCCCCSHH----HHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHH-----C
T ss_pred EEcccccccc----cCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHc-----C
Confidence 8765443221 3468999999999865 689999999999999999999999965321 111111111 1
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.. ....|.....+..+.+|+.+||+.||++|||+.++++
T Consensus 243 ~~-----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 243 KY-----------TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CC-----------CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC-----------CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 10 0111222244567899999999999999999999885
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=324.08 Aligned_cols=249 Identities=22% Similarity=0.292 Sum_probs=199.8
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
.++|...+.||+|+||.||+++. +++.||+|.+........+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 35688899999999999999998 6889999999866554556788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe---ecCCcceEeeeeccccc
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF---QEQNVAKFFDFCVSISI 208 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~dfg~a~~~ 208 (344)
+++++|.+++...+ .+++.++..++.|++.||.||| +.+|+||||||+||++ +.++.++|+|||++...
T Consensus 88 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 88 VSGGELFDRILERG-----VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred CCCccHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 99999999886543 5889999999999999999999 9999999999999999 78889999999998754
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
.... .....|++.|+|||++.+..++.++||||||+++|+|++|..||..... ............ ..
T Consensus 160 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~---~~- 226 (304)
T 2jam_A 160 QNGI-----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE----SKLFEKIKEGYY---EF- 226 (304)
T ss_dssp CCBT-----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHCCC---CC-
T ss_pred CCCc-----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHcCCC---CC-
Confidence 3221 1134689999999999999999999999999999999999999865321 111111111000 00
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.. +.....+..+.+|+.+||+.||++|||+.++++
T Consensus 227 ---------~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 227 ---------ES---PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ---------CT---TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ---------Cc---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 001133456899999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=324.98 Aligned_cols=250 Identities=21% Similarity=0.277 Sum_probs=198.5
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
..+.|...+.||+|+||.||+|.. +++.||+|.+.... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 456788999999999999999999 57899999987653 35678899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|+++++|.+++.... ..+++.++..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 105 ~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 105 YCGAGSVSDIIRLRN----KTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp CCTTEEHHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred cCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 999999999986433 36899999999999999999999 99999999999999999999999999999977654
Q ss_pred CCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEI 290 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (344)
.... .....|++.|+|||++.+..++.++||||||+++|+|++|..||..... .... ..... ...
T Consensus 178 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~----~~~~~-~~~--- 242 (314)
T 3com_A 178 TMAK---RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP----MRAI----FMIPT-NPP--- 242 (314)
T ss_dssp TBSC---BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH----HHHH----HHHHH-SCC---
T ss_pred hccc---cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh----HHHH----HHHhc-CCC---
Confidence 3221 1245689999999999998999999999999999999999999864321 1111 00000 000
Q ss_pred cccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 291 VDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.........+..+.+|+.+||+.||++|||+.++++
T Consensus 243 ---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 243 ---------PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---------CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---------cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 001111133456899999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=320.56 Aligned_cols=249 Identities=19% Similarity=0.243 Sum_probs=199.4
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc------hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS------EEYCCFNCIAFASQMSHKNILKFVGCCLETELPI 126 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~ 126 (344)
++|...+.||+|+||.||+|+. +++.||+|.+...... ..+.+.+|+.++++++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 5688889999999999999999 5789999998754321 2466889999999999999999999999999999
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC----cceEeee
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN----VAKFFDF 202 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~df 202 (344)
+||||+++++|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++ .++|+||
T Consensus 85 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEeecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEec
Confidence 9999999999999997543 5899999999999999999999 99999999999999998877 8999999
Q ss_pred ecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 203 CVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 203 g~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
|++......... ....|++.|+|||++.+..++.++||||||+++|+|++|..||..... ....... .
T Consensus 157 g~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~----~ 224 (283)
T 3bhy_A 157 GIAHKIEAGNEF----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK----QETLTNI----S 224 (283)
T ss_dssp TTCEECC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHH----H
T ss_pred ccceeccCCCcc----cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch----HHHHHHh----H
Confidence 999876443221 134689999999999988999999999999999999999999865321 1111111 0
Q ss_pred ccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..... .........+..+.+|+.+||+.||++|||+.++++
T Consensus 225 -~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 225 -AVNYD-----------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp -TTCCC-----------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hcccC-----------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00000 000001123456899999999999999999999987
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=340.13 Aligned_cols=195 Identities=19% Similarity=0.298 Sum_probs=154.4
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeC-----Cc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLET-----EL 124 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----~~ 124 (344)
.++|...+.||+|+||+||+|+. +++.||||++...... ..+.+.+|+.++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36799999999999999999988 6789999998765332 346688999999999999999999998543 46
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeec
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV 204 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~ 204 (344)
.|+||||+. ++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPV-----YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEeccc-cchhhhcccCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeeccccc
Confidence 899999984 79999987653 5899999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCccc------------------------ccCCcccccccccccccc-CcCCCCcccchHHHHHHHHHHHcC
Q 048160 205 SISIPEGKTHV------------------------NDNNKVIGTFGFIAPEYM-STANCNEKSDVYSFGALLLELLTG 257 (344)
Q Consensus 205 a~~~~~~~~~~------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g 257 (344)
++......... .......||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 98764322110 111235789999999986 456799999999999999999994
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=330.13 Aligned_cols=258 Identities=15% Similarity=0.185 Sum_probs=204.1
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEE-----E--CCccEEEEEecCCCCchhhhHhhHHHHHhcCC---CCceeeeeeEE
Q 048160 50 LKAATNNYDPEKVITKDLLYKLYKGF-----L--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMS---HKNILKFVGCC 119 (344)
Q Consensus 50 i~~~~~~~~~~~~ig~G~~g~V~~~~-----~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~~~~~~ 119 (344)
+....++|...+.||+|+||+||+|. . .++.||+|++... ....+.+|+.++..++ |+||+++++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 33445678888899999999999994 2 6789999998765 3456778888888887 99999999999
Q ss_pred eeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec------
Q 048160 120 LETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE------ 193 (344)
Q Consensus 120 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~------ 193 (344)
..++..++||||+++|+|.+++..........+++.+++.++.|++.||.||| +.+|+||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC-
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcc
Confidence 99999999999999999999996421111136999999999999999999999 999999999999999998
Q ss_pred -----CCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccC
Q 048160 194 -----QNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFEN 268 (344)
Q Consensus 194 -----~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 268 (344)
++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-- 290 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKG-TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG-- 290 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTT-EEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET--
T ss_pred ccccccCCEEEeeCchhhhhhccCCC-ceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC--
Confidence 899999999999765322111 111245789999999999999999999999999999999999999864321
Q ss_pred cchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHHHHHh
Q 048160 269 GEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDR-PTMVQVAKQLRQLHK 342 (344)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Ps~~ei~~~L~~l~~ 342 (344)
+ ........ ...+ ....+.+++..|++.+|.+| |++.++.+.|+++.+
T Consensus 291 ~------------------~~~~~~~~----~~~~----~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 291 G------------------ECKPEGLF----RRLP----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp T------------------EEEECSCC----TTCS----SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred C------------------ceeechhc----cccC----cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 0 00001100 1111 13357789999999999999 788888888887754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=324.19 Aligned_cols=263 Identities=15% Similarity=0.193 Sum_probs=199.1
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCC-CCceeeeeeEEee--CCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCCLE--TELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~--~~~~~lv~ 129 (344)
++|...+.||+|+||+||+|+. +++.||+|.+... ..+.+.+|+.++++++ ||||+++++++.. ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5688899999999999999988 7889999998754 3567889999999997 9999999999987 56789999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC-cceEeeeeccccc
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN-VAKFFDFCVSISI 208 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~dfg~a~~~ 208 (344)
||+.+++|.+++. .+++.++..++.|++.||.||| +.+|+||||||+|||++.++ .++|+|||++...
T Consensus 113 e~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp ECCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 9999999999884 3788899999999999999999 99999999999999999777 8999999999876
Q ss_pred CCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHH-----HHh
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR-----KSI 282 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~ 282 (344)
...... ....++..|+|||++.+ ..++.++||||||+++|+|++|..||.................. ...
T Consensus 182 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 182 HPGQEY----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp CTTCCC----CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred CCCCcc----ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHH
Confidence 543322 24578999999999877 66899999999999999999999999754332111111100000 000
Q ss_pred ccCC--c----ccccccccc---cCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ESNS--F----KEIVDPIIV---GEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ~~~~--~----~~~~~~~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... . ......... ............+..+.+|+.+||+.||++|||+.++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 0 000000000 000000011124567899999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=322.40 Aligned_cols=247 Identities=22% Similarity=0.302 Sum_probs=202.8
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC-CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL-NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
+.|...+.||+|+||.||+|.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4588889999999999999998 67899999987553 23456788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+++++|.+++... ++++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++......
T Consensus 102 ~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 102 LGGGSALDLLEPG------PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CTTEEHHHHHTTS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred CCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999999652 5889999999999999999999 999999999999999999999999999999776543
Q ss_pred CcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
... .....|++.|+|||++.+..++.++||||||+++|+|++|..||..... ......+. ......
T Consensus 173 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~----~~~~~~-- 238 (303)
T 3a7i_A 173 QIK---RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-----MKVLFLIP----KNNPPT-- 238 (303)
T ss_dssp BCC---BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHH----HSCCCC--
T ss_pred ccc---cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-----HHHHHHhh----cCCCCC--
Confidence 221 1245789999999999998999999999999999999999999864321 11111111 111000
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ 336 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~ 336 (344)
.+ ...+..+.+|+..||+.||++|||+.+|++.
T Consensus 239 ----------~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 239 ----------LE--GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ----------CC--SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ----------Cc--cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 0233458899999999999999999999863
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=328.48 Aligned_cols=262 Identities=21% Similarity=0.288 Sum_probs=202.4
Q ss_pred hcCCCCCCccccCCCceEEEEEE-------CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCcc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL-------QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELP 125 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~-------~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~ 125 (344)
.++|...+.||+|+||.||+|++ .+..||+|.+..... .....+.+|+.++++++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46799999999999999999985 355799999875533 3345688999999999999999999999999999
Q ss_pred EEEEeecCCCCccccccCCCC--CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec---CCcceEe
Q 048160 126 ILVFEFVACGTLADRIHDPNG--SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE---QNVAKFF 200 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~ 200 (344)
++||||+++++|.+++..... .....+++.+++.++.|++.||.||| +.+|+||||||+||+++. +..++|+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999975432 11135889999999999999999999 999999999999999984 4469999
Q ss_pred eeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHH
Q 048160 201 DFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVR 279 (344)
Q Consensus 201 dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 279 (344)
|||++......... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.... .......+.
T Consensus 186 Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~~~~~~~~~ 259 (327)
T 2yfx_A 186 DFGMARDIYRASYY-RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----NQEVLEFVT 259 (327)
T ss_dssp CCHHHHHHHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHHHHHHHH
T ss_pred cccccccccccccc-ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC-----HHHHHHHHh
Confidence 99998765432211 11123467889999999988899999999999999999998 888875431 111111111
Q ss_pred HHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 280 KSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
..... ..+ ..++..+.+|+.+||+.||++|||+.+|++.|..+..
T Consensus 260 ----~~~~~------------~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 260 ----SGGRM------------DPP--KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp ----TTCCC------------CCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----cCCCC------------CCC--CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 11000 000 1334568999999999999999999999999998754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=328.66 Aligned_cols=250 Identities=18% Similarity=0.239 Sum_probs=192.7
Q ss_pred hcCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCC--CceeeeeeEEeeCCccEEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSH--KNILKFVGCCLETELPILV 128 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H--~niv~~~~~~~~~~~~~lv 128 (344)
.+.|...+.||+|+||.||++.. ++..||||++...... ..+.+.+|+.++.+++| |||+++++++..+...++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45688899999999999999998 6778999998755332 23668899999999986 9999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
||+ .+++|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+|||++ ++.+||+|||+++..
T Consensus 88 ~e~-~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp ECC-CSEEHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EeC-CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 995 5789999997653 5889999999999999999999 99999999999999997 678999999999876
Q ss_pred CCCCcccccCCccccccccccccccCc-----------CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHH
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMST-----------ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL 277 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 277 (344)
....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ....+
T Consensus 158 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~--- 230 (343)
T 3dbq_A 158 QPDTTSV-VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---QISKL--- 230 (343)
T ss_dssp -------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS---HHHHH---
T ss_pred Ccccccc-cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh---HHHHH---
Confidence 5432211 1124578999999999864 6789999999999999999999999964321 10111
Q ss_pred HHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 278 VRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
......... ..+|. ..+..+.+|+..||+.||++|||+.++++
T Consensus 231 -~~~~~~~~~------------~~~~~--~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 231 -HAIIDPNHE------------IEFPD--IPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp -HHHHCTTSC------------CCCCC--CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHHhcCCcc------------cCCcc--cCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 111111100 00111 12345889999999999999999999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=344.61 Aligned_cols=249 Identities=16% Similarity=0.244 Sum_probs=200.1
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||.||+|+. +++.||+|++..... .....+.+|+.++++++||||+++++++...+..|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 5677888999999999999999 688999999865421 22356779999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||++||+|.+++...... ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 265 E~~~gg~L~~~l~~~~~~-~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp CCCTTCBHHHHHHTSSTT-SCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeccCCCHHHHHHHhhcc-cccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999988654311 135899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
..... .....||+.|+|||++.+..++.++|||||||++|||++|..||........... +.. ......
T Consensus 341 ~~~~~---~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~-~~~---~i~~~~---- 409 (543)
T 3c4z_A 341 AGQTK---TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE-LKQ---RVLEQA---- 409 (543)
T ss_dssp TTCCC---BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHH-HHH---HHHHCC----
T ss_pred CCCcc---cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHH-HHH---HHhhcc----
Confidence 43321 1245799999999999999999999999999999999999999976432111111 111 111100
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM 330 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 330 (344)
..+|. ..+..+.+|+.+||+.||++||++
T Consensus 410 ----------~~~p~--~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 410 ----------VTYPD--KFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ----------CCCCT--TSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ----------cCCCc--ccCHHHHHHHHHhccCCHhHCCCC
Confidence 00111 334568899999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=344.50 Aligned_cols=250 Identities=22% Similarity=0.242 Sum_probs=199.2
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-------------chhhhHhhHHHHHhcCCCCceeeeee
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-------------SEEYCCFNCIAFASQMSHKNILKFVG 117 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~~~~ 117 (344)
..+.|...+.||+|+||+||+|+. .+..||+|.+..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 457799999999999999999998 567899999875431 22456789999999999999999999
Q ss_pred EEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC--
Q 048160 118 CCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN-- 195 (344)
Q Consensus 118 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-- 195 (344)
++.++...++|||||++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCC
Confidence 9999999999999999999999886543 5899999999999999999999 99999999999999998776
Q ss_pred -cceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHH
Q 048160 196 -VAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFL 274 (344)
Q Consensus 196 -~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 274 (344)
.+||+|||++......... ....||+.|+|||++. ..++.++||||||+++|+|++|..||..... ...+
T Consensus 186 ~~~kl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~ 256 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDYKL----RDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND----QDII 256 (504)
T ss_dssp SSEEECCCTTCEECCTTSCB----CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH
T ss_pred ccEEEEECCCCEEcCCCCcc----ccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHHH
Confidence 6999999999876543322 2457899999999986 4689999999999999999999999965321 1111
Q ss_pred HHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 275 QELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... . ... ....+.....+..+.+|+.+||+.||.+|||+.++++
T Consensus 257 ~~i~----~-~~~-----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 257 KKVE----K-GKY-----------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHH----H-CCC-----------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHH----c-CCC-----------CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1111 1 100 0001111133567899999999999999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=341.47 Aligned_cols=248 Identities=23% Similarity=0.261 Sum_probs=196.1
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC--CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL--NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
+.|...+.||+|+||+||+|+. .+..||+|++.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4588899999999999999999 67889999987653 2335668899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC---CcceEeeeecccc
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ---NVAKFFDFCVSIS 207 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~dfg~a~~ 207 (344)
||++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.. +.+||+|||++..
T Consensus 117 ~~~~g~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 117 CYKGGELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp CCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred cCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 999999999886543 5889999999999999999999 9999999999999999764 4599999999987
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
....... ....||+.|+|||++. ..++.++|||||||++|+|++|..||..... ...+..... ...
T Consensus 189 ~~~~~~~----~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~-----~~~ 254 (494)
T 3lij_A 189 FENQKKM----KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD----QEILRKVEK-----GKY 254 (494)
T ss_dssp CBTTBCB----CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHH-----TCC
T ss_pred CCCCccc----cccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHh-----CCC
Confidence 6543321 2457899999999986 5689999999999999999999999965321 111111111 100
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. ...+.....+..+.+|+.+||+.||++|||+.++++
T Consensus 255 ~-----------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 255 T-----------FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp C-----------CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C-----------CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0 001111134456899999999999999999999885
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=320.42 Aligned_cols=245 Identities=17% Similarity=0.253 Sum_probs=195.8
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv 128 (344)
.++|...+.||+|+||.||+|.. +++.||+|++..... .....+.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 46688999999999999999999 688999999876432 3345678999999999 899999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC--------------
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ-------------- 194 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-------------- 194 (344)
|||+++++|.+++..... ....+++.++..++.|++.||.||| +.+|+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EECCTTCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred EEecCCCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999865311 0024889999999999999999999 9999999999999999844
Q ss_pred -----CcceEeeeecccccCCCCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccC
Q 048160 195 -----NVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFEN 268 (344)
Q Consensus 195 -----~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 268 (344)
..++|+|||.+....... ...||+.|+|||++.+. .++.++||||||+++|+|++|..|+....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---
T ss_pred ccCCceEEEEcccccccccCCcc-------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---
Confidence 478999999987764322 33589999999999766 56789999999999999999987764321
Q ss_pred cchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 269 GEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... ....... ..+. ..+..+.+|+.+||+.||++|||+.++++
T Consensus 236 ----~~~~-----~~~~~~~------------~~~~--~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 ----QWHE-----IRQGRLP------------RIPQ--VLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ----HHHH-----HHTTCCC------------CCSS--CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHHH-----HHcCCCC------------CCCc--ccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 0111 1111111 0111 23456899999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=335.35 Aligned_cols=263 Identities=17% Similarity=0.231 Sum_probs=208.3
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCC-CceeeeeeEEeeCCccEEEEe
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSH-KNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~~~~~~~~~~~~~lv~e 130 (344)
.++|...+.||+|+||.||+|++ ++..||||++.... ....+.+|+.+++.++| ++|+.+..++..+...++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46799999999999999999998 68899999876553 23467899999999987 666677777778889999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe---ecCCcceEeeeecccc
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF---QEQNVAKFFDFCVSIS 207 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~dfg~a~~ 207 (344)
|+ +++|.+++.... ..+++.+++.++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 84 ~~-g~sL~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CC-CCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 99 899999997543 36899999999999999999999 9999999999999999 6889999999999987
Q ss_pred cCCCCccc----ccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhc
Q 048160 208 IPEGKTHV----NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE 283 (344)
Q Consensus 208 ~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (344)
........ .......||..|+|||++.+..++.++||||||+++|||++|..||........ ...+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~ 234 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVA 234 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH-HHHHHHHHHHHHH
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH-HHHHHHHhhcccc
Confidence 65443221 112245789999999999999999999999999999999999999976432111 1112211111110
Q ss_pred cCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 284 SNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.....+. ..++.++.+|+..||+.||++||++.+|++.|+.+..
T Consensus 235 -~~~~~l~--------------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 235 -TSIEALC--------------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp -SCHHHHH--------------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred -ccHHHHh--------------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1110000 0234568999999999999999999999999999865
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=354.43 Aligned_cols=258 Identities=17% Similarity=0.232 Sum_probs=202.8
Q ss_pred HHhcCCCCCCccccCCCceEEEEEEC-----CccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCcc
Q 048160 52 AATNNYDPEKVITKDLLYKLYKGFLQ-----DRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELP 125 (344)
Q Consensus 52 ~~~~~~~~~~~ig~G~~g~V~~~~~~-----~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~ 125 (344)
...++|...+.||+|+||.||+|.+. +..||+|++...... ..+.+.+|+.++++++||||+++++++. ++..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 34466788889999999999999982 346899988765333 2366889999999999999999999985 4568
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred EEEEEcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCC
Confidence 99999999999999997554 35889999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhcc
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIES 284 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (344)
+......... .....+|+.|+|||++.+..++.++||||||+++|||++ |..||..... . .....+ ..
T Consensus 539 ~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~----~-~~~~~i---~~- 607 (656)
T 2j0j_A 539 RYMEDSTYYK--ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----N-DVIGRI---EN- 607 (656)
T ss_dssp CSCCC------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----H-HHHHHH---HH-
T ss_pred eecCCCccee--ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH----H-HHHHHH---Hc-
Confidence 8765433221 113456789999999988899999999999999999997 8888764321 1 111111 11
Q ss_pred CCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 285 NSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.. ....| ..++..+.+|+.+||+.||++|||+.+|++.|+++.+
T Consensus 608 ~~------------~~~~~--~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 608 GE------------RLPMP--PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp TC------------CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC------------CCCCC--ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 10 00011 1344568999999999999999999999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=319.70 Aligned_cols=244 Identities=20% Similarity=0.289 Sum_probs=193.3
Q ss_pred CCCCCccccCCCceEEEEEE--CCccEEEEEecCCC--CchhhhHhhHHHHHhcCCCCceeeeeeEEee----CCccEEE
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL--NSEEYCCFNCIAFASQMSHKNILKFVGCCLE----TELPILV 128 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----~~~~~lv 128 (344)
|...+.||+|+||.||+|.. ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.. +...++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 56677899999999999998 56789999886543 2334668899999999999999999999875 3568999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCC--eeeecccccceEee-cCCcceEeeeecc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRP--IVFRDIKPSTILFQ-EQNVAKFFDFCVS 205 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~dfg~a 205 (344)
|||+++++|.+++.... .+++..+..++.|++.||.||| +.+ |+||||||+||+++ .++.++|+|||++
T Consensus 108 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEecCCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 99999999999997643 5889999999999999999999 888 99999999999997 7899999999999
Q ss_pred cccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
......... ...||+.|+|||++. ..++.++||||||+++|+|++|..||..... . ........ ..
T Consensus 180 ~~~~~~~~~-----~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~---~~~~~~~~-~~ 245 (290)
T 1t4h_A 180 TLKRASFAK-----AVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN----A---AQIYRRVT-SG 245 (290)
T ss_dssp GGCCTTSBE-----ESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----H---HHHHHHHT-TT
T ss_pred ccccccccc-----cccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc----H---HHHHHHHh-cc
Confidence 765433221 346899999999886 4589999999999999999999999865321 1 11111111 11
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.....+ ....+..+.+|+..||+.||++|||+.+|++
T Consensus 246 ~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 246 VKPASF-------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCCGGG-------------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcccc-------------CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 000000 0122346899999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=337.33 Aligned_cols=199 Identities=18% Similarity=0.282 Sum_probs=166.0
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeC-----Cc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLET-----EL 124 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----~~ 124 (344)
.++|...+.||+|+||.||+|+. +++.||||++...... ..+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 36799999999999999999998 6788999999765332 345688999999999999999999998766 56
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeec
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV 204 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~ 204 (344)
.|+||||+. ++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI-----FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecCC-cCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 899999996 69999997653 5899999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCccc-------------------ccCCcccccccccccccc-CcCCCCcccchHHHHHHHHHHHcCCCCC
Q 048160 205 SISIPEGKTHV-------------------NDNNKVIGTFGFIAPEYM-STANCNEKSDVYSFGALLLELLTGKRIS 261 (344)
Q Consensus 205 a~~~~~~~~~~-------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~p~ 261 (344)
++......... .......||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 98765432110 111346789999999986 5566999999999999999999865444
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=327.07 Aligned_cols=259 Identities=18% Similarity=0.174 Sum_probs=201.6
Q ss_pred HHHHHHHhcCCCCC-CccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCC-CCceeeeeeEEe
Q 048160 47 AQELKAATNNYDPE-KVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMS-HKNILKFVGCCL 120 (344)
Q Consensus 47 ~~~i~~~~~~~~~~-~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~~~~~~~ 120 (344)
+.......+.|... +.||+|+||.||+|.. +++.||+|++..... .....+.+|+.++.++. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33344445557766 8899999999999999 588999999876432 23466889999999995 699999999999
Q ss_pred eCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec---CCcc
Q 048160 121 ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE---QNVA 197 (344)
Q Consensus 121 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~ 197 (344)
.....++||||+++|+|.+++..... ..+++.++..++.|++.||.||| +.+|+||||||+||+++. ++.+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELA---EMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcE
Confidence 99999999999999999999865432 36899999999999999999999 999999999999999987 7899
Q ss_pred eEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHH
Q 048160 198 KFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL 277 (344)
Q Consensus 198 kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 277 (344)
||+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||..... .......
T Consensus 174 kL~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i 245 (327)
T 3lm5_A 174 KIVDFGMSRKIGHACEL----REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN----QETYLNI 245 (327)
T ss_dssp EECCGGGCEEC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHH
T ss_pred EEeeCccccccCCcccc----ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHH
Confidence 99999999876543221 135789999999999999999999999999999999999999965321 1111111
Q ss_pred HHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 278 VRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. ... ... ..+.....+..+.+|+.+||+.||++|||+.++++
T Consensus 246 ~-~~~--~~~-------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 246 S-QVN--VDY-------------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp H-HTC--CCC-------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred H-hcc--ccc-------------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 1 100 000 00111133456889999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=318.77 Aligned_cols=244 Identities=21% Similarity=0.290 Sum_probs=200.3
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||.||+|+. ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 5688899999999999999999 56789999986432 122356789999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++....
T Consensus 94 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG-----RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp CCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 9999999999987643 5889999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
.... ....|++.|+|||++.+..++.++||||||+++|+|++|..||..... ...... ... ...
T Consensus 166 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~----~~~-~~~-- 229 (284)
T 2vgo_A 166 SLRR-----RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH----TETHRR----IVN-VDL-- 229 (284)
T ss_dssp SSCB-----CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHH----HHT-TCC--
T ss_pred cccc-----ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH----hHHHHH----Hhc-ccc--
Confidence 3221 245689999999999998999999999999999999999999865321 111111 110 000
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..|. ..+..+.+++..||+.||++|||+.++++
T Consensus 230 -----------~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 -----------KFPP--FLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -----------CCCT--TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----------CCCC--cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0011 23346889999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=328.46 Aligned_cols=263 Identities=19% Similarity=0.277 Sum_probs=190.9
Q ss_pred HHHHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCC-CCceeeeeeEEee---
Q 048160 48 QELKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCCLE--- 121 (344)
Q Consensus 48 ~~i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~--- 121 (344)
+.+.....+|...+.||+|+||.||+|++ +++.||+|++........+.+.+|+.++.++. ||||+++++++..
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 33344456789999999999999999999 78899999987665555677889999999996 9999999999853
Q ss_pred -----CCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCC--eeeecccccceEeecC
Q 048160 122 -----TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRP--IVFRDIKPSTILFQEQ 194 (344)
Q Consensus 122 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nill~~~ 194 (344)
....++||||+. |+|.+++...... .++++.+++.++.|++.||.||| +.+ |+||||||+|||++.+
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~ 174 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESR--GPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQ 174 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHHTT--CSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTT
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCC
Confidence 335799999996 7998888541111 25899999999999999999999 888 9999999999999999
Q ss_pred CcceEeeeecccccCCCCccc---------ccCCcccccccccccccc---CcCCCCcccchHHHHHHHHHHHcCCCCCC
Q 048160 195 NVAKFFDFCVSISIPEGKTHV---------NDNNKVIGTFGFIAPEYM---STANCNEKSDVYSFGALLLELLTGKRISY 262 (344)
Q Consensus 195 ~~~kl~dfg~a~~~~~~~~~~---------~~~~~~~g~~~y~aPE~~---~~~~~~~~~Di~slG~il~el~~g~~p~~ 262 (344)
+.+||+|||++.......... .......||+.|+|||++ .+..++.++||||||+++|+|++|..||.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254 (337)
T ss_dssp SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 999999999998765432211 011134589999999998 56678999999999999999999999986
Q ss_pred CCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 263 SSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
..... ... ..... .+.....+..+.+|+.+||+.||++|||+.++++.|..+..
T Consensus 255 ~~~~~--------~~~-------------~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 255 DGAKL--------RIV-------------NGKYS-----IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp --------------------------------CC-----CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhHH--------Hhh-------------cCccc-----CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 43210 000 00000 00000122347899999999999999999999999998865
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=323.87 Aligned_cols=268 Identities=17% Similarity=0.228 Sum_probs=199.3
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEee--------C
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLE--------T 122 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~--------~ 122 (344)
++|...+.||+|+||.||+|+. +++.||+|++...... ....+.+|+.++++++||||+++++++.. +
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5688999999999999999999 6789999998655332 23567799999999999999999999987 3
Q ss_pred CccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeee
Q 048160 123 ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF 202 (344)
Q Consensus 123 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~df 202 (344)
+..++||||+. ++|.+.+.... ..+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+||
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccC-CCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 46899999997 57777776544 35899999999999999999999 999999999999999999999999999
Q ss_pred ecccccCCCCcc-cccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHH
Q 048160 203 CVSISIPEGKTH-VNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280 (344)
Q Consensus 203 g~a~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 280 (344)
|++......... ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ...+... ..
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i-~~ 243 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE----QHQLALI-SQ 243 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHH-HH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHH-HH
Confidence 999876533221 112224578999999999876 4589999999999999999999999875321 1111111 11
Q ss_pred Hhcc---CCcccc-----ccccc--ccCCCCChhhH---HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 281 SIES---NSFKEI-----VDPII--VGEEGLWPEKE---KQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 281 ~~~~---~~~~~~-----~~~~~--~~~~~~~~~~~---~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... ..+... ..... .+......... ..+..+.+|+.+||+.||++|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 1111 001100 00000 00000000000 01355889999999999999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=329.04 Aligned_cols=253 Identities=21% Similarity=0.339 Sum_probs=202.4
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--------hhhhHhhHHHHHhcC-CCCceeeeeeEE
Q 048160 51 KAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--------EEYCCFNCIAFASQM-SHKNILKFVGCC 119 (344)
Q Consensus 51 ~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--------~~~~~~~E~~~l~~l-~H~niv~~~~~~ 119 (344)
....++|...+.||+|+||.||+|.+ +|+.||||++...... ..+.+.+|+.+++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 34456788889999999999999998 5889999998765321 134567999999999 799999999999
Q ss_pred eeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceE
Q 048160 120 LETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKF 199 (344)
Q Consensus 120 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 199 (344)
...+..++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999997543 5889999999999999999999 999999999999999999999999
Q ss_pred eeeecccccCCCCcccccCCccccccccccccccCc------CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhH
Q 048160 200 FDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST------ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYF 273 (344)
Q Consensus 200 ~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 273 (344)
+|||++......... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ...
T Consensus 242 ~DfG~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~----~~~ 313 (365)
T 2y7j_A 242 SDFGFSCHLEPGEKL----RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ----ILM 313 (365)
T ss_dssp CCCTTCEECCTTCCB----CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHH
T ss_pred EecCcccccCCCccc----ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH----HHH
Confidence 999998876543322 24578999999998853 3588999999999999999999999965321 111
Q ss_pred HHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 274 LQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+.... . ... ....+.....+..+.+|+.+||+.||++|||+.++++
T Consensus 314 ~~~i~-~----~~~-----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 314 LRMIM-E----GQY-----------QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHH-H----TCC-----------CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHH-h----CCC-----------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111 0 000 0000111123456899999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=330.58 Aligned_cols=249 Identities=18% Similarity=0.215 Sum_probs=193.2
Q ss_pred cCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCC--chhhhHhhHHHHHhcCC--CCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMS--HKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~--H~niv~~~~~~~~~~~~~lv~ 129 (344)
..|...+.||+|+||.||+|.. .+..||||++..... ...+.+.+|+.++++++ ||||+++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4588899999999999999998 678899999865532 23466889999999996 599999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
| +.+++|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+|||++ ++.+||+|||+++...
T Consensus 136 E-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp E-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred e-cCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 9 56789999997653 5888899999999999999999 99999999999999995 6899999999998765
Q ss_pred CCCcccccCCccccccccccccccCc-----------CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHH
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMST-----------ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELV 278 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 278 (344)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ....+
T Consensus 206 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~~~~~---- 277 (390)
T 2zmd_A 206 PDTTSV-VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---QISKL---- 277 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC---HHHHH----
T ss_pred CCCccc-cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH---HHHHH----
Confidence 432211 1124579999999999865 3689999999999999999999999964321 11111
Q ss_pred HHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 279 RKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
......... ...+. ..+..+.+|+..||+.||++|||+.+|++
T Consensus 278 ~~~~~~~~~---------~~~~~-----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 278 HAIIDPNHE---------IEFPD-----IPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHHHCTTSC---------CCCCC-----CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhCcccc---------CCCCc-----cchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 111111100 01111 11345889999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=326.89 Aligned_cols=262 Identities=16% Similarity=0.196 Sum_probs=193.6
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeCC------
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLETE------ 123 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------ 123 (344)
.+.|...+.||+|+||.||+|.. +++.||||++...... ..+.+.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46788899999999999999998 6889999998665332 2456789999999999999999999997653
Q ss_pred ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeee
Q 048160 124 LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFC 203 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg 203 (344)
..|+||||+ +++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeee
Confidence 459999999 78999998752 4889999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ...+........
T Consensus 174 ~a~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~l~~i~~~~g 243 (367)
T 1cm8_A 174 LARQADSEM------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH----LDQLKEIMKVTG 243 (367)
T ss_dssp TCEECCSSC------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHC
T ss_pred ccccccccc------CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcC
Confidence 998754321 13578999999999877 6799999999999999999999999975422 111222111110
Q ss_pred ccCC----------cccccccccccCCCCChh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ESNS----------FKEIVDPIIVGEEGLWPE-KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ~~~~----------~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+.. ....+..........+.. ....+..+.+|+.+||+.||++|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000 000000000000000000 0133456899999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=326.48 Aligned_cols=266 Identities=17% Similarity=0.248 Sum_probs=203.1
Q ss_pred cHHHHHHHhcCCCCCCccccCCCceEEEEEECCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCC
Q 048160 46 TAQELKAATNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETE 123 (344)
Q Consensus 46 ~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~ 123 (344)
...+.....++|...+.||+|+||.||+|++.+ .||+|++..... ...+.+.+|+.++++++||||+++++++....
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 344445556789999999999999999999865 599999875432 23456789999999999999999999999999
Q ss_pred ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeee
Q 048160 124 LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFC 203 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg 203 (344)
..++||||+++++|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+||+++ ++.++|+|||
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCS
T ss_pred ceEEEeecccCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecC
Confidence 9999999999999999997654 35889999999999999999999 99999999999999998 6799999999
Q ss_pred cccccCCCCc--ccccCCccccccccccccccCc---------CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchh
Q 048160 204 VSISIPEGKT--HVNDNNKVIGTFGFIAPEYMST---------ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEY 272 (344)
Q Consensus 204 ~a~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 272 (344)
++........ .........|++.|+|||++.. ..++.++||||||+++|+|++|..||..... .
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~- 249 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----E- 249 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH----H-
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----H-
Confidence 9876532211 1111223468999999999864 3578999999999999999999999865321 1
Q ss_pred HHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 273 FLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
........ ........ . ..+..+.+|+..||+.||++|||+.+|++.|+++.+
T Consensus 250 ---~~~~~~~~-~~~~~~~~-------~------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 250 ---AIIWQMGT-GMKPNLSQ-------I------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp ---HHHHHHHT-TCCCCCCC-------S------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred ---HHHHHhcc-CCCCCCCc-------C------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11111111 11110000 0 122347899999999999999999999999988764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=327.28 Aligned_cols=262 Identities=17% Similarity=0.196 Sum_probs=202.5
Q ss_pred hcCCCCCCccccCCCceEEEEEECCccEEEEEecCCCCch-----------------hhhHhhHHHHHhcCCCCceeeee
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSE-----------------EYCCFNCIAFASQMSHKNILKFV 116 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv~~~ 116 (344)
.++|...+.||+|+||.||+|+.+++.||+|.+....... .+.+.+|+.++++++||||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 3578899999999999999999999999999986442211 16788999999999999999999
Q ss_pred eEEeeCCccEEEEeecCCCCcccc------ccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCC-CCeeeecccccce
Q 048160 117 GCCLETELPILVFEFVACGTLADR------IHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFS-RPIVFRDIKPSTI 189 (344)
Q Consensus 117 ~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlk~~Ni 189 (344)
+++...+..++||||+++|+|.++ +..... ..+++..+..++.|++.||.||| + .+|+||||||+||
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT---CFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNI 183 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSC---CCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGE
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccc---cCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhE
Confidence 999999999999999999999999 654212 36899999999999999999999 8 9999999999999
Q ss_pred EeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcC-CCCc-ccchHHHHHHHHHHHcCCCCCCCCCcc
Q 048160 190 LFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNE-KSDVYSFGALLLELLTGKRISYSSCFE 267 (344)
Q Consensus 190 ll~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~Di~slG~il~el~~g~~p~~~~~~~ 267 (344)
+++.++.++|+|||++....... .....|+..|+|||++.+. .++. ++||||||+++|+|++|..||......
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDKK-----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTTE-----ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred EEcCCCcEEEecccccccccccc-----ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99999999999999998764431 1245789999999999877 6666 999999999999999999999754321
Q ss_pred CcchhHHHHHHHHHhccC-Cccc----ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 268 NGEEYFLQELVRKSIESN-SFKE----IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
...... ..... .... ......... ........+..+.+|+.+||+.||++|||+.++++
T Consensus 259 ----~~~~~~---i~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 ----VELFNN---IRTKNIEYPLDRNHFLYPLTNKK--STCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp ----HHHHHH---HTSCCCCCCCSSSSSTTTTCC----------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ----HHHHHH---HhccCcCCccchhhhhccccccc--cccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111 11110 0000 000000000 00000134467899999999999999999999876
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=322.59 Aligned_cols=254 Identities=19% Similarity=0.278 Sum_probs=199.2
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEee--CCccEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLE--TELPIL 127 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~l 127 (344)
.++|...+.||+|+||.||+|+. +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.. +...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 45788899999999999999999 678899999875532 234568899999999999999999998854 568899
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCC-----eeeecccccceEeecCCcceEeee
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRP-----IVFRDIKPSTILFQEQNVAKFFDF 202 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~dlk~~Nill~~~~~~kl~df 202 (344)
||||+++++|.+++...... ...+++..+..++.|++.||.||| +.+ |+||||||+||+++.++.++|+||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEeCCCCCCHHHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 99999999999998643210 024889999999999999999999 777 999999999999999999999999
Q ss_pred ecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 203 CVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 203 g~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
|++.......... ....|+..|+|||++.+..++.++||||||+++|+|++|..||..... ......+.
T Consensus 161 g~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~i~--- 229 (279)
T 2w5a_A 161 GLARILNHDTSFA---KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAGKIR--- 229 (279)
T ss_dssp CHHHHC---CHHH---HHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHH---
T ss_pred chheeeccccccc---cccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-----HHHHHHHh---
Confidence 9998765432211 134688999999999888899999999999999999999999865321 11111111
Q ss_pred ccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 048160 283 ESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337 (344)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L 337 (344)
...... .+. ..+..+.+++.+||+.||++|||+.+|++.+
T Consensus 230 -~~~~~~------------~~~--~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 230 -EGKFRR------------IPY--RYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp -HTCCCC------------CCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred -hccccc------------CCc--ccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 111110 111 2345689999999999999999999998754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=323.07 Aligned_cols=250 Identities=20% Similarity=0.241 Sum_probs=195.3
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--------chhhhHhhHHHHHhcCCCCceeeeeeEEeeC
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--------SEEYCCFNCIAFASQMSHKNILKFVGCCLET 122 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~ 122 (344)
..++|...+.||+|+||.||+|.. +++.||||.+..... .....+.+|+.++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 345689999999999999999998 678999999865421 1234578999999999999999999998765
Q ss_pred CccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCc---ceE
Q 048160 123 ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNV---AKF 199 (344)
Q Consensus 123 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl 199 (344)
. .++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++. +||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred c-eEEEEecCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEE
Confidence 4 899999999999999887643 5889999999999999999999 999999999999999987654 999
Q ss_pred eeeecccccCCCCcccccCCccccccccccccccC---cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHH
Q 048160 200 FDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMS---TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQE 276 (344)
Q Consensus 200 ~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 276 (344)
+|||++......... ....||+.|+|||++. ...++.++||||||+++|+|++|..||........ +..
T Consensus 159 ~Dfg~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~ 230 (322)
T 2ycf_A 159 TDFGHSKILGETSLM----RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS----LKD 230 (322)
T ss_dssp CCCTTCEECCCCHHH----HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC----HHH
T ss_pred ccCccceeccccccc----ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH----HHH
Confidence 999999876543211 1346899999999874 46789999999999999999999999865432111 111
Q ss_pred HHHHHhccCCcccccccccccCCCCChhh-HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 277 LVRKSIESNSFKEIVDPIIVGEEGLWPEK-EKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+.. . .....+.. ...+..+.+|+.+||+.||++|||+.++++
T Consensus 231 ~~~~----~------------~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 231 QITS----G------------KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHH----T------------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHh----C------------ccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1111 0 01111110 123456899999999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=319.36 Aligned_cols=247 Identities=19% Similarity=0.254 Sum_probs=201.5
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
.++|...+.||+|+||.||++.. .++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 35688889999999999999999 577899999865422 2345678999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||+++++|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++...
T Consensus 94 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EECCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 99999999999886543 5889999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
...... .....|++.|+|||++.+..++.++||||||+++|+|++|..||..... .... .... ....
T Consensus 166 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~----~~~~-~~~~- 232 (294)
T 2rku_A 166 EYDGER---KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL----KETY----LRIK-KNEY- 232 (294)
T ss_dssp CSTTCC---BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHH----HHHH-TTCC-
T ss_pred ccCccc---cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHH----HHHh-hccC-
Confidence 433221 1235689999999999988899999999999999999999999865321 1111 1111 1100
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..|. ..+..+.+++.+||+.||++|||+.++++
T Consensus 233 ------------~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 ------------SIPK--HINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ------------CCCT--TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ------------CCcc--ccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 0010 22345889999999999999999999886
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=328.76 Aligned_cols=261 Identities=16% Similarity=0.235 Sum_probs=191.9
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCC------
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETE------ 123 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------ 123 (344)
.++|...+.||+|+||.||+|.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 36789999999999999999998 688999999876432 23456789999999999999999999987654
Q ss_pred ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeee
Q 048160 124 LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFC 203 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg 203 (344)
..++||||++ ++|.+++.. .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ceEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEee
Confidence 6799999997 578888753 4788999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHH---
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK--- 280 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--- 280 (344)
+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...+...+..
T Consensus 173 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~ 244 (371)
T 2xrw_A 173 LARTAGTSFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH----IDQWNKVIEQLGT 244 (371)
T ss_dssp C--------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHC-CCC
T ss_pred cccccccccc----cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCC
Confidence 9976543221 1145789999999999998999999999999999999999999975422 1111111110
Q ss_pred ---------------HhccC------CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 281 ---------------SIESN------SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 281 ---------------~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..... .+...+..... ..........+..+.+|+.+||+.||++|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLF--PADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGS--CCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccC--cccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00000 00000000000 0001111234677999999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=325.79 Aligned_cols=247 Identities=19% Similarity=0.258 Sum_probs=201.7
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
.++|...+.||+|+||.||++.. +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 35688899999999999999999 567899999865422 2345678999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||+++++|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++...
T Consensus 120 ~e~~~~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp ECCCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 99999999999887543 5889999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
...... .....|+..|+|||++.+..++.++||||||+++|+|++|..||..... ........ ....
T Consensus 192 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~-----~~~~- 258 (335)
T 2owb_A 192 EYDGER---KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL----KETYLRIK-----KNEY- 258 (335)
T ss_dssp CSTTCC---BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHH-----HTCC-
T ss_pred ccCccc---ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH----HHHHHHHh-----cCCC-
Confidence 533221 1245689999999999888899999999999999999999999865321 11111111 0000
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+. ..+..+.+|+.+||+.||++|||+.++++
T Consensus 259 ------------~~~~--~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 ------------SIPK--HINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ------------CCCT--TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ------------CCCc--cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 22345789999999999999999999886
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=325.32 Aligned_cols=273 Identities=19% Similarity=0.236 Sum_probs=199.5
Q ss_pred cHHHHHHHhcCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCch-----------hhhHhhHHHHHhcCCCCcee
Q 048160 46 TAQELKAATNNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSE-----------EYCCFNCIAFASQMSHKNIL 113 (344)
Q Consensus 46 ~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv 113 (344)
...++....++|...+.||+|+||.||+|.. ++..||||++....... .+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4567788889999999999999999999988 78899999986543221 25678999999999999999
Q ss_pred eeeeEEeeC-----CccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccc
Q 048160 114 KFVGCCLET-----ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPST 188 (344)
Q Consensus 114 ~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N 188 (344)
++++++... ...++||||+. |+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~N 164 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGN 164 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGG
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHH
Confidence 999998543 35799999997 68888887554 36899999999999999999999 9999999999999
Q ss_pred eEeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCcc
Q 048160 189 ILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFE 267 (344)
Q Consensus 189 ill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 267 (344)
|+++.++.++|+|||++......... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~- 239 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADANK----THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF- 239 (362)
T ss_dssp EEECTTCCEEECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-
T ss_pred EEEcCCCCEEEEecCccccccccccc----ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH-
Confidence 99999999999999999754433221 24578899999999877 6789999999999999999999999975421
Q ss_pred CcchhHHHHHHHHHhccCCcc-----------ccccccccc-CCCCChh-hHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 048160 268 NGEEYFLQELVRKSIESNSFK-----------EIVDPIIVG-EEGLWPE-KEKQLLSYTELAIKCLSKSEQDRPTMVQVA 334 (344)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~-~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~ 334 (344)
...+........ ..... ..+...... ....+.. .+..+..+.+|+.+||+.||++|||+.+++
T Consensus 240 ---~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 315 (362)
T 3pg1_A 240 ---YNQLNKIVEVVG-TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315 (362)
T ss_dssp ---HHHHHHHHHHHC-CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ---HHHHHHHHHHcC-CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence 111222211110 00000 000000000 0000000 112345689999999999999999999998
Q ss_pred H
Q 048160 335 K 335 (344)
Q Consensus 335 ~ 335 (344)
+
T Consensus 316 ~ 316 (362)
T 3pg1_A 316 R 316 (362)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=328.08 Aligned_cols=263 Identities=22% Similarity=0.320 Sum_probs=199.1
Q ss_pred ccccccHHHHHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcC-CCCceeeeee
Q 048160 41 PIQNFTAQELKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQM-SHKNILKFVG 117 (344)
Q Consensus 41 ~~~~~~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~ 117 (344)
++..++..++....++|...+.||+|+||.||+|++ +++.||+|.+.... ...+.+.+|+.+++++ +||||+++++
T Consensus 10 ~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~ 88 (326)
T 2x7f_A 10 SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYG 88 (326)
T ss_dssp ------CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEE
T ss_pred cchhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeee
Confidence 445566666667788899999999999999999999 78899999986543 2456788999999999 7999999999
Q ss_pred EEee------CCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe
Q 048160 118 CCLE------TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF 191 (344)
Q Consensus 118 ~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 191 (344)
++.. ....++||||+++|+|.+++....+ ..+++..+..++.|++.||.||| +.+|+|+||||+||++
T Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~ 162 (326)
T 2x7f_A 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLL 162 (326)
T ss_dssp EEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEE
T ss_pred EEeeccCccccceEEEEEEcCCCCcHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEE
Confidence 9987 4678999999999999999875432 35889999999999999999999 9999999999999999
Q ss_pred ecCCcceEeeeecccccCCCCcccccCCccccccccccccccC-----cCCCCcccchHHHHHHHHHHHcCCCCCCCCCc
Q 048160 192 QEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMS-----TANCNEKSDVYSFGALLLELLTGKRISYSSCF 266 (344)
Q Consensus 192 ~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 266 (344)
+.++.++|+|||++........ ......|++.|+|||++. +..++.++||||||+++|+|++|..||.....
T Consensus 163 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 239 (326)
T 2x7f_A 163 TENAEVKLVDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 239 (326)
T ss_dssp CTTCCEEECCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred cCCCCEEEeeCcCceecCcCcc---ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH
Confidence 9999999999999876543221 112456899999999986 45689999999999999999999999864321
Q ss_pred cCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 267 ENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..... .... ....... .. ..+..+.+|+.+||+.||++|||+.++++
T Consensus 240 ----~~~~~----~~~~-~~~~~~~-------~~------~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 240 ----MRALF----LIPR-NPAPRLK-------SK------KWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp ----HHHHH----HHHH-SCCCCCS-------CS------CSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ----HHHHH----Hhhc-CccccCC-------cc------ccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111 1111 1110000 01 22346899999999999999999999886
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=314.83 Aligned_cols=245 Identities=22% Similarity=0.229 Sum_probs=192.6
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||.||+|.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 5688899999999999999998 68899999986542 122356789999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++....
T Consensus 91 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 91 EYVSGGELFDYICKHG-----RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp ECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred eccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 9999999999997543 5889999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCcccccCCccccccccccccccCcCCC-CcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANC-NEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
..... ....+++.|+|||.+.+..+ +.++||||||+++|+|++|..||..... . .....+.. ..
T Consensus 163 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~-~~~~~~~~----~~-- 227 (276)
T 2h6d_A 163 DGEFL----RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV----P-TLFKKIRG----GV-- 227 (276)
T ss_dssp C-----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH----H-HHHHHHHH----CC--
T ss_pred CCcce----ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH----H-HHHHHhhc----Cc--
Confidence 43221 13468999999999987765 6899999999999999999999864311 1 11111110 00
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
...|. ..+..+.+++.+||+.||++|||+.+|++
T Consensus 228 -----------~~~~~--~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 228 -----------FYIPE--YLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp -----------CCCCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------ccCch--hcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 00011 22345889999999999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=331.94 Aligned_cols=252 Identities=8% Similarity=-0.022 Sum_probs=179.1
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhhHHHHHhcC--CCCceeeee-------eEEe
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFNCIAFASQM--SHKNILKFV-------GCCL 120 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~E~~~l~~l--~H~niv~~~-------~~~~ 120 (344)
.+|...+.||+|+||+||+|++ +++.||+|++..... ...+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4588889999999999999998 678999999987643 2234566775444444 699988755 4443
Q ss_pred eC-----------------CccEEEEeecCCCCccccccCCCCCCCccccHHHH------HHHHHHHHHHHHHhhcCCCC
Q 048160 121 ET-----------------ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHR------LKVAMEIANAVAYLHVGFSR 177 (344)
Q Consensus 121 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~ 177 (344)
.. ...++||||++ |+|.+++...+ ..+.+..+ ..++.|++.||.||| +.
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~ 213 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQ---SK 213 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HT
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHH---HC
Confidence 32 23799999998 89999997643 13444445 677899999999999 99
Q ss_pred CeeeecccccceEeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCc--CCCCcccchHHHHHHHHHHH
Q 048160 178 PIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST--ANCNEKSDVYSFGALLLELL 255 (344)
Q Consensus 178 ~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~ 255 (344)
+|+||||||+|||++.++.+||+|||+++....... ...+|+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 287 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP------ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE------GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCCcc------CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence 999999999999999999999999999986643211 2356799999999987 67999999999999999999
Q ss_pred cCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 256 TGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 256 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+|..||........ ..................+.....+..+.+|+.+||+.||++|||+.++++
T Consensus 288 tg~~Pf~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 288 CLFLPFGLVTPGIK---------------GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HSSCSTTBCCTTCT---------------TCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred hCCCCCCCcCcccc---------------cchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99999975422100 000000000000111112222244567899999999999999999999874
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=329.08 Aligned_cols=266 Identities=20% Similarity=0.227 Sum_probs=194.1
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeC------
Q 048160 51 KAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLET------ 122 (344)
Q Consensus 51 ~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~------ 122 (344)
....++|...+.||+|+||+||+|+. ++..||+|++.... ....+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999998 78899999986542 2345799999999999999999998543
Q ss_pred --------------------------------CccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHH
Q 048160 123 --------------------------------ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAY 170 (344)
Q Consensus 123 --------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~ 170 (344)
...++||||++ |+|.+.+...... ...+++..+..++.|++.||.|
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHH
Confidence 34789999998 5777766421000 0268999999999999999999
Q ss_pred hhcCCCCCeeeecccccceEee-cCCcceEeeeecccccCCCCcccccCCccccccccccccccCcC-CCCcccchHHHH
Q 048160 171 LHVGFSRPIVFRDIKPSTILFQ-EQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFG 248 (344)
Q Consensus 171 LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG 248 (344)
|| +.+|+||||||+||+++ .++.+||+|||+++......... ...+|+.|+|||++.+. .++.++||||||
T Consensus 157 LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 229 (383)
T 3eb0_A 157 IH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV----AYICSRFYRAPELMLGATEYTPSIDLWSIG 229 (383)
T ss_dssp HH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCC----CCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred HH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCc----CcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence 99 99999999999999998 68899999999998765433222 45679999999998775 489999999999
Q ss_pred HHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC---------CcccccccccccCCCCChh--hHHHHHHHHHHHH
Q 048160 249 ALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN---------SFKEIVDPIIVGEEGLWPE--KEKQLLSYTELAI 317 (344)
Q Consensus 249 ~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~ 317 (344)
|++|+|++|..||..... ...+...+.....+. ......-+.. ....|.. ....+..+.+|+.
T Consensus 230 ~il~ell~g~~pf~~~~~----~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~ 303 (383)
T 3eb0_A 230 CVFGELILGKPLFSGETS----IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTL--KAKDWRKILPEGTPSLAIDLLE 303 (383)
T ss_dssp HHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCC--CCCCHHHHSCTTCCHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCHHHHHHhCcccccccCCcc--CcccHHhhCCCCCCHHHHHHHH
Confidence 999999999999975422 222222222111100 0000000000 0000000 0123456899999
Q ss_pred HccccCCCCCCCHHHHHH
Q 048160 318 KCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 318 ~cl~~dP~~RPs~~ei~~ 335 (344)
+||+.||++|||+.|+++
T Consensus 304 ~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 304 QILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHCCSSGGGSCCHHHHHT
T ss_pred HHccCChhhCCCHHHHhc
Confidence 999999999999999974
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=320.52 Aligned_cols=267 Identities=17% Similarity=0.188 Sum_probs=192.8
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEe------------
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCL------------ 120 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~------------ 120 (344)
++|...+.||+|+||.||+|.. .++.||+|++........+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 5688899999999999999999 47899999987765555677889999999999999999999873
Q ss_pred --eCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEee-cCCcc
Q 048160 121 --ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ-EQNVA 197 (344)
Q Consensus 121 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~ 197 (344)
.....++||||+. |+|.+++... ++++..+..++.|++.||.||| +.+|+||||||+||+++ .++.+
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQG------PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEE
T ss_pred ccccCceeEEeeccC-CCHHHHhhcC------CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeE
Confidence 3467899999997 6999998652 5889999999999999999999 99999999999999998 56799
Q ss_pred eEeeeecccccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHH
Q 048160 198 KFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQE 276 (344)
Q Consensus 198 kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 276 (344)
||+|||++.................++..|+|||.+.+ ..++.++||||||+++|+|++|..||..... ......
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~~~~~~ 236 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE----LEQMQL 236 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH----HHHHHH
Confidence 99999999876533222222234567899999998765 6789999999999999999999999975422 111111
Q ss_pred HHHHHhcc---------CCcccccccccccCCCCChh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 277 LVRKSIES---------NSFKEIVDPIIVGEEGLWPE-KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 277 ~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
........ .................... ....+..+.+|+.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 11110000 00000000000000000000 0123567899999999999999999999976
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=326.16 Aligned_cols=271 Identities=17% Similarity=0.173 Sum_probs=203.0
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeC----
Q 048160 50 LKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLET---- 122 (344)
Q Consensus 50 i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~---- 122 (344)
+....++|...+.||+|+||.||+|.. ++..||+|++...... ..+.+.+|+.++++++||||+++++++...
T Consensus 22 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp BCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred eccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 334456799999999999999999998 6788999998754332 336688999999999999999999998765
Q ss_pred -CccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEee
Q 048160 123 -ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFD 201 (344)
Q Consensus 123 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~d 201 (344)
...++||||+. |+|.+++... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|
T Consensus 102 ~~~~~iv~e~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~D 171 (364)
T 3qyz_A 102 MKDVYIVQDLME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICD 171 (364)
T ss_dssp CCCEEEEEECCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred cceEEEEEcccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEe
Confidence 36799999997 6999988653 4889999999999999999999 99999999999999999999999999
Q ss_pred eecccccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHH
Q 048160 202 FCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280 (344)
Q Consensus 202 fg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 280 (344)
||++.................||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ...+......
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~ 247 (364)
T 3qyz_A 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY----LDQLNHILGI 247 (364)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG----GGHHHHHHHH
T ss_pred CcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh----HHHHHHHHHH
Confidence 9999876543332222234578999999998654 4589999999999999999999999865432 1112222111
Q ss_pred HhccCCccc-----------ccccccccCCCCChh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 281 SIESNSFKE-----------IVDPIIVGEEGLWPE-KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 281 ~~~~~~~~~-----------~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.. ...... ............+.. ....+..+.+|+.+||+.||++|||+.++++
T Consensus 248 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 248 LG-SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HC-SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hC-CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 10 000000 000000000000000 0123456899999999999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=318.35 Aligned_cols=252 Identities=20% Similarity=0.267 Sum_probs=184.3
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchh--hhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEE--YCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~--~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
.++|+..+.||+|+||+||+|+. +++.||+|++........ +.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 45688899999999999999999 788999999976543222 22345556688899999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCC-CeeeecccccceEeecCCcceEeeeeccccc
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSR-PIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
||++ |+|.+++....... ..+++..+..++.|++.||.||| +. +|+||||||+||+++.++.++|+|||++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKG-QTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred ehhc-cchHHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9997 58877764310000 36899999999999999999999 87 9999999999999999999999999999776
Q ss_pred CCCCcccccCCcccccccccccccc----CcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYM----STANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES 284 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (344)
...... ....||+.|+|||++ ....++.++||||||+++|+|++|..||..... ....+.... ..
T Consensus 161 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~----~~ 229 (290)
T 3fme_A 161 VDDVAK----DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT---PFQQLKQVV----EE 229 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC---HHHHHHHHH----HS
T ss_pred cccccc----cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc---hHHHHHHHh----cc
Confidence 543222 134689999999996 456789999999999999999999999864321 111111111 11
Q ss_pred CCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 285 NSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
... ..+. ...+..+.+|+.+||+.||++|||+.++++
T Consensus 230 ~~~-------------~~~~-~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 230 PSP-------------QLPA-DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCC-------------CCCT-TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC-------------Cccc-ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 100 0000 133456899999999999999999999987
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=321.15 Aligned_cols=267 Identities=20% Similarity=0.270 Sum_probs=185.3
Q ss_pred HHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC-CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 52 AATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL-NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 52 ~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
...++|...+.||+|+||.||+|.. ++..||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 3457899999999999999999988 67899999886543 23346678999999999999999999999999999999
Q ss_pred EeecCCCCccccccCC---CCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 129 FEFVACGTLADRIHDP---NGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
|||+++++|.+++... .......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999988631 0001135889999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCcc--cccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 206 ISIPEGKTH--VNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 206 ~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
......... ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~---- 240 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP----MKVLMLTL---- 240 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG----GGHHHHHH----
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch----hhHHHHHh----
Confidence 776533211 111224568999999999865 5689999999999999999999999865422 11111111
Q ss_pred ccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. ............ .. .....+..+.+|+.+||+.||++|||+.++++
T Consensus 241 ~-~~~~~~~~~~~~--~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 241 Q-NDPPSLETGVQD--KE---MLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp T-SSCCCTTC-------C---CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred c-cCCCcccccccc--ch---hhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0 100000000000 00 00023346889999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=350.92 Aligned_cols=243 Identities=19% Similarity=0.258 Sum_probs=199.3
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCC---CCchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccE
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGN---LNSEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPI 126 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~ 126 (344)
..++|...+.||+|+||.||+|+. +++.||||++... .....+.+..|..++..+ +||||+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 346799999999999999999999 5678999998754 223345677899999988 6999999999999999999
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
+||||+++|+|.+++...+ .+++.+++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 419 lV~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEeCcCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceee
Confidence 9999999999999997653 5899999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
........ .....||+.|+|||++.+..|+.++||||||+++|||++|..||..... ......+ ...
T Consensus 491 ~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~----~~~~~~i----~~~-- 557 (674)
T 3pfq_A 491 ENIWDGVT---TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSI----MEH-- 557 (674)
T ss_dssp ECCCTTCC---BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHH----HSS--
T ss_pred ccccCCcc---cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH----HHHHHHH----HhC--
Confidence 64332221 2256799999999999999999999999999999999999999975321 1111111 110
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCH
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTM 330 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 330 (344)
...+|. ..+.++.+|+.+||+.||++||++
T Consensus 558 ------------~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 558 ------------NVAYPK--SMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp ------------CCCCCT--TSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred ------------CCCCCc--cCCHHHHHHHHHHccCCHHHCCCC
Confidence 011111 334568999999999999999997
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=326.28 Aligned_cols=262 Identities=18% Similarity=0.226 Sum_probs=182.7
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeC------C
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLET------E 123 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~------~ 123 (344)
.++|...+.||+|+||.||+|.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46799999999999999999997 688999999876533 2345678999999999999999999998754 5
Q ss_pred ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeee
Q 048160 124 LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFC 203 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg 203 (344)
..++|+||+ +++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCEEEEECC-CEECC-----C------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC--
T ss_pred eEEEEeccc-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecc
Confidence 679999999 68999988752 5899999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
+++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ...+........
T Consensus 178 ~a~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~l~~i~~~~g 247 (367)
T 2fst_X 178 LARHTADEM------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH----IDQLKLILRLVG 247 (367)
T ss_dssp -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHC
T ss_pred ccccccccC------CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhC
Confidence 997654321 13578999999999877 6789999999999999999999999965421 111222211111
Q ss_pred ccC-----C-----cccccccccccCCCCChh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ESN-----S-----FKEIVDPIIVGEEGLWPE-KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ~~~-----~-----~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+. . ....+..........++. ....+..+.+|+.+||+.||++|||+.++++
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 000 0 000000000000000000 0123456899999999999999999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=317.56 Aligned_cols=251 Identities=20% Similarity=0.300 Sum_probs=201.7
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---------chhhhHhhHHHHHhcCC-CCceeeeeeEEe
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---------SEEYCCFNCIAFASQMS-HKNILKFVGCCL 120 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~~~~~~~ 120 (344)
..++|...+.||+|+||.||+|.. +++.||+|.+..... ...+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 346799999999999999999999 678999999865431 12355779999999996 999999999999
Q ss_pred eCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEe
Q 048160 121 ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFF 200 (344)
Q Consensus 121 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 200 (344)
.+...++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEe
Confidence 9999999999999999999997643 5889999999999999999999 9999999999999999999999999
Q ss_pred eeecccccCCCCcccccCCccccccccccccccC------cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHH
Q 048160 201 DFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMS------TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFL 274 (344)
Q Consensus 201 dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 274 (344)
|||++......... ....|++.|+|||++. ...++.++||||||+++|+|++|..||..... ....
T Consensus 167 dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~ 238 (298)
T 1phk_A 167 DFGFSCQLDPGEKL----REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----MLML 238 (298)
T ss_dssp CCTTCEECCTTCCB----CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH
T ss_pred cccchhhcCCCccc----ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH----HHHH
Confidence 99999876543322 2456899999999884 45688999999999999999999999865321 1111
Q ss_pred HHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 275 QELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..... .... ...+.....+..+.+|+.+||+.||++|||+.++++
T Consensus 239 ~~~~~-----~~~~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 RMIMS-----GNYQ-----------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHH-----TCCC-----------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhc-----CCcc-----------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11111 1000 001111134556899999999999999999999875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=312.11 Aligned_cols=251 Identities=19% Similarity=0.235 Sum_probs=194.4
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC----CchhhhHhhHHHHHhcCCCCceeeeeeEEe--eCCc
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL----NSEEYCCFNCIAFASQMSHKNILKFVGCCL--ETEL 124 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~~~~~~~--~~~~ 124 (344)
..++|...+.||+|+||.||+|.. ++..||+|.+.... ....+.+.+|+.++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 347899999999999999999998 67789999986542 234566889999999999999999999984 4567
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeec
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV 204 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~ 204 (344)
.++||||+.++ |.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPE---KRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTT---CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEehhccCC-HHHHHHhCcc---cccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccc
Confidence 89999999865 6666654322 35889999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCcccccCCccccccccccccccCcCC--CCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 205 SISIPEGKTHVNDNNKVIGTFGFIAPEYMSTAN--CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 205 a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
+.......... ......|+..|+|||++.+.. ++.++||||||+++|+|++|..||..... ......+.
T Consensus 156 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~i~--- 226 (305)
T 2wtk_C 156 AEALHPFAADD-TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-----YKLFENIG--- 226 (305)
T ss_dssp CEECCTTCSSC-EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHH---
T ss_pred ccccCcccccc-ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-----HHHHHHHh---
Confidence 98764322111 112456899999999987644 47899999999999999999999865321 11111111
Q ss_pred ccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... ..+. .++..+.+|+.+||+.||++|||+.++++
T Consensus 227 -~~~~-------------~~~~--~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 227 -KGSY-------------AIPG--DCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp -HCCC-------------CCCS--SSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -cCCC-------------CCCC--ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1100 0000 23446889999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=326.91 Aligned_cols=196 Identities=22% Similarity=0.251 Sum_probs=169.3
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcC------CCCceeeeeeEEeeCCccE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQM------SHKNILKFVGCCLETELPI 126 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~~~~~~~~~~~~~ 126 (344)
.+|...+.||+|+||.||+|.. .++.||||++.... .....+.+|+.+++.+ +|+||+++++++......+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 4688899999999999999998 57899999987542 2335567888888877 5779999999999999999
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCc--ceEeeeec
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNV--AKFFDFCV 204 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~dfg~ 204 (344)
+||||+. ++|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++. +||+|||+
T Consensus 176 lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEeccC-CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999996 799998876442 24889999999999999999999 999999999999999999887 99999999
Q ss_pred ccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCC
Q 048160 205 SISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSS 264 (344)
Q Consensus 205 a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 264 (344)
+....... ....||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 249 a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 249 SCYEHQRV------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CEETTCCC------CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceecCCcc------cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 97654321 1457899999999999999999999999999999999999998654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=325.29 Aligned_cols=268 Identities=15% Similarity=0.185 Sum_probs=199.0
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCC--------CCceeeeeeEEe---
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMS--------HKNILKFVGCCL--- 120 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~~~~~~~--- 120 (344)
.++|...+.||+|+||+||+|+. +++.||+|++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 36799999999999999999988 6788999998754 233466789999999995 788999999987
Q ss_pred -eCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCC-CeeeecccccceEeecCC---
Q 048160 121 -ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSR-PIVFRDIKPSTILFQEQN--- 195 (344)
Q Consensus 121 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlk~~Nill~~~~--- 195 (344)
.+...++||||+ +++|.+.+..... ..+++.++..++.|++.||.||| +. +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNY---QGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhh
Confidence 456889999999 5666666644321 35899999999999999999999 87 999999999999998765
Q ss_pred ----------------------------------------------cceEeeeecccccCCCCcccccCCcccccccccc
Q 048160 196 ----------------------------------------------VAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIA 229 (344)
Q Consensus 196 ----------------------------------------------~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~a 229 (344)
.+||+|||++....... ....||+.|+|
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~------~~~~gt~~y~a 261 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF------TEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS------CSCCSCGGGCC
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC------ccCCCCCcccC
Confidence 79999999998764321 23478999999
Q ss_pred ccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcc--hhHHHHHHHHHhc-------cCCc-cccccccc--c-
Q 048160 230 PEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGE--EYFLQELVRKSIE-------SNSF-KEIVDPII--V- 296 (344)
Q Consensus 230 PE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~-------~~~~-~~~~~~~~--~- 296 (344)
||++.+..++.++|||||||++|+|++|..||......... ...+......... .... ...+.... .
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 99999999999999999999999999999999764332211 1111111110000 0000 00000000 0
Q ss_pred -cCCCC----------ChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 297 -GEEGL----------WPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 297 -~~~~~----------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..... +......+..+.+|+.+||+.||++|||+.+|++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00000 1112356678999999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=312.84 Aligned_cols=250 Identities=22% Similarity=0.269 Sum_probs=200.4
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
..++|...+.||+|+||.||+|+. +++.||+|++..... ...+.+.+|+.++++++||||+++++++......++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 345699999999999999999999 678999999865432 3456788999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC---CcceEeeeecc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ---NVAKFFDFCVS 205 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~dfg~a 205 (344)
|||+++++|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+||+++.+ +.++|+|||++
T Consensus 100 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp ECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEccCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999998886543 5889999999999999999999 9999999999999999754 46999999999
Q ss_pred cccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
......... ....+++.|+|||.+.+ .++.++||||||+++|+|++|..||..... . .....+ . ..
T Consensus 172 ~~~~~~~~~----~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~-~~~~~~---~-~~ 237 (287)
T 2wei_A 172 TCFQQNTKM----KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE----Y-DILKRV---E-TG 237 (287)
T ss_dssp GTBCCCSSC----SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----H-HHHHHH---H-HC
T ss_pred eeecCCCcc----ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH----H-HHHHHH---H-cC
Confidence 876543221 13468999999999865 489999999999999999999999875321 1 111111 1 11
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
... ...+.....+..+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~-----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 238 KYA-----------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCC-----------CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC-----------CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 100 011111133456899999999999999999999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=324.54 Aligned_cols=273 Identities=18% Similarity=0.201 Sum_probs=181.6
Q ss_pred CCC-CCccccCCCceEEEEEE----CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEee--CCccEEEE
Q 048160 57 YDP-EKVITKDLLYKLYKGFL----QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLE--TELPILVF 129 (344)
Q Consensus 57 ~~~-~~~ig~G~~g~V~~~~~----~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~lv~ 129 (344)
|.. .++||+|+||+||+|++ .+..||+|++.... ....+.+|+.++++++||||+++++++.. +...++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 554 56899999999999997 36789999987553 23567899999999999999999999965 66889999
Q ss_pred eecCCCCccccccCCC----CCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe----ecCCcceEee
Q 048160 130 EFVACGTLADRIHDPN----GSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF----QEQNVAKFFD 201 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~d 201 (344)
||+. |+|.+++.... ......+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9996 68887764211 001124889999999999999999999 9999999999999999 6778999999
Q ss_pred eecccccCCCCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCc-----chhHHH
Q 048160 202 FCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENG-----EEYFLQ 275 (344)
Q Consensus 202 fg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~~~~ 275 (344)
||+++................||+.|+|||++.+. .++.++|||||||++|+|++|..||........ ....+.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 99998765433222222346789999999998874 589999999999999999999999975433110 011122
Q ss_pred HHHHHHhccC--Ccccccc---------cccccCCCCChhhH-------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 276 ELVRKSIESN--SFKEIVD---------PIIVGEEGLWPEKE-------KQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 276 ~~~~~~~~~~--~~~~~~~---------~~~~~~~~~~~~~~-------~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+.....+. .+..... .............. ..+..+.+|+.+||+.||++|||+.++++
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 2222111110 0000000 00000000000000 01345789999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=318.71 Aligned_cols=254 Identities=19% Similarity=0.244 Sum_probs=176.8
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc-hhhhHhhHHH-HHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS-EEYCCFNCIA-FASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~-~~~~~~~E~~-~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
.++|...+.||+|+||.||+|.. +++.||||++...... ....+.+|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 46788999999999999999999 5889999999765432 2344556665 778889999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCC-CeeeecccccceEeecCCcceEeeeeccccc
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSR-PIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
||+. |+|.+++..........+++..+..++.|++.||.||| +. +|+||||||+||+++.++.+||+|||++...
T Consensus 101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9997 58877765210000036889999999999999999999 88 9999999999999999999999999999766
Q ss_pred CCCCcccccCCcccccccccccccc----CcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYM----STANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES 284 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (344)
...... ....||+.|+|||++ .+..++.++||||||+++|+|++|..||......
T Consensus 177 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----------------- 235 (327)
T 3aln_A 177 VDSIAK----TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV----------------- 235 (327)
T ss_dssp ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------------
T ss_pred cccccc----ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-----------------
Confidence 433221 134689999999998 4566899999999999999999999998643110
Q ss_pred CCcccccccccccCCCCChh--hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 285 NSFKEIVDPIIVGEEGLWPE--KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+.+.....+..+..+. ....+..+.+|+..||+.||++|||+.+|++
T Consensus 236 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 236 ---FDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---HHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00011111111111110 0123456899999999999999999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=318.10 Aligned_cols=261 Identities=17% Similarity=0.254 Sum_probs=195.5
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch--hhhHhhHHHHHhcCCCCceeeeeeEEeeCCcc----
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE--EYCCFNCIAFASQMSHKNILKFVGCCLETELP---- 125 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~---- 125 (344)
.++|...+.||+|+||.||+|.. +++.||+|++....... ...+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46788899999999999999998 68899999997654333 46678999999999999999999999877654
Q ss_pred --EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeee
Q 048160 126 --ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFC 203 (344)
Q Consensus 126 --~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg 203 (344)
++||||+. ++|.+++.. .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred eEEEEEcccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999997 688887743 4889999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
+++...... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ...+........
T Consensus 190 ~a~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~ 259 (371)
T 4exu_A 190 LARHADAEM------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY----LDQLTQILKVTG 259 (371)
T ss_dssp CC--------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHC
T ss_pred cccccccCc------CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhC
Confidence 997654321 13567999999999877 6789999999999999999999999975421 111222211110
Q ss_pred ccCC-----c-----ccccccccccCCCCChh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ESNS-----F-----KEIVDPIIVGEEGLWPE-KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ~~~~-----~-----~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... . ..............+.. .+..+..+.+|+.+||+.||++|||+.++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0000 0 00000000000000000 0123567899999999999999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=316.13 Aligned_cols=275 Identities=16% Similarity=0.155 Sum_probs=189.8
Q ss_pred cHHHHHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCC
Q 048160 46 TAQELKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETE 123 (344)
Q Consensus 46 ~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~ 123 (344)
...+.....++|...+.||+|+||.||+|+. ++..||||++..... ......+++..++.++||||+++++++....
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp SSHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 3445667778999999999999999999998 578999999865432 2345667888889999999999999987644
Q ss_pred c-------cEEEEeecCCCCccccccC---CCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec
Q 048160 124 L-------PILVFEFVACGTLADRIHD---PNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE 193 (344)
Q Consensus 124 ~-------~~lv~e~~~~gsL~~~l~~---~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~ 193 (344)
. .++||||+++ +|...+.. .. ..+++..+..++.|++.||.|||.. +.+|+||||||+|||++.
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~ 166 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQ----VAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNE 166 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEET
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeC
Confidence 3 7899999985 55443321 11 3578889999999999999999943 679999999999999997
Q ss_pred -CCcceEeeeecccccCCCCcccccCCccccccccccccccCcCC-CCcccchHHHHHHHHHHHcCCCCCCCCCccCcch
Q 048160 194 -QNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTAN-CNEKSDVYSFGALLLELLTGKRISYSSCFENGEE 271 (344)
Q Consensus 194 -~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 271 (344)
++.+||+|||++......... ....||+.|+|||++.+.. ++.++||||||+++|+|++|..||..... .
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~----~ 238 (360)
T 3e3p_A 167 ADGTLKLCDFGSAKKLSPSEPN----VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS----A 238 (360)
T ss_dssp TTTEEEECCCTTCBCCCTTSCC----CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----H
T ss_pred CCCcEEEeeCCCceecCCCCCc----ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh----H
Confidence 899999999999876543322 1456899999999986654 89999999999999999999999975422 2
Q ss_pred hHHHHHHHHHhccCC-------cccccccccccCCCCChh-----hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 272 YFLQELVRKSIESNS-------FKEIVDPIIVGEEGLWPE-----KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 272 ~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+............ ...............|.. ....+..+.+|+.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 239 GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 222222221110000 000000000000000110 0024567999999999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=325.41 Aligned_cols=264 Identities=18% Similarity=0.198 Sum_probs=190.9
Q ss_pred cCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCc------cEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETEL------PIL 127 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~------~~l 127 (344)
.+|...+.||+|+||+||+|+. .+..||+|++.... ....+|+.+++.++||||+++++++..... .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 4588899999999999999999 66679999986542 223479999999999999999999865433 789
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEee-cCCcceEeeeeccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ-EQNVAKFFDFCVSI 206 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~dfg~a~ 206 (344)
||||++++ +...+..... ....+++..+..++.|++.||.||| +.+|+||||||+|||++ .++.+||+|||+++
T Consensus 116 v~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 116 VLEYVPET-VYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEECCSEE-HHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EeeccCcc-HHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 99999854 4333221000 0035889999999999999999999 99999999999999999 79999999999998
Q ss_pred ccCCCCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
........ ....+|+.|+|||++.+. .++.++|||||||++|||++|..||..... ...+...+.....+.
T Consensus 191 ~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~l~~i~~~~g~p~ 262 (394)
T 4e7w_A 191 ILIAGEPN----VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG----IDQLVEIIKVLGTPS 262 (394)
T ss_dssp ECCTTCCC----CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCC
T ss_pred cccCCCCC----cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCC
Confidence 76443322 145789999999998765 589999999999999999999999975422 122222222110000
Q ss_pred C------ccccccccccc-CCCCChh--hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 S------FKEIVDPIIVG-EEGLWPE--KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ~------~~~~~~~~~~~-~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. ........... ....+.. ....+.++.+|+.+||+.||++|||+.++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0 00000000000 0000000 0123457899999999999999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=326.33 Aligned_cols=262 Identities=21% Similarity=0.252 Sum_probs=191.6
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeC------CccE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLET------ELPI 126 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~------~~~~ 126 (344)
..|...+.||+|+||.||+|++ +++.||||++.... ....+|+.++++++||||+++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 3588889999999999999999 68899999986542 2345799999999999999999998542 1367
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC-CcceEeeeecc
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ-NVAKFFDFCVS 205 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~dfg~a 205 (344)
+||||+++ +|.+.+..... ....+++..+..++.|++.||.||| +.+|+||||||+|||++.+ +.+||+|||++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eehhcccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 99999974 66655432100 0035889999999999999999999 9999999999999999965 57899999999
Q ss_pred cccCCCCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc
Q 048160 206 ISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES 284 (344)
Q Consensus 206 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (344)
+........ ....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+.+.+.....+
T Consensus 205 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~----~~~l~~i~~~lg~p 276 (420)
T 1j1b_A 205 KQLVRGEPN----VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQLVEIIKVLGTP 276 (420)
T ss_dssp EECCTTCCC----CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCSC
T ss_pred hhcccCCCc----eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCC
Confidence 876443222 245789999999998764 789999999999999999999999975421 22222222211100
Q ss_pred ---------CCcccccccccccCCCCChh--hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 285 ---------NSFKEIVDPIIVGEEGLWPE--KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 285 ---------~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.......-+.+ ....|.. ....+.++.+|+.+||+.||++|||+.|+++
T Consensus 277 ~~~~~~~~~~~~~~~~~p~~--~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 277 TREQIREMNPNYTEFKFPQI--KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CHHHHHHHCSCCCCCCCCCC--CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHhhChhhhhhccCcc--CCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00000000000 0001110 0123457899999999999999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=309.48 Aligned_cols=252 Identities=19% Similarity=0.300 Sum_probs=189.9
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEee----------
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLE---------- 121 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~---------- 121 (344)
.++|+..+.||+|+||.||+|+. +++.||+|++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45688899999999999999998 6889999998543 2334668899999999999999999998865
Q ss_pred ---CCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcce
Q 048160 122 ---TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAK 198 (344)
Q Consensus 122 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 198 (344)
....++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEE
Confidence 356799999999999999997543 35788899999999999999999 99999999999999999999999
Q ss_pred EeeeecccccCCCCcc-----------cccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCc
Q 048160 199 FFDFCVSISIPEGKTH-----------VNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCF 266 (344)
Q Consensus 199 l~dfg~a~~~~~~~~~-----------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~ 266 (344)
|+|||++......... ........|++.|+|||++.+. .++.++||||||+++|+|++ ||....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~- 232 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM- 232 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-
Confidence 9999998766432110 1111245689999999999764 68999999999999999998 553211
Q ss_pred cCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 267 ENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.......... .... .+ .+..+ ...+..+.+|+.+||+.||++|||+.++++
T Consensus 233 ------~~~~~~~~~~-~~~~--~~-------~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 ------ERVNILKKLR-SVSI--EF-------PPDFD--DNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ------HHHHHHHHHH-STTC--CC-------CTTCC--TTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------hHHHHHHhcc-cccc--cc-------Ccccc--ccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1111111111 1000 00 00011 133456789999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=311.37 Aligned_cols=262 Identities=18% Similarity=0.207 Sum_probs=199.5
Q ss_pred cCCCCCCccccCCCceEEEEEE---CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCC------ceeeeeeEEeeCCcc
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL---QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHK------NILKFVGCCLETELP 125 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~---~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~------niv~~~~~~~~~~~~ 125 (344)
++|...+.||+|+||.||+|.. +++.||+|++.... ...+.+.+|+.+++.++|+ +|+++++++...+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 5788999999999999999987 57889999986542 3346678999999998765 499999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec------------
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE------------ 193 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~------------ 193 (344)
++||||+ +++|.+++..... .++++.++..++.|++.||.||| +.+|+||||||+||+++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGF---LPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred EEEEcCC-CCCHHHHHHhcCC---CCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccc
Confidence 9999999 7999999876542 35889999999999999999999 999999999999999987
Q ss_pred -------CCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCc
Q 048160 194 -------QNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCF 266 (344)
Q Consensus 194 -------~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 266 (344)
++.++|+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|..||.....
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEHH------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSCC------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred cccccccCCCceEeeCcccccCcccc------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 6689999999997654321 245789999999999998999999999999999999999999965422
Q ss_pred cCcchhHHHHHHHHHhccCC--------ccccccc-----------------ccccCCCCChhhHHHHHHHHHHHHHccc
Q 048160 267 ENGEEYFLQELVRKSIESNS--------FKEIVDP-----------------IIVGEEGLWPEKEKQLLSYTELAIKCLS 321 (344)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 321 (344)
...... +........ ....+.. ...............+..+.+|+.+||+
T Consensus 240 ----~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 240 ----KEHLAM-MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp ----HHHHHH-HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred ----HHHHHH-HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence 111111 111110000 0000000 0000000000112456779999999999
Q ss_pred cCCCCCCCHHHHHH
Q 048160 322 KSEQDRPTMVQVAK 335 (344)
Q Consensus 322 ~dP~~RPs~~ei~~ 335 (344)
.||++|||+.||++
T Consensus 315 ~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 315 YDPAKRITLREALK 328 (339)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred cCcccccCHHHHhc
Confidence 99999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=332.31 Aligned_cols=249 Identities=21% Similarity=0.298 Sum_probs=185.1
Q ss_pred cCCCCCCccccCCCce-EEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEEEeec
Q 048160 55 NNYDPEKVITKDLLYK-LYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~-V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
.+|...+.||+|+||+ ||++..+++.||||++.... ...+.+|+.+++++ +|||||++++++.+....++|||||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 4588889999999998 55666699999999987653 33467899999999 7999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec---C--CcceEeeeecccc
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE---Q--NVAKFFDFCVSIS 207 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~--~~~kl~dfg~a~~ 207 (344)
. |+|.+++..... .+...++..++.|++.||.||| +.+|+||||||+|||++. + ..++|+|||+++.
T Consensus 101 ~-g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 101 A-ATLQEYVEQKDF----AHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp S-EEHHHHHHSSSC----CCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred C-CCHHHHHHhcCC----CccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 6 699999976542 3444556789999999999999 999999999999999953 2 3577999999987
Q ss_pred cCCCCcccccCCccccccccccccccC---cCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhc
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMS---TANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIE 283 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (344)
...............||+.|+|||++. ...++.++|||||||++|||++ |..||..... .... ....
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-----~~~~----~~~~ 243 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-----RQAN----ILLG 243 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-----HHHH----HHTT
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-----HHHH----HHhc
Confidence 754432222223457899999999997 3567889999999999999999 7777743211 0000 0010
Q ss_pred cCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 284 SNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... ............+.+|+.+||+.||++|||+.+|++
T Consensus 244 ~~~~------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 244 ACSL------------DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCCC------------TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCc------------cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0000 000111144556889999999999999999999984
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=315.28 Aligned_cols=269 Identities=17% Similarity=0.205 Sum_probs=200.1
Q ss_pred HHhcCCCCCCccccCCCceEEEEEE---CCccEEEEEecCCCC--chhhhHhhHHHHHhcC---CCCceeeeeeEEe---
Q 048160 52 AATNNYDPEKVITKDLLYKLYKGFL---QDRPISVMKFGGNLN--SEEYCCFNCIAFASQM---SHKNILKFVGCCL--- 120 (344)
Q Consensus 52 ~~~~~~~~~~~ig~G~~g~V~~~~~---~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~~~~~~~--- 120 (344)
...++|...+.||+|+||.||+|+. +++.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3457799999999999999999998 467899999865432 2234566888877776 8999999999987
Q ss_pred --eCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcce
Q 048160 121 --ETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAK 198 (344)
Q Consensus 121 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 198 (344)
.....++||||+. |+|.+++..... ..+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEE
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEE
Confidence 4567899999997 699999875432 24889999999999999999999 99999999999999999999999
Q ss_pred EeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHH
Q 048160 199 FFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELV 278 (344)
Q Consensus 199 l~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 278 (344)
|+|||++....... ......|+..|+|||++.+..++.++||||||+++|+|++|..||..... ...+....
T Consensus 161 l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~i~ 232 (326)
T 1blx_A 161 LADFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD----VDQLGKIL 232 (326)
T ss_dssp ECSCCSCCCCCGGG----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHH
T ss_pred EecCcccccccCCC----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHH
Confidence 99999987654322 11245689999999999988999999999999999999999999875422 22222222
Q ss_pred HHHhccC--Cccccc---ccccc-cCCCCCh-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 279 RKSIESN--SFKEIV---DPIIV-GEEGLWP-EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 279 ~~~~~~~--~~~~~~---~~~~~-~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
....... .+.... ..... ....... .....+..+.+|+.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 233 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 2111100 000000 00000 0000000 00123456889999999999999999999984
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=317.52 Aligned_cols=251 Identities=19% Similarity=0.243 Sum_probs=171.8
Q ss_pred hcCCCCC-CccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEee----CCccE
Q 048160 54 TNNYDPE-KVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLE----TELPI 126 (344)
Q Consensus 54 ~~~~~~~-~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----~~~~~ 126 (344)
.++|... +.||+|+||.||+|.. +++.||+|++.... ....+....++.+.||||+++++++.. +...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4568874 4699999999999999 58899999986531 122223345667799999999999876 44589
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec---CCcceEeeee
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE---QNVAKFFDFC 203 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~dfg 203 (344)
+||||+++|+|.+++....+ ..+++.++..++.|++.||.||| +.+|+||||||+||+++. ++.++|+|||
T Consensus 103 lv~e~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 99999999999999976543 35899999999999999999999 999999999999999976 4559999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhc
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE 283 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (344)
++........ ....+|+.|+|||++.+..++.++||||||+++|+|++|..||.............. ...
T Consensus 177 ~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-----~~~ 246 (336)
T 3fhr_A 177 FAKETTQNAL-----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR-----RIR 246 (336)
T ss_dssp TCEEC---------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred cceecccccc-----ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH-----hhh
Confidence 9976543221 135679999999999888899999999999999999999999965432111000000 000
Q ss_pred cCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 284 SNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
... . ....+.....+..+.+|+.+||+.||++|||+.++++
T Consensus 247 ~~~--------~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 247 LGQ--------Y---GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ---------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccc--------c---ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 0 0000111134556899999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=313.34 Aligned_cols=261 Identities=17% Similarity=0.244 Sum_probs=195.1
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch--hhhHhhHHHHHhcCCCCceeeeeeEEeeCCc-----
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE--EYCCFNCIAFASQMSHKNILKFVGCCLETEL----- 124 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~----- 124 (344)
.++|...+.||+|+||.||+|.. +++.||||++....... .+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 35688899999999999999998 68899999997654322 3567899999999999999999999987654
Q ss_pred -cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeee
Q 048160 125 -PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFC 203 (344)
Q Consensus 125 -~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg 203 (344)
.++||||+. ++|.+++.. .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred eEEEEecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecc
Confidence 499999997 688888753 4889999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
++....... ....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ...+........
T Consensus 172 ~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~ 241 (353)
T 3coi_A 172 LARHADAEM------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY----LDQLTQILKVTG 241 (353)
T ss_dssp CTTC--------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH----HHHHHHHHHHHC
T ss_pred cccCCCCCc------cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhC
Confidence 987653221 13467999999999877 6789999999999999999999999975421 111222111110
Q ss_pred ccC-----Cc-----ccccccccccCCCCCh-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ESN-----SF-----KEIVDPIIVGEEGLWP-EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ~~~-----~~-----~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
... .. ...+..........++ .....+..+.+|+.+||+.||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp BCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 00 0000000000000011 01134567899999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=314.78 Aligned_cols=268 Identities=17% Similarity=0.166 Sum_probs=197.7
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeC-----Ccc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLET-----ELP 125 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----~~~ 125 (344)
.++|...+.||+|+||.||+|.. +++.||||++...... ....+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 46788999999999999999998 5889999999754332 245677999999999999999999998764 678
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
++||||+. ++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 90 ~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEeccC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 99999997 6899988753 4889999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCcccc-------cCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHH
Q 048160 206 ISIPEGKTHVN-------DNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL 277 (344)
Q Consensus 206 ~~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 277 (344)
........... ......||+.|+|||++.. ..++.++||||||+++|+|++|..||..... ...+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~ 235 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY----RHQLLLI 235 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHH
Confidence 87653321110 1123468999999998754 6789999999999999999999999875421 1111111
Q ss_pred HHHHhccCC---cccc--------cccccccCCCCCh-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 278 VRKSIESNS---FKEI--------VDPIIVGEEGLWP-EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 278 ~~~~~~~~~---~~~~--------~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
......+.. .... ............. ..+..+..+.+|+.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 111111000 0000 0000000000000 00133456899999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=315.04 Aligned_cols=251 Identities=20% Similarity=0.298 Sum_probs=178.7
Q ss_pred HhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch-h-hhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE-E-YCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~-~-~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
..++|...+.||+|+||.||+|++ +++.||||++....... . +.+..+..+++.++||||+++++++..++..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 346688889999999999999999 68899999987654322 2 2334555678888999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCC-CeeeecccccceEeecCCcceEeeeecccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSR-PIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
|||+ ++.+..+..... ..+++..+..++.|++.||.||| +. +|+||||||+||+++.++.++|+|||++..
T Consensus 103 ~e~~-~~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp ECCC-SEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred Eecc-CCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 9999 455555544322 25889999999999999999999 85 999999999999999999999999999876
Q ss_pred cCCCCcccccCCccccccccccccccC-----cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMS-----TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
....... ....+++.|+|||++. ...++.++||||||+++|+|++|..||..... .........
T Consensus 175 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~---- 243 (318)
T 2dyl_A 175 LVDDKAK----DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT---DFEVLTKVL---- 243 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS---HHHHHHHHH----
T ss_pred ccCCccc----cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc---cHHHHHHHh----
Confidence 5433221 1346899999999984 45688999999999999999999999864321 111111111
Q ss_pred ccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.. ..+..+.....+..+.+|+.+||+.||++|||+.+|++
T Consensus 244 ~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 244 QE-------------EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HS-------------CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cc-------------CCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11 01111111123456889999999999999999999876
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=326.19 Aligned_cols=253 Identities=21% Similarity=0.259 Sum_probs=183.4
Q ss_pred CCCCCccccCCCceEEEEE-ECCccEEEEEecCCCCchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 57 YDPEKVITKDLLYKLYKGF-LQDRPISVMKFGGNLNSEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~-~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
|...+.||+|+||+||.+. .+++.||||++..+ ..+.+.+|+.+++++ +||||+++++++.++...++|||||.
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 4446789999999996544 48999999998654 245677999999886 89999999999999999999999996
Q ss_pred CCccccccCCCCCCC--ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC-------------CcceE
Q 048160 135 GTLADRIHDPNGSQL--EPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ-------------NVAKF 199 (344)
Q Consensus 135 gsL~~~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-------------~~~kl 199 (344)
|+|.+++........ ....+..++.++.|++.||.||| +.+|+||||||+|||++.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 699999976542110 01123345779999999999999 9999999999999999754 48999
Q ss_pred eeeecccccCCCCccc-ccCCccccccccccccccCc-------CCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcc
Q 048160 200 FDFCVSISIPEGKTHV-NDNNKVIGTFGFIAPEYMST-------ANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGE 270 (344)
Q Consensus 200 ~dfg~a~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~ 270 (344)
+|||++.......... .......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.....
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---- 245 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS---- 245 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT----
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh----
Confidence 9999998775433211 11224578999999999865 568999999999999999999 8888854321
Q ss_pred hhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 271 EYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.......... ... ..........+.++.+|+.+||+.||++|||+.+|++
T Consensus 246 --~~~~i~~~~~---~~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 --RESNIIRGIF---SLD----------EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --HHHHHHHTCC---CCC----------CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --hHHHHhcCCC---Ccc----------cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0011111100 000 0011112356678999999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=317.62 Aligned_cols=246 Identities=17% Similarity=0.258 Sum_probs=198.2
Q ss_pred HHHHHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc------hhhhHhhHHHHHhcCC--CCceeeee
Q 048160 47 AQELKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS------EEYCCFNCIAFASQMS--HKNILKFV 116 (344)
Q Consensus 47 ~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~~~ 116 (344)
..+.....++|...+.||+|+||.||+|.. +++.||||.+...... ....+.+|+.++++++ |+||++++
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 344445567899999999999999999998 7889999998765322 2245678999999996 59999999
Q ss_pred eEEeeCCccEEEEeecCC-CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEee-cC
Q 048160 117 GCCLETELPILVFEFVAC-GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ-EQ 194 (344)
Q Consensus 117 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~ 194 (344)
+++...+..++|+|++.+ ++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++ .+
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNR 186 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTT
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCC
Confidence 999999999999999976 89999987643 5889999999999999999999 99999999999999999 78
Q ss_pred CcceEeeeecccccCCCCcccccCCccccccccccccccCcCCC-CcccchHHHHHHHHHHHcCCCCCCCCCccCcchhH
Q 048160 195 NVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANC-NEKSDVYSFGALLLELLTGKRISYSSCFENGEEYF 273 (344)
Q Consensus 195 ~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 273 (344)
+.+||+|||++........ ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||....
T Consensus 187 ~~~kL~Dfg~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------- 253 (320)
T 3a99_A 187 GELKLIDFGSGALLKDTVY-----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------- 253 (320)
T ss_dssp TEEEECCCTTCEECCSSCB-----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------
T ss_pred CCEEEeeCccccccccccc-----cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------
Confidence 8999999999987653321 13468999999999877765 688999999999999999999985421
Q ss_pred HHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 274 LQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
... ... . .+ .. ..+..+.+|+.+||+.||++|||+.+|++
T Consensus 254 --~~~----~~~-~--~~-------~~------~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 254 --EII----RGQ-V--FF-------RQ------RVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp --HHH----HCC-C--CC-------SS------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --hhh----ccc-c--cc-------cc------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000 0 00 00 22346889999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=312.88 Aligned_cols=261 Identities=18% Similarity=0.249 Sum_probs=196.3
Q ss_pred ccccHHHHHHHhcCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCC--chhhhHhhHHHHHhcCC--CCceeeeee
Q 048160 43 QNFTAQELKAATNNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMS--HKNILKFVG 117 (344)
Q Consensus 43 ~~~~~~~i~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~--H~niv~~~~ 117 (344)
+.+.++.+....++|...+.||+|+||.||++.. +++.||+|++..... ...+.+.+|+.++.+++ |+||+++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 3445555555667799999999999999999998 678899999865432 23466889999999997 599999999
Q ss_pred EEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcc
Q 048160 118 CCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA 197 (344)
Q Consensus 118 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 197 (344)
++..++..++||| +.+++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++ ++.+
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~-~~~~ 165 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGML 165 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEE
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEE-CCeE
Confidence 9999999999999 55789999997653 5889999999999999999999 99999999999999996 5899
Q ss_pred eEeeeecccccCCCCcccccCCccccccccccccccCc-----------CCCCcccchHHHHHHHHHHHcCCCCCCCCCc
Q 048160 198 KFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-----------ANCNEKSDVYSFGALLLELLTGKRISYSSCF 266 (344)
Q Consensus 198 kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 266 (344)
||+|||++.......... ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus 166 kL~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (313)
T 3cek_A 166 KLIDFGIANQMQPDTTSV-VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244 (313)
T ss_dssp EECCCSSSCC---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred EEeeccccccccCccccc-cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH
Confidence 999999998764432211 1123468999999999865 4688999999999999999999999864321
Q ss_pred cCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 267 ENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
... ............ . .+. ..+..+.+|+.+||+.||++|||+.++++
T Consensus 245 ---~~~----~~~~~~~~~~~~---------~---~~~--~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 245 ---QIS----KLHAIIDPNHEI---------E---FPD--IPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp ---HHH----HHHHHHCTTSCC---------C---CCC--CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---HHH----HHHHHHhccccc---------C---Ccc--cchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 011 111111111000 0 000 12346889999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=316.66 Aligned_cols=201 Identities=19% Similarity=0.252 Sum_probs=169.8
Q ss_pred HHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCC-CC-----ceeeeeeEEeeCC
Q 048160 52 AATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-HK-----NILKFVGCCLETE 123 (344)
Q Consensus 52 ~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~~~~~~~~~~ 123 (344)
...++|...+.||+|+||+||+|.. +++.||||++.... .....+.+|+.+++.++ |+ +|+++++++...+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 3457899999999999999999998 67889999987542 23456778888888885 44 4999999999999
Q ss_pred ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEee--cCCcceEee
Q 048160 124 LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ--EQNVAKFFD 201 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~d 201 (344)
..++||||+. |+|.+++..... ..+++..+..++.|++.||.|||+. ..+|+||||||+|||++ .++.+||+|
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred ceEEEEecCC-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 9999999996 699999876432 2588999999999999999999932 36899999999999995 477899999
Q ss_pred eecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCC
Q 048160 202 FCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSS 264 (344)
Q Consensus 202 fg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 264 (344)
||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 205 FG~a~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 205 FGSSCQLGQRI------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CTTCEETTCCC------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCceeccccc------ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99998764321 1457899999999999999999999999999999999999999754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=313.41 Aligned_cols=243 Identities=20% Similarity=0.294 Sum_probs=190.0
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc------hhhhHhhHHHHHhcC----CCCceeeeee
Q 048160 50 LKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS------EEYCCFNCIAFASQM----SHKNILKFVG 117 (344)
Q Consensus 50 i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~------~~~~~~~E~~~l~~l----~H~niv~~~~ 117 (344)
.....++|...+.||+|+||.||+|+. +++.||+|.+...... ....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 445567899999999999999999998 6788999998655321 234466899999999 8999999999
Q ss_pred EEeeCCccEEEEee-cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEee-cCC
Q 048160 118 CCLETELPILVFEF-VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ-EQN 195 (344)
Q Consensus 118 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~ 195 (344)
++...+..++|+|| +.+++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++ .++
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTT
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCC
Confidence 99999999999999 78899999997643 5899999999999999999999 99999999999999999 889
Q ss_pred cceEeeeecccccCCCCcccccCCccccccccccccccCcCCCC-cccchHHHHHHHHHHHcCCCCCCCCCccCcchhHH
Q 048160 196 VAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCN-EKSDVYSFGALLLELLTGKRISYSSCFENGEEYFL 274 (344)
Q Consensus 196 ~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 274 (344)
.++|+|||++........ ....|+..|+|||++.+..+. .++||||||+++|+|++|..||....
T Consensus 178 ~~kl~dfg~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------- 243 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEPY-----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------- 243 (312)
T ss_dssp EEEECCCSSCEECCSSCB-----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------
T ss_pred eEEEEEcchhhhcccCcc-----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---------
Confidence 999999999887654321 135689999999998777664 58999999999999999999985321
Q ss_pred HHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 275 QELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... ... ..+. ..+..+.+|+.+||+.||++|||+.++++
T Consensus 244 -~~~~-----~~~-------------~~~~--~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 -EILE-----AEL-------------HFPA--HVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -HHHH-----TCC-------------CCCT--TSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -HHhh-----hcc-------------CCcc--cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0100 000 0000 23346889999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=317.68 Aligned_cols=267 Identities=15% Similarity=0.156 Sum_probs=196.8
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCC-----------CCceeeeeeEEee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-----------HKNILKFVGCCLE 121 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~~~~~~~~ 121 (344)
++|...+.||+|+||.||+|+. +++.||||++.... ...+.+.+|+.++++++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5688999999999999999998 78899999987542 23466789999999886 8999999999886
Q ss_pred CC----ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCC-CeeeecccccceEeec---
Q 048160 122 TE----LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSR-PIVFRDIKPSTILFQE--- 193 (344)
Q Consensus 122 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlk~~Nill~~--- 193 (344)
.. ..++||||+ +++|.+++..... ..+++..+..++.|++.||.||| +. +|+||||||+|||++.
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEET
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCC
Confidence 54 789999999 8999999876432 25889999999999999999999 87 9999999999999954
Q ss_pred ---CCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCc-
Q 048160 194 ---QNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENG- 269 (344)
Q Consensus 194 ---~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~- 269 (344)
.+.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEHY------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBCC------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CcCcceEEEcccccccccCCCC------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 3479999999997664321 134789999999999999999999999999999999999999975432110
Q ss_pred -chhHHHHHHHHHhcc-------CC-------cccccccccccCC--------CCChhhHHHHHHHHHHHHHccccCCCC
Q 048160 270 -EEYFLQELVRKSIES-------NS-------FKEIVDPIIVGEE--------GLWPEKEKQLLSYTELAIKCLSKSEQD 326 (344)
Q Consensus 270 -~~~~~~~~~~~~~~~-------~~-------~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~l~~~cl~~dP~~ 326 (344)
....+.......... .. ............. .........+..+.+|+.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 111111111110000 00 0000000000000 001112356778999999999999999
Q ss_pred CCCHHHHHH
Q 048160 327 RPTMVQVAK 335 (344)
Q Consensus 327 RPs~~ei~~ 335 (344)
|||+.+|++
T Consensus 325 Rpt~~ell~ 333 (373)
T 1q8y_A 325 RADAGGLVN 333 (373)
T ss_dssp CBCHHHHHT
T ss_pred cCCHHHHhh
Confidence 999999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=310.31 Aligned_cols=263 Identities=14% Similarity=0.175 Sum_probs=197.2
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CC-ccEEEEEecCCCCchhhhHhhHHHHHhcCCCCc------eeeeeeEEeeCCc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QD-RPISVMKFGGNLNSEEYCCFNCIAFASQMSHKN------ILKFVGCCLETEL 124 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~-~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~~~~~~~~~~~ 124 (344)
.++|...+.||+|+||.||+|.. .+ ..||+|.+.... ...+.+.+|+.++++++|++ ++.+++++.....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 36789999999999999999998 33 679999986542 33466788999999997665 9999999999999
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe-------------
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF------------- 191 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill------------- 191 (344)
.++||||+ +++|.+++..... ..+++.++..++.|++.||.||| +.+|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNF---QPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred EEEEEecc-CCChHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccc
Confidence 99999999 5777777654432 25889999999999999999999 9999999999999999
Q ss_pred ------ecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCC
Q 048160 192 ------QEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSC 265 (344)
Q Consensus 192 ------~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 265 (344)
+.++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|..||....
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEHH------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSCC------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccCCCcEEEeecCccccccccc------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 677899999999997643322 24578999999999999999999999999999999999999997543
Q ss_pred ccCcchhHHHHHHHHHhccCC--------ccccc-cc----------------ccccCCCCChhhHHHHHHHHHHHHHcc
Q 048160 266 FENGEEYFLQELVRKSIESNS--------FKEIV-DP----------------IIVGEEGLWPEKEKQLLSYTELAIKCL 320 (344)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~-~~----------------~~~~~~~~~~~~~~~~~~l~~l~~~cl 320 (344)
. ...+... ........ ....+ .. ...............+..+.+|+.+||
T Consensus 244 ~----~~~~~~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 318 (355)
T 2eu9_A 244 N----REHLVMM-EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML 318 (355)
T ss_dssp H----HHHHHHH-HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred H----HHHHHHH-HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHh
Confidence 2 1111111 11100000 00000 00 000000000011134567899999999
Q ss_pred ccCCCCCCCHHHHHH
Q 048160 321 SKSEQDRPTMVQVAK 335 (344)
Q Consensus 321 ~~dP~~RPs~~ei~~ 335 (344)
+.||++|||+.++++
T Consensus 319 ~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 319 EFDPAQRITLAEALL 333 (355)
T ss_dssp CSSTTTSCCHHHHTT
T ss_pred cCChhhCcCHHHHhc
Confidence 999999999999874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=335.15 Aligned_cols=272 Identities=18% Similarity=0.223 Sum_probs=199.9
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEee------CCc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLE------TEL 124 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~------~~~ 124 (344)
.++|...+.||+|+||.||+|.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36799999999999999999998 688999999876533 334668899999999999999999998765 667
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCc---ceEee
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNV---AKFFD 201 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~d 201 (344)
.++||||+++|+|.+++...... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++. ++|+|
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~--~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENC--CGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCT--TCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred EEEEEEeCCCCCHHHHHHhcccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 89999999999999999764421 25888899999999999999999 999999999999999997664 89999
Q ss_pred eecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHH
Q 048160 202 FCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS 281 (344)
Q Consensus 202 fg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 281 (344)
||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.... ..+....
T Consensus 168 FG~a~~~~~~~~~----~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-------~~~~~~i 236 (676)
T 3qa8_A 168 LGYAKELDQGELC----TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-------VQWHGKV 236 (676)
T ss_dssp CCCCCBTTSCCCC----CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-------HHSSTTC
T ss_pred ccccccccccccc----ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-------hhhhhhh
Confidence 9999876543322 2457899999999999999999999999999999999999999754211 0000000
Q ss_pred hccCCccccccccccc-----CCCCCh--hhHHHHHHHHHHHHHccccCCCCCCCHHH-----HHHHHHHHH
Q 048160 282 IESNSFKEIVDPIIVG-----EEGLWP--EKEKQLLSYTELAIKCLSKSEQDRPTMVQ-----VAKQLRQLH 341 (344)
Q Consensus 282 ~~~~~~~~~~~~~~~~-----~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~e-----i~~~L~~l~ 341 (344)
...............+ .....| .....+..+.+|+..||++||++|||+.+ ..+.+..+.
T Consensus 237 ~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp C------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred hcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 0000000000000000 000111 11245677999999999999999999987 445555443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=298.31 Aligned_cols=229 Identities=11% Similarity=0.073 Sum_probs=182.3
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch---hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE---EYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
+.|...+.||+|+||.||+|++ .++.||+|.+....... .+.+.+|+..+.+++||||+++++++..++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 5699999999999999999999 48899999997664322 366889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+++++|.+++... ....++..++.|++.||.||| +.+|+||||||+|||++.++.++|++++.
T Consensus 111 e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~~----- 175 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPAT----- 175 (286)
T ss_dssp ECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCCC-----
T ss_pred EecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEeccc-----
Confidence 999999999999542 244568889999999999999 99999999999999999999999874432
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
++ .++.++||||||+++|+|++|+.||........ +.
T Consensus 176 ------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-----------------~~- 212 (286)
T 3uqc_A 176 ------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-----------------LA- 212 (286)
T ss_dssp ------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-----------------SE-
T ss_pred ------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-----------------hH-
Confidence 22 368999999999999999999999975432110 00
Q ss_pred ccccccccCCCCC-hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 290 IVDPIIVGEEGLW-PEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 290 ~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.......+..... ......+..+.+|+.+||+.||++| |+.++++.|.++..
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 213 PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp ECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred HHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 0001111111100 0011345678999999999999999 99999999998754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=330.66 Aligned_cols=240 Identities=21% Similarity=0.301 Sum_probs=193.6
Q ss_pred hcCCCCCCccccCCCceEEEEEE---CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCc-----
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL---QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETEL----- 124 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~---~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~----- 124 (344)
.++|.+.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 36799999999999999999998 478899999865433 234567899999999999999999999987665
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeec
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV 204 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~ 204 (344)
.|+||||+++++|.+++.. .+++.+++.++.|++.||.||| +.+|+||||||+|||++.+ .+||+|||+
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred eEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEeccc
Confidence 6999999999999987754 4889999999999999999999 9999999999999999875 899999999
Q ss_pred ccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc
Q 048160 205 SISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES 284 (344)
Q Consensus 205 a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (344)
++..... ....||+.|+|||++.+.. +.++||||||+++|+|++|..||.....
T Consensus 228 a~~~~~~-------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~------------------ 281 (681)
T 2pzi_A 228 VSRINSF-------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV------------------ 281 (681)
T ss_dssp CEETTCC-------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC------------------
T ss_pred chhcccC-------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc------------------
Confidence 9876433 2457899999999986654 8999999999999999999887643211
Q ss_pred CCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHh
Q 048160 285 NSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-TMVQVAKQLRQLHK 342 (344)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~ei~~~L~~l~~ 342 (344)
... .. .......+..+.+|+.+||+.||++|| +++++.+.|..+.+
T Consensus 282 ~~~-----------~~-~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 282 DGL-----------PE-DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp SSC-----------CT-TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ccc-----------cc-cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 000 00 011113446789999999999999999 57777777776643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=294.00 Aligned_cols=227 Identities=19% Similarity=0.264 Sum_probs=178.0
Q ss_pred cCCCCC-CccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHH-hcCCCCceeeeeeEEee----CCccE
Q 048160 55 NNYDPE-KVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFA-SQMSHKNILKFVGCCLE----TELPI 126 (344)
Q Consensus 55 ~~~~~~-~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~~~~~~~~----~~~~~ 126 (344)
++|... +.||+|+||.||+|.. +++.||+|.+.. ...+.+|+.++ +.++||||+++++++.. +...+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 557666 7799999999999998 678999999854 24567888887 55689999999999887 67789
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec---CCcceEeeee
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE---QNVAKFFDFC 203 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~dfg 203 (344)
+||||+++|+|.+++....+ ..+++.++..++.|++.||.||| +.+|+||||||+||+++. ++.++|+|||
T Consensus 92 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 99999999999999976542 35899999999999999999999 999999999999999998 7889999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhc
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE 283 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (344)
++.... +..++.++||||||+++|+|++|..||........
T Consensus 166 ~a~~~~-------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-------------- 206 (299)
T 3m2w_A 166 FAKETT-------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------------- 206 (299)
T ss_dssp TCEECT-------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------
T ss_pred cccccc-------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh--------------
Confidence 985432 23467899999999999999999999965321000
Q ss_pred cCCcccccccccccCCCCChh--hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 284 SNSFKEIVDPIIVGEEGLWPE--KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.......... .....+. ....+.++.+|+.+||+.||++|||+.++++
T Consensus 207 ---~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 207 ---SPGMKTRIRM-GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp ----CCSCCSSCT-TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---hHHHHHHHhh-ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000011111 1111111 1234567999999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=309.35 Aligned_cols=237 Identities=13% Similarity=0.072 Sum_probs=177.2
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch---hhhHhhHHHHHhcCCC-Cceeee--------------
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE---EYCCFNCIAFASQMSH-KNILKF-------------- 115 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~---~~~~~~E~~~l~~l~H-~niv~~-------------- 115 (344)
+|...+.||+|+||+||+|++ +++.||||++....... .+.+.+|+.+++.++| +|...+
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 466778899999999999998 58999999987443322 5678899999999987 322111
Q ss_pred -------eeEEee-----CCccEEEEeecCCCCcccccc------CCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCC
Q 048160 116 -------VGCCLE-----TELPILVFEFVACGTLADRIH------DPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSR 177 (344)
Q Consensus 116 -------~~~~~~-----~~~~~lv~e~~~~gsL~~~l~------~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 177 (344)
+.+... ....+++|+++ +++|.+++. ... ..+++..++.++.|++.||.||| +.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~ 230 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTH----KSLVHHARLQLTLQVIRLLASLH---HY 230 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTS----HHHHHHHHHHHHHHHHHHHHHHH---HT
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccC----CCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 111111 22356777766 589998884 212 46888999999999999999999 99
Q ss_pred CeeeecccccceEeecCCcceEeeeecccccCCCCcccccCCcccccccccccccc----------CcCCCCcccchHHH
Q 048160 178 PIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYM----------STANCNEKSDVYSF 247 (344)
Q Consensus 178 ~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~Di~sl 247 (344)
+|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||
T Consensus 231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred CcccCCcccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 9999999999999999999999999998765432 124567 999999998 55568899999999
Q ss_pred HHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCC
Q 048160 248 GALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDR 327 (344)
Q Consensus 248 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 327 (344)
||++|||++|+.||...... .......... . ..+..+.+|+.+||+.||++|
T Consensus 304 Gvil~elltg~~Pf~~~~~~---------------------~~~~~~~~~~-~------~~~~~~~~li~~~l~~dP~~R 355 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAAL---------------------GGSEWIFRSC-K------NIPQPVRALLEGFLRYPKEDR 355 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGG---------------------SCSGGGGSSC-C------CCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHHCCCCCCCcchh---------------------hhHHHHHhhc-c------cCCHHHHHHHHHHccCChhhC
Confidence 99999999999999653211 1111111111 1 123468999999999999999
Q ss_pred CCHHHHHH
Q 048160 328 PTMVQVAK 335 (344)
Q Consensus 328 Ps~~ei~~ 335 (344)
||+.++++
T Consensus 356 pt~~~~l~ 363 (413)
T 3dzo_A 356 LLPLQAME 363 (413)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHHh
Confidence 99877753
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=302.25 Aligned_cols=243 Identities=11% Similarity=0.107 Sum_probs=183.9
Q ss_pred hcCCCCCCccccCCCceEEEEEECCccEEEEEecCCCC--------chhhhHhhHHHHHhcCC---------CCceeeee
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLN--------SEEYCCFNCIAFASQMS---------HKNILKFV 116 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~--------~~~~~~~~E~~~l~~l~---------H~niv~~~ 116 (344)
.++|...+.||+|+||+||+|+++++.||||++..... ...+.+.+|+.+++.++ ||||+++.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 35688899999999999999999999999999876532 22366889999998886 66666666
Q ss_pred eEE-----------------ee-------------CCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHH
Q 048160 117 GCC-----------------LE-------------TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIAN 166 (344)
Q Consensus 117 ~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~ 166 (344)
+++ .+ ....++||||+++|++.+.+... .+++.++..++.|++.
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~------~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK------LSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT------CCCHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc------CCCHHHHHHHHHHHHH
Confidence 553 32 67899999999999877776442 4789999999999999
Q ss_pred HHHHhhcCCCCCeeeecccccceEeecCC--------------------cceEeeeecccccCCCCcccccCCccccccc
Q 048160 167 AVAYLHVGFSRPIVFRDIKPSTILFQEQN--------------------VAKFFDFCVSISIPEGKTHVNDNNKVIGTFG 226 (344)
Q Consensus 167 ~l~~LH~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~ 226 (344)
||.|||+ +.+|+||||||+|||++.++ .+||+|||+|+..... ...||+.
T Consensus 173 aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------~~~gt~~ 242 (336)
T 2vuw_A 173 SLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------IVVFCDV 242 (336)
T ss_dssp HHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------EEECCCC
T ss_pred HHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------cEEEeec
Confidence 9999993 47899999999999999887 8999999999865431 3478999
Q ss_pred cccccccCcCCCCcccchHHHHHH-HHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhh
Q 048160 227 FIAPEYMSTANCNEKSDVYSFGAL-LLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEK 305 (344)
Q Consensus 227 y~aPE~~~~~~~~~~~Di~slG~i-l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (344)
|+|||++.+.. +.++|||||+++ .+++++|..||... ............... .......+..
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-------~~~~~~~~~~~~~~~---------~~~~~~~~~~ 305 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-------LWLHYLTDKMLKQMT---------FKTKCNTPAM 305 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-------HHHHHHHHHHHHTCC---------CSSCCCSHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-------hhhhHHHHhhhhhhc---------cCcccchhhh
Confidence 99999998766 899999998777 67788888886310 000111111111100 0111222334
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 048160 306 EKQLLSYTELAIKCLSKSEQDRPTMVQVA 334 (344)
Q Consensus 306 ~~~~~~l~~l~~~cl~~dP~~RPs~~ei~ 334 (344)
...+.++.+|+.+||+.| |+.+++
T Consensus 306 ~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 306 KQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 467888999999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-33 Score=274.40 Aligned_cols=183 Identities=14% Similarity=0.089 Sum_probs=129.4
Q ss_pred cccCCCceEEEEEE--CCccEEEEEecCCCC----------chhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEEE
Q 048160 63 ITKDLLYKLYKGFL--QDRPISVMKFGGNLN----------SEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 63 ig~G~~g~V~~~~~--~~~~vavk~~~~~~~----------~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~ 129 (344)
.+.|+.|.+..++. .|..+++|.+..+.. ...++|.+|+++|+++ .|+||+++++++.++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 34555555555444 678899999876521 2235688999999999 6999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||++|++|.+++...+ +++.. .|+.||+.||.|+| +.+||||||||+|||++.++.+||+|||+|+...
T Consensus 322 Eyv~G~~L~d~i~~~~-----~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE-----EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp ECCCSEEHHHHHHTTC-----CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred ecCCCCcHHHHHHhCC-----CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999998754 46654 48899999999999 9999999999999999999999999999998765
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCC
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRI 260 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 260 (344)
..... ....+||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus 391 ~~~~~---~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDCSW---PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---CC---SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCcc---ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 43322 224689999999999965 457789999999998877655443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-29 Score=244.53 Aligned_cols=185 Identities=14% Similarity=0.111 Sum_probs=146.9
Q ss_pred CCCccccCCCceEEEEEECCccEEEEEecCCCCch--------hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 59 PEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSE--------EYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 59 ~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~--------~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
..+.||+|+||.||+|.+.+..+++|+........ .+.+.+|+.++++++||||+++..++...+..++|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 45789999999999998899999999865432211 2347899999999999999977777778888899999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|+++++|.+++.. +..++.|++.||.||| +.+|+||||||+|||++. .+||+|||+++....
T Consensus 420 ~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 420 YINGKLAKDVIED-------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp CCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred CCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 9999999999864 3578999999999999 999999999999999998 999999999988754
Q ss_pred CCcccc----cCCccccccccccccccCc--CCCCcccchHHHHHHHHHHHcCCCCC
Q 048160 211 GKTHVN----DNNKVIGTFGFIAPEYMST--ANCNEKSDVYSFGALLLELLTGKRIS 261 (344)
Q Consensus 211 ~~~~~~----~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~ 261 (344)
...... ......||+.|+|||++.. ..|+..+|+|+..+-..+-+.++.++
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 322110 1124578999999999977 56888999999999888887776654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.3e-25 Score=196.20 Aligned_cols=146 Identities=14% Similarity=0.036 Sum_probs=116.1
Q ss_pred HhcCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCc------------------hhhhHhhHHHHHhcCCCCcee
Q 048160 53 ATNNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNS------------------EEYCCFNCIAFASQMSHKNIL 113 (344)
Q Consensus 53 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~------------------~~~~~~~E~~~l~~l~H~niv 113 (344)
...-|...+.||+|+||.||+|.+ +++.||+|.+...... ....+.+|+.++++++ | +
T Consensus 88 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 88 SGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 344455669999999999999999 6889999998654221 2345789999999999 5 6
Q ss_pred eeeeEEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec
Q 048160 114 KFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE 193 (344)
Q Consensus 114 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~ 193 (344)
++.+++. .+..++||||++|++|.+ +... ....++.|++.||.||| +.+|+||||||+|||++
T Consensus 165 ~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~~-----------~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~- 227 (282)
T 1zar_A 165 AVPKVYA-WEGNAVLMELIDAKELYR-VRVE-----------NPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS- 227 (282)
T ss_dssp SSCCEEE-EETTEEEEECCCCEEGGG-CCCS-----------CHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-
T ss_pred CcCeEEe-ccceEEEEEecCCCcHHH-cchh-----------hHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-
Confidence 6666554 356799999999999998 5321 13469999999999999 99999999999999999
Q ss_pred CCcceEeeeecccccCCCCcccccCCccccccccccccccC
Q 048160 194 QNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMS 234 (344)
Q Consensus 194 ~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 234 (344)
++.++|+|||+++. +..+.|||++.
T Consensus 228 ~~~vkl~DFG~a~~----------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 EEGIWIIDFPQSVE----------------VGEEGWREILE 252 (282)
T ss_dssp TTEEEECCCTTCEE----------------TTSTTHHHHHH
T ss_pred CCcEEEEECCCCeE----------------CCCCCHHHHHH
Confidence 99999999999853 33457888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=4.8e-21 Score=167.98 Aligned_cols=136 Identities=12% Similarity=0.098 Sum_probs=104.0
Q ss_pred CCCCCccccCCCceEEEEEE--CCcc--EEEEEecCCCCch------------------------hhhHhhHHHHHhcCC
Q 048160 57 YDPEKVITKDLLYKLYKGFL--QDRP--ISVMKFGGNLNSE------------------------EYCCFNCIAFASQMS 108 (344)
Q Consensus 57 ~~~~~~ig~G~~g~V~~~~~--~~~~--vavk~~~~~~~~~------------------------~~~~~~E~~~l~~l~ 108 (344)
|.....||+|+||.||+|.+ +|.. ||||.+....... ...+.+|+.++.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999998 7888 9999875442110 125679999999998
Q ss_pred CCce--eeeeeEEeeCCccEEEEeecCC-C----CccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeee
Q 048160 109 HKNI--LKFVGCCLETELPILVFEFVAC-G----TLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVF 181 (344)
Q Consensus 109 H~ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 181 (344)
|+|+ +.++++ ...+|||||+.+ | +|.++.. ..++..+..++.|++.||.|||. ..+|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~--~~givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR--------ELKELDVEGIFNDVVENVKRLYQ--EAELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG--------GGGGSCHHHHHHHHHHHHHHHHH--TSCEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh--------ccChHHHHHHHHHHHHHHHHHHH--HCCEEe
Confidence 8764 444442 367899999942 4 4444332 12344677899999999999995 579999
Q ss_pred ecccccceEeecCCcceEeeeeccccc
Q 048160 182 RDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 182 ~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999988 8999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.2e-18 Score=159.33 Aligned_cols=136 Identities=11% Similarity=0.077 Sum_probs=98.4
Q ss_pred CCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCc--------------hhhh--------HhhHHHHHhcCCCCce
Q 048160 56 NYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNS--------------EEYC--------CFNCIAFASQMSHKNI 112 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~--------------~~~~--------~~~E~~~l~~l~H~ni 112 (344)
=|++...||+|++|.||+|.. +|+.||||+++..... .... ..+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 378889999999999999998 7899999987543110 0011 1245666666644333
Q ss_pred e--eeeeEEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceE
Q 048160 113 L--KFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTIL 190 (344)
Q Consensus 113 v--~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil 190 (344)
. ..+++ ...+|||||++|++|..+.... ....++.|++.+|.+|| ..+||||||||.|||
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~~~-----------~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NIL 237 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSSVP-----------DPASLYADLIALILRLA---KHGLIHGDFNEFNIL 237 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCCCS-----------CHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEE
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhcccH-----------HHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEE
Confidence 2 22221 2347999999998887655321 23467899999999999 999999999999999
Q ss_pred eecCC----------cceEeeeecccccC
Q 048160 191 FQEQN----------VAKFFDFCVSISIP 209 (344)
Q Consensus 191 l~~~~----------~~kl~dfg~a~~~~ 209 (344)
++.++ .+.|+||+-+....
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred EeCCCCcccccccccceEEEEeCCcccCC
Confidence 98877 38899998775543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.2e-13 Score=120.91 Aligned_cols=146 Identities=14% Similarity=0.074 Sum_probs=113.7
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCC-CCceeeeeeEEeeCCccEEE
Q 048160 50 LKAATNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCCLETELPILV 128 (344)
Q Consensus 50 i~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv 128 (344)
+....++|.....++.|+.+.||++...++.+++|............+.+|+.+++.+. +..++++++++..++..|+|
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 34455678777788888889999998888899999986532223456889999999985 67889999999988899999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVG---------------------------------- 174 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------------------------------- 174 (344)
|||++|.+|.+.+... .....++.+++.+|..||..
T Consensus 89 ~e~i~G~~l~~~~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 89 MSEADGVLCSEEYEDE----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EECCSSEEHHHHCCTT----------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEecCCeehhhccCCc----------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 9999998887764211 12246788899999999940
Q ss_pred ----------------------CCCCeeeecccccceEeecCCcceEeeeecc
Q 048160 175 ----------------------FSRPIVFRDIKPSTILFQEQNVAKFFDFCVS 205 (344)
Q Consensus 175 ----------------------~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a 205 (344)
....++|+|+++.||+++.+..+.|+||+.+
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 0145899999999999987666779999776
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.29 E-value=7.7e-12 Score=108.80 Aligned_cols=135 Identities=13% Similarity=-0.028 Sum_probs=97.3
Q ss_pred CCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCc--eeeeeeEEeeCCccEEEEeec
Q 048160 56 NYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKN--ILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~~~~~~~~~~~~~lv~e~~ 132 (344)
++......+.|..+.||++.. ++..+++|..... ....+.+|+.+++.+.+.+ +++++++...++..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 344333334556689999987 4677999986554 2355778999999986444 667899888777889999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCC-------------------------------------
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGF------------------------------------- 175 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------- 175 (344)
+|.+|. ... .. ...++.+++..|..||...
T Consensus 98 ~G~~l~--~~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 98 PGQDLL--SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp SSEETT--TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred CCcccC--cCc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 988884 221 11 1256777888888888311
Q ss_pred ------------------CCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 176 ------------------SRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 176 ------------------~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
...++|+|++|.||+++.+..+.++||+.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877667799998864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.22 E-value=4.2e-11 Score=109.54 Aligned_cols=142 Identities=13% Similarity=0.094 Sum_probs=106.9
Q ss_pred CCccccCCCceEEEEEECCccEEEEEec--CCCC-chhhhHhhHHHHHhcCC--CCceeeeeeEEeeC---CccEEEEee
Q 048160 60 EKVITKDLLYKLYKGFLQDRPISVMKFG--GNLN-SEEYCCFNCIAFASQMS--HKNILKFVGCCLET---ELPILVFEF 131 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~~~~~vavk~~~--~~~~-~~~~~~~~E~~~l~~l~--H~niv~~~~~~~~~---~~~~lv~e~ 131 (344)
.+.|+.|.++.||+....+..+++|+.. .... .....+.+|+.+++.+. +..++++++++.+. +..++||||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 4568899999999999888888998765 3221 22356778999999997 45688999988776 347899999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCC------------------------------------
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGF------------------------------------ 175 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 175 (344)
++|.++.+... ..++..++..++.+++..|..||...
T Consensus 123 v~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 123 VSGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred cCCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99887754221 23677888889999999999999410
Q ss_pred -------------------CCCeeeecccccceEeecCCc--ceEeeeeccccc
Q 048160 176 -------------------SRPIVFRDIKPSTILFQEQNV--AKFFDFCVSISI 208 (344)
Q Consensus 176 -------------------~~~ivH~dlk~~Nill~~~~~--~kl~dfg~a~~~ 208 (344)
...++|+|+++.||+++.++. +.|+||+.+...
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 257999999999999987653 689999987653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.97 E-value=3.9e-10 Score=100.65 Aligned_cols=188 Identities=13% Similarity=0.119 Sum_probs=119.8
Q ss_pred CCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCC-CCc--eeeeeeEEeeCC---ccEEEEeecC
Q 048160 60 EKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKN--ILKFVGCCLETE---LPILVFEFVA 133 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~~~~~~~~~~---~~~lv~e~~~ 133 (344)
.+.++.|....||+.. ..+++|..... .....+.+|+.+++.+. +.. +++++.....+. ..|+||++++
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC---CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568899999999764 67888875432 23456789999998884 322 455655544333 3478999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVG--------------------------------------- 174 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------------------------------------- 174 (344)
|.+|.+... ..++..++..++.+++..|..||..
T Consensus 100 G~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 100 GVPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CEECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CeECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 888865322 1356677777888888888888831
Q ss_pred ----------------CCCCeeeecccccceEeec--CCcceEeeeecccccCCCCcccccCCcc--ccc---------c
Q 048160 175 ----------------FSRPIVFRDIKPSTILFQE--QNVAKFFDFCVSISIPEGKTHVNDNNKV--IGT---------F 225 (344)
Q Consensus 175 ----------------~~~~ivH~dlk~~Nill~~--~~~~kl~dfg~a~~~~~~~~~~~~~~~~--~g~---------~ 225 (344)
....++|+|+++.||+++. ...+.++||+.+...+............ .+. .
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 1145799999999999998 5668899999876643321110000000 000 0
Q ss_pred cccc-ccccCcCCCCcccchHHHHHHHHHHHcCCCCC
Q 048160 226 GFIA-PEYMSTANCNEKSDVYSFGALLLELLTGKRIS 261 (344)
Q Consensus 226 ~y~a-PE~~~~~~~~~~~Di~slG~il~el~~g~~p~ 261 (344)
+... |+.... .....+.|+++.++|.+.+|..++
T Consensus 253 ~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0111 121111 112257899999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=4.6e-07 Score=79.00 Aligned_cols=133 Identities=8% Similarity=-0.017 Sum_probs=92.7
Q ss_pred ccccCCCc-eEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCC-CCceeeeeeEEeeCCccEEEEeecCCCCc
Q 048160 62 VITKDLLY-KLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCCLETELPILVFEFVACGTL 137 (344)
Q Consensus 62 ~ig~G~~g-~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~gsL 137 (344)
.+..|..+ .||+... .+..+++|+-... ....+.+|...|+.+. +--+.++++++.+++..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445554 6898776 4567888875433 3456778999998885 34478899999999999999999998777
Q ss_pred cccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 048160 138 ADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVG------------------------------------------- 174 (344)
Q Consensus 138 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------------------------------------------- 174 (344)
.+..... ......+..+++..|.-||..
T Consensus 108 ~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 108 FQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred cccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 6544221 112234555566666666621
Q ss_pred ------------CCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 175 ------------FSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 175 ------------~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
....++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 02247999999999999987777899998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=5.3e-07 Score=80.36 Aligned_cols=136 Identities=12% Similarity=0.050 Sum_probs=91.7
Q ss_pred CccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCCC---ceeeeeeEEe-eCCccEEEEeecCCCC
Q 048160 61 KVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHK---NILKFVGCCL-ETELPILVFEFVACGT 136 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~~~~~~~-~~~~~~lv~e~~~~gs 136 (344)
..++.|....||+. +..+++|.-.. ......+.+|+.+|..+.+. .+++++.++. ..+..++||||++|.+
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE---CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 45778888889988 67888888422 22345678999999999752 3677777764 3455789999999887
Q ss_pred ccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 048160 137 LADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVG------------------------------------------ 174 (344)
Q Consensus 137 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------------------------------------------ 174 (344)
|.+..-. .++..+...++.+++..|..||..
T Consensus 100 l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 100 LGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred Cchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 7653211 133344444445555554444421
Q ss_pred ---------------CCCCeeeecccccceEeec---CCc-ceEeeeeccccc
Q 048160 175 ---------------FSRPIVFRDIKPSTILFQE---QNV-AKFFDFCVSISI 208 (344)
Q Consensus 175 ---------------~~~~ivH~dlk~~Nill~~---~~~-~kl~dfg~a~~~ 208 (344)
....++|+|+.+.||+++. ++. +.|+||+.+...
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1446799999999999987 344 589999877543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=1.3e-06 Score=79.32 Aligned_cols=79 Identities=5% Similarity=-0.059 Sum_probs=56.0
Q ss_pred Ccc-ccCCCceEEEEEEC--------CccEEEEEecCCC---CchhhhHhhHHHHHhcCC-C--CceeeeeeEEeeC---
Q 048160 61 KVI-TKDLLYKLYKGFLQ--------DRPISVMKFGGNL---NSEEYCCFNCIAFASQMS-H--KNILKFVGCCLET--- 122 (344)
Q Consensus 61 ~~i-g~G~~g~V~~~~~~--------~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~~~~~~~~~--- 122 (344)
+.| +.|....+|+.... +..+++|...... ......+.+|+.+++.+. + -.++++++++.++
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 77888899988765 6678888754332 111245678999998884 2 3578888887665
Q ss_pred CccEEEEeecCCCCccc
Q 048160 123 ELPILVFEFVACGTLAD 139 (344)
Q Consensus 123 ~~~~lv~e~~~~gsL~~ 139 (344)
...++||||++|.++.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877765
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.96 E-value=3.6e-05 Score=69.10 Aligned_cols=73 Identities=10% Similarity=0.153 Sum_probs=43.8
Q ss_pred ccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCC--CCceeeeee------EEeeCCccEEEEeecC
Q 048160 62 VITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMS--HKNILKFVG------CCLETELPILVFEFVA 133 (344)
Q Consensus 62 ~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~~~~------~~~~~~~~~lv~e~~~ 133 (344)
.|+.|..+.||+....+..+++|+.... ...+..|+.++..|. .-.+++++. +...++..++|++|++
T Consensus 39 ~l~gG~~n~~~~v~~~~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~ 114 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE 114 (346)
T ss_dssp ECC----CEEEEEEETTEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred eccccccCcEEEEEeCCCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence 3555678899999887777999988652 233344556555553 123444443 1224567789999999
Q ss_pred CCCcc
Q 048160 134 CGTLA 138 (344)
Q Consensus 134 ~gsL~ 138 (344)
|.++.
T Consensus 115 G~~~~ 119 (346)
T 2q83_A 115 GRPFE 119 (346)
T ss_dssp CBCCC
T ss_pred CccCC
Confidence 86653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=4.3e-05 Score=70.37 Aligned_cols=74 Identities=11% Similarity=-0.011 Sum_probs=50.0
Q ss_pred CCccccCCCceEEEEEE--CCccEEEEEecCCCC-------chhhhHhhHHHHHhcCCC---CceeeeeeEEeeCCccEE
Q 048160 60 EKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-------SEEYCCFNCIAFASQMSH---KNILKFVGCCLETELPIL 127 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-------~~~~~~~~E~~~l~~l~H---~niv~~~~~~~~~~~~~l 127 (344)
.+.||.|..+.||++.. .++.+++|....... ...+.+..|..+++.+.. ..+++++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 45689999999999965 567899998653321 123446778888887742 345567654 3456789
Q ss_pred EEeecCCC
Q 048160 128 VFEFVACG 135 (344)
Q Consensus 128 v~e~~~~g 135 (344)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.85 E-value=0.00013 Score=64.86 Aligned_cols=75 Identities=7% Similarity=-0.080 Sum_probs=60.8
Q ss_pred CCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCC---CCceeeeeeEEeeCCccEEEEeecCCCC
Q 048160 60 EKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMS---HKNILKFVGCCLETELPILVFEFVACGT 136 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~~~lv~e~~~~gs 136 (344)
...|+.|....+|+...++..+++|..... ....+.+|+..|+.|. ...++++++++...+..++||||+++.+
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 356889999999999888888999886533 3456788999888884 3678899999887788999999999876
Q ss_pred c
Q 048160 137 L 137 (344)
Q Consensus 137 L 137 (344)
+
T Consensus 118 ~ 118 (312)
T 3jr1_A 118 N 118 (312)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00026 Score=62.10 Aligned_cols=78 Identities=12% Similarity=0.026 Sum_probs=55.7
Q ss_pred CCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCC---CceeeeeeEEeeCCccEEEEee
Q 048160 56 NYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSH---KNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~~~~~~~~~~~~~lv~e~ 131 (344)
.......+|.|..+.||+.+. +|+.|++|+-..........+.+|+..|+.|.- --+++++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 344456789999999999999 778899998655443344567789999988842 2355666542 34789999
Q ss_pred cCCCCc
Q 048160 132 VACGTL 137 (344)
Q Consensus 132 ~~~gsL 137 (344)
.+++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 886654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00036 Score=64.71 Aligned_cols=73 Identities=5% Similarity=-0.012 Sum_probs=46.4
Q ss_pred CCccccCCCceEEEEEECCccEEEEEecCCCC------c---hhhhHhhHHHHHh-cCCCCceeeeeeEEeeCCccEEEE
Q 048160 60 EKVITKDLLYKLYKGFLQDRPISVMKFGGNLN------S---EEYCCFNCIAFAS-QMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~------~---~~~~~~~E~~~l~-~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
.+.||.|....||++..+++.++||....... . ....+..|+..+. ......+++++.+. ....++||
T Consensus 39 i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv~ 116 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIGM 116 (420)
T ss_dssp EEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEEE
T ss_pred EEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEEE
Confidence 45688899999999987778899995322110 0 1222334433222 22335677888775 56778999
Q ss_pred eec-CC
Q 048160 130 EFV-AC 134 (344)
Q Consensus 130 e~~-~~ 134 (344)
||+ ++
T Consensus 117 e~l~~g 122 (420)
T 2pyw_A 117 RYLEPP 122 (420)
T ss_dssp CCCCTT
T ss_pred eecCCc
Confidence 999 76
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.0008 Score=59.33 Aligned_cols=72 Identities=10% Similarity=0.077 Sum_probs=45.9
Q ss_pred CCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCce-eeeeeEEeeCCccEEEEeec-CCCCc
Q 048160 60 EKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNI-LKFVGCCLETELPILVFEFV-ACGTL 137 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~-~~gsL 137 (344)
.+.|+.|....+|+. ..+++|+...... ..-...+|+.+++.+...++ ++++++. ....++++||+ ++.++
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 577888999999999 6788888654421 11223468888877742222 5666543 34457899999 65454
Q ss_pred c
Q 048160 138 A 138 (344)
Q Consensus 138 ~ 138 (344)
.
T Consensus 96 ~ 96 (301)
T 3dxq_A 96 S 96 (301)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.44 E-value=0.0008 Score=59.77 Aligned_cols=160 Identities=15% Similarity=0.167 Sum_probs=87.6
Q ss_pred ccHHHHHHHhcCCCCC-----CccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCc--eeeeee
Q 048160 45 FTAQELKAATNNYDPE-----KVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKN--ILKFVG 117 (344)
Q Consensus 45 ~~~~~i~~~~~~~~~~-----~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~~~~ 117 (344)
++.+++......|... +.|+.|....+|+....+..+++|...... ....+..|+.++..+...+ +++++.
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 5566666666666542 235567778899998876789999876531 2334556787777774212 344443
Q ss_pred E------EeeCCccEEEEeecCCCCcccc--------------cc----CCCCCC---CccccHHHHHH-----------
Q 048160 118 C------CLETELPILVFEFVACGTLADR--------------IH----DPNGSQ---LEPFLMKHRLK----------- 159 (344)
Q Consensus 118 ~------~~~~~~~~lv~e~~~~gsL~~~--------------l~----~~~~~~---~~~l~~~~~~~----------- 159 (344)
. ...++..+++++|++|.++... ++ ...... .....|.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 2 1223556899999987654320 11 000000 00001111000
Q ss_pred -HHHHHHHHHHHhhc----CCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 160 -VAMEIANAVAYLHV----GFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 160 -i~~~i~~~l~~LH~----~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
+...+...+..+.. .....++|+|+.+.||+++.+..+.++||+.+.
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 00112333444431 114578999999999999887666899997664
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0047 Score=54.84 Aligned_cols=164 Identities=15% Similarity=0.064 Sum_probs=90.1
Q ss_pred ccccccHHHHHHHhcCCCC-----CCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCC--Cce
Q 048160 41 PIQNFTAQELKAATNNYDP-----EKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSH--KNI 112 (344)
Q Consensus 41 ~~~~~~~~~i~~~~~~~~~-----~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H--~ni 112 (344)
+....+.+++......|.. ...++ |....||+... +|+.+++|....... ....+..|+.++..+.. -.+
T Consensus 7 ~~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~v 84 (328)
T 1zyl_A 7 TFQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPV 84 (328)
T ss_dssp CCCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSB
T ss_pred CCCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCee
Confidence 3445566666555544432 22355 77788999887 455799998764321 23456678888887742 224
Q ss_pred eeeeeE-----EeeCCccEEEEeecCCCCccc-----------c---cc----CCCCCCCccccHHHH------------
Q 048160 113 LKFVGC-----CLETELPILVFEFVACGTLAD-----------R---IH----DPNGSQLEPFLMKHR------------ 157 (344)
Q Consensus 113 v~~~~~-----~~~~~~~~lv~e~~~~gsL~~-----------~---l~----~~~~~~~~~l~~~~~------------ 157 (344)
++++.. ...++..++|++|++|.++.. . ++ .........+.+...
T Consensus 85 p~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 164 (328)
T 1zyl_A 85 AAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDAT 164 (328)
T ss_dssp CCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCS
T ss_pred cceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcC
Confidence 555543 112345578999998755431 0 00 000000011111110
Q ss_pred ----------HHHHHHHHHHHHHhhc-CCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 158 ----------LKVAMEIANAVAYLHV-GFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 158 ----------~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
...+..++..+.-+-. .....++|+|+.+.||+++ + .+.++||+.+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 165 LIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp SSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 1111222222222210 1156789999999999998 4 8899999876543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.24 E-value=0.001 Score=55.17 Aligned_cols=103 Identities=14% Similarity=0.100 Sum_probs=66.9
Q ss_pred CccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCccc
Q 048160 136 TLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHV 215 (344)
Q Consensus 136 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~ 215 (344)
||.++|...+ .++++.+++.++.|.+.+|.-+-. ...-..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 34 SL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 34 SLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc---------
Confidence 7888887766 589999999999999999887621 01111233456889999999887653 1110
Q ss_pred ccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCC
Q 048160 216 NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRIS 261 (344)
Q Consensus 216 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~ 261 (344)
.....+.|||... ...+.+.=|||+|+++|.-+-...|.
T Consensus 98 ------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 98 ------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp ---------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred ------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 0123456788763 34467788999999999988777653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0015 Score=58.46 Aligned_cols=144 Identities=10% Similarity=0.017 Sum_probs=73.8
Q ss_pred CccccCCCce-EEEEEEC-CccEEEEEecCCCCchhhhHhhHHHHHhcCC--CCceeeeeeEEeeCCccEEEEeecCCCC
Q 048160 61 KVITKDLLYK-LYKGFLQ-DRPISVMKFGGNLNSEEYCCFNCIAFASQMS--HKNILKFVGCCLETELPILVFEFVACGT 136 (344)
Q Consensus 61 ~~ig~G~~g~-V~~~~~~-~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~~~~~~~~~~~~~lv~e~~~~gs 136 (344)
..|+.|.... +|+.... ++.+++|...... ...+..|+.++..+. .-.+++++.+... ..+++||++.+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCCcc
Confidence 3455554433 6777764 7777777643321 134456777777774 2346677776433 3378999987655
Q ss_pred ccccccCCC---------------------CCCCccccHHHHH-------H-------------HHHHHHHHHHHhh---
Q 048160 137 LADRIHDPN---------------------GSQLEPFLMKHRL-------K-------------VAMEIANAVAYLH--- 172 (344)
Q Consensus 137 L~~~l~~~~---------------------~~~~~~l~~~~~~-------~-------------i~~~i~~~l~~LH--- 172 (344)
+.+++.... ......+...... . ....+...+..+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 543322100 0000112111100 0 0001111122221
Q ss_pred cCCCCCeeeecccccceEeecC----CcceEeeeecccccC
Q 048160 173 VGFSRPIVFRDIKPSTILFQEQ----NVAKFFDFCVSISIP 209 (344)
Q Consensus 173 ~~~~~~ivH~dlk~~Nill~~~----~~~kl~dfg~a~~~~ 209 (344)
......++|+|+.+.||+++.+ +.+.++||+.+...+
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 1115689999999999999874 678999998876543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0015 Score=60.72 Aligned_cols=73 Identities=12% Similarity=0.029 Sum_probs=48.7
Q ss_pred CCccccCCCceEEEEEEC---------CccEEEEEecCCCCchhhhHhhHHHHHhcCCCCc-eeeeeeEEeeCCccEEEE
Q 048160 60 EKVITKDLLYKLYKGFLQ---------DRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKN-ILKFVGCCLETELPILVF 129 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~~---------~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~~~~~~~~~~~~~lv~ 129 (344)
...|+.|-...+|+.... ++.+++|+..... ..+.+.+|..+++.+...+ .+++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 345777888899999874 3678888764321 1144557988888885333 4677776543 3899
Q ss_pred eecCCCCcc
Q 048160 130 EFVACGTLA 138 (344)
Q Consensus 130 e~~~~gsL~ 138 (344)
||++|.+|.
T Consensus 152 e~l~G~~l~ 160 (429)
T 1nw1_A 152 EYIPSRPLS 160 (429)
T ss_dssp CCCCEEECC
T ss_pred EEeCCcccC
Confidence 999864543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.93 E-value=0.002 Score=58.80 Aligned_cols=142 Identities=13% Similarity=0.135 Sum_probs=79.7
Q ss_pred CCccccCCCceEEEEEEC---------CccEEEEEecCCCCchhhhHhhHHHHHhcCC-CCceeeeeeEEeeCCccEEEE
Q 048160 60 EKVITKDLLYKLYKGFLQ---------DRPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~~---------~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~ 129 (344)
.+.|..|-...+|+.... ++.+++++... .........+|..+++.+. +.-.+++++++.+ .+|+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 345667778889999873 36788887432 2223455668999998884 3334777777654 2899
Q ss_pred eecCCCCcccc-c----------------cCCCC--CCCccccHHHHHHHHHHHHH-------------------HHHHh
Q 048160 130 EFVACGTLADR-I----------------HDPNG--SQLEPFLMKHRLKVAMEIAN-------------------AVAYL 171 (344)
Q Consensus 130 e~~~~gsL~~~-l----------------~~~~~--~~~~~l~~~~~~~i~~~i~~-------------------~l~~L 171 (344)
||++|.+|..- + +...- .......+.++..+..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99997665421 1 11100 00001123333333332211 12222
Q ss_pred h-----cCCCCCeeeecccccceEeecC----CcceEeeeeccc
Q 048160 172 H-----VGFSRPIVFRDIKPSTILFQEQ----NVAKFFDFCVSI 206 (344)
Q Consensus 172 H-----~~~~~~ivH~dlk~~Nill~~~----~~~kl~dfg~a~ 206 (344)
. ......++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 1 1224578999999999999876 688999997764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0044 Score=58.04 Aligned_cols=73 Identities=16% Similarity=0.043 Sum_probs=47.1
Q ss_pred CccccCCCceEEEEEECC--ccEEEEEecCCCCchhhhHhhHHHHHhcCCCCce-eeeeeEEeeCCccEEEEeecCCCCc
Q 048160 61 KVITKDLLYKLYKGFLQD--RPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNI-LKFVGCCLETELPILVFEFVACGTL 137 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~~--~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~~~gsL 137 (344)
..|+.|-...+|+....+ ..+++|+...... ..-.-.+|..++..|...++ +++++.+.. .+|+||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 456777788999999865 7788887643321 11112478888988864444 677877632 369999987555
Q ss_pred c
Q 048160 138 A 138 (344)
Q Consensus 138 ~ 138 (344)
.
T Consensus 189 ~ 189 (458)
T 2qg7_A 189 S 189 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0064 Score=55.10 Aligned_cols=72 Identities=17% Similarity=0.168 Sum_probs=43.3
Q ss_pred CccccCCCceEEEEEECC----------ccEEEEEecCCCCchhhhHhhHHHHHhcCCCCc-eeeeeeEEeeCCccEEEE
Q 048160 61 KVITKDLLYKLYKGFLQD----------RPISVMKFGGNLNSEEYCCFNCIAFASQMSHKN-ILKFVGCCLETELPILVF 129 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~~----------~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~~~~~~~~~~~~~lv~ 129 (344)
..|+.|..-.+|+....+ +.+++|...... ........|..+++.+...+ ++++++.. ..++|+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 456778788999998854 567777654332 11112357888888875323 45777654 237899
Q ss_pred eecCCCCc
Q 048160 130 EFVACGTL 137 (344)
Q Consensus 130 e~~~~gsL 137 (344)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.47 E-value=0.027 Score=50.35 Aligned_cols=33 Identities=12% Similarity=0.209 Sum_probs=28.4
Q ss_pred CCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 176 SRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 176 ~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
...++|+|+.+.||+++.++.+.++||+.+...
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 467899999999999998888999999776543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.46 E-value=0.029 Score=51.88 Aligned_cols=72 Identities=15% Similarity=0.073 Sum_probs=46.8
Q ss_pred CccccCCCceEEEEEEC---------CccEEEEEecCCCCchhhhHhhHHHHHhcCC-CCceeeeeeEEeeCCccEEEEe
Q 048160 61 KVITKDLLYKLYKGFLQ---------DRPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~---------~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e 130 (344)
+.+..|-...+|+.... +..+++++..... ...-...+|..+++.+. +.-.+++++.+. .++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 44666778889999885 5778888754332 11122347888888884 333566666432 378999
Q ss_pred ecCCCCc
Q 048160 131 FVACGTL 137 (344)
Q Consensus 131 ~~~~gsL 137 (344)
|++|.+|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998654
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=90.97 E-value=0.039 Score=51.66 Aligned_cols=59 Identities=7% Similarity=-0.081 Sum_probs=17.8
Q ss_pred CCccccCCCceEEEEEECC--ccEEE------EEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEee
Q 048160 60 EKVITKDLLYKLYKGFLQD--RPISV------MKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLE 121 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~~~--~~vav------k~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~ 121 (344)
.+.|| ||.||+|.+.+ .+||| |..+.... .....+.+|..++.+++|||+++.+++...
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 45565 99999999954 57888 76554322 223457889999999999999999988654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=81.83 E-value=5.1 Score=32.92 Aligned_cols=116 Identities=9% Similarity=0.021 Sum_probs=75.3
Q ss_pred CCCceeeeeeEEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccccc
Q 048160 108 SHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPS 187 (344)
Q Consensus 108 ~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~ 187 (344)
.||+.+.. .+-.+++. +++.|-...+...+-.- ..++...++.++..|+....+++ .-+|--|.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~--v~~~y~~~~~~~~f~~i------k~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDS--FQIHYDINDNHTPFDNI------KSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSE--EEEEECCCTTSEEGGGG------GGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGG
T ss_pred cCCcccce-EEEEcccE--EEEEEEcCcccCCHHHH------HhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecc
Confidence 57888765 44455554 44455444444444432 25778889999999988776555 2367789999
Q ss_pred ceEeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCC
Q 048160 188 TILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISY 262 (344)
Q Consensus 188 Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 262 (344)
|++++.++.+++.-.|+...+++.. .+...=.-.+=+++..+++++..|.
T Consensus 109 NL~f~~~~~p~i~~RGik~~l~P~~-------------------------~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVVDPLP-------------------------VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GEEECTTSCEEESCCEETTTBSCCC-------------------------CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred eEEEcCCCCEEEEEccCccCCCCCC-------------------------CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999999888753322110 1111112366777888888887663
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 344 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-40 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-39 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-38 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-37 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-37 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-37 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-36 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-36 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-36 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-35 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-35 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-34 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-34 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-34 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-33 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-33 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-32 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-32 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-32 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-32 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-32 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-32 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-31 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-31 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-30 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-30 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-30 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-29 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-29 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-28 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-28 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-27 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-27 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-25 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-25 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-25 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-25 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-24 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-24 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-24 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-22 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-22 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-22 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-21 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-21 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-21 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-20 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-20 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-19 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-18 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-18 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-17 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-16 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-16 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-14 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-14 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-13 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-44
Identities = 60/279 (21%), Positives = 111/279 (39%), Gaps = 31/279 (11%)
Query: 70 KLYKGFLQDR-PISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128
+YKG + ++ + N + + H NIL F+G +L +V
Sbjct: 23 TVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIV 81
Query: 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPST 188
++ +L +H F M + +A + A + YLH + I+ RD+K +
Sbjct: 82 TQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNN 134
Query: 189 ILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCN---EKSDVY 245
I E K DF ++ + ++ G+ ++APE + + N +SDVY
Sbjct: 135 IFLHEDLTVKIGDFGLATVKSRWSGS-HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 193
Query: 246 SFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEK 305
+FG +L EL+TG+ + R I + + P + P+
Sbjct: 194 AFGIVLYELMTGQLP------------YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241
Query: 306 EKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKSI 344
K+L++ +CL K +RP Q+ + L +S+
Sbjct: 242 MKRLMA------ECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 6e-41
Identities = 53/274 (19%), Positives = 107/274 (39%), Gaps = 31/274 (11%)
Query: 70 KLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129
+++ G+ +K + Q+ H+ +++ + + ++
Sbjct: 28 EVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIIT 86
Query: 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTI 189
E++ G+L D + P+G +L L +A +IA +A++ R + RD++ + I
Sbjct: 87 EYMENGSLVDFLKTPSGIKLTIN---KLLDMAAQIAEGMAFIE---ERNYIHRDLRAANI 140
Query: 190 LFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGA 249
L + K DF ++ I + + + + APE ++ KSDV+SFG
Sbjct: 141 LVSDTLSCKIADFGLARLIEDNEYTAREG--AKFPIKWTAPEAINYGTFTIKSDVWSFGI 198
Query: 250 LLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQL 309
LL E++T RI Y + E++ + G + P+ +
Sbjct: 199 LLTEIVTHGRIPY--------------------PGMTNPEVIQNLERGYRMVRPDNCPEE 238
Query: 310 LSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343
L +L C + +DRPT + L +
Sbjct: 239 LY--QLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 4e-40
Identities = 57/272 (20%), Positives = 109/272 (40%), Gaps = 37/272 (13%)
Query: 70 KLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPI-LV 128
+ G + ++V + ++ + + +Q+ H N+++ +G +E + + +V
Sbjct: 22 DVMLGDYRGNKVAVKCIKNDATAQAF--LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79
Query: 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPST 188
E++A G+L D + S L LK ++++ A+ YL V RD+
Sbjct: 80 TEYMAKGSLVDYLRSRGRSVLGG---DCLLKFSLDVCEAMEYLE---GNNFVHRDLAARN 133
Query: 189 ILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFG 248
+L E NVAK DF ++ + + APE + + KSDV+SFG
Sbjct: 134 VLVSEDNVAKVSDFGLTKEASSTQDTGK------LPVKWTAPEALREKKFSTKSDVWSFG 187
Query: 249 ALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQ 308
LL E+ + R+ Y K++V + G + P+
Sbjct: 188 ILLWEIYSFGRVPY--------------------PRIPLKDVVPRVEKGYKMDAPDGCPP 227
Query: 309 LLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340
+ E+ C RP+ +Q+ +QL +
Sbjct: 228 AVY--EVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 1e-39
Identities = 53/281 (18%), Positives = 103/281 (36%), Gaps = 37/281 (13%)
Query: 70 KLYKGFLQDRP------ISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETE 123
+ KG+ Q + + ++K N + + Q+ + I++ +G C E E
Sbjct: 22 TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 80
Query: 124 LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRD 183
+LV E G L + K+ +++ +++ + YL V RD
Sbjct: 81 SWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRD 132
Query: 184 IKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSD 243
+ +L Q+ AK DF +S ++ + + + APE ++ + KSD
Sbjct: 133 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSD 192
Query: 244 VYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWP 303
V+SFG L+ E + + Y E+ + GE P
Sbjct: 193 VWSFGVLMWEAFSYGQKPY--------------------RGMKGSEVTAMLEKGERMGCP 232
Query: 304 EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKSI 344
+ + +L C + ++RP V +LR + +
Sbjct: 233 AGCPREMY--DLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 4e-38
Identities = 45/244 (18%), Positives = 93/244 (38%), Gaps = 30/244 (12%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
Q+ + I++ +G C L +LV E G L + + + ++
Sbjct: 60 AQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKRE----EIPVSNVAEL 114
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
+++ + YL + V RD+ +L ++ AK DF +S ++ ++ +
Sbjct: 115 LHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280
+ APE ++ + +SDV+S+G + E L+ + Y
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY------------------ 213
Query: 281 SIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340
+ E++ I G+ P + L L C +DRP + V +++R
Sbjct: 214 --KKMKGPEVMAFIEQGKRMECPPECPPELY--ALMSDCWIYKWEDRPDFLTVEQRMRAC 269
Query: 341 HKSI 344
+ S+
Sbjct: 270 YYSL 273
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-37
Identities = 49/291 (16%), Positives = 112/291 (38%), Gaps = 27/291 (9%)
Query: 70 KLYKGFLQDRPISVMKFGGNLNSEEYCCFNC-IAFASQMSHKNILKFVGCCLETELPI-- 126
++++G + ++V F + E I + H+NIL F+ +
Sbjct: 18 EVWRGKWRGEEVAVKIF--SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75
Query: 127 --LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGF-----SRPI 179
LV ++ G+L D ++ ++ +K+A+ A+ +A+LH+ I
Sbjct: 76 LWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 129
Query: 180 VFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDN-NKVIGTFGFIAPEYMSTAN- 237
RD+K IL ++ D +++ ++ N +GT ++APE + +
Sbjct: 130 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN 189
Query: 238 -----CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292
+++D+Y+ G + E+ I E+ + + + K + +
Sbjct: 190 MKHFESFKRADIYAMGLVFWEIARRCSIGGIH--EDYQLPYYDLVPSDPSVEEMRKVVCE 247
Query: 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343
+ + + L ++ +C + R T +++ K L QL +
Sbjct: 248 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 6e-37
Identities = 45/286 (15%), Positives = 102/286 (35%), Gaps = 31/286 (10%)
Query: 55 NNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILK 114
+ K + + G + + +K + E +SH+ +++
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 115 FVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVG 174
G C + ++ E++A G L + + + F + L++ ++ A+ YL
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLES- 118
Query: 175 FSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMS 234
+ + RD+ L +Q V K DF +S + + + + + PE +
Sbjct: 119 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG--SKFPVRWSPPEVLM 174
Query: 235 TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPI 294
+ + KSD+++FG L+ E+ + ++ Y E + E + I
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPY--------------------ERFTNSETAEHI 214
Query: 295 IVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340
G P + + + C + +RPT + + +
Sbjct: 215 AQGLRLYRPHLASEKVY--TIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 7e-37
Identities = 58/274 (21%), Positives = 110/274 (40%), Gaps = 31/274 (11%)
Query: 70 KLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129
++ G+ ++ +K E ++SH +++ G CLE LVF
Sbjct: 20 LVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79
Query: 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTI 189
EF+ G L+D + G + L + +++ +AYL ++ RD+
Sbjct: 80 EFMEHGCLSDYLRTQRGLFAA----ETLLGMCLDVCEGMAYLE---EACVIHRDLAARNC 132
Query: 190 LFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGA 249
L E V K DF ++ + + + + + +PE S + + KSDV+SFG
Sbjct: 133 LVGENQVIKVSDFGMTRFVLDDQYT--SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGV 190
Query: 250 LLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQL 309
L+ E+ + +I Y E+ S E+V+ I G P
Sbjct: 191 LMWEVFSEGKIPY--------------------ENRSNSEVVEDISTGFRLYKPRLASTH 230
Query: 310 LSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343
+ ++ C + +DRP ++ +QL ++ +S
Sbjct: 231 VY--QIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (331), Expect = 1e-36
Identities = 52/319 (16%), Positives = 110/319 (34%), Gaps = 46/319 (14%)
Query: 42 IQNFTAQELKAATNNYDPEKVITKDLLYKL---------YKGFLQD-----RPISVMKFG 87
I FT ++ A + E I+ + ++ G L+ +++
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 88 GNLNSEEYCCF-NCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNG 146
++ F + + Q H N++ G ++ +++ EF+ G+L + +G
Sbjct: 64 SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG 123
Query: 147 SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206
+ + IA + YL V RD+ IL V K DF +S
Sbjct: 124 QFTV----IQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 176
Query: 207 SIPEGKTHVNDNNKV--IGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSS 264
+ + + + + + APE + SDV+S+G ++ E+++ Y
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY-- 234
Query: 265 CFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSE 324
+ +++++ I P L +L + C K
Sbjct: 235 ------------------WDMTNQDVINAIEQDYRLPPPMDCPSALH--QLMLDCWQKDR 274
Query: 325 QDRPTMVQVAKQLRQLHKS 343
RP Q+ L ++ ++
Sbjct: 275 NHRPKFGQIVNTLDKMIRN 293
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 3e-36
Identities = 51/308 (16%), Positives = 108/308 (35%), Gaps = 37/308 (12%)
Query: 49 ELKAATNNYDPEKVITKDLLYKLYKGFLQD--RPISVMKFGGNLNSEEYCCF-NCIAFAS 105
ELK ++++ + ++K + ++ + +
Sbjct: 2 ELK--DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59
Query: 106 QMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIA 165
+ + I+ F G + E + G+L + + KV++ +
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVI 114
Query: 166 NAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTF 225
+ YL I+ RD+KPS IL + K DF VS + + N +GT
Sbjct: 115 KGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-----NSFVGTR 167
Query: 226 GFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL-------- 277
+++PE + + + +SD++S G L+E+ G+ + E F ++
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227
Query: 278 ----------VRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLS--YTELAIKCLSKSEQ 325
++S I + + P+ + S + + KCL K+
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287
Query: 326 DRPTMVQV 333
+R + Q+
Sbjct: 288 ERADLKQL 295
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 4e-36
Identities = 53/233 (22%), Positives = 89/233 (38%), Gaps = 37/233 (15%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
+ S + H NIL+ G + L+ E+ GT+ + + F +
Sbjct: 57 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATY 111
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
E+ANA++Y H S+ ++ RDIKP +L K DF S+ P +
Sbjct: 112 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-----T 163
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280
+ GT ++ PE + +EK D++S G L E L GK
Sbjct: 164 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP-------------------- 203
Query: 281 SIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQV 333
E+N+++E I E + +L + L + RP + +V
Sbjct: 204 -FEANTYQETYKRISRVEFTFPDFVTEGAR---DLISRLLKHNPSQRPMLREV 252
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 3e-35
Identities = 53/296 (17%), Positives = 107/296 (36%), Gaps = 36/296 (12%)
Query: 55 NNYDPEKVITKDLLYKLYKGFLQD------RPISVMKFGGNLNSEEYCCF-NCIAFASQM 107
+ +KVI ++YKG L+ P+++ ++ F Q
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 108 SHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANA 167
SH NI++ G + + +++ E++ G L + + +G F + + + IA
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAG 122
Query: 168 VAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGF 227
+ YL + V RD+ IL V K DF +S + + + +
Sbjct: 123 MKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 228 IAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287
APE +S SDV+SFG ++ E++T + + + + + +
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGE----RPYWELSNHEVMKAINDGFRLPTP 235
Query: 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343
+ I +L ++C + RP + L +L ++
Sbjct: 236 MDCPSAIY------------------QLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 9e-35
Identities = 50/240 (20%), Positives = 94/240 (39%), Gaps = 29/240 (12%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
+ + H+N+++ G L + +V E G+L DR+ G FL+ +
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQG----HFLLGTLSRY 116
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
A+++A + YL S+ + RD+ +L +++ K DF + ++P+ H
Sbjct: 117 AVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280
F + APE + T + SD + FG L E+ T + + +++ K
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW-------IGLNGSQILHK 226
Query: 281 SIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340
I E P E + ++C + +DRPT V + L +
Sbjct: 227 --------------IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 1e-34
Identities = 48/257 (18%), Positives = 105/257 (40%), Gaps = 31/257 (12%)
Query: 81 ISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETE--LPILVFEFVACGTLA 138
+ +G +E+ + + ++ H NI+++ ++ +V E+ G LA
Sbjct: 34 WKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLA 93
Query: 139 DRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLH--VGFSRPIVFRDIKPSTILFQEQNV 196
I + + + L+V ++ A+ H ++ RD+KP+ + +
Sbjct: 94 SVITK-GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN 152
Query: 197 AKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
K DF ++ + + +GT +++PE M+ + NEKSD++S G LL EL
Sbjct: 153 VKLGDFGLARILNHDTSFAKA---FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 209
Query: 257 GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELA 316
F + +EL K I F+ I + ++ ++++
Sbjct: 210 LMPP-----FTAFSQ---KELAGK-IREGKFRRIPYR--------YSDELNEIIT----- 247
Query: 317 IKCLSKSEQDRPTMVQV 333
+ L+ + RP++ ++
Sbjct: 248 -RMLNLKDYHRPSVEEI 263
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 3e-34
Identities = 57/274 (20%), Positives = 102/274 (37%), Gaps = 31/274 (11%)
Query: 70 KLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129
+++ G +K ++ H+ +++ E + I V
Sbjct: 32 EVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VT 90
Query: 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTI 189
E+++ G+L D + G + + + +A +IA+ +AY+ V RD++ + I
Sbjct: 91 EYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANI 144
Query: 190 LFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGA 249
L E V K DF ++ I + + + APE KSDV+SFG
Sbjct: 145 LVGENLVCKVADFGLARLIEDNEYTARQG--AKFPIKWTAPEAALYGRFTIKSDVWSFGI 202
Query: 250 LLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQL 309
LL EL T R+ Y +E++D + G P + +
Sbjct: 203 LLTELTTKGRVPY--------------------PGMVNREVLDQVERGYRMPCPPECPES 242
Query: 310 LSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343
L +L +C K ++RPT + L S
Sbjct: 243 LH--DLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 8e-34
Identities = 58/282 (20%), Positives = 107/282 (37%), Gaps = 37/282 (13%)
Query: 70 KLYKGFLQDR-----PISVMKFGGNLNSEEYCCF-NCIAFASQMSHKNILKFVGCCLETE 123
+Y G L D +V + E F SH N+L +G CL +E
Sbjct: 42 CVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 101
Query: 124 -LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFR 182
P++V ++ G L + I + +K + +++A + +L + V R
Sbjct: 102 GSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLAS---KKFVHR 154
Query: 183 DIKPSTILFQEQNVAKFFDFCVSISIPEGKTH-VNDNNKVIGTFGFIAPEYMSTANCNEK 241
D+ + E+ K DF ++ + + + V++ ++A E + T K
Sbjct: 155 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK 214
Query: 242 SDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGL 301
SDV+SFG LL EL+T Y + +I ++ G L
Sbjct: 215 SDVWSFGVLLWELMTRGAPPY--------------------PDVNTFDITVYLLQGRRLL 254
Query: 302 WPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343
PE L E+ +KC + RP+ ++ ++ + +
Sbjct: 255 QPEYCPDPLY--EVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 3e-33
Identities = 44/250 (17%), Positives = 92/250 (36%), Gaps = 39/250 (15%)
Query: 108 SHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLE-------------PFLM 154
+H NI+ +G C +++ E+ G L + + S + +
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 155 KHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214
+ L + ++A +A+L S+ + RD+ IL + K DF ++ I +
Sbjct: 145 EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFL 274
V N ++APE + +SDV+S+G L EL + Y + +
Sbjct: 202 VVKGN-ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---F 257
Query: 275 QELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVA 334
+++++ S + + ++ C RPT Q+
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMY------------------DIMKTCWDADPLKRPTFKQIV 299
Query: 335 KQL-RQLHKS 343
+ + +Q+ +S
Sbjct: 300 QLIEKQISES 309
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (307), Expect = 3e-33
Identities = 62/324 (19%), Positives = 118/324 (36%), Gaps = 53/324 (16%)
Query: 44 NFTAQELKAATNNYDPEKVITKDLLYKLYKGFLQD-------RPISVMKFGGNLNSEEYC 96
N L+ NN + + I + ++++ ++V +++
Sbjct: 2 NPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61
Query: 97 CF-NCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQL------ 149
F A ++ + NI+K +G C + L+FE++A G L + + + +
Sbjct: 62 DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121
Query: 150 -------------EPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNV 196
P +L +A ++A +AYL R V RD+ L E V
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMV 178
Query: 197 AKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT 256
K DF +S +I + D N ++ PE + +SDV+++G +L E+ +
Sbjct: 179 VKIADFGLSRNIYSADYYKADGN-DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 257 GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELA 316
Y + +E++ + G PE L L
Sbjct: 238 YGLQPY--------------------YGMAHEEVIYYVRDGNILACPENCPLELY--NLM 275
Query: 317 IKCLSKSEQDRPTMVQVAKQLRQL 340
C SK DRP+ + + L+++
Sbjct: 276 RLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-32
Identities = 56/236 (23%), Positives = 89/236 (37%), Gaps = 31/236 (13%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
I ++H+N++KF G E + L E+ + G L DRI G +
Sbjct: 54 ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRF 108
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
++ V YLH I RDIKP +L E++ K DF ++ NK
Sbjct: 109 FHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNK 164
Query: 221 VIGTFGFIAPEYMSTANCN-EKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR 279
+ GT ++APE + + E DV+S G +L +L G+ + +
Sbjct: 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKE 221
Query: 280 KSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335
K N +K+I LL K L ++ R T+ + K
Sbjct: 222 KKTYLNPWKKI------------DSAPLALLH------KILVENPSARITIPDIKK 259
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 120 bits (303), Expect = 1e-32
Identities = 53/275 (19%), Positives = 107/275 (38%), Gaps = 31/275 (11%)
Query: 70 KLYKGFLQDRPISV-MKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128
++Y+G + ++V +K E A ++ H N+++ +G C ++
Sbjct: 32 EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91
Query: 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPST 188
EF+ G L D + + N ++ L +A +I++A+ YL + + RD+
Sbjct: 92 TEFMTYGNLLDYLRECNRQEVSA---VVLLYMATQISSAMEYLE---KKNFIHRDLAARN 145
Query: 189 ILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFG 248
L E ++ K DF +S + + + APE ++ + KSDV++FG
Sbjct: 146 CLVGENHLVKVADFGLSRLMTGDTYTAH--AGAKFPIKWTAPESLAYNKFSIKSDVWAFG 203
Query: 249 ALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQ 308
LL E+ T S + + + EL+ K + + +
Sbjct: 204 VLLWEIATYGM----SPYPGIDLSQVYELLEKDYRMERPEGCPEKVY------------- 246
Query: 309 LLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343
EL C + DRP+ ++ + + +
Sbjct: 247 -----ELMRACWQWNPSDRPSFAEIHQAFETMFQE 276
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 3e-32
Identities = 48/249 (19%), Positives = 88/249 (35%), Gaps = 43/249 (17%)
Query: 107 MSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLE---------------- 150
SH+NI+ +G C + L+FE+ G L + + E
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 151 --PFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208
+ L A ++A + +L + V RD+ +L V K DF ++ I
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFEN 268
+V N ++APE + KSDV+S+G LL E+ + Y
Sbjct: 215 MSDSNYVVRGN-ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG---- 269
Query: 269 GEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP 328
+++N +K I + + + E+ ++ C + + RP
Sbjct: 270 -----------IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQ------SCWAFDSRKRP 312
Query: 329 TMVQVAKQL 337
+ + L
Sbjct: 313 SFPNLTSFL 321
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 4e-32
Identities = 47/233 (20%), Positives = 92/233 (39%), Gaps = 33/233 (14%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
I + + NI+ ++ L + +V E++A G+L D + + + V
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE------GQIAAV 121
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
E A+ +LH S ++ RDIK IL K DF I ++ +
Sbjct: 122 CRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS---T 175
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280
++GT ++APE ++ K D++S G + +E++ G+ + EN
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN---ENPLRALYL----- 227
Query: 281 SIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQV 333
I +N E+ +P + + L+ +CL + R + ++
Sbjct: 228 -IATNGTPELQNPEKLSAIF------RDFLN------RCLDMDVEKRGSAKEL 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 5e-32
Identities = 52/303 (17%), Positives = 106/303 (34%), Gaps = 46/303 (15%)
Query: 55 NNYDPEKVITKDLLYKLYKGFLQD----RPISVMKFGGNLNSEEYCCF-NCIAFASQMS- 108
N+ + VI + ++ K ++ ++ + + +++ F + ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 109 HKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEP-----------FLMKHR 157
H NI+ +G C L E+ G L D + + +P +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 158 LKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217
L A ++A + YL + + RD+ IL E VAK DF +S
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--- 183
Query: 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL 277
++A E ++ + SDV+S+G LL E+++ Y
Sbjct: 184 -TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--------------- 227
Query: 278 VRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQL 337
+ E+ + + G P + +L +C + +RP+ Q+ L
Sbjct: 228 -----CGMTCAELYEKLPQGYRLEKPLNCDDEVY--DLMRQCWREKPYERPSFAQILVSL 280
Query: 338 RQL 340
++
Sbjct: 281 NRM 283
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 5e-32
Identities = 53/238 (22%), Positives = 83/238 (34%), Gaps = 36/238 (15%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
I + H NI+K + ++ EF A G + + + P V
Sbjct: 60 IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER----PLTESQIQVV 115
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
+ +A+ YLH I+ RD+K ILF K DF VS +
Sbjct: 116 CKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDS 169
Query: 221 VIGTFGFIAPEYMSTANC-----NEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQ 275
IGT ++APE + + K+DV+S G L+E+ + +
Sbjct: 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP-----HHELNPMRVL 224
Query: 276 ELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQV 333
+ KS +P + + W K L KCL K+ R T Q+
Sbjct: 225 LKIAKS----------EPPTLAQPSRWSSNFKDFLK------KCLEKNVDARWTTSQL 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 117 bits (294), Expect = 4e-31
Identities = 55/257 (21%), Positives = 89/257 (34%), Gaps = 41/257 (15%)
Query: 81 ISVMKFGGNLNSEEYCCF-NCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLAD 139
I M + G ++E++ + F ++ H N +++ GC L LV E+
Sbjct: 45 IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDL 104
Query: 140 RIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKF 199
P V +AYLH S ++ RD+K IL E + K
Sbjct: 105 LEVHKK-----PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKL 156
Query: 200 FDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANC---NEKSDVYSFGALLLELLT 256
DF + + + N +GT ++APE + + + K DV+S G +EL
Sbjct: 157 GDFGSA-------SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209
Query: 257 GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELA 316
K + + I N + W E + +
Sbjct: 210 RKPPLF--------NMNAMSALYH-IAQNESPALQSGH-------WSEYFRNFVD----- 248
Query: 317 IKCLSKSEQDRPTMVQV 333
CL K QDRPT +
Sbjct: 249 -SCLQKIPQDRPTSEVL 264
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 116 bits (292), Expect = 4e-31
Identities = 59/248 (23%), Positives = 103/248 (41%), Gaps = 37/248 (14%)
Query: 101 IAFASQMSHKNILKFVGCCLETE----LPILVFEFVACGTLADRIHDPNGSQLEPFLMKH 156
A+ ++H I+ LP +V E+V TL D +H P K
Sbjct: 58 AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKR 112
Query: 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN 216
++V + A+ + H I+ RD+KP+ I+ N K DF ++ +I + V
Sbjct: 113 AIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 169
Query: 217 DNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQE 276
VIGT +++PE + + +SDVYS G +L E+LTG+ ++ Q
Sbjct: 170 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG---DSPVSVAYQ- 225
Query: 277 LVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLS--YTELAIKCLSKSEQDRP-TMVQV 333
V E+ + P + LS + +K L+K+ ++R T ++
Sbjct: 226 ------------------HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 267
Query: 334 AKQLRQLH 341
L ++H
Sbjct: 268 RADLVRVH 275
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 7e-31
Identities = 46/242 (19%), Positives = 83/242 (34%), Gaps = 32/242 (13%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
Q H +I+K +G E + I + E G L + + +
Sbjct: 59 ALTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVRKY----SLDLASLILY 113
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
A +++ A+AYL S+ V RDI +L + K DF +S + + + +K
Sbjct: 114 AYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA--SK 168
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280
++APE ++ SDV+ FG + E+L + N ++ R
Sbjct: 169 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 228
Query: 281 SIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340
+ N + L KC + RP ++ QL +
Sbjct: 229 PMPPNCPPTLYS----------------------LMTKCWAYDPSRRPRFTELKAQLSTI 266
Query: 341 HK 342
+
Sbjct: 267 LE 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-30
Identities = 53/273 (19%), Positives = 97/273 (35%), Gaps = 42/273 (15%)
Query: 70 KLYKGFLQDRPISV----MKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLET--- 122
+YKG + + V ++ SE + H NI++F T
Sbjct: 24 TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 83
Query: 123 -ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVF 181
+ +LV E + GTL + + + +K +I + +LH + PI+
Sbjct: 84 KKCIVLVTELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIH 137
Query: 182 RDIKPSTILFQEQN-VAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNE 240
RD+K I K D ++ VIGT F+APE +E
Sbjct: 138 RDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-----AVIGTPEFMAPEMYEE-KYDE 191
Query: 241 KSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEG 300
DVY+FG +LE+ T + + V ++ SF ++ P +
Sbjct: 192 SVDVYAFGMCMLEMATSEYPYSECQ----NAAQIYRRVTSGVKPASFDKVAIPEVK---- 243
Query: 301 LWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQV 333
E+ C+ +++ +R ++ +
Sbjct: 244 -------------EIIEGCIRQNKDERYSIKDL 263
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 3e-30
Identities = 53/271 (19%), Positives = 93/271 (34%), Gaps = 37/271 (13%)
Query: 81 ISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADR 140
+ ++K HKNI+ +G C + ++ E+ + G L +
Sbjct: 50 VKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 109
Query: 141 IH-----------DPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTI 189
+ +P+ + E K + A ++A + YL S+ + RD+ +
Sbjct: 110 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 166
Query: 190 LFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGA 249
L E NV K DF ++ I + N ++APE + +SDV+SFG
Sbjct: 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNG-RLPVKWMAPEALFDRIYTHQSDVWSFGV 225
Query: 250 LLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQL 309
LL E+ T Y +E+ + G P
Sbjct: 226 LLWEIFTLGGSPY--------------------PGVPVEELFKLLKEGHRMDKPSNCTNE 265
Query: 310 LSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340
L + C RPT Q+ + L ++
Sbjct: 266 LY--MMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 5e-30
Identities = 39/242 (16%), Positives = 88/242 (36%), Gaps = 31/242 (12%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
+ + + ++ + +G CL + + ++ + + G L D + + + ++ L
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGS----QYLLNW 116
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
++IA + YL R +V RD+ +L + K DF ++ + + +
Sbjct: 117 CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG- 172
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280
++A E + +SDV+S+G + EL+T Y
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY------------------ 214
Query: 281 SIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340
+ EI + GE P + + +KC RP ++ + ++
Sbjct: 215 --DGIPASEISSILEKGERLPQPPICTIDVY--MIMVKCWMIDADSRPKFRELIIEFSKM 270
Query: 341 HK 342
+
Sbjct: 271 AR 272
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 113 bits (284), Expect = 2e-29
Identities = 37/235 (15%), Positives = 80/235 (34%), Gaps = 33/235 (14%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
I S + H ++ + ++++EF++ G L +++ D + ++
Sbjct: 74 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEY 129
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILF--QEQNVAKFFDFCVSISIPEGKTHVNDN 218
++ + ++H V D+KP I+F + N K DF ++ + ++
Sbjct: 130 MRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---- 182
Query: 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELV 278
GT F APE +D++S G L LL+G
Sbjct: 183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN------------- 229
Query: 279 RKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQV 333
+ + + + ++ + + + K L R T+ Q
Sbjct: 230 ----DDETLRNVKSCDWNMDDSAFSGISEDGK---DFIRKLLLADPNTRMTIHQA 277
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 2e-29
Identities = 51/275 (18%), Positives = 100/275 (36%), Gaps = 37/275 (13%)
Query: 81 ISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPI-LVFEFVACGTLAD 139
+ ++K G + H N++ +G C + P+ ++ EF G L+
Sbjct: 48 VKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 107
Query: 140 RIHD-----------PNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPST 188
+ P + ++H + + ++A + +L SR + RD+
Sbjct: 108 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARN 164
Query: 189 ILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFG 248
IL E+NV K DF ++ I + +V + ++APE + +SDV+SFG
Sbjct: 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGD-ARLPLKWMAPETIFDRVYTIQSDVWSFG 223
Query: 249 ALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQ 308
LL E+ + Y + E + ++ + D + Q
Sbjct: 224 VLLWEIFSLGASPYPGVKID-------EEFCRRLKEGTRMRAPDYT--------TPEMYQ 268
Query: 309 LLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343
+ C RPT ++ + L L ++
Sbjct: 269 TML------DCWHGEPSQRPTFSELVEHLGNLLQA 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 6e-29
Identities = 50/291 (17%), Positives = 100/291 (34%), Gaps = 38/291 (13%)
Query: 48 QELKAATNNYDPEKVITKDLLYKLYKGFLQDRP----ISVMKFGGNLNSEEYCCF-NCIA 102
Q K ++ K++ + + I +++ + +
Sbjct: 1 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60
Query: 103 FASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAM 162
S++ H +K + E + G L I F
Sbjct: 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTA 115
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVI 222
EI +A+ YLH + I+ RD+KP IL E + DF + + N+ +
Sbjct: 116 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FV 171
Query: 223 GTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282
GT +++PE ++ + + SD+++ G ++ +L+ G F G EY +
Sbjct: 172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP-----FRAGNEYLI-------- 218
Query: 283 ESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQV 333
F++I+ E +P+ + L+ K L R ++
Sbjct: 219 ----FQKIIKLEYDFPEKFFPK-ARDLVE------KLLVLDATKRLGCEEM 258
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-28
Identities = 45/245 (18%), Positives = 99/245 (40%), Gaps = 31/245 (12%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDP-----NGSQLEPFLMK 155
+ + + ++++ +G + + +++ E + G L + N L P +
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 156 HRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHV 215
+++A EIA+ +AYL+ + V RD+ + E K DF ++ I E +
Sbjct: 134 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 216 NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQ 275
K + +++PE + SDV+SFG +L E+ T Y
Sbjct: 191 K-GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY------------- 236
Query: 276 ELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335
+ S ++++ ++ G P+ +L EL C + + RP+ +++
Sbjct: 237 -------QGLSNEQVLRFVMEGGLLDKPDNCPDMLF--ELMRMCWQYNPKMRPSFLEIIS 287
Query: 336 QLRQL 340
+++
Sbjct: 288 SIKEE 292
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 109 bits (273), Expect = 8e-28
Identities = 41/248 (16%), Positives = 86/248 (34%), Gaps = 35/248 (14%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
I+ +Q+ H ++ + +L+ EF++ G L DRI + +
Sbjct: 77 ISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY----KMSEAEVINY 132
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILF--QEQNVAKFFDFCVSISIPEGKTHVNDN 218
+ + ++H IV DIKP I+ ++ + K DF ++ + +
Sbjct: 133 MRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---- 185
Query: 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELV 278
T F APE + +D+++ G L LL+G F ++
Sbjct: 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP-----FAGEDDL------ 234
Query: 279 RKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQ-- 336
+ + + +E + + + L K + R T+ +
Sbjct: 235 ------ETLQNVKRCDWEFDEDAFSSVSPEAK---DFIKNLLQKEPRKRLTVHDALEHPW 285
Query: 337 LRQLHKSI 344
L+ H ++
Sbjct: 286 LKGDHSNL 293
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 105 bits (264), Expect = 3e-27
Identities = 48/232 (20%), Positives = 83/232 (35%), Gaps = 38/232 (16%)
Query: 108 SHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANA 167
H NI++ LVF+ + G L D + + K K+ +
Sbjct: 68 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEV 122
Query: 168 VAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGF 227
+ LH IV RD+KP IL + K DF S + G+ +V GT +
Sbjct: 123 ICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----REVCGTPSY 175
Query: 228 IAPEYMSTANC------NEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS 281
+APE + + ++ D++S G ++ LL G F + ++ + ++
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-----FWHRKQMLMLRMIMSG 230
Query: 282 IESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQV 333
E D + + K L+S + L Q R T +
Sbjct: 231 NYQFGSPEWDD---------YSDTVKDLVS------RFLVVQPQKRYTAEEA 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 5e-27
Identities = 44/237 (18%), Positives = 88/237 (37%), Gaps = 37/237 (15%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
I+ + H+NIL E +++FEF++ + +RI+ + +
Sbjct: 52 ISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF----ELNEREIVSY 107
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ--EQNVAKFFDFCVSISIPEGKTHVNDN 218
++ A+ +LH S I DI+P I++Q + K +F + + G
Sbjct: 108 VHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---- 160
Query: 219 NKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELV 278
+ + APE + +D++S G L+ LL+G F Q+++
Sbjct: 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP-----FLAETN---QQII 212
Query: 279 RKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYT--ELAIKCLSKSEQDRPTMVQV 333
I+ E + E+ + +S + + L K + R T +
Sbjct: 213 EN--------------IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 105 bits (262), Expect = 9e-27
Identities = 45/248 (18%), Positives = 83/248 (33%), Gaps = 32/248 (12%)
Query: 101 IAFASQMSHKNILKFVG-CCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLK 159
M + + C E + ++V E + F +K L
Sbjct: 53 SKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR-----KFSLKTVLL 107
Query: 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ---NVAKFFDFCVSISIPEGKTHVN 216
+A ++ + + Y+H S+ + RD+KP L N+ DF ++ + +TH +
Sbjct: 108 LADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 164
Query: 217 D----NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEY 272
N + GT + + + + D+ S G +L+ G
Sbjct: 165 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT---- 220
Query: 273 FLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQ 332
R+ E S K++ PI V +G E + C S D+P
Sbjct: 221 -----KRQKYERISEKKMSTPIEVLCKGYPSE-------FATYLNFCRSLRFDDKPDYSY 268
Query: 333 VAKQLRQL 340
+ + R L
Sbjct: 269 LRQLFRNL 276
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 1e-25
Identities = 39/242 (16%), Positives = 79/242 (32%), Gaps = 29/242 (11%)
Query: 105 SQMSHKNILKFVGCCLETELP-----ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLK 159
H N+++ C + LVFE V P +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP----GVPTETIKD 120
Query: 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNN 219
+ ++ + +LH S +V RD+KP IL K DF ++
Sbjct: 121 MMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL----T 173
Query: 220 KVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR 279
V+ T + APE + ++ D++S G + E+ K + F + +
Sbjct: 174 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL-----FRGSSDVDQLGKIL 228
Query: 280 KSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYT--------ELAIKCLSKSEQDRPTMV 331
I ++ + + + + + + + +L +KCL+ + R +
Sbjct: 229 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288
Query: 332 QV 333
Sbjct: 289 SA 290
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 101 bits (253), Expect = 2e-25
Identities = 51/236 (21%), Positives = 87/236 (36%), Gaps = 35/236 (14%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
IA ++ H NI+ L+ + V+ G L DRI + + + ++
Sbjct: 58 IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRL 112
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILF---QEQNVAKFFDFCVSISIPEGKTHVND 217
++ +AV YLH IV RD+KP +L+ E + DF +S G
Sbjct: 113 IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL--- 166
Query: 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL 277
+ GT G++APE ++ ++ D +S G + LL G F + + L E
Sbjct: 167 -STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP-----FYDENDAKLFEQ 220
Query: 278 VRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQV 333
+ K+ D + K + + K + R T Q
Sbjct: 221 ILKAEYEFDSPYWDD---------ISDSAKDFIR------HLMEKDPEKRFTCEQA 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 102 bits (254), Expect = 3e-25
Identities = 44/241 (18%), Positives = 87/241 (36%), Gaps = 36/241 (14%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
++ S I+ + + + + G L + F
Sbjct: 58 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-----VFSEADMRFY 112
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
A EI + ++H +R +V+RD+KP+ IL E + D ++ + K H
Sbjct: 113 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-----A 164
Query: 221 VIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR 279
+GT G++APE + + +D +S G +L +LL G F + E+ R
Sbjct: 165 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS-----PFRQHKTKDKHEIDR 219
Query: 280 KSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQV-AKQLR 338
++ E+ D + + LL L + R + A++++
Sbjct: 220 MTLTMAV--ELPDSF--------SPELRSLLE------GLLQRDVNRRLGCLGRGAQEVK 263
Query: 339 Q 339
+
Sbjct: 264 E 264
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 3e-25
Identities = 54/258 (20%), Positives = 85/258 (32%), Gaps = 37/258 (14%)
Query: 81 ISVMKFGGNLNSEEYCCF--NCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLA 138
I +K L ++ C + H + E V E++ G L
Sbjct: 32 IKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLM 91
Query: 139 DRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAK 198
I + F + A EI + +LH S+ IV+RD+K IL + K
Sbjct: 92 YHIQSCH-----KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIK 143
Query: 199 FFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
DF + G N GT +IAPE + N D +SFG LL E+L G+
Sbjct: 144 IADFGMCKENMLGDAK---TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
Query: 259 RISYSSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIK 318
+E+ I + EK+ +L +K
Sbjct: 201 SP---------------------FHGQDEEELFHSIRMDNPFYPRWLEKEAK---DLLVK 236
Query: 319 CLSKSEQDRPTMVQVAKQ 336
+ + R + +Q
Sbjct: 237 LFVREPEKRLGVRGDIRQ 254
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.2 bits (246), Expect = 1e-24
Identities = 42/243 (17%), Positives = 79/243 (32%), Gaps = 26/243 (10%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
I ++SH NI+ + LVF+F+ + H
Sbjct: 51 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAY 105
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
+ + YLH I+ RD+KP+ +L E V K DF ++ S
Sbjct: 106 MLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA---YTH 159
Query: 221 VIGTFGFIAPEYMSTANC-NEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR 279
+ T + APE + A D+++ G +L ELL + +
Sbjct: 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF-----LPGDSDLDQLTRIF 214
Query: 280 KSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYT---------ELAIKCLSKSEQDRPTM 330
+++ + + ++ D + + + L + +L + R T
Sbjct: 215 ETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA 274
Query: 331 VQV 333
Q
Sbjct: 275 TQA 277
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.0 bits (246), Expect = 3e-24
Identities = 45/234 (19%), Positives = 83/234 (35%), Gaps = 33/234 (14%)
Query: 107 MSHKNILKFVGCC----LETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAM 162
+I++ V + ++V E + G L RI D + F + ++
Sbjct: 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMK 118
Query: 163 EIANAVAYLHVGFSRPIVFRDIKPSTILF---QEQNVAKFFDFCVSISIPEGKTHVNDNN 219
I A+ YLH S I RD+KP +L+ + + K DF + +
Sbjct: 119 SIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL----T 171
Query: 220 KVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR 279
T ++APE + ++ D++S G ++ LL G F + + ++
Sbjct: 172 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP-----FYSNHGLAISPGMK 226
Query: 280 KSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQV 333
I + E +P E+ K L+ L R T+ +
Sbjct: 227 TRIRMGQY-EFPNPEWSE----VSEEVKMLIR------NLLKTEPTQRMTITEF 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.1 bits (241), Expect = 8e-24
Identities = 51/237 (21%), Positives = 84/237 (35%), Gaps = 36/237 (15%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
++ ++ H N++ IL+ E VA G L D + + E + +
Sbjct: 64 VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-----ESLTEEEATEF 118
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA----KFFDFCVSISIPEGKTHVN 216
+I N V YLH S I D+KP I+ ++NV K DF ++ I G
Sbjct: 119 LKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-- 173
Query: 217 DNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQE 276
+ GT F+APE ++ ++D++S G + LL+G + E
Sbjct: 174 --KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANVS 229
Query: 277 LVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQV 333
V E F K + + L K + R T+
Sbjct: 230 AVNYEFEDEYFSNT------------SALAKDFIR------RLLVKDPKKRMTIQDS 268
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 93.7 bits (232), Expect = 2e-22
Identities = 36/246 (14%), Positives = 80/246 (32%), Gaps = 33/246 (13%)
Query: 108 SHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANA 167
I E +LV + G + + D G F +K A ++
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDL--LGPSLEDLLDLCG---RKFSVKTVAMAAKQMLAR 113
Query: 168 VAYLHVGFSRPIVFRDIKPSTILFQEQ-----NVAKFFDFCVSISIPEGKTHVNDNNK-- 220
V +H + +V+RDIKP L N+ DF + + T + +
Sbjct: 114 VQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
Query: 221 --VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELV 278
+ GT +++ + + D+ + G + + L G ++ + +
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 230
Query: 279 RKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLR 338
+K +S +E+ PE+ + + Y + + P +
Sbjct: 231 KK--QSTPLRELCAGF--------PEEFYKYMHY------ARNLAFDATPDYDYLQGLFS 274
Query: 339 QLHKSI 344
++ + +
Sbjct: 275 KVLERL 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.7 bits (232), Expect = 3e-22
Identities = 43/250 (17%), Positives = 86/250 (34%), Gaps = 30/250 (12%)
Query: 101 IAFASQMSHKNILKFVGCCLETELP------ILVFEFVACGTLADRIHDPNGSQLEPFLM 154
+ ++ H NI++ + LV ++V H Q +
Sbjct: 64 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ--TLPV 121
Query: 155 KHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTI-LFQEQNVAKFFDFCVSISIPEGKT 213
+ ++ ++AY+H S I RDIKP + L + V K DF + + G+
Sbjct: 122 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178
Query: 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYF 273
+ + + + + DV+S G +L ELL G+ I F
Sbjct: 179 N---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI-----FPGDSGVD 230
Query: 274 LQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYT----------ELAIKCLSKS 323
+ K + + + ++I + E +P+ + + L + L +
Sbjct: 231 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 290
Query: 324 EQDRPTMVQV 333
R T ++
Sbjct: 291 PTARLTPLEA 300
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.4 bits (231), Expect = 4e-22
Identities = 45/247 (18%), Positives = 84/247 (34%), Gaps = 25/247 (10%)
Query: 101 IAFASQMSHKNILKFVGCCLETEL----PILVFEFVACGTLADRIHDPNGSQLEPFLMKH 156
I + H+NI+ + + + + L + + H
Sbjct: 57 IKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT------QHLSNDH 110
Query: 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN 216
+I + Y+H S ++ RD+KPS +L K DF ++ H
Sbjct: 111 ICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 167
Query: 217 DNNKVIGTFGFIAPEYMSTANC-NEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQ 275
+ + T + APE M + + D++S G +L E+L+ + I + + + L
Sbjct: 168 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 227
Query: 276 ELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYT---------ELAIKCLSKSEQD 326
L S E I++ P K K + +L K L+ +
Sbjct: 228 ILGSPSQE--DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 285
Query: 327 RPTMVQV 333
R + Q
Sbjct: 286 RIEVEQA 292
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 91.3 bits (226), Expect = 1e-21
Identities = 48/240 (20%), Positives = 93/240 (38%), Gaps = 39/240 (16%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
S ++H I++ G + + ++ +++ G L + F
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFY 109
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
A E+ A+ YLH S+ I++RD+KP IL + K DF + +P+
Sbjct: 110 AAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT------ 160
Query: 221 VIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280
+ GT +IAPE +ST N+ D +SFG L+ E+L G
Sbjct: 161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG---------------------YT 199
Query: 281 SIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQV-AKQLRQ 339
++ + + I+ E P + + +L + +++ R +Q + ++
Sbjct: 200 PFYDSNTMKTYEKILNAELRFPPFFNEDVK---DLLSRLITRDLSQRLGNLQNGTEDVKN 256
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.7 bits (224), Expect = 2e-21
Identities = 38/239 (15%), Positives = 77/239 (32%), Gaps = 16/239 (6%)
Query: 101 IAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKV 160
I+ +++H NI+K + LVFEF+ +
Sbjct: 52 ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT----GIPLPLIKSY 107
Query: 161 AMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNK 220
++ +A+ H S ++ RD+KP +L + K DF ++ + V
Sbjct: 108 LFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYTH 161
Query: 221 VIGTFGFIAPE-YMSTANCNEKSDVYSFGALLLELLTGKRI-SYSSCFENGEEYFLQELV 278
+ T + APE + + D++S G + E++T + + S + F
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 221
Query: 279 RKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAI----KCLSKSEQDRPTMVQV 333
+ + D + + K + E + L R +
Sbjct: 222 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.1 bits (223), Expect = 2e-21
Identities = 36/227 (15%), Positives = 72/227 (31%), Gaps = 44/227 (19%)
Query: 109 HKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAV 168
+++ + + +L+ E G + ++ AV
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAV 123
Query: 169 AYLHVGFSRPIVFRDIKPSTILF-QEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGF 227
+ H + ++ RDIK IL + K DF + + GT +
Sbjct: 124 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-----TVYTDFDGTRVY 175
Query: 228 IAPEYMSTAN-CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNS 286
PE++ + V+S G LL +++ G FE+ EE ++ + S+
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDEEIIRGQVFFRQRVSSE 230
Query: 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQV 333
+ ++ CL+ DRPT ++
Sbjct: 231 CQHLIR-------------------------WCLALRPSDRPTFEEI 252
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 87.6 bits (216), Expect = 2e-20
Identities = 45/287 (15%), Positives = 87/287 (30%), Gaps = 18/287 (6%)
Query: 55 NNYDPEKVITKDLLYKLYKGFLQDRP---ISVMKFGGNLNSEEYCCFNCIAFASQMSHKN 111
Y + I + +YK + ++ I+ ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 112 ILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYL 171
I+K + +LVFE + +++ N +AY
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYC 116
Query: 172 HVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPE 231
H R ++ RD+KP +L + K DF ++ + ++++ +
Sbjct: 117 H---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIVTLWYRAPDV 171
Query: 232 YMSTANCNEKSDVYSFGALLLELLTGKR----ISYSSCFENGEEYFLQELVRKSIESNSF 287
M + + D++S G + E++ G +S + +
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 288 KEIVDPIIVGEEGLWPEKEKQL-LSYTELAIKCLSKSEQDRPTMVQV 333
+ V E W K L S +L K L R T Q
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.3 bits (215), Expect = 2e-20
Identities = 32/259 (12%), Positives = 72/259 (27%), Gaps = 16/259 (6%)
Query: 81 ISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADR 140
+ ++ + I ++ HKNI++ + LVFEF
Sbjct: 32 LKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYF 91
Query: 141 IHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFF 200
E ++ + + H R ++ RD+KP +L K
Sbjct: 92 DSCNGDLDPE-----IVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLA 143
Query: 201 DFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRI 260
+F ++ + + +V+ + + D++S G + EL R
Sbjct: 144 NFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
Query: 261 SY--SSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAI- 317
+ + + + F + S ++ D +
Sbjct: 202 LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRD 261
Query: 318 ---KCLSKSEQDRPTMVQV 333
L + R + +
Sbjct: 262 LLQNLLKCNPVQRISAEEA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.8 bits (206), Expect = 6e-19
Identities = 40/271 (14%), Positives = 85/271 (31%), Gaps = 26/271 (9%)
Query: 81 ISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPI--------LVFEFV 132
+ + I + H+N++ + C P LVF+F
Sbjct: 40 LKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC 99
Query: 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ 192
+ L F + +V + N L+ I+ RD+K + +L
Sbjct: 100 EHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNG---LYYIHRNKILHRDMKAANVLIT 151
Query: 193 EQNVAKFFDFCVSISIPEGK-THVNDNNKVIGTFGFIAPEYM-STANCNEKSDVYSFGAL 250
V K DF ++ + K + N + T + PE + + D++ G +
Sbjct: 152 RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI 211
Query: 251 LLELLTGKRISYSSCFENGEEYFLQEL------VRKSIESNSFKEIVDPIIVGEEGLWPE 304
+ E+ T I + ++ Q V ++++ E ++ + + +
Sbjct: 212 MAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDR 271
Query: 305 KEKQLLSYT--ELAIKCLSKSEQDRPTMVQV 333
+ + +L K L R
Sbjct: 272 LKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.9 bits (204), Expect = 2e-18
Identities = 54/291 (18%), Positives = 99/291 (34%), Gaps = 41/291 (14%)
Query: 55 NNYDPEKVITKDLLYKLYKGFLQDRP----ISVMKFGGNLNSEEYCCF-NCIAFASQMSH 109
N++D K++ K K+ + + +++ + +E H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 110 KNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVA 169
+ + V E+ G L + F + EI +A+
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALE 119
Query: 170 YLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIA 229
YLH SR +V+RDIK ++ + K DF + + GT ++A
Sbjct: 120 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTPEYLA 173
Query: 230 PEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289
PE + + D + G ++ E++ G+ F N + L EL+ +E
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-----FYNQDHERLFELILM-------EE 221
Query: 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQV-AKQLRQ 339
I P + E K LL+ L K + R AK++ +
Sbjct: 222 IRFPRTLSPEA------KSLLA------GLLKKDPKQRLGGGPSDAKEVME 260
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.0 bits (199), Expect = 7e-18
Identities = 45/310 (14%), Positives = 98/310 (31%), Gaps = 36/310 (11%)
Query: 45 FTAQELKAAT----NNYDPEKVITKDLLYKLYKGFLQD--RPISVMKFGGNLNSEEYC-- 96
F QE+ Y + + + +++ K SE +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 97 CFNCIAFASQMSHKNILKFVGCCLETELP------ILVFEFVACGTLADRIHDPNGSQLE 150
+ + M H+N++ + E LV F GT ++
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF--MGTDLGKLMKHE----- 116
Query: 151 PFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210
+ ++ + Y+H + I+ RD+KP + E K DF ++
Sbjct: 117 KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173
Query: 211 GKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGE 270
T V+ + ++ + D++S G ++ E++TGK + S +
Sbjct: 174 EMTG-----YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL 228
Query: 271 EYFLQELVR------KSIESNSFKEIVDPIIVGEEGLWPEKEKQL-LSYTELAIKCLSKS 323
+ ++ + ++S+ K + + E+ + L K L
Sbjct: 229 KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLD 288
Query: 324 EQDRPTMVQV 333
+ R T +
Sbjct: 289 AEQRVTAGEA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.0 bits (191), Expect = 6e-17
Identities = 42/241 (17%), Positives = 71/241 (29%), Gaps = 30/241 (12%)
Query: 101 IAFASQMSHK-NILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLK 159
+ ++ L+ +++ G L + F
Sbjct: 79 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-----RFTEHEVQI 133
Query: 160 VAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNN 219
EI A+ +LH I++RDIK IL DF +S +T +
Sbjct: 134 YVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 190
Query: 220 KVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR 279
+ + ++ D +S G L+ ELLTG
Sbjct: 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG-------------- 236
Query: 280 KSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQV-AKQLR 338
E NS EI I+ E E +L + L K + R A +++
Sbjct: 237 ---EKNSQAEISRRILKSEPPYPQEMSALAK---DLIQRLLMKDPKKRLGCGPRDADEIK 290
Query: 339 Q 339
+
Sbjct: 291 E 291
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 77.2 bits (189), Expect = 2e-16
Identities = 35/162 (21%), Positives = 64/162 (39%), Gaps = 14/162 (8%)
Query: 98 FNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHR 157
N ++ ++K + +V E+VA G + + ++ F H
Sbjct: 89 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-----RIGRFSEPHA 143
Query: 158 LKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVND 217
A +I YLH S +++RD+KP +L +Q + DF + K
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGR 194
Query: 218 NNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKR 259
+ GT +APE + + N+ D ++ G L+ E+ G
Sbjct: 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 75.6 bits (185), Expect = 5e-16
Identities = 45/248 (18%), Positives = 80/248 (32%), Gaps = 33/248 (13%)
Query: 104 ASQMSHKNILKFVGCCLE--TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVA 161
+ NI+ + + P LVFE V
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYM 135
Query: 162 MEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN-VAKFFDFCVSISIPEGKTHVNDNNK 220
EI A+ Y H S I+ RD+KP ++ ++ + D+ ++ G+ + N
Sbjct: 136 YEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY----NV 188
Query: 221 VIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFEN----------G 269
+ + F PE + + D++S G +L ++ K + G
Sbjct: 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248
Query: 270 EEYFLQELVRKSIESN-SFKEIVDPIIVGEEGLWPEKEKQLLSYTE---LAIKCLSKSEQ 325
E + + +IE + F +I+ + E Q L E K L Q
Sbjct: 249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308
Query: 326 DRPTMVQV 333
R T +
Sbjct: 309 SRLTAREA 316
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 71.6 bits (174), Expect = 1e-14
Identities = 34/239 (14%), Positives = 89/239 (37%), Gaps = 21/239 (8%)
Query: 20 MLKNGKFLLQKLIASCNGDYNPIQNFTAQELKAATNNYDPEKVITKDLLYKLYKGFLQDR 79
K+ +++L + + G ++ + + A+++ N + K++ D +Y +
Sbjct: 9 PYKDARYILVRKLGW--GHFSTV--WLAKDMV--NNTHVAMKIVRGDKVYTE----AAED 58
Query: 80 PISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLAD 139
I +++ + ++ + M +ILK + + V +
Sbjct: 59 EIKLLQRVNDADNTKEDS---------MGANHILKLLDHFNHKGPNGVHVVMVFEVLGEN 109
Query: 140 RIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKF 199
+ + + + +++ ++ + Y+H I+ DIKP +L + + +
Sbjct: 110 LLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPEN 167
Query: 200 FDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGK 258
+ + I T + +PE + A +D++S L+ EL+TG
Sbjct: 168 LIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.0 bits (170), Expect = 5e-14
Identities = 41/257 (15%), Positives = 87/257 (33%), Gaps = 39/257 (15%)
Query: 101 IAFASQMSHKNILKFVGCCL------ETELPILVFEFVACGTLADRIHDPNGSQLEPFLM 154
+ ++HKNI+ + E + LV E + + +
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--------H 118
Query: 155 KHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214
+ + ++ + +LH S I+ RD+KPS I+ + K DF ++ +
Sbjct: 119 ERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 175
Query: 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFL 274
+ T + APE + E D++S G ++ E++ K + + + +
Sbjct: 176 ----TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231
Query: 275 QEL--------------VRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAI--- 317
++L VR +E+ + + + L+P + A
Sbjct: 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291
Query: 318 -KCLSKSEQDRPTMVQV 333
K L R ++
Sbjct: 292 SKMLVIDPAKRISVDDA 308
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.4 bits (166), Expect = 1e-13
Identities = 42/244 (17%), Positives = 77/244 (31%), Gaps = 24/244 (9%)
Query: 101 IAFASQMSHKNILKFVGCCLE----TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKH 156
+ M H+N++ + E + G + I H
Sbjct: 68 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-----KLTDDH 122
Query: 157 RLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVN 216
+ +I + Y+H S I+ RD+KPS + E K DF ++ T
Sbjct: 123 VQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDE 174
Query: 217 DNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQE 276
V + ++ + N+ D++S G ++ ELLTG+ + + + + L+
Sbjct: 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234
Query: 277 LVRKSIESNSFKEIVDPIIVGEEGLWPEK---EKQLLSYTELAI----KCLSKSEQDRPT 329
+ E + K + LA+ K L R T
Sbjct: 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294
Query: 330 MVQV 333
Q
Sbjct: 295 AAQA 298
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 45.5 bits (107), Expect = 2e-06
Identities = 23/160 (14%), Positives = 50/160 (31%), Gaps = 30/160 (18%)
Query: 96 CCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMK 155
N ++ + E ++ E + +L ++
Sbjct: 60 SARNEFRALQKLQGLAVP----KVYAWEGNAVLMELIDAK------------ELYRVRVE 103
Query: 156 HRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF--CVSISIPEGKT 213
+ +V I VA + R IV D+ +L E+ + DF V + +
Sbjct: 104 NPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWRE 159
Query: 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLE 253
+ + + I T + + Y + D+ S +L+
Sbjct: 160 ILERDVRNIIT--YFSRTY------RTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 344 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.76 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.16 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.55 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.04 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.93 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.92 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-58 Score=406.41 Aligned_cols=257 Identities=21% Similarity=0.327 Sum_probs=203.1
Q ss_pred cCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
++|+..+.||+|+||+||+|++ ++..||||++..... ..+.+.+|+.++++++|||||+++|++..++..++|||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4677889999999999999999 677899999876543 45679999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~g~L~~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 84 HGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999987654 36889999999999999999999 99999999999999999999999999999987654332
Q ss_pred ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDP 293 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (344)
... ....||+.|+|||++.+..|+.++|||||||++|||+|+..|++.... ...+...+...
T Consensus 157 ~~~--~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~----~~~~~~~i~~~------------ 218 (263)
T d1sm2a_ 157 TSS--TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----NSEVVEDISTG------------ 218 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC----HHHHHHHHHHT------------
T ss_pred eee--cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC----HHHHHHHHHhc------------
Confidence 221 135689999999999999999999999999999999997767654322 11111111111
Q ss_pred ccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 294 IIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
.....|. .++.++.+|+.+||+.||++|||+++|++.|++|.++
T Consensus 219 ----~~~~~p~--~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 219 ----FRLYKPR--LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp ----CCCCCCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCcc--ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 0111111 3445689999999999999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-58 Score=405.78 Aligned_cols=263 Identities=22% Similarity=0.316 Sum_probs=206.8
Q ss_pred hcCCCCCCccccCCCceEEEEEECCccEEEEEecCCC--CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNL--NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
.++|...+.||+|+||+||+|++++ .||||+++... ....+.|.+|+.++++++|||||+++|++.+ +..++||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 4678999999999999999999865 49999986542 3345678899999999999999999999754 568999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
|++|+|.+++.... ..+++.+++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 85 CEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCEEEHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred CCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999997654 36899999999999999999999 999999999999999999999999999999876543
Q ss_pred CcccccCCccccccccccccccCc---CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMST---ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
... .......||+.|+|||++.+ ..|+.++|||||||++|||+||+.||..... ...+...+..........
T Consensus 158 ~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~----~~~~~~~~~~~~~~p~~~ 232 (276)
T d1uwha_ 158 SGS-HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN----RDQIIFMVGRGYLSPDLS 232 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----HHHHHHHHHHTSCCCCGG
T ss_pred CCc-ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh----HHHHHHHHhcCCCCCcch
Confidence 221 11224578999999999864 3589999999999999999999999864321 112222222211111111
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhC
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKSI 344 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~l 344 (344)
. ....++..+.+|+.+||+.||++|||+.+|++.|+.+.+++
T Consensus 233 ~--------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 233 K--------------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp G--------------SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred h--------------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 0 01134567899999999999999999999999999998865
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.8e-58 Score=408.43 Aligned_cols=270 Identities=18% Similarity=0.299 Sum_probs=203.3
Q ss_pred ccccHHHHHHHhcCC---------CCCCccccCCCceEEEEEE--CCc---cEEEEEecCCCC-chhhhHhhHHHHHhcC
Q 048160 43 QNFTAQELKAATNNY---------DPEKVITKDLLYKLYKGFL--QDR---PISVMKFGGNLN-SEEYCCFNCIAFASQM 107 (344)
Q Consensus 43 ~~~~~~~i~~~~~~~---------~~~~~ig~G~~g~V~~~~~--~~~---~vavk~~~~~~~-~~~~~~~~E~~~l~~l 107 (344)
..++++++..++.+| +..+.||+|+||+||+|++ +++ .||||++..... ...+.|.+|+.+|+++
T Consensus 5 d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l 84 (299)
T d1jpaa_ 5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84 (299)
T ss_dssp CGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC
T ss_pred CCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC
Confidence 345666666665444 4457899999999999998 232 588998876543 3346789999999999
Q ss_pred CCCceeeeeeEEeeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccccc
Q 048160 108 SHKNILKFVGCCLETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPS 187 (344)
Q Consensus 108 ~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~ 187 (344)
+|||||+++|++..++..++|||||++|+|.+++.... ..+++.+++.++.|++.||.||| +.+|+||||||+
T Consensus 85 ~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~ 157 (299)
T d1jpaa_ 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAAR 157 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGG
T ss_pred CCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccc
Confidence 99999999999999999999999999999999887654 36899999999999999999999 999999999999
Q ss_pred ceEeecCCcceEeeeecccccCCCCcccc--cCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCC
Q 048160 188 TILFQEQNVAKFFDFCVSISIPEGKTHVN--DNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSS 264 (344)
Q Consensus 188 Nill~~~~~~kl~dfg~a~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~ 264 (344)
|||++.++.+||+|||+++.......... ......||+.|+|||++.+..++.++|||||||++|||+| |..||...
T Consensus 158 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~ 237 (299)
T d1jpaa_ 158 NILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237 (299)
T ss_dssp GEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred eEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence 99999999999999999987754332211 1112357899999999999999999999999999999998 78887543
Q ss_pred CccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 265 CFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
. ...+...+. .. .... ....++..+.+|+.+||+.||++|||+.+|++.|+++.+
T Consensus 238 ~-----~~~~~~~i~---~~-------------~~~~--~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 238 T-----NQDVINAIE---QD-------------YRLP--PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp C-----HHHHHHHHH---TT-------------CCCC--CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred C-----HHHHHHHHH---cC-------------CCCC--CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 2 111111111 11 1111 111455678999999999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-58 Score=407.29 Aligned_cols=262 Identities=21% Similarity=0.294 Sum_probs=214.4
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 50 LKAATNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 50 i~~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
++...++|+..+.||+|+||+||+|++ +++.||||+++.+.. ..+.+.+|+.+|++++|||||+++|++.+++..++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 333446688889999999999999999 578899999876543 45678999999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
|||||++|+|.+++..... ..+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+|+.
T Consensus 91 v~E~~~~g~l~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp EEECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred EeecccCcchHHHhhhccc---cchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceee
Confidence 9999999999999865432 36899999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
.......... ...|++.|+|||++.+..|+.++|||||||++|||++|..||+.... ...+.+.+.. +.
T Consensus 165 ~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~----~~~~~~~i~~----~~- 233 (287)
T d1opja_ 165 MTGDTYTAHA--GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYELLEK----DY- 233 (287)
T ss_dssp CCSSSSEEET--TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHHHHHHHHT----TC-
T ss_pred cCCCCceeec--cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch----HHHHHHHHhc----CC-
Confidence 7554332221 34578999999999999999999999999999999998888765432 1112222211 10
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
....| ..++.++.+|+.+||+.||++|||+.+|++.|+++.+
T Consensus 234 -----------~~~~~--~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 234 -----------RMERP--EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp -----------CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred -----------CCCCC--ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 01111 1345678999999999999999999999999988753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-57 Score=401.14 Aligned_cols=258 Identities=18% Similarity=0.275 Sum_probs=208.6
Q ss_pred cCCCCCCc-cccCCCceEEEEEE----CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEE
Q 048160 55 NNYDPEKV-ITKDLLYKLYKGFL----QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 55 ~~~~~~~~-ig~G~~g~V~~~~~----~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 128 (344)
++|...+. ||+|+||+||+|.+ ++..||||+++..... ..+.|.+|+.+|++++|||||+++|++.+ +..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 34555554 99999999999987 2346999999766443 34678999999999999999999999864 567999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
||||++|+|.+++.... ..+++.++..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 87 mE~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcc
Confidence 99999999999986554 36899999999999999999999 999999999999999999999999999999987
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
..............||+.|+|||++.+..++.++|||||||++|||+| |..||..... ..+...+ ..
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-----~~~~~~i----~~--- 227 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PEVMAFI----EQ--- 227 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----HHHHHHH----HT---
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-----HHHHHHH----Hc---
Confidence 665444333345578999999999998999999999999999999998 8888864321 1111111 11
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
+..+..|. .++.++.+|+.+||+.||++|||+.+|.+.|+.+..+
T Consensus 228 ---------~~~~~~p~--~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 228 ---------GKRMECPP--ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ---------TCCCCCCT--TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------CCCCCCCC--cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11111121 4556789999999999999999999999999877643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-57 Score=400.55 Aligned_cols=248 Identities=19% Similarity=0.294 Sum_probs=207.5
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
+.|+..+.||+|+||+||+|+. +|+.||||++........+.+.+|+.++++++|||||++++++.+++..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4699999999999999999998 68899999997665556677899999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++|+|.+++... .+++.++..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 100 ~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 100 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp TTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999988653 4899999999999999999999 9999999999999999999999999999998765433
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
.. .....||+.|+|||++.+..|+.++|||||||++|+|++|..||..... ...+...... .
T Consensus 171 ~~---~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----~~~~~~~~~~----~------- 232 (293)
T d1yhwa1 171 SK---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----LRALYLIATN----G------- 232 (293)
T ss_dssp CC---BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHH----C-------
T ss_pred cc---ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH----HHHHHHHHhC----C-------
Confidence 22 1245799999999999999999999999999999999999999964321 1111111111 1
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+..+.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 233 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 233 ------TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ------SCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ------CCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111111134567899999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-57 Score=401.56 Aligned_cols=258 Identities=19% Similarity=0.321 Sum_probs=209.4
Q ss_pred hcCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
.++|+..+.||+|+||+||+|++ ++..||||++..... ..+.|.+|+.++++++|||||+++|++.+ +..++|||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 35688889999999999999999 567899999976543 45679999999999999999999998864 5679999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++|+|.+++....+ .++++.+++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+|+......
T Consensus 90 ~~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 90 ENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp TTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999998765432 35899999999999999999999 9999999999999999999999999999998876543
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
.... ....||+.|+|||++.+..++.++|||||||++|||+||..|++.... .......+. . +
T Consensus 164 ~~~~--~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~----~~~~~~~i~---~-~------- 226 (272)
T d1qpca_ 164 YTAR--EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----NPEVIQNLE---R-G------- 226 (272)
T ss_dssp EECC--TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHHHHH---T-T-------
T ss_pred cccc--cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC----HHHHHHHHH---h-c-------
Confidence 3222 245688999999999989999999999999999999998777765322 111111111 1 0
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
.....| ..++.++.+|+.+||+.||++|||+++|++.|+.+..+
T Consensus 227 -----~~~~~p--~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 227 -----YRMVRP--DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp -----CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCc--ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 111111 13455789999999999999999999999999987654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-57 Score=396.00 Aligned_cols=252 Identities=21% Similarity=0.263 Sum_probs=203.1
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
.++|+..+.||+|+||+||+|++ +++.||||++..... ...+.+.+|+.++++++|||||++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 46788999999999999999998 688999999875532 234668899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
||++|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 y~~gg~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp CCTTEEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred ccCCCcHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 999999999997653 6999999999999999999999 99999999999999999999999999999987654
Q ss_pred CCcccccCCccccccccccccccCcCCC-CcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTANC-NEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
.... .......||+.|+|||++.+..+ +.++|||||||++|||++|..||....... ....... ....
T Consensus 156 ~~~~-~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~~~~~----~~~~--- 224 (271)
T d1nvra_ 156 NNRE-RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSDWK----EKKT--- 224 (271)
T ss_dssp TTEE-CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS---HHHHHHH----TTCT---
T ss_pred CCcc-ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH---HHHHHHh----cCCC---
Confidence 3321 12235689999999999988776 578999999999999999999996543211 1111111 0000
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..+.....+.++.+|+.+||+.||++|||+.||++
T Consensus 225 -----------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 -----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111133456789999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-57 Score=401.49 Aligned_cols=250 Identities=21% Similarity=0.255 Sum_probs=206.6
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
+.|+..+.||+|+||+||+|++ ++..||||++........+.+.+|+.+|++++|||||++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4588889999999999999998 67889999998777667788999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++|+|.+++.... .++++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 92 AGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp TTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 9999999876543 36899999999999999999999 9999999999999999999999999999987653221
Q ss_pred cccccCCccccccccccccccC-----cCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMS-----TANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
. ......||+.|+|||++. ...|+.++|||||||++|||++|..||..... ...+.....
T Consensus 165 ~---~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~----~~~~~~i~~-------- 229 (288)
T d2jfla1 165 Q---RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP----MRVLLKIAK-------- 229 (288)
T ss_dssp H---HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG----GGHHHHHHH--------
T ss_pred c---cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH----HHHHHHHHc--------
Confidence 1 112457999999999984 45689999999999999999999999865321 111221111
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+..+..+.....+.++.+|+.+||+.||++|||+.|+++
T Consensus 230 ---------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 230 ---------SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ---------SCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---------CCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111222245567899999999999999999999976
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=396.05 Aligned_cols=250 Identities=20% Similarity=0.288 Sum_probs=199.6
Q ss_pred CccccCCCceEEEEEEC----CccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecCC
Q 048160 61 KVITKDLLYKLYKGFLQ----DRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVAC 134 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~----~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 134 (344)
+.||+|+||+||+|.+. ++.||||+++..... ..+.+.+|+.+|++++|||||+++|+|.. +..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 56999999999999872 357999998755332 24678999999999999999999999864 457899999999
Q ss_pred CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCcc
Q 048160 135 GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKTH 214 (344)
Q Consensus 135 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~ 214 (344)
|+|.+++.... ++++.+++.++.|++.||.||| +.+|+||||||+|||++.++.+|++|||+++........
T Consensus 92 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 99999997654 6899999999999999999999 999999999999999999999999999999887655443
Q ss_pred cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCccccccc
Q 048160 215 VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVDP 293 (344)
Q Consensus 215 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (344)
........||+.|+|||++.+..++.++|||||||++|||+| |..||.... ...+...+. .+
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-----~~~~~~~i~----~~-------- 226 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-----GSEVTAMLE----KG-------- 226 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHH----TT--------
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC-----HHHHHHHHH----cC--------
Confidence 333335578999999999999999999999999999999998 788875421 111111111 11
Q ss_pred ccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 294 IIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.....|. .++.++.+|+.+||+.||++|||+.+|.+.|+....
T Consensus 227 ----~~~~~p~--~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 227 ----ERMGCPA--GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp ----CCCCCCT--TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCc--ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 1111111 445678999999999999999999999999887653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-56 Score=396.72 Aligned_cols=259 Identities=20% Similarity=0.299 Sum_probs=202.3
Q ss_pred cCCCCCCccccCCCceEEEEEECC------ccEEEEEecCCCCch-hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFLQD------RPISVMKFGGNLNSE-EYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~~~------~~vavk~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
+.|+..++||+|+||+||+|.+.+ ..||||++....... ...|.+|+.++++++|||||+++|++.+....++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 347778899999999999999822 369999997654433 3568899999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
|||||.++++.+++.... ..+++.+++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 87 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEecccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999998876554 36899999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
...............||+.|+|||++.+..++.++|||||||++|||+++..|++.... ...+...+. .+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~----~~~~~~~i~----~~-- 229 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS----NHEVMKAIN----DG-- 229 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHHHH----TT--
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC----HHHHHHHHh----cc--
Confidence 75543322222234678999999999999999999999999999999998877765322 111111111 11
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.....| ..++..+.+|+.+||+.||++|||+.+|++.|+++.+
T Consensus 230 ----------~~~~~~--~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 230 ----------FRLPTP--MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp ----------CCCCCC--TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----------CCCCCc--hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 111111 1345678999999999999999999999999998865
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-56 Score=389.06 Aligned_cols=252 Identities=17% Similarity=0.256 Sum_probs=208.5
Q ss_pred cCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeecC
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFVA 133 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 133 (344)
++|+..+.||+|+||+||+|++ +++.||||+++.... ..+.+.+|+.++++++||||++++|++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5799999999999999999999 566899999986543 35679999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~g~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 83 NGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TEEHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCcHHHhhhccc----cCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 999999976654 36889999999999999999999 99999999999999999999999999999987654432
Q ss_pred ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
.. .....||+.|+|||.+.+..++.++||||||+++|||+| |+.||.... ...+...+. .+
T Consensus 156 ~~--~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~-----~~~~~~~i~----~~------- 217 (258)
T d1k2pa_ 156 TS--SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-----NSETAEHIA----QG------- 217 (258)
T ss_dssp CC--CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----HHHHHHHHH----TT-------
T ss_pred ee--ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC-----HHHHHHHHH----hC-------
Confidence 22 223568999999999999999999999999999999998 677775431 111111111 11
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQ 339 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~ 339 (344)
.....| ..++..+.+|+.+||+.||++|||+.+|++.|..
T Consensus 218 -----~~~~~p--~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 218 -----LRLYRP--HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -----CCCCCC--TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -----CCCCCc--ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 111111 1344578999999999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-56 Score=389.50 Aligned_cols=244 Identities=22% Similarity=0.325 Sum_probs=203.6
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|+..+.||+|+||+||+|+. +++.||+|++.... ....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4688899999999999999999 67889999986432 223456789999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
|||++|+|.+++.... ++++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+|....
T Consensus 86 Ey~~~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp ECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred eecCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecC
Confidence 9999999999997643 6899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
.... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+ .. .
T Consensus 158 ~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i---~~-~---- 219 (263)
T d2j4za1 158 SSRR-----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRI---SR-V---- 219 (263)
T ss_dssp CCCC-----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHH---HT-T----
T ss_pred CCcc-----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-----HHHHHHHH---Hc-C----
Confidence 4322 24579999999999999999999999999999999999999986431 11111111 11 0
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. ...|. ..+.++.+|+.+||+.||++|||+.||++
T Consensus 220 --------~-~~~p~--~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 220 --------E-FTFPD--FVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --------C-CCCCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------C-CCCCc--cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 0 01111 33456899999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-56 Score=392.85 Aligned_cols=254 Identities=19% Similarity=0.259 Sum_probs=189.9
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEee--CCccEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLE--TELPILV 128 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~lv 128 (344)
++|+..+.||+|+||+||+|+. +|+.||+|.+..... ...+.+.+|+.++++++|||||++++++.+ ++..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5688999999999999999998 678999999876543 234568899999999999999999999864 4568999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcC--CCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVG--FSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
||||++|+|.+++...... ...+++.+++.++.|++.||.|||+. ...+|+||||||+|||++.++.+||+|||+|+
T Consensus 84 mEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999988542100 02589999999999999999999921 01349999999999999999999999999998
Q ss_pred ccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
........ .....||+.|+|||++.+..|+.++|||||||++|||++|..||.... ...+...+ ....
T Consensus 163 ~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~-----~~~~~~~i----~~~~ 230 (269)
T d2java1 163 ILNHDTSF---AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-----QKELAGKI----REGK 230 (269)
T ss_dssp HC--------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHH----HHTC
T ss_pred ecccCCCc---cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC-----HHHHHHHH----HcCC
Confidence 87543322 124678999999999999999999999999999999999999986431 11111111 1111
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.. ..|. ..+.++.+|+.+||+.||++|||+.||++
T Consensus 231 ~~------------~~~~--~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 231 FR------------RIPY--RYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CC------------CCCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC------------CCCc--ccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11 1111 33456899999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-56 Score=402.10 Aligned_cols=268 Identities=19% Similarity=0.256 Sum_probs=204.9
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc-hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS-EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
.++|+..+.||+|+||+||+|+. ++..||+|+++..... ..+.+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46799999999999999999998 6789999998765433 34568899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCC-CeeeecccccceEeecCCcceEeeeecccccC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSR-PIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||++|+|.+++.+.+ .+++..+..++.|++.||.||| +. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 85 y~~gg~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp CCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred cCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 999999999997653 5899999999999999999999 74 89999999999999999999999999998653
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhc------
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE------ 283 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------ 283 (344)
.. ......||+.|+|||++.+..|+.++||||+||++|||++|+.||......................
T Consensus 157 ~~-----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 157 DS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp HH-----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred CC-----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 21 2225689999999999999999999999999999999999999997643211000000000000000
Q ss_pred ---------------cCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 284 ---------------SNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 284 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.....+..+.......+..+.. ..+.++.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSG-VFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCCBT-TBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCccc-cCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000000000011111111111 23456899999999999999999999987
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-55 Score=382.90 Aligned_cols=243 Identities=21% Similarity=0.269 Sum_probs=193.1
Q ss_pred CCCCccccCCCceEEEEEE--CCccEEEEEecCCC--CchhhhHhhHHHHHhcCCCCceeeeeeEEee----CCccEEEE
Q 048160 58 DPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL--NSEEYCCFNCIAFASQMSHKNILKFVGCCLE----TELPILVF 129 (344)
Q Consensus 58 ~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----~~~~~lv~ 129 (344)
+..+.||+|+||+||+|++ ++..||+|++.... ....+.+.+|+++|++++|||||++++++.+ +..+|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 3446799999999999999 57789999987553 2334568899999999999999999999875 34579999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCC--eeeecccccceEee-cCCcceEeeeeccc
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRP--IVFRDIKPSTILFQ-EQNVAKFFDFCVSI 206 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~dfg~a~ 206 (344)
|||++|+|.+++.... .+++.++..++.|++.||+||| +++ |+||||||+|||++ .++.+||+|||+|+
T Consensus 92 E~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 9999999999997643 5899999999999999999999 887 99999999999996 57899999999998
Q ss_pred ccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
....... ....||+.|+|||++.+ .++.++|||||||++|||++|..||..... ...+...+ ..+.
T Consensus 164 ~~~~~~~-----~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~----~~~~~~~i----~~~~ 229 (270)
T d1t4ha_ 164 LKRASFA-----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRV----TSGV 229 (270)
T ss_dssp GCCTTSB-----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHH----TTTC
T ss_pred eccCCcc-----CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc----HHHHHHHH----HcCC
Confidence 6543221 24679999999999865 699999999999999999999999964321 11111111 1111
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... .....++++.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~~~-------------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 230 KPAS-------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CCGG-------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcc-------------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1000 01123446889999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.6e-55 Score=390.81 Aligned_cols=250 Identities=22% Similarity=0.280 Sum_probs=189.7
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
.+.|...+.||+|+||+||+|+. +++.||||.+..... .....+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 45688899999999999999998 578899999876533 234557899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEee---cCCcceEeeeecccc
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ---EQNVAKFFDFCVSIS 207 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~dfg~a~~ 207 (344)
||+||+|.+++...+ .+++.++..++.|++.||.||| +.+|+||||||+||++. .++.+||+|||+|+.
T Consensus 88 ~~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCSCBHHHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred ccCCCcHHHhhhccc-----CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 999999999997654 6999999999999999999999 99999999999999994 578999999999987
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
....... ....||+.|+|||++.+..|+.++|||||||++|||++|..||..... . .+...+ .. ...
T Consensus 160 ~~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----~-~~~~~i---~~-~~~ 226 (307)
T d1a06a_ 160 EDPGSVL----STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND----A-KLFEQI---LK-AEY 226 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----H-HHHHHH---HT-TCC
T ss_pred ccCCCee----eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH----H-HHHHHH---hc-cCC
Confidence 6543322 245799999999999999999999999999999999999999965321 1 111111 11 000
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
....+.....++++.+|+.+||+.||++|||+.|+++
T Consensus 227 -----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 227 -----------EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -----------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----------CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0001111134556899999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=383.60 Aligned_cols=257 Identities=18% Similarity=0.248 Sum_probs=195.9
Q ss_pred hcCCCCCCccccCCCceEEEEEEC-----CccEEEEEecCCCCch-hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQ-----DRPISVMKFGGNLNSE-EYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~-----~~~vavk~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
.++|+..+.||+|+||.||+|++. +..||||.+....... .+.+.+|+.++++++|||||+++|++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 356888899999999999999982 2358888886554433 466889999999999999999999986 467899
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
||||+++|+|.+++.... .++++.+++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus 85 v~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEeccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhhee
Confidence 999999999999876544 36899999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
........ .....||+.|+|||++.+..++.++|||||||++|||++ |..||..... ..+...+.
T Consensus 158 ~~~~~~~~--~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-----~~~~~~i~------- 223 (273)
T d1mp8a_ 158 MEDSTYYK--ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVIGRIE------- 223 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHHH-------
T ss_pred ccCCccee--ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-----HHHHHHHH-------
Confidence 65433222 124567899999999999999999999999999999998 6766654321 11111111
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
.+.....| ..++..+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus 224 ---------~~~~~~~~--~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 224 ---------NGERLPMP--PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ---------TTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------cCCCCCCC--CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11111111 14456789999999999999999999999999998753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-55 Score=383.14 Aligned_cols=251 Identities=22% Similarity=0.283 Sum_probs=198.0
Q ss_pred cCCCCCCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeC-CccEEEEeecC
Q 048160 55 NNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLET-ELPILVFEFVA 133 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-~~~~lv~e~~~ 133 (344)
++|+..+.||+|+||.||+|++.|..||||+++.+. ..+.+.+|+.++++++||||++++|++.++ +.+++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 457777889999999999999999999999997653 457789999999999999999999998654 56899999999
Q ss_pred CCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCCc
Q 048160 134 CGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGKT 213 (344)
Q Consensus 134 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~ 213 (344)
+|+|.+++..... ..+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.+|++|||+++.......
T Consensus 85 ~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~ 158 (262)
T d1byga_ 85 KGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 158 (262)
T ss_dssp TEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCCCc
Confidence 9999999865321 35899999999999999999999 99999999999999999999999999999986543221
Q ss_pred ccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 214 HVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 214 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
...++..|+|||++.+..+++++||||||+++|||+| |+.||... . ...+...+
T Consensus 159 ------~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-~----~~~~~~~i-------------- 213 (262)
T d1byga_ 159 ------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-P----LKDVVPRV-------------- 213 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-C----GGGHHHHH--------------
T ss_pred ------cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC-C----HHHHHHHH--------------
Confidence 3467889999999999999999999999999999998 56555432 1 11111111
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
..+..+..|. .+++++.+|+.+||+.||++|||+.+|++.|+++..
T Consensus 214 --~~~~~~~~~~--~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 214 --EKGYKMDAPD--GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp --TTTCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HcCCCCCCCc--cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 1111111111 344678999999999999999999999999998864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=391.33 Aligned_cols=260 Identities=20% Similarity=0.299 Sum_probs=204.7
Q ss_pred hcCCCCCCccccCCCceEEEEEEC--C-----ccEEEEEecCCCC-chhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFLQ--D-----RPISVMKFGGNLN-SEEYCCFNCIAFASQM-SHKNILKFVGCCLETEL 124 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~~--~-----~~vavk~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~ 124 (344)
.++|...+.||+|+||+||+|++. + ..||+|++..... .....+.+|+.++.++ +|||||+++|++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 356888899999999999999982 2 2589999865533 3446688999999998 89999999999999999
Q ss_pred cEEEEeecCCCCccccccCCCCC------------------CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccc
Q 048160 125 PILVFEFVACGTLADRIHDPNGS------------------QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKP 186 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~ 186 (344)
.++|||||++|+|.+++...... ....+++..++.++.|++.||.||| +.+|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCch
Confidence 99999999999999999765321 1135889999999999999999999 99999999999
Q ss_pred cceEeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCC
Q 048160 187 STILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSC 265 (344)
Q Consensus 187 ~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~ 265 (344)
+|||++.++.+||+|||+|+.......... .....||+.|+|||++.+..++.++|||||||++|||+| |..||....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVV-RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEE-ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hccccccCCeEEEeeccccccccCCCceee-eccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999987654332211 124567999999999999999999999999999999998 788875432
Q ss_pred ccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 048160 266 FENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQ 339 (344)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~ 339 (344)
. ...+...+.... ....| ..++.++.+|+.+||+.||++|||++||++.|..
T Consensus 272 ~----~~~~~~~~~~~~----------------~~~~p--~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 272 V----DANFYKLIQNGF----------------KMDQP--FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp C----SHHHHHHHHTTC----------------CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H----HHHHHHHHhcCC----------------CCCCC--CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 1 112222221110 00111 1345678999999999999999999999999863
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-55 Score=387.23 Aligned_cols=257 Identities=20% Similarity=0.282 Sum_probs=202.3
Q ss_pred hcCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
.++|+..+.||+|+||.||+|++ ++..||||++..... ..+.|.+|+.++++++|||||+++|++. ++..++|||||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 35688899999999999999999 556899999875543 4577999999999999999999999985 45689999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++|+|..++..... ..+++.+++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 94 ~~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 94 SKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp TTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred CCCchhhhhhhccc---ccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 99999988865322 25899999999999999999999 9999999999999999999999999999998765433
Q ss_pred cccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcccccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIVD 292 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (344)
... .....||+.|+|||++....++.++||||||+++|||++|+.||+.... .......+. . ..
T Consensus 168 ~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~----~~~~~~~i~---~-~~------ 231 (285)
T d1fmka3 168 YTA--RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVE---R-GY------ 231 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHHHHH---T-TC------
T ss_pred cee--eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC----HHHHHHHHH---h-cC------
Confidence 221 1235689999999999999999999999999999999998888765432 111111111 1 10
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 293 PIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.... ...++.++.+|+.+||+.||++|||+++|++.|+....
T Consensus 232 ------~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 232 ------RMPC--PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp ------CCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ------CCCC--CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 0011 11445678999999999999999999999999887553
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-54 Score=389.43 Aligned_cols=243 Identities=21% Similarity=0.279 Sum_probs=198.8
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch---hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE---EYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
.|+..+.||+|+||+||+|+. +++.||||++....... .+.+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 388889999999999999998 67889999987654322 3557899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
||++|+|..++.... ++++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+|.....
T Consensus 96 ~~~~g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp CCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCCCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 999999987665443 6899999999999999999999 99999999999999999999999999999976543
Q ss_pred CCcccccCCccccccccccccccCc---CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMST---ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSF 287 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (344)
. ....||+.|+|||++.+ ..|+.++|||||||++|||++|..||..... ...+.... .. ..
T Consensus 168 ~-------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~----~~~~~~i~----~~-~~ 231 (309)
T d1u5ra_ 168 A-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIA----QN-ES 231 (309)
T ss_dssp B-------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHH----HS-CC
T ss_pred C-------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH----HHHHHHHH----hC-CC
Confidence 2 24579999999999864 4589999999999999999999999864321 11111111 11 00
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 288 KEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. ..+ ....+..+.+|+.+||+.||++|||+.++++
T Consensus 232 ~------------~~~-~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 P------------ALQ-SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp C------------CCS-CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C------------CCC-CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 0 000 0133456899999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.9e-54 Score=391.02 Aligned_cols=251 Identities=16% Similarity=0.204 Sum_probs=208.1
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
.++|.+.+.||+|+||.||+|+. +|+.||||++........+.+.+|+.++++++|||||++++++.+++..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999998 6889999999877666667788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEee--cCCcceEeeeecccccC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ--EQNVAKFFDFCVSISIP 209 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~dfg~a~~~~ 209 (344)
|++|+|.+++.... ..+++.++..++.||+.||.||| +.+|+||||||+|||++ .++.+||+|||+|+...
T Consensus 105 ~~gg~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 105 MSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CCSCBHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 99999999986544 36999999999999999999999 99999999999999995 45789999999998775
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
...... ...||+.|+|||++.+..++.++|||||||++|+|++|..||.... ....+........ ...
T Consensus 178 ~~~~~~----~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~----~~~~~~~i~~~~~---~~~- 245 (350)
T d1koaa2 178 PKQSVK----VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN----DDETLRNVKSCDW---NMD- 245 (350)
T ss_dssp TTSCEE----EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHTCC---CSC-
T ss_pred cccccc----eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCC---CCC-
Confidence 443322 4578999999999999999999999999999999999999986431 1111221111100 000
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+.....+.++.+|+.+||+.||++|||+.|+++
T Consensus 246 ------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 246 ------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp ------------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111133456899999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-54 Score=389.22 Aligned_cols=267 Identities=21% Similarity=0.316 Sum_probs=211.5
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEEC-------CccEEEEEecCCCCch-hhhHhhHHHHHhcCCCCceeeeeeEEee
Q 048160 50 LKAATNNYDPEKVITKDLLYKLYKGFLQ-------DRPISVMKFGGNLNSE-EYCCFNCIAFASQMSHKNILKFVGCCLE 121 (344)
Q Consensus 50 i~~~~~~~~~~~~ig~G~~g~V~~~~~~-------~~~vavk~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~~~~~~~~ 121 (344)
++...++|+..+.||+|+||+||+|++. +..||||++....... .+.+.+|+.++++++||||+++++++..
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 3345678999999999999999999973 3679999997665443 4568999999999999999999999999
Q ss_pred CCccEEEEeecCCCCccccccCCCC-------------------CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeee
Q 048160 122 TELPILVFEFVACGTLADRIHDPNG-------------------SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFR 182 (344)
Q Consensus 122 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 182 (344)
....++||||+++|+|.+++..... .....+++.+++.++.|++.||.||| +.+|+||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEee
Confidence 9999999999999999998864321 11135888999999999999999999 9999999
Q ss_pred cccccceEeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCC
Q 048160 183 DIKPSTILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISY 262 (344)
Q Consensus 183 dlk~~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 262 (344)
||||+|||++.++.+||+|||+|+........ .......|++.|+|||.+.+..|+.++|||||||++|||++|..|++
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccc-cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 99999999999999999999999876443222 12224568899999999999999999999999999999999976544
Q ss_pred CCCccCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 263 SSCFENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
.... .. +..... ..+.. +..|. .++.++.+|+.+||+.||++||||.+|++.|++|.+
T Consensus 244 ~~~~----~~---e~~~~v-~~~~~------------~~~p~--~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 244 YGMA----HE---EVIYYV-RDGNI------------LACPE--NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TTSC----HH---HHHHHH-HTTCC------------CCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCC----HH---HHHHHH-HcCCC------------CCCCc--cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 3321 11 111111 11111 11111 345578999999999999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.6e-54 Score=392.72 Aligned_cols=251 Identities=18% Similarity=0.208 Sum_probs=207.8
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
.+.|+..+.||+|+||+||+|+. +++.||||++..........+.+|+.+|++++|||||++++++.+++..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35699999999999999999998 6889999999877655567788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEee--cCCcceEeeeecccccC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ--EQNVAKFFDFCVSISIP 209 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~dfg~a~~~~ 209 (344)
|++|+|.+++.... .++++.++..++.||+.||.||| +.+|+||||||+|||++ .++.+||+|||+|....
T Consensus 108 ~~gg~L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 108 LSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp CCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred CCCChHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecC
Confidence 99999998876654 36999999999999999999999 99999999999999997 57899999999998876
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
...... ...||+.|+|||++.+..|+.++|||||||++|+|++|..||..... ...+....... ....
T Consensus 181 ~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~~~~i~~~~---~~~~- 248 (352)
T d1koba_ 181 PDEIVK----VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----LETLQNVKRCD---WEFD- 248 (352)
T ss_dssp TTSCEE----EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHHHHHHHCC---CCCC-
T ss_pred CCCcee----eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCC---CCCC-
Confidence 543322 45789999999999999999999999999999999999999964321 11111111100 0000
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.+.....+.++.+|+.+||+.||++|||+.|+++
T Consensus 249 ------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 249 ------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp ------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001134456899999999999999999999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=385.92 Aligned_cols=248 Identities=19% Similarity=0.266 Sum_probs=201.5
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|+..+.||+|+||+||+|+. +++.||||++.... ....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5699999999999999999998 67899999986432 223456889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
|||++|+|.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus 88 Ey~~gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp CCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EccCCCCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecc
Confidence 9999999999887654 6999999999999999999999 9999999999999999999999999999998775
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
...... ......||+.|+|||++.+..|+.++|||||||++|||++|..||.... ......... ..
T Consensus 160 ~~~~~~-~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~~~~~~~i~-----~~---- 225 (288)
T d1uu3a_ 160 PESKQA-RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN----EYLIFQKII-----KL---- 225 (288)
T ss_dssp -----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHH-----TT----
T ss_pred cCCccc-ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC----HHHHHHHHH-----cC----
Confidence 432221 1224579999999999999999999999999999999999999996431 111111111 00
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. ...|. ..++++.+|+.+||+.||++|||++|+++
T Consensus 226 --------~-~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 226 --------E-YDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp --------C-CCCCT--TCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred --------C-CCCCc--cCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 0 01111 23456899999999999999999998743
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-54 Score=381.83 Aligned_cols=249 Identities=19% Similarity=0.228 Sum_probs=204.4
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC------chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCcc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN------SEEYCCFNCIAFASQMSHKNILKFVGCCLETELP 125 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~ 125 (344)
.+.|...+.||+|+||+||+|+. +|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35689999999999999999998 688999999864422 1246688999999999999999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC----cceEee
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN----VAKFFD 201 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~d 201 (344)
|+|||||++|+|.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+||+++.++ .+|++|
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEcCCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecc
Confidence 99999999999999997653 5899999999999999999999 99999999999999998776 589999
Q ss_pred eecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHH
Q 048160 202 FCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS 281 (344)
Q Consensus 202 fg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 281 (344)
||+|......... ....||+.|+|||++.+..++.++|||||||++|||++|..||..... ...+...
T Consensus 161 fG~a~~~~~~~~~----~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----~~~~~~i---- 228 (293)
T d1jksa_ 161 FGLAHKIDFGNEF----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANV---- 228 (293)
T ss_dssp CTTCEECTTSCBC----SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHH----
T ss_pred hhhhhhcCCCccc----cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH----HHHHHHH----
Confidence 9999877544322 245789999999999999999999999999999999999999975321 1111111
Q ss_pred hccCCcccccccccccCCCCCh-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 282 IESNSFKEIVDPIIVGEEGLWP-EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.. . .....+ .....+..+.+|+.+||+.||++|||+.+|++
T Consensus 229 ~~-~------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 229 SA-V------------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HT-T------------CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Hh-c------------CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0 111111 11134567899999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=383.83 Aligned_cols=256 Identities=18% Similarity=0.314 Sum_probs=200.5
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCc----cEEEEEecCCC-CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDR----PISVMKFGGNL-NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPIL 127 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~----~vavk~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 127 (344)
++|+..+.||+|+||+||+|.+ +|+ .||+|++.... ....+.+.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 3588899999999999999998 333 58999887543 33456789999999999999999999999865 5678
Q ss_pred EEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccc
Q 048160 128 VFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSIS 207 (344)
Q Consensus 128 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~ 207 (344)
++||+.+|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus 88 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEECCTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred EEEeccCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeecccccee
Confidence 899999999999887654 36899999999999999999999 99999999999999999999999999999988
Q ss_pred cCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccCC
Q 048160 208 IPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESNS 286 (344)
Q Consensus 208 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (344)
........ ......||+.|+|||++.+..|+.++|||||||++|||+| |..||... . ...+...+..
T Consensus 161 ~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~-~----~~~~~~~i~~------ 228 (317)
T d1xkka_ 161 LGAEEKEY-HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-P----ASEISSILEK------ 228 (317)
T ss_dssp TTTTCC---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-C----GGGHHHHHHH------
T ss_pred cccccccc-cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC-C----HHHHHHHHHc------
Confidence 75443322 1123468999999999999999999999999999999999 55555432 1 1112222211
Q ss_pred cccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 287 FKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
+.....| ..++..+.+|+.+||+.||++|||+.+|++.|.++.+
T Consensus 229 ----------~~~~~~p--~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 229 ----------GERLPQP--PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ----------TCCCCCC--TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------CCCCCCC--cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1111111 1445678999999999999999999999999988754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-53 Score=376.64 Aligned_cols=270 Identities=19% Similarity=0.250 Sum_probs=202.1
Q ss_pred CCCCCCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHh--hHHHHHhcCCCCceeeeeeEEeeCC----ccEEEE
Q 048160 56 NYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCF--NCIAFASQMSHKNILKFVGCCLETE----LPILVF 129 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~--~E~~~l~~l~H~niv~~~~~~~~~~----~~~lv~ 129 (344)
.|...+.||+|+||+||+|+++|+.||||++.... ...+. .|+..+.+++|||||+++|++.+.+ .+++||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 35566789999999999999999999999986542 23333 4566667889999999999998654 579999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcC-----CCCCeeeecccccceEeecCCcceEeeeec
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVG-----FSRPIVFRDIKPSTILFQEQNVAKFFDFCV 204 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~kl~dfg~ 204 (344)
|||++|+|.+++++. ++++.+++.++.|++.||.|||+. ..++|+||||||+|||++.++.+||+|||+
T Consensus 81 Ey~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp ECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 999999999999764 488999999999999999999931 136999999999999999999999999999
Q ss_pred ccccCCCCccc-ccCCccccccccccccccCcCC------CCcccchHHHHHHHHHHHcCCCCCCCCCccCcch------
Q 048160 205 SISIPEGKTHV-NDNNKVIGTFGFIAPEYMSTAN------CNEKSDVYSFGALLLELLTGKRISYSSCFENGEE------ 271 (344)
Q Consensus 205 a~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~------~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------ 271 (344)
++......... .......||+.|+|||++.+.. ++.++|||||||++|||+||..||..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 98775543222 1223467999999999987642 6789999999999999999998875433221110
Q ss_pred -hHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 272 -YFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 272 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
....... ......... ...+........+..+.+|+.+||+.||++|||+.||++.|+++.++
T Consensus 235 ~~~~~~~~-~~~~~~~~~--------p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 235 DPSVEEMR-KVVCEQKLR--------PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SCCHHHHH-HHHTTSCCC--------CCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchHHHHH-HHHhccccC--------CCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 0111111 111111110 01011111224567799999999999999999999999999998753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=382.37 Aligned_cols=260 Identities=20% Similarity=0.259 Sum_probs=204.6
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCc--cEEEEEecCC-CCchhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCccEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDR--PISVMKFGGN-LNSEEYCCFNCIAFASQM-SHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~--~vavk~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv 128 (344)
++|+..+.||+|+||+||+|++ ++. .||||++... .....+.+.+|+.+|+++ +|||||+++|++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 5688889999999999999999 333 5788887644 333456789999999999 799999999999999999999
Q ss_pred EeecCCCCccccccCCCC-----------CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcc
Q 048160 129 FEFVACGTLADRIHDPNG-----------SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVA 197 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 197 (344)
|||+++|+|.+++..... .....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence 999999999999865421 11136899999999999999999999 9999999999999999999999
Q ss_pred eEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHH
Q 048160 198 KFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQEL 277 (344)
Q Consensus 198 kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 277 (344)
||+|||+++....... .....||..|+|||.+.+..++.++||||||+++|||++|..||+.... ...+
T Consensus 167 kl~DfG~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~----~~~~--- 235 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----CAEL--- 235 (309)
T ss_dssp EECCTTCEESSCEECC----C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHH---
T ss_pred EEcccccccccccccc----ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC----HHHH---
Confidence 9999999976543222 1244689999999999999999999999999999999998776543321 1111
Q ss_pred HHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 278 VRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
..... .+..+..|. .++.++.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus 236 ~~~i~-------------~~~~~~~~~--~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 236 YEKLP-------------QGYRLEKPL--NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHHGG-------------GTCCCCCCT--TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHH-------------hcCCCCCCc--cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 11111 111111111 4456789999999999999999999999999998753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-53 Score=377.82 Aligned_cols=255 Identities=22% Similarity=0.358 Sum_probs=204.1
Q ss_pred CCccccCCCceEEEEEECC-----ccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeC-CccEEEEeec
Q 048160 60 EKVITKDLLYKLYKGFLQD-----RPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLET-ELPILVFEFV 132 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~~~-----~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-~~~~lv~e~~ 132 (344)
.++||+|+||+||+|++.+ ..||||++..... ...+.|.+|+.+|++++|||||+++|++.+. ...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 3679999999999999822 2589999875433 3446799999999999999999999998764 5789999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 112 ~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 9999999987655 35778889999999999999999 9999999999999999999999999999998776443
Q ss_pred ccc-ccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccccc
Q 048160 213 THV-NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKEIV 291 (344)
Q Consensus 213 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (344)
... .......||+.|+|||.+....++.++||||||+++|||++|+.||........ ....
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~----~~~~-------------- 246 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVY-------------- 246 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHH--------------
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH----HHHH--------------
Confidence 222 122235689999999999999999999999999999999999988875432111 1111
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 292 DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
+..+..+..|. .++..+.+|+.+||+.||++|||+.||++.|+++.++
T Consensus 247 --i~~g~~~~~p~--~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 247 --LLQGRRLLQPE--YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp --HHTTCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --HHcCCCCCCcc--cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11111111111 3445689999999999999999999999999998764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=375.70 Aligned_cols=256 Identities=20% Similarity=0.326 Sum_probs=196.1
Q ss_pred cCCCCCCccccCCCceEEEEEEC---C--ccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFLQ---D--RPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPI 126 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~~---~--~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~ 126 (344)
++|+..+.||+|+||.||+|++. + ..||||++.... ....+.|.+|+.++++++|||||+++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 45888899999999999999972 2 368999887542 2334678999999999999999999999975 4678
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
+|||||++|+|.+++.... .++++..++.++.|++.||.||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 87 lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeeeecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhh
Confidence 9999999999998876544 36999999999999999999999 9999999999999999999999999999999
Q ss_pred ccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHc-CCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLT-GKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
................|+..|+|||++.+..++.++||||||+++|||+| |..||.... .. +........+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~-----~~---~~~~~i~~~~ 231 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-----GS---QILHKIDKEG 231 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HH---HHHHHHHTSC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC-----HH---HHHHHHHhCC
Confidence 87665544333335567889999999999999999999999999999998 788875321 11 1111111111
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQL 340 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l 340 (344)
.. .+.....+..+.+|+.+||+.||++|||+.+|.+.|.+.
T Consensus 232 ~~--------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 ER--------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CC--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC--------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 10 011113445689999999999999999999999988764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.9e-53 Score=376.79 Aligned_cols=261 Identities=22% Similarity=0.347 Sum_probs=202.5
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc---hhhhHhhHHHHHhcCCCCceeeeeeEEeeCC----c
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS---EEYCCFNCIAFASQMSHKNILKFVGCCLETE----L 124 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~----~ 124 (344)
.+.|.+.+.||+|+||+||+|+. +++.||||.+...... ....+.+|+.++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 35689999999999999999998 6889999999765332 2356889999999999999999999987654 3
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeec
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV 204 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~ 204 (344)
.|+|||||+|++|.+++...+ ++++.+++.++.|++.||.||| +.+|+||||||+|||++.++..+++|||.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred EEEEEECCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhh
Confidence 789999999999999887654 6899999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc
Q 048160 205 SISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES 284 (344)
Q Consensus 205 a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 284 (344)
+.................||+.|+|||++.+..++.++|||||||++|||+||..||.... ....+... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~----~~~~~~~~----~~~ 229 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS----PVSVAYQH----VRE 229 (277)
T ss_dssp CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHH----HHC
T ss_pred hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC----HHHHHHHH----Hhc
Confidence 8766544333333335679999999999999999999999999999999999999986431 11111111 111
Q ss_pred CCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHh
Q 048160 285 NSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-TMVQVAKQLRQLHK 342 (344)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~ei~~~L~~l~~ 342 (344)
..... .......+..+.+|+.+||+.||++|| |++++++.|.++.+
T Consensus 230 ~~~~~------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 230 DPIPP------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp CCCCG------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred CCCCC------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 11000 000113345689999999999999999 89999999998753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=380.39 Aligned_cols=271 Identities=18% Similarity=0.294 Sum_probs=201.2
Q ss_pred HHHHHHhcCCCCCCccccCCCceEEEEEEC-------CccEEEEEecCCCC-chhhhHhhHHHHHhcC-CCCceeeeeeE
Q 048160 48 QELKAATNNYDPEKVITKDLLYKLYKGFLQ-------DRPISVMKFGGNLN-SEEYCCFNCIAFASQM-SHKNILKFVGC 118 (344)
Q Consensus 48 ~~i~~~~~~~~~~~~ig~G~~g~V~~~~~~-------~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~~~~~ 118 (344)
+.+....++|...+.||+|+||.||+|++. ++.||||+++.... ...+.+.+|+..+.++ +|+|||.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 334334467899999999999999999972 25799999876543 3345677888888877 68999999999
Q ss_pred EeeC-CccEEEEeecCCCCccccccCCCCC-----------CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccc
Q 048160 119 CLET-ELPILVFEFVACGTLADRIHDPNGS-----------QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKP 186 (344)
Q Consensus 119 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~ 186 (344)
+... ...++|||||++|+|.+++...... ....+++.+++.++.|++.||.||| +.+|+||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCc
Confidence 8764 4689999999999999998653211 1135889999999999999999999 99999999999
Q ss_pred cceEeecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCc
Q 048160 187 STILFQEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCF 266 (344)
Q Consensus 187 ~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 266 (344)
+|||++.++.+||+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||++|..|++....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTS-CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceeECCCCcEEEccCcchhhccccccc-cccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999876543322 122346799999999999999999999999999999999998765443322
Q ss_pred cCcchhHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 267 ENGEEYFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
. ...+...+.. +.. ...| ..+++++.+|+.+||+.||++|||+.+|++.|+++.++
T Consensus 242 ~---~~~~~~~~~~----~~~------------~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 242 I---DEEFCRRLKE----GTR------------MRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp C---SHHHHHHHHH----TCC------------CCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H---HHHHHHHHhc----CCC------------CCCC--ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1 1112221111 110 1111 13445689999999999999999999999999998764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=380.54 Aligned_cols=246 Identities=19% Similarity=0.242 Sum_probs=204.4
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|...+.||+|+||.||+|+. +++.||+|++.+.. ....+.+.+|+.+|++++|||||++++++.+.+..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5688999999999999999998 78899999987542 223466789999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
|||++|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+...
T Consensus 85 ey~~gg~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 85 EYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eccCCCchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 9999999999997654 5899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
..... .....||+.|+|||++.+..|+.++|||||||++|||++|..||..... ......... .
T Consensus 157 ~~~~~---~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~----~~~~~~i~~-----~---- 220 (337)
T d1o6la_ 157 SDGAT---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELILM-----E---- 220 (337)
T ss_dssp CTTCC---BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHH-----C----
T ss_pred cCCcc---cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH----HHHHHHHhc-----C----
Confidence 43322 2256899999999999999999999999999999999999999975421 111111111 1
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT-----MVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ei~~ 335 (344)
. ...|. ..+.++.+|+.+||+.||++||+ +.+|++
T Consensus 221 --------~-~~~p~--~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 221 --------E-IRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --------C-CCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --------C-CCCCc--cCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1 11111 33456889999999999999995 777765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-52 Score=374.38 Aligned_cols=243 Identities=21% Similarity=0.298 Sum_probs=202.4
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|++.+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688899999999999999998 68899999986542 223466889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
|||+||+|..++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 E~~~gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp CCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eecCCccccccccccc-----cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEec
Confidence 9999999999887654 5788889999999999999999 9999999999999999999999999999998765
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
... ....||+.|+|||++.+..|+.++|||||||++|+|++|..||.... .......... .
T Consensus 156 ~~~------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~----~~~~~~~i~~----~----- 216 (316)
T d1fota_ 156 DVT------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN----TMKTYEKILN----A----- 216 (316)
T ss_dssp SCB------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHH----C-----
T ss_pred ccc------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC----HHHHHHHHHc----C-----
Confidence 432 24679999999999999999999999999999999999999996532 1111111111 0
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-----TMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ei~~ 335 (344)
.. ..|. ..+.++.+++.+||+.||.+|| |+++|++
T Consensus 217 --------~~-~~p~--~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 217 --------EL-RFPP--FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp --------CC-CCCT--TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --------CC-CCCC--CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 10 0111 2345688999999999999996 8888875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.2e-52 Score=369.01 Aligned_cols=249 Identities=20% Similarity=0.312 Sum_probs=203.4
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCch---------hhhHhhHHHHHhcCC-CCceeeeeeEEeeC
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE---------EYCCFNCIAFASQMS-HKNILKFVGCCLET 122 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~---------~~~~~~E~~~l~~l~-H~niv~~~~~~~~~ 122 (344)
++|+..+.||+|+||+||+|+. +++.||||++....... .+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6788899999999999999998 77899999987653211 235779999999997 99999999999999
Q ss_pred CccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeee
Q 048160 123 ELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDF 202 (344)
Q Consensus 123 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~df 202 (344)
+..|+|||||++|+|.+++...+ ++++.++..++.||+.||+||| +++|+||||||+||+++.++.+||+||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred cceEEEEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccc
Confidence 99999999999999999997654 6999999999999999999999 999999999999999999999999999
Q ss_pred ecccccCCCCcccccCCccccccccccccccCc------CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHH
Q 048160 203 CVSISIPEGKTHVNDNNKVIGTFGFIAPEYMST------ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQE 276 (344)
Q Consensus 203 g~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 276 (344)
|+++........ ....||..|+|||.+.+ ..++.++||||+||++|+|++|..||..... ......
T Consensus 155 G~a~~~~~~~~~----~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~----~~~~~~ 226 (277)
T d1phka_ 155 GFSCQLDPGEKL----REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----MLMLRM 226 (277)
T ss_dssp TTCEECCTTCCB----CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHH
T ss_pred hheeEccCCCce----eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH----HHHHHH
Confidence 999887553322 24578999999998853 3578899999999999999999999975321 111111
Q ss_pred HHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 277 LVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
... ... ....+.....++++.+|+.+||++||++|||+.||++
T Consensus 227 i~~-----~~~-----------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 227 IMS-----GNY-----------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHH-----TCC-----------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHh-----CCC-----------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111 110 0011112245567899999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=374.17 Aligned_cols=250 Identities=20% Similarity=0.260 Sum_probs=198.9
Q ss_pred hcCCCCC-CccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcC-CCCceeeeeeEEee----CCcc
Q 048160 54 TNNYDPE-KVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQM-SHKNILKFVGCCLE----TELP 125 (344)
Q Consensus 54 ~~~~~~~-~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~----~~~~ 125 (344)
.++|.+. +.||+|+||+||+|+. +++.||||++.. ...+.+|+.++.++ +|||||++++++.+ +..+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 4678876 4699999999999998 678999999853 34577899987655 79999999999875 4568
Q ss_pred EEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec---CCcceEeee
Q 048160 126 ILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE---QNVAKFFDF 202 (344)
Q Consensus 126 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~df 202 (344)
|+|||||+||+|.+++...++ ..+++.++..++.|++.||.||| +.+|+||||||+|||++. ++.+||+||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~---~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC---CCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEECCCCCcHHHHHHhcCC---CCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccc
Confidence 999999999999999976543 36999999999999999999999 999999999999999975 457999999
Q ss_pred ecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 203 CVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 203 g~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
|+|+........ ....||+.|+|||++.+..|+.++|||||||++|+|++|..||........
T Consensus 159 G~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~------------- 221 (335)
T d2ozaa1 159 GFAKETTSHNSL----TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------------- 221 (335)
T ss_dssp TTCEECCCCCCC----CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------
T ss_pred ceeeeccCCCcc----ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-------------
Confidence 999876544322 245799999999999999999999999999999999999999965321100
Q ss_pred ccCCcccccccccccCCC-CChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ESNSFKEIVDPIIVGEEG-LWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
...+...+..+... +.+.....+.++.+|+.+||+.||++|||+.|+++
T Consensus 222 ----~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 222 ----SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ----------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----HHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00011111111111 11222345678999999999999999999999976
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-52 Score=372.87 Aligned_cols=249 Identities=16% Similarity=0.230 Sum_probs=204.1
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
.++|.+.+.||+|+||+||+|.. +++.||||.+.... .....+.+|+.+|++++|||||++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 36688899999999999999998 67889999997653 2345578999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC--CcceEeeeecccccC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ--NVAKFFDFCVSISIP 209 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~dfg~a~~~~ 209 (344)
|+||+|.+++...+ ..+++.++..++.||+.||+||| +.+|+||||||+|||++.+ ..+|++|||+++...
T Consensus 83 ~~gg~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 83 ISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred CCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 99999999997654 26899999999999999999999 9999999999999999854 478999999998765
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
...... ...+|+.|+|||.+.+..|+.++|||||||++|+|++|..||..... ...+.....
T Consensus 156 ~~~~~~----~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~----~~~~~~i~~---------- 217 (321)
T d1tkia_ 156 PGDNFR----LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMN---------- 217 (321)
T ss_dssp TTCEEE----EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHH----------
T ss_pred cCCccc----ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH----HHHHHHHHh----------
Confidence 433222 45789999999999999999999999999999999999999965321 111111111
Q ss_pred ccccccccCCCCC-hhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 IVDPIIVGEEGLW-PEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
+..... +.....+.++.+|+.+||+.||++|||+.|+++
T Consensus 218 -------~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 218 -------AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -------TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -------CCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 010000 011123456899999999999999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-52 Score=371.72 Aligned_cols=261 Identities=19% Similarity=0.244 Sum_probs=203.1
Q ss_pred cCCCCCCccccCCCceEEEEEECC---------ccEEEEEecCCCCch-hhhHhhHHHHHhcC-CCCceeeeeeEEeeCC
Q 048160 55 NNYDPEKVITKDLLYKLYKGFLQD---------RPISVMKFGGNLNSE-EYCCFNCIAFASQM-SHKNILKFVGCCLETE 123 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~~~---------~~vavk~~~~~~~~~-~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~ 123 (344)
++|...+.||+|+||.||+|+..+ ..||||+++.+.... ...+.+|+..+.++ +|||||+++++|.++.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 567888999999999999999721 369999997765433 46678999999888 7999999999999999
Q ss_pred ccEEEEeecCCCCccccccCCCCC-----------CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEee
Q 048160 124 LPILVFEFVACGTLADRIHDPNGS-----------QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ 192 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 192 (344)
..++|||||++|+|.+++...... ....+++.+++.++.|++.||+||| +.+|+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeec
Confidence 999999999999999999654311 1135899999999999999999999 99999999999999999
Q ss_pred cCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcC-CCCCCCCCccCcch
Q 048160 193 EQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTG-KRISYSSCFENGEE 271 (344)
Q Consensus 193 ~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g-~~p~~~~~~~~~~~ 271 (344)
.++.+||+|||+++......... ......+|+.|+|||.+.+..|+.++||||||+++|||+++ ..||... . .
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~-~----~ 243 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-P----V 243 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTC-CCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-C----H
T ss_pred CCCCeEeccchhhcccccccccc-ccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC-C----H
Confidence 99999999999998775433221 22245689999999999999999999999999999999985 5555322 1 1
Q ss_pred hHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 272 YFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
..+...+ ..+ .....|. .++..+.+|+.+||+.||++|||+.||++.|++|..
T Consensus 244 ~~~~~~i----~~~------------~~~~~p~--~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 EELFKLL----KEG------------HRMDKPS--NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHHH----HTT------------CCCCCCS--SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHH----HcC------------CCCCCCc--cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1111111 111 1111111 344568999999999999999999999999999865
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=376.54 Aligned_cols=267 Identities=18% Similarity=0.286 Sum_probs=210.2
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEEC-------CccEEEEEecCCCCch-hhhHhhHHHHHhcCCCCceeeeeeEEee
Q 048160 50 LKAATNNYDPEKVITKDLLYKLYKGFLQ-------DRPISVMKFGGNLNSE-EYCCFNCIAFASQMSHKNILKFVGCCLE 121 (344)
Q Consensus 50 i~~~~~~~~~~~~ig~G~~g~V~~~~~~-------~~~vavk~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~~~~~~~~ 121 (344)
++...++|...+.||+|+||+||+|.+. +..||||++....... ...+.+|+.++++++|||||+++|++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 3334467888899999999999999983 3679999997654332 3457899999999999999999999999
Q ss_pred CCccEEEEeecCCCCccccccCCCC-----CCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCc
Q 048160 122 TELPILVFEFVACGTLADRIHDPNG-----SQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNV 196 (344)
Q Consensus 122 ~~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 196 (344)
....++|||||++|+|.+++..... .....+++.++..++.|++.||.||| +.+|+||||||+|||++.++.
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCce
Confidence 9999999999999999998753211 11135788999999999999999999 999999999999999999999
Q ss_pred ceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHH
Q 048160 197 AKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQE 276 (344)
Q Consensus 197 ~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 276 (344)
+||+|||+|+......... ......||+.|+|||.+.+..++.++||||||+++|||+||..|++.... .. +
T Consensus 172 ~Kl~DFGla~~~~~~~~~~-~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~---~~----~ 243 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---NE----Q 243 (308)
T ss_dssp EEECCTTCCCGGGGGGCEE-GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---HH----H
T ss_pred EEEeecccceeccCCccee-eccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC---HH----H
Confidence 9999999998765433222 12245689999999999999999999999999999999999765554321 11 1
Q ss_pred HHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 277 LVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
....... + .....| ..++..+.+|+.+||+.||++|||+.+|++.|++..+
T Consensus 244 ~~~~i~~-~------------~~~~~p--~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 244 VLRFVME-G------------GLLDKP--DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHHHT-T------------CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHh-C------------CCCCCc--ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1111111 1 111111 1345679999999999999999999999999987643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-51 Score=375.42 Aligned_cols=243 Identities=17% Similarity=0.224 Sum_probs=202.7
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 129 (344)
++|++.+.||+|+||.||+|++ +|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4699999999999999999998 68899999986432 123456789999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccC
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIP 209 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~ 209 (344)
||+.+|+|..++...+ .+++.++..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus 121 e~~~~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ccccccchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 9999999999987654 5899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCccc
Q 048160 210 EGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFKE 289 (344)
Q Consensus 210 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (344)
... ....||+.|+|||++.+..++.++|||||||++|||++|..||.... ....+..... .
T Consensus 193 ~~~------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~----~~~~~~~i~~----~----- 253 (350)
T d1rdqe_ 193 GRT------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ----PIQIYEKIVS----G----- 253 (350)
T ss_dssp SCB------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHH----C-----
T ss_pred ccc------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC----HHHHHHHHhc----C-----
Confidence 322 24679999999999999999999999999999999999999996431 1111111111 0
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 048160 290 IVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRP-----TMVQVAK 335 (344)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ei~~ 335 (344)
.. ..|. ..+.++.+|+.+||+.||.+|+ |+.+|++
T Consensus 254 --------~~-~~p~--~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 254 --------KV-RFPS--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --------CC-CCCT--TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --------CC-CCCc--cCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 00 0011 3345689999999999999994 8998875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=370.28 Aligned_cols=264 Identities=19% Similarity=0.294 Sum_probs=210.9
Q ss_pred hcCCCCCCccccCCCceEEEEEE-------CCccEEEEEecCCCCc-hhhhHhhHHHHHhcC-CCCceeeeeeEEeeCCc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL-------QDRPISVMKFGGNLNS-EEYCCFNCIAFASQM-SHKNILKFVGCCLETEL 124 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~-------~~~~vavk~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~ 124 (344)
.++|...+.||+|+||.||+|++ .++.||||+++..... ....+.+|+.+++++ +|||||+++|++.++..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 46688889999999999999987 2357999999765443 345688999999999 69999999999999999
Q ss_pred cEEEEeecCCCCccccccCCCCC-------------CCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEe
Q 048160 125 PILVFEFVACGTLADRIHDPNGS-------------QLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILF 191 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 191 (344)
.++|||||++|+|.+++...... ....+++..+..++.||+.||.||| +.+|+||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccc
Confidence 99999999999999998654321 1135889999999999999999999 9999999999999999
Q ss_pred ecCCcceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcch
Q 048160 192 QEQNVAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEE 271 (344)
Q Consensus 192 ~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 271 (344)
+.++.++++|||+++......... ......||+.|+|||++....++.++||||||+++|||+|+..|++......
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~--- 254 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--- 254 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSE-ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---
T ss_pred cccCcccccccchheeccCCCcce-EeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH---
Confidence 999999999999998776543322 2234678999999999999999999999999999999999766665443211
Q ss_pred hHHHHHHHHHhccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 272 YFLQELVRKSIESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
..+...+....+ ...| ...+..+.+|+.+||+.||++|||+.+|++.|+++..
T Consensus 255 ~~~~~~i~~~~~----------------~~~~--~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 255 SKFYKMIKEGFR----------------MLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHHHHHHHHTCC----------------CCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCC----------------CCCc--ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 122222221111 0111 1334568999999999999999999999999998654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-51 Score=378.23 Aligned_cols=247 Identities=18% Similarity=0.271 Sum_probs=197.0
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC---chhhhHhh---HHHHHhcCCCCceeeeeeEEeeCCccE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN---SEEYCCFN---CIAFASQMSHKNILKFVGCCLETELPI 126 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~---~~~~~~~~---E~~~l~~l~H~niv~~~~~~~~~~~~~ 126 (344)
++|++.+.||+|+||.||+|+. +|+.||||++..... .....+.+ |+.+++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 6799999999999999999998 688999999854321 11222333 467788889999999999999999999
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
+|||||++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+
T Consensus 84 ivmE~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEecCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceee
Confidence 9999999999999997653 5889999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
....... ....||+.|+|||++.. ..|+.++|||||||++|||++|..||....... ......... .
T Consensus 156 ~~~~~~~-----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~~~~~~-~- 223 (364)
T d1omwa3 156 DFSKKKP-----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTL-T- 223 (364)
T ss_dssp ECSSSCC-----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-----HHHHHHHSS-S-
T ss_pred ecCCCcc-----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcc-c-
Confidence 7654322 24579999999999875 568999999999999999999999997542211 111111100 0
Q ss_pred CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 048160 286 SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT-----MVQVAK 335 (344)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ei~~ 335 (344)
.....|. ..++++.+|+.+||+.||++||| +++|++
T Consensus 224 ------------~~~~~~~--~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 224 ------------MAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ------------CCCCCCS--SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ------------CCCCCCC--CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0011111 33456899999999999999999 677764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-51 Score=365.17 Aligned_cols=261 Identities=19% Similarity=0.178 Sum_probs=194.5
Q ss_pred CCccccCCCceEEEEEE--CCccEEEEEecCCCCch-----hhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEeec
Q 048160 60 EKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSE-----EYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEFV 132 (344)
Q Consensus 60 ~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~-----~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 132 (344)
.++||+|+||+||+|+. +++.||||++....... .+.+.+|+.++++++|||||++++++..++..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 46799999999999998 67899999986543222 345789999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCCC
Q 048160 133 ACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEGK 212 (344)
Q Consensus 133 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~~ 212 (344)
.++++..+..... .+++.++..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~~~~~~~~~~~~~-----~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHTTCCS-----SCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred cchHHhhhhhccc-----CCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9877776665432 5888999999999999999999 9999999999999999999999999999998765433
Q ss_pred cccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhcc--CCccc
Q 048160 213 THVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIES--NSFKE 289 (344)
Q Consensus 213 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 289 (344)
.. .....||+.|+|||++... .|+.++|||||||++|||++|..||..... ...+.........+ .....
T Consensus 155 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~----~~~l~~i~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 155 RA---YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD----LDQLTRIFETLGTPTEEQWPD 227 (299)
T ss_dssp CC---CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCTTTSSS
T ss_pred cc---ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH----HHHHHHHHHhcCCCChhhccc
Confidence 22 1245789999999998654 579999999999999999999988865321 11222222211110 00000
Q ss_pred ---ccccccccCCCCChhh---HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 290 ---IVDPIIVGEEGLWPEK---EKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 290 ---~~~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..........+..+.. ...+.++.+|+.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000000011111110 123457899999999999999999999985
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=371.56 Aligned_cols=245 Identities=21% Similarity=0.309 Sum_probs=200.2
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCC---CchhhhHhhHHHHHh-cCCCCceeeeeeEEeeCCccEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNL---NSEEYCCFNCIAFAS-QMSHKNILKFVGCCLETELPILV 128 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~---~~~~~~~~~E~~~l~-~l~H~niv~~~~~~~~~~~~~lv 128 (344)
++|...+.||+|+||+||+|+. +++.||||++.+.. ....+.+.+|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5788899999999999999999 78899999986532 223345667777665 68999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccccc
Q 048160 129 FEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISI 208 (344)
Q Consensus 129 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~ 208 (344)
||||++|+|.+++.... .+++.++..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 82 mEy~~~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EeecCCCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhc
Confidence 99999999999997654 5889999999999999999999 999999999999999999999999999999866
Q ss_pred CCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccCCcc
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESNSFK 288 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (344)
...... .....||+.|+|||++.+..|+.++|||||||++|+|++|..||..... ........ ..
T Consensus 154 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~----~~~~~~i~-----~~--- 218 (320)
T d1xjda_ 154 MLGDAK---TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE----EELFHSIR-----MD--- 218 (320)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH-----HC---
T ss_pred cccccc---ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH----HHHHHHHH-----cC---
Confidence 543322 2245799999999999999999999999999999999999999965321 11111111 00
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 048160 289 EIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMV-QVA 334 (344)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-ei~ 334 (344)
.+..|. ..+.++.+|+.+||+.||++|||+. +|+
T Consensus 219 ----------~~~~p~--~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 219 ----------NPFYPR--WLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp ----------CCCCCT--TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ----------CCCCCc--cCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 111111 3345689999999999999999985 664
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=362.77 Aligned_cols=267 Identities=16% Similarity=0.209 Sum_probs=199.0
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
++|+..+.||+|+||+||+|+. +++.||||++...... ..+.+.+|+.++++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5799999999999999999998 6889999999655332 34678899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
|+.+ ++.+++..... ..+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+|++|||+|+....
T Consensus 82 ~~~~-~~~~~~~~~~~---~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASAL---TGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp CCSE-EHHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ecCC-chhhhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccC
Confidence 9975 44444432221 35899999999999999999999 99999999999999999999999999999987654
Q ss_pred CCcccccCCccccccccccccccCcCC-CCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC--Cc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTAN-CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN--SF 287 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 287 (344)
.... .....||+.|+|||++.... ++.++|||||||++|+|++|+.||..... ...+........... ..
T Consensus 155 ~~~~---~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~ 227 (298)
T d1gz8a_ 155 PVRT---YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE----IDQLFRIFRTLGTPDEVVW 227 (298)
T ss_dssp CSBC---TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCTTTS
T ss_pred Cccc---ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH----HHHHHHHHHhcCCCchhhc
Confidence 3322 22457899999999987766 47899999999999999999999965321 122222222111110 00
Q ss_pred ccccc-cccccCCCCCh--h----hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 288 KEIVD-PIIVGEEGLWP--E----KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 288 ~~~~~-~~~~~~~~~~~--~----~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..... .......+.+. . ....+.++.+|+.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00000 00000000000 0 0123356899999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-51 Score=359.37 Aligned_cols=238 Identities=18% Similarity=0.269 Sum_probs=194.2
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc------hhhhHhhHHHHHhcCC--CCceeeeeeEEeeCCc
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS------EEYCCFNCIAFASQMS--HKNILKFVGCCLETEL 124 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~~~~~~~~~~~ 124 (344)
++|++.+.||+|+||+||+|+. ++..||||++...... ....+.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5688899999999999999998 6889999998754221 1234679999999997 8999999999999999
Q ss_pred cEEEEeecCC-CCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecC-CcceEeee
Q 048160 125 PILVFEFVAC-GTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQ-NVAKFFDF 202 (344)
Q Consensus 125 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~df 202 (344)
.++||||+.+ +++.+++.... .+++.++..++.|++.||.||| +.+|+||||||+|||++.+ +.+||+||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEEeccCcchHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECcc
Confidence 9999999975 57777776543 5899999999999999999999 9999999999999999854 79999999
Q ss_pred ecccccCCCCcccccCCccccccccccccccCcCCC-CcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHH
Q 048160 203 CVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANC-NEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS 281 (344)
Q Consensus 203 g~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 281 (344)
|+|+....... ....||+.|+|||++.+..+ +.++|||||||++|||++|..||.... ....
T Consensus 156 G~a~~~~~~~~-----~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------~i~~-- 218 (273)
T d1xwsa_ 156 GSGALLKDTVY-----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIR-- 218 (273)
T ss_dssp TTCEECCSSCB-----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHH--
T ss_pred ccceecccccc-----cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------HHhh--
Confidence 99986543321 24679999999999987765 577999999999999999999986421 0110
Q ss_pred hccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 282 IESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
. .. .++. ..+.++.+|+.+||+.||++|||+.|+++
T Consensus 219 --~-~~-------------~~~~--~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 219 --G-QV-------------FFRQ--RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp --C-CC-------------CCSS--CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --c-cc-------------CCCC--CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 00 0000 23456899999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.4e-49 Score=353.45 Aligned_cols=266 Identities=19% Similarity=0.200 Sum_probs=199.8
Q ss_pred cCCCCCCccccCCCceEEEEEE-CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEee
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFEF 131 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 131 (344)
++|...+.||+|+||+||+|++ +++.||||++...... ..+.+.+|+.+|++++|||||++++++..++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5688889999999999999998 6789999999765332 246788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCCC
Q 048160 132 VACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPEG 211 (344)
Q Consensus 132 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~~ 211 (344)
+.++.+..+....+ .+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+|++|||.+......
T Consensus 82 ~~~~~~~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHHhhcC-----CcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 98776666665443 6999999999999999999999 999999999999999999999999999999876543
Q ss_pred CcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC--Ccc
Q 048160 212 KTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN--SFK 288 (344)
Q Consensus 212 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 288 (344)
... .....+++.|+|||.+.+. .++.++|||||||++|||++|+.||..... ...+........... ...
T Consensus 154 ~~~---~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~ 226 (286)
T d1ob3a_ 154 VRK---YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE----ADQLMRIFRILGTPNSKNWP 226 (286)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCTTTST
T ss_pred ccc---cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH----HHHHHHHHHhhCCCChhhcc
Confidence 322 1244689999999998764 568999999999999999999999965321 222222221111100 000
Q ss_pred ---cc---cccccccCCCCChh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 289 ---EI---VDPIIVGEEGLWPE-KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 289 ---~~---~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.. ...........++. ....++.+.+|+.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000000101111 1123456899999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=357.44 Aligned_cols=267 Identities=17% Similarity=0.200 Sum_probs=197.0
Q ss_pred hcCCCCCCccccCCCceEEEEEE--C-CccEEEEEecCCCCc--hhhhHhhHHHHHhcC---CCCceeeeeeEEee----
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--Q-DRPISVMKFGGNLNS--EEYCCFNCIAFASQM---SHKNILKFVGCCLE---- 121 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~-~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l---~H~niv~~~~~~~~---- 121 (344)
.++|++.+.||+|+||+||+|++ + ++.||||++...... ....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46799999999999999999998 2 557999998654322 234566888887776 79999999999863
Q ss_pred -CCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEe
Q 048160 122 -TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFF 200 (344)
Q Consensus 122 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 200 (344)
....+++|||+.++++........ ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCceEEEEEEeccCCchhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeec
Confidence 346799999998876655444333 35889999999999999999999 9999999999999999999999999
Q ss_pred eeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHH
Q 048160 201 DFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK 280 (344)
Q Consensus 201 dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 280 (344)
|||+++...... ......||+.|+|||++.+..|+.++||||+||++|||++|..||.... ....+......
T Consensus 159 dfg~~~~~~~~~----~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~ 230 (305)
T d1blxa_ 159 DFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS----DVDQLGKILDV 230 (305)
T ss_dssp SCCSCCCCCGGG----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHH
T ss_pred chhhhhhhcccc----cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC----HHHHHHHHHHh
Confidence 999987654322 2225689999999999999999999999999999999999999996542 12222222221
Q ss_pred HhccCC--ccc---ccccc-cccCCCCCh-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 281 SIESNS--FKE---IVDPI-IVGEEGLWP-EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 281 ~~~~~~--~~~---~~~~~-~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
...... +.. ..... ........+ .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 111100 000 00000 000000000 01123456889999999999999999999975
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.6e-48 Score=343.12 Aligned_cols=264 Identities=13% Similarity=0.149 Sum_probs=209.1
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCC-CceeeeeeEEeeCCccEEEEe
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSH-KNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~~~~~~~~~~~~~lv~e 130 (344)
.++|.+.+.||+|+||+||+|++ +++.||||.+.... ..+.+.+|++.++.++| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 46799999999999999999998 68899999876543 34567789999999975 899999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeec-----CCcceEeeeecc
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQE-----QNVAKFFDFCVS 205 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~dfg~a 205 (344)
|+ +++|.+++...+ ..++..++..++.|++.||.||| +.+|+||||||+|||++. ++.++++|||+|
T Consensus 82 ~~-~~~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ec-CCCHHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEccccee
Confidence 99 689999887654 36899999999999999999999 999999999999999974 568999999999
Q ss_pred cccCCCCcc----cccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHH
Q 048160 206 ISIPEGKTH----VNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKS 281 (344)
Q Consensus 206 ~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 281 (344)
+........ ........||+.|+|||++.+..++.++||||||+++|||++|..||.......... .... +...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~-~~~~-i~~~ 231 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-KYER-IGEK 231 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-HHHH-HHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH-HHHH-HHhc
Confidence 876543211 112234679999999999999999999999999999999999999997543322211 1111 1111
Q ss_pred hccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 048160 282 IESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHKS 343 (344)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~~ 343 (344)
.......++. ..+++++.+++..||+.+|++||+++.+.+.|.++.+.
T Consensus 232 ~~~~~~~~l~--------------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 232 KQSTPLRELC--------------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp HHHSCHHHHT--------------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cCCCChHHhc--------------CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 1111111110 12345689999999999999999999999999887653
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-48 Score=345.66 Aligned_cols=263 Identities=17% Similarity=0.222 Sum_probs=200.1
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCcee-eeeeEEeeCCccEEEEe
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNIL-KFVGCCLETELPILVFE 130 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~~~~~~~~~~~~~lv~e 130 (344)
.+.|+..+.||+|+||+||+|++ +++.||||.+.... ..+.+.+|+++++.++|+|++ .+.++..+++..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 35699999999999999999998 68899999877653 345688999999999876655 44555677788999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEee---cCCcceEeeeecccc
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQ---EQNVAKFFDFCVSIS 207 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~dfg~a~~ 207 (344)
|+ +++|.+.+.... ..+++.++..++.|++.||+||| +.+|+||||||+|||++ .+..++++|||+|+.
T Consensus 84 ~~-~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred Ec-CCchhhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 99 467777665443 36899999999999999999999 99999999999999975 455799999999998
Q ss_pred cCCCCccc----ccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhc
Q 048160 208 IPEGKTHV----NDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE 283 (344)
Q Consensus 208 ~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (344)
........ .......||+.|+|||++.+..++.++|||||||++|||++|..||.......... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~-~~~~~~~~~~~ 234 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYERISEKKMS 234 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHH
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH-HHHHhhcccCC
Confidence 75433221 12235679999999999999999999999999999999999999997543221111 11111111000
Q ss_pred cCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 048160 284 SNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAKQLRQLHK 342 (344)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~~L~~l~~ 342 (344)
...... ...++.++.+|+..||+.||++||++.+|.+.|+.+..
T Consensus 235 -~~~~~~--------------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 235 -TPIEVL--------------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp -SCHHHH--------------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred -CChhHh--------------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 000000 01344568999999999999999999999998887753
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=353.29 Aligned_cols=268 Identities=16% Similarity=0.192 Sum_probs=196.9
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC-chhhhHhhHHHHHhcCCCCceeeeeeEEeeCC----ccE
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN-SEEYCCFNCIAFASQMSHKNILKFVGCCLETE----LPI 126 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~----~~~ 126 (344)
+++|+..+.||+|+||+||+|+. +++.||||++..... ...+.+++|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35688899999999999999998 688999999975533 33466889999999999999999999997654 235
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
++++|+.+|+|.+++... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++.
T Consensus 87 ~l~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp EEEEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 556667789999999753 4899999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC
Q 048160 207 SIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN 285 (344)
Q Consensus 207 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (344)
................||+.|+|||++.. ..++.++||||+||++|+|++|+.||...... ........ .....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~----~~~~~~~~-~~~~~ 232 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL----DQLNHILG-ILGSP 232 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHH-HHCSC
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH----HHHHHHhh-hccCC
Confidence 76544333333345679999999999854 56789999999999999999999999654221 11111111 00000
Q ss_pred Ccccc-----------cccccccCCCCChh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 286 SFKEI-----------VDPIIVGEEGLWPE-KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 286 ~~~~~-----------~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..... ...........+.. .+..+.++.+|+.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 00000000000000 0122346889999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.9e-48 Score=348.68 Aligned_cols=263 Identities=16% Similarity=0.195 Sum_probs=198.9
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCC-CCceeeeeeEEeeC--CccEEEE
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCCLET--ELPILVF 129 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~--~~~~lv~ 129 (344)
++|++.+.||+|+||+||+|+. +++.||||+++.. ..+.+.+|+.+|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999998 6889999998754 3567889999999996 99999999998743 5689999
Q ss_pred eecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC-cceEeeeeccccc
Q 048160 130 EFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN-VAKFFDFCVSISI 208 (344)
Q Consensus 130 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~dfg~a~~~ 208 (344)
|||.+++|..+.+ .+++.++..++.||+.||.||| +.+|+||||||+|||++.++ .++++|||+|+..
T Consensus 112 e~~~~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 112 EHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp ECCCSCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred eecCCCcHHHHhc--------CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceec
Confidence 9999999987642 4889999999999999999999 99999999999999999765 6899999999876
Q ss_pred CCCCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHH-----Hh
Q 048160 209 PEGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRK-----SI 282 (344)
Q Consensus 209 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~ 282 (344)
...... ....+|+.|+|||.+.+. .++.++||||+||++|++++|+.||................... ..
T Consensus 181 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 181 HPGQEY----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp CTTCCC----CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred cCCCcc----cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhh
Confidence 544322 245789999999998765 47999999999999999999999997654322211111111100 00
Q ss_pred ccCC------ccccccccccc---CCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ESNS------FKEIVDPIIVG---EEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ~~~~------~~~~~~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... ........... .....+.....+.++.+|+.+||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00000000000 00111111234567899999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=345.01 Aligned_cols=267 Identities=15% Similarity=0.174 Sum_probs=205.3
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEeeCCccEEEEe
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 130 (344)
+.|+..+.||+|+||+||+|++ +++.||||+++.... .....+.+|+.++++++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4688899999999999999998 678899999865533 234678899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeecccccCC
Q 048160 131 FVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSISIPE 210 (344)
Q Consensus 131 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~~~~~ 210 (344)
++.+++|..++...+ .+++..+..++.|++.||+||| ..+|+||||||+|||++.++.+|++|||.++....
T Consensus 82 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecccccccccccccc-----ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccC
Confidence 999999888876654 5889999999999999999999 99999999999999999999999999999987754
Q ss_pred CCcccccCCccccccccccccccCcCC-CCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhccC--Cc
Q 048160 211 GKTHVNDNNKVIGTFGFIAPEYMSTAN-CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIESN--SF 287 (344)
Q Consensus 211 ~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 287 (344)
..... ....++..|+|||++.... ++.++|||||||++|||++|+.||+..... ............... ..
T Consensus 154 ~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 154 PVRCY---SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV---DDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp CCSCC---CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH---HHHHHHHHHHHCCCCTTTC
T ss_pred CCccc---eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH---HHHHHHHHhhcCCCChhhh
Confidence 43222 1345678899999987765 689999999999999999999998764331 112222211111110 00
Q ss_pred cccc-------ccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 288 KEIV-------DPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 288 ~~~~-------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
.... .................++.+.+|+.+||++||++|||++||++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00000011111111234456899999999999999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=345.38 Aligned_cols=270 Identities=16% Similarity=0.180 Sum_probs=195.1
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCC--chhhhHhhHHHHHhcCCCCceeeeeeEEee--------
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLN--SEEYCCFNCIAFASQMSHKNILKFVGCCLE-------- 121 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-------- 121 (344)
.++|++.+.||+|+||+||+|++ +++.||||++..... .....+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36789999999999999999998 688999999865422 334668899999999999999999999865
Q ss_pred CCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEee
Q 048160 122 TELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFD 201 (344)
Q Consensus 122 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~d 201 (344)
....++||||+.++.+....... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+|++|
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~-----~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECC
T ss_pred CceEEEEEeccCCCccchhhhcc-----cccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeee
Confidence 34578999999877666554443 25888999999999999999999 99999999999999999999999999
Q ss_pred eecccccCCCCcc-cccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHH
Q 048160 202 FCVSISIPEGKTH-VNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVR 279 (344)
Q Consensus 202 fg~a~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 279 (344)
||+++........ ........||+.|+|||++.+. .+++++|||||||++|||++|+.||..... ...+.....
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~----~~~~~~i~~ 236 (318)
T d3blha1 161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE----QHQLALISQ 236 (318)
T ss_dssp CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHH
T ss_pred cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH----HHHHHHHHH
Confidence 9999876543221 1222245789999999998765 689999999999999999999999865321 111111111
Q ss_pred HHhcc--CCccccc-----ccccccCCCCChhh-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 280 KSIES--NSFKEIV-----DPIIVGEEGLWPEK-----EKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 280 ~~~~~--~~~~~~~-----~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
..... ....... ...........+.. ......+.+|+.+||++||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 11110 0000000 00000000111111 012346789999999999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=349.30 Aligned_cols=251 Identities=18% Similarity=0.217 Sum_probs=200.5
Q ss_pred cCCCCCCccccCCCceEEEEEE-----CCccEEEEEecCCCC----chhhhHhhHHHHHhcCCC-CceeeeeeEEeeCCc
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL-----QDRPISVMKFGGNLN----SEEYCCFNCIAFASQMSH-KNILKFVGCCLETEL 124 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~vavk~~~~~~~----~~~~~~~~E~~~l~~l~H-~niv~~~~~~~~~~~ 124 (344)
++|+..+.||+|+||+||+|+. +|+.||||.+..... ...+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999987 367899999865421 234567899999999976 899999999999999
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeec
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV 204 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~ 204 (344)
.++||||+.+|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eeeeeecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccc
Confidence 999999999999999997654 5778899999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCcccccCCccccccccccccccCcC--CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 205 SISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA--NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 205 a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
++......... .....|++.|+|||.+.+. .++.++|||||||++|+|++|+.||................ .
T Consensus 176 a~~~~~~~~~~--~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~----~ 249 (322)
T d1vzoa_ 176 SKEFVADETER--AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI----L 249 (322)
T ss_dssp EEECCGGGGGG--GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH----H
T ss_pred hhhhccccccc--ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc----c
Confidence 98765433222 2256789999999998764 46789999999999999999999997654322222211111 1
Q ss_pred ccCCcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 048160 283 ESNSFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPT-----MVQVAK 335 (344)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ei~~ 335 (344)
... ...|. ..+.++.+|+.+||++||++||| ++|+++
T Consensus 250 ~~~--------------~~~~~--~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 KSE--------------PPYPQ--EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HCC--------------CCCCT--TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred cCC--------------CCCcc--cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 110 00111 34557899999999999999994 788875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-48 Score=350.93 Aligned_cols=257 Identities=20% Similarity=0.230 Sum_probs=190.3
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCceeeeeeEEeeC------CccEE
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNILKFVGCCLET------ELPIL 127 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~------~~~~l 127 (344)
+|+..++||+|+||+||+|++ +++.||||++.... ....+|+.+|++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 477788999999999999999 68899999987653 2345799999999999999999998643 24689
Q ss_pred EEeecCCCCccccc---cCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC-cceEeeee
Q 048160 128 VFEFVACGTLADRI---HDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN-VAKFFDFC 203 (344)
Q Consensus 128 v~e~~~~gsL~~~l---~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~dfg 203 (344)
|||||+++.+..+. ... ..+++.++..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~-----~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG 168 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAK-----QTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFG 168 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred EEeccCCccHHHHHhhhhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEeccc
Confidence 99999865433332 222 36899999999999999999999 99999999999999999775 89999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCc-CCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMST-ANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
++......... ....||+.|+|||.+.+ ..++.++||||+||++|||++|..||..... ...+...+....
T Consensus 169 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~----~~~l~~i~~~~g 240 (350)
T d1q5ka_ 169 SAKQLVRGEPN----VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQLVEIIKVLG 240 (350)
T ss_dssp TCEECCTTSCC----CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH----HHHHHHHHHHHC
T ss_pred chhhccCCccc----ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH----HHHHHHHHHHhC
Confidence 99876543322 24578999999998765 5689999999999999999999999965422 111222211100
Q ss_pred ----------ccCCcccccccccccCCCCCh--hhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ----------ESNSFKEIVDPIIVGEEGLWP--EKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ----------~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
........+... ....+. .....++++.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 241 TPTREQIREMNPNYTEFKFPQI---KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CCCHHHHHHHCC---CCCCCCC---CCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CChHHhhhhhccchhhcccccc---ccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000 000000 00123456899999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-48 Score=351.52 Aligned_cols=262 Identities=16% Similarity=0.191 Sum_probs=191.6
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeCC------
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLETE------ 123 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------ 123 (344)
.+.|+..+.||+|+||+||+|.. +++.||||++...... ..+.+.+|+.+|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46788899999999999999998 6889999999765332 2456789999999999999999999997654
Q ss_pred ccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeee
Q 048160 124 LPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFC 203 (344)
Q Consensus 124 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg 203 (344)
..|+||||| +.+|..+++.. .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+|++|||
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccccc
Confidence 469999999 56777776542 5899999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCcccccCCccccccccccccccCcC-CCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh
Q 048160 204 VSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTA-NCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI 282 (344)
Q Consensus 204 ~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 282 (344)
+|+...... ....||+.|+|||++.+. .++.++||||+||++|+|++|+.||..... ...+........
T Consensus 167 ~a~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~----~~~~~~~~~~~~ 236 (346)
T d1cm8a_ 167 LARQADSEM------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH----LDQLKEIMKVTG 236 (346)
T ss_dssp TCEECCSSC------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHC
T ss_pred ceeccCCcc------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh----HHHHHHHHhccC
Confidence 998764322 245789999999998764 568999999999999999999999865421 111111111100
Q ss_pred ccC-------Cccc---ccccccccCCCCChh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ESN-------SFKE---IVDPIIVGEEGLWPE-KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ~~~-------~~~~---~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
... .... ............++. ....++.+.+|+.+||+.||++|||+.||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 0000 000000000000000 0123456789999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=344.35 Aligned_cols=260 Identities=17% Similarity=0.212 Sum_probs=189.7
Q ss_pred cCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEee------CCc
Q 048160 55 NNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLE------TEL 124 (344)
Q Consensus 55 ~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~------~~~ 124 (344)
+.|++.+.||+|+||+||+|++ +|+.||||++...... ....+.+|+.++++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 5688899999999999999998 6899999999765432 23557899999999999999999999864 357
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeec
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV 204 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~ 204 (344)
.|+|||||.++ +.+.+.. .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++++|||+
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~-------~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eEEEEeccchH-HHHhhhc-------CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhh
Confidence 89999999755 4444432 4789999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHh--
Q 048160 205 SISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSI-- 282 (344)
Q Consensus 205 a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 282 (344)
++........ ....+|+.|+|||++.+..+++++||||+||++++|++|+.||..... .......+....
T Consensus 166 ~~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~----~~~~~~i~~~~~~~ 237 (355)
T d2b1pa1 166 ARTAGTSFMM----TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY----IDQWNKVIEQLGTP 237 (355)
T ss_dssp -------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCC
T ss_pred hhcccccccc----ccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH----HHHHHHHHHhccCC
Confidence 8766543322 245789999999999999999999999999999999999999864321 111111111100
Q ss_pred ----------------ccC------CcccccccccccCCCCChhhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 283 ----------------ESN------SFKEIVDPIIVGEEGLWPEKEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 283 ----------------~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
... .....+.... ...........+.++.+|+.+||+.||++|||++||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL--FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp CHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGG--SCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHhhhhHHHHhhcCcccccccccccccccc--ccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 0000010000 11112223356778999999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=340.31 Aligned_cols=263 Identities=17% Similarity=0.219 Sum_probs=194.0
Q ss_pred hcCCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCc--hhhhHhhHHHHHhcCCCCceeeeeeEEeeC-----Cc
Q 048160 54 TNNYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNS--EEYCCFNCIAFASQMSHKNILKFVGCCLET-----EL 124 (344)
Q Consensus 54 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----~~ 124 (344)
.+.|+..+.||+|+||+||+|+. +++.||||++...... ..+.+.+|+.++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999998 6899999999765432 335678999999999999999999998643 23
Q ss_pred cEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceEeeeec
Q 048160 125 PILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKFFDFCV 204 (344)
Q Consensus 125 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~ 204 (344)
.+++++|+.+|+|.+++... .+++.++..++.|++.||.||| +++|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred eEEEEEeecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccch
Confidence 46677888899999999653 5899999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCcccccCCccccccccccccccCcCC-CCcccchHHHHHHHHHHHcCCCCCCCCCccCcchhHHHHHHHHHhc
Q 048160 205 SISIPEGKTHVNDNNKVIGTFGFIAPEYMSTAN-CNEKSDVYSFGALLLELLTGKRISYSSCFENGEEYFLQELVRKSIE 283 (344)
Q Consensus 205 a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 283 (344)
+...... .....|++.|+|||.+.+.. ++.++|||||||++|+|++|..||..... .............
T Consensus 168 a~~~~~~------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~----~~~~~~i~~~~~~ 237 (348)
T d2gfsa1 168 ARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH----IDQLKLILRLVGT 237 (348)
T ss_dssp --CCTGG------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCC
T ss_pred hcccCcc------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCC
Confidence 8755322 12457899999999876654 68999999999999999999999975422 1111111111110
Q ss_pred cCC-----c-----ccccccccccCCCCChh-hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 048160 284 SNS-----F-----KEIVDPIIVGEEGLWPE-KEKQLLSYTELAIKCLSKSEQDRPTMVQVAK 335 (344)
Q Consensus 284 ~~~-----~-----~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ei~~ 335 (344)
... . ..............+.. ....+.++.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000 0 00000000000000000 0123456899999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-40 Score=303.52 Aligned_cols=268 Identities=14% Similarity=0.124 Sum_probs=186.5
Q ss_pred CCCCCCccccCCCceEEEEEE--CCccEEEEEecCCCCchhhhHhhHHHHHhcCC-----------CCceeeeeeEEeeC
Q 048160 56 NYDPEKVITKDLLYKLYKGFL--QDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-----------HKNILKFVGCCLET 122 (344)
Q Consensus 56 ~~~~~~~ig~G~~g~V~~~~~--~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~~~~~~~~~ 122 (344)
.|++.+.||+|+||+||+|+. +|+.||||+++.+. ...+.+.+|+.+++.++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 388899999999999999998 78999999997653 23456778999888875 57899999987643
Q ss_pred --CccEEEEeecCCCCcccc-ccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCC----
Q 048160 123 --ELPILVFEFVACGTLADR-IHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQN---- 195 (344)
Q Consensus 123 --~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---- 195 (344)
...+++++++..+..... ...... ..+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTT
T ss_pred cccceeeeeeecccccccccccccccc---cCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccc
Confidence 456677777654433222 211111 368889999999999999999993 38999999999999998765
Q ss_pred --cceEeeeecccccCCCCcccccCCccccccccccccccCcCCCCcccchHHHHHHHHHHHcCCCCCCCCCccCcc--h
Q 048160 196 --VAKFFDFCVSISIPEGKTHVNDNNKVIGTFGFIAPEYMSTANCNEKSDVYSFGALLLELLTGKRISYSSCFENGE--E 271 (344)
Q Consensus 196 --~~kl~dfg~a~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~ 271 (344)
.++++|||.+....... ....||+.|+|||++....++.++||||+||++++|++|+.||......... .
T Consensus 168 ~~~~kl~dfg~s~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEHY------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp EEEEEECCCTTCEETTBCC------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cceeeEeeccccccccccc------ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 38999999987654322 2457899999999999999999999999999999999999998754321111 1
Q ss_pred hHHHHHHHHHhc--------cCCcccccc------cccccCCC--------CChhhHHHHHHHHHHHHHccccCCCCCCC
Q 048160 272 YFLQELVRKSIE--------SNSFKEIVD------PIIVGEEG--------LWPEKEKQLLSYTELAIKCLSKSEQDRPT 329 (344)
Q Consensus 272 ~~~~~~~~~~~~--------~~~~~~~~~------~~~~~~~~--------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 329 (344)
..+...+..... .......++ ........ ........+..+.+|+.+||++||.+|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 111111111000 000000000 00000000 01112356678999999999999999999
Q ss_pred HHHHHH
Q 048160 330 MVQVAK 335 (344)
Q Consensus 330 ~~ei~~ 335 (344)
++|+++
T Consensus 322 a~e~L~ 327 (362)
T d1q8ya_ 322 AGGLVN 327 (362)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 999975
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=2.5e-25 Score=184.44 Aligned_cols=161 Identities=15% Similarity=0.097 Sum_probs=117.4
Q ss_pred CCCccccCCCceEEEEEE-CCccEEEEEecCCCCc------------------hhhhHhhHHHHHhcCCCCceeeeeeEE
Q 048160 59 PEKVITKDLLYKLYKGFL-QDRPISVMKFGGNLNS------------------EEYCCFNCIAFASQMSHKNILKFVGCC 119 (344)
Q Consensus 59 ~~~~ig~G~~g~V~~~~~-~~~~vavk~~~~~~~~------------------~~~~~~~E~~~l~~l~H~niv~~~~~~ 119 (344)
+.+.||+|+||+||+|+. +|+.||||.+...... ......+|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 457899999999999998 7899999987533111 012234688899999999999988653
Q ss_pred eeCCccEEEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecccccceEeecCCcceE
Q 048160 120 LETELPILVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVGFSRPIVFRDIKPSTILFQEQNVAKF 199 (344)
Q Consensus 120 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 199 (344)
..+++|||+++..+.+ ++...+..++.|++.||.||| ..+|+||||||+|||++.+ .+++
T Consensus 84 ----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp ----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEE
T ss_pred ----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEE
Confidence 2479999998765533 233345678999999999999 9999999999999999865 4899
Q ss_pred eeeecccccCCCCcccccCCcccccccccc------ccccCcCCCCcccchHHHHHHH
Q 048160 200 FDFCVSISIPEGKTHVNDNNKVIGTFGFIA------PEYMSTANCNEKSDVYSFGALL 251 (344)
Q Consensus 200 ~dfg~a~~~~~~~~~~~~~~~~~g~~~y~a------PE~~~~~~~~~~~Di~slG~il 251 (344)
+|||.|......... .|.. .+.+ ...|+.++|+||..--+
T Consensus 144 iDFG~a~~~~~~~~~-----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWR-----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHH-----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcH-----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 999998765432211 1111 1111 34578899999986544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.76 E-value=1.1e-08 Score=87.01 Aligned_cols=149 Identities=15% Similarity=0.068 Sum_probs=102.3
Q ss_pred HHHHHHhcCCCCCCccccCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCC-CCceeeeeeEEeeCCccE
Q 048160 48 QELKAATNNYDPEKVITKDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCCLETELPI 126 (344)
Q Consensus 48 ~~i~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~ 126 (344)
.|+.....+|+..+..+-++.+.||+...+++.+++|+...........+.+|+.++..+. +--+++++.+...++..+
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3555555666655544334456899998888889999887665445556778998888774 444788888888888899
Q ss_pred EEEeecCCCCccccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhcC--------------------------------
Q 048160 127 LVFEFVACGTLADRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHVG-------------------------------- 174 (344)
Q Consensus 127 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------------------------------- 174 (344)
+||++.+|.++.+...... ....++.+++..+..||..
T Consensus 87 lv~~~l~G~~~~~~~~~~~----------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDEQ----------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEECCSSEEHHHHTTTCS----------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEecccccccccccccc----------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 9999999877755432211 1122344455555555520
Q ss_pred ------------------------CCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 175 ------------------------FSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 175 ------------------------~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
....++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 02347899999999999987777799997763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.16 E-value=4.2e-06 Score=69.98 Aligned_cols=128 Identities=15% Similarity=0.006 Sum_probs=82.2
Q ss_pred cccCCC-ceEEEEEECCc-cEEEEEecCCCCchhhhHhhHHHHHhcCC--CCceeeeeeEEeeCCccEEEEeecCCCCcc
Q 048160 63 ITKDLL-YKLYKGFLQDR-PISVMKFGGNLNSEEYCCFNCIAFASQMS--HKNILKFVGCCLETELPILVFEFVACGTLA 138 (344)
Q Consensus 63 ig~G~~-g~V~~~~~~~~-~vavk~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 138 (344)
+..|.. +.||+...++. .+++|...... ...+.+|+..++.+. .-.+++++++..+++..++||++++|.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 444443 57899988554 56777654442 334667888887774 334678888888888899999999876654
Q ss_pred ccccCCCCCCCccccHHHHHHHHHHHHHHHHHhhc---------------------------------------------
Q 048160 139 DRIHDPNGSQLEPFLMKHRLKVAMEIANAVAYLHV--------------------------------------------- 173 (344)
Q Consensus 139 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--------------------------------------------- 173 (344)
+.. .... ..+.++...|.-||.
T Consensus 95 ~~~----------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 95 SSH----------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TSC----------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred ccc----------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 321 1111 112223333333331
Q ss_pred ----------CCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 174 ----------GFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 174 ----------~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
.....++|+|+.|.||+++.+..+.|+||+.+.
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 012347999999999999987777899997663
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.55 E-value=0.00029 Score=62.58 Aligned_cols=74 Identities=11% Similarity=-0.009 Sum_probs=48.7
Q ss_pred CccccCCCceEEEEEE--CCccEEEEEecCC-------CCchhhhHhhHHHHHhcCC---CCceeeeeeEEeeCCccEEE
Q 048160 61 KVITKDLLYKLYKGFL--QDRPISVMKFGGN-------LNSEEYCCFNCIAFASQMS---HKNILKFVGCCLETELPILV 128 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~--~~~~vavk~~~~~-------~~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~~~lv 128 (344)
+.||.|....||+... .++.|+||.-... .....+....|...+..+. ...+++++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 3588899999999987 4568999974321 1112234556888777663 2457777765 45567899
Q ss_pred EeecCCCC
Q 048160 129 FEFVACGT 136 (344)
Q Consensus 129 ~e~~~~gs 136 (344)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997644
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.04 E-value=0.002 Score=54.96 Aligned_cols=160 Identities=11% Similarity=0.102 Sum_probs=85.3
Q ss_pred ccHHHHHHHhcCCCCCCccc-----cCCCceEEEEEECCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCce--eeeee
Q 048160 45 FTAQELKAATNNYDPEKVIT-----KDLLYKLYKGFLQDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNI--LKFVG 117 (344)
Q Consensus 45 ~~~~~i~~~~~~~~~~~~ig-----~G~~g~V~~~~~~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~~~~ 117 (344)
.+.+|+.....+|...+... .|---+.|..+.+++.+++|++.... ..+.+..|+.++..|...++ +..+.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 56788888888888755543 45456789999977889999986542 23445567777777743222 11111
Q ss_pred ------EEeeCCccEEEEeecCCCCcccccc------------------CCCCCCCccccH------------------H
Q 048160 118 ------CCLETELPILVFEFVACGTLADRIH------------------DPNGSQLEPFLM------------------K 155 (344)
Q Consensus 118 ------~~~~~~~~~lv~e~~~~gsL~~~l~------------------~~~~~~~~~l~~------------------~ 155 (344)
+..-......++.+..+......-. ............ .
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 1112334456666665433321000 000000000000 0
Q ss_pred HHHHHHHHHHHHHHHhh-cCCCCCeeeecccccceEeecCCcceEeeeeccc
Q 048160 156 HRLKVAMEIANAVAYLH-VGFSRPIVFRDIKPSTILFQEQNVAKFFDFCVSI 206 (344)
Q Consensus 156 ~~~~i~~~i~~~l~~LH-~~~~~~ivH~dlk~~Nill~~~~~~kl~dfg~a~ 206 (344)
.....+......+.-.. ..-..+++|+|+.++||+++.+...-++||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 01111222222222222 1125689999999999999998888899998763
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.93 E-value=0.01 Score=50.74 Aligned_cols=68 Identities=15% Similarity=0.049 Sum_probs=43.6
Q ss_pred ceEEEEEE-CCccEEEEEecCCCCchhhhHhhHHHHHhcCCCCcee--eeee-----EEeeCCccEEEEeecCCCCc
Q 048160 69 YKLYKGFL-QDRPISVMKFGGNLNSEEYCCFNCIAFASQMSHKNIL--KFVG-----CCLETELPILVFEFVACGTL 137 (344)
Q Consensus 69 g~V~~~~~-~~~~vavk~~~~~~~~~~~~~~~E~~~l~~l~H~niv--~~~~-----~~~~~~~~~lv~e~~~~gsL 137 (344)
-.||+++. +|..+++|....... ..+++..|...+..|...+|. ..+. ....+...+.++++.+|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 36999998 677899988765532 345677888888887532221 1111 12335567889999876443
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.92 E-value=0.012 Score=51.81 Aligned_cols=72 Identities=14% Similarity=0.056 Sum_probs=46.8
Q ss_pred CccccCCCceEEEEEECC---------ccEEEEEecCCCCchhhhHhhHHHHHhcCC-CCceeeeeeEEeeCCccEEEEe
Q 048160 61 KVITKDLLYKLYKGFLQD---------RPISVMKFGGNLNSEEYCCFNCIAFASQMS-HKNILKFVGCCLETELPILVFE 130 (344)
Q Consensus 61 ~~ig~G~~g~V~~~~~~~---------~~vavk~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e 130 (344)
+.|+-|-.=.+|++...+ ..|+++... ... ..-...+|..+++.+. +.-.+++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 457667777899998732 335555544 322 2234558888888885 4445688887753 58999
Q ss_pred ecCCCCcc
Q 048160 131 FVACGTLA 138 (344)
Q Consensus 131 ~~~~gsL~ 138 (344)
|++|.+|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99865543
|